{"originalText": "，患者3月前因“直腸癌”於在我院於全麻上行直腸癌根治術（DIXON術），手術過程順利，術後給予抗感染及營養支援治療，患者恢復好，切口癒合良好。，術後病理示：直腸腺癌（中低度分化），浸潤潰瘍型，面積3.5*2CM，侵達外膜。雙端切線另送“近端”、“遠端”及環周底部切除面未查見癌。腸壁一站（10個）、中間組（8個）淋巴結未查見癌。，免疫組化染色示：ERCC1瀰漫（+）、TS少部分弱（+）、SYN（-）、CGA（-）。術後查無化療禁忌後給予3週期化療，，方案為：奧沙利鉑150MG D1，亞葉酸鈣0.3G+替加氟1.0G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，患者副反應輕。院外期間患者一般情況好，無噁心，無腹痛腹脹脹不適，無現患者為行復查及化療再次來院就診，門診以“直腸癌術後”收入院。   近期患者精神可，飲食可，大便正常，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 11}, {"label_type": "手術", "overlap": 0, "start_pos": 21, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 159}, {"end_pos": 234, "label_type": "藥物", "overlap": 0, "start_pos": 230}, {"end_pos": 247, "label_type": "藥物", "overlap": 0, "start_pos": 243}, {"end_pos": 255, "label_type": "藥物", "overlap": 0, "start_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 315}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 347}]}
{"originalText": "，患者因罹患“胃癌”於2013-10-29在我院予行全麻上胃癌根治術，，術中見：腹腔內腹水，腹膜無轉移，肝臟未觸及明顯轉移性灶，腫瘤位於胃體、胃底部，小彎側偏後壁，約5*4*2CM大小，腫瘤已侵達漿膜外，第1、3組淋巴結腫大，腫瘤尚能活動，經探查決定行全胃切除，空腸J字代胃術。手術順利，術後積極予相關對症支援治療；，後病理示：胃底、體小彎側低分化腺癌，部分為印戒細胞癌影象，蕈傘型，面積5.2*3.5CM，區域性侵達粘膜上層，並於少數腺管內查見癌栓。雙端切線及另送“近端切線”未查見癌。呈三組（5/13個）淋巴結癌轉移。一組（7個）、四組（13個）、五組（1個）、六組（4個）淋巴結未查見癌。，癌組織免疫組化染色示：ERCC1（+）、β-TUBULIN-III（+）、TS（-）、RRM1（-）、TOPOII陽性細胞數約20%、CERBB-2（2+） 。依據患者病情及腫瘤病理與分期繼續術後輔助性化療指徵存在，患者及家屬拒絕化療。自術後出院以來，患者一般情況保持良好；無發熱，偶有噁心，無嘔吐，無反酸、噯氣，無明顯進食不適，偶有進食後輕微腹脹，無腹痛。現患者為行進一步複查並必要時適當處理而再來我院就診，門診依情以“胃惡性腫瘤術後”收入院。目前患者精神及情緒狀態良好，食慾較術前明顯減少，飲食可，夜間睡眠後；今8個月體重減輕18KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 9}, {"end_pos": 34, "label_type": "手術", "overlap": 0, "start_pos": 29}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"end_pos": 138, "label_type": "手術", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 164, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 291}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 474, "label_type": "解剖部位", "overlap": 0, "start_pos": 473}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 508, "end_pos": 515}]}
{"originalText": "，患者3月餘前於我院診斷為“直腸癌”，於2015-10-26在全麻上行腹腔鏡直腸癌根治術，，術後病理示：，201518502：（直腸）腺癌（中度分化），浸潤潰瘍型，體積2.7*2*0.8CM，侵達漿膜。 雙端切線及另送“近切線”、“遠切線”未查見癌。 腸壁一站（6個）、中間組（3個）、中央組（3個）淋巴結未查見癌。低級別腺管狀腺瘤。，免疫組化染色示：TS部分（+）、SYN（-）。，術後病理分期：PT3N0M0，II期，DUKES B。依情2015-11-08.2015-12-09給予奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1G D2-6 靜滴，同時輔以鎮吐、升血、免疫調節等對症支援治療。化療過程總體順利。現為複查化療來我院，門診以“直腸癌術後”收入院。目前患者精神好，食慾及飲食好，夜間睡眠良好，小便正常，大便4-5次/天，基本成形。否認近期明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 126, "end_pos": 153}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"end_pos": 248, "label_type": "藥物", "overlap": 0, "start_pos": 244}, {"end_pos": 261, "label_type": "藥物", "overlap": 0, "start_pos": 257}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 336}]}
{"originalText": "，患者因“結腸癌”於2012-12-13在我院於全麻上行右半結腸切15除術，手術過程順利，術後給予抗感染及營養支援治療，患者恢復好，切口癒合良好，，術後病理：13862.2012結腸腺癌（中度分化），潰瘍型，面積6.5*3.5，侵達漿膜脂肪組織。雙端切線未查見癌。結腸腺管狀腺瘤。呈腸壁一站（1/5個）淋巴結癌轉移。腸壁二站（3個）淋巴結未查見癌。，免疫組化染色示癌組織：ERCC1(+)、TS少數細胞（+）。（PT4AN1M0，IIIA，DUCKS C）。後患者恢復好出院，術後給予化療2週期。   院外期間患者一般情況好，無噁心，無腹痛腹脹脹不適，現患者為行復查及化療再次來院就診，門診以“結腸癌術後”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 37, "label_type": "手術", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 139}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 154}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 169}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 297, "end_pos": 302}]}
{"originalText": "，緣於入院前4月餘因中下腹部悶痛不適伴排黑便於我院就診，診斷為“胃癌”，於2014年06月06日在全麻上行“腹腔鏡輔助上根治性遠端胃大部切除術（ROUX-Y吻合術D2）”手術順利。術後病理（201417771），：“（遠端胃）胃體小彎早期（IIC型）低分化腺癌，部分為印戒細胞癌，侵及粘膜上層，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到小彎淋巴結5個，大彎淋巴結5個，幽門下淋巴結18個，幽門上淋巴結3個，及另送（第8P組）淋巴結2個，均未見癌轉移。另送（胃右動脈根部淋巴結）為脂肪、脈管及神經組織。，免疫組化結果：CK(L)（+++），CD68（組織細胞+），KI67（50%+）”，術後給予對症、抗感染治療，恢復良好,傷口癒合良好。分別於2014.07.16、2014.08.13、2014.09.17、2014.10.29予“奧沙利鉑（齊沙）150MGIVGTTD1+替吉奧膠囊（艾奕）40MGPOBIDD2-15”方案行術後第1、2、3、4週期化療，化療過程順利。今為第5週期化療再次入院。自下次出院後飲食、睡眠可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"end_pos": 71, "label_type": "手術", "overlap": 0, "start_pos": 54}, {"end_pos": 83, "label_type": "手術", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 139}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 375, "label_type": "藥物", "overlap": 0, "start_pos": 371}, {"end_pos": 378, "label_type": "藥物", "overlap": 0, "start_pos": 376}, {"end_pos": 397, "label_type": "藥物", "overlap": 0, "start_pos": 392}, {"end_pos": 400, "label_type": "藥物", "overlap": 0, "start_pos": 398}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 468}, {"end_pos": 472, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}]}
{"originalText": "，緣於入院前5月餘因“反覆返酸、噯氣7年”就診我院，，行胃鏡檢查示：“1.胃竇癌2.慢性萎縮性胃炎”，，病理示：“胃管狀腺癌II-III級”，下腹部平掃+，增強示：“胃腫瘤，伴腹腔、腹膜後多發淋巴結腫大”，考慮腫瘤區域性較晚期，遂於2015.04.18、2015.05.11、2015.06.02、2015.06.29、2015.08.02予“安素泰210MGIVGTTD1+奧沙利鉑（艾恆）150MGIVGTTD2+希羅達1000MGBIDPOD1-14”方案新輔助化療，輔以止吐、制酸、保胃、保肝、營養支援等治療。化療後未見明顯骨髓抑制，一般情況尚可。並於入院前1月餘（2015.09.01）全麻上行“腹腔鏡上根治性遠端胃大部切除術”。術順，術後恢復可，，術後病理：(遠端胃)，：胃體及胃竇小彎側早期隆起型（0-I型）低黏附性癌，印戒細胞癌為主，部分為低分化腺癌及未分化癌，浸潤脈管及神經組織，脈管內見癌栓，侵及黏膜上層。標本下切端、上切端及另送(下切端)，均未見癌浸潤。找到小彎側淋巴結0/13個，大彎側淋巴結2/10個，幽門下淋巴結1/4個，幽門上淋巴結5/6個，另送(胃右動脈根部）淋巴結2/8個，(胃壁)淋巴結0/4個，見癌轉移。，免疫組化染色結果：CK(PAN)（+++），E-CADHERIN（+++），CDX-2（+++），CGA（+），CD56（-），SY（-），HER-2（-）。門診擬“胃竇術後化療”收入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 99}, {"end_pos": 174, "label_type": "藥物", "overlap": 0, "start_pos": 171}, {"end_pos": 191, "label_type": "藥物", "overlap": 0, "start_pos": 187}, {"end_pos": 194, "label_type": "藥物", "overlap": 0, "start_pos": 192}, {"end_pos": 211, "label_type": "藥物", "overlap": 0, "start_pos": 208}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 265, "end_pos": 269}, {"end_pos": 317, "label_type": "手術", "overlap": 0, "start_pos": 302}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 341, "end_pos": 387}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 439}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 503}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 604, "end_pos": 610}]}
{"originalText": "，入院前1月餘因“進行性吞嚥困難1年”就診我院，，查胃鏡示：，食管佔位伴狹窄：癌不能排除，，活檢病理示：“鱗狀下皮呈乳頭狀增生，部分鱗狀下皮呈低級別下皮內瘤變”，完善頸胸腹部，CT：食管下段部分管壁不規則增厚，考慮為食管癌，伴右側鎖骨下窩、食管旁溝及縱膈內多發淋巴結轉移；另病變下緣一食管憩室。考慮食管癌伴縱隔淋巴結轉移，為提高手術切除率，建議行術前新輔助化療，告知患者家屬，其表示理解，遂於2016.12.26、2017.01.16按氟尿嘧啶3000MG微量泵泵入+洛鉑50MGIVGTTD2+多西他賽（泰索帝）120MGIVGTTD2”第1、2週期化療，輔以保肝、止吐、制酸、營養支援等治療，療程較為順利，未見明顯化療副反應。現為求進一步治療，遂再次就診我科，門診擬“食管癌術前化療”收住院。末次出院以來，精神、睡眠一般，大小便如常，體重無明顯增減。", "entities": [{"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 79}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 83, "end_pos": 90}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 160}, {"end_pos": 222, "label_type": "藥物", "overlap": 0, "start_pos": 218}, {"end_pos": 236, "label_type": "藥物", "overlap": 0, "start_pos": 234}, {"end_pos": 252, "label_type": "藥物", "overlap": 0, "start_pos": 248}, {"end_pos": 256, "label_type": "藥物", "overlap": 0, "start_pos": 253}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 336, "end_pos": 339}]}
{"originalText": "患者4月餘前因“下腹疼痛不適，伴反酸、噯氣”在我院完善相關檢查後確診“胃體胃竇癌”，於2015-10-10在全麻上行“胃癌根治術（遠端胃大部分切除）”，術程順利，術後預防感染支援對症等處理，恢復好，切口甲級癒合。術後病理示：“胃體胃竇癌 PT4AN3AM0 IIIC期。”於2015-11-05、2015-12-07、2016-01-14、2016-02-15、2016-03-18日在我院行SOX（奧沙利鉑 100MG IVDRIP+替吉奧 60MG QN+替吉奧 40MG QM）方案化療，化療期間患者未訴特殊不適，未見明顯副反應。現在為上一步治療來我院門診就診，擬“胃癌綜合治療後”收入我科。術後出院至今患者精神尚可，食慾為半流為主，大小便正常，體重增加約2KG。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 40}, {"label_type": "手術", "overlap": 0, "start_pos": 59, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 134}, {"end_pos": 204, "label_type": "藥物", "overlap": 0, "start_pos": 200}, {"end_pos": 221, "label_type": "藥物", "overlap": 0, "start_pos": 218}, {"end_pos": 233, "label_type": "藥物", "overlap": 0, "start_pos": 230}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 293}]}
{"originalText": "，患者因壺腹部佔位於2016-07-22日在我科行胰十二指腸切除術+肝囊腫開窗引流+肝活檢術，，術後病理示：壺腹部鱗狀細胞癌（低度分化），體積4*2.8*2.5CM，侵達十二指腸粘膜層，侵及胰腺組織，於較多脈管內查見癌栓。膽總管、胃、十二指腸切線及胰腺切除面未查見癌；膽總管殘端切線於少數脈管內查見癌栓。呈胰腺周圍淋巴結（1/2個）癌轉移。胃周圍（2個）淋巴結未查見癌。慢性膽囊炎。（肝囊腫右、左）纖維性囊壁樣結構，慢性發炎，區域性襯覆單層立方下皮。（肝活檢）肝組織一塊，部分肝細胞淤膽，肝被膜及匯管區較多炎細胞浸潤。，免疫組化染色示：CK5/6（+）、P63（+）、CK7（-）、CK20（-）、SYN（-）。患者術後恢復良好，無特殊不適，2016.10.6入院行靜脈化療治療，2016.12.5入院行介入及靜脈化療，2017.2.16入院行靜脈化療，治療結束後出院。患者出院後，自覺全身乏力，無明顯腹脹、腹痛，無噁心、嘔吐，無心慌、胸悶等不適。今患者為術後綜合治療，來我院就診，門診以“胰十二指腸術後”收入院。   患者自術後以來，神志清，精神好，飲食可，睡眠可，大小便無異常，體重略增加。", "entities": [{"end_pos": 7, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"end_pos": 33, "label_type": "手術", "overlap": 0, "start_pos": 25}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 68}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 190}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "手術", "overlap": 0, "start_pos": 225, "end_pos": 228}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 243, "end_pos": 244}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 414, "end_pos": 415}, {"end_pos": 418, "label_type": "解剖部位", "overlap": 0, "start_pos": 417}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 444, "end_pos": 451}]}
{"originalText": "，緣於入院前3年餘於我院診斷為胃癌，於2012-04-11在全麻上行腹腔鏡上根治性全胃切除術，術後病理示(201210103)，：食管胃交界潰瘍型管狀腺癌II－III級，侵出漿膜層，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到賁門左淋巴結1/15個，小彎淋巴結0/2個，大彎淋巴結0/1個，幽門下淋巴結0/5個，幽門上淋巴結0/5個，及另送（第8組）淋巴結0/4個見癌轉移。，免疫組化：KI67（30%+），P53（-），CD56（-），SY（-），CGA（-），CK18（+++）。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。術後再入院行洛鉑50MG+表柔比星100MGD1+希羅達1500MGBIDD1-D14方案化療6週期，未見明顯化療反應，2天前,自訴腹痛,臍周明顯,呈陣發性,可自行緩解,伴肛門停止排氣排便.現感症狀加重,無明顯緩解方式,為求進一步診治遂來我院，門診擬腹痛待查收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 84}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 283, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"end_pos": 292, "label_type": "藥物", "overlap": 0, "start_pos": 288}, {"end_pos": 303, "label_type": "藥物", "overlap": 0, "start_pos": 300}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 341}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 345}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 361, "end_pos": 363}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 400, "end_pos": 404}, {"end_pos": 426, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}]}
{"originalText": "，緣於入院前3月因“直腸癌”就診我院，於2016年11月10日在全麻上行腹腔鏡上直腸根治術（DIXON手術）,探查腹腔內無明顯出血，沒有明顯粘連，無明顯腹水，腫瘤位於腹膜返折下5CM對系膜側，侵及漿膜層，未形成腸梗阻，近端無擴張，周圍未見明顯腫大淋巴結。術順,術後予預防感染、制酸、補液、營養支援、增強免疫力等處理，術後恢復可。術後病理（201641027），：（直腸），：直腸隆起型中分化管狀腺癌，小灶區為黏液腺癌，侵犯腸壁全層，脈管見癌侵犯，未見明確神經侵犯，手術標本下、上切端及另送（下切端）、（上切端）未見癌浸潤。找到腸周淋巴結3/14枚及另送（腸繫膜上動脈根部）淋巴結0/4枚，（中間組）淋巴結1/9枚，見癌轉移。，免疫組化：腫瘤細胞示CK7（-），CK20（+++），KI67（60%+）。MLH-1（++），MSH-2（+++），MSH-6（+++），PMS-2（+）提示該病例腫瘤微衛星穩定(MSS)，請結合臨床。檢測到KRAS基因存在G13D突變。未檢測到NRAS基因熱點突變。未檢測到BRAF基因V600E突變。於2016-12-10予“奧沙利鉑200MGIVGTTD1+卡培他濱1500MGBIDD1-D14”方案化療，此次為化療再次就診我院，門診擬直腸癌術後化療收入院。自下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 212}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 294, "end_pos": 302}, {"end_pos": 483, "label_type": "藥物", "overlap": 0, "start_pos": 479}, {"end_pos": 500, "label_type": "藥物", "overlap": 0, "start_pos": 496}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 536, "end_pos": 541}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 565}, {"end_pos": 569, "label_type": "解剖部位", "overlap": 0, "start_pos": 568}]}
{"originalText": "，患者12天前因“子宮內膜複雜性增生”在我院行全子宮切除術+兩側輸卵管切除術+盆腔粘連鬆解術。，術中探查: 部分大網膜粘連於左前腹壁，分離粘連後見肝臟表面光滑，大網膜及腸管表面未見明顯異常。盆腹腔內少量血性積液。子宮前位，約2個月妊娠大小，表面光滑，區域性質硬，呈腺肌病樣改變，子宮後壁上段與部分腸繫膜粘連，右側卵巢粘連於子宮右後壁，左側卵巢萎縮，粘連於子宮左後壁和側腹膜。兩側輸卵管外觀正常。，術中腹腔沖洗液送快速病理檢查結果提示：（腹腔沖洗液）離心塗片查見大量間皮細胞及少量淋巴細胞、中性粒細胞。子宮內膜呈孕激素類藥物治療後改變，冰凍切片區域性查見少許複雜性增生的內膜。未累及子宮頸外口切線。手術順利，，術後常規病理回示：子宮內膜複雜性增生，部分腺體呈高級別下皮內瘤變，部分割槽域為高分化子宮內膜樣腺癌，位於粘膜內，未累及子宮頸頸管內口，未累及底部切除面及外口殘端切線。慢性子宮頸炎。（兩側）輸卵管組織。，免疫組化染色示：ER（+）、PR（+）、P53少量（+）。建議進一步治療。患者現無腹痛及陰道流血，無其他不適。今日患者為行進一步治療來院就診，門診以“子宮內膜病變術後”收入院。   患者自發病以來，一般情況可，精神、睡眠良好，飲食一般，大小便無異常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 46}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 65}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 148}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 162}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 350}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 384, "end_pos": 390}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 391}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 443}, {"end_pos": 448, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 477, "end_pos": 485}]}
{"originalText": "，緣於入院前20餘日於我院診為乙狀結腸癌，於2015-10-21在全麻上行乙狀結腸癌根治術，，術中見：腹腔內無明顯腹水，腹腔、盆腔、大網膜無明顯轉移結節，肝臟質地大小正常，未觸及腫物，膽囊未觸及結石。腫瘤位於乙狀結腸上段，約6×5㎝，未形成腸梗阻，近端腸管無擴張，周圍可見少許腫大淋巴結。診斷“乙狀結腸癌”，遂決定行“乙狀結腸癌根治術。術後病理示.(乙狀結腸)，：腸潰瘍型管狀腺癌II級，侵犯腸壁全層及腸周脂肪組織，侵犯神經組織，未見肯定脈管侵犯，手術標本下、上切端及另送（下切端）（上切端）均未見癌浸潤；找到腸周淋巴結9個，未見癌轉移。2.該病例檢測到KRAS基因12號密碼子GLY12ASP突變。3.該病例未檢測到BRAF基因V600E突變。，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。2015-11-21行第1週期化療，具體方案為“沙利鉑140MGD1IVGTT+氟尿嘧啶700MGD1IVGTT+氟尿嘧啶4200MGD1-D2微量泵泵人+亞葉酸650MGD1-D2IVGTT”，此次為術後第2次化療再次就診我院，門診擬乙狀結腸癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 20}, {"end_pos": 45, "label_type": "手術", "overlap": 0, "start_pos": 37}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 152}, {"end_pos": 167, "label_type": "手術", "overlap": 0, "start_pos": 159}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 182, "end_pos": 193}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"end_pos": 397, "label_type": "藥物", "overlap": 0, "start_pos": 393}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 410}, {"end_pos": 434, "label_type": "藥物", "overlap": 0, "start_pos": 431}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 471, "end_pos": 478}, {"end_pos": 502, "label_type": "解剖部位", "overlap": 0, "start_pos": 501}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}]}
{"originalText": "，緣於入院前2個月因診斷為“胃癌”，於2014年12月09日在我院全麻上行“根治性遠端胃大部切除術，ROUX-Y吻合，D2，R0”，術順，術後予以制酸、保肝、增強免疫力、抗腫瘤、抗感染、抑制消化液分泌及對症支援治療。術後病理（201443329），：(遠端胃)，：胃角潰瘍型粘液腺癌，部分為印戒細胞癌，侵出漿膜外，手術標本下、上切端均未見癌浸潤，找到小彎淋巴結2/14個，大彎淋巴結0/7個，幽門上淋巴結2/15個，見癌轉移。（201443369），：找到(第7組)淋巴結0/1個、(第8組)淋巴結2/2個、(第9組)淋巴結0/1個，見癌轉移。2015.01.09按“奧沙利鉑150MGD1多柔比星脂質體（裡葆多）40MGD2希羅達1000MGD1-14”行第1週期術後輔助化療，輔以護胃，保肝，止嘔吐等對症處理。1天前無明顯誘因出現發熱，無寒戰，無肢體抽搐，遂來我院就診，門診擬“胃角潰瘍型粘液腺癌（PT4AN2M0IIIB期）術後化療，發熱待查”收住入院。自發病以來，患者精神、飲食、睡眠尚可，大小便正常，體重未見明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 38}, {"end_pos": 58, "label_type": "手術", "overlap": 0, "start_pos": 50}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 150}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 236}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 262}, {"end_pos": 288, "label_type": "藥物", "overlap": 0, "start_pos": 284}, {"end_pos": 302, "label_type": "藥物", "overlap": 0, "start_pos": 295}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 316, "label_type": "藥物", "overlap": 0, "start_pos": 313}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 391, "end_pos": 417}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 420, "end_pos": 424}]}
{"originalText": "，入院前8天（2013.12.06）因“宮頸鱗癌IB1期”就診我院全麻上行行腹腔粘連鬆解術+部分大網膜切除術+廣泛全子宮+兩側卵巢移位術+盆腔淋巴結清掃術，術前查，CA125：18.42U/ML，術後病理回報（201338627），：1、（全子宮），：宮頸浸潤型鱗狀細胞癌II級，侵及肌層（浸潤深度＜1/2宮頸全層），脈管內見癌栓，手術標本陰道切端及兩側宮旁組織均未見癌浸潤。宮體肌間平滑肌瘤，宮內膜呈增生狀態。2、找到（右髂總）淋巴結0/6個，（右盆腔）淋巴結2/40個，（右側腹股溝）淋巴結0/2個，（左髂總）淋巴結0/9個，（左盆腔）淋巴結1/16個見癌轉移。3、（大網膜），：送檢網膜組織未見癌細胞種植轉移。，免疫組化：KI67（40%+），CK5/6（+++），CK(H)（+++），P63（++++），CEA（++），CK18（-），術後予補液、營養支援等治療，恢復良好，傷口癒合II/甲。今為行第1次化療，再次就診我院，門診擬“宮頸鱗癌（IB1期，II級）術後”收入院。下次出院以來，精神、睡眠、飲食好，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 38, "end_pos": 77}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 139}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 179}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 421, "end_pos": 437}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}]}
{"originalText": "，患者7月前因“下腹腹脹伴反酸”至我院就診，完善相關檢查，診斷“胃體胃竇癌(CT4N2M0,IIIB期)”，建議先行化療，患者及家屬表示理解同意，遂於2015-5-26、2015-06-19、2015-07-13分別予XELOX(希羅達 1250MG BID PO D1-14+奧沙利鉑150MG IVDRIP Q3W)化療三程,過程順利，無明顯副反應，後於2015-08-24在全麻上行胃癌根治術（遠端胃大切），術程順利，術後預防感染支援對症等處理。，術後病理示：胃中至低分化管狀腺癌（LAUREN，分型：腸型），浸潤至胃壁漿膜上層，可見神經束侵犯，未見明確脈管內癌栓；腫瘤消退分級（MANDARD），：TRG4；網膜組織未見癌；LN（-）；YPT3N0M0，IIA期。術後恢復可，於2015-10-10、開始採用XELOX化療方案化療（奧沙利鉑150MG Q3W IVDRIP+卡培他濱1250MGBID*14天）一程，過程順利。現為行上程化療來我院就診，擬“胃癌綜合治療後”收入我科。自下次出院以來，患者精神可，食慾尚可，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 52}, {"end_pos": 118, "label_type": "藥物", "overlap": 0, "start_pos": 115}, {"end_pos": 143, "label_type": "藥物", "overlap": 0, "start_pos": 139}, {"label_type": "手術", "overlap": 0, "start_pos": 193, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 233, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 262}, {"end_pos": 374, "label_type": "藥物", "overlap": 0, "start_pos": 370}, {"end_pos": 395, "label_type": "藥物", "overlap": 0, "start_pos": 391}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 432, "end_pos": 439}]}
{"originalText": "，2009年12月底出現黑便，，於當地行胃鏡檢查並行病理檢查示: 胃體中下部潰瘍， 病理示中分化腺癌， 無腹脹、泛酸、噯氣、噁心、嘔吐、 無頭暈、 心悸、乏力等症， 2010年1月13日於我院胃胰科行胃癌根治術， 2010年1月18日，我院病理：切緣未見癌， 胃體可見3X2X1CM3潰瘍型腫物， 鏡上為中分化腺癌侵及胃壁全層至漿膜層，網膜未見癌， 肝總動脈旁（0/1)、 胃大彎（0/1)淋巴結未見癌， 賁門左(3/3)、 胃小彎(8/9)、幽門上（2/2)淋巴結可見腺癌轉移，，免疫組化：CEA(+)、 P53(+)、 PR(-)、 ER-B(+)、 ER(+++)、 共計，LN: 13/16轉移， 術後於2010年2月-2010年8月行術後化療6程， 具體用藥為艾素100MG 靜點+ 希羅達1500MG BID PO，2014年6月初出現右側下上肢活動受限， 7月份症狀逐漸加重， 7月10日就診於*****， ，行MRI檢查提示：胃癌術後多發腦轉移， 行甘露醇及地塞米松、 洛賽克治療後效果不佳。遂於我院就診，2014-8-5行奧沙利鉑150MG D1+ 替吉奧 50MG BID D1-14化療一程，2014-08-18開始行三維適形全腦放療，劑量30GY/10F。2014-09-19始行替吉奧 50MG BID D1-14單藥化療一程。本次為行上一程化療收入我科， 我科以“胃癌術後腦轉移 RTXNXM1 IV期”收入， 入科以來， 精神飲食尚可， 無噁心、 嘔吐,二便正常，體重無明顯減低。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 45, "end_pos": 50}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 98}, {"end_pos": 105, "label_type": "手術", "overlap": 0, "start_pos": 100}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 152, "end_pos": 157}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 160}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 233}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 237}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 335}, {"end_pos": 350, "label_type": "藥物", "overlap": 0, "start_pos": 347}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 374}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 421, "end_pos": 430}, {"end_pos": 436, "label_type": "藥物", "overlap": 0, "start_pos": 433}, {"end_pos": 441, "label_type": "藥物", "overlap": 0, "start_pos": 437}, {"end_pos": 446, "label_type": "藥物", "overlap": 0, "start_pos": 443}, {"end_pos": 474, "label_type": "藥物", "overlap": 0, "start_pos": 470}, {"end_pos": 487, "label_type": "藥物", "overlap": 0, "start_pos": 484}, {"end_pos": 526, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"end_pos": 555, "label_type": "藥物", "overlap": 0, "start_pos": 552}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 596, "end_pos": 615}]}
{"originalText": "，患者因低位直腸癌於2014-08-27在全麻上行直腸癌根治術（DIXON）。，術中探查見：腹腔內無腹水，腹膜無轉移，肝臟未觸及轉移結節，腫瘤位於腹膜返折處，手術順利，術後給予抑酸、抗感染、營養支援等治療。術後病理（201413291），：（直腸）腺癌(中度分化),浸潤潰瘍型,體積7.5*4.5*2CM,部分侵穿纖維膜達脂肪組織，距底部切除面甚近，區域性侵達漿膜，漿膜面未查見癌。 雙端切線及另送“近切線”、“遠切線”未查見癌。 呈一站（6/10個）淋巴結癌轉移。 中央組（7個）淋巴結未查見癌。 ，癌組織免疫組化染色示：TS（-）、SYN（-）。術後給予3週期化療，，方案為：奧沙利鉑200MG D1，亞葉酸鈣0.3G+替加氟1.0G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，過程順利，自下次出院以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適；未現明顯腹痛、腹脹。現患者為行復查並輔助化療而再來我院就診，門診以“直腸癌術後”收入院。   患者精神好，食慾、飲食好，睡眠可；肛門排氣排便存在。無體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 25, "end_pos": 38}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 73, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 243}, {"end_pos": 293, "label_type": "藥物", "overlap": 0, "start_pos": 289}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 302}, {"end_pos": 314, "label_type": "藥物", "overlap": 0, "start_pos": 311}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 436}]}
{"originalText": "，緣於入院前6月餘於我院診為胃竇癌，於2016年02月26日在全麻上行腹腔鏡上根治性遠端胃切除術，術順，，病理：（遠端胃），：胃竇潰瘍型低黏附性癌（印戒細胞癌為主，部分為未分化癌及黏液腺癌），侵犯脈管及神經組織，脈管內見癌栓，侵出漿膜層。手術標本下切端、上切端及另送（下切端）均未見癌浸潤。找到小彎側淋巴結0/8個，幽門下淋巴結0/1個，幽門上淋巴結4/9個，另送（第1組）淋巴結0/1個,（第7組）淋巴結0/1個，（第8組）淋巴結0/6個，（第9組）淋巴結0/1個，見癌轉移。另送（第12組淋巴結）鏡上為脂肪、纖維及脈管組織。（小腸），：送檢小腸組織，未見癌浸潤。，免疫組化染色結果：KI67（70%陽性），P53（-），P170（+++），GSTπ（-），EGFR（+++），5-FU（+），HER-2（-）。術後予制酸、營養支援等治療好轉後出院。術後予2016-04-12、2016.5.6、2016.5.30、2016.6.23、2016.8.9行“洛鉑D150MGIVGTT+卡培他濱D2-141500MGPOBID”化療6次，輔以保肝、保胃、止吐抗腫瘤治療。此次入院前2天因無明顯誘因出現中下腹絞痛，伴噁心，無嘔吐，無畏冷、寒戰，無腹脹、腹痛等其他不適，求診我科，門診擬胃竇癌術後化療後，腹痛待查收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 48, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 95}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 190}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 195, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 221, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 249}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 431, "label_type": "藥物", "overlap": 0, "start_pos": 429}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 443}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 475}, {"end_pos": 503, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 523, "label_type": "解剖部位", "overlap": 0, "start_pos": 522}, {"end_pos": 526, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 541, "end_pos": 546}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 550, "end_pos": 554}, {"end_pos": 576, "label_type": "解剖部位", "overlap": 0, "start_pos": 575}, {"end_pos": 579, "label_type": "解剖部位", "overlap": 0, "start_pos": 578}]}
{"originalText": "，患者於2015年5月26日在我院行腹腔鏡檢查+卵巢腫瘤活檢術。，術後病理學檢查報告：(左卵巢)破碎卵巢組織見部分異型性腺體和分化較低的片巢狀細胞，局灶伴鱗狀下皮化生，符合惡性腫瘤，考慮為腺癌。於5月30日給予TP方案化療（紫杉醇（特素）240MG靜脈滴注，順鉑90MG腹腔灌注）。於７月３日在全麻上經腹行全子宮切除術+兩側附件切除術+大網膜部分切除術+闌尾切除術。，術後病檢示：1、（左卵巢）中-低分化漿液性乳頭狀腺癌，同側輸卵管未見癌累及。右卵巢見癌轉移，右輸卵管、子宮未見癌轉移。闌尾未見癌轉移。大網膜見癌轉移。2、子宮平滑肌瘤。於７月１３日行紫杉醇（泰素）240MG靜脈滴注＋順鉑90MG灌腹，8月14日行紫杉醇（泰素）240MG+順鉑100MG靜脈滴注化療，9月19日、10月21日、11月19日、12月19日行紫杉醇（泰素）240MG+奧沙利鉑200MG化療。化療過程中，患者有噁心、嘔吐、脫髮等症狀，化療結束後緩解。入院前20天，患者於我科門診複查，門診給予“華蟾素片”治療，自訴用藥後患者感腹痛、腹脹，尚能忍受，無腹瀉、噁心、嘔吐等。因腹痛持續，患者遂於今日來院。門診以“第六次化療後、卵巢漿液性乳頭狀腺癌IIIC期”收住入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 31, "label_type": "手術", "overlap": 0, "start_pos": 18}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"end_pos": 115, "label_type": "藥物", "overlap": 0, "start_pos": 112}, {"end_pos": 118, "label_type": "藥物", "overlap": 0, "start_pos": 116}, {"end_pos": 131, "label_type": "藥物", "overlap": 0, "start_pos": 129}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"label_type": "手術", "overlap": 0, "start_pos": 150, "end_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 210}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 235}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 261, "end_pos": 267}, {"end_pos": 278, "label_type": "藥物", "overlap": 0, "start_pos": 275}, {"end_pos": 281, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"end_pos": 294, "label_type": "藥物", "overlap": 0, "start_pos": 292}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"end_pos": 313, "label_type": "藥物", "overlap": 0, "start_pos": 311}, {"end_pos": 322, "label_type": "藥物", "overlap": 0, "start_pos": 320}, {"end_pos": 364, "label_type": "藥物", "overlap": 0, "start_pos": 361}, {"end_pos": 367, "label_type": "藥物", "overlap": 0, "start_pos": 365}, {"end_pos": 378, "label_type": "藥物", "overlap": 0, "start_pos": 374}, {"end_pos": 441, "label_type": "藥物", "overlap": 0, "start_pos": 437}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 453}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"end_pos": 466, "label_type": "解剖部位", "overlap": 0, "start_pos": 465}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 501, "end_pos": 516}]}
{"originalText": "，2016.1.29患者以“陰道不規則出血半年”為主訴首次入院，我院病理科會診為浸潤性低分化鱗狀細胞癌，診斷宮頸鱗癌IIB期，，術前予TP化療2週期：紫杉醇480MG、順鉑220MG，檢查無手術禁忌症，2016-03-18在全麻上行III型全子宮及及兩附件兩附件切除及盆腔淋巴結清掃術及腹主動脈旁淋巴結活檢術，術順，，術後病理回報：盆腔及腹主動脈淋巴結未見轉移癌。宮旁及子宮動脈未見癌。全子宮及兩附件示宮頸及宮體上段肌層（均大於1/2肌層）中見異型細胞呈小巢團狀排列，病變診斷為低分化癌，符合腺鱗癌，可見脈管癌栓，陰道穹窿可見個別散在的癌細胞，檢查現為術後放療入院。自起病以來，患者精神、睡眠可，食慾如常，大小便正常，體重無上降。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 62}, {"end_pos": 78, "label_type": "藥物", "overlap": 0, "start_pos": 75}, {"end_pos": 86, "label_type": "藥物", "overlap": 0, "start_pos": 84}, {"label_type": "手術", "overlap": 0, "start_pos": 116, "end_pos": 154}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 249}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}]}
{"originalText": "2014-08因食納差，檢查發現下腹包塊，2014-09-03在全麻上行剖腹探查術，術中見腫瘤位於十二指腸，約10*11*10CM，質硬，與周圍組織粘連緻密無法切除，行胃空腸吻合術（未見手術記錄）。術後病理：（十二指腸腫物）梭形細胞腫瘤，瘤細胞細胞增生活躍，核分裂多見，大於10/10HPF，CD117(3+),CD34(-),DOG-1(3+),CK(-),S-100(-),SMA(-),KI67(+25%)。術後口服伊馬替尼（**產）治療至今。患者目前乏力，近1月出現黑便，一般情況尚可。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 36}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 90, "label_type": "手術", "overlap": 0, "start_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 104, "end_pos": 118}, {"end_pos": 215, "label_type": "藥物", "overlap": 0, "start_pos": 211}]}
{"originalText": "，者約於1個月前因“結腸惡性腫瘤”於2013-04-28日在全麻上行左半結腸切除術。手術過程順利，術後給予抗感染及營養支援治療，患者恢復好。，術後病理：4976.2013 結腸腺癌（中低分化），浸潤潰瘍型，面積5.5*5.5CM，區域性粘液腺癌影象，侵達漿膜脂肪組織。雙端切線未查見癌，呈腸壁一站（2/8個）淋巴癌轉移。腸壁二站（2個）、中間組（4個）淋巴結未查見癌。，免疫組化染色示癌組織：ERCC1(+),TS（-）。術後分期 PT4N1M0 III期，術後給予化療治療，，方案為：奧沙利鉑200MG D1+右亞葉酸鈣50 MGD2-6 +氟尿苷1000MG D2-6 靜滴。    院外期間，患者無發熱，無腹痛腹脹不適，大便通暢。現患者為行復查化療來我科就診，以“結腸癌術後”收入院。    病人自下次出院以來，神志清，精神可，飲食可，大、小便正常，體重未見明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 16}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 178}, {"end_pos": 246, "label_type": "藥物", "overlap": 0, "start_pos": 242}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 255}, {"end_pos": 274, "label_type": "藥物", "overlap": 0, "start_pos": 271}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 307}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 334, "end_pos": 339}]}
{"originalText": "，患者2015-09-15因“腹痛伴大便性狀習慣改變1月”就診於我院結直腸科，外院腸鏡檢查提示結腸肝曲環周腫物，腸鏡不能透過，活檢病理提示腺癌，遂2015-09-18行全麻上“左半結腸切除術”，過程順利，，術後病理示：鏡檢為中分化腺癌，癌組織浸潤至腸壁漿膜上層；未見明確脈管內癌栓及神經束侵犯；各切緣未見癌；淋巴結2/10見腺癌轉移，，免疫組化：ER（-），ERCC1（+），MSH2（+），MSH6（+），MLH1（+），PMS2（+），KI67（40%+），，分期為：PT3N1BM0IIIB期，術後恢復可。2015-10-15於我科行第1程XELOX方案術後輔助化療，過程順利，現患者為行進一步治療入我科。患者3周來，無發熱，胃納可，睡眠一般，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"end_pos": 95, "label_type": "手術", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 164}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 316}]}
{"originalText": "，緣於入院前半個月前我院行胃鏡檢查提示：食管炎（A級），賁門息肉樣隆起，共雙枚，大小分別為1.0CM、1.5CM，慢性萎縮性胃炎，十二指腸球部潰瘍（S2期），十二指腸球部炎症。，胃鏡病理：（十二指腸降部）間質中量慢性炎症細胞及少量急性炎症細胞浸潤，灶性腺體呈腺瘤樣增生。（賁門）腺下皮輕度腸化，其上見胃固有腺，間質大量急、慢性炎症細胞浸潤。，腸鏡檢查示：結腸多發息肉，直徑0.6CM-1CM。予內鏡上切除部分小息肉。，病理：（肝曲）腸管狀腺瘤，伴腺下皮低級別下皮內瘤變，（橫結腸）腸管狀腺瘤，伴腺下皮低級別下皮內瘤變（中度不典型增生）。無腹痛、腹脹、腹瀉、嘔血、排黑便、排血便、裡急後重，無噁心、嘔吐，無反酸、噯氣、胸骨後燒灼感，無消瘦、食慾減退等。今為求進一步診治求診我院，門診擬“胃腸息肉”收住院。近半個月以來，精神、睡眠、食慾尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 27}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 64}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 87}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 234}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 267}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 346}]}
{"originalText": "，緣於入院前39個月因反覆左上腹痛於我院行腹部B超示：回盲部壁增厚,癌可能。並於2010.11.1於我院腫瘤外科在全麻上行左半結腸切除術,盲腸部可及一大約3CM*4CM腫物，侵及漿膜層。術後病理（201026573），示：(左半結腸)大腸回盲部結外粘膜相關淋巴組織邊緣區B細胞淋巴瘤(MALT),侵犯漿膜層，手術標本雙切端未見腫瘤。找到腸周淋巴結1/19個見淋巴瘤細胞浸潤。，免疫組化：CD3（-），CD5（-），CD10（-），CD20（+++），CD21（-），CD23（-），CD30（-），CYCLIND1（-），KI67（10%），BCL-2（+++），CD56（-）。術後恢復可，切口II/甲癒合。術後進一步查胸部+全腹CT未見明顯復發轉移徵象，術後先後予CHOP（環磷醯胺1100MGIV，D1+表柔比星90MGIV，D1+長春新鹼2MG，IV，D1+潑尼松10MGTID，D1-D14）3周方案全身化療4週期，輔以保肝、止吐、調節免疫力等處理，化療過程較順利。最後一次化療2011年1月27日。此後定期（3個月）複查胸部+全腹CT增強未見覆發轉移徵象，血清β2微球蛋白陰性。今無腹痛、腹脹、腹瀉，無噁心、嘔吐等不適，今為求複查再次就診我院，門診擬回盲部淋巴瘤術後收住院。本次發病以來，精神、睡眠、食慾可，大小便如常，體重無驟變。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 21, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 30}, {"end_pos": 68, "label_type": "手術", "overlap": 0, "start_pos": 61}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 147}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 311, "end_pos": 318}, {"end_pos": 343, "label_type": "藥物", "overlap": 0, "start_pos": 339}, {"end_pos": 359, "label_type": "藥物", "overlap": 0, "start_pos": 355}, {"end_pos": 373, "label_type": "藥物", "overlap": 0, "start_pos": 369}, {"end_pos": 386, "label_type": "藥物", "overlap": 0, "start_pos": 383}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 466, "end_pos": 473}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 497}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 504, "label_type": "解剖部位", "overlap": 0, "start_pos": 503}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 531, "end_pos": 539}]}
{"originalText": "，緣於入院前3月餘前於我院診為胃癌，於2014-12-12在全麻上行腹腔鏡上根治性遠端胃大部切除術，術順。術後病理示（胃大部），：胃體大彎側潰瘍型低分化腺癌，侵及漿膜層，侵犯神經，手術標本下、上雙切端及另送（下切端）、（上切端）均未見癌浸潤。找到小彎淋巴結0/10個，大彎淋巴結2/8個，幽門下淋巴結0/2個，幽門上淋巴結0/2個，及另送的（第一組）淋巴結0/1個，（第七組）淋巴結0/5個，（第八組）淋巴結0/1個，（第十二組）淋巴結0/3個，見癌轉移。（第九組），：送檢脂肪、纖維及神經組織。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。患者於2015-01-05行“奧沙利鉑（齊沙）200MGIVGTT+替吉奧60MGPOD1-14。”化療方案治療1週期，輔以止吐、制酸、保肝等對症支援治療，患者口服替吉奧時出現面板瘙癢、皮疹等不適，2015-01-24行“替加氟3.6G泵入+奧沙利鉑130MGIVGTT+亞葉酸鈣300MGIVGTT”方案化療，2015-02-11，2015-02-28予“替加氟3.6G泵入+奧沙利鉑130MGIVGTT+亞葉酸鈣300MGIVGTT”方案化療輔以止吐、保肝、制酸等處理。今為行第5週期化療治療，再次就診我院，門診擬胃癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 78}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 204}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 209, "end_pos": 218}, {"end_pos": 296, "label_type": "藥物", "overlap": 0, "start_pos": 292}, {"end_pos": 299, "label_type": "藥物", "overlap": 0, "start_pos": 297}, {"end_pos": 314, "label_type": "藥物", "overlap": 0, "start_pos": 311}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 370, "end_pos": 372}, {"end_pos": 391, "label_type": "藥物", "overlap": 0, "start_pos": 388}, {"end_pos": 402, "label_type": "藥物", "overlap": 0, "start_pos": 398}, {"end_pos": 417, "label_type": "藥物", "overlap": 0, "start_pos": 413}, {"end_pos": 459, "label_type": "藥物", "overlap": 0, "start_pos": 456}, {"end_pos": 470, "label_type": "藥物", "overlap": 0, "start_pos": 466}, {"end_pos": 485, "label_type": "藥物", "overlap": 0, "start_pos": 481}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 506, "end_pos": 507}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 536, "end_pos": 540}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}]}
{"originalText": "，患者2014年3月無明顯誘因上出現中下腹疼痛，較劇烈，每次持續2-3分鐘，不伴放射痛，有反酸噯氣，患者食慾欠佳，進食油膩食物後即感噁心，無腹脹腹瀉，無嘔血黑便。於2014-4-1行PET-CT考慮為胃竇部MT伴胃周淋巴結轉移；脂肪肝；肝左後葉上段及兩腎囊腫；左腎小結石；2014-04-02在我院全麻上行胃癌根治術，畢II式遠端胃。術中見腹腔無腹水，肝臟、腹盆腔大網膜無異常。胃竇部小彎側直徑2CM增厚區，未浸潤漿膜，胃周圍可見肝動脈旁3CM腫瘤結節，淋巴結明顯腫大。，病理：(遠端胃)下皮性惡性腫瘤，部分割槽為神經內分泌癌(G3，約佔腫瘤體積40%)；部分為肉瘤樣癌(約佔腫瘤體積40%)；部分為管狀腺癌，分化II級(LAUREN分型腸型，約佔腫瘤組織20%)。癌組織浸潤胃壁肌層。雙切緣未見癌累及。檢出大彎側淋巴結8枚，均未見癌轉移(0/8)；檢出小彎側淋巴結19枚，其中5枚見癌轉移(5/19)，另見癌結節1枚；檢出幽門上淋巴結12枚，其中3枚見癌轉移(3/12)。免疫組化(2014-N3491)，:TP(60%+),TS(20%+),B-TUBULIN(30%+),KI67(60%+),TOPII-A(40%+),ERCC-1(-),C-MET(-),HER-2(0),CK廣(神經內分泌癌及腸型腺癌區域100%++,肉瘤樣癌區域約10%+),SYN(30%++),CHG(30%++),CD56(部分+)。 手術過程順利。術後恢復良好。患者術後分期PT2N3M0 IIIA期，有術後輔助化療指徵，考慮患者術後病理提示部分神經內分泌癌、部分肉瘤樣癌、部分管狀腺癌，擬三藥聯合方案，於2014.5.12、2014.6.2、2014.6.23、2014.7.15行第1-4次EOX方案術後輔助化療，，計劃用藥：表柔比星 50MG/M2，奧沙利鉑 130MG/M2，希羅達 1000MG/M2 BID D1-14，，計算用藥：表柔比星 76.605MG D1，奧沙利鉑 199.173MG D1，希羅達 1532.1MG/M2 BID D1-14，，實際用藥：表柔比星100MG D1，奧沙利鉑 150MG D1，希羅達 1500MG BID D1-14 Q3W，期間於2014.7.15複查腹部CT未見明確復發轉移灶。患者化療耐受可，今日為行第5次輔助化療治療入院。患者患病以來，精神可，夜眠可，二便無殊，近期體重穩定。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 91, "end_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 135}, {"label_type": "手術", "overlap": 0, "start_pos": 153, "end_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 338}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 353}, {"end_pos": 382, "label_type": "解剖部位", "overlap": 0, "start_pos": 376}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 667, "end_pos": 673}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 674, "end_pos": 680}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 681, "end_pos": 687}, {"end_pos": 763, "label_type": "藥物", "overlap": 0, "start_pos": 759}, {"end_pos": 776, "label_type": "藥物", "overlap": 0, "start_pos": 772}, {"end_pos": 789, "label_type": "藥物", "overlap": 0, "start_pos": 786}, {"end_pos": 820, "label_type": "藥物", "overlap": 0, "start_pos": 816}, {"end_pos": 837, "label_type": "藥物", "overlap": 0, "start_pos": 833}, {"end_pos": 854, "label_type": "藥物", "overlap": 0, "start_pos": 851}, {"end_pos": 887, "label_type": "藥物", "overlap": 0, "start_pos": 883}, {"end_pos": 900, "label_type": "藥物", "overlap": 0, "start_pos": 896}, {"end_pos": 913, "label_type": "藥物", "overlap": 0, "start_pos": 910}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 949, "end_pos": 953}]}
{"originalText": "，緣於入院前6月餘於我院診為胃竇癌，於2016-6-14在全麻上行腹腔鏡上根治性遠端胃大部切除術。，術中見：腹腔鏡探查見腹腔內無明顯腹水，盆腔、腹壁、大網膜未見明顯轉移結節，肝臟質地大小正常，未見明顯腫物，膽囊無腫大。胃竇幽門管可見病灶，侵及漿膜層，侵及部分肝臟，侵及部分胰腺及橫結腸繫膜，周圍可見大量腫大淋巴結，最大約1.5×1㎝，考慮為“胃竇癌伴出血伴肝臟、胰腺受侵”。術後病理（201620266）示（遠端胃），：胃竇浸潤型管狀腺癌II-III級，侵出漿膜層，侵犯肝被膜至肝實質。手術標本下、上切端及另送（下切端）均未見癌浸潤。找到小彎淋巴結0/7個，幽門下淋巴結1/4個，幽門上淋巴結2/8個，見癌轉移。，免疫組化：KI67（50%+），CK8（++），CK7（-），CK20（++），CD56（-），HER-2（-），術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。術後分別於2016-09-04、2016-10-12、2016-11-07行樂沙定150MGIVGTTD1+替吉奧40MGPOBIDD1-14方案化療，此次為行第4次化療就診我院，門診擬胃竇癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 48, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 185}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 236}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 239, "end_pos": 242}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 434, "label_type": "藥物", "overlap": 0, "start_pos": 430}, {"end_pos": 450, "label_type": "藥物", "overlap": 0, "start_pos": 447}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 486, "end_pos": 491}, {"end_pos": 515, "label_type": "解剖部位", "overlap": 0, "start_pos": 514}, {"end_pos": 518, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}]}
{"originalText": "，患者於2016-10-12在全麻上行\\\"胃癌根治術\\\"（遠端胃切除術），，術後病理回報:“（胃大體）鏡檢為胃低粘附性癌，符合低分化腺癌，LAUREN，分型：瀰漫型，癌組織浸潤至胃壁漿膜上層，可見脈管內癌栓及神經束侵犯；網膜組織未見癌。淋巴結46枚，4枚見癌。（遠、近切緣）未見癌”。2016-11-11，2016-12-05，2016-12-28已行SOX方案化療3程，現為行上一程術後輔助化療收入我科。患者目前無噁心、嘔吐，無腹瀉、腹脹，精神尚可，食慾一般，大小便正常，身體減輕4KG。", "entities": [{"end_pos": 26, "label_type": "手術", "overlap": 0, "start_pos": 21}, {"end_pos": 35, "label_type": "手術", "overlap": 0, "start_pos": 29}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}]}
{"originalText": "，患者於2015年初患者出現嘔吐、嘔吐血性胃內容物，，外院查胃鏡示：胃竇癌伴胃瀦留，考慮胃癌，於2015-02-09於外院行“胃癌根治術”，病理提示低分化腺癌，，術後病理診斷：PT4N1M0（我院會診病理切片示（胃竇）鏡檢為低分化腺癌，浸潤胃壁全層至漿膜外脂肪組織。送檢雙切緣未見癌。送檢癌結節一枚，淋巴結4枚，1/4見癌轉移。）。術後於我院複查CT示未見覆發轉移。於2015-03及04月、2015-5-4給予SOX方案化療3程順利，無不適。今為求進一步診治來我院。患者發病以來,有嘔吐等症狀。精神不佳,飲食睡眠佳,大小便正常，體重無減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 46}, {"end_pos": 68, "label_type": "手術", "overlap": 0, "start_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 79}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 173, "end_pos": 175}]}
{"originalText": "，緣於入院前1月餘於我院診為肝曲結腸粘液腺癌侵犯十二指腸及肝門區，於2016-08-03在全麻上行剖腹探查+胃空腸吻合+升結腸-橫結腸側側吻合術，，術中見:腹腔內無明顯腹水，肝臟表面光滑，盆腔、腸繫膜、網膜表面未見明顯結節，升結腸腸管略擴張，結腸肝曲可觸及一大小約8*7CM腫物，質硬，侵出漿膜層，並向後侵犯包繞十二指腸降部、水平部，向下侵犯肝十二指腸韌帶上方，腫物部分與後腹膜粘連緻密固定無法分離。遂行下術，術順，術後予補液、抗感染、營養支援等治療。，術後病理：(左結腸動脈旁淋巴結)，：送檢淋巴結1個見粘液腺癌轉移，結合免疫組化結果，考慮消化系統來源。，免疫組化結果：CK7（-），CK20（+++），PAX-8（-），CDX2（+++）。並於2016-08-24予“樂沙定100MGIVGTTQDD1+卡培他濱1500MGPOBID×14天”方案行第1週期化療，輔以保胃、保護粘膜、止吐及營養支援處理。今為行上一週期化療，就診我院門診，門診擬“升結腸癌術後化療”收住入院，病程中精神、飲食、睡眠尚可，大小便正常，體重較前上降2KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 72}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 98}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 166}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 257}, {"end_pos": 339, "label_type": "藥物", "overlap": 0, "start_pos": 336}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 354}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 425, "end_pos": 433}]}
{"originalText": "，患者因“反覆餐後腹脹、噁心1月餘”於2015-07-03入住我院，外院未經提示胃癌，於2015-07-16在全麻上行胃癌姑息切除術（遠端胃大切），，術中探查見：小網膜囊可見少量硬結，盆底、橫結腸、肝臟、胰腺、脾臟等未見種植轉移結節，腫物位於胃竇，大小約6*8CM，突破漿膜，侵犯周圍結締組織，遂行胃癌姑息切除術，術後預防感染支援對症等處理，恢復好，切口甲級癒合。術後病理示1（胃大體）鏡檢為中至低分化腺癌，部分為粘液腺癌（LAUREN，分型：混合型），癌組織浸潤至胃壁漿膜層；可見脈管內癌栓及神經束侵犯；網膜組織中見淋巴結2枚，2/2見腺癌轉移。2（第1組淋巴結）5枚，4/5見腺癌轉移。3（第3組淋巴結）4枚，3/4見腺癌轉移。4（第4組淋巴結）11枚，7/11見腺癌轉移。5（第5組淋巴結）3枚，3/3見腺癌轉移。6（第6組淋巴結）鏡上為脂肪結締組織，未見癌。7（第7組淋巴結）3枚，3/3見腺癌轉移。8（第8組淋巴結）2枚，2/2見腺癌轉移。9（第12A組淋巴結）鏡上為脂肪結締組織，未見癌。10（近切緣）未見癌。11（遠切緣）未見癌。，免疫組化：VEGF（+），HER-2（0）。，原位雜交：EBERS（-）。術後於2015-09-17、2015-10-15、2015-11-12予以SOX（S-1 60MG，BID×D1-14+OXA190MG×D1）方案化療3程。今為求進一步診治來我院。患者發病以來,無腹痛、噁心、嘔吐、反酸、噯氣。精神佳,飲食睡眠佳,大小便正常，體重無減輕。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 42}, {"label_type": "手術", "overlap": 0, "start_pos": 59, "end_pos": 73}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 156, "label_type": "手術", "overlap": 0, "start_pos": 149}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 196, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 234}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 269, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 297, "end_pos": 303}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 324}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 334, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 347}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 355, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 362, "end_pos": 368}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 385, "end_pos": 391}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 399, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 412}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 420, "end_pos": 422}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 427, "end_pos": 435}, {"end_pos": 554, "label_type": "藥物", "overlap": 0, "start_pos": 551}, {"end_pos": 573, "label_type": "藥物", "overlap": 0, "start_pos": 570}, {"end_pos": 610, "label_type": "解剖部位", "overlap": 0, "start_pos": 609}]}
{"originalText": "，緣於入院前20個月因“中下腹悶痛”就診於我院，查胃鏡提示胃竇潰瘍，惡性待排，住胸外科於2012.05.21在全麻上行根治性遠端胃大部切除＋畢Ｉ式吻合術，術中探查未見腹水，盆底、肝臟表面無轉移性結節，腫瘤位於胃竇小彎側，呈潰瘍型，範圍約4CMX3CM，侵及漿膜，另見小彎側胃壁3枚米粒大小結節，，切除結節送術中冰凍示：平滑肌和小淋巴結2個，送檢淋巴結呈反應性增生。手術順利，術後病理（201214740），：(胃)，：胃竇小彎側潰瘍型管狀腺癌II級，侵及漿膜層，侵犯神經組織，脈管內見癌栓。手術標本下、上切端及另送（下切端）均未見癌浸潤。找到小彎淋巴結1/14個、大彎淋巴結1/18個、幽門下淋巴結1/2個、幽門上淋巴結1/9個及另送(賁門右)淋巴結0/3個、(胃右動脈旁)淋巴結0/7個、(脾動脈旁)淋巴結0/2個、(肝總動脈旁)淋巴結0/4個見癌轉移，（201214606），：(胃壁結節)送檢少量平滑肌組織及淋巴結二個，淋巴結反應性增生。術後予“5-FU7500MG泵入+CF300MG靜滴D1-5+順鉑30MG靜滴D1-5Q3W”化療3週期及口服希羅達化療2週期（具體不詳），末次化療時間2012.10。術後定期複查未見腫瘤復發轉移。12，周前複查腹部B超：肝左葉實質性佔位性病變，大小約27MM×26MM，，下消化道鋇餐：吻合口區鋇劑透過順暢，兩肺紋理增多增粗。遂就診我科，查下腹部，CT：1、肝右內葉佔位性病變，與2012-05-15舊片對比為新增病灶，考慮肝轉移瘤，另肝內數個小囊腫，2、兩腎多發囊腫，兩腎小結石或鈣化；CEA24.8NG/ML；CA199149.1U/ML。於2013.11.2、2013.11.16、2013.11.30予FOLFOX兩週方案“奧沙利鉑(艾恆)120MG靜滴D1+亞葉酸鈣300MG靜滴D1、2+替加氟3G持續泵入44HD1Q2W”姑息性化療3週期，過程順利。後複查腹部CT平掃+，增強：1、胃大部切除術後，殘胃充盈欠佳，吻合口區未見明顯佔位性病變。2、肝右內葉佔位性病變，考慮肝轉移瘤，與2013-10-31舊片對比較前明顯減小，另肝內數個小囊腫。3、所攝入右側腎下腺內側肢增粗，部分略呈結節狀，轉移不能排除。4、兩腎多發囊腫；兩腎小結石或鈣化。CER13.97NG/ML，CA12510.95U/ML。療效評價為PR。於2013.12.16在基礎麻醉上行超聲引導上右肝腫塊射頻消融術，術順，術後無腹痛、噁心、嘔吐等不適。於2013.12.21、2013.01.04予原方案（FOLFOX兩週方案）化療第4、第5週期。目前患者無腹痛、噁心、嘔吐，無納差、乏力，無眼黃、尿黃、面板黃，今為進一步診治，門診擬“胃癌術後肝轉移”收入我科。術後精神、睡眠、食慾尚可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 33}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"label_type": "手術", "overlap": 0, "start_pos": 59, "end_pos": 76}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 224}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 354, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 393}, {"end_pos": 430, "label_type": "藥物", "overlap": 0, "start_pos": 426}, {"end_pos": 441, "label_type": "藥物", "overlap": 0, "start_pos": 439}, {"end_pos": 455, "label_type": "藥物", "overlap": 0, "start_pos": 453}, {"end_pos": 480, "label_type": "藥物", "overlap": 0, "start_pos": 477}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 528, "end_pos": 532}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 533}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 559, "end_pos": 565}, {"end_pos": 579, "label_type": "解剖部位", "overlap": 0, "start_pos": 577}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 593, "end_pos": 599}, {"end_pos": 606, "label_type": "解剖部位", "overlap": 0, "start_pos": 602}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 635, "end_pos": 639}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 651, "end_pos": 657}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 667, "end_pos": 670}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 680, "end_pos": 685}, {"end_pos": 743, "label_type": "藥物", "overlap": 0, "start_pos": 739}, {"end_pos": 746, "label_type": "藥物", "overlap": 0, "start_pos": 744}, {"end_pos": 761, "label_type": "藥物", "overlap": 0, "start_pos": 757}, {"end_pos": 776, "label_type": "藥物", "overlap": 0, "start_pos": 773}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 808, "end_pos": 818}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 821, "end_pos": 828}, {"end_pos": 831, "label_type": "解剖部位", "overlap": 0, "start_pos": 830}, {"end_pos": 856, "label_type": "解剖部位", "overlap": 0, "start_pos": 852}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 864, "end_pos": 868}, {"end_pos": 893, "label_type": "解剖部位", "overlap": 0, "start_pos": 892}, {"end_pos": 913, "label_type": "解剖部位", "overlap": 0, "start_pos": 905}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 933, "end_pos": 939}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 940, "end_pos": 948}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 949, "end_pos": 952}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 963, "end_pos": 968}, {"label_type": "手術", "overlap": 0, "start_pos": 1004, "end_pos": 1018}, {"end_pos": 1026, "label_type": "解剖部位", "overlap": 0, "start_pos": 1025}, {"end_pos": 1091, "label_type": "解剖部位", "overlap": 0, "start_pos": 1090}, {"end_pos": 1108, "label_type": "解剖部位", "overlap": 0, "start_pos": 1107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1129, "end_pos": 1136}]}
{"originalText": "，患者因“進食阻擋感1月餘”於2017.10.23第1次入住我院，入院後完善相關輔助檢查，CT檢查示“考慮食管上段賁門CA可能性大，請結合內鏡檢查；肝多發囊腫；肝內鈣化灶”，給予抑酸、保護胃黏膜、抗氧化等對症支援治療，結合患者病史、胃鏡檢查、活檢病理，診斷賁門腺癌明確，為行手術治療於2017.10.25由消化科轉入胸外1科。轉科後完善相關術前檢查，排除手術禁忌後，於2017.10.27全麻上行賁門癌根治術，術後病理（2017.10.31，病理號201725281），示：賁門腺癌（中度分化），浸潤潰瘍型，體積4*3.5*0.6CM，侵達漿膜；雙端切線未查見癌；一組（1個）、二組（1個）、三組（4個）、“上段食管旁”（3個）、“賁門周圍”（4個）、“胃右動脈旁”（8個）淋巴結未查見癌。，免疫組化染色示：CERBB-2（3+）、SYN（-）、β-TUBULIN-III少數（+）、 RRM1少數（+）、TOPOII多數（+）。術後給予霧化、化痰、抗感染、抑酸、止疼、補液、營養支援等治療，患者術後恢復良好，經口進食未訴明顯不適、病情平穩後出院。   患者自出院以來半流質飲食，偶有進食哽噎感，伴胸骨後燒灼感，無進食疼痛，無噯氣、呃逆，無聲音嘶啞、飲食嗆咳，無咳嗽、咳痰，無咯血，無胸痛、胸悶，無心悸，無噁心、嘔吐，無腹痛、腹瀉，今患者為求進一步診治，再次來我院就診，擬行全身化療為主的腫瘤綜合治療，門診以“賁門癌”收入院。   患者神志清，精神、睡眠好，半流質飲食，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 45, "end_pos": 47}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 80, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"end_pos": 204, "label_type": "手術", "overlap": 0, "start_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 237, "end_pos": 253}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 499, "end_pos": 501}, {"end_pos": 543, "label_type": "解剖部位", "overlap": 0, "start_pos": 542}, {"end_pos": 546, "label_type": "解剖部位", "overlap": 0, "start_pos": 545}, {"end_pos": 550, "label_type": "解剖部位", "overlap": 0, "start_pos": 549}, {"end_pos": 561, "label_type": "解剖部位", "overlap": 0, "start_pos": 560}, {"end_pos": 564, "label_type": "解剖部位", "overlap": 0, "start_pos": 563}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 605, "end_pos": 608}]}
{"originalText": "，緣於1月餘前因“進行性吞嚥困難伴疼痛半年，加重半個月”就診我院，查胃鏡示“食管癌（距門齒22CM）”，病理（，病理號：201334934）示“食管鱗狀細胞癌II級”；，胸腹部CT示：1、食管下段管壁不規則增厚，符合食管癌改變，腫塊與氣管後壁分界不清，鄰近食管下段周圍多發腫大淋巴結，下腹部賁門周圍一淋巴結輕度增大，2、兩上肺少許慢性炎症；兩側胸腔少量積液，3、左側甲狀腺甲狀腺佔位性病變。考慮腫瘤較大，尚不適手術，予排除化療禁忌症，於2013.11.15按“順鉑40MGD1-3+安素泰240MGD2”行新輔助化療，輔以止吐、制酸、保胃、抗過敏等治療，化療過程順利，無訴特殊不適。今為行化療再次入院。近來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 82}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 85, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 153}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 232, "label_type": "藥物", "overlap": 0, "start_pos": 230}, {"end_pos": 244, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}]}
{"originalText": "，緣於入院前2月於我院查胃鏡示：1.食管癌；2.慢性萎縮性胃炎；3.胃角潰瘍(S2期)，，胃鏡病理：(門齒30CM)，：送檢食管粘膜，鱗狀下皮高級別下皮內瘤變，部分癌變為鱗狀。胸部CT平掃+，增強示：主動脈弓上緣水平至右上上肺靜脈水平食管壁不規則明顯增厚，考慮食管癌，侵犯外膜可能，伴縱膈及所攝入右鎖骨窩區、肝胃間隙多發腫大淋巴結，遂門診擬食管癌收入院，患者食管中上段鱗癌診斷明確，據其腫瘤分期需行術前新輔助化療，2016-05-29、2016-06-25予以TP方案“紫杉醇（泰素）210MGIVGTTD2+順鉑40MGIVGTTD1-3”方案化療，輔以保肝、保胃、抗腫瘤等治療。發病以來，精神、睡眠可，食慾欠佳，大小便如常，體重減輕6公斤。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 21}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 43}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 67, "end_pos": 79}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 88, "end_pos": 98}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 186}, {"end_pos": 238, "label_type": "藥物", "overlap": 0, "start_pos": 235}, {"end_pos": 241, "label_type": "藥物", "overlap": 0, "start_pos": 239}, {"end_pos": 257, "label_type": "藥物", "overlap": 0, "start_pos": 255}, {"end_pos": 280, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}]}
{"originalText": "，緣於入院前4月餘因胸悶、氣促就診我院，，查全腹部CT提示：1、胃體部大彎、小彎壁不規則增厚，伴肝胃間隙、腹膜後多發淋巴結腫大，網膜增厚，為胃CA侵出漿膜層併網膜種植轉移。2、腹腔、盆腔見大量積液。3、脾內類圓形低密度影，可能為轉移瘤。4、兩附件區多發囊實性病灶，為種植轉移可能性大。5、所攝入兩肺少許炎症，兩側胸腔少量積液。6、所攝入右房、右室增大。，我院麻醉胃鏡：胃體癌慢性萎縮性胃炎。，病理示：（胃體）送檢炎性肉芽組織中見多灶粘液湖，其內漂浮個別印戒樣細胞，高度可疑癌。2014.03.03行“腹腔置管引流術”，於2014.03.05、2014.04.10予“樂沙定100MG+裡葆多40MG”方案化療，輔以保肝、止吐、補液等處理。過程順利，無訴不適。03.14予腹腔腔內注射替加氟1G*3天+腫瘤壞死因子200萬IU。於2014.05.14按“奧沙利鉑(艾恆)150MG靜滴D1+裡葆多40MGD2”方案化療，05.19、05.22、05.26予腹腔內注射“腫瘤壞死因子300萬IU”。2014.06.23按“紫杉醇（安素泰）180MG+替吉奧60MGBID*14D”方案化療，輔予止吐、保肝、營養等治療,於2014.06.25予腫瘤壞死因子300萬IU腹腔滴注。此次為化療再次就診我院，門診擬胃體癌伴腹腔種植轉移收入院。下次出院以來精神、睡眠、飲食尚可，訴偶有下腹脹痛不適，無發熱，大小便正常，體重較前無明顯變化。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 85}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 194}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 257, "label_type": "手術", "overlap": 0, "start_pos": 250}, {"end_pos": 286, "label_type": "藥物", "overlap": 0, "start_pos": 283}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 292}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 344, "label_type": "藥物", "overlap": 0, "start_pos": 341}, {"end_pos": 356, "label_type": "藥物", "overlap": 0, "start_pos": 350}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 376}, {"end_pos": 383, "label_type": "藥物", "overlap": 0, "start_pos": 381}, {"end_pos": 397, "label_type": "藥物", "overlap": 0, "start_pos": 394}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 427}, {"end_pos": 439, "label_type": "藥物", "overlap": 0, "start_pos": 433}, {"end_pos": 462, "label_type": "藥物", "overlap": 0, "start_pos": 459}, {"end_pos": 466, "label_type": "藥物", "overlap": 0, "start_pos": 463}, {"end_pos": 476, "label_type": "藥物", "overlap": 0, "start_pos": 473}, {"end_pos": 500, "label_type": "解剖部位", "overlap": 0, "start_pos": 499}, {"end_pos": 525, "label_type": "藥物", "overlap": 0, "start_pos": 519}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 531}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 551, "end_pos": 561}, {"end_pos": 587, "label_type": "解剖部位", "overlap": 0, "start_pos": 585}]}
{"originalText": "，患者因“下腹部隱痛不適3月”於2014年4月就診我院門診，行胃鏡病理示低分化腺癌，後入住我院胃腸外科於2014年5月6日在全麻上予行根治性遠端胃大部切除、畢II式吻合術，術後病理（201406646），：胃竇部腺癌(中、低度分化)，體積4.6*4.5*0.3CM，侵達粘膜上層。雙端切線未查見癌。呈四組（2/5個）、五組（1/3個）淋巴結癌轉移。六組（4個）、“1、3、7組”（10個）淋巴結未查見癌。（腹膜後）脂肪壞死結節。，免疫組化染色示：ERCC1少量（+）、β-TUBULIN-III少量（+）、TS少量（+）、RRM1（-）、TOPOII多量（+）、CERBB-2（-）、SYN（-）、CGA（-） 。術後患者恢復順利，並行輔助化療5週期，，化療方案為：奧沙利鉑200MG D1，希羅達2.0G BID D1-D14；化療期間患者無明顯副反應。末次化療時間2014年10月8日。患者為行復查於2014年12月入住我科複查，CT：胃賁門癌術後CT所見，建議結合臨床，左肺結節灶，較前無明顯變化。肝臟多發低密度，符合囊腫CT表現，較前無明顯變化，建議複查。複查腹部彩超示；肝內鈣化灶，肝囊腫，膽囊息肉，右上腹皮上脂肪層強回聲團，考慮脂肪瘤。此次為行復查入院。     目前患者精神及情緒狀態可，飲食好，夜間睡眠可，大小便正常，近期無明顯體重變化。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 5}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 49}, {"label_type": "手術", "overlap": 0, "start_pos": 67, "end_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 116}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 204}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 333}, {"end_pos": 349, "label_type": "藥物", "overlap": 0, "start_pos": 346}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 417, "end_pos": 419}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 420, "end_pos": 426}, {"end_pos": 440, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 452}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 464, "end_pos": 466}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 484, "end_pos": 488}, {"end_pos": 491, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 496, "end_pos": 499}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 500, "end_pos": 504}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 505, "end_pos": 508}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 520, "end_pos": 523}]}
{"originalText": "，患者因患“胃癌”於2006-8-9於我院在全麻上予行“姑息性近端胃大部切除、幽門成形術”，，術後病理回示：賁門腺癌（中度分化），浸潤潰瘍型，面積6*3CM，侵穿漿膜，周圍淋巴結未查見癌。術後行6週期化療，化療期間病人無明顯不適，適應性良好。自出院後，患者每年複查1次，一般情況保持良好,近來感下腹部隱痛不適，無發熱、腹瀉、腹脹，無反酸、噯氣等不適。３月前患者再次來院複查，查CEA明顯增高，為83.96NG/ML,，行胃鏡檢查示：食管上端近原手術吻合口見菜花樣病變，胃食管食管吻合口以遠至胃體，見大面積的菜花樣隆起，，病理示：（胃體）高級別下皮內瘤變（重度異型增生及原位癌）。考慮胃癌術後復發可能性大，已給予序貫化療３次，方案為奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴。經化療後CEA指標呈上降趨勢，最近１次CEA為50.12NG/ML化療期間患者消化道反應較重、白細胞降低，均給予對症處理。出院後一般情況良好，進食、大小便恢復正常。現患者為行進一步複查治療就診，門診以“胃癌術後”收入院。   目前患者精神及情緒狀態可，食慾、飲食可，夜間睡眠正常，大小便正常，近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 70}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 188, "end_pos": 191}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 264, "end_pos": 288}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"end_pos": 319, "label_type": "藥物", "overlap": 0, "start_pos": 315}, {"end_pos": 332, "label_type": "藥物", "overlap": 0, "start_pos": 328}, {"end_pos": 346, "label_type": "藥物", "overlap": 0, "start_pos": 343}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 380, "end_pos": 383}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 462, "end_pos": 466}]}
{"originalText": "，患者2010年8月無明顯誘因上出現下腹部疼痛，呈陣發性，隱痛，不劇烈，不伴噁心、嘔吐、腹瀉、便血、黑便、嘔血等，外院查腸鏡檢查，未見明顯異常,於2011年3月8日外院胃鏡示胃體腫瘤？胃竇多發息肉（I型），，我院會診病理示：（胃底）粘膜固有層內見異型細胞，部分呈印戒細胞樣，腫瘤性病變不能除外，免疫組化考慮非霍奇金淋巴瘤，，瀰漫大B細胞型：CK廣（-）、CK8（-）、LCA（+++）、CD79A（+++100%）、CD20（+++100%）、CD3（少數小淋巴細胞+）、CD10（部分+）、BCL-2（+）、MUC-1（部分+）、KI-67（++90%）、CD30（++）、CD15（-）、CD56（-）、GRANB（-）。，外院腹部B超：脾稍大、肝膽囊胰體腎未見明顯異常、腹腔未見明顯積液。2011年3月21，外院行腹部CT示：下腹部CT增強未見明顯異常。遂於2011/3/25收入我科。，入院後血常規：，紅細胞計數: 4.65X10^12/L；，血紅蛋白: 132G/L；，血小板計數: 168X10^9/L；，白細胞計數: 4.53X10^9/L；，中性粒細胞百分比: 66.7%；，淋巴細胞百分比: 22.7%；PET/，CT：淋巴瘤病例；胃體、胃竇區域性胃壁增厚伴糖代謝異常增高，符合淋巴瘤影象表現。，骨髓穿刺塗片：骨髓增生欠活躍，髓象中紅系增生尚可，粒、巨二系增生欠活躍，形態、比例均無明顯異常。，骨髓活檢：（骨髓）鏡上為骨髓滴，免疫組化結果示，造血組織三系細胞均可見到，各系細胞形態未見明顯異常，未見到淋巴瘤累及骨髓證據，請結合臨床。免疫組化(11-N1436)，：MPO(粒系+) CD61(巨核+) CD68(組織細胞+) CD34(-) CD20(少數淋巴+) CD79A(少數淋巴+) CD3(少數淋巴+) CD56(-) KI-67(50%+) CYCLIND1(-) VS38C(少數+) BCL-2(少數淋巴+) CD10(-) TDT(-) 網染示網狀纖維不增生。患者於2011-3-29/2011-4-29行R-CHOP方案化療（美羅華 0.6 D0+CTX1.2 D1+蓋諾40MG D1+EADM120MG D1+DEX15MG D1-D5），化療過程中無明顯不適。，患者出院後隨訪血常規：5/11，紅細胞計數: 4.02X10^12/L；，血紅蛋白:112G/L；，血小板計數:140X10^9/L；，白細胞計數:1.2X10^9/L；，中性粒細胞百分比:24.0%；，淋巴細胞百分比: 0.7%；5-18，隨訪血常規: 紅細胞計數 4.57X10^12/L；，血紅蛋白:125G/L；，血小板計數:292X10^9/L；，白細胞計數:6.3X10^9/L；，中性粒細胞百分比:83.9%；，淋巴細胞百分比: 14.6%。患者出院後無明顯不適，現為行第3次化療收入病房。患者發病以來，神清，精神可，胃納可，二便可，體重無明顯上降。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 102}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 169}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 316, "end_pos": 320}, {"end_pos": 322, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 328}, {"end_pos": 331, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 366, "end_pos": 371}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 405, "end_pos": 410}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 426, "end_pos": 430}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 440, "end_pos": 445}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 459, "end_pos": 464}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 479, "end_pos": 487}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 496, "end_pos": 503}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 511, "end_pos": 518}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 519, "end_pos": 522}, {"end_pos": 527, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 528}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 532, "end_pos": 533}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 547, "end_pos": 550}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 658, "end_pos": 661}, {"end_pos": 884, "label_type": "藥物", "overlap": 0, "start_pos": 881}, {"end_pos": 895, "label_type": "藥物", "overlap": 0, "start_pos": 892}, {"end_pos": 904, "label_type": "藥物", "overlap": 0, "start_pos": 902}, {"end_pos": 915, "label_type": "藥物", "overlap": 0, "start_pos": 912}, {"end_pos": 928, "label_type": "藥物", "overlap": 0, "start_pos": 925}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 968, "end_pos": 973}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 989, "end_pos": 993}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1002, "end_pos": 1007}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1020, "end_pos": 1025}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1038, "end_pos": 1046}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1054, "end_pos": 1061}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1080, "end_pos": 1085}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1100, "end_pos": 1104}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1113, "end_pos": 1118}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1131, "end_pos": 1136}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1149, "end_pos": 1157}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1165, "end_pos": 1172}, {"end_pos": 1219, "label_type": "解剖部位", "overlap": 0, "start_pos": 1218}]}
{"originalText": "，緣於入院前1年餘患者因“體檢發現“血PSA”升高1個月”為主訴入院，，入院後查免疫:T--PSA5.05NG/ML、F--PSA0.463NG/ML、F/T9.2。行“B超引導上經直腸前列腺穿刺活檢”，恢復好，病理報告（201231203），：1.（右外側中部），:前列腺癌GLEANSON分級III級（評分2＋3＝5分）。，免疫組化染色：灶性CK(H)、P63示腺體基底細胞消失，P504S腺體陽性。2.（右、左外側基底部）、（左外側中部）、（右、左外側尖部），:前列腺增生症，伴PINI級。，免疫組化染色：CK(H)（基底細胞+），P63（基底細胞+），P504S（－）。，全身骨ECT示：未見明顯異常。當時予擬手術治療，因患者暫不想手術並要求出院，故未經手術治療，予口服‘氟他安’治療，並囑其出院後定期複查。1年患者定期複查PSA均無異常。今為進一步診療求診我院。門診擬“前列腺癌”收入院。患者自發病來體重無明顯變化，體力情況良好，小便如前所述，大便正常，睡眠良好，食慾一般，精神狀態一般。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 43, "end_pos": 49}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 59, "end_pos": 65}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 76, "end_pos": 79}, {"end_pos": 100, "label_type": "手術", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 134, "end_pos": 152}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 247}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 290, "end_pos": 296}, {"end_pos": 343, "label_type": "藥物", "overlap": 0, "start_pos": 340}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 366, "end_pos": 369}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 394}]}
{"originalText": "入院前2+月，因診斷結腸腫瘤於我科住院治療，於2015年09月24日在全麻上行腹腔鏡上腹腔探查術、中轉開腹，右半結腸癌根治術、小腸繫膜結節活檢、開腹腫瘤特殊治療、腸粘連鬆解術。術後病檢示（病理號1508031）：右半結腸粘液性腺癌（中分化），侵及漿膜層外脂肪組織、腸繫膜及網膜癌轉移、腸繫膜淋巴結未見癌轉移（0/14），兩側切緣未見癌累及。術後予以止血、鎮痛、補液、抑酸、霧化祛痰、抗感染等對症治療。目前患者無噁心、嘔吐、腹痛、腹脹、便血等表現，今日前來我院，擬行第2次化療，故以\\\"右半結腸癌術後 第2次化療\\\"收入我科住院治療。   近期患者精神、食慾、睡眠可，大小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 39, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 120}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 141}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 242, "end_pos": 249}]}
{"originalText": "，2016.2.17行“胃癌切除術”，具體術式不詳，術後病理示（遠端胃及大網膜），切除：潰瘍型低分化腺癌，伴印戒細胞癌，LAUREN，分型：瀰漫型；癌侵及漿膜；可見脈管癌栓及神經侵犯（免疫組化CD34、D2-40證實）；十二指腸殘端及胃殘端未見癌；網膜組織未見癌；淋巴結可見癌轉移（第1組6/12，第3組1/1，第4SB組0/0，第4D組0/1，第5組1/1，第6組6/8，第7組1/1，第8組1/3，第9組0/3，第11P組0/0，第12A組0/0，第14V組1/1）；（第1組淋巴結）其中一枚淋巴結內見異位胰腺組織；- ，腫瘤病理分期：PT4AN3B。，免疫組化結果顯示腫瘤:AFP(－),CMET(1+),EBER(－),EGFR(2+),HER2(0),KI-67(+25～50%),MLH1(+＞75%),MSH2(+＞75%),MSH6(+＞75%),PDL-1(－),PMS2(+＞75%),SALL4(－),CK(+)。，淋巴結轉移癌：CK（+）。入組RESOLVE A組 已行XELOX方案化療3週期，末次化療2016.04.11，化療後出現噁心2度，影響進食，目前患者大小便基本正常，化療後體重上降3KG。", "entities": [{"end_pos": 17, "label_type": "手術", "overlap": 0, "start_pos": 12}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 34, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 114}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 243}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}]}
{"originalText": "，患者因卵巢癌於2016-04-12行“經腹筋膜外子宮+兩附件切除+大網膜切除+闌尾切除+盆腔轉移病灶清除+腫瘤細胞減滅術”，手術過程順利，術後輸液抗炎治療。，常規病理結果示：（兩側附件）高級別漿液性乳頭狀癌，右卵巢腫物切面積2.8*1.5CM，左卵巢腫物切面積6*3.5CM，兩側輸卵管查見癌。闌尾、“盆腔轉移灶”查見癌，另送大網膜組織中查見癌。（子宮）萎縮的子宮內膜；慢性宮頸炎。右宮旁查見癌，左宮旁未查見癌。，免疫組化：ER(2+,20%),PR(1+,2%),WT-1(+),P53(-),KI67陽性率約50%。於2016-01-22給予多西他賽（多帕菲）100MG+卡鉑400MG方案化療，患者住院期間化療毒副反應輕。今日入院，擬行第2次化療。患者自出院後，無發熱，無咳嗽咳痰，噁心嘔吐輕，無腹痛腹脹，無陰道流血及排液，飲食睡眠可，大小便無異常，體重增加1KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手術", "overlap": 0, "start_pos": 20, "end_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 104}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 201}, {"end_pos": 278, "label_type": "藥物", "overlap": 0, "start_pos": 274}, {"end_pos": 282, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"end_pos": 291, "label_type": "藥物", "overlap": 0, "start_pos": 289}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}]}
{"originalText": "患者因“腹痛1月餘”於2011-11-17入我院，查CA125為1349U/ML，CA153為189.7U/ML，NSE為25.15NG/ML。B超提示“左側卵巢實性佔位伴中至大量腹水”，考慮“卵巢癌”，於2011-11-24行“腫瘤細胞減滅術（全子宮+兩附件切除術+大網膜切除術+DIXON術+回盲部切除術）”。術程順利，減瘤滿意，殘存腫瘤直徑小於1CM。術後病理示：兩側卵巢見低分化漿液性腺癌浸潤，脈管內見癌栓；子宮底壁外膜層、右輸卵管外膜層、直腸外膜層及肌層見漿液性腺癌浸潤；回盲部腸管腸壁漿膜層、肌層、粘膜上層及粘膜層均見低分化漿液性腺癌浸潤，脈管內見癌栓，另見2枚淋巴結有腺癌轉移；餘送檢、大網膜、結腸表面腫物均見低分化腺癌浸潤。術後診斷“卵巢漿液性腺癌IIIC期”。術後出現腸瘻，保守治療效果欠佳，遂於2011-12-09行“腹腔清創引流+迴腸造瘻術”，術後予加強營養等治療。一般情況恢復、腹壁切口癒合良好後於2012-01-18、2012-02-23、2012-5-17予TP（北華素180MG，波貝500MG）方案化療3程，化療後無明顯噁心、嘔吐反應，出現兩腳底麻木感，予營養神經治療後好轉。今遵原主診教授意見為行化療入院。下次出院至今，患者精神、食慾、睡眠可，大便正常，小便順暢，體重稍有增加。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 26, "end_pos": 31}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 41, "end_pos": 46}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 57, "end_pos": 60}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 100}, {"label_type": "手術", "overlap": 0, "start_pos": 115, "end_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 247}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 265, "end_pos": 273}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 293}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 312, "end_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 325, "end_pos": 337}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 343, "end_pos": 345}, {"label_type": "手術", "overlap": 0, "start_pos": 369, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"end_pos": 449, "label_type": "藥物", "overlap": 0, "start_pos": 446}, {"end_pos": 457, "label_type": "藥物", "overlap": 0, "start_pos": 455}, {"end_pos": 489, "label_type": "解剖部位", "overlap": 0, "start_pos": 486}]}
{"originalText": "，患者3余月前因“胃癌”於我院在全麻上行“胃大部切除術”。，術中探查：未見腹水，P0H0，腫瘤位於胃竇小彎明顯浸透漿膜外，漿膜呈皺縮上凹狀部分網膜覆蓋其下。，術後病理：，病理診斷：，進行期胃竇癌：BORRMANN3型 浸潤深度（SE）　浸潤潰瘍型，低－中分化腺癌 斷端無癌 ，靜脈癌栓：，無　淋巴管癌栓：無　伴淋巴結轉移(1/38枚) 。（，病理號：199546）。患者術後恢復良好。今為求進一步治療，遂來我院。病來，患者飲食睡眠可，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"end_pos": 27, "label_type": "手術", "overlap": 0, "start_pos": 21}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 131}]}
{"originalText": "緣於入院前1餘年前於我院診為胃癌，於2012-08-07在全麻上行根治術全胃切除術。術後病理（201223223）示全胃：食管胃交界潰瘍型管狀腺癌，II-III級，侵出漿膜層，侵犯脈管和神經。手術標本下切端見癌浸潤，手術標本上切端和另送（下切端）未見癌浸潤。鏡上找到賁門周淋巴結3/8個、小彎淋巴結3/4個、大彎淋巴結0/1個、幽門下淋巴結0/4個和幽門上淋巴結0/1個見癌轉移。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲，並順利出院，2012.09.24行“伊立替康280MG+替吉奧60MGBID×14D”方案化療1週期，2012.10.23按“伊立替康280MG+替吉奧40MGBID×14D”方案化療1週期，2012.11.20按“伊立替康240MG+替吉奧80MGBID×7D”化療1次,2012.12.22按““安素泰210MG+艾奕40MGBID×14D”化療1次，2013.1.18予“安素泰240MG+替吉奧40MGBID×14D”方案化療1次，2013.02.23按T“安素泰240MG”方案化療1週期。2014.08.28予“表柔比星70MGIVGTTD1+替吉奧40MGBID×10D”方案化療1次，2014.09.22予“表柔比星70MGIVGTTD1+安素泰210MGIVGTTD1+替吉奧40MGBID×14D”。今為再次化療就診我院，門診擬胃癌術後化療後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 81}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 241, "label_type": "藥物", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "藥物", "overlap": 0, "start_pos": 247}, {"end_pos": 286, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 292}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 327}, {"end_pos": 340, "label_type": "藥物", "overlap": 0, "start_pos": 337}, {"end_pos": 372, "label_type": "藥物", "overlap": 0, "start_pos": 369}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 411, "label_type": "藥物", "overlap": 0, "start_pos": 408}, {"end_pos": 420, "label_type": "藥物", "overlap": 0, "start_pos": 417}, {"end_pos": 455, "label_type": "藥物", "overlap": 0, "start_pos": 452}, {"end_pos": 485, "label_type": "藥物", "overlap": 0, "start_pos": 481}, {"end_pos": 500, "label_type": "藥物", "overlap": 0, "start_pos": 497}, {"end_pos": 535, "label_type": "藥物", "overlap": 0, "start_pos": 531}, {"end_pos": 550, "label_type": "藥物", "overlap": 0, "start_pos": 547}, {"end_pos": 566, "label_type": "藥物", "overlap": 0, "start_pos": 563}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 593, "end_pos": 597}, {"end_pos": 622, "label_type": "解剖部位", "overlap": 0, "start_pos": 621}, {"end_pos": 625, "label_type": "解剖部位", "overlap": 0, "start_pos": 624}]}
{"originalText": "，患者4年前因\\\"胸中段段食管中-低分化鱗癌\\\"於我院行“經右胸食管癌根治+胃食管主動脈弓下吻合術”，，術後複查：2015年2月25日，我院CT檢查示：食道癌術後改變，縱隔胃代食管未見明顯軟組織腫物。氣管右側旁淋巴結轉移。，超聲檢查示：右側頸部VI區及IV區小淋巴結，其中VI區最大淋巴結較前次檢查（2014-11-04）增大，考慮惡性可能性大。2015年02月27日，右頸腫大淋巴結穿刺活檢病理考慮：增生的纖維組織中見高至中分化鱗狀細胞癌浸潤，考慮為食管癌轉移。現患者出現聲嘶20天，考慮右頸轉移淋巴結侵犯喉返神經。今為進一步診治收入我科。起病以來，患者無發熱、咳嗽，無胸悶、胸痛，無噁心、嘔吐，胃納、睡眠、精神可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 49}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 81}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 136, "end_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 192}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 255}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}]}
{"originalText": "，緣於4個月前因食管胃交界腺癌於我院行（2015.10.19）正中開腹根治性全胃切除+食管-空腸ROUX-EN-Y吻合+空腸造瘻+脾切除術，術後病理（201537413），：(全胃)，：食管-胃交界處潰瘍型混合型腺神經內分泌癌【腺癌為管狀腺癌II-III級，神經內分泌腫瘤為G3型（神經內分泌癌）】，浸潤脈管及神經組織，脈管內見癌栓，侵出漿膜層。手術標本下切端、上切端，及另送(最下切端)均未見癌浸潤。找到賁門周淋巴結1/4個，小彎側淋巴結1/11個，大彎側淋巴結0/6個，幽門上淋巴結0/2個。脾臟組織。，免疫組化染色結果：KI67（30%陽性），P53（++），MLH1（++），MSH-6（+++），CGA（+++），CD56（++），SY（++）。（MM2051901）該病例未檢測到KRAS基因12、13號密碼子熱點突變。（MM20151902）該病例未檢測到BRAF基因V600E突變。術後恢復良好，目前進食半流質膳食，無不適。分別於2015.11.25、2015.12.25、2016.01.21日行3週期化療，“順鉑40MG靜滴D1-3+紫杉醇180MG靜滴D2”方案，今為求術後第4週期化療再診我院，門診擬食管胃交界腺癌術後化療收住我科。近來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 15}, {"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 69}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 93, "end_pos": 149}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 466, "label_type": "藥物", "overlap": 0, "start_pos": 464}, {"end_pos": 480, "label_type": "藥物", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 512, "end_pos": 521}]}
{"originalText": "，患者5年餘前因\\\"升結腸癌\\\"在外院手術治療，術後規律完成輔助化療（XELOX方案化療8程），但未規律複查。近1年偶有大便帶血，量少，大便不成形，1-3次/天，無腹痛、腹脹，無黑便、噁心等，未予重視。於2015-01月至外院複查腸鏡發現距肛40CM結腸腫物，腸鏡不能透過，活檢病理提示腺癌。 於2015-01-22至我院全麻上行\\\"右半結腸切除術\\\"，，術後病理示：（乙狀結腸大體）鏡檢為腸低分化腺癌（印戒細胞癌），浸潤至腸壁漿膜上層，未見脈管內癌栓及神經束侵犯；網膜組織未見癌。區域淋巴結15/22（+），，免疫組化：ER（-），ERCC1（+），MLH1（+），MSH2（-），MSH6（-），PMS2（+），KI67（40%+），CK（+）。，術後分期：PT3N2BM0 IIIC期。於2015-03-25、2015-04-11、2015-04-28、2015-05-12及2015-05-26;2015-6-9、2015-06-23給予 FOLFOX 方案化療7程順利，化療耐受性可，今為進一步治療入院。近期患者精神胃納睡眠尚可，大小便正常，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 145}, {"end_pos": 174, "label_type": "手術", "overlap": 0, "start_pos": 167}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 212, "end_pos": 213}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}]}
{"originalText": "入院前1月，患者因確診“食管下段鱗癌”於2016年04月11日在全麻+兩腔上行經頸胸腹下段食管癌切除術、術後標本送病檢（1603183）：食管鱗狀細胞癌侵及全層，遠近切緣均未見癌累及，賁門上淋巴結見癌轉移（1/1）,胃右動脈旁、隆突上淋巴結未見癌轉移，術後予以心電監護、禁食、水、胃腸減壓、靜脈高營養、抗感染、祛痰、解痙、護胃、止血、降血壓等對症支援治療後，好轉出院。今患者為行第一次化療來我院就診，門診以“食管癌”收入我科住院治療。   自患病以來，患者精神、食慾、睡眠尚可，二便正常，體徵無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"end_pos": 51, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 76}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 108, "end_pos": 120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 140, "end_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 207}]}
{"originalText": "，患者於69天前於我院因“，盆腔包塊：卵巢CA?”行“腹腔鏡上腹膜活檢術+右側卵巢切除術”，術中切除右側卵巢及2.0CM*1.0CM大小腹膜送冰凍病理切片，2013-4-27 ，冰凍切片報告單檢查報告：1、（右卵巢）卵巢組織中見腺癌。2、（腹膜）纖維脂肪組織中見腺癌。檢查無活動性出血後，手術順利，麻醉滿意，術中出血約50ML，術畢安返病房。2013-4-28 ，組織病理檢查報告：1、（右卵巢）送檢組織中見腺癌組織，待免疫組化進一步明確型別。2、（腹膜）送檢纖維脂肪組織中可見少許腺癌組織。2013-05-03（右卵巢）中-低分化宮內膜樣腺癌伴腹膜轉移。，術後給予：補液、抗炎對症治療。術後給予紫杉醇靜滴+順鉑腹腔灌注化療雙次，化療過程中病員有噁心、嘔吐等不適。現患者來我院要求行第3次化療。\\U0004   患者本次發病以來，食慾減退， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 23}, {"label_type": "手術", "overlap": 0, "start_pos": 27, "end_pos": 44}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 116}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 133}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 277}, {"end_pos": 301, "label_type": "藥物", "overlap": 0, "start_pos": 298}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 304}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}]}
{"originalText": "緣於入院1年前於我院診為“直腸癌伴肝轉移”，於2015年12月07日在全麻上行“腹腔鏡上直腸姑息性切除術+末段迴腸造瘻術”，術順，術後病理示：（直腸）大腸潰瘍型管狀腺癌II級，部分為篩狀粉刺型，侵出外膜層，手術標本雙切端及另送(下切端)(上切端)均未見癌浸潤，找到腸周淋巴結2/21個，及另送(腸繫膜上動脈根部)淋巴結0/1個，見癌轉移。術後恢復良好。於2015.12.30、2016.01.21、2016.02.13、2016.03.06、2016.03.30、2016.04.22、2016.05.12、2016.06.03、2016.06.27、2016.07.21、2016.08.11、2016.9.02、2016.10.27、2016.11.18、2016.12.23行“伊立替康240MGIVGTTD1+卡培他濱1500MGPOBIDD1-D14”化療，輔以止吐、制酸、保肝、增強免疫等，化療過程順利，未見明顯不適。出院後無頭暈、乏力，無口腔潰瘍、手足麻木無力等不適。此次為行第16次化療就診我院，門診擬“直腸癌術後化療”收入院。下次出院以來精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 40, "end_pos": 60}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 87}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 346, "label_type": "藥物", "overlap": 0, "start_pos": 342}, {"end_pos": 363, "label_type": "藥物", "overlap": 0, "start_pos": 359}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 426}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 431, "end_pos": 432}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 432, "end_pos": 433}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 460, "end_pos": 465}]}
{"originalText": "緣於1個多月前因食管下段癌於我院行胸腹腔鏡聯合全胸段食管切除+食管-胃底右頸部吻合術。手術順利。術後病理（病理號：201607041）示食管髓質型高分化鱗狀細胞癌，侵及外膜層，手術標本雙切端未見癌浸潤，找到食管周淋巴結1個，未見癌轉移。現患者一般情況尚可，無明顯噁心、嘔吐，無頭暈、頭痛，無咳嗽、咳痰，無胸悶、胸痛，無腹痛、腹脹，無周身骨骼疼痛等不適。今為求入院第1週期化療再診我院，門診擬食管癌（T3N2M0IIIB期）收住我科。近來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 17, "end_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 81}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 211}]}
{"originalText": "，患者2月餘前因“反覆劍突上痛3年餘，加重2月。”入院，入院完善輔助檢查後於2015.12.09在OR於全麻上行“遠端胃切除+B-II重建+空腸BRAUN吻合”術，術後予以預防感染，對症支援治療，恢復順利，，術後病理:（胃大體）鏡檢為胃粘液腺癌，LAUREN，分型：腸型，浸潤至胃壁漿膜層，可見脈管及神經束侵犯；網膜組織未見癌。切緣未見癌。淋巴結6/44見粘液腺癌轉移。，免疫組化：癌細胞 HER-2（0），VEGF（+）。，原位雜交：EBERS（-）。術後於2016-01-20行SOX（奧沙利鉑 150MG + 替吉奧 50MG BID）第1療程化療，無明顯不良反應。現為行術後第二次化療返院。自下次出院，患者無發熱，無頭痛、頭暈，無咳嗽、咳痰，無心悸、胸悶、胸痛，無尿頻、尿急。精神、睡眠可，胃納一般，二便正常，患者體重上降2KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 49, "end_pos": 51}, {"label_type": "手術", "overlap": 0, "start_pos": 57, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"end_pos": 249, "label_type": "藥物", "overlap": 0, "start_pos": 245}, {"end_pos": 262, "label_type": "藥物", "overlap": 0, "start_pos": 258}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 329}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}]}
{"originalText": "，緣於入院前28個月因結腸息肉行腹部CT示肝臟數個低、稍低密度灶，部分為小囊腫，部分轉移瘤不能排除，並於2012.03.06行腹腔鏡上乙狀結腸病損切除術，術後病理(201206355)，示：(降結腸腫瘤及腸管系膜)，：腸潰瘍型管狀腺癌II級，侵出外膜層。手術標本雙切口及另送(下切端)、(上切端)均未見癌浸潤。找到腫物周淋巴結4/10個，腸周淋巴結2/8個見癌轉移，術後患者恢復順利出院。於2012-4-25在B超引導上行“左肝轉移灶射頻消融術”，並於2012-5-8及2012-5-30行2次“艾恆150MG+希羅達1000MGBID*14天”化療。於2012-06-22、2012-08-24、2012-10-11、2013-01-18、2013-03-11、2013-04-08行肝動脈置管(5-FU+亞葉酸鈣+艾恆)化療，此後不定期複查。今為進一步治療就診於我院，門診擬結腸癌肝轉移術後介入術後收入院。目前患者精神、睡眠、飲食尚可，大小便無明顯異常，體重未見明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 15}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 76, "label_type": "手術", "overlap": 0, "start_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 101}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 120}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 222, "label_type": "手術", "overlap": 0, "start_pos": 212}, {"end_pos": 250, "label_type": "藥物", "overlap": 0, "start_pos": 248}, {"end_pos": 259, "label_type": "藥物", "overlap": 0, "start_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 344}, {"end_pos": 353, "label_type": "藥物", "overlap": 0, "start_pos": 349}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 354}, {"end_pos": 361, "label_type": "藥物", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 389, "end_pos": 397}]}
{"originalText": "，患者5月餘前因“發作性胸悶、憋氣半年餘，加重1月餘”入院，，行腸鏡檢查提示：結腸癌、結腸多發息肉。查無手術禁忌後於2016-11-03日在全身麻醉上行左半結腸切除術。，術後病理示：結腸腺癌（中-低度分化），浸潤潰瘍型，體積7.5*4*1.7CM，侵穿漿膜，未累及底部切除面及雙端切線。 “一站”（7個）、“二站”（5個）、“三站”（12個）淋巴結未查見癌。慢性闌尾炎，外膜有較多中性粒細胞浸潤。，癌組織免疫組化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（±）。院外期間患者一般情況好，無噁心，無腹痛腹脹脹不適，現患者為行復查及化療來院就診，門診以“結腸癌術後”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 43, "end_pos": 49}, {"end_pos": 83, "label_type": "手術", "overlap": 0, "start_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 301, "end_pos": 306}]}
{"originalText": "，患者2016年2月因“反覆下腹痛4月餘。”入院，入院完善輔助檢查，，明確診斷：胃癌。後於2016-02-17在OR於全麻上行“腹腔鏡輔助胃癌根治術（遠端胃切除+B-II重建+空腸空腸Ｂｒａｕｎ吻合）”，術後予以預防感染，對症支援治療，恢復順利，，術後病理回報：（胃大體）鏡檢為中-低分化腺癌，部分為印戒細胞癌，LAUREN，分型：混合型，癌組織浸潤至胃壁漿膜上層，可見脈管內癌栓及神經束侵犯。切緣未見癌。淋巴結）2/46見腺癌轉移。，免疫組化：CK（+），VEGF（+），HER-2（-）。，原位雜交：EBERS（-）。 術後於2016-03-21、2016-04-11、2016-05-03、2016-05-23、2016-06-13、2016-07-05在我院行(奧沙利鉑 150MG Q3W IVDRIP D1 + 替吉奧 60MG BID PO D1-14)化療6療程，過程順利。現為行術後第7療程化療返院治療。自下次出院以來，患者體重無明顯變化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 74, "label_type": "手術", "overlap": 0, "start_pos": 64}, {"end_pos": 80, "label_type": "手術", "overlap": 0, "start_pos": 75}, {"end_pos": 87, "label_type": "手術", "overlap": 0, "start_pos": 81}, {"end_pos": 99, "label_type": "手術", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 177}, {"end_pos": 339, "label_type": "藥物", "overlap": 0, "start_pos": 335}, {"end_pos": 366, "label_type": "藥物", "overlap": 0, "start_pos": 362}]}
{"originalText": "，患者約於1個月前因“胃癌”於2014-10-23在全麻上行根治性胃大部切除、畢I式吻合術，手術順利，術後給予輸液、抗生素及營養支援等治療。，術後病理示：（9302.2012）胃竇大彎側腺癌（中度分化），浸潤潰瘍型，面積2.5*2CM，厚2.8CM，侵達漿膜。雙端切線未查見癌。四組（5個）、六組（9個）、“1、3、7組”（8個）淋巴結，未查見癌。，術後病理分期：PT4AN0M0，IIB期。院外期間，患者無發熱，無腹痛腹脹不適，大便通暢。現患者為行復查化療來我科就診，以“胃癌術後”收入院。    病人自下次出院以來，神志清，精神可，飲食可，大、小便正常，體重未見明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 168}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 237, "end_pos": 241}]}
{"originalText": "患者因“下腹部疼痛不適，以進食後尤甚，伴返酸、噯氣”，在我院確診胃癌，遂於2015.3.13在我院手術室全麻上行\\\"胃癌根治術（遠端胃大部切除+ROUX-EN-Y重建）\\\"，術程順利，術後恢復可。術後病理提示：T3N3M0，IIIB。 已於2015.4.3、2015.4.22、2015-05-14、2015-6-4,2015-6-26行5程化療，方案為奧沙利鉑+替吉奧，化療期間無明顯副反應，現複查血常規、肝腎功能結果基本正常。現為行上一程化療收入我科。起病以來，患者精神尚可，食慾一般，大小便正常，身體無明顯消瘦。", "entities": [{"end_pos": 7, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"end_pos": 63, "label_type": "手術", "overlap": 0, "start_pos": 58}, {"label_type": "手術", "overlap": 0, "start_pos": 64, "end_pos": 83}, {"end_pos": 181, "label_type": "藥物", "overlap": 0, "start_pos": 177}, {"end_pos": 185, "label_type": "藥物", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 206}]}
{"originalText": "，患者2015年9月9日於全麻上經腹腔鏡直腸癌DIXON術，，術後病理：直腸癌（漿膜上層），扁平隆起型，高分化腺癌，I級，斷端無癌，淋巴結可見癌轉移（5/13枚），，浸潤深度：漿膜上層，周圍神經節侵犯（+)，脈管癌栓（-），結外腫瘤種植（-)，PTNM，分期：T3N2AM0，IIIB期，，免疫組化：KI67（50-70%+），P53(>90%+)，CDX2(>90%+)，CA199(+)，CEA(+++)，GSTP1(+++)，EGFR(+++)，VEGF(++)，MLH1(>90%+)，MSH2(>90%+)，MSH6(>90%+)，PMS2(>90%+)。血管內皮細胞CD34（+）其內未見癌栓，淋巴管內皮細胞D2-40(+)其內未見癌栓,周圍神經S100（+）可見癌侵犯，，病理號：1806。術後患者恢復良好，術後行腹腔穿刺化療一次，今為求進一步治療收入我科。近日無發熱，飲食睡眠可，大小便正常，無腹痛，無便血，近來體重未見明顯變化。ECOG，評分：1分。", "entities": [{"end_pos": 29, "label_type": "手術", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 60}, {"end_pos": 366, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 405}]}
{"originalText": "，患者3月前因“下腹部疼痛不適半年餘，加重伴進食後嘔吐2月餘”入院,於2016-9-7在全麻上行胃癌根治術（畢-II式吻合），手術過程順利，術後患者恢復好，切口癒合好，按期拆線。，術後病理：胃竇低分化腺癌，體積3.5*3.5*1.6CM，浸潤潰瘍型，侵穿漿膜。雙端切線未查見癌。呈“第六組”（6/13個）、“胃第六組”（1/1）淋巴結癌轉移。第三組（4個）、第四組（4個）、“胃第七組”（1個）淋巴結未查見癌。第五組查見癌結節一個。，癌組織免疫組化染色示：CERBB-2（1+）、SYN（-）、β-TUBULIN-III（-）、 RRM1個別（+）、TOPOII（+）。根據患者病情具有化療指徵，於2016-09-25開始第一週期化療，，方案為：奧沙利鉑200MG D1，亞葉酸鈣0.3G+氟尿嘧啶0.75G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，患者化療耐受可，無明顯化療副反應。現患者為求明確診療來我院就診，門診以“胃癌術後”收入我科。   患者自發病以來，精神可，飲食欠佳，睡眠可，二便正常，體重減輕約14KG。體力無明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 53, "label_type": "手術", "overlap": 0, "start_pos": 48}, {"end_pos": 61, "label_type": "手術", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 154, "end_pos": 167}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 200}, {"end_pos": 327, "label_type": "藥物", "overlap": 0, "start_pos": 323}, {"end_pos": 340, "label_type": "藥物", "overlap": 0, "start_pos": 336}, {"end_pos": 349, "label_type": "藥物", "overlap": 0, "start_pos": 345}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 419, "end_pos": 423}]}
{"originalText": "，患者4月前因“下腹部疼痛不適10餘年，加重1月餘”入院，2016-06-02在全麻上行胃癌根治+幽門成形術，手術過程順利，術後患者恢復好，切口癒合好，按期拆線。，術後病理：（201611546），：胃體小彎腺癌（中度分化），區域性伴神經內分泌分化，體積2*1*0.5CM，潰瘍型，侵達淺肌層。雙端切線及另送“近切線”未查見癌。 呈“三組”淋巴結（8/13個）淋巴結癌轉移。“四組”（5個）淋巴結未查見癌。 ，癌組織免疫組化染色示：TS部分（+）、TOPOII多數（+）、β-TUBULIN-III少數（+）、 RRM1（-）、SYN部分（-）、CERBB-2（-）。術後給予輔助化療，，方案為：奧沙利鉑150MG D1+亞葉酸鈣0.3G D2-6 +氟尿嘧啶750MG D2-6 靜滴。現患者為求複查化療來我院就診，為行進一步治療，門診以\\\"胃癌術後\\\"收入我科。   患者自發病以來，精神可，飲食可，睡眠可，二便正常，體重體力無明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 44, "end_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 197}, {"end_pos": 301, "label_type": "藥物", "overlap": 0, "start_pos": 297}, {"end_pos": 314, "label_type": "藥物", "overlap": 0, "start_pos": 310}, {"end_pos": 329, "label_type": "藥物", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 371, "end_pos": 375}]}
{"originalText": "，患者於1月前因“反覆中下腹悶痛不適3月”入院，診為胃癌，於2013年12月10日在全麻上行根治性全胃切除術+食管空腸ROUX-Y吻合術（D2），手術順利。術中見腹腔內無明顯粘連，無明顯腹水，盆腔、腹壁、大網膜無明顯轉移結節，肝臟表面光滑，未見明顯轉移灶，腫瘤位於賁門胃體下段小彎側，侵出漿膜層，活動度可，周圍可及明顯腫大淋巴結，主要位於胃小彎側及胃右動脈旁。術後病理（201339038），：（全胃），：食管胃交界潰瘍型低分化腺癌，侵出漿膜層，侵犯神經，脈管內見癌栓，手術標本下、上切端及另送（下切端）均未見癌浸潤，找到賁門左淋巴結1/2個，小彎淋巴結5/11個，大彎淋巴結0/1個，幽門上淋巴結0/3個，及另送的（胃右動脈根部）淋巴結2/5個見癌轉移。另送（脾門淋巴結）為纖維、脂肪組織。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。此次為術後第1次化療入院。患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 26, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 72}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 175}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 203, "end_pos": 216}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 319}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}]}
{"originalText": "，患者約於5月前因“乙狀結腸癌”於2017-02-07在全麻上行乙狀結腸癌根治術，手術過程順利，術後患者恢復好，切口癒合好，按期拆線。，術後病理:（乙狀結腸）腺癌，中、低度分化，浸潤潰瘍型，體積5*3*1.3CM，侵穿漿膜， 雙端切線及另送“近切線”、“遠切線”未查見癌。 呈腸壁一站（4/10個）淋巴結癌轉移。 中間組淋巴結（1個）未查見癌。，免疫組化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、 MSH6（+）、PMS2（+）。查無化療禁忌後於2017-03-05開始給予規律化療5週期，，方案為：奧沙利鉑200MG D1，亞葉酸鈣0.3G+氟尿嘧啶0.75G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，患者副反應輕。院外期間患者一般情況好，無噁心，無腹痛腹脹不適，1天前患者發現白細胞低，現患者為行復查及化療再次來院就診，門診以“乙狀結腸癌術後”收入院。          發病以來，患者精神好，飲食好，睡眠好，小便正常，體重無明顯改變。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 40, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 163}, {"end_pos": 268, "label_type": "藥物", "overlap": 0, "start_pos": 264}, {"end_pos": 281, "label_type": "藥物", "overlap": 0, "start_pos": 277}, {"end_pos": 290, "label_type": "藥物", "overlap": 0, "start_pos": 286}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 388, "end_pos": 395}]}
{"originalText": "，患者6月餘前因“直腸癌”在我院行直腸癌DIXON手術，手術過程順利，術後給予抗感染、營養支援並補液治療，患者2017-02-15因“直腸癌術後吻合口瘻”行“橫結腸造口術”，手術過程順利，術後給予抗感染、營養支援、補液及對症治療，，術後病理檢查結果回示：（直腸）腺癌（中、低度分化，區域性伴神經內分泌分化；部分為粘液腺癌，約佔30%）， 隆起型，體積2*2*1.5CM，區域性侵達深肌層，並腸壁外脂肪組織內查見癌轉移 灶（1處），長徑約0.7CM，雙端切線及另送“近切線”、“遠切線”未查見癌。 多發性增生性（鋸齒狀）息肉。 一站淋巴結（8個）未查見癌。，癌組織免疫組化染色示：SYN區域性（+）、BRAF（-）、MSH2（+）、MSH6（+）、 MLH1（+）、PMS2（+）。病情穩定後出院.患者於2017-6-2、2017-7-2及2017-7-30來我院入住我科，排除化療禁忌後給予奧沙利鉑200MGD1+氟尿嘧啶0.75G D2-D6+亞葉酸鈣0.3G D2-D6，輔以保肝、護胃、止吐等對症支援治療，過程順利，患者耐受可，化療結束後出院。   出院後患者病情穩定，無發熱畏寒，無噁心嘔吐，無咳嗽胸悶，無腹脹腹瀉以及腹痛，精神好，飲食好，睡眠好，小便正常，體重無明顯改變。現患者為求進一步治療入院，門診以“直腸癌術後”收入院。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"end_pos": 27, "label_type": "手術", "overlap": 0, "start_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 67, "end_pos": 76}, {"end_pos": 85, "label_type": "手術", "overlap": 0, "start_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 266}, {"end_pos": 396, "label_type": "藥物", "overlap": 0, "start_pos": 392}, {"end_pos": 408, "label_type": "藥物", "overlap": 0, "start_pos": 404}, {"end_pos": 424, "label_type": "藥物", "overlap": 0, "start_pos": 420}, {"end_pos": 439, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 441}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 506}, {"end_pos": 511, "label_type": "解剖部位", "overlap": 0, "start_pos": 510}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 555, "end_pos": 560}]}
{"originalText": "，患者於2012-11無明顯誘因出現下腹不適，輕度腹痛，與飲食無關，伴噯氣，無反酸、腹脹、噁心、嘔吐及黑便。2012-11-9，就診*********行電子胃鏡檢查：胃竇小彎側見一巨大潰瘍，大小約4.0X4.0CM,周圍粘膜紅腫，累及胃角，，胃竇活檢病理為：粘膜慢性炎伴潰瘍形成，區域性腺體排列紊亂，不排外惡變可能.2012-11-22，入**三院行電子胃鏡檢查示：胃角結構破壞，可見一3X3CM巨大潰瘍，底部凹凸不平，，胃角粘膜活檢病理為：低分化腺癌。後轉我院就診，於2012-12-14日在全麻上行“胃癌根治術”術程順利，術後病理為胃低分化腺癌，浸潤至漿膜層，淋巴結7(+)/34，後遵原主診醫師意見2013-01-06、2013-01-25、2-25、3-15予多西他賽＋S-1”化療3程，過程順利。現為上一程化療入院，起病以來，精神、飲食、睡眠尚可，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 220, "end_pos": 225}, {"end_pos": 256, "label_type": "手術", "overlap": 0, "start_pos": 251}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 273}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 333}, {"end_pos": 341, "label_type": "藥物", "overlap": 0, "start_pos": 338}]}
{"originalText": "患者3個多月前因“大便習性改變4個月。”到我院就診，經腸鏡、MR等檢查考慮為直腸腫物，侵犯粘膜上層，經多次表面活檢及穿刺病理均未見癌。2016-3-11全麻上行TEM術，術中見腫物巨大，並與固有肌層粘連，予粘膜上層分離並分塊切除。術中冰凍病理報告未見癌。術後石蠟病理提示腺癌，侵犯粘膜肌層並有中斷。術後診斷為腺癌PT1N0M0。考慮腫物基底為下次腸鏡息肉切除後疤痕，可能有殘留，2016-5-21全麻上行腹腔鏡DIXON+迴腸造瘻術，術後病理：腸壁及淋巴結未見癌殘留。術後恢復較慢。出院後造口排液較稀，無腹痛、發熱等其他不適。現為造口回納收入院。自下次出院以來，患者無噁心、嘔吐等，無發熱、咳嗽、身目黃染，無骶部痛等，精神可，納眠可，小便無異常，體重上降月8KG。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 40}, {"end_pos": 84, "label_type": "手術", "overlap": 0, "start_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 163}, {"label_type": "手術", "overlap": 0, "start_pos": 202, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 228}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}]}
{"originalText": "緣於入院前9月於我院診為胃癌，於2014-02-24在全麻上行腹腔鏡上根治性遠端胃大部切除術，術後病理示（遠端胃）胃竇小彎側潰瘍型管狀腺癌II-III級，侵出漿膜層，侵犯神經，脈管內見癌栓，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到小彎淋巴結3/9個，大彎淋巴結4/6個，幽門下淋巴結0/5個，幽門上淋巴結0/3個，及另送（第8組）淋巴結1/2個，（第15組）淋巴結0/1個見癌轉移。另送（第14V組淋巴結）為脂肪、纖維及脈管組織。免疫組化結果：CK7（+++），CK20（-），VILLIN（+++），CEA（+++），CDX-2（灶+），CGA（-），CD56（-），SY（-），KI67（30%+），HER-2（++）。術後恢復情況良好，術後已予“奧沙利鉑200MGD1+多柔比星60MGD1+替吉奧60MGBIDD1-D14”方案化療6週期，過程順利，效果良好，未見明顯化療副反應。此次為複查就診我院，門診擬胃癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 31}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 76}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 188}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 208}, {"end_pos": 336, "label_type": "藥物", "overlap": 0, "start_pos": 332}, {"end_pos": 348, "label_type": "藥物", "overlap": 0, "start_pos": 344}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 355}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 413, "end_pos": 417}, {"end_pos": 441, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 443}]}
{"originalText": "，患者因“直腸癌”於2017-02-17在全麻上行直腸癌根治術(DIXON)，術後給予抗感染、營養支援、抑酸治療，患者恢復好，切口癒合良好。，術後病理：直腸腺癌（中、低度分化），部分呈粘液腺癌分化，隆起型，體積9*9*2.5CM，侵穿漿膜，於外膜脂肪組織內查見一處癌轉移灶。雙端切線及另送“近切線”、“遠切線”未查見癌。呈“一站”（1/12個）淋巴結癌轉移。 “中央組”（2個）、“中間組”（1個）未查見癌。，免疫組化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。 2017-03-17開始化療，方案為奧沙利鉑200MGD1，亞葉酸鈣300MG+氟尿嘧啶750MG D2-D6，化療期間有噁心、無嘔吐，院外期間患者一般情況好，無噁心，無腹痛腹脹不適，現患者為行復查及化療再次來院就診，門診以“直腸癌術後”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 25, "end_pos": 38}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 175}, {"end_pos": 283, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 291}, {"end_pos": 305, "label_type": "藥物", "overlap": 0, "start_pos": 301}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 374, "end_pos": 379}]}
{"originalText": "，緣於入院前4月餘在我院診為“胃竇癌”，於2015年07月21日在全麻上行根治性遠端胃切除、胃空腸ROUX-Y吻合術（D2）。，術中見：腹腔內無明顯腹水，腹腔內未見轉移結節，肝臟質地大小正常，未見明顯腫物，膽囊無腫大。病灶位於胃角處向下侵犯胃體中段，明顯侵出漿膜面，胃右動脈附近可見一腫大淋巴結，大小約3.0×3.0右左。手術順利。術後病理（201526673），示:1.(遠端胃)，：胃體前壁及胃竇潰瘍型管狀腺癌II-III級，伴壞死，侵出漿膜層。手術標本下切端、上切端及另送(下切端)均未見癌浸潤。找到小彎側淋巴結1/10個，大彎側淋巴結0/4個，幽門下淋巴結0/1個，幽門上淋巴結1/6個，及另送(胃右動脈根部)淋巴結0/2個，見癌轉移。，免疫組化染色結果：CGA（-），CD56（-），SY（-），KI67（60%陽性），CK(PAN)（+++），HER-2（-）；術後預防性抗感染、補液、營養等對症治療，恢復良好後出院。術後分別於2015.09.21、2015.10.26予“奧沙利鉑（樂沙定）200MGIVGGTD1+希羅達1500MGPOBIDD1-14”方案化療2個週期。化療過程順利，無特殊不適。今為行第3次化療，再次就診於我院，門診擬“胃管狀腺癌術後（PT4AN1M0IIIA期）化療”收入住院。自下次出院以來，精神可，睡眠可，飲食稍差，大、小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 58}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 134}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 214}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 443}, {"end_pos": 451, "label_type": "藥物", "overlap": 0, "start_pos": 448}, {"end_pos": 468, "label_type": "藥物", "overlap": 0, "start_pos": 465}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 528, "end_pos": 550}]}
{"originalText": "入院前３月，患者因直腸癌於本院行腹腔鏡輔助上直腸癌根治術（MILES），手術順利。術後組織病理檢查報告示直腸潰瘍型中分化管狀腺癌，浸及腸壁全層，可見神經侵犯及癌栓。切端未見癌累及。腸壁淋巴結可見癌轉移（1/2）。術後患者恢復好，無畏寒發熱，無噁心嘔吐，無腹脹腹痛，造瘻口排便排氣通暢，已行FOLFOX方案化療2次，為求術後第３次化療於今日入院。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 16, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 68}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}]}
{"originalText": "，2012-11-30行右乳癌根治術，術後病理示（右）乳腺浸潤性導管癌，II級，大小1.8×XXX1.7×XXX1.5CM，未見脈管癌栓；乳頭及面板未見特殊。，腫瘤病理分期：PT1C。（右腋窩前哨）淋巴結未見癌轉移（0/1）；（右腋窩前哨及導絲定位）淋巴結未見癌轉移（0/2）。，免疫組化染色結果：CK(-)。，免疫組化：ER(+>75%),PR(+約20%），HER-2（1+）。術後CEF方案化療6週期，現口服來曲唑（芙瑞）內分泌治療。 5-20本院胃鏡檢查提示慢性胃炎，HP(-)。現噁心未吐，進食少，大便可，睡眠差。", "entities": [{"end_pos": 18, "label_type": "手術", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 39}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 128}, {"end_pos": 210, "label_type": "藥物", "overlap": 0, "start_pos": 207}, {"end_pos": 213, "label_type": "藥物", "overlap": 0, "start_pos": 211}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 233, "end_pos": 237}]}
{"originalText": "緣於入院前4年餘因“乙狀結腸癌”於我院行“腹腔鏡輔助上乙狀結腸癌根治術”，術後病理(201131862)回報“(乙狀)結腸蕈傘型管狀腺癌II級，侵及漿膜層，手術標本下、上切端及另送(下、上切端)未見癌浸潤，找到腸周淋巴結11個均未見癌轉移，另送(腸繫膜上動脈根部淋巴結)為脂肪脈管結締組織”，術後恢復良好出院，出院後於門診定期複查期間發現肝、肺、骨多發轉移。3年前開始口服希羅達及中藥治療（具體不詳），治療期間未訴不適。入院前2天患者無明顯誘因出現納差，並逐漸出現乏力感，無噁心、嘔吐，無腹痛、腹脹、腹瀉，無發熱、畏寒等不適，今為求進一步診治，就診我院，門診擬“乙狀結腸癌術後伴肝、骨、肺多發轉移”收治入院，自發病以來，飲食較差，睡眠可，二便正常，體重較前無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"end_pos": 35, "label_type": "手術", "overlap": 0, "start_pos": 21}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 71}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 189, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 298}]}
{"originalText": "，緣於入院前[主訴單一時間1年於我院診斷“降結腸癌”，查無禁忌後，於2014年04月28日在全麻上行腹腔鏡上右半結腸切除術。，術中見：無腹水，肝表面光滑，胃及空腸未見明顯病變。降結腸可見一大約2*3CM隆起型腫物，質硬，侵出漿膜層，腸繫膜根部未見明顯腫大淋巴結，術順，術後予抗炎、制酸、補液等對症治療，，術後病理示：（結腸），：腸隆起型管狀腺癌II級，侵及粘膜上層，手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤；找到腸周淋巴結14個，及另送（腸繫膜動脈根部）淋巴結2個，均未見癌轉移。，免疫組化結果：KI67（40%陽性），P53（-），P170（+），GSTπ（+），EGFR（-），5-FU（++），MLH1（++），MSH6（++），MGMT（++）。該病例未檢測到BRAF基因V600E突變、未檢測到KRAS基因12、13號密碼子熱點突變。術後恢復良好。1周前患者於我院行PET-CT提示肝轉移，無寒戰、發熱，無噁心、嘔吐，無反酸、噯氣、腹脹、消瘦、頭暈、乏力、面板鞏膜黃染再次。就診於我院，遂門診擬降結腸癌術後收入院。自發病以來，精神、睡眠、食慾尚可，大便如下述，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 25}, {"end_pos": 61, "label_type": "手術", "overlap": 0, "start_pos": 50}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 117}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 164, "end_pos": 175}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 395, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 404}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 459, "end_pos": 465}]}
{"originalText": "患者1月餘前因“胃惡性腫瘤”於我院就診，於2016-10-25在全麻上行“胃癌根治術”，手術順利，術後恢復良好，術後病理胃竇小彎腺癌（中度分化），體積4*3.5*1.4CM，浸潤潰瘍型，侵達漿膜，累及十二指腸，於部分脈管中查見癌栓，未累及近端切線。距遠端切線甚近。呈“五組”（1/1個）、“第六組”（2/2個）淋巴結癌轉移。四組（7個）、六組（7個）、“一三七組”（10個）淋巴結未查見癌。免疫組化染色示癌組織：CERBB-2（2+）、SYN（-）、β-TUBULIN-III（-）、RRM1少數（+）、TOPOII多數（+）、CD34血管（+）、D2-40淋巴結（+）。結合患者病情及腫瘤病理與分期繼續予行術後化療，給予“奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴”方案化療，同時輔以鎮吐、升血、免疫調節等對症支援治療，恢復良好出院。今為行第二次化療於我科就診，門診以“胃癌術後”收入院。  患者自發病以來，精神情緒及體力良好，食慾、飲食、睡眠好，小便正常。體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"end_pos": 42, "label_type": "手術", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 72}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 190}, {"end_pos": 316, "label_type": "藥物", "overlap": 0, "start_pos": 312}, {"end_pos": 329, "label_type": "藥物", "overlap": 0, "start_pos": 325}, {"end_pos": 343, "label_type": "藥物", "overlap": 0, "start_pos": 340}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 414}]}
{"originalText": "，緣於入院前1+個月（2014.05.30）因“卵巢漿液性乳頭狀囊腺癌”就診我科在全麻上行“全子宮+兩附件切除+腹盆腔粘連鬆解術”，術前查，CA125：144.50U/ML（2014.05.27）；，術中見：腹水300ML，色黃，子宮略小，子宮右前側壁上段見結節狀增生約0.8CM，右卵巢萎縮狀，右輸卵管未見佔位病變，左附件區一囊實性包塊約7*9*12CM，表面不規則，包膜尚完整，與腸管及左側腹壁廣泛粘連，鬆解粘連後見腸繫膜及陶氏腔少許乳頭狀結節。術中滿意減瘤（無肉眼殘留）。術後恢復可，腹部切口癒合良好，術後病理回報（201416906），：左卵巢高級別漿液性乳頭狀囊腺癌，伴壞死；另見輸卵管下皮呈中度不典型增生；（201416919），：送檢(腸繫膜結節)中見腺癌浸潤；（C1401074）腹水塗片未見腫瘤細胞。入院前31天（2014.06.13）查CA12581.07U/ML，遂於入院前27天（2014.06.17）予以“‘紫杉醇240MGIVGTTD1+洛鉑50MGIPD1’”方案行術後第1次輔助化療，化療過程順利，停藥第5天出現骨髓抑制I度、藥物性肝損害，予升白、保肝對症治療後好轉出院。出院後一般情況可，現擬行術後第2次化療，就診我院門診，門診擬“卵巢漿液性乳頭狀囊腺癌（IIIB期，G1）術後”收住入院。自下次出院以來，飲食、睡眠可，二便正常，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 35}, {"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 64}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 70, "end_pos": 75}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 197, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 211}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 235, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 298}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 325, "end_pos": 326}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 420, "label_type": "藥物", "overlap": 0, "start_pos": 417}, {"end_pos": 435, "label_type": "藥物", "overlap": 0, "start_pos": 433}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 472, "end_pos": 478}, {"end_pos": 483, "label_type": "解剖部位", "overlap": 0, "start_pos": 482}, {"end_pos": 492, "label_type": "解剖部位", "overlap": 0, "start_pos": 491}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 533, "end_pos": 556}]}
{"originalText": "緣於入院前8日於我院診為“宮頸鱗癌”，於2015年04月22日在全麻上行“廣泛全子宮兩附件切除術+盆腔淋巴結清掃術+闊韌帶肌瘤剝除術+陰道頂懸吊術”，術中見“腹腔內未見明顯腹水；子宮萎縮，表面凹凸不平，活動可；左側闊韌帶見一肌瘤，大小約3×4CM；兩側輸卵管結紮術後改變；兩側卵巢外觀正常，肝、脾、膈上、腸管、腸繫膜、腹膜等未見明顯異常”。術後病理（201514785）示：“(全子宮+兩附件)1.宮頸內生浸潤性鱗狀細胞癌II級，腫瘤垂直浸潤＞1/2肌層，水平浸潤25MM，組織學內口、陰道切端、右宮旁組織及左宮旁組織均未腫瘤侵犯；找到(右盆腔）淋巴結5個，(左盆腔）淋巴結8個，(右髂總）淋巴結2個，(左髂總）淋巴結6個，均未見癌轉移；2.子宮肌間多發性平滑肌瘤，伴玻璃樣變性，宮內膜呈萎縮改變；3.右、左卵巢組織；4.右、左輸卵管組織”。術後給予對症、營養支援等治療，恢復良好，傷口癒合II/甲，予辦理出院。此次為化療就診我院，門診擬“宮頸鱗癌術後”收入院。自病以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 73}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 132, "label_type": "手術", "overlap": 0, "start_pos": 124}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 160}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 199, "end_pos": 214}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 248, "end_pos": 250}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 321, "end_pos": 332}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 420, "end_pos": 426}, {"end_pos": 447, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"end_pos": 450, "label_type": "解剖部位", "overlap": 0, "start_pos": 449}]}
{"originalText": "，患者1個月餘前因“吞嚥困難1月餘。”就診我院我科，完善相關檢查後診斷殘胃癌，排除手術禁忌症後於2016.5.23在全麻上行殘胃癌切除術+複雜腸粘連鬆解術+ROUX-EN-Y吻合術，術程順利，術後預防感染支援對症等處理，恢復好，切口甲級癒合。，術後病理示：中至低分化腺癌（LAUREN，分型：腸型），癌組織浸潤至胃壁漿膜層並侵犯鄰近的肝組織被膜，並累及食管壁深肌層，可見脈管內癌栓及神經束侵犯；PT4N3M0 IIIC期。患者術後恢復可，出院後生活質量可，於2016.6.24於我院經隨機分組納入CAPITAL臨床試驗行術後輔助化療，簽署知情同意書後行 SOX （奧沙利鉑150ｍｇ+替吉奧60MG BID）方案化療一程，化療過程順利，出現I°骨髓抑制，無其他明顯不適。現為行上一程化療來我院門診就診，擬“殘胃癌綜合治療後”收入我科。起病以來，患者精神尚可，食慾尚可，大小便正常，體重稍減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 38}, {"label_type": "手術", "overlap": 0, "start_pos": 62, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 168}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"end_pos": 286, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 292}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 320, "end_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 353, "end_pos": 361}]}
{"originalText": "入院前4+月，患者因“大便習慣改變伴大便帶血6月，加重2月。”於我科住院治療，完善相關檢查，診斷為“直腸腺癌（PT2N0M0）”，於2016年2月6日在全麻上行腹腔鏡上直腸癌根治術（DIXON）。術後病理報告（1601061）：（直腸）中分化腺癌，侵及深肌層。遠、近端切緣及環周切緣未見癌累及。腸周淋巴結未見癌轉移（0/11）。術後予以補液、止血、抗感染、對症支援、傷口換藥等處理，恢復較好，無特殊不適，好轉出院。術後分別於2016-02-27日、3月25日、4月19日,5月13日於我科行化療4次，方案均為奧沙利鉑+雷替曲塞，化療後患者偶有肢體麻木，無明顯噁心、嘔吐、腹痛、腹脹、便血等表現，遵醫囑於今日至我院行直腸癌術後第5次化療。故以\\\"直腸癌術後第5次化療\\\"收入我科住院治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 63}, {"label_type": "手術", "overlap": 0, "start_pos": 80, "end_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 123}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 254}, {"end_pos": 263, "label_type": "藥物", "overlap": 0, "start_pos": 259}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 322, "end_pos": 327}]}
{"originalText": "，緣於入院前1月於我院診為小腸癌，於2015-11-09在全麻上行小腸癌根治術，，術中見：腹腔內無明顯腹水，大網膜、盆腹腔未見轉移結節，距TREITZ韌帶約6CM處空腸可觸及腫物，大小約7×5×4CM，侵出漿膜層，環周生長，系膜側可觸及多個腫大淋巴結，最大直徑約0.8CM，近端腸管無明顯擴張。術後病理（201540286）示(小腸)，：潰瘍型乳頭狀-管狀腺癌II級，侵及漿膜層，手術標本雙切端及另送（近切端）（遠切端）均未見癌浸潤。找到腸周淋巴結19個及另送（系膜）淋巴結1個，(腸繫膜根部)淋巴結1個，均未見癌轉移。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。此次為化療再次就診我院，門診擬小腸管狀腺癌（PT4AN0M0IIB期）術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 39, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 183}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 304, "end_pos": 326}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}]}
{"originalText": "，患者因“便血伴便細近2月，加重5天”進一步確診為直腸癌於2016-4-11在我院予行全麻上直腸腫瘤DIXON切除術，，術中探查見：腹腔內無腹水，腹膜無轉移，肝臟未觸及轉移病灶，腫瘤位於直腸上段，腹腔內無法觸及，病人肥胖，系膜未觸及腫大淋巴結。手術順利，術後積極予相關對症支援治療並恢復總體平穩；相關手術病理示直腸腺癌（中、低度分化）,隆起型,體積3.5*3*0.8CM,侵達淺肌層,未累及底部切除面。雙端切線及另送“近切線”、“遠切線”未查見癌。腸壁一站（13個）、二站（10個）淋巴結未查見癌。，免疫組化染色示：SYN（-）、TS較多（+）。患者於術後20天康復出院；依據患者病情及腫瘤病理與分期繼續術後輔助性化療指徵存在，依情於2016-4-26給予術後首週期輔助化療，，具體用藥為：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時輔以鎮吐、升血、免疫調節等對症支援治療（化療過程總體順利）。其後給予原方案化療3週期。自下次出院以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適；持續未現明顯腹痛、腹脹。現患者為行復查並輔助化療而再來我院就診，門診依情以“直腸癌術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；肛門排氣排便存在（排便次數偏多）。述近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 28}, {"end_pos": 58, "label_type": "手術", "overlap": 0, "start_pos": 46}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 73, "end_pos": 74}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 95}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 244}, {"end_pos": 349, "label_type": "藥物", "overlap": 0, "start_pos": 345}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 358}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 373}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 491, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 519, "end_pos": 524}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 556, "end_pos": 558}]}
{"originalText": "，患者2015-06因“無明顯誘因出現大便帶鮮血，量少，伴大便次數增加至2-3次/天5月”，外院腸鏡檢查提示乙狀結腸距肛門18-20CM腫物，大小2×1CM，腸鏡能透過，活檢病理提示腺癌，大腸多發息肉。轉診我院2015-06-20在全麻上行DIXON術，，術後病理示：（乙狀結腸大體）鏡檢為結腸中分化腺癌，浸潤至腸壁漿膜上層，癌組織侵犯神經束，脈管內見癌栓；經多取材另見淋巴結2枚，未見癌。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央組淋巴結）1枚，未見癌。5（中間組淋巴結）2枚，1/2見腺癌轉移。6（腸旁淋巴結）2枚，未見癌。，免疫組化：ER（-），ERCC1（+），MLH1（+），MSH2（+），MSH6（+），PMS2（+），KI67（70%+），分期PT3N1AM0,IIIB期。術順，術後切口癒合佳。於2015-07-18、2015-08-07、2015-08-28行XELOX方案輔助化療3程，過程順利。3程化療後於2015-09-17行胸片及彩超複查未見腫瘤復發轉移徵象。現患者為行上程化療入院。近3周來，患者精神睡眠可，胃納可，二便正常，體重無明顯上降。", "entities": [{"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 100}, {"end_pos": 126, "label_type": "手術", "overlap": 0, "start_pos": 120}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 157}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 249}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 429, "end_pos": 431}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 432, "end_pos": 434}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}]}
{"originalText": "，入院前5個月餘診斷為“賁門-胃體癌”，於2013.12.25在我科行“腹腔鏡輔助上根治性全胃切除（D2）+食管空腸ROUX-EN-Y吻合術”，術順，術後病理（201341015），：(全胃)，：食管胃交界潰瘍型管狀腺癌III級，伴神經內分泌分化，侵出漿膜層，手術標本下、上切端和另送（下切端）均未見癌浸潤。找到賁門周淋巴結11個，小彎淋巴結13個、大彎淋巴結11個、幽門下淋巴結4個、幽門上淋巴結14個和另送(胃右動脈根部)淋巴結4個、(脾門)淋巴結4個均未見癌轉移。另送(脾動脈旁淋巴結)為纖維脈管脂肪組織。，免疫組化結果：KI67（60%），P53（+++），P170（++），GSTπ（++），EGFR（-），5-FU（++），HER-2（-），SY（+）。術後予預防感染、補液、營養支援、調節免疫等治療，恢復良好後出院。於2014.01.28,2014.02.21，2014.3.18，2014.04.16按“奧沙利鉑100MGIVGTTD1+替吉奧40MGBIDPOD2-15”方案行術後化療，輔以保肝、止吐、增強免疫等治療，過程順利。現為行術後第4週期化療就診我院，門診擬“胃癌術後化療”收入院。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 70}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 98, "end_pos": 123}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 410}, {"end_pos": 430, "label_type": "藥物", "overlap": 0, "start_pos": 427}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 494, "end_pos": 498}]}
{"originalText": "，患者因“大便帶血”並進一步確診為直腸癌於2015-2-9在全麻上行腹會陰聯合直腸癌根治術（MILES手術）。，術中探查見：腹腔內無腹水，腹膜無轉移，肝臟未觸及轉移結節，腫瘤位於直腸上段，腹腔內無法探及。直腸繫膜內可觸及腫大淋巴結。手術順利，患者術後積極予相關對症支援治療並恢復總體平穩。相關手術病理(201502427），回示：（直腸）腺癌（中度分化），浸潤型，體積5*4.5*1CM，侵達外膜。 雙端切線未查見癌； 一站（12個）、二站（4個）、中間組（5個）及中央組（1個）淋巴結未查見癌；，免疫組化染色示癌組織：TS少量（+）、SYN（-）。患者術後於相關化療治療。現患者1月前出現陰道內流出少量液體，於2016-10-13日行腹盆部CT示盆腔內佔位性病變，考慮區域性復發並侵及區域性陰道壁可能性大，門診依情以“直腸癌術後復發”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠好；間斷性結腸造口排氣排便順暢並性狀良好。述近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 54}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 243}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 318, "end_pos": 323}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 346}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}]}
{"originalText": "，因“進食後胸骨不適半年”，當地胃鏡提示：胃竇潰瘍型隆起性病變。診斷胃癌。體重較前稍有上降。我院行胃癌根治術，，術後病理：胃隆起型高分化腺癌，伴粘液分泌，大小10.5×XXX6.5CM，LAUREN，分型：腸型；癌侵及漿膜上纖維脂肪組織；可見脈管癌栓；胃殘端、（十二指腸殘端）及網膜組織均未見癌；淋巴結未見癌轉移（第1組0/2、第3組0/0、第4SB組0/7、第4D組0/2、第5組0/3、第6組0/21、第7組0/11、第8A組0/4、第8P組0/1、第9組0/9、第11P組0/1、第12A組0/0、第12P組0/1)；，腫瘤病理分期：PT3N0。，免疫組化結果顯示:B-CATENIN(+),CD147(+),CD44(－),CMET(1+),EGFR(3+),HER2(0),KI67(+90%),MLH1(+＜25%),MSH2(+＞75%),MSH6(+＞75%),P-CADHERIN(+＞75%),PMS2(+25～50%),TTF-1(－)。術後恢復可，擬行術後化療。2015-6-11開始行SOX術後輔助化療，無明顯不良反應。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 36}, {"end_pos": 54, "label_type": "手術", "overlap": 0, "start_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 70}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}]}
{"originalText": "，患者因“直腸癌”於2016-11-08於我院在全麻上予行直腸HARTMANN手術，術後病理（3766.2013），回示：病理診斷 ，:直腸腺癌（中度分化），浸潤潰瘍型，體積8*6*0.6CM，侵達外膜脂肪組織，未累及切除面。雙端切線未查見癌。呈腸壁一站（1/22個）淋巴結癌轉移。腸壁二站（2個）淋巴結未查見癌。低級別腺管狀腺瘤。，免疫組化染色示癌組織：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。患者術後恢復好。根據患者病情，除外化療禁忌症，於2016-12-8、201-01-08給予化療雙週期，，方案為：奧沙利鉑200MG DL+亞葉酸鈣0.3GD2-6+替加氟1000MG D2-6靜滴，同時給予升白細胞、護肝、止吐、免疫增強治療，無明顯化療副反應。自下次出院後，患者一般情況保持良好， 無乏力感，無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯 腹痛、腹脹；大小便情況良好。現患者為行復查來我院就診，門診以“直腸癌術後”收入院。目前患者精神及情緒狀態可，食慾、飲食好，夜間睡眠可，大便出現便祕，不規律，不成形，小便正常，近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 123, "end_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 152}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 165}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"end_pos": 298, "label_type": "藥物", "overlap": 0, "start_pos": 294}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 411, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 441, "end_pos": 446}]}
{"originalText": "緣於入院前9天（2013.12.24）因“卵巢癌”於我院行“全子宮+兩附件切除術+闌尾+大網膜切除術+盆腔淋巴結清掃術”。術中見腹腔內淡黃色腹水約200ML，取腹水30ML送細胞學檢查，子宮體前位，常大，右卵巢囊實性增大約10*10*10CM大小，色灰白，表面光滑，包膜完整，組織脆爛，與周圍組織無粘連，內見淡黃色粘稠樣液體流出，右輸卵管及左附件外觀正常，肝、脾、膈上、腸管、腸繫膜、腹膜等未見明顯異常。切除右附件送冰凍，病理回報（201340780）：卵巢惡性下皮性腫瘤，考慮為粘液性囊腺癌，輸卵管未見腫瘤細胞浸潤。遂行下術，術順，術後恢復好，術後病理（201340902）（左側）卵巢及輸卵管組織；盆腔淋巴結均未見癌轉移；(大網膜)送檢網膜組織未見癌細胞種植轉移；（闌尾）闌尾組織未見癌細胞種植轉移，呈闌尾周圍炎改變。（C132334）腹水塗片未見腫瘤細胞。餘病理未報。現患者無畏冷、發熱，無咳嗽、咳痰，無腹痛、腹脹，無頭暈、眼花，胸悶、心悸等不適，要求入院化療，門診擬“右卵巢粘液性囊腺癌IA期術後”收入院。發病以來，精神、睡眠、食慾一般，大小便正常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 59}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 188, "end_pos": 189}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 193}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 227, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 246}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 353}, {"end_pos": 371, "label_type": "解剖部位", "overlap": 0, "start_pos": 370}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 405}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 408}, {"end_pos": 413, "label_type": "解剖部位", "overlap": 0, "start_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 415, "end_pos": 416}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 418}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 438, "end_pos": 452}]}
{"originalText": "患者於2014年7月7日因“卵巢癌”在全麻上行剖腹探查+卵巢癌細胞減滅術（全子宮、兩側附件、大網膜、闌尾、盆腔轉移灶、直腸轉移灶切除+盆腔淋巴結清掃術），術後病檢結果為：左卵巢漿液性乳頭狀腺癌； (直腸表面轉移灶、腹腔轉移灶)見癌組織。（大網膜）未見癌累及。（右盆腔淋巴結、左盆腔淋巴結）未見癌轉移（0/6、0/6）。於7月20日行術後第一次TP方案（紫杉醇靜脈滴入+順鉑腹腔灌注）聯合化療，於2014年8月12日第二次行TP（紫杉醇靜脈滴入+順鉑腹腔灌注）方案化療，於2014年9月2日行第三次化療，化療方案為TP方案（紫杉醇+奈達鉑）靜脈化療，於2014年9月22日行第四次化療，化療方案為TP方案（紫杉醇+奈達鉑）靜脈化療，化療後無明顯毒副反應。於2014年10月13日行第五次化療，化療方案為TP方案（紫杉醇+奈達鉑）靜脈化療，化療後無明顯毒副反應。於2014年11月04日第六次化療，化療方案為TP方案（紫杉醇+奈達鉑）靜脈化療，化療後無明顯毒副反應，出院後定期複查電解質及血常規。今患者為行第7次化療再入院，門診擬以“卵巢漿液性乳頭狀腺癌IIIC期術後，擬行第7次化療”收治入院。   患者自患病以來，精神、食慾尚可，睡眠可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 96}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 179, "label_type": "藥物", "overlap": 0, "start_pos": 176}, {"end_pos": 186, "label_type": "藥物", "overlap": 0, "start_pos": 184}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 214}, {"end_pos": 224, "label_type": "藥物", "overlap": 0, "start_pos": 222}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 264, "label_type": "藥物", "overlap": 0, "start_pos": 261}, {"end_pos": 268, "label_type": "藥物", "overlap": 0, "start_pos": 265}, {"end_pos": 305, "label_type": "藥物", "overlap": 0, "start_pos": 302}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 306}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 355}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 359}, {"end_pos": 410, "label_type": "藥物", "overlap": 0, "start_pos": 407}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 465, "end_pos": 482}]}
{"originalText": "，緣於入院前6個月“進行性眼黃、尿黃、面板黃染30天”為主訴入我科住院，考慮十二指腸乳頭佔位，並於全麻上行“胰十二指腸切除術”，術中見腹腔內無腹水，腹壁及盆底未觸及種植結節。肝臟表面張力高，呈淤膽改變，形態、大小正常，未觸及腫物，膽囊約8×5×4CM3，表面張力高，無充血、水腫，未觸及結石，肝臟及膽囊與大網膜粘連明顯，予鬆解。膽總管擴張，直徑約1.5CM。十二指腸降部觸及一腫物，質硬。，術後病理回報：1、（胰十二指腸），：十二指腸乳頭部浸潤型管狀腺癌II-III級，侵犯神經，侵及深肌層，未侵犯膽總管及胰腺，手術標本胃切端、小腸切端、胰腺切端及膽總管切端均未見癌浸潤。找到胃周淋巴結1個、胰腺周淋巴結2個，及另送（肝十二指腸韌帶）淋巴結1個和（肝總動脈旁）淋巴結4個均未見癌轉移。2、，膽囊：慢性膽囊炎，膽石症。術後患者恢復好，面板黃染逐漸消退，無發熱、嘔吐、腹瀉、血便等。近1個月患者偶有下腹部悶痛，行走時明顯，無發熱、嘔吐、腹脹、黑便、面板黃染等不適。為進一步複查，再次求診我院，門診擬“十二指腸癌術後”收住入院。本病以來患者精神睡眠食慾大致可，二便無明顯異常，體重無明顯改變。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 62, "label_type": "手術", "overlap": 0, "start_pos": 54}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 234}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"end_pos": 320, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 448, "end_pos": 455}]}
{"originalText": "緣於入院前1+月,於我院診斷“子宮內膜癌”，在全麻上行“全子宮切除術+兩側附件切除術+腫瘤細胞減滅術+骶韌帶懸吊術+大網膜腫物切除術”，術後予以預防感染、補液、營養支援等治療，術後病理（201340184）（全子宮）：惡性苗勒氏管混合瘤，侵及宮體漿膜層(浸潤深度&GT;1/2肌層)，宮頸組織學內口見腫瘤浸潤。宮體肌間多發平滑肌瘤。慢性宮頸炎。術後診斷“子宮惡性苗勒氏管混合瘤IIIA期”，於2013.12.30及2014.01.21行化療，化療方案為“異環磷醯胺2G靜滴D1-3+洛鉑40MG腹腔注射”，並輔以止吐、保肝、抗過敏、補液等支援治療，2次化療過程中均出現骨髓抑制II度，予“惠爾血”升白處理。今為化療再次就診我院，門診擬“子宮惡性苗勒氏管混合瘤IIIA期”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 66}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 144}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 193}, {"label_type": "藥物", "overlap": 0, "start_pos": 227, "end_pos": 232}, {"end_pos": 243, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 284, "end_pos": 291}, {"end_pos": 297, "label_type": "藥物", "overlap": 0, "start_pos": 294}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 318, "end_pos": 334}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}]}
{"originalText": "術前化療XELOX方案2週期，行根治性遠端胃大部切除，術後病理：胃竇小彎側潰瘍型中-低分化腺癌，大小1.6×1.6CM，侵至胃壁深肌層（約4/5固有肌層），部分腫瘤細胞變性壞死（30％），未見脈管癌栓，淋巴結未見癌轉移（第3組0/4、4D組0/2、第6組0/5、第7+9組0/6、第8組0/2、第11P組0/1、第12A、第1組0/0、第4SB組0/0、第5組0/0、第8P組0/0），胃斷端及十二指腸斷端未見癌，網膜組織未見特殊。目前進食可。", "entities": [{"end_pos": 26, "label_type": "手術", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}]}
{"originalText": "，患者於2017-5-22在全麻上行3D腹腔鏡上直腸癌根治術（DIXON）。手術過程順利，術後患者恢復良好。術後病理（201711714），：直腸管狀粘液腺癌（低分化），浸潤潰瘍型，體積3*2.5*1CM，浸潤漿膜上層。未侵犯切線（近切線12CM、遠切線甚近）。 呈一站（11/11個）、二站（3/3個）淋巴結癌轉移。，免疫組化染色示癌組織：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。術後恢復順利，先後給予2次輔助化療（具體用藥為），今日為行術後複查及再次化療治療來院，門診以“直腸癌術後”收入。患者無發熱，無頭痛、頭暈，無胸悶、心慌，無噁心、嘔吐，無腹脹、腹痛，無黑便、便血；自下次出院以來病情穩定，精神可，食慾及飲食正常，夜間睡眠好，大便約2次/日，質軟成形，小便次數有所增多，量及性狀無明顯異常，體重無明顯改變。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 24, "end_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 265, "end_pos": 270}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}]}
{"originalText": "，緣於入院前3個月於我院診為胃癌，於2015-12-29在全麻上行根治性全胃切除術（食管空腸ROUX-Y吻合、D2+、R0)，術後病理（201547566），示：(全胃)，:胃體－胃竇潰瘍型管狀腺癌II級，侵及漿膜層，侵犯神經及脈管組織。手術標本下切端、上切端及另送（下切端）均未見癌浸潤。找到賁門周淋巴結2/14個，小彎側淋巴結0/1個，大彎側淋巴結0/1個，幽門下淋巴結0/1個，幽門上淋巴結0/5個及另送(第8組)淋巴結0/1個、(第9組）淋巴結0/4個、(第11D組)淋巴結0/2個、(第11P組)淋巴結0/6個、(第14V組)淋巴結0/2個見癌轉移。另送(第12組淋巴結)鏡上為纖維脂肪組織。，免疫組化結果：腫瘤細胞示CK7（+），CK20（+），VILLIN（+），CDX-2（+），CEA（+），HER-2（2+），KI67（40%+）。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。於2016.01.27、2016.02.17、2016.03.07予“奧沙利鉑（艾恆）200MG靜滴D1+氟尿嘧啶4000MG持續48H泵入”方案化療，輔以止吐、保胃、護肝等支援治療，化療過程順利，未見明顯化療副反應。此次為第4次化療再次就診我院，門診擬胃癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 33, "end_pos": 62}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 102}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 283, "end_pos": 290}, {"end_pos": 444, "label_type": "藥物", "overlap": 0, "start_pos": 440}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 445}, {"end_pos": 462, "label_type": "藥物", "overlap": 0, "start_pos": 458}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 491, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 532, "end_pos": 536}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}, {"end_pos": 563, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}]}
{"originalText": "，緣於入院前1月於我院診為“胃竇癌”，於2016年10月27日在全麻上行腹腔鏡上根治性遠端胃大部切除術（D2,ROUX-EN-Y吻合）。，手術經過如上:腹腔鏡探查見腹腔內無明顯腹水，盆腔、腹壁、大網膜無轉移結節，肝臟質地大小正常，未見明顯轉移病灶。腹腔鏡上探查腫瘤位於胃竇小彎側，未侵及漿膜層，周圍未及明顯腫大淋巴結，遂決定行“腹腔鏡輔助上根治性遠端胃大部切除+殘胃空腸ROUX-Y吻合術（D2）”。術後予預防性抗感染、制酸、免疫調節及營養支援等治療，恢復良好,傷口癒合II/甲。，術後病理：1、（遠端胃），：胃體胃竇交界前壁早期（0-I型）管狀腺癌II級，部分為黏液腺癌，侵及黏膜上層。手術標本下、上切端及另送（下切端）均未見癌浸潤。找到另送（第1組）淋巴結0/4個，（第3組）淋巴結0/2個，（第4SB組）淋巴結0/4個，（第4D組）淋巴結0/4個，（第6組）淋巴結0/5個，（第7組）淋巴結0/8個，（第8A組）淋巴結0/1個，（第9組）淋巴結0/1個，（第11P組）淋巴結0/1個，（第12A組）淋巴結1/1個，見癌轉移。2、（第5組淋巴結），：送檢為纖維、脂肪和脈管組織。，免疫組化：KI67（50%+），CK7（+++），CK20（個別細胞陽性），VILLIN（+++），CD56（-）。此次為化療再次就診我院，門診擬“胃竇癌術後”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 78}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "手術", "overlap": 0, "start_pos": 164, "end_pos": 198}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 255, "end_pos": 286}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 330}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 335, "end_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 348, "end_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 372}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 377, "end_pos": 385}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 390, "end_pos": 398}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 425}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 430, "end_pos": 440}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 445, "end_pos": 455}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 474}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 566, "end_pos": 571}, {"end_pos": 594, "label_type": "解剖部位", "overlap": 0, "start_pos": 593}, {"end_pos": 597, "label_type": "解剖部位", "overlap": 0, "start_pos": 596}]}
{"originalText": "，患者3月餘前因“便血1年加重1天”入住我院，入院後完善相關檢查，，結腸鏡結果示：直腸癌，取病理送檢。，病理示：（直腸）腺癌（201709974）。查無手術禁忌，於2017-05-15日行“直腸MILES術”，手術順利，術後恢復可，，術後病理：（，病理號：201710980）（直腸）腺癌（中度分化），浸潤潰瘍型，體積5*3.5*0.8CM，浸潤非腹膜覆蓋的結直腸周圍組織，雙端切線未查見癌。呈“中間組”（2/10個）淋巴結轉移。一站(4個）淋巴結未查見癌。，免疫組化染色示癌組織：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。術後給予3程化療，，具體用藥為：奧沙利鉑200MGD1+亞葉酸鈣0.3G D2-6 +替加氟（方克）1G D2-6 靜脈滴注；同時予鎮吐、升血及免疫調節等對症支援治療。過程順利，患者出院。出院後病情穩定，現為求進一步複查治療入院，門診以“直腸癌術後”收入院。患者自發病以來神志清，精神、飲食可，夜間睡眠可，無發熱，大小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 41, "end_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 62}, {"end_pos": 103, "label_type": "手術", "overlap": 0, "start_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 175}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 197, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 215, "end_pos": 224}, {"end_pos": 308, "label_type": "藥物", "overlap": 0, "start_pos": 304}, {"end_pos": 320, "label_type": "藥物", "overlap": 0, "start_pos": 316}, {"end_pos": 334, "label_type": "藥物", "overlap": 0, "start_pos": 331}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 335}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 407, "end_pos": 412}]}
{"originalText": "，患者4個月前因“便祕2月餘”入住我院消化內科，行胸、腹、，盆腔CT示：兩肺上葉纖維灶，肝多發囊腫、腎囊腫，直腸壁增厚、符合直腸CA表現。為行手術治療，轉我科。完善相關術前檢查後，於2016-02-15行直腸癌根治術，，術後病理：直腸腺癌（中低度分化），部分呈粘液腺癌影象，浸潤潰瘍型，體積6.5*5*0.6CM。 侵達被膜。 雙端切線及另送“直腸近切線”、“直腸遠切線”未查見癌。 呈腸壁一站（2/11個）淋巴結癌轉移。 符合炎性增生性息肉。 ，免疫組化染色示：TS部分（+）、SYN（-）。術後給予補液，換藥及對症支援治療並口服希羅達行化學治療。   院外期間患者一般情況可，無發熱，無腹痛腹脹脹不適，現患者為行復查及本週期化療再次來我院就診，門診以“直腸術後”收住入院。   患者自下次出院來，神志清，精神可，飲食尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 25, "end_pos": 34}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 66}, {"end_pos": 108, "label_type": "手術", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 142}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 214, "end_pos": 221}, {"end_pos": 269, "label_type": "藥物", "overlap": 0, "start_pos": 266}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 328, "end_pos": 332}]}
{"originalText": "，患者入院完善相關檢查，診斷\\\"乙狀結腸癌 右腎下腺轉移？ \\\"，未見手術禁忌，2015-07-31全麻上行乙狀結腸切除+右腎下腺切除術，術中見腫瘤侵犯漿膜，近端結腸不全梗阻，，術後病理回報：1（乙狀結腸大體）鏡檢為中分化腺癌，浸潤至腸壁漿膜上層，未見明確脈管及神經束侵犯，並可見膿腫形成。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央淋巴結）鏡上為脂肪結締組織，未見癌。5（中間淋巴結）5枚，未見癌。6（腸旁淋巴結）10枚，未見癌。7（右腎下腺腫物）鏡上為腎下腺組織，未見癌。，免疫組化：ER（-），ERCC1（+），MSH2（-），MSH6（+），PMS2（+），MLH1（+），KI67（60%+）。患者術後恢復可。並於今日來診入院行術後輔助治療。患者發病以來，精神飲食睡眠一般,大小便正常，體重無減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 54, "end_pos": 68}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 194}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}]}
{"originalText": "，患者2012年底開始出現接觸性出血，2013年4月曾行宮頸細胞學檢查及HPV檢查未發現異常（未見單），2014年8月我院門診就診，，TCT:鏡上見異型腺細胞，考慮為腺癌。遂行（宮頸腫物）活檢術，，術後病理：鏡檢為低分化癌。婦科檢查可見宮頸下脣可見結節狀腫物約3X2.5CM，考慮“宮頸癌IB1期”，於2014-09-16在行“宮頸癌根治術(II型子宮切除+兩側附件切除+盆腔淋巴結清掃術+腹主動脈旁淋巴結活檢術）”。，術後病檢結果示：（全子宮+兩附件）鏡檢為宮頸低分化癌，結合免疫組化結果，符合低分化腺鱗癌，浸潤宮頸及宮頸管淺肌層（&LT;1/2肌層），未累及陰道穹窿及子宮體上段；未見明確脈管內癌栓及神經束侵犯。淋巴結未見腫瘤轉移。術後於2014-09-25、2014-10-21予TP方案（紫杉醇+順鉑）化療2程，下次化療結束後白細胞最低達2.1×109/L，予瑞白升白治療後血常規恢復正常。今再次返院化療入院。患者起病以來，精神可，無嘔吐，入睡好，陰道無流血，二便正常，體重無明顯改變。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 85}, {"end_pos": 97, "label_type": "手術", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 111}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"label_type": "手術", "overlap": 0, "start_pos": 164, "end_pos": 207}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 248, "end_pos": 254}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 289}, {"end_pos": 351, "label_type": "藥物", "overlap": 0, "start_pos": 348}, {"end_pos": 354, "label_type": "藥物", "overlap": 0, "start_pos": 352}, {"end_pos": 386, "label_type": "藥物", "overlap": 0, "start_pos": 384}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}]}
{"originalText": "，緣於入院前1月因門診胃鏡檢查示：“賁門潰瘍型胃癌”，，病理：腺癌，門診擬“賁門癌”收住入院，入院後完善相關檢查未見明顯手術禁忌症，2014年07月07日在全麻上行“根治性全胃切除術（食道空腸ROUX-Y吻合、D2、R0）”，術順，術後予換藥、止血、補液、營養心肌、維持電解質平衡等治療。，術後病理結果：1、，全胃：食管胃交界潰瘍型管狀腺癌II，侵出漿膜層，侵犯神經，脈管內見癌栓，手術標本上切端未見癌浸潤。找到賁門周淋巴結1/7個，小彎淋巴結2/6個，大彎淋巴結0/4個，幽門下淋巴結0/1個，幽門上淋巴結0/4個，及另送的（第8組）淋巴結0/3個，（第9組）淋巴結0/5個，（第十一組）淋巴結0/1個，（腹主動脈旁）淋巴結0/1個，（空腸繫膜）淋巴結0/1個見癌轉移。2、（食管上段旁）、（第十組），：送檢脈管、纖維及脂肪組織。3、（大網膜結節），：送檢纖維脂肪組織中見癌浸潤。此次為化療再次就診我院，門診擬胃癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"label_type": "手術", "overlap": 0, "start_pos": 83, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 131}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 158, "end_pos": 172}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 298}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 406, "end_pos": 410}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 433, "end_pos": 434}, {"end_pos": 437, "label_type": "解剖部位", "overlap": 0, "start_pos": 436}]}
{"originalText": "患者於約4月前無明顯誘因上開始出現陰道出血，於******健院行宮頸活檢提示中分化鱗癌，後至我院行病理會診提示低分化癌，考慮為低分化鱗狀細胞癌。臨床考慮宮頸癌IIA2期。2016-01-18、2016-2-15於我院行力樸素+順鉑方案2程。2016-03-15全麻上行III型子宮切除、兩附件切除、盆腔淋巴結清掃。術後病理：（子宮）鏡檢為宮頸低分化鱗狀細胞癌，浸潤宮頸及宮頸管深肌層；累及陰道穹窿；可見脈管內癌栓，未見明確神經束侵犯；萎縮性子宮內膜；平滑肌瘤。送檢（左髂內淋巴結）1枚，見癌轉移，其餘多組淋巴結送檢均未見癌。術後恢復好，現患者按主診教授意見入院行術後輔助化療，2016-04-07給予TC（力撲素240MGD1+順鉑50MGD1）方案化療1程順利，無不適。查體無特殊。患者發病以來,精神、飲食、睡眠尚可,大小便無明顯異常。體重無明顯減輕。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 43}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 84}, {"end_pos": 112, "label_type": "藥物", "overlap": 0, "start_pos": 109}, {"end_pos": 115, "label_type": "藥物", "overlap": 0, "start_pos": 113}, {"label_type": "手術", "overlap": 0, "start_pos": 134, "end_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 179}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 224}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 316, "label_type": "藥物", "overlap": 0, "start_pos": 314}]}
{"originalText": "，患者2個月前因下腹部不適於我院就診，，入院後行胃鏡檢查示：於胃體上部、胃角後壁處可見較深凹陷性病變，佔胃腔1/2周，中央可見巨大潰瘍，表面覆汙苔，周圍粘膜不規則，有明顯浸潤並周邊呈堤形隆起；病變部位胃腔狹小，內鏡尚能透過；賁門部未受侵犯。胃鏡病理（201600649），示：（胃角、胃體後壁）低分化腺癌。於2016-01-14在全麻上行根治性胃癌根治術+畢I式吻合，，術後病理示：（201600925）胃體、胃竇低分化腺癌，浸潤潰瘍型，體積14*9*1.6CM，侵穿漿膜，並於部分脈管內查見癌栓。累及近端切線，遠端切線及另送“遠端切線”未查見癌。呈三組（3/3個）、四組（11/17個）、六組（9/11個）、“胃1、3、7組”（2/5個）淋巴結癌轉移。 “胃第六組”（1個）淋巴結未查見癌。，癌組織免疫組化染色示：RRM1（-）、TS局灶（+）、TOPOII部分（+）、 β-TUBULIN-III（-）、SYN（-）、CERBB-2（-）。術後給予靜脈營養、抑酸、補液、補充白蛋白、抗感染等對症治療。患者恢復良好出院，現患者為進一步行化療來我院，門診以“胃癌術後”收入我科。   患者自發病以來，精神可，飲食欠佳，睡眠可，二便正常，體重體力無明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 152}, {"label_type": "手術", "overlap": 0, "start_pos": 169, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 323}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 329, "end_pos": 341}, {"end_pos": 442, "label_type": "藥物", "overlap": 0, "start_pos": 439}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 479, "end_pos": 483}]}
{"originalText": "入院前3月，患者因結腸鏡發現左半結腸腫瘤就診於我院我科，於2015-09-23我院在全麻上行“剖腹探查、結腸癌根治術、腸粘連鬆解術”，手術順利，術後予止血、預防性抗感染、補液、對症等治療。術後病檢（1508028）：（升結腸）粘液性腺癌，侵及全層，遠、近切緣未見癌累及，腸周脂肪組織中淋巴結未見癌轉移（0/8），（腸繫膜結節）見癌組織（2枚），（腹膜結節）未見癌組織。術後恢復可，病情好轉出院。於2015-10-20及2015-11-10在我科行化療，目前患者無畏寒、發熱，無咳嗽、咳痰，無噁心、嘔吐，無腹痛、腹瀉，無胸悶、胸痛、心悸等不適。患者為求第三次化療，以“左半結腸癌術後3月，擬行第四次化療”收入我科住院治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 47, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 136}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 174}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 283, "end_pos": 290}]}
{"originalText": "患者7月前於我院行剖腹探查+胃癌根治（D2，R1）+放射性粒子植入術，手術順利，術後安返病房，術後給予補液、消腫、營養支援等對症處理，術後患者恢復順利，術後病理檢查結果：（胃竇）低分化腺癌。胃第八組淋巴結）可見癌轉移（1/1）。（胃竇）潰瘍型低分化腺癌，浸及胃壁全層，神經見癌侵犯，脈管中見癌栓，上切端見癌累及，下切端食管復鱗下皮輕度不典型增生，胃小彎、大彎淋巴結見癌轉移（各為7/8、7/8），網膜中未見癌轉移，患者出院後無特處不適。1周前無明顯誘因出現全身乏力，且食慾減退，無畏寒、發熱，無腹痛，無噁心嘔吐等症狀，為弄清病情並及時治療，今入我院我科。\\U0004   患者自起病以來，精神略差，胃納較差，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 9, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 94}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 126}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 130}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 182}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}]}
{"originalText": "患者6月餘前（2015-7-16）因結腸癌於我院行左半結腸切除術+淋巴結清掃術，術後常規病理示：（25232.15）（左半結腸）中低分化腺癌，潰瘍型，切面積6*4.5CM，侵達外膜，下上切緣、闌尾及另送吻合器切緣均未查見癌。腸周淋巴結14枚，其中7枚查見轉移（7/14）；另送腸繫膜根部淋巴結1枚，未查見轉移癌（0/1）。術後給予消炎營養支援治療，病情好轉後出院。後患者因“術後腸梗阻”再次入院，行保守治療好轉後出院。後患者再次返院行奧沙利鉑+CF+替加氟方案化療5週期，耐受好。現患者為行上一週期化療治療再次來我院，門診以“結腸癌術後化療”收入院。自發病來，患者飲食睡眠尚可，二便無明顯異常，體重較前無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 21}, {"label_type": "手術", "overlap": 0, "start_pos": 25, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 70}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 192}, {"end_pos": 221, "label_type": "藥物", "overlap": 0, "start_pos": 217}, {"end_pos": 224, "label_type": "藥物", "overlap": 0, "start_pos": 222}, {"end_pos": 228, "label_type": "藥物", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 268}]}
{"originalText": "，緣於入院前4月餘於我院診斷為直腸癌，於2016-01-21在全麻上行腹腔鏡上直腸癌姑息性切除術DIXON，，術後病理：（201602459）1、（直腸），：腸潰瘍型管狀腺癌II級，侵及外膜層。手術標本下、上切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結0/6個，未見癌轉移。腸周脂肪組織中找到12枚癌結節。2、（腸繫膜上動脈根部淋巴結），：送檢為纖維、脂肪及脈管組織。3、（盆壁結節），：送檢為癌結節。，免疫組化：KI67（50%+），CK7（-），CK20（+++），VILLIN（++++），CDX-2（+++），CD56（-），MLH1（+），MSH2（+），PMS2（-），MSH-6（+）。，微衛星穩定性：MSI-L。，病理：（MM20160170）該病例檢測到KRAS基因12號密碼子G12D突變。，病理：(MM20160171)該病例未檢測到BRAF基因V600E突變。術後給予對症、營養支援等治療，恢復可。於2016.03.19,2016.5.4予“伊立替康240MGD1+卡培他濱片1500MGBIDD1-14”方案化療，輔以保胃、保肝、增強免疫等，未見明顯化療副反應。出院後無腹痛、腹脹，無嘔血、黑便，無發熱、寒戰等。此次為行上一週期化療再次就診我院，門診擬直腸癌術後化療收入院。下次出院以來精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 90}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 146}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 445, "label_type": "藥物", "overlap": 0, "start_pos": 441}, {"end_pos": 458, "label_type": "藥物", "overlap": 0, "start_pos": 453}, {"end_pos": 482, "label_type": "解剖部位", "overlap": 0, "start_pos": 481}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 506}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 509}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 547, "end_pos": 552}]}
{"originalText": "緣於入院前4月餘於我院診為“胃癌、直腸癌”，於2016.6.11在全麻上行“全腹腔鏡上根治性遠端胃大部切除術+直腸癌根治術”。術後病理示“（遠端胃)胃角潰瘍型低黏附性癌(低分化腺癌，部分為印戒細胞癌)，侵出漿膜層，侵犯神經及脈管組織，手術標本下、上切端及另送(胃下切端)均未見癌浸潤；找到胃小彎淋巴結0/18個，大彎及網膜淋巴結0/9個，幽門下淋巴結1/1個，幽門上淋巴結0/8個，見癌轉移。小彎側脂肪組織見少量胰腺組織”，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。術後分別於2016.7.13、2016.8.3、2016.8.23予“樂沙定200MGIVGTTQDD1+卡培他濱片1500MGPOBIDD1-14”方案化療。於2016.09.21行迴腸造口還納術，術後恢復可，此次為行再次化療就診我院，門診擬胃癌、直腸癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 38, "end_pos": 61}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 100}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 164}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 279, "label_type": "藥物", "overlap": 0, "start_pos": 276}, {"end_pos": 298, "label_type": "藥物", "overlap": 0, "start_pos": 294}, {"end_pos": 340, "label_type": "手術", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 363, "end_pos": 365}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 366, "end_pos": 371}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}]}
{"originalText": "，緣於入院前2月餘因“胃癌”於2015.11.27全麻上行“腹腔鏡輔助上根治性全胃切除術（D2）”，術後病理回報（201543270），：（全胃），：胃體小彎側浸潤型管狀腺癌II-III級，部分為粘液腺癌和低粘附性癌，侵及漿膜層，脈管內見癌栓。手術標本下、上切端及另送（下切端）未見癌浸潤。找到賁門左淋巴結0/21個，小彎淋巴結11/13個，大彎淋巴結1/7個，幽門下淋巴結0/2個，幽門上淋巴結1/8個，另送（第7組）淋巴結3/4個，（第8組）淋巴結1/3個，（第9組）淋巴結7/7個，（第11組）淋巴結3/5個，（第12A組）淋巴結0/1個，（第12P組）淋巴結0/1個，見癌轉移。，免疫組化：KI67（60%腫瘤細胞陽性），CK7（+），CK20（-），VILLIN（+++），CK18（+++），HER-2（-），CEA（+++），E-CADHERIN（+++），CD68（+++），CD163（-），CD34（+++），D2-40（+），CD31（+++），CD56（-），SYN（-），CGA（-）。於2015.12.23、2016.01.14日行“伊立替康240MGIVGTTD1+替吉奧60MGPOBIDD1-14”方案化療。為求再次術後化療就診我院，門診擬胃癌術後化療收入院，下次出院以來，精神、睡眠、食慾差，大便，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 108}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 239}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 253}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 258, "end_pos": 268}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 283}, {"end_pos": 485, "label_type": "藥物", "overlap": 0, "start_pos": 481}, {"end_pos": 501, "label_type": "藥物", "overlap": 0, "start_pos": 498}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 537, "end_pos": 541}]}
{"originalText": "患者2-月前因診斷為升結腸惡性腫瘤及肝內外膽管結石行根治性左半結腸切除術+膽總管探查術。升結腸腫瘤病理型別：左半結腸潰瘍型中分化管狀乳頭狀腺癌，免疫組化 CK7（－） CK20（+++） CEA（++） VILLIN（+++） CDX－2（++） KI-67（+++）＞90% P53（+） CERBB-2（－） EGFR（+） GST－π（+） TOPOII（++） PGP（+） SYN（－） CGA（－） NSE（－） CD56（－） MLH－1（++） MSH－2（+++） MSH－6（+++） PMS－2（++）；分期T3N1M0。今可按照FOXFOL方案行第二次化療。遂以“升結腸腫瘤根治術後2-月，擬行第2次化療”收治入院。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 25}, {"label_type": "手術", "overlap": 0, "start_pos": 26, "end_pos": 43}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 303}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 341}]}
{"originalText": "緣於入院前4年因“乙狀結腸癌”就診我院，於我院行“腹腔鏡輔助上乙狀結腸癌根治術”，術中見“腫瘤位於乙狀結腸中段，約3*2.5CM，對系膜側侵出漿膜層，未侵犯周圍組織，周圍無明顯腫大淋巴結”，術後病理(201131862)回報“(乙狀)結腸蕈傘型管狀腺癌II級，侵及漿膜層，手術標本下、上切端及另送(下、上切端)未見癌浸潤，找到腸周淋巴結11個均未見癌轉移，另送(腸繫膜上動脈根部淋巴結)為脂肪脈管結締組織”，術後病情恢復良好出院，後門診定期複查發現肝、肺、骨多發轉移。入院前2年前開始給予口服希羅達及中藥治療，無訴腹痛、腹脹，無畏冷、發熱等不適。今為再次治療，門診擬“乙狀結腸癌術後伴肝、肺骨多發轉移”收治入院，自發病以來，飲食較差，睡眠可，二便正常，無消瘦乏力，體重較前無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 14}, {"end_pos": 39, "label_type": "手術", "overlap": 0, "start_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 129}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 233}, {"end_pos": 249, "label_type": "藥物", "overlap": 0, "start_pos": 246}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 284, "end_pos": 300}]}
{"originalText": "，緣於入院前4月餘診為直腸癌，於2014年11月19日在全麻上行“腹腔鏡上直腸癌根治術（MILES）”，手術順利。術後病理(201440195），：“（直腸）直腸潰瘍型管狀腺癌II級並壞死，侵出外膜層，未侵及齒狀線，侵犯神經組織，下、上切端及環周切緣均未見癌浸潤。腫物周圍淋巴結6個、腸周淋巴結14個未見癌轉移。，病理分期：PT4AN0M0，IIB期。”術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。於2015年1月7日、2015年2月4日、2015年3月4日行“奧沙利鉑（齊沙）250MGIVGTTD1+希羅達1500MGPOBIDD1-14”方案3次化療，未見明顯化療副反應，今返院行第4週期化療，門診擬“直腸癌術後化療”收入院。出院後飲食、睡眠可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 33, "end_pos": 50}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 91}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 240, "label_type": "藥物", "overlap": 0, "start_pos": 236}, {"end_pos": 243, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 257}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 309, "end_pos": 314}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}]}
{"originalText": "，緣於入院前5月餘，以“排便次數增多伴血便1個月。”為主訴入院，診斷直腸癌，遂於2013-5-7在全麻上行腹腔鏡上直腸癌根治術+預防性迴腸造瘻，術順，術後予防感染、補液等治療。，病理示：1、大腸潰瘍型管狀腺癌II級，侵及深肌層，手術標本吻合切端見少量癌浸潤，手術標本另一切端及另送（下切端）、（上切端）均未見癌浸潤。找到腫物周淋巴結6個，腸周淋巴結9個均未見癌轉移。另送（腸繫膜上動脈根部淋巴結）為脂肪、脈管及神經組織。2、大腸管狀腺瘤，伴低級別下皮內瘤變。，免疫組化結果：CK7（-），CK20（++），VILLIN（+++），CEA（+++），CDX-2（+++），CD56（-），KI67（50%+）。今患者再次入院，要求關閉造瘻口，門診擬“直腸癌術後，迴腸造瘻術後”收入院，自發病以來，精神、睡眠、食慾尚可，大便經造瘻口排出可，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 37}, {"label_type": "手術", "overlap": 0, "start_pos": 53, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 166}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 324, "end_pos": 336}]}
{"originalText": "患者於1月餘前因“直腸癌”在我科行“腹腔鏡上直腸癌根治術（MILES）+放射性粒子植入術”，手術順利，術後病理結果為：（直腸）潰瘍型中分化管狀腺癌浸及腸壁深肌層，雙切端未見癌累及，腸壁淋巴結見癌轉移（1/10）。術後患者恢復較好，出院後患者無腹痛、腹脹，無畏寒發熱，會陰部切口逐步癒合，現已明顯變淺變小，肉芽組織生長良好，今患者為求術後第1次全身靜脈化療來我院就診，門診以“直腸癌（MILES）術後”收入我科。\\U0004   患者發病以來，神志 清晰，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 18, "end_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 59, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 76}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 199}]}
{"originalText": "，患者於4月前（2015-09-07）因“1.盆腔包塊（卵巢CA？）；2.糖尿病”在全麻上行剖腹探查+全子宮兩附件切除+大網膜切除+闌尾切除+放射性粒子置入術。，術中見：右側附件失去正常形態，大小約10X9X8CM，實性，表面充血水腫，呈紫藍色，可見爛魚肉樣組織，質脆，易觸血，侵及後盆壁，與宮底、乙狀結腸形成粘連。鈍性分離粘連後，見子宮常大，子宮底、前壁見轉移癌灶。左側輸卵管見少量轉移灶，左卵巢形態正常。大網膜增厚、盆腔腹膜見散狀結節病灶，最大約3CM。術中切除右附件交家屬過目後送病理行冰凍切片示“（右附件）卵巢漿液性乳頭狀囊腺癌浸及輸卵管”，遂行子宮、左側附件、大網膜、闌尾切除術後標本送病檢，，術後病檢示：1、（腫瘤組織）送檢物為漿液性乳頭狀囊腺癌。2、子宮表面見癌組織累及，宮腔、宮頸及右附件均未見癌累及。3、大網膜及闌尾均未見癌轉移。並於09-11行順鉑100MG腹腔灌注、09-15行紫杉醇210MG靜滴第一次化療。分別於2015-10-20、2015-12-01予患者行紫杉醇（特素)210MG+奧沙利鉑180MG化療2個療程，化療過程較為順利，患者噁心、嘔吐等不適症狀較輕。現患者無特殊不適，要求行第四次化療。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 79}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 212, "end_pos": 213}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 252, "end_pos": 268}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 277}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 294, "label_type": "手術", "overlap": 0, "start_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 320, "end_pos": 329}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}, {"end_pos": 384, "label_type": "藥物", "overlap": 0, "start_pos": 382}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 403, "label_type": "藥物", "overlap": 0, "start_pos": 400}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 444}, {"end_pos": 450, "label_type": "藥物", "overlap": 0, "start_pos": 448}, {"end_pos": 461, "label_type": "藥物", "overlap": 0, "start_pos": 457}]}
{"originalText": "，患者3月前因“反覆腹痛、腹瀉10余天，加重3天”入院，於2016-03-18在全麻上行乙狀結腸部分切除+乙狀結腸單腔造瘻術，手術過程順利。，術後病理：結腸腺癌（中度分化），浸潤潰瘍型，體積5*4*0.9CM，侵達漿膜脂肪組織。雙端切線及環周底部切除面未查見癌。腸壁一站（8/14個）淋巴結癌轉移。符合結腸炎性息肉。，免疫組化染色示癌組織：SYN（-）、TS弱（+）。2月前患者造口旁出現可復性腫物，站立和用力後增大，平臥後可以回納消失，伴造口脫垂及腸粘膜滲血，現患者為求進一步診治，門診以“造口旁疝”收入我科。   患者精神欠佳，普通飲食，大小便正常，體重較前無明顯變化。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 44, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 157}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 250}]}
{"originalText": "，緣於入院前1月餘於我院診為回盲部腫瘤，於2013-12-10在全麻上行根治性左半結腸切除術，術後病理（201339034）示回盲部浸潤型粘液腺癌，侵犯漿膜外，手術標本回腸切端、結腸切端均未見癌浸潤，送檢淋巴結未見癌轉移，術後給予對症、營養支援等治療，術後恢復良好,傷口癒合II/甲，術後於2014.01.02，行化療治療：FOLFOX，方案：替加氟3.4持續泵入/CF0.3D1-2+奧沙利鉑200MGD1，輔以保肝、制酸、止吐、提高免疫力，化療過程順利，無明顯化療不良反應，今為再次化療入院，門診擬回盲部腺癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 73}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 175, "label_type": "藥物", "overlap": 0, "start_pos": 172}, {"end_pos": 185, "label_type": "藥物", "overlap": 0, "start_pos": 183}, {"end_pos": 197, "label_type": "藥物", "overlap": 0, "start_pos": 193}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 258}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}]}
{"originalText": "，患者因患“乙狀結腸癌”於2014-02-25於我院在全麻上予行乙狀結腸癌根治術；術後病理(201402452），示：（乙狀結腸）腺癌（中、低度分化），隆起型，面積3.5*2CM，侵達漿膜脂肪組織，雙端切線及另送“近端切線”、“遠端切線”未查見癌。一站（13個）、中間組（3個）、中央組（5個）淋巴結未查見癌。，免疫組化染色示癌組織：ERCC1少數（+）、TS（-）。，病理分期為：PT3N0M0 IIA期 DUKESB。依情行術後輔助化療指證存在，排除化療禁忌後，先後給予6個週期輔助化療，，具體化療方案為：奧沙利鉑150MG D1，亞葉酸鈣0.3G+替加氟1.0G D2-D6，同時給予升白細胞、保肝、護胃、止吐、免疫增強治療。自下次出院後，患者一般情況保持良好，無乏力感，無發熱，無噁心、嘔吐，無胸悶、心慌，無頭暈、頭痛，無反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹；大小便情況良好。現患者為行復查來我院就診，門診以“乙狀結腸癌術後”收入院。目前患者精神及情緒狀態可，食慾、飲食好，夜間睡眠可，大小便正常，近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 11}, {"end_pos": 40, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 59, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 150}, {"end_pos": 259, "label_type": "藥物", "overlap": 0, "start_pos": 255}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 268}, {"end_pos": 280, "label_type": "藥物", "overlap": 0, "start_pos": 277}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 414, "end_pos": 421}]}
{"originalText": "緣於3月前因殘胃癌在我院於2014年01月02日在全麻上行根治性殘胃癌切除術手術順利。術後病理示（殘胃）胃近賁門處潰瘍型管狀腺癌II-III級，部分為粘液腺癌，侵及漿膜層，侵犯神經，脈管內見癌栓，未見侵犯食管胃交界區。手術標本下切端、吻合腸管雙切端及另送（下切端）均未見癌浸潤，找到賁門**/8個，小彎側淋巴結0/6個，大彎側淋巴結0/2個，見癌轉移。術後恢復良好，順利出院。出院後於術後2周出現“腹痛伴肛門停止排氣、排便”再次就診我院，考慮“粘連性小腸梗阻”予禁食、胃腸減壓、灌腸、抑制消化液分泌、營養支援等積極保守治療後，患者腹痛一度好轉後再次呈持續性腹痛伴陣發性加劇，遂於2014.1.25全麻上行“剖腹探查+小腸粘連鬆解術”，術順，術後恢復良好，出院後無腹痛、腹脹、噁心、嘔吐等不適，2014.02.17、2014.3.3、2014.4.1於我院行“奧沙利鉑100MGD1IVGTT+亞葉酸鈣200MGD1-2IVGTT+替加氟3.0GCIV”方案術後3週期化療，化療過程順利，無特殊不適，此次為化療再次入院。患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 104, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 222, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 236}, {"end_pos": 241, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"label_type": "手術", "overlap": 0, "start_pos": 303, "end_pos": 315}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 383, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"end_pos": 400, "label_type": "藥物", "overlap": 0, "start_pos": 396}, {"end_pos": 418, "label_type": "藥物", "overlap": 0, "start_pos": 415}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 475}]}
{"originalText": "，緣於入院前1月於我院診為胃角癌，2015年09月07日在全麻上行腹腔鏡輔助上根治性遠端胃大部切除術（畢II式，D2），術後予預防性抗感染、制酸、補液支援等治療。術後病理（201532192），：(遠端胃大部分)，:胃角潰瘍型管狀腺癌II級，侵及漿膜層，手術標本雙切端及另送(下切端)均未見癌浸潤。找到小彎淋巴結2/21個、大彎淋巴結0/2個、幽門下淋巴結0/2個、幽門上淋巴結1/11個，及另送(胃右A根部）淋巴結0/3個、(第8P）淋巴結1/6個，見癌轉移。術後恢復良好,傷口癒合II/甲。此次為化療再次就診我院，門診擬胃角癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 33, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 120}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 198, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 262, "end_pos": 267}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}]}
{"originalText": "，緣於入院前5月餘於我院診斷為“直腸癌伴兩肺多發轉移瘤”，予2016-07-08行“腹腔鏡上直腸部分切除術（姑息性）+乙狀結腸造瘻術”，，術中見：腹腔內無明顯出血，沒有明顯粘連，無腹水，腫瘤下緣位於腹膜反折下2CM右左，明顯累及漿膜面，侵犯左側盆壁，腫瘤上緣於腹腔內不可探及，術中診斷“直腸癌伴肺轉移”，考慮腫瘤晚期，外侵明顯，遂決定行“腹腔鏡上姑息性直腸癌切除術（HARTMANN）+乙狀結腸造瘻術”。術順，術後予止血、止痛，抑酸保胃、保肝，增強免疫，加強營養支援等治療，恢復良好。，術後病理示：(直腸)，：腸潰瘍型管狀腺癌II級，部分為篩狀粉刺型，伴壞死，侵犯神經及脈管，見脈管內癌栓，侵及漿膜層。手術標本下、上切端均未見癌浸潤。找到腸周淋巴結2/12個，見癌轉移，找到癌結節3個。另送(腸繫膜上動脈根部淋巴結)鏡上為脂肪、血管及纖維結締組織。，免疫組化染色結果：KI67（80%陽性），EGFR（+），P53（+），P16（+）。於2016.07.30、2016.8.20、2016.09.10、2016.10.14行“伊立替康240MGIVGTTD1+卡培他濱1500MGPOBIDD1-14+洛鉑40MG腹腔灌注D1”方案化療。於2016.11.12予“伊立替康240MGIVGTTD1+卡培他濱1500MGPOBIDD1-14”方案化療，今為第6次化療，就診我院，門診擬“直腸癌術後化療”收入院。自下次發病以來，精神、睡眠、食慾尚可，大便如下述，小便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 27}, {"label_type": "手術", "overlap": 0, "start_pos": 42, "end_pos": 66}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 150}, {"label_type": "手術", "overlap": 0, "start_pos": 169, "end_pos": 200}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 255, "end_pos": 266}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 467, "label_type": "藥物", "overlap": 0, "start_pos": 463}, {"end_pos": 484, "label_type": "藥物", "overlap": 0, "start_pos": 480}, {"end_pos": 503, "label_type": "藥物", "overlap": 0, "start_pos": 501}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 507}, {"end_pos": 536, "label_type": "藥物", "overlap": 0, "start_pos": 532}, {"end_pos": 553, "label_type": "藥物", "overlap": 0, "start_pos": 549}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 592, "end_pos": 597}]}
{"originalText": "，患者5個半月前(2014-12-23)因“直腸癌”，在我院全麻上上行直腸高位前切除術。術中探查H0P0，病灶大小約3*2.5*1.0CM，位於直腸下段，左前壁，漿膜為脂肪遮蓋。餘腹膜內未見異常。，術後病理：，進展期直腸癌：隆起型　中分化管狀腺癌　斷端無癌。淋巴結見轉移癌（1/15枚）DUKES分期C期（，病理號：178036），術後3周（4個半月前）因膽囊炎、膽囊結石，在我院普外科行急診膽囊切除術。恢復順利，2015-5-4於我科行希羅達、艾恆化療一次，現為再次行化療而入我科，患者病來食慾佳，睡眠良好，大便不成形，小便正常，近半年自覺體重上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 25}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 186}, {"label_type": "手術", "overlap": 0, "start_pos": 196, "end_pos": 201}, {"end_pos": 222, "label_type": "藥物", "overlap": 0, "start_pos": 219}, {"end_pos": 225, "label_type": "藥物", "overlap": 0, "start_pos": 223}]}
{"originalText": "，罹患殘胃癌於2013-9-6在我院予行全麻上全胃切除術（空腸J字代胃）；，術中探查見：腹腔內嚴重粘連，腹腔內無腹水，肝臟無法探查，盆底腹膜無異常；腫瘤位於殘胃後壁，潰瘍性腫塊，約10 X 8CM。腫瘤侵出漿膜層。患者術後積極予相關對症支援治療並恢復順利良好。相關手術病理(2013 11248），示：殘胃低分化腺癌，體積7.5*7*3.2CM，蕈傘型，侵達漿膜。雙端切線及另送“胃遠端切線”未查見癌。賁門周圍（10個）淋巴結未查見癌。，免疫組化染色示癌組織：ERCC1（+）、β-TUBULIN-III（+）、TS（-）、RRM1（-）、TOPOII（陽性數60%）、CERBB-2（-）。合患者病情及腫瘤病理與分期繼續予行術後化療相關輔助治療指徵存在；依情先後予2013-9、2013-10予行術後輔助化療2週期，，具體用藥為：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時輔以鎮吐、升血、免疫調節等對症支援治療（化療期間患者總體耐受性良好；複查血像示外周血白細胞減少，予瑞白升血處理）。自下次出院（2013-10-23）以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無明顯反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹。現患者為行規律性複查並完善相關後續輔助治療而再至我科就診，遂依情以“胃惡性腫瘤術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 3, "end_pos": 6}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 36}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 213}, {"end_pos": 370, "label_type": "藥物", "overlap": 0, "start_pos": 366}, {"end_pos": 383, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"end_pos": 397, "label_type": "藥物", "overlap": 0, "start_pos": 394}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 453, "end_pos": 459}, {"end_pos": 465, "label_type": "藥物", "overlap": 0, "start_pos": 463}, {"end_pos": 535, "label_type": "解剖部位", "overlap": 0, "start_pos": 534}, {"end_pos": 538, "label_type": "解剖部位", "overlap": 0, "start_pos": 537}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 574, "end_pos": 581}]}
{"originalText": "，患者於2016-11-04在全麻上行\\\"胃癌根治術(全胃）\\\"，，術後病理回報:“（胃大體）鏡檢為中至低分化腺癌，LAUREN，分型：腸型，癌組織侵犯至胃壁漿膜上層，並累及食管壁外膜層；未見明確脈管內癌栓，可見神經束侵犯；網膜組織未見癌。淋巴結41枚，2枚見癌。（遠、近切緣）未見癌”。術後預防感染、抑制分泌、靜脈營養等對症支援處理，恢復好，2016-12-05已予行一程術後輔助化療，以現為行上一程化療收住我科，起病以來，患者精神尚可，食慾欠佳，大小便正常，體重上降3KG。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 21, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 43, "end_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 89}]}
{"originalText": "緣於入院前1餘年前於我院診為胃癌，於2012-08-07在全麻上行根治術全胃切除術。術後病理（201223223）示全胃：食管胃交界潰瘍型管狀腺癌，II-III級，侵出漿膜層，侵犯脈管和神經。手術標本下切端見癌浸潤，手術標本上切端和另送（下切端）未見癌浸潤。鏡上找到賁門周淋巴結3/8個、小彎淋巴結3/4個、大彎淋巴結0/1個、幽門下淋巴結0/4個和幽門上淋巴結0/1個見癌轉移。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲，並順利出院，2012.09.24行“伊立替康280MG+替吉奧60MGBID×14D”方案化療1週期，2012.10.23按“伊立替康280MG+替吉奧40MGBID×14D”方案化療1週期，2012.11.20按“伊立替康240MG+替吉奧80MGBID×7D”化療1次,2012.12.22按““安素泰210MG+艾奕40MGBID×14D”化療1次，2013.1.18予“安素泰240MG+替吉奧40MGBID×14D”方案化療1次，2013.02.23按T“安素泰240MG”方案化療1週期。2014.08.28予“表柔比星70MGIVGTTD1+替吉奧40MGBID×10D”方案化療1次。今為再次化療就診我院，門診擬胃癌術後化療後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 81}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 241, "label_type": "藥物", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "藥物", "overlap": 0, "start_pos": 247}, {"end_pos": 286, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 292}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 327}, {"end_pos": 340, "label_type": "藥物", "overlap": 0, "start_pos": 337}, {"end_pos": 372, "label_type": "藥物", "overlap": 0, "start_pos": 369}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 411, "label_type": "藥物", "overlap": 0, "start_pos": 408}, {"end_pos": 420, "label_type": "藥物", "overlap": 0, "start_pos": 417}, {"end_pos": 455, "label_type": "藥物", "overlap": 0, "start_pos": 452}, {"end_pos": 485, "label_type": "藥物", "overlap": 0, "start_pos": 481}, {"end_pos": 500, "label_type": "藥物", "overlap": 0, "start_pos": 497}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 533, "end_pos": 537}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}]}
{"originalText": "，緣於入院前1月於我院診為直腸癌，於2014-03-03在全麻上行腹腔鏡上直腸癌根治術DIXON，，術中見：腹腔網膜及盆底光滑無結節，無腹水，肝表面光滑，胃及空腸未見明顯病變。直腸腹膜返折距離肛門約10CM可觸及一腫物，大小約3CM*2CM，質硬，未侵犯漿膜層，腸繫膜上動脈根部可觸及多枚腫大，與腹壁明顯粘連，予分離，見腸管周圍數個腫大淋巴結，大者直徑約1CM，決定行“腹腔鏡直腸癌根治切除術”。。術後病理(201405649)示1.大腸潰瘍型管狀腺癌II級，侵犯淺肌層。周圍腸管粘膜及粘膜上層淋巴組織增生活躍。手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結1/18個，及另送（腸繫膜上血管旁）淋巴結0/7個見癌轉移。，免疫組化結果：CK7（-），CK20（+），VILLIN（+++），CEA（+++），CDX-2（+++），CGA（-），CD56（-），SY（-），KI67（60%+）。2.大腸管狀腺瘤，伴低級別下皮內瘤變。，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。於2014.3.25、2014.4.9、2014.4.24、2014.5.14予“奧沙利鉑150MGIVGTTD1+替加氟3.6GCIVD1+亞葉酸鈣300MGIVGTTD1-2”方案行4次化療，此次為術後第5次化療再次就診我院，門診擬直腸癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 33, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 54, "end_pos": 55}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 148, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 161}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 196, "label_type": "手術", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 217, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 239}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 300, "end_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 416}, {"end_pos": 502, "label_type": "藥物", "overlap": 0, "start_pos": 498}, {"end_pos": 518, "label_type": "藥物", "overlap": 0, "start_pos": 515}, {"end_pos": 532, "label_type": "藥物", "overlap": 0, "start_pos": 528}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 575, "end_pos": 580}, {"end_pos": 602, "label_type": "解剖部位", "overlap": 0, "start_pos": 601}, {"end_pos": 605, "label_type": "解剖部位", "overlap": 0, "start_pos": 604}]}
{"originalText": "，患者20余天月前行姑息性乙狀結腸部分切除術，術後病理（201413928），：乙狀結腸粘液腺癌，體積10*8*2.5CM，浸潤潰瘍型，侵達漿膜並侵穿纖維膜達脂肪組織。雙端切線及另送“近切線”、“遠切線”未查見癌。腸壁一站（7個）、中間組（6個）淋巴結未查見癌。，免疫組化染色示癌組織：TS大部分（+）、SYN（-）。患者於1天前開始出現腹脹、嘔吐胃內容物，未排氣、排便。急來我院門診就診，為行進一步診治門診依情以“結腸術後”收入院。患者自發病以來，無反覆發熱、畏寒，未現尿頻、尿急、尿痛及排尿困難。目前精神差，不能進飲食。否認近期明顯體重改變。", "entities": [{"end_pos": 22, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 126}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 212}]}
{"originalText": "，緣於入院前5月餘於我院診斷為“賁門癌”，於2015-12-21在全麻上行腹腔鏡上根治性全胃切除術+膽囊切除術。術後病理示1、（全胃），：食管胃交界潰瘍型管狀腺癌II-III級，侵出漿膜層，侵犯神經組織。手術標本下切端見癌浸潤。手術標本上切端及另送（下切端）均未見癌浸潤。找到賁門左淋巴結4/9個，賁門右淋巴結0/1個，小彎淋巴結1/1個，大彎淋巴結0/0個，幽門下淋巴結0/3個，幽門上淋巴結0/1個，及另送（第7組）淋巴結1/1個，（第8組）淋巴結0/1個，（第11組）淋巴結2/3個，（第12組）淋巴結0/6個，見癌轉移。，免疫組化：KI67（80%腫瘤細胞陽性），CK7（++），CK20（-），VILLIN（+++），CEA（+++），CD56（-），CGA（-），SYN（-），HER-2（-）。2、（第9組淋巴結），：送檢脂肪及脈管組織。3、（膽囊），：膽囊組織。術後恢復可，於2016.01.21、2016.02.14、2016.03.08、2016.04.01、2016.04.28予“伊立替康240MGIVGTTD1+替吉奧40MGPOBIDD1-14”方案化療，輔以止吐、增強免疫、營養支援等治療，化療過程順利，無化療副反應。今為行第6週期化療，求診於我院門診，門診擬“賁門腺癌（PT4AN3M0，IIIC期）術後化療”收入院。自下次出院以來精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 55}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 88}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 240}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 356, "end_pos": 364}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 379}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"end_pos": 456, "label_type": "藥物", "overlap": 0, "start_pos": 452}, {"end_pos": 472, "label_type": "藥物", "overlap": 0, "start_pos": 469}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 546, "end_pos": 550}]}
{"originalText": "，患者約於3年前因“乙狀結腸癌”於2014-02-19日在全麻上行乙狀結腸部分切除、乙狀結腸單腔造瘻，闌尾切除術。手術過程順利，術後給予抗感染及營養支援治療，患者恢復好。，術後病理：結腸腺癌(中低度分化),浸潤潰瘍型,面積2.2*1.2CM，侵達漿膜，少數脈管內查見癌栓。雙端切線未查見癌。結腸腸壁部分壞死、穿孔，腸繫膜及腸壁周圍脂肪組織化膿、壞死。腸壁一站（3個）淋巴結未查見癌。慢性闌尾炎。，免疫組化染色示癌組織：ERCC1（+）、TS（+）。術後給予患者化療4週期，，方案為：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時給與升白細胞、護肝、止吐、免疫增強治療，患者化療過程平穩。後患者拒絕繼續化療，未規律複查。院外期間，患者無發熱，無腹痛腹脹不適，大便通暢。現患者為行復查來我科就診，以“乙狀結腸癌術後、乙狀結腸造瘻術後”收入院。   病人自下次出院以來，神志清，精神可，飲食可，大、小便正常，體重未見明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"label_type": "手術", "overlap": 0, "start_pos": 33, "end_pos": 56}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 196}, {"end_pos": 245, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 254}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 269}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 373, "end_pos": 380}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 381, "end_pos": 389}]}
{"originalText": "，患者1月前因“腹部不適伴黑便1月餘”入院，，腰骶部平掃示：腰1壓縮性骨折，，腰椎退行性變：腰2/3、3/4、4/5椎間盤突出並腰4/5水平雙側隱窩狹窄，骶1-3水平椎管侷限性膨大，不除外骶管囊腫。，腹部CT示：膽囊結石，胃腔擴張、幽門部周圍壁厚。，行胃鏡示：胃癌伴幽門梗阻；，病理示：（胃竇、幽門）腺癌。 ，幽門螺旋桿菌染色示：陽性（1+）。於2016-04-12全麻上行根治性胃大部切除+畢I式吻合術。，術後病理示：（201607470）胃竇腺癌（中低度分化），浸潤潰瘍型，體積4*4*2CM，侵達漿膜脂肪組織，部分侵穿漿膜。雙端切線及另送“遠端”切線未查見癌。呈六組（2/9個）淋巴結癌轉移。三組（2個）、四組（3個）、另送“1、3、7組”（6個）淋巴結未查見癌。，免疫組化染色示癌組織：CERBB-2（-）、SYN（-）、β-TUBULIN-III部分（+）、TS部分弱（+）、RRM1部分（+）、TOPOII部分（+）。患者為求進一步診治，來我院就診，門診以“胃癌術後”收入院。   發病以來，食慾差，睡眠可，大小便正常，體重較前無明顯變化。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 23, "end_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 30, "end_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 98}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 152}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 155, "end_pos": 163}, {"label_type": "手術", "overlap": 0, "start_pos": 187, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 284, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 330}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 435, "end_pos": 439}]}
{"originalText": "患者6周前因“血便伴大便習慣改變1月餘”,確診為“1、乙狀結腸腺癌並肝轉移2、兩肺結節 轉移瘤？”後，完善檢查，無手術禁忌症，於2013-12-27全麻上行姑息性“乙狀結腸切除”，術順，術後恢復可，術後病理結果回示：1（乙狀結腸） 鏡檢為結腸中至低分化管狀腺癌，癌組織浸潤至腸壁漿膜層外脂肪結締組織，可見神經束侵犯及脈管內癌栓。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央組淋巴結）4枚，未見癌。5（中間組淋巴結）2枚，未見癌，另見2枚腫瘤種植結節。6（腸周淋巴結）6枚，1/6見腺癌轉移。術後預防感染、對症、支援治療，術後診斷1.乙狀結腸腺癌並肝轉移 PT4AN1M1 IV期;2.兩肺結節 轉移瘤？3.子宮肌瘤4.慢性膽囊炎 5.左腎囊腫。現術後第6周，今為進一步治療遂入我科。患者現無發熱、乏力、咳嗽、氣促、身目黃染等，精神睡眠可，胃納一般，大小便可，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 27, "end_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 47}, {"end_pos": 88, "label_type": "手術", "overlap": 0, "start_pos": 78}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 130}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 138}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 242, "end_pos": 244}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 268, "end_pos": 278}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 302}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 305, "end_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 319, "end_pos": 323}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}]}
{"originalText": "患者因\\\"體檢發現肝佔位10天\\\"於2012年1月到我院就診，經完善檢查診斷為結腸腺癌並肝多發轉移,無手術禁忌症，於2012-02-06日全麻上行“DIXON'S+腸粘連鬆解術”，術順，術後恢復順利。術後病理示中分化腺癌，浸潤至漿膜上，淋巴結3/9轉移。於術後3周始返院行FOLFIRI（開普拓+5-FU/CF）化療8週期，加安維汀7週期。2012-6-20查CT示肝臟各葉可見多發異常密度影，病變較前縮小（最大者由20×31MM縮至15×28MM），病變數目大致同前。多學科討論決定暫停開普拓及安維汀，繼續予5FU/CF維持化療，結合射頻治療。後患者於2012年7月11日行肝轉移瘤射頻消融術，術程順利。現為進一步治療入住我科，患者精神、飲食、睡眠可，大小便正常，無腹痛、腹脹、噁心、嘔吐，體重無明顯減輕。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 49}, {"label_type": "手術", "overlap": 0, "start_pos": 74, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"end_pos": 147, "label_type": "藥物", "overlap": 0, "start_pos": 144}, {"end_pos": 152, "label_type": "藥物", "overlap": 0, "start_pos": 148}, {"end_pos": 155, "label_type": "藥物", "overlap": 0, "start_pos": 153}, {"end_pos": 166, "label_type": "藥物", "overlap": 0, "start_pos": 163}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 180, "end_pos": 182}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 247, "label_type": "藥物", "overlap": 0, "start_pos": 244}, {"end_pos": 251, "label_type": "藥物", "overlap": 0, "start_pos": 248}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 255}, {"end_pos": 261, "label_type": "藥物", "overlap": 0, "start_pos": 259}, {"end_pos": 297, "label_type": "手術", "overlap": 0, "start_pos": 288}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}]}
{"originalText": "，緣於3月前因“反覆進食受阻2月餘。”為主訴入院，診斷食管佔位，排除手術禁忌症後於2016-01-20在全麻上行胸腔鏡上全胸段食管切除+食管-胃底右頸部吻合術，術順，術後恢復可，術後病理（201602316），：(食管及胃底)，：食管潰瘍型鱗狀細胞癌II級，侵及外膜層，手術標本下、上切端均未見癌浸潤，找到胃周淋巴結1/17個，另送(隆突上)淋巴結0/2個、(右喉返喉返神經旁)淋巴結0/8個、(左喉返喉返神經旁)淋巴結個0/5、(右鎖骨下)淋巴結0/4個、(下段食管旁)淋巴結0/1個、(頸段食管旁)淋巴結0/2個、(上段食管旁)個淋巴結0/1個，見癌轉移。排除化療禁忌症後於2016.02.19、2016.03.13、2016.04.08以“順鉑40MGD1-2，紫杉醇（泰素）180MGD2”行化療，輔以保肝、護胃、提高免疫力等處理，未見明顯化療副反應，現為求第4期化療，就診我院，門診擬“食管癌術後化療後”收住入院，自出院以來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 27, "end_pos": 31}, {"label_type": "手術", "overlap": 0, "start_pos": 56, "end_pos": 79}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 128}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 325, "label_type": "藥物", "overlap": 0, "start_pos": 323}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 334}, {"end_pos": 340, "label_type": "藥物", "overlap": 0, "start_pos": 338}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 398, "end_pos": 403}]}
{"originalText": "入院前5+月，患者因胃癌於2014.5.21全麻上行腹腔鏡胃癌根治術中轉開腹全胃切除空腸食管ROUX-ENY吻合術+橫結腸部分切除術。術後抗感染補液及營養支援治療。術後病檢：（1404047）&LT;胃&GT;低分化腺癌，部分為印戒細胞癌，侵及全層，雙側切緣未見癌累及，大彎淋巴結未見癌轉移(0/3),小彎淋巴結見癌轉移(10/15),&LT;7、8、9組&GT;淋巴結見癌轉移(8/9)，大網膜組織未見癌累及，經科內討論於6月2日行奧沙利鉑+氟尿嘧啶化療及對症治療。2014年07月03日患者行術後第二次化療，2014年08月18日患者行術後第三次化療，2014年09月25日患者行術後四次化療，患者化療副反應較輕，化療後精神、食慾、睡眠尚可，未有發熱，未明顯見脫髮，無咳嗽、咳痰，今日患者為擬行第5次化療，到我院門診就診，門診以“胃癌術後第5次化療”收入我科住院治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 26, "end_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 119}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 185}, {"end_pos": 221, "label_type": "藥物", "overlap": 0, "start_pos": 217}, {"end_pos": 226, "label_type": "藥物", "overlap": 0, "start_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 367, "end_pos": 371}]}
{"originalText": "，緣於3個月前於我院查腹部CT示：1、橫結腸近脾區腸壁增厚，伴鄰近脂肪間隙內數個淋巴結，考慮新生物可能，建議進一步腸鏡檢查。2、肝內多發佔位性病變，考慮多發轉移瘤。，行腸鏡示：結腸癌，病理回報為（降結腸）大腸管狀腺癌II級。於2013年11月21日在全麻上行“腹腔鏡輔助上姑息性右半結腸切除術”，手術順利。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。術後病理示“（右半結腸）大腸隆起型管狀腺癌II級，侵出漿膜層，漿膜面見癌結節形成，脈管內見癌栓，手術標本雙切端均未見癌浸潤。找到腸周淋巴結4/18個見癌轉移。，免疫組化結果：CK20（++），CK7（-），VILLIN（+++），CEA（+++），CDX-2（+++），CGA（-），SY（-），CD56（-），KI67（40%+）。”根據術後病理，腫瘤分期為PT4BN2AM1IV期。據其腫瘤分期有化療指徵，於2013-12-06以“伊立替康280MGIVGTTD1+替吉奧60MGPOBIDD1-14”方案化療，化療過程順利，無明顯化療副作用。此次為化療再次入院。自出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 11, "end_pos": 15}, {"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 111}, {"end_pos": 146, "label_type": "手術", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 204}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 402, "label_type": "藥物", "overlap": 0, "start_pos": 398}, {"end_pos": 418, "label_type": "藥物", "overlap": 0, "start_pos": 415}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 479}]}
{"originalText": "胃癌術後2年，外院檢查提示左上腹包塊，腎積水外院2014-4-17胃鏡提示胃底體粘膜水腫，僵硬（BORRMANNIV）。活檢病理為低分化腺癌，部分印戒。2014.4.30行胃癌根治術，術中不詳，術後病理：胃小彎瀰漫浸潤性低分化腺癌，部分為印戒，3X3CM，侵潤胃壁全層，切緣、大網膜無癌累及，小彎側大彎側淋巴結10枚無癌轉移。HER-2( 0) 。現術後恢復可，可進少量半流食，進食後無明顯不適，體重較術前上降約5KG近期檢查發現左上腹腫塊，左腎積水。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 0, "end_pos": 4}, {"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 37, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"end_pos": 91, "label_type": "手術", "overlap": 0, "start_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 115}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 131}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 146, "end_pos": 155}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 225}]}
{"originalText": "，患者於4年餘前在我科行剖腹探查+乙狀結腸腫瘤切除＋近端造口、遠端封閉+結腸減壓，3年餘前行乙狀結腸造口還納術，已於2012年8月完成FOLFRI化療方案五次，2014年3月入院複查發現卵巢轉移，遂行經腹全子宮+兩附件切除術+闌尾切除術+大網膜切除+左側淋巴結清掃術+盆腔粘連鬆解，術中冰凍病理結果示左卵巢腺癌；手術順利，術後患者恢復可，半年前*****行CT檢查後發現發現網膜及系膜多發腫瘤轉移，遂行規範XELOX化療4次。1月前，患者因“乙狀結腸癌術後3年餘，肛門停止排氣排便7天”入院。，入院後全腹部增強CT提示：結腸CA伴卵巢轉移術後改變，小腸梗阻，考慮末端迴腸粘連狹窄所致可能。遂於2015-12-03在全麻上行剖腹探查+腸粘連鬆解+左半結腸切除術，手術順利，，術中冰凍切片提示：（左半結腸）腺癌，雙切端未見癌累及。，術後病理診斷：左半結腸中分化管狀腺癌，浸及腸壁全層，脈管內見癌栓。雙切端未見癌累及。腸壁下淋巴結未見癌轉移（0/10）。患者入院前無發熱、寒戰，無噁心、嘔吐，無反酸、噯氣，今為行第5次化療前來我院，門診擬“乙狀結腸癌、卵巢轉移”收入我科。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 12, "end_pos": 40}, {"end_pos": 55, "label_type": "手術", "overlap": 0, "start_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 93, "end_pos": 97}, {"label_type": "手術", "overlap": 0, "start_pos": 100, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 155}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 178, "end_pos": 180}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 228}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 250, "end_pos": 257}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 260, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 274, "end_pos": 278}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "手術", "overlap": 0, "start_pos": 311, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 345, "end_pos": 353}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 371, "end_pos": 382}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 385, "end_pos": 386}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 412}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 467, "end_pos": 477}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}]}
{"originalText": "，緣於入院前1月於我院診為回盲部癌，於2015-06-23在全麻上行腹腔鏡上左半結腸切除術，，術中見：腹腔內無明顯出血，無明顯腹水，於回盲部見腫瘤，大小約6×5×4CM，累及迴腸末端約3.0CM，侵出漿膜層，與周圍組織無明顯粘連，未形成梗阻，近端腸管無擴張，周圍及腸繫膜根部未見明顯腫大淋巴結。術後病理（201523144）示(左半結腸)，：腸浸潤性管狀腺癌II級，侵犯迴盲瓣及迴腸，侵及漿膜層，見神經侵犯，手術標本雙切端及另送（下切端）（上切端）均未見癌浸潤，找到闌尾根部淋巴結3個，迴腸周淋巴結7個，結腸周圍淋巴結26個，另送(回結腸動脈根部）淋巴結4個，(結腸中動脈根部）淋巴結4個，均未見癌轉移；慢性闌尾炎。該病例未檢測到KRAS基因12、13號密碼子熱點突變。該病例未檢測到BRAF基因V600E突變。，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。此次為行第1次化療再次就診我院，門診擬回盲部癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 17}, {"end_pos": 45, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 182}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 302, "end_pos": 307}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 405, "end_pos": 411}, {"end_pos": 433, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 435}]}
{"originalText": "，患者4月前因“胃癌”於2017-05-04在我院於全麻上行胃癌癌根治術（遠端胃大部切除+畢I式吻合術），手術過程順利，術後給予抗感染及營養支援治療，患者恢復好，切口癒合良好，病癒出院。，術後病理示：（201710017）胃竇前壁腺癌（低分化）粘液性印戒，面積5*4.5CM，厚1.2CM，侵達漿膜。雙端切線未查見癌。三組（5個）、四組（4個）、七組（1個）、“1、3、7組”（12個）淋巴結，未查見癌。，免疫組化染色示：CERB-2（-）、SYN少量（+）、β-TUBULIN-III部分（+）、RRM1（-）、TOPO II少量（+），於我院行化療，，化療方案為：奧沙利鉑200MG D1+亞葉酸鈣0.3D2-6 +氟尿嘧啶750MG D2-6 靜滴，同時予以升白細胞、止吐、抑酸、保肝、免疫增強治療。   院外期間患者一般情況好，無噁心，無腹痛腹脹脹不適，現患者為行復查及化療再次來院就診，門診以“胃癌術後”收入院。   近期患者一般情況良好，神志清，精神良好，飲食、睡眠良好，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 10}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 127}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 196}, {"end_pos": 288, "label_type": "藥物", "overlap": 0, "start_pos": 284}, {"end_pos": 301, "label_type": "藥物", "overlap": 0, "start_pos": 297}, {"end_pos": 314, "label_type": "藥物", "overlap": 0, "start_pos": 310}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 344}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 402, "end_pos": 406}]}
{"originalText": "，患者3月餘前無明顯誘因出現下腹部疼隱痛，程度輕微，可自行忍受，予抑酸等處理後疼痛可緩解，腹痛無向腰背部放射，無腹脹、腹瀉，無噁心、嘔吐，無便血、黑便。遂就診於我院，，查胃鏡示：胃竇幽門前見一潰瘍型腫物，胃竇腔變形，狹窄。，活檢提示：（胃竇幽門前潰瘍型腫物活檢）鏡檢為中至低分化腺癌，LAUREN，分型：考慮混合型。入院後完善相關檢查，未見明顯手術禁忌，有手術適應症，於2017-04-07在我院行“腹腔鏡胃癌根治術”，術程順利，術後恢復良好。，病理檢查：（胃大體）鏡檢為胃中至低分化腺癌，LAUREN，分型：混合型，癌組織浸潤至胃壁漿膜層，可見脈管內癌栓及神經束侵犯；網膜組織未見癌。（近切緣）（遠切緣），鏡上：粘膜慢性炎，局灶腺體伴輕度不典型增生及腸下皮化生。（淋巴結）6/52見腺癌轉移；，免疫組化：VEGF（局灶弱+），HER-2（0），CK（+）。，原位雜交：EBERS（-）。術後分期為T4N2M0 IIIB期，術後恢復可，雙便正常，體重上降20+斤。術後於2017-05-04行XELOX方案化療1程，現按主診教授意見收入我科。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 51}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 118, "end_pos": 120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 122}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 134, "end_pos": 141}, {"end_pos": 208, "label_type": "手術", "overlap": 0, "start_pos": 200}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 251}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 265, "end_pos": 266}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 344}]}
{"originalText": "，患者因“胃癌”於2015-5-19於我院行“胃癌根治術”，術後恢復良好，，術後病理示：胃竇腺癌，中度分化，浸潤潰瘍型，體積8*5*2.2CM，侵穿漿膜，部分脈管內查見癌栓，並大彎側、小彎側脂肪組織內及大網膜內多灶性癌轉移，雙端切線未查見癌。呈四組（3/9個）、六組（1/6個）淋巴結癌轉移及“肝圓韌帶”癌轉移。三組（2個）、五組（1個）、“1、3、7組”（13個）淋巴結未查見癌。，癌組織免疫組化染色示：β-TUBULIN-III局灶（+）、TS（-）、RRM1局灶（+）、TOPOII少數（+）、CERBB-2（-）、SYN（-）。，依情予行術後2療程化療：奧沙利鉑150MG D1+亞葉酸鈣0.3G D2-6+替加氟1GD2-6,化療過程順利，無明顯不適，現為進一步治療至我科就診，遂依情以“胃惡性腫瘤術後”收入院。發病來，患者目前患者精神好，食慾一般，夜間睡眠可，小便正常，大便未訴異常，近期體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 7}, {"end_pos": 28, "label_type": "手術", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 142}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 186}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"end_pos": 298, "label_type": "藥物", "overlap": 0, "start_pos": 294}, {"end_pos": 311, "label_type": "藥物", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 349, "end_pos": 356}]}
{"originalText": "，患者因“乙狀結腸癌”於2012-11-30在我院於全麻上行乙狀結腸癌根治術，手術過程順利，術後給予抗感染及營養支援治療，患者恢復好，切口癒合良好。，術後病理示：（13304.2012）(乙狀結腸）腺癌（中度分化，部分為粘液腺癌影象），符合絨毛狀管狀腺瘤癌變，面積為4*3.5CM，侵穿漿膜，雙側切線及另送“近端”、“遠端”切線未查見癌。一站淋巴結（9個）、中間組淋巴結（7個）未查見癌。查無化療禁忌後，分別於2012-12-20、2013-1-21、2013-2-16行3次化療治療，，化療方案為：奧沙利鉑150MG D1，亞葉酸鈣0.3G+替加氟1.0G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，患者副反應輕。   院外期間患者一般情況好，無噁心，無腹痛腹脹脹不適，現患者為行復查及化療再次來院就診，門診以“乙狀結腸癌術後”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 10}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 93, "end_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 185}, {"end_pos": 254, "label_type": "藥物", "overlap": 0, "start_pos": 250}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 263}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 272}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 364, "end_pos": 371}]}
{"originalText": "，緣於入院1月餘前於我院診為降結腸中分化管狀腺癌，於2016年03月04日在全麻上行“腹腔鏡上根治性右半結腸切除術”，術後病理（N201601905），：（右半結腸），：結腸潰瘍型中分化管狀腺癌，侵犯腸壁全層及腸周脂肪組織，侵犯神經、脈管組織，手術標本雙切端及另送(上切端)均未見癌浸潤,另送(下切端)漿膜外纖維脂肪組織中見癌浸潤。找到腸周淋巴結5/15個見癌轉移。另送(右結腸根部淋巴結)、(結腸中血管右支根部淋巴結)鏡上為纖維、血管、脂肪組織。（MN20160037），：該病例未檢測到BRAF基因V600E突變。（MN20160037），：該病例檢測到KRAS基因12號密碼子G12S突變。術順安返，予預防性抗感染、制酸、提高免疫力、營養支援等治療好轉後出院。於2016.04.12予“安維汀200MGIVGTTD1+奧沙利鉑120MGIVGTTD2+氟尿嘧啶3400MGCIV48H+亞葉酸鈣300MGIVGTTD1-2”方案化療1個週期，化療過程順利，化療後未見明顯不良反應。此次為化療再次就診我院，門診擬結腸癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 24}, {"end_pos": 57, "label_type": "手術", "overlap": 0, "start_pos": 43}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 106}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 349, "label_type": "藥物", "overlap": 0, "start_pos": 346}, {"end_pos": 366, "label_type": "藥物", "overlap": 0, "start_pos": 362}, {"end_pos": 383, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"end_pos": 400, "label_type": "藥物", "overlap": 0, "start_pos": 396}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 458, "end_pos": 463}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}]}
{"originalText": "患者於2015.10.28在我院因“絕經2年後陰道不規則流血2月”行經腹廣泛性子宮+兩附件切除術+盆腔淋巴結清掃術，手術順利，術後病理示：（38711.15）（宮頸）中低分化鱗狀細胞癌，腫瘤切面積4.8×2.6CM，侵及宮頸全層及宮頸內口；陰道壁、右左宮旁組織未查見癌；右閉孔淋巴結4枚（0/4）、左閉孔淋巴結5枚（0/5）均未查見轉移癌；右髂血管淋巴結9枚，其中8枚查見轉移癌（8/9），左髂血管淋巴結7枚，其中1枚查見轉移癌（1/7）；萎縮性子宮內膜，兩側輸卵管大致正常，兩側卵巢白體。於2015.11.13行紫杉醇+順鉑化療1週期，化療過程中出現紫杉醇過敏，後於2015.12.09改為力樸素270MG+順鉑120MG化療1週期，未訴明顯不適。後為行進一步治療轉入我科，排除放化療禁忌後，給予區域性放療計劃，計劃量DT=4500CGY/25F，同時順鉑40MG D1-3+力撲素270MG D1化療1週期，過程順利，無明顯不適。後為行進一步診治，就診我院。排除化療禁忌後於2016.2.16給予力撲素270MG D1+順鉑40MG D1-3化療1週期，過程順利，無明顯不適。現為行上週期化療再次收入我科。患者自下次出院以來，飲食睡眠可，大小便正常，體重無明顯改變。", "entities": [{"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 92}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 223, "end_pos": 225}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 244}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 257}, {"end_pos": 263, "label_type": "藥物", "overlap": 0, "start_pos": 261}, {"end_pos": 279, "label_type": "藥物", "overlap": 0, "start_pos": 276}, {"end_pos": 299, "label_type": "藥物", "overlap": 0, "start_pos": 296}, {"end_pos": 307, "label_type": "藥物", "overlap": 0, "start_pos": 305}, {"end_pos": 378, "label_type": "藥物", "overlap": 0, "start_pos": 376}, {"end_pos": 391, "label_type": "藥物", "overlap": 0, "start_pos": 388}, {"end_pos": 452, "label_type": "藥物", "overlap": 0, "start_pos": 449}, {"end_pos": 463, "label_type": "藥物", "overlap": 0, "start_pos": 461}]}
{"originalText": "，2017年02月17日在全麻上行腹腔鏡探查，根治性全胃切除術。，術後病理：（全胃和大網膜），切除： - 潰瘍型低分化腺癌，LAUREN，分型：混合型； - 位於粘膜層； - 未見脈管癌栓； - （食管斷端）、（十二指腸殘端）未見癌； - 大網膜未見癌； - 淋巴結未見癌轉移（第1組0/3、第2組0/2、第3組0/0、第4D組0/1、第4SA組0/0、第5組0/2、第7組0/3、第8A組0/1、第8P組0/2、第9組0/2、第11D組0/3、第12A組0/0、第6組0/3、第11P組0/4、第4SB組0/0）； - ，腫瘤病理分期：PT1AN0。，免疫組化結果顯示:CD56(－),CGA(－),CK(+),KI-67(+40%),SYN(－)。術後恢復可。，術後基線：胸CT（-),腹盆，CT：盆腔少量積液，較前增多。2017-3-15 C125 76.84。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 31}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 101}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 338, "end_pos": 341}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 345, "end_pos": 350}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}]}
{"originalText": "，緣於入院前44天因“盲腸癌”於2016.05.30在全麻上行“腹腔鏡上左半結腸根治性切除術”，，術中見：腹腔內無明顯出血，無明顯腹水，腫瘤位於盲腸，腫瘤侵犯左外側腹壁，未形成梗阻，近端腸管無擴張，周圍可見數個腫大淋巴結。術後病理（201618360），示：(左半結腸)，：結腸潰瘍型管狀腺癌II級，伴壞死，侵出外膜層；迴腸末端淋巴組織增生。手術標本回腸切端、結腸切端及另送（近切端）、（遠切端）均未見癌浸潤。找到迴腸周淋巴結1/5個、結腸周淋巴結3/10個，及另送(回結腸動脈根部)淋巴結2/2，見癌轉移。，免疫組化：13號KI67（60%+），CK8（+++），CEA（+++），P53（-）；22號KI67（生髮中心80%+，濾泡間區2%+），CD3（T細胞+++），CD20（B細胞+++），BCL-2（+++）。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。並於2016.06.23予“奧沙利鉑150MGIVGTTD1+卡培他濱片1000MGPOBIDD1-14”方案化療1週期，輔以制酸、保肝、止吐等預處理，化療過程順利，無明顯不適。此次為化療再次就診我院，門診擬“盲腸癌術後化療”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 94}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 162}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 408, "label_type": "藥物", "overlap": 0, "start_pos": 404}, {"end_pos": 425, "label_type": "藥物", "overlap": 0, "start_pos": 421}, {"end_pos": 458, "label_type": "解剖部位", "overlap": 0, "start_pos": 457}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 495, "end_pos": 500}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 524}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 527}]}
{"originalText": "，患者於入院前4個月因“反覆血便6個月”住我院查腹部，CT:1、乙狀結腸管壁不規則增厚，符合乙狀結腸CA（浸潤型）改變，侵犯漿膜層，伴周圍少許淋巴結。2、闌尾切除術後改變。遂於2013.11.14全麻上“腹腔鏡上乙狀結腸癌根治術”，術順，術後予預防感染、營養支援、補液等治療。，術後病理：(乙狀結腸)，:腸潰瘍型管狀腺癌II級，侵及深肌層，侵犯神經組織，手術標本下、上切端及另送(下切端)、(上切端)均未見癌浸潤，找到腸周淋巴結17個，及另送(直腸下動脈旁染色淋巴結1)淋巴結1個，(直腸下動脈旁染色淋巴結2)淋巴結1個，(腸繫膜上動脈)淋巴結2個均未見癌浸潤。術後恢復可，進食半流質飲食無腹痛、腹脹等不適，創口癒合良好，於2013.12.23、2014.01.12、2014.02.05、2014.02.27予以“奧沙利鉑200MGIVGTTD1+希羅達1500MGPOBIDD1-14”方案化療，化療期間輔以預防性制酸、止吐等治療，化療期間未見明顯不適。今為第5次化療就診我院，門診擬“結腸癌術後”收住入院，自患病以來患者精神、睡眠、飲食一般，大小便正常，體重無明顯改變。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 24, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 57}, {"label_type": "手術", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 114, "label_type": "手術", "overlap": 0, "start_pos": 102}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 152, "end_pos": 163}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 234}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 254}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 358}, {"end_pos": 378, "label_type": "藥物", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 445, "end_pos": 450}]}
{"originalText": "，緣於入院前4個月因“乙轉結腸癌”於2014年01月09日行“腹腔鏡上乙狀結腸癌根治術”。術後病理（201400845），：1、（乙狀結腸），：大腸潰瘍型乳頭狀-管狀腺癌II級，侵及漿膜，手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤。找到腫物周淋巴結9個，腸周淋巴結8個，均未見癌轉移。2、（腸繫膜上動脈根部）送檢脈管、纖維及脂肪組織。，術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。於2014.02.04、2014.02.24、2014.03.17、2014.04.10、2014.4.30予“奧沙利鉑(艾恆)200MG靜滴D1+卡培他濱片(希羅達)1500MG口服BIDD1-14”方案化療5週期，化療過程順利，輔以制酸、止吐等處理。此次為化療再次入院。患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 31}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 130}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 152}, {"end_pos": 261, "label_type": "藥物", "overlap": 0, "start_pos": 257}, {"end_pos": 264, "label_type": "藥物", "overlap": 0, "start_pos": 262}, {"end_pos": 279, "label_type": "藥物", "overlap": 0, "start_pos": 275}, {"end_pos": 284, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}]}
{"originalText": "，患者因“，盆腔包塊：卵巢癌？”於2013-12-30我可行腫瘤細胞減滅術（全子宮切除+兩附件切除+盆腔淋巴結切除+腹主動脈淋巴結切除+大網膜切除+腸粘連鬆解術），術程順利，術後恢復良好。，術後病理提示：兩側卵巢見低分化腺癌浸潤，形態較符合高級別漿液性腺癌，子宮體後壁外膜層及肌層見腺癌浸潤，宮頸管後壁外膜層見腺癌浸潤，大網膜纖維組織中見低分化腺癌浸潤，兩側輸卵管、宮頸及盆腔淋巴結均未見癌。結合術後病理診斷為“卵巢低分化腺癌IIIC期”，今為術後輔助化療收入院，患者近1月以來精神可，大小便無異常，體重無明顯減輕。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 38, "end_pos": 80}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 146, "end_pos": 149}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 157}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 206, "end_pos": 218}]}
{"originalText": "，患者於3月餘前因胰腺腫物於我科行胰十二指腸切除、聯合胰腺體頸部切除、胃造瘻、空腸造瘻術”，，術後病理示:胰腺導管內乳頭狀粘連性腫瘤伴下皮重度不典型增生.術後予保肝、制酸、輸白蛋白、對症等治療。術後恢復可，予帶T管、胃、空腸造瘻管、左腹腔引流管出院。2月餘前T管管周出現明顯滲液，呈濃稠狀，，入院查下腹部CT示:腹腔積液.予行B超引導上腹腔穿刺置管引流後予抗感染、補液、保肝等處理後腹腔管、胃空腸造瘻管、T管均拔除後出院，現患者無腹痛、腹脹，無畏寒、發熱，無眼黃、尿黃、面板黃等不適，今為進一步複查，來我院，門診以胰十二指腸切除術後收入院。患者自發病以來飲食少，大小便無異常，體重無明顯增減。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 17, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 76}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 150, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 156, "end_pos": 160}, {"end_pos": 176, "label_type": "手術", "overlap": 0, "start_pos": 163}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 193, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 235}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 257, "end_pos": 266}]}
{"originalText": "，緣於入院前1年餘因“食管中段癌（PT2N0M0）II期”就診我院2013.08.12在全麻上行食管中段癌切除+食管-胃底弓下吻合術，，術中探查：胸腔無粘連，無淡黃色積液；腫物位於主動脈弓後，區域性增厚約2.5CM，未累及外膜，食管旁多發淋巴結腫大。，術後病理示：（201324854）(食管)，：食管潰瘍型鱗狀細胞癌II級，侵及深肌層（1/2肌層），手術標本下上切端均未見癌浸潤，找到食管周淋巴結3個及另送(中段食管旁）淋巴結11個，(胃右動脈旁）淋巴結14個，均未見癌轉移，(賁門旁淋巴結）為血管、脂肪、纖維結締組織及橫紋肌組織。，免疫組化結果：KI67（50%），P53（+++），P170（-），GSTπ（+++），EGFR（+++）。現為術後複查再次就診我院。下次出院至今患者無胸悶、憋氣；無胸背痛；無腹痛、腹脹；無嘔血、黑便；偶有返酸。飲食睡眠較好。大小便正常。體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 48, "end_pos": 66}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 121}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 161}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}]}
{"originalText": "患者因\\\"子宮肌瘤\\\"於2013年9月10日行全子宮切除術+右側附件切除術，術後外院病理結果示子宮內膜樣腺癌（中-低分化），浸潤深肌層，累及宮頸管，診斷為子宮內膜癌。術後恢復可。2013-10-30、2013-11-22行TP方案化療（多帕菲、伯爾定）2程。2013-12-12行“力樸素+伯爾定”化療1程。現按主診教授意見入院行上一程化療。患者近期精神、睡眠、胃納可，大小便無異常，體重未見明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 47, "end_pos": 61}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 121, "label_type": "藥物", "overlap": 0, "start_pos": 118}, {"end_pos": 125, "label_type": "藥物", "overlap": 0, "start_pos": 122}, {"end_pos": 144, "label_type": "藥物", "overlap": 0, "start_pos": 141}, {"end_pos": 148, "label_type": "藥物", "overlap": 0, "start_pos": 145}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}]}
{"originalText": "，患者約於6個月前因“乙狀結腸癌”於2017-01-23在全麻上行“乙狀結腸根治術”，手術過程順利，術後患者恢復好，切口癒合好，按期拆線。術後病理( 201701617)，：乙狀結腸粘液腺癌，浸潤潰瘍型，體積6.5*4*1.3CM，區域性侵穿漿膜。雙端切線及另送“近切線”、“遠切線”未查見癌。呈一站（3/8個）、中間組（1/8個）淋巴結癌轉移。，免疫組化染色示癌組織：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。患者術後出現發熱，尿培養+藥敏(20170204)，: 銅綠假單胞菌，給予抗炎、退熱等藥物治療後，症狀逐漸緩解後出院。患者出院後規律至我院複查，給予6週期化療，，方案為：奧沙利鉑200MG D1，亞葉酸鈣0.3G+氟尿嘧啶0.75G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，患者副反應輕。   院外期間，患者無發熱，無腹痛腹脹不適，大便通暢。現患者為行復查化療來我科就診，以“乙狀結腸癌術後”收入院。   病人自下次出院以來，神志清，精神可，飲食可，大、小便正常，體重未見明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 168}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 240, "end_pos": 243}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 244, "end_pos": 246}, {"end_pos": 320, "label_type": "藥物", "overlap": 0, "start_pos": 316}, {"end_pos": 333, "label_type": "藥物", "overlap": 0, "start_pos": 329}, {"end_pos": 342, "label_type": "藥物", "overlap": 0, "start_pos": 338}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 399, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 427, "end_pos": 434}]}
{"originalText": "，患者因患“胃癌”於2017-07-10日在全麻上行全胃切除術+空腸J字代胃術，手術順利，術後給予抗炎、抑酸、營養支援及對症支援治療，術後病理示術後病理（201715979），示：胃體腺癌（低分化），浸潤潰瘍型，體積2.5*1*1.3CM，侵達漿膜。雙端切線及另送“食管切線”未查見癌。一組（7個）、三組（2個）、四組（4個）、五組（1個）及六組（2個）淋巴結未查見癌。，免疫組化染色示：CERBB-2（-）、SYN（-）、β-TUBULIN-III少數（+）、RRM1（-）、TOPOII部分（+）。術後給予化療1療程，，方案：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，現患者為行復查化療來我院就診，門診以“胃癌術後”收入院。自下次出院後，患者一般情況保持良好， 無乏力感，無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯 腹痛、腹脹；大小便情況良好。目前患者精神及情緒狀態可，食慾、飲食好，夜間睡眠可，大小便正常，近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 26, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 180}, {"end_pos": 269, "label_type": "藥物", "overlap": 0, "start_pos": 265}, {"end_pos": 282, "label_type": "藥物", "overlap": 0, "start_pos": 278}, {"end_pos": 296, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 330, "end_pos": 334}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}]}
{"originalText": "患者1年餘前（2014-9-30）因“胃癌”於我院行胃癌根治術（畢I），術後給予消炎營養支援治療，患者出現腸梗阻症狀，於2014-10-15在全麻上行腸粘連鬆解術+空腸造瘻術，術後給予消炎、營養支援治療，病情好轉後出院。術中常規病理示：（胃）中分化腺癌，潰瘍型，腫物切面積4.5*1CM，侵達漿膜脂肪組織，雙端切緣及吻合器切緣未查見癌。小彎側淋巴結22枚，其中2枚（2/22）查見轉移；大彎側淋巴結12枚，其中4枚（4/12）查見轉移。另送網膜組織內未查見癌。後患者再次入院行奧沙利鉑+CF+替加氟方案化療8個週期，耐受良好。後患者反覆腹痛，給予對症後症狀均可緩解。現患者為進一步診療，再次來我院，門診以“胃癌術後腸粘連”收入院。自發病以來，患者神志清，精神可，睡眠尚可，昨日排便一次，小便無明顯異常，體重較下次入院無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"end_pos": 35, "label_type": "手術", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 56}, {"label_type": "手術", "overlap": 0, "start_pos": 75, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 126}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 242, "label_type": "藥物", "overlap": 0, "start_pos": 238}, {"end_pos": 245, "label_type": "藥物", "overlap": 0, "start_pos": 243}, {"end_pos": 249, "label_type": "藥物", "overlap": 0, "start_pos": 246}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 303, "end_pos": 307}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 310}]}
{"originalText": "，緣於入院3月餘前我院診斷為賁門癌，於2015.11.06在氣管插管全麻上行“腹腔鏡輔助上根治性全胃切除術”，，術中見：腹腔內無腹水，腹腔內未見明顯轉移結節，腫瘤位於賁門，大小約5.0×5.0CM，呈浸潤潰瘍型，侵及漿膜層，周圍有腫大淋巴結.術中診斷“賁門癌”。，術後病理示：食管胃交界處潰瘍型中－低分化腺癌,侵犯漿膜層，侵犯脈管及神經組織，間質見多量淋巴細胞浸潤。手術標本下切端粘膜上層可見脈管癌栓，標本上切端均未見癌浸潤。找到賁門周淋巴結9/20個，小彎淋巴結0/29個，大彎淋巴結0/8個，幽門下淋巴結0/3個，幽門上淋巴結0/4個，網膜淋巴結0/1個及另送（胃右動脈根部）淋巴結1/9個見癌轉移。（胃右動脈根部）淋巴結見多發下皮樣結節，呈肉芽腫性炎改變。術後給予對症、營養支援等處理，恢復良好，切口癒合為II/甲。術後於2015.12.5、2015.12.27、2016.01.23予以“伊立替康240MGIVGTTD1+替吉奧60MGPOBIDD1-D14”方案化療，輔以保胃、保肝、增強免疫、營養補液治療。今為術後4次化療，再次入院，門診擬“賁門癌術後化療”收入住院，自下次出院以來飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 32, "label_type": "解剖部位", "overlap": 0, "start_pos": 30}, {"end_pos": 53, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 154}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 402, "label_type": "藥物", "overlap": 0, "start_pos": 398}, {"end_pos": 418, "label_type": "藥物", "overlap": 0, "start_pos": 415}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"end_pos": 446, "label_type": "解剖部位", "overlap": 0, "start_pos": 445}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 477, "end_pos": 482}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}]}
{"originalText": "，患者因“直腸癌”於2015-06-16在我院在全麻上行根治性DIXON手術，手術過程順利，術後患者恢復好，切口癒合好，按期拆線。，術後病理：（直腸）腺癌（中度分化），隆起型，體積8.5*7*1.5CM，侵達深肌層，底部切除面 未查見癌。 雙端切線及另送“近切線”、“遠切線”未查見癌。 一站（5個）、中央組（11個）、中間組（1個）淋巴結未查見癌。 ，免疫組化染色示：TS少量（+）、SYN（-）。後患者出現發熱及左下腹痛，行CT檢查示膽總管結石並以下水平膽系擴張，請肝膽外科會診後給予抗生素及保肝治療，患者症狀明顯好轉。   院外期間患者一般情況好，無噁心，無腹痛腹脹不適，2015年9月21日門診行結腸鏡檢查發現結腸多發息肉，並行內鏡上結腸息肉電切術，術後恢復好，現患者為行復查再次來院就診，為行進一步治療，門診以“直腸癌術後、結腸多發息肉”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 170}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 214, "end_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 224}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"end_pos": 328, "label_type": "手術", "overlap": 0, "start_pos": 318}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 361, "end_pos": 366}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 367, "end_pos": 373}]}
{"originalText": "，緣於入院前2個月在我院診為“降結腸癌”，並於2014.04.28在全麻上行“腹腔鏡輔助上根治性右半結腸切除術+小腸腫物切除術”，術順，術後病理（201412664），：（右半結腸），：1.腸隆起型絨毛狀-管狀腺癌II級，癌組織侵犯脈管組織，侵及淺肌層。手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤；找到腸周淋巴結23個，均未見癌轉移。腸周見癌結節1個。2.腸絨毛狀-管狀腺瘤，伴腺下皮低級別下皮內瘤變。（小腸），：送檢組織鏡上為梭形細胞增生結節（最大徑0.5CM），細胞核呈短梭形，可見核仁，胞漿嗜鹼性，排列呈束狀，核分裂像少見（&LT;2個/50HPF），結合免疫組化結果，考慮危險度低的胃腸道間質瘤，因送檢組織均為腫瘤組織，未見腸粘膜，無法判斷切緣情況，請結合臨床診斷。建議隨訪。，免疫組化結果：CK(PAN)（-），CD117（+++），CD34（++），DOG1（+++），DESMIN（-），H-CALDESMON（-），ACTIN(SM)（-），S100（個別細胞陽性），NF(PAN)（-），CD57（-），KI67（2%陽性）。術後予營養支援治療，恢復良好。術後按“奧沙利鉑(齊沙)150MGIVGTTD1+希羅達1000.00MGPOBIDD2-15”方案化療，於2014-05-28行第1週期化療。今入院行術後第2週期化療，門診擬“降結腸癌術後化療”收住入院。自術後出院以來，精神、睡眠、食慾尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 19}, {"label_type": "手術", "overlap": 0, "start_pos": 39, "end_pos": 63}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 110}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 193}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 301, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 323}, {"end_pos": 501, "label_type": "藥物", "overlap": 0, "start_pos": 497}, {"end_pos": 504, "label_type": "藥物", "overlap": 0, "start_pos": 502}, {"end_pos": 521, "label_type": "藥物", "overlap": 0, "start_pos": 518}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 582, "end_pos": 588}]}
{"originalText": "，緣於入院前1月於我院診為乙狀結腸癌，於2015-05-03在全麻上行腹腔鏡上乙狀結腸根治性切除術，術後病理（201614352），示：“乙狀結腸浸潤性管狀腺癌I-II級，侵及漿膜上層。手術標本下、上切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結10個，及另送的（直腸下動脈根部）淋巴結3個，均未見癌轉移。，免疫組化：KI-67（20%+），CK7（+），CK20（+++），VILLIN（++++），CDX2（+++），β-CATENIN（膜+++）。該病例未檢測到KRAS基因12、13號密碼子熱點突變。，病理：該病例未檢測到BRAF基因V600E突變”，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。2016.06.03予“奧沙利鉑200MGIVGTTD1+卡培他濱1500MGPOBIDD2-14”方案化療1個療程，輔以止吐、保肝、制酸、增強免疫等治療，無明顯化療毒副反應。此次為行上一週期化療，門診擬乙狀結腸癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 18}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 85}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 332, "label_type": "藥物", "overlap": 0, "start_pos": 328}, {"end_pos": 349, "label_type": "藥物", "overlap": 0, "start_pos": 345}, {"end_pos": 382, "label_type": "解剖部位", "overlap": 0, "start_pos": 381}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 418, "end_pos": 425}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}]}
{"originalText": "，緣於入院前25天因胃體癌於2015年11月24日在我院全麻上行“腹腔鏡輔助上根治性全胃切除術”，，術中探查見：腹腔內無明顯腹水，盆腔、腹壁、大網膜無轉移結節，肝臟質地大小正常，膽囊無腫大。胃體病灶不能探及，周圍無明顯腫大淋巴結，手術順利，術後予抗感染、營養支援、免疫等治療，術後恢復良好，術後病理（201541588），：（全胃)，:胃竇小彎側潰瘍型管狀腺癌II級，侵犯肌層。手術標本下、上切端及另送（下切端）均未見癌浸潤。找到賁門周淋巴結0/7個，幽門上淋巴結0/13個，及另送(第1組）淋巴結0/1個、（第7組）淋巴結1/7個、（第8組）淋巴結2/9個、（第9組）淋巴結0/2個，見癌轉移。另送（第11組淋巴結）、（第12組淋巴結）鏡上為纖維、血管、脂肪組織。小彎側、幽門下、大彎側脂肪組織未找見淋巴結；，免疫組化：腫瘤細胞示KI67（20％陽性），P53（-），P170（++），GSTπ（-），EGFR（-），5-FU（+），HER-2（+），CK(L)（++）。此次為術後第1週期化療再次入院。患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 47, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 183}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 262}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 267, "end_pos": 275}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 280, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 300, "end_pos": 319}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 333, "end_pos": 335}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 343}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 410}, {"end_pos": 467, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}]}
{"originalText": "，緣於入院前2月餘於我院診為“直腸癌”，於2015-10-12在全麻上行腹腔鏡上直腸根治術（DIXON手術）中轉開腹+膀胱病損修補術，，術中見：腹腔內無明顯出血，腫瘤位於直乙交界處，與膀胱分界不清，形成腸梗阻，近端稍擴張，周圍見數個明顯腫大淋巴結。，術後病理：（201541031）（直腸），：腸外生型管狀腺癌II級，侵犯腸壁全層及腸周脂肪組織，間質見多量急慢性炎症細胞及組織細胞浸潤。手術標本雙切端及另送(下切端)、(上切端)均未見癌浸潤。找到腸周淋巴結68個未見癌轉移。於2015.12.18予“奧沙利鉑(艾恆)200MG靜滴D1+卡培他濱片(希羅達)1500MG口服BIDD1-14方案”化療，輔予止吐、保胃、護肝等相關治療。化療過程順利，無化療副反應。此次為第2次化療，再次就診我院，門診擬“直腸癌術後化療”收入我科。自下次出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 66}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 167}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 254, "label_type": "藥物", "overlap": 0, "start_pos": 250}, {"end_pos": 257, "label_type": "藥物", "overlap": 0, "start_pos": 255}, {"label_type": "藥物", "overlap": 0, "start_pos": 268, "end_pos": 272}, {"end_pos": 277, "label_type": "藥物", "overlap": 0, "start_pos": 274}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 350, "end_pos": 355}, {"end_pos": 378, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 380}]}
{"originalText": "患者8個月前因“進行性吞嚥困難1個月”就診於我院，完善術前準備後，於2013-10-08行“胸段段食管食管切除+食管-胃左胸頂吻合術+左側第5肋骨固定術”，術順，術後恢復良好後出院。術後病理示：胸段食管多中心鱗狀下皮癌，其一為潰瘍性鱗狀細胞癌I-II級，侵犯神經，侵出外膜，其二為浸潤型鱗狀細胞癌I-II級，侵犯神經及齒狀線。找到賁門淋巴結1/7，左喉返神經旁淋巴結1/3，見癌轉移。於2013.12.01、2013.12.26按“洛鉑50MGD1+多帕菲120MGIVGTT”方案化療2個週期，並於2014.01.19、2014.02.13按“洛鉑50MGD1+安素泰180MGD2IVGTT”方案化療第3、4週期，輔以制酸、保胃、保肝、止吐等治療，化療過程順利，現為化療4週期後複查就診我院，門診擬“食管癌術後化療後”收住入院。下次出院至今無胸悶、憋氣、胸背痛，無腹痛、腹脹，無嘔血、黑便。精神、睡眠、飲食較好，大小便正常，體重無明顯變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 153}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 183}, {"end_pos": 218, "label_type": "藥物", "overlap": 0, "start_pos": 216}, {"end_pos": 228, "label_type": "藥物", "overlap": 0, "start_pos": 225}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 273}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 319, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 352, "end_pos": 357}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 379, "end_pos": 380}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 380, "end_pos": 381}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}]}
{"originalText": "患者2008.2.1因“大便性狀改變，發現結腸腫塊10天”入我院全科，2.5行乙狀結腸癌根治術（應用吻合器），術中探查：腹腔及其他臟器未及異常，乙狀結腸近直腸處可及4×4CM腫塊，術中病理“潰瘍性腺癌，分化II－III級，侵及全層，切緣未見癌累及，腸旁淋巴結19枚，均未及癌轉移”。分別1.28（樂沙定，君瑞清），2.23（樂沙定，替加氟）行介入化療。今為再次行介入化療入院。病程中，患者精神可，胃納差，睡眠可，雙便正常。", "entities": [{"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 47, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 100}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 151, "label_type": "藥物", "overlap": 0, "start_pos": 148}, {"end_pos": 155, "label_type": "藥物", "overlap": 0, "start_pos": 152}, {"end_pos": 165, "label_type": "藥物", "overlap": 0, "start_pos": 162}, {"end_pos": 169, "label_type": "藥物", "overlap": 0, "start_pos": 166}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}]}
{"originalText": "，緣於入院前1月於我院診斷為結腸肝曲癌，於2014-10-20在全麻上行腹腔鏡上擴大根治性左半結腸切除術，，術中見：腹腔內無明顯出血，無明顯粘連，無明顯腹水，肝臟無明顯轉移結節，腫瘤位於結腸肝曲，大小約5*3CM，侵出漿膜層，未明顯侵及十二指腸，周圍可及多發腫大淋巴結。術後病理（病理號201435395）示（左半結腸），：大腸隆起型管狀腺癌II級，侵及漿膜，侵犯神經，手術標本雙切端及另送（近切端）、（遠切端）均未見癌浸潤。找到迴腸周淋巴結1個，結腸周淋巴結50個，另送（回結腸動脈根部）淋巴結5個，（結腸中動脈根部）淋巴結5個均未見癌轉移。另見闌尾組織，術後給予對症、營養支援等治療，恢復良好，傷口癒合II/甲，出院後無發熱、畏冷，無咳嗽、咳痰，無胸悶、心悸，無腹痛、腹脹、腹瀉等不適，今為行術後第1次化療就診我院，門診擬結腸肝曲癌術後收入院。下次出院以來，精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"end_pos": 52, "label_type": "手術", "overlap": 0, "start_pos": 36}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 174}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 329}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 336}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 363, "end_pos": 370}]}
{"originalText": "，患者2月前於我院在全麻上行手術，探查腹腔內無腹水，腹膜無轉移，肝臟未觸及轉移結節，腫瘤位於結腸肝曲，約5×4×4CM，已侵出漿膜，侵犯十二指腸和胰頭，並造成腫瘤與盲腸之間閉袢性梗阻，梗阻腸腔明顯擴張，腸腔內大量稀薄糞便，結腸繫膜未見明顯腫大淋巴結，探查後決定行姑息性左半結腸切除術。手術過程順利。，術後病理結果示：（左半結腸）腺癌（中度分化），結合免疫組化考慮來自結腸，部分細胞伴神經內分泌分化。浸潤潰瘍型，體積4.5*3.5*1.2CM，侵穿漿膜及纖維膜。，術後病理結果示：（左半結腸）腺癌（中度分化），結合免疫組化考慮來自結腸，部分細胞伴神經內分泌分化。浸潤潰瘍型，體積4.5*3.5*1.2CM，侵穿漿膜及纖維膜。 雙端切線及底部切除面未查見癌。 腸壁一站(8個)、二站(4個)、三站(3個)、中間組(5個)淋巴結未查見癌。 ，免疫組化染色示：CK7(-)、CK20(+)、VILLIN(+)、CDX-2(+)、TS部分(+)、 SYN（少數細胞陽性）。現患者為行進一步診治，門診以“結腸癌術後”收入我科。患者術後精神、飲食可，小便正常，大便排便費力，體重無明顯變化。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 26, "end_pos": 27}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"end_pos": 141, "label_type": "手術", "overlap": 0, "start_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 247}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 327, "end_pos": 361}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 446, "end_pos": 451}]}
{"originalText": "，患者因“宮頸癌”於2015-09-02在我院於全麻上行腹腔鏡上盆腔淋巴結清掃+腹主動脈旁淋巴結取樣+廣泛子宮+兩側輸卵管切除術+左側卵巢切除+右側卵巢懸吊術。，術後病理檢查示：宮頸腺癌，符合中腎管癌，侵犯宮頸壁全層及宮頸管內口。右盆腔淋巴結12枚，其中一枚查見轉移癌（31622.15)。，免疫組化：ER(-) PR(-) CR(-) CK(-) P16(-) NAPSINA(-)PAX-8個別腺體弱陽性，P53(-) CEA(+) WT-1(-)KI-67陽性率50%。術後一般情況可，2015-09-14給予紫杉醇240MG+順鉑110MG化療，化療過程順利，副反應不重。2015-10-9予紫杉醇240MG+順鉑110MG方案化療，予心電監護，水極化，化療過程順利，無明顯化療反應。2015-11-9 在我院放療二科予紫杉醇240MG D1 +順鉑40MG D1-3方案化療，盆腔適形放療中，放化療過程順利，情況好轉出院。於2015-12-25日、2016-1-17日給予紫杉醇240MG+順鉑110MG藥物化療2次。現患者無腹痛，無發熱，無腰骶疼痛。為求第6次化療，門診以“宮頸癌術後化療”收入院。患者一般情況可，睡眠飲食可，大小便無明顯異常，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 112}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 261, "label_type": "藥物", "overlap": 0, "start_pos": 258}, {"end_pos": 269, "label_type": "藥物", "overlap": 0, "start_pos": 267}, {"end_pos": 303, "label_type": "藥物", "overlap": 0, "start_pos": 300}, {"end_pos": 311, "label_type": "藥物", "overlap": 0, "start_pos": 309}, {"end_pos": 367, "label_type": "藥物", "overlap": 0, "start_pos": 364}, {"end_pos": 379, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 444, "label_type": "藥物", "overlap": 0, "start_pos": 441}, {"end_pos": 452, "label_type": "藥物", "overlap": 0, "start_pos": 450}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 468}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 476, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 477, "end_pos": 478}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 493, "end_pos": 498}]}
{"originalText": "，患者於2015年11月26日因“宮頸癌IAI”在全麻上行腹腔鏡上廣泛子宮+兩附件切除術+盆腔淋巴結清掃術。，術中見：子宮表面光滑，正常大小，兩側輸卵管、卵巢均未見明顯異常。兩側骶、主韌帶無明顯增厚。兩側盆腔未見明顯腫大淋巴結。窺器擴開宮頸口，宮頸後脣可見活檢創面，陰道壁粘膜光滑，無異常，術畢安返病房。，術後常規病理回示：（942790.15）（子宮）低分化鱗狀細胞癌，4處癌灶，，切面積分別是：0.8*0.3CM、0.4*0.2CM、0.3*0.2CM、0.2*0.1CM，侵及宮頸管深度小於1/3，並查見鱗狀下皮高級別下皮內瘤變累及腺體。右、左宮宮旁組織及陰道斷端未查見癌。萎縮的子宮內膜。（兩側）輸卵管組織。（兩側卵巢）白體。另送檢右盆腔淋巴結4枚，均未查見轉移癌（0/4)，另送檢“左盆腔淋巴結”為脂肪結締組織，未查見癌。。今為術後第1次化療就診我院，門診以“宮頸癌術後化療”收入院，患者自發病以來，飲食睡眠可，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 23}, {"label_type": "手術", "overlap": 0, "start_pos": 29, "end_pos": 53}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 80}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 173, "end_pos": 185}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 267}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 272, "end_pos": 276}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 293, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 316}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 346, "end_pos": 352}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 390}]}
{"originalText": "，患者6個月前（2014-5）無明顯誘因出現排便習慣改變，大便2-4次/日，呈稀糊狀，伴裡急後重感，無膿血，無腹痛腹脹，無噁心嘔吐，無發熱，自訴口服中藥（具體不詳）效果不明顯。遂就診於我院消化內科，2014年7月9日，行腸鏡檢查示：，直腸：肛緣至距肛緣約7CM見約環2/3管腔不規則隆起病變，表面糜爛結節狀。，診斷意見：直腸CARCINOMA。2014年7月16日於我院胃腸外科在全麻上行腹會陰直腸癌根治術（MILES手術），術中見腫瘤位於腹膜返折上方，巨大充滿小骨盆腔，，術後病理示：距肛門側切緣4CM處，腸粘膜面見8*7*2.5CM灰白潰瘍型腫物，，診斷意見：A(直腸腫瘤)，:黏液腺癌(中低分化)，侵及外膜；L251(14/14)、L252(3/8)，：淋巴結轉移癌；L253(0/1)，：淋巴結淋巴組織增生（，病理號：Z0480550）。，免疫組化：，A2：C-ERBB-2(1+) D2-40(-) CEA(+) CK20(+) CK7(-) KI-67(約50%+) CD34(-)。術後恢復可，於我科行XELOX方案化療3週期，，具體用藥：艾恆 200MG D1 靜點，希羅達 1500MG 日二次口服。末次化療後出現I°粒細胞上降，未治療。現為行進一步治療收入我科。患者目前一般狀況可，無發熱，無腹痛、腹瀉及便血，飲食睡眠可，二便正常，周身無疼痛，病來體重無明顯減輕，ECOG評分1分。", "entities": [{"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 171}, {"label_type": "手術", "overlap": 0, "start_pos": 194, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 235, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 284, "end_pos": 288}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"end_pos": 479, "label_type": "藥物", "overlap": 0, "start_pos": 477}, {"end_pos": 496, "label_type": "藥物", "overlap": 0, "start_pos": 492}, {"end_pos": 557, "label_type": "解剖部位", "overlap": 0, "start_pos": 556}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}]}
{"originalText": "2年前，患者因“反覆腹脹1年”入我院，考慮“胃底賁門惡性腫瘤可能”，2014-09-19在我院於全麻上行“剖腹探查、根治性全胃切除術、食管-空腸ROUX-EN-Y吻合術”，手術順利，術後病理診斷示“（胃）中分化腺癌，侵及腸壁全層至漿膜外，雙切端未見癌累及，胃大、小彎淋巴結未見癌轉移（分別為0/5、0/9），網膜未見癌累及”。術後積極予以抗感染、營養支援、對症和支援治療，患者好轉出院。術後已行6次全身靜脈化療（FOLFOX方案）。現囑醫囑，為例行術後複查收入我科。\\U0004   患者起病以來，精神尚可，胃納可，睡眠可，大小便正常，體重未見明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 30}, {"label_type": "手術", "overlap": 0, "start_pos": 53, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}]}
{"originalText": "患者2016年8月因“發現上腹包塊4個月”就診我院，考慮卵巢惡性腫瘤，於2016-09-13於全麻上行腫瘤細胞減滅術（I型全子宮切除+兩側附件切除+大網膜切除+盆腔及腹主動脈旁淋巴結清掃+腸修補術），術中冰凍提示為高級別漿液性癌，手術為滿意減滅術。因患者術前貧血，術中輸注紅細胞400ML及新鮮冰凍血漿400ML，無明顯輸血反應，手術過程順利，術後予心電監護、吸氧、抗炎、補液等對症支援治療。並於2016-09-20行TC方案（進口紫杉醇210MG D1，伯爾定550MG D1）化療第一程、2016-10-12行TC方案（紫杉醇210MG D1+卡鉑700MG D1）化療第二程、2016-11-07行TC方案（紫杉醇210MG D1+卡鉑700MG D1）化療第三程，現為行上一程化療入院。患者近期精神、睡眠稍差，食慾欠佳，二便如常，體重近期無明顯改變。既往化療及腫瘤標誌物情況：。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 34}, {"label_type": "手術", "overlap": 0, "start_pos": 51, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 114}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 216}, {"end_pos": 231, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"end_pos": 265, "label_type": "藥物", "overlap": 0, "start_pos": 262}, {"end_pos": 276, "label_type": "藥物", "overlap": 0, "start_pos": 274}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"end_pos": 321, "label_type": "藥物", "overlap": 0, "start_pos": 319}]}
{"originalText": "，根治性全胃切除術後2月餘複查。，術後病理：胃體小彎側潰瘍型低分化腺癌（LAUREN，分型：瀰漫型），大小5×3.5CM；侵至漿膜層，見神經侵犯，免疫組化CD34(+),D2-40(+)示脈管癌栓；食道殘端及十二指腸殘端均未見癌；淋巴結見癌轉移【共44枚，21，枚轉移：第1組0/5、第2組0/0、第3組8/13、第4SA組0/2、第4SB組0/0、第4D組5/7、第5組1/1、第6組5/5、（第7、9組）0/6、第8組1/1、第11P組0/1、12A組0/2、 14V1/1】；，腫瘤病理學分期：PT4N3B。，免疫組化結果顯示:CD34(+),CD44(+),CMET(+),D2-40(+),EGFR(+),HER2(－),KI-67(+25～50%),P170(+),P27(+25～50%),P53(+25～50%),TOPOII(+＜25%)。術後化療1週期SOX（2013-8-8，樂沙定200MG D1，愛斯萬 60MG BID1-14，Q3WKS），骨髓毒性II度，升白治療，胃腸道反應0度，外周神經毒性I度。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1, "end_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 50}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 240}, {"end_pos": 402, "label_type": "藥物", "overlap": 0, "start_pos": 399}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 411}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 448, "end_pos": 449}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 449, "end_pos": 450}]}
{"originalText": "，緣於入院前4月餘於我院診為結腸肝曲管狀腺癌，於2014-10-20在全麻上行腹腔鏡上擴大根治性左半結腸癌切除，，術中見：腹腔內無明顯出血，無明顯粘連，無明顯腹水，肝臟無明顯轉移結節，腫瘤位於結腸肝曲，大小約5*5CM，侵出漿膜層，未明顯侵及十二指腸，周圍可及多發腫大淋巴結。術後病理（病理號201435397、201433427），：（左半結腸），：大腸潰瘍型管狀腺癌II-III級，部分為粘液腺癌，侵出漿膜，侵犯神經，脈管內見癌栓，手術標本回腸切端、結腸切端及另送（近切端）、（遠切端）均未見癌浸潤。找到迴腸周淋巴結0/5個，結腸周淋巴結7/27個，及另送（結腸中動脈根部）淋巴結3/11個，（回結腸動脈根部）淋巴結0/6個，見癌轉移。另見闌尾組織。該病例未檢測到KRAS基因12、13號密碼子熱點突變、BRAF基因V600E突變。，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。於2014-11-29、2014-12-20、2015-01-10、2015-02-03予“奧沙利鉑150MG靜滴D1+希羅達1000MG口服D2-15”行第1、2、3、4次化療方案，化療過程順利，無明顯化療副作用。此次為擬行第5次化療方案再次就診我院，門診擬結腸肝曲管狀腺癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 22}, {"end_pos": 55, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 176, "end_pos": 192}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 196, "end_pos": 200}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 322}, {"end_pos": 448, "label_type": "藥物", "overlap": 0, "start_pos": 444}, {"end_pos": 461, "label_type": "藥物", "overlap": 0, "start_pos": 458}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 528, "end_pos": 538}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}]}
{"originalText": "緣於1年前因左肝原發性肝癌於我院行左半肝切除術+膽囊切除術,術順,術後病理(201237164)示:左半肝肝臟原發性巨塊型中分化肝癌,侵及肝被膜,脈管內見癌栓,周邊組織呈空泡性及脂肪性變.術後恢復可。無腹脹、腹痛。無噁心、嘔吐，無發熱、寒戰及黃疸。無畏冷、寒戰、發熱。現患者返院複查，門診擬“肝癌術後”收住入院，自發病以來，患者食慾尚可，精神可，體重無明顯上降，大、小便正常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 17, "end_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 150}]}
{"originalText": "緣於入院前4月餘於我院診為直腸癌，於2014-07-07在全麻上行腹腔鏡上直腸癌根治術。術後病理示（直腸）：大腸隆起型管狀-絨毛狀腺癌II級，侵及外膜，侵犯神經，脈管內見癌栓，手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結5/16個見癌轉移。未檢測到BRAF基因V600E突變。檢測到KRAS基因12號密碼子GLY12ASP和13號密碼子GLY13ASP突變。，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。術後於我院以樂沙定200MGD1+希羅達1500MGD1-D14方案行4週期化療,化療過程順利，化療期間複查CT，效果良好。此次為化療再次就診我院，門診擬直腸管狀-絨毛狀腺癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 70}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 231, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"end_pos": 242, "label_type": "藥物", "overlap": 0, "start_pos": 239}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 276, "end_pos": 278}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 311}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}]}
{"originalText": "，緣於2個月餘前入院，診斷為直腸隆起型管狀腺癌，於2014.01.16在我科行“腹腔鏡上直腸癌根治術（DIXON）”。術後病理示（201401611），：(直腸)，：腸隆起型絨毛狀-管狀腺癌II級，侵犯脈管組織，脈管內見癌栓，侵及深肌層（&GT;1/2肌層），手術標本雙切端、環周切緣及另送(下切端)、(上切端)均未見癌浸潤。找到腸周淋巴結2/18個，見癌轉移。另送(腸繫膜上動脈根部)鏡上為脂肪、脈管及纖維結締組織。，免疫組化結果：KI67（80%陽性），P53（+++），P170（++），GSTπ（個別細胞陽性），EGFR（-），5-FU（-），MLH1（+++），MSH6（個別細胞陽性），MGMT（++）。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。並於2014.02.16開始予“奧沙利鉑150MGIVGTTD1+希羅達1000MGPOBIDD2-15”方案行術後第1週期化療，患者耐受良好，此次為第2次化療再次入院。出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 23}, {"label_type": "手術", "overlap": 0, "start_pos": 40, "end_pos": 57}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 98}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 268}, {"end_pos": 355, "label_type": "藥物", "overlap": 0, "start_pos": 351}, {"end_pos": 371, "label_type": "藥物", "overlap": 0, "start_pos": 368}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}]}
{"originalText": "，外院腸鏡示：乙狀結腸距肛門20CM可見環周樣結節狀粘膜不規則隆起。，病理：乙狀結腸高分化腺癌。2017-8-22行乙狀結腸癌手術，（直腸下段），切除：- 中分化腺癌，伴鈣化，最大徑4.5CM；- 可見脈管癌栓及神經侵犯；- 癌組織侵達漿膜上，漿膜上另見癌結節；- （近端）及（遠端）切緣未見癌；- 淋巴結可見癌轉移（腸周1/13，直腸下動脈旁0/1），未侵犯淋巴結被膜外；- ，腫瘤病理分期：PT3N1A。，免疫組化結果顯示:BRAF(－),CMET(2+),EGFR(3+),HER2(1+),KI-67(70%),MLH1(+),MSH2(+),MSH6(+),PMS2(+)。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 47}, {"end_pos": 65, "label_type": "手術", "overlap": 0, "start_pos": 58}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 176}]}
{"originalText": "，緣於入院前3月餘於我院診斷為“直腸癌”，於2014-10-09行“腹腔鏡上直腸癌根治術”，術順，術後病理示（直腸），：腸潰瘍型管狀腺癌II級，癌組織侵犯脈管及神經組織，侵及外膜層。手術標本雙切端、環周切緣及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結2/9個見癌轉移。另送(腸繫膜上動脈根部淋巴結)鏡上為脂肪、脈管、神經及纖維結締組織。，免疫組化染色結果：KI67（50%陽性），P53（+++），P170（+++），GSTπ（+），EGFR（++），5-FU（+），MLH1（+++），MSH-6（+++），MGMT（-）。於2014.11.19、2014.12.24予按奧沙利鉑(樂沙定)200MGIVGTTD1+希羅達1000MGPOBIDD1-D14方案化療，輔以保肝、止吐、制酸等對症處理，化療過程順利，此次為行第3次化療，門診擬“直腸癌術後化療”收入我科。自入院以來，精神、睡眠、飲食良好，體力情況良好，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 71}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 236, "label_type": "藥物", "overlap": 0, "start_pos": 232}, {"end_pos": 297, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"end_pos": 301, "label_type": "藥物", "overlap": 0, "start_pos": 298}, {"end_pos": 318, "label_type": "藥物", "overlap": 0, "start_pos": 315}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 377, "end_pos": 382}]}
{"originalText": "，患者2016.1.28因左下腹疼痛4天入我院普外科。當時無噁心、嘔吐，無反酸、噯氣，無嘔血，腹部CT示結腸肝曲佔位，考慮結腸癌並腹腔淋巴結轉移，腹部B超示左側腹部包塊，考慮佔位性病變，腸繫膜及腹膜後淋巴結腫大。入院後給予完善各項檢查，於2016-1-30在全麻上行腹腔鏡擴大根治性左半結腸切除術，，術後病理：（結腸）中分化腺癌，部分為粘液腺癌（後者約佔60%），潰瘍型，腫瘤切面積9*2.5CM，侵透漿膜，迴腸切緣、結腸切緣、闌尾及網膜組織未查見癌，腸周淋巴結36枚，其中1枚查見轉移癌。患者術後恢復可，入我科後複查CT未見腫瘤復發及轉移徵象，2016-2-18起給予MFOLFOX6方案化療5週期，，具體為：奧沙利鉑130MG D1+右亞葉酸鈣300MG D1+氟尿嘧啶0.625G D1，3.75G 輸液泵維持46小時，耐受可。今為行上一週期化療再次入院。患者自下次出院以來，神志清，精神可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 47, "end_pos": 51}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 72}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 103}, {"end_pos": 148, "label_type": "手術", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 172}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 259, "end_pos": 261}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 306}, {"end_pos": 324, "label_type": "藥物", "overlap": 0, "start_pos": 319}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 333}]}
{"originalText": "，患者於2014-6外院檢查發現AFP升高。2014-6-22，六院行CT檢查：肝左葉巨大佔位，肝癌可能大。2014-7-1來我院就診，，行MRI檢查示：肝左葉巨塊型MT，大小約8.4X11.5CM。7/，15查AFP: 6428.0NG/ML；7/18行特殊肝段切除術（V、VI、VIII段）+膽囊切除術。，術後病理：（肝左葉）肝細胞肝癌，III級，伴出血、壞死，脈管內見癌栓。肝切緣未見癌組織累及。周圍肝組織匯管區淋巴細胞浸潤伴纖維組織增生（G1S2），部分割槽肝細胞大細胞變。（膽囊）慢性炎。檢出膽囊旁淋巴結1枚，慢性炎。免疫組化(2014-N8731)2，號蠟塊:AFP(++),HEPA(++),CK7(-),CK19(-),CD34(血竇豐富),KI67(50%陽性),GS(++),HSP70(++),GPC3(-),OPN(-)。術後手術區積液，予以置管引流。7/，25出院前查AFP: 1362.0NG/ML；出院後，隨訪腹部，CT：肝MT術後改變，術區積液、積氣，隨訪；肝臟囊腫，8/，18隨訪AFP：113NG/ML。現為進一步介入治療收入院。患者發病以來，胃納可、夜寐可、二便正常、體重無明顯減輕。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 35, "end_pos": 37}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 50}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 70, "end_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 85}, {"label_type": "手術", "overlap": 0, "start_pos": 128, "end_pos": 153}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 165, "end_pos": 175}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 247}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 396, "end_pos": 399}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 419, "end_pos": 424}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 425, "end_pos": 430}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 444, "end_pos": 448}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 456, "end_pos": 459}, {"end_pos": 490, "label_type": "解剖部位", "overlap": 0, "start_pos": 489}]}
{"originalText": "患者於2016-01-08因“結腸癌”於我院行左半結腸切除+淋巴結清掃術，術後病理示：（01083.16）結合986.16（結腸）中分化腺癌，隆起型，腫瘤切面積8*5.5CM，侵達漿膜，下、上切線均未查見癌，腸周查見淋巴結17枚，其中2枚查見癌（2/17）。（膀胱）結締組織急慢性炎，其內查見少許異型下皮，考慮為腺癌累及。術後給予抗炎、補液、營養及對症治療，術後恢復可。現患者無噁心、嘔吐，無腹痛、腹脹，大便通暢，為行化療治療，今日就診於我院，門診以“結腸癌術後化療”收住入院。患者自發病以來，神志清，精神可，食慾、睡眠可，小便正常，體重變化不明顯。高血壓病史30餘年，未規律服藥，現血壓正常。患乙型病毒性肝炎20年。尿頻、排尿困難1年餘，未行治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 104, "end_pos": 111}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 156, "end_pos": 158}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 231}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 278}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 298, "end_pos": 305}]}
{"originalText": "患者1月前因\\\"間斷下腹痛1年，發現結腸佔位2天\\\"於我院行左半結腸切除術，手術順利，病理回報為（左半結腸）結腸隆起型高中分化腺癌，部分為粘液腺癌，大小10×5×4CM，癌侵及漿膜上纖維脂肪組織，距環周切緣約3MM，未見脈管癌栓，淋巴結未見癌轉移（腸周0/13，結腸中血管旁0/2），（近端）及（遠端）切緣未見特殊。免疫組化結果顯示 CD44(+)，CMET(+)，COX2(+)，EGFR()，HER2(1+)，KI-67(+20%)，MLH1(+50～75%)，MMP7(弱+)，MSH2(+25～50%)，MSH6()，P170()，P27(+25～50%)，P53(+50～75%)，TOPOII(+＜10%)。現患者為求進一步治療，以“結腸癌術後”收入院。患者自發病以來，精神飲食可，睡眠可，二便正常，體重無明顯減輕。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 37, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 323, "end_pos": 328}]}
{"originalText": "緣於入院前5月因診為降結腸癌伴肝轉移，於2016.01.15、2016.02.05在我院予“奧沙利鉑200MGIVGTTD1+卡培他濱片(希羅達)1500MGBIDPOD1-14”方案行術前新輔助化療，未見明顯化療後不良反應，於2016年02月29日於我院行腹腔鏡上右半結腸切除術（姑息性），術順，術後病理回報（201605763）：結腸隆起型黏液腺癌，侵及漿膜上層，侵犯脈管組織，未見肯定神經侵犯。手術標本遠、近切端均未見癌浸潤。找到腸周淋巴結4/22個，見癌轉移。腸周脂肪中找到4枚癌結節。腸粘膜潰瘍。另送（右結腸動脈根部）、（腸繫膜上靜脈根部）鏡上為纖維、血管及脂肪組織。術後恢復可，無腹痛、腹脹，無噁心、嘔吐等不適，術後予“鹽酸伊立替康240MG靜滴D1+卡培他濱片1500MGBIDPOD1-14”“鹽酸伊立替康240MG靜滴D1+安維汀400MG（自備）D1+替吉奧60MGBIDPOD1-14”方案化療3次，化療期間予制酸、補液、營養支援等對症處理。為進一步治療，門診擬“降結腸癌伴肝轉移（PT1N2AM1AIVA期）”收入院，自下次出院以來，精神、睡眠、飲食可，大小便如常，體重未見明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 18}, {"end_pos": 50, "label_type": "藥物", "overlap": 0, "start_pos": 46}, {"end_pos": 68, "label_type": "藥物", "overlap": 0, "start_pos": 63}, {"end_pos": 72, "label_type": "藥物", "overlap": 0, "start_pos": 69}, {"end_pos": 140, "label_type": "手術", "overlap": 0, "start_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 176}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 256, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 266, "end_pos": 267}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 322, "label_type": "藥物", "overlap": 0, "start_pos": 316}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 332}, {"end_pos": 361, "label_type": "藥物", "overlap": 0, "start_pos": 355}, {"end_pos": 374, "label_type": "藥物", "overlap": 0, "start_pos": 371}, {"end_pos": 389, "label_type": "藥物", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 443, "end_pos": 451}]}
{"originalText": "，患者2014年上半年無明顯誘因出現大便帶鮮血，量少，伴大便次數增加至8-10次/天，稀爛，偶有裡急後重，2014年11他也前出現間歇性臍周隱痛，大便後可緩解。無噁心、發熱等不適。到外院對症處理，便血癥狀無明顯緩解。2015-1-9，外院腸鏡檢查提示:距肛門17-19CM乙狀結腸腫物，腸鏡能透過。活檢病理提示高分化腺癌。後至我院就診，完善檢查後於2015年1月22日全麻上行腹腔鏡上DIXON術，術程順利，，術後病理結果回報：（乙狀結腸大體）鏡檢為腸中分化腺癌，浸潤至腸壁漿膜上層，未見明確脈管內癌栓及神經束侵犯。（中央淋巴結）1枚，未見癌。（中間淋巴結）2枚，未見癌。（腸旁淋巴結）6枚，未見癌。（系膜根部淋巴結）1枚，未見癌。，分期為：PT3N0M0 IIA期。，免疫組化：MLH1（+），MSH2（+），MSH6（+），PMS2（+）。於2015-03-23開始至今行希羅達7程口服化療順利,化療後未出現明顯副反應。現患者為進一步診治入院遵主診教授意見行本週期化療。目前患者一般情況可，無發熱、咳嗽、身目黃染，無骶部痛等，精神可，納眠可，小便無異常，手術至今體重約上降15KG。", "entities": [{"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 160}, {"end_pos": 198, "label_type": "手術", "overlap": 0, "start_pos": 188}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 236}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 278}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 391, "label_type": "藥物", "overlap": 0, "start_pos": 388}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}]}
{"originalText": "患者因胃MT於2010年1月14日在我科行腹腔鏡根治性全胃切除術，術後病理示：(全胃)平坦型低分化腺癌,侵及全層及周圍脂肪組織,呈瀰漫浸潤性生長,侵及神經束,部分脈管可見癌栓,雙切緣未見腫瘤累及. 檢出小彎淋巴結13枚,其中9枚見癌轉移; 檢出大彎淋巴結3枚,均可見癌轉移; 檢出幽門下淋巴結2枚,均未見癌轉移; 檢出幽門上淋巴結13枚,均見癌轉移; 另送14組淋巴結2枚,均可見癌轉移; 另送切緣未見癌累及。患者術少量多餐，偶有腹瀉，無發熱、噁心、嘔吐等。已行2次化療，現為化療收住入院。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 3, "end_pos": 6}, {"end_pos": 32, "label_type": "手術", "overlap": 0, "start_pos": 21}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 51}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}]}
{"originalText": "，患者近1月前（2016-02-23）前因“胃癌”於我院行胃癌姑息性切除術（遠端胃大部切除+畢I式吻合），，術中探查見：腫瘤位於胃竇小彎側，大小約5*4*3CM,侵透漿膜並侵及胰腺，胃周可見多組腫大淋巴結，其中7、8、9組淋巴結融合成團，並與胰腺浸潤。，術後常規病理示：（胃）低分化腺癌，局灶伴印戒細胞癌分化，瀰漫浸潤型，腫瘤切面積5.5*0.8CM，侵及胃壁深肌層。雙端切緣、吻合器切緣及網膜組織未查見癌。大彎側淋巴結11枚，其中3枚（3/11）查見轉移；第7、8組淋巴結9枚，其中1枚（1/9）查見轉移；小彎側淋巴結8枚，均未查見轉移（0/8）。，免疫組化：CK（+）、HER-2（2+）、SYN（-）、E-CAD（+）。術後給予消炎、營養支援治療，病情好轉後出院。現患者無噁心、嘔吐，無腹痛、腹脹，半流質飲食，二便正常。現為求進一步治療，門診以“胃癌術後”收入院。自下次出院來，神志清，精神可，飲食可，體重較前無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 24}, {"label_type": "手術", "overlap": 0, "start_pos": 29, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 68}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 114}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 152}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 237}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 376, "end_pos": 380}]}
{"originalText": "，緣於入院前1月餘於我院診為直腸癌，於2016.01.12在全麻上行腹腔鏡上直腸癌根治術DIXON，，術中見：上腹部粘連，腹腔內無明顯出血，無明顯腹水，盆腔、腹壁、大網膜、肝臟未見明顯轉移結節，腹腔位於直腸下段，大小約3*2.5CM，可疑侵及漿膜層。術後病理（201601067），：(直腸)，：腸隆起型絨毛狀-管狀腺癌II級，局灶性浸潤深肌層（&GT;1/2肌層），並見淋巴管內癌栓。手術標本雙切端及另送（下切端）、(上切端)均未見癌浸潤。找到腸周淋巴結9個（經本組下級醫師複核淋巴結），另送(腸繫膜上動脈根部）淋巴結1個，均未見癌轉移。，免疫組化染色結果：KI67（60%陽性），P53（+++），P170（+++），5-FU（++），MLH1（+++），MSH2（+++），PMS2（+++），MSH-6（+++）。DNA錯配修復的MMR蛋白（PMS2、MSH6、MLH1和MSH2）免疫組化染色提示本例腫瘤微衛星穩定（MSS）。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲出院。於2016.01.30行“奧沙利鉑(樂沙定)150MGIVGTTD1+卡培他濱片(希羅達)1000MGPOBIDD1-14”方案化療，輔以保胃、保肝、止吐等治療，未見明顯化療副反應。今為行第2次化療再次就診我院，門診擬“直腸癌術後化療”收住入院。自下次出院以來，。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 80}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 105}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 163}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 315, "label_type": "藥物", "overlap": 0, "start_pos": 311}, {"end_pos": 466, "label_type": "藥物", "overlap": 0, "start_pos": 462}, {"end_pos": 470, "label_type": "藥物", "overlap": 0, "start_pos": 467}, {"end_pos": 489, "label_type": "藥物", "overlap": 0, "start_pos": 484}, {"end_pos": 493, "label_type": "藥物", "overlap": 0, "start_pos": 490}, {"end_pos": 520, "label_type": "解剖部位", "overlap": 0, "start_pos": 519}, {"end_pos": 523, "label_type": "解剖部位", "overlap": 0, "start_pos": 522}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 559, "end_pos": 564}]}
{"originalText": "，緣於4月前因反覆進食阻塞3個月就診於我院，完善術前準備後，於20160106行胸腹腔鏡聯合全胸段食管切除+食管-胃底右頸部吻合+右甲狀腺結節切除術。手術順利，術後恢復良好後出院，，術後病理示：（食管及胃底）食管多中心性蕈傘型鱗狀細胞癌II級，侵及外膜層，侵犯神經及脈管組織，手術標本下、上切端及另送(最下切端)均未見癌浸潤。找到食管周淋巴結0/2個，胃周淋巴結0/5個，及另送(右喉返喉返神經旁)淋巴結0/16個，（左喉返喉返神經神經旁）淋巴結0/5個，(頸部右喉返喉返神經旁)淋巴結1/1個，(隆突上)淋巴結0/2個，(上段食管旁)淋巴結0/5個，（賁門旁）淋巴結0/4個見癌轉移。，免疫組化：腫瘤細胞示KI67（60%陽性），CK(H)（+），P63（+），P53（個別細胞陽性），P170（++），GSTπ（-），EGFR（++）。排除化療禁忌症後於2016-02-03，2016-02-28，2016-03-22以“順鉑40MGD1-3，紫杉醇210MGD2”方案行3週期次化療，輔以保肝，護胃，提高免疫力等處理，未見明顯化療副反應。現為求第4次化療，就診我科，擬“食管癌術後”入我科。下次出院至今無胸悶、憋氣；無胸背痛；無腹痛、腹脹；無嘔血、黑便；偶有返酸。飲食睡眠較好。大小便正常。體重無明顯變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 40, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 121}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 415, "label_type": "藥物", "overlap": 0, "start_pos": 413}, {"end_pos": 427, "label_type": "藥物", "overlap": 0, "start_pos": 424}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 488, "end_pos": 493}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"end_pos": 514, "label_type": "解剖部位", "overlap": 0, "start_pos": 512}, {"end_pos": 518, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}, {"end_pos": 521, "label_type": "解剖部位", "overlap": 0, "start_pos": 520}]}
{"originalText": "，緣於入院前1月於我院診為胃癌，於2013-11-29在全麻上行根治性遠端胃大部切除術，，術中見：腹腔內無明顯腹水，盆腔、腹壁、大網膜無轉移結節，肝臟質地大小正常，未及明顯轉移結節。胃腔擴張明顯，胃壁水腫增厚，腫瘤位於幽門管大彎側偏前壁，活動度可，侵出漿膜層，未侵犯胰腺，周圍可及腫大淋巴結。術後病理示（201337693）(遠端胃)，：胃竇潰瘍型管狀腺癌II-III級，少部分為低粘附性癌（主要為印戒細胞癌），脈管內見癌栓，侵出漿膜層，手術標本下切端、上切端及另送(下切端)均未見癌浸潤。找到大彎側淋巴結0/1個，小彎側淋巴結4/6個，幽門下淋巴結4/6個，幽門上淋巴結4/7個另送(胃右動脈根部)淋巴結1/9個，見癌轉移。找到小彎側癌結節1個，幽門下癌結節1個，幽門上癌結節1個，另送(第14V組淋巴結)鏡上為脈管、脂肪、纖維結締組織。，免疫組化結果：KI67（75%陽性），P53（+++），P170（-），GSTπ（+），EGFR（-），5-FU（++），HER-2（-）。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。此次為化療就診我院，門診擬胃癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 15}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 205}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 317}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 345, "end_pos": 353}, {"end_pos": 427, "label_type": "藥物", "overlap": 0, "start_pos": 423}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 483, "end_pos": 487}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}, {"end_pos": 512, "label_type": "解剖部位", "overlap": 0, "start_pos": 511}]}
{"originalText": "患者於2014年05月因“子宮內膜癌”於******健院行“腹腔鏡上廣泛切除術+兩附件切除術+盆腔LN及腹主動脈旁淋巴結清掃術”術後病理為“子宮內膜樣腺鱗癌II級伴鱗狀生化”。2014年5月至7月行TC方案化療3程。2015年11月複查CT提示“盆腔以及兩側髂血管旁多發腫大淋巴結，考慮M”。2015年12月PET/CT示“兩髂及兩閉孔多個淋巴結代謝活躍，考慮M”。遂至我院就診，當時因患者拒絕化療未及時治療。現患者訴陰道口瘙癢嚴重，裡急後重感，於2016-03-07給予TC（進口）方案化療1程。今再次來我院就診。患者發病以來,精神一般,飲食睡眠不佳,大小便不正常：裡急後重感，體重有減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 86}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 118, "end_pos": 120}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 130}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 154, "end_pos": 160}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}]}
{"originalText": "，患者約於7年前因“結腸癌”於2009-09-08日在全麻上行左半結腸切除術。手術過程順利，術後給予抗感染及營養支援治療，患者恢復好。，術後病理：（7282.2009）結腸腺癌（中低度分化），浸潤潰瘍型，面積4*3CM，侵達漿膜脂肪組織。累及闌尾漿膜面。雙端切線未查見癌。呈一站（1/22）個淋巴結癌轉移。術後給予患者化療6週期，，方案為：奧沙利鉑200MG D1（1-3期）奧沙利鉑150MG D1（4-6期），亞葉酸鈣0.3G+替加氟1.0G D2-D6。現患者腹脹，食慾差，就診於我院門診。    患者院外就診期間，神志清，精神可，大、小便正常，體重未見明顯變化。門診以“左半結腸切除術後7年餘”收入我院。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 149}, {"end_pos": 174, "label_type": "藥物", "overlap": 0, "start_pos": 170}, {"end_pos": 192, "label_type": "藥物", "overlap": 0, "start_pos": 188}, {"end_pos": 211, "label_type": "藥物", "overlap": 0, "start_pos": 207}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 216}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 289, "end_pos": 297}]}
{"originalText": "，緣於4月前因“下腹部悶痛不適”腹部CT提示肝佔位，進一步於我院行“腹腔鏡上右肝腫物切除術+膽囊切除術”。，術後病理報告示：1.（右肝臟腫物），：肝臟原發性中分化肝細胞-膽管細胞混合型癌，伴壞死，侵及肝被膜及周邊肝組織。癌周肝臟組織，肝細胞水腫變性，匯管區小膽管增生，伴中量慢性炎症細胞浸潤。2（膽囊），：慢性膽囊炎。，免疫組化：CK7(-),CK20（+++），VILLIN(+++)，CDX-2(-),CK19(+++),CA19-9(-),GLYPICAN-3（+），CEA（-），KI67(70%),TTF-1(-),NSE(-),SY(-),PAS(灶性區域少量陽性)，AB染色（-）。術後患者無不適。無畏寒、寒戰、發熱，無噁心、嘔吐、納差，無面板黃、眼黃、尿黃。無腹痛、腹脹、腹瀉，無返酸，噯氣。定期我院門診隨訪，評估病情穩定。今為複查來我院，門診擬“肝癌術後”收入院。自發病以來，食慾正常，睡眠、精神可，體重無明顯上降，大、小便正常。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 51}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 158}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 341}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 382, "end_pos": 386}]}
{"originalText": "患者於2011.8.3在全麻上行剖腹探查+腸減壓+根治性左半結腸切除術，術後恢復可，病理型別為結腸潰瘍型中分化管狀腺癌，浸及腸壁全層，脈管內見癌栓。雙切端及闌尾均未見癌累及。腸壁下淋巴結未見癌轉移（0/12），另送（系膜）組織未見癌轉移，分期(T4N0M0) 。術後已行6次FOLFOX方案全身化療，化療期間患者無噁心、嘔吐、腹瀉等不適，化療過程順利，本次為術後複查入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 16, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 47, "end_pos": 59}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}]}
{"originalText": "，入院前3個月餘於我院診為胃癌，於2015年04月06日在全麻上行“腔鏡上根治性全胃切除術+食管空腸ROUX-Y吻合術（D2）+脾切除術”。術後病理（201512223），：(全胃)，：食管胃交界潰瘍型管狀腺癌II-III級，侵及漿膜層，累及神經。手術標本下、上切端及另送(下切端)均未見癌浸潤。找到賁門周淋巴結1/3個，小彎淋巴結1/11個，大彎淋巴結1/1個，幽門上0/5個，另送(第7組）淋巴結0/1個，(第8組）淋巴結0/1個，(第9組）淋巴結1/4個，(第10組）淋巴結1/3個，(第11組）淋巴結1/2個，(第15組）淋巴結0/1個，見癌轉移。幽門下淋巴結及另送(第12組淋巴結)未查見淋巴結。另送脾臟組織，未見癌浸潤。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。於2015.05.04、2015.06.23、2015.06.13行“奧沙利鉑200MGIVGTTD1+替吉奧60MGPOBIDD1-14”方案化療3次，輔予保胃、制酸、止吐、補液等，無明顯藥物毒性反應。今為術後第4次輔助化療,門診以“胃賁門管狀腺癌（PT4AN2M0IIIB期）術後”收入院。自出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 15}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 68}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 93, "end_pos": 112}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 240}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 268}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 382, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 398, "label_type": "藥物", "overlap": 0, "start_pos": 395}, {"end_pos": 424, "label_type": "解剖部位", "overlap": 0, "start_pos": 423}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 483}, {"end_pos": 503, "label_type": "解剖部位", "overlap": 0, "start_pos": 502}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}]}
{"originalText": "，緣於入院前2月餘前於我院確診為“直腸癌”，2015.07.11日行腹腔鏡上直腸部分切除術,術後予以制酸,抗炎,護胃等對症處理,術後病理示(201525467)，:，：(直腸)，：腸隆起型管狀腺癌II級，伴壞死，侵及外膜層，手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結13個均未見癌轉移。(MM20151216)，:該病例未檢測到KRAS基因12、13號密碼子熱點突變。該病例未檢測到BRAF基因V600E突變，術後於2015.07.29、2015.08.25予以“卡培他濱1500MGPOBIDD1-D14+奧沙利鉑200MGD1IVGTT”方案化療,期間輔以保胃,保肝止嘔吐等對症處理。此次為行第3週期化療再次就診我院，門診擬直腸癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"end_pos": 45, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 101}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 250, "label_type": "藥物", "overlap": 0, "start_pos": 246}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 268}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 328, "end_pos": 333}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}]}
{"originalText": "，其於1月前因結腸佔位性病變於2013.06.13下午在全麻上行遂行結腸癌根治術+放射性粒子置入術，術中冰凍提示乙狀結腸腺癌，侵及腸壁深肌層，雙切緣陰性。手術順利，，術後病檢提示：乙狀結腸潰瘍型中分化管狀乳頭狀腺癌，浸及腸壁全層，脈管、神經未見癌侵犯，雙切端未見癌累及，淋巴結見癌轉移（1/5），，腫瘤分期：T3NXM1 。術後予以預防感染、抗腫瘤等對症支援治療，恢復良好，並於2013.06.24治癒出院。出院後食慾較好，體重增加約6KG，未訴特殊不適，今患者為行第1次全身靜脈化療入院。\\U0004   患者發病以來，神志 清晰，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}]}
{"originalText": "，緣於5月餘前因“直腸癌”就診我院,於2016.06.29行“腔鏡上直腸根治術（DIXON手術）”，探查腹腔內無明顯出血，無明顯腹水，無明顯粘連，無明顯腹腔腫瘤種植轉移，腫瘤位於腹膜返折下7CM，侵出前壁漿膜層，未形成腸梗阻，近端無擴張，周圍少許腫大淋巴結。術順，術後予預防感染、制酸、補液、營養支援等治療，，術後病理示：（直腸）大腸潰瘍型管狀腺癌II級，侵出外膜層，可見脈管內癌栓，未見明確神經侵犯。，病理：手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤，另送（上切端）灶性腺下皮呈低級別下皮內瘤變。找到腸周淋巴結1/24個，及另送（腸繫膜上動脈根部）淋巴結0/1個，見癌轉移。，免疫組化：KI67（60%+），P53（+++），CK7（-），CK20（+++），CEA（++）。術後恢復可，無噁心、嘔吐、腹痛、腹脹、發熱、畏寒等不適。術後於2016.07.26、2016.08.17、2016.09.12、2016.10.08、2016.10.30、2016.11.21予以“奧沙利鉑150MGIVGTTD1+卡培他濱1500MGBIDD1-D14”方案化療，為行上一週期化療，就診我院,門診擬直腸癌術後化療收治入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 47}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 177}, {"end_pos": 262, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"end_pos": 448, "label_type": "藥物", "overlap": 0, "start_pos": 444}, {"end_pos": 465, "label_type": "藥物", "overlap": 0, "start_pos": 461}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 503, "end_pos": 508}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 532}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}]}
{"originalText": "，患者因直腸癌於2014年12月05日行直腸前切除術，，術後病理：直腸（切除），：潰瘍型中分化腺癌，腫物最大徑6CM；侵及周圍脂肪組織及漿膜上層；可見脈管癌栓； 淋巴結可見癌轉移（19/24）； - 環周切緣、（近端）及（遠端）均未見癌；另送腸管未見癌； ，腫瘤病理分期：PT3N2B。現為行術後輔助化療入院，患者自發病以來精神睡眠食慾尚好，小便如常，大便如下述，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"end_pos": 26, "label_type": "手術", "overlap": 0, "start_pos": 20}, {"end_pos": 35, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 41, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}]}
{"originalText": "患者1月餘前於我院診斷為“乙狀結腸腫物，惡性待排”完善術前檢查，排除手術禁忌症後於2013-01-31行乙狀結腸切除術，術後恢復可，有排氣排便，術後病理示：乙狀結腸中分化腺癌，浸潤至腸壁粘膜上層，未見神經束侵犯，未見脈管內癌栓，中間淋巴結轉移一枚（1/7），中央淋巴結（0/5），腸旁淋巴結（0/2），患者術後於2013年2月26日開始行XELOX方案化療5程，過程順利，現為進一步治療入住本科。患者自下次出院以來，食慾、睡眠及精神良好，小便正常，體力無上降，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 24}, {"end_pos": 59, "label_type": "手術", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 87}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 114, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 134}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}]}
{"originalText": "，緣於入院前4個月(2015-09-14)，於我院查腸鏡：升結腸腸乳頭狀管狀腺癌II級，遂於3個月前(2015年09月21日)全麻上行腹腔鏡上左半結腸根治性切除術，，術中探查見：探查腹腔內無明顯出血，無明顯腹水，升結腸可見腫瘤，近端幾達回盲部，遠端近肝曲，明顯侵出漿膜層，與周圍組織稍明顯粘連，未形成梗阻，近端腸管無擴張，周圍及腸繫膜根部可見數個腫大淋巴結；術後病理(N201503896)，：左半結腸回盲部隆起型管狀腺癌II級，伴神經內分泌分化及壞死，侵及漿膜層，脈管內見癌栓，手術標本結腸切端、迴腸切端及另送（下切端）、（上切端）均未見癌浸潤。找到迴腸周淋巴結2個，結腸周淋巴結29個均未見癌轉移。術順，術後分別於2015-10-22、2015-11-13、2015-12-05、2015-12-27行“奧沙利鉑D1200MGIVGTT+希羅達D2-141500MGPOBID”方案化療4次，化療過程順利，今為進一步化療，門診擬“結腸癌術後”收住入院。自下次出院以來，精神、食慾、睡眠尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 43}, {"end_pos": 81, "label_type": "手術", "overlap": 0, "start_pos": 67}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 197, "end_pos": 214}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 354}, {"end_pos": 374, "label_type": "藥物", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 417, "end_pos": 422}]}
{"originalText": "，患者2016年4月初無明顯誘因出現腹部絞痛，伴噁心、嘔吐，無嘔血、黃疸等不適，在院外考慮“腸套疊”，遂轉至**一院就診，入院後行CT檢查提示全身多發性淋巴結腫大，考慮淋巴瘤；左上腹回-迴腸套疊，考慮小腸淋巴瘤；脾大，脾內多髮結節，考慮淋巴瘤。完善相關檢查後於2016-04-08在**一院行腹腔鏡探查、左半結腸切除術，，術後病理回報：送檢腸管見一息肉樣腫物，病變符合套細胞淋巴瘤，，免疫組化：CYCLIND1、CD5、CD20、CD79A、BCL-2、SOX11均為（+），CD23、CD3、CD10、BCL-6均為（-），KI67(30%+)。術後恢復可。2016-04-20查PET/CT，提示：全身多發淋巴結腫大，最大者約1.4*1.0CM(右頸部V區)、4.6*3.2CM(左髂血管旁)、5.9*2.6CM(左側腹股溝區，SUVMAX 4.2)；脾大，代謝不均勻增高，符合淋巴瘤；中軸骨、骨盆骨髓瀰漫性代謝輕度增高，考慮反應性改變與淋巴瘤累及鑑別。現為進一步治療，來我院就診，門診擬“套細胞淋巴瘤”收入我科。起病以來，患者未訴發熱、偶有盜汗，術後近一月體重上降5KG。精神稍差，食慾、睡眠可，大小便正常。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 49}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 65, "end_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 121}, {"label_type": "手術", "overlap": 0, "start_pos": 146, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 190}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 291, "end_pos": 297}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"end_pos": 346, "label_type": "解剖部位", "overlap": 0, "start_pos": 342}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 391, "end_pos": 394}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 421, "end_pos": 424}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 447, "end_pos": 453}]}
{"originalText": "，患者2015.11.27因“卵巢癌”於我院全麻上行經腹子宮+兩側附件切除+大網膜切除+部分腸壁轉移病灶切除術。，術中探查見：盆腹腔可見淡黃色腹水，量約500ML，子宮前位，萎縮，前壁可見菜花樣結節，右側卵巢約3*2CM大小，表面不規則菜花狀突起，質脆，左側卵巢約2*2CM大小，形態似右側卵巢，大網膜攣縮呈厚餅狀，質硬，與腸管形成緻密粘連，結腸、升結腸、橫結腸、直腸前前壁腫物與腸管緻密粘連，直腸前壁、結腸肝區及肝上極均可見不規則菜花樣突起，腹盆壁、小腸表面可見大量結節樣突起，質脆，易脫落。，術中切除右側附件送快速病理回示：（右附件）影象符合高級別漿液性乳頭狀癌。，術後常規病理示：（兩附件區）卵巢高級別漿液性乳頭狀癌，兩側輸卵管查見癌，腫瘤自子宮漿膜面侵達宮壁肌層，送檢（腸壁轉移灶）和大網膜組織均查見癌；右、左宮宮旁組織未查見癌。（子宮）萎縮狀態子宮內膜。慢性宮頸炎。，免疫組化：ER（80%+），PR（-），WT-1（+），P53（+）。術後恢復可，根據術後病理，於2015.12.06、2015.12.30、2016.01.21、2016.2.14、2016.3.10給予順鉑120MG+多帕菲120MG方案化療5療程，現患者欲行第6次化療來院就診，門診以“卵巢癌術後化療”收入院，患者者飲食睡眠正常，大小便無異常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 26, "end_pos": 55}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 163}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 191}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 283}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 293, "end_pos": 311}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 339, "end_pos": 340}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 370}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 382, "end_pos": 387}, {"end_pos": 494, "label_type": "藥物", "overlap": 0, "start_pos": 492}, {"end_pos": 503, "label_type": "藥物", "overlap": 0, "start_pos": 500}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 535, "end_pos": 540}]}
{"originalText": "患者入院3-月前，因直腸癌於2015-11-17行腹腔鏡上直腸癌根治術，術後病檢：（直腸）印戒細胞癌，侵及腸周脂肪組織，兩側切緣未見癌累及，腸周圍脂肪組織中淋巴結見癌轉移（9/13）。術後恢復良好，好轉後出院。院外未訴特殊不適，無畏寒、發熱、腹痛、腹瀉、腹脹、噁心、嘔吐等不適。於2015-12-19遵醫囑行第一次化療，方案為FOLFOX4（奧沙利鉑+5-氟尿嘧啶），化療期間無化療副反應，複查血常規未見明顯異常後出院。院外無特殊不適，無腹痛、腹脹、腹瀉、噁心、嘔吐等不適。今為行第二次化療就診我院，門診以“直腸癌術後，擬行第二次化療”收入我科住院治療。。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 35, "label_type": "手術", "overlap": 0, "start_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 41, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 175, "label_type": "藥物", "overlap": 0, "start_pos": 171}, {"end_pos": 182, "label_type": "藥物", "overlap": 0, "start_pos": 178}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 254, "end_pos": 259}]}
{"originalText": "，緣於入院前23天因“反覆中下腹悶痛2周於外院”，行胃鏡檢查示：糜爛性胃炎（II級），胃角潰瘍性質待定。病理（S201439361），：（胃角，活檢）粘膜腺癌。遂於2014.11.28於我院行在全麻上行根治性遠端胃大部切除術（畢II式，D2)。術順，術後恢復良好，，術後病理：（201441656），：(遠端胃大部)，:胃角潰瘍癌變，為管狀腺癌II級，其中部分為黏液腺癌，侵及肌層，間質纖維母細胞增生，並多量嗜酸性粒細胞浸浸潤，未見明確的脈管內癌栓及神經侵犯，標本雙切端均未見癌浸潤。找到小彎側淋巴結12個，大彎側淋巴結1個，幽門上淋巴結3個，及另送(幽門下）淋巴結1個，(肝總動脈旁）淋巴結3個，(腹腔動脈旁）淋巴結4個，均未見癌轉移。，免疫組化：腫瘤細胞示KI67（70%+），P53（+），P170（++），GSTπ（+），EGFR（+），5-FU（+），HER-2（-）。下次出院至今，進食流質膳食可，無噁心、嘔吐，無腹痛、腹脹、腹瀉，無嘔血、黑便等不適，今為進一步複查就診我院，門診擬“胃癌術後”收住入院。自發病以來，患者精神、飲食、睡眠可，大小便正常，體重無明顯增減。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 42}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "手術", "overlap": 0, "start_pos": 101, "end_pos": 121}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 448, "end_pos": 452}]}
{"originalText": "，緣於入院1年半前無明顯誘因感下腹悶痛不適，就診我院查腹部CT示“，胰頭佔位:考慮假乳頭狀”，於2013.04.11在全麻上行“胰頭腫物切除、肝腫物切除、小腸憩室切除、胰腸吻合、空腸造瘻術”，術順，術後病理（201310448），示：肝轉移胰腺實性-假乳頭狀瘤。1.（胰頭腫物）胰腺實性-假乳頭狀瘤，伴出血壞死，侵犯胰腺被摸。另送（肝結節）組織見腫瘤細胞浸潤；2.（小腸）送檢小腸組織，小腸全層見異位胰腺組織；3.（肝結節）肝轉移性胰腺實性-假乳頭狀瘤。，免疫組化結果：CK(PAN)(++),KI67(6%),SY(+),CD56(+++),CGA(-),CD10(++),CD99(-),E-CADHERIN(-)。今為複查就診我院，門診擬胰腺實性假乳頭狀瘤伴肝轉移術後收入院。自發病以來，精神、飲食、睡眠尚可，大小便正常，體重無明顯改變。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 27, "end_pos": 31}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"label_type": "手術", "overlap": 0, "start_pos": 64, "end_pos": 94}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 149}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 322, "end_pos": 331}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 332, "end_pos": 337}]}
{"originalText": "，患者2016.1.26因“腹水原因待查”於我院在全麻上行經腹腹膜外子宮切除+兩附件切除+全盆腹膜切除+盆腔淋巴結清掃+腹主動脈旁淋巴結清掃+闌尾切除術，，術後常規病理回示：（兩側卵巢）高級別漿液性乳頭狀癌，，右側腫瘤體積：12*9.5*5CM，左側腫瘤體積11*10*5.5CM，腫瘤侵及兩側輸卵管壁外膜，右側輸卵管粘膜查見癌。子宮漿膜面、腹膜、大網膜、闌尾漿膜面均查見癌。右髂血管淋巴結4枚，其中1枚（1/4）查見轉移；左髂血骨淋巴結3枚，其中1枚（1/3）查見轉移；右閉孔淋巴結2枚，其中1枚（1/2）查見轉移，左閉孔淋巴結3枚，其中2枚（2/3）查見轉移；上腔靜脈旁淋巴結1枚，其內（1/1）查見轉移；髂前淋巴結1枚，其內（1/1）查見轉移；腹主動脈旁淋巴結3枚，均（3/3）查見轉移；“腹膜外腫瘤”內查見淋巴結1枚，其內（1/1）查見轉移癌。另送“右髂血管淋巴結”3枚及“左髂血管淋巴結”1枚，均未查見轉移。，免疫組化：CK（+）、CK7（+）、P53（+）、KI67陽性率約60%，ER（約30%，+）、PR（約90%，++）、WT-1（+）、CR局灶(+)。（，病理號：03351.16）。今日擬行卵巢癌術後第一次化療入院，門診以“卵巢癌術後化療 ”收入院。患者自下次出院後，食慾欠佳，睡眠好，大小便正常，無明顯噁心、嘔吐，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 29, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 103}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 172}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 379}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 391}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 506, "end_pos": 511}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 523, "end_pos": 528}]}
{"originalText": "，患者半個月前無明顯誘因出現陣發性腹部絞痛，臍周為主，伴腹脹，噁心、嘔吐，停止排氣排便。無頭暈、乏力、發熱等不適。就診外院，予胃腸減壓、抑制消化液、抗炎、補液、灌腸等治療，現腹痛緩解，今晨排不成形大便1次。2014-12-01外院腸鏡檢查提示結腸肝曲腫物，腸鏡不能透過，活檢病理提示腺癌。2014-12-16日於全麻上行“左半結腸切除+開腹惡性腫瘤特殊治療”術，，術後病理：1（結腸大體）鏡檢為中分化腺癌，部分為黏液腺癌，浸潤至漿膜上層，可見脈管內癌栓，未見神經束侵犯；闌尾粘膜慢性炎；另送檢16枚淋巴結均未見癌。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央淋巴結）鏡上為脂肪結締組織，未見癌。5（中間淋巴結）鏡上為脂肪結締組織，未見癌。6（腸旁淋巴結）4枚，未見癌。7（闌尾）鏡上為粘膜慢性炎。，免疫組化：ER（-），ERCC1（+），PMS2（+），MLH1（+），MSH2（+），MSH6（+），KI67（70%+）。 術後恢復順利。起病以來無發熱，睡眠一般，小便正常，體重上降8KG。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"end_pos": 29, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 143}, {"label_type": "手術", "overlap": 0, "start_pos": 161, "end_pos": 178}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 206, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 242}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 279, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 301, "end_pos": 306}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 349}]}
{"originalText": "，患者因“胃惡性腫瘤”於2017-07-04在全麻上予行胃空腸吻合+空腸側側吻合術；，術中探查見：腹腔內少量腹水，肝臟正常，腫瘤位於胃竇小彎側為主，遠端繞胃近1周，已累及十二指腸第1段，約8*7*5CM大小，造成幽門梗阻，近端胃腔明顯擴張，胃壁水腫增厚。腫瘤已侵出漿膜，與胰腺被膜及胰頭浸潤粘連，第3、4、5、6、7、8及12組淋巴結明顯腫大，其中5、8、12組淋巴結與胰腺融合成團，探查發現原發腫瘤無法切除。術中遂行胃空腸吻合+空腸側側吻合術。病理學檢查回示（201715397），：（大網膜）纖維脂肪組織內浸潤的低分化腺癌。 胃型粘膜充血、水腫，輕度急慢性發炎。結合患者病情及腫瘤病理與分期繼續予行術後化療相關輔助治療指徵存在；依情於2017-7-19開始予行術後首週期輔助化療，同時輔以鎮吐、升血、免疫調節等對症支援治療（化療期間患者總體耐受性良好），患者現為求進一步治療來院就診，門診依情以“胃惡性腫瘤術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 10}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 41}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 184}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "手術", "overlap": 0, "start_pos": 209, "end_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 243, "end_pos": 263}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 400, "end_pos": 407}]}
{"originalText": "，緣於入院前7月餘因“食管胃交界區癌”於我科行根治性全胃及食管上段切除+食管-空腸ROUX-EN-Y吻合術（2015-09-17），術後病理（201533702）示“（食管上段+全胃），：食管胃交界浸潤型管狀腺癌II級，侵及漿膜層，侵犯神經，手術標本下、上切端均未見癌浸潤，找到大彎淋巴結6個，幽門下淋巴結3個，幽門上淋巴結6個均未見癌轉移。，201534030：1.(下切端)，：送檢切端組織未見癌浸潤。2.找到(賁門旁)淋巴結4/9個，(胃右動脈旁)淋巴結1/12個，(腹腔動脈旁)淋巴結0/1個，(肝總動脈旁)淋巴結0/1個，見癌轉移”。術後恢復良好，並按“安素泰210MGD1+順鉑40MGD1-3”方案行術後輔助化療1週期（2015-10-21），因第1次化療消化道反應劇烈，故於2015.11.13、2015.12.05、2015-12-28以“洛鉑50MG靜滴D1+紫杉醇注射液(安素泰)210MG靜滴D1”方案行第2、3、4週期化療，輔以保肝、止吐、制酸、營養支援等治療，療程較為順利。今為行術後複查再診我院，門診擬“食管胃交界區癌術後化療後”收住入院。近來，精神、飲食、睡眠可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 109}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 381, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"end_pos": 393, "label_type": "藥物", "overlap": 0, "start_pos": 390}, {"end_pos": 400, "label_type": "藥物", "overlap": 0, "start_pos": 397}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 467, "end_pos": 476}]}
{"originalText": "，緣於1月前因進行性吞嚥困難1個月就診於我院，完善術前準備後於2014-08-07在全麻上行經左胸三切口食管下段癌切除+食管胃底左頸部吻合+左側第5肋骨固定術，，術中所見：全胸腔少量粘連，探查腫瘤位於食管下段，奇靜脈弓上，區域性增厚長約6CM，累及外膜，區域性侵出外膜，下段食管旁及縱隔多發淋巴結腫大。切除全胸段食管，並將胃底引線送至頸部，行食管-胃底手工吻合。術順，術後安返病房，術後給予預防感染、營養支援、制酸、霧化祛痰等治療，患者恢復良好。術後病理（201425956），：(食管)，：食管潰瘍型鱗狀細胞癌II級，侵出外膜層，手術標本雙切端及另送(上切端)均未見癌轉移。找到食管周淋巴結1/2個，另送(上切端)周淋巴結0/2個，(頸部食管旁)淋巴結0/2個，(下段食管旁)淋巴結0/1個，(胸部入口處)淋巴結1/1個，(胃右動脈旁)淋巴結0/5個，(肝總動脈旁)淋巴結0/2個見癌轉移。今為入院化療，遂就診我院。門診擬“食管癌術後”收入我科，下次出院至今患者無胸悶、憋氣；無胸背痛；無腹痛、腹脹；無嘔血、黑便；偶有返酸。飲食睡眠較好。大小便正常，體重無明顯變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 79}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "手術", "overlap": 0, "start_pos": 169, "end_pos": 178}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 257}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 411, "end_pos": 416}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 440, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 443}, {"end_pos": 447, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}]}
{"originalText": "，緣於3月前（2014-11-18）因食管癌於我院行“胸腹腔鏡聯合翻身三切口全胸段食管切除+食管-胃底右頸吻合+空腸造瘻術”。手術順利，術後恢復良好後出院。術後病理（201441090），：（食管及胃底），：食管隆起型鱗狀細胞癌II級，伴壞死，癌組織侵犯脈管及神經組織，脈管內見癌栓，侵及外膜層。手術標本下切端、上切端均未見癌浸潤。找到食管周淋巴結1/2個，胃周淋巴結0/2個，及另送（下段食管旁）淋巴結0/1個，（上段食管旁）淋巴結0/3個，（左喉返旁神經）淋巴結0/4個，（第7組）淋巴結0/8個，（第8組）淋巴結0/2個見癌轉移。，免疫組化染色結果：KI67（40%陽性），P53（++），P170（-），GSTπ（++），EGFR（+++）。於2014.12.24、2015.01.14按“洛鉑50MGD1+氟尿嘧啶4000MGCIV44H”方案行術後2週期化療，並輔予保肝、止嘔、制酸、增強免疫等輔助治療。現為求化療求診我科，門診擬“食管上段鱗癌術後”收入院。術後至今偶有返酸，進食半流質尚順暢。飲食睡眠較好。大小便正常。體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "手術", "overlap": 0, "start_pos": 27, "end_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 117}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 251, "end_pos": 259}, {"end_pos": 351, "label_type": "藥物", "overlap": 0, "start_pos": 349}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 358}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 390}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 422, "end_pos": 430}]}
{"originalText": "1+月前，患者因“大便習慣改變、便血”於我院胃腸外科住院治療，行鋇劑灌腸提示乙狀結腸佔位性病變；上腹部CT提示乙狀結腸壁佔位性病變；於2015.08.21在全麻上行腹腔鏡上腹腔探查術+中轉開腹+術中冰凍活檢+乙狀結腸癌根治術+小腸部分切除術、腸吻合術，術中見腫瘤位於右上腹，與右側盆壁粘連緊密，同時與部分小腸、膀胱壁粘連，腹腔少量清亮腹水，腫瘤與盆壁粘連分離困難，升結腸、橫結腸未見異常，於乙狀結腸靠近降結腸處捫及一直徑約5X4CM質硬腫塊，腫瘤浸透腸壁，與右側盆壁廣泛粘連且緊密，與右側膀胱壁部分粘連，小腸距回盲部約180CM處與腫瘤粘連，乙狀結腸繫膜間及根部可捫及腫大淋巴結。手術過程順利，術後傷口出現感染，予以頭孢替安抗感染等治療，傷口逐漸癒合。術後病檢：乙狀結腸低分化腺癌侵及漿膜層，腸繫膜淋巴結見癌轉移（5/6），送檢右側盆壁見癌累及；於2015.09.04予以FOLFOX4（奧沙利鉑150MG D1+亞葉酸鈣0.3G D1~2+5-FU 0.625G D1~2靜脈注射+5-FU 1G D1~2靜脈滴入）、2015.09.23予以FOLFOX4（奧沙利鉑150MG D1+亞葉酸鈣0.3G D1~2+5-FU 0.7G D1~2靜脈注射+5-FU 1G D1~2靜脈滴入）化療，化療過程中無噁心、嘔吐等不適，化療結束後複查血常規未見骨髓抑制；患者今為行進一步治療於我科住院治療。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 24}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 48, "end_pos": 53}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"label_type": "手術", "overlap": 0, "start_pos": 82, "end_pos": 125}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 312, "label_type": "藥物", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 340}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 398, "label_type": "藥物", "overlap": 0, "start_pos": 394}, {"end_pos": 411, "label_type": "藥物", "overlap": 0, "start_pos": 407}, {"end_pos": 425, "label_type": "藥物", "overlap": 0, "start_pos": 421}, {"end_pos": 446, "label_type": "藥物", "overlap": 0, "start_pos": 442}, {"end_pos": 484, "label_type": "藥物", "overlap": 0, "start_pos": 480}, {"end_pos": 497, "label_type": "藥物", "overlap": 0, "start_pos": 493}, {"end_pos": 511, "label_type": "藥物", "overlap": 0, "start_pos": 507}, {"end_pos": 530, "label_type": "藥物", "overlap": 0, "start_pos": 526}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 573, "end_pos": 577}]}
{"originalText": "，患者2015-03無明顯誘因出現大便帶暗紅血，量少，伴大便次數增加至2-3次/天，稀爛，偶有裡急後重，外院腸鏡檢查提示升結腸近肝曲環形腫物，腸鏡能透過，活檢病理提示腺癌；升結腸、乙狀結腸、直腸多發小息肉。後就診我院，完善檢查後診斷為升結腸癌，未見遠處轉移，遂於2015-07-06全麻上行“左半結腸切除術”，，術後病理結果回示：1（近切緣）未見癌。2（遠切緣）未見癌。3（根部淋巴結）5枚，未見癌。4（中間組淋巴結）4枚，未見癌。5（腸旁淋巴結）15枚，未見癌；另見癌結節一枚。6（腸大體）鏡檢為中至低分化腺癌，浸潤至腸壁漿膜上層，未見明確脈管及神經束侵犯；闌尾及小腸粘膜慢性炎。，免疫組化：MSH2（+），MSH6（+），PMS2（+），MLH1（+），ER（-），ERCC1（+），KI67（60%+）。診斷分期PT3N1CM0IIIB期。患者術後恢復良好，現為進一步治療收入我科。自下次出院以來，胃納可，睡眠一般，小便正常，體重無上降。", "entities": [{"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 85}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"end_pos": 153, "label_type": "手術", "overlap": 0, "start_pos": 146}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 249, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 261}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 280, "end_pos": 290}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}]}
{"originalText": "患者1月餘前因“大便帶血3月餘。”入院，診斷為“直腸癌”，患者入院後完善相關輔助檢查，排除禁忌後於2016-01-17日在全麻上行腹腔鏡直腸癌根治術，術後病理檢查結果:（直腸）中分化腺癌，潰瘍型，腫物切面積3.5*0.5CM，侵透外膜達周圍脂肪組織，手術下上切線及環周切線均未查見癌，腸周淋巴結13枚中均未查見轉移。現患者為求化療治療再次就診於我科。患者近日來飲食、睡眠可，小便正常，大便同下，體重正常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"end_pos": 74, "label_type": "手術", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 97}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}]}
{"originalText": "，患者2013年8月16日於我科全麻上行乙狀結腸癌根治術，，術後病理：進展期乙狀結腸癌，潰瘍浸潤型，中分化腺癌，，浸潤深度：透漿膜，，生長方式：浸潤型生長，肌間神經節侵犯（+），II級，斷端無癌，淋巴結未見癌轉移（0/19枚），DUKES，分期：B2期。，免疫組化結果：KI67>80%,P53>70%,CDX2 >50%,CA199(+),NM23(+),MLH1>70%,MSH2>70%,MSH6>60%,，病理號：517。患者術後行腹腔化療2次，XELOX輔助化療4次，無明顯不良反應，今為求進一步輔助化療收入我科。患者近日無發熱，飲食睡眠可，小便正常，大便日一次，無腹瀉，無便血，近來體重未見明顯減輕。ECOG，評分：1分。", "entities": [{"end_pos": 28, "label_type": "手術", "overlap": 0, "start_pos": 20}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 55}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}]}
{"originalText": "患者1月餘前因“噯氣、劍突上隱痛5月餘。”於我院就診後，完善輔助檢查後於2015.04.29行“胃癌根治術（D2全胃+ROUX-EN-Y重建）”，術後病理提示：胃食管結合部腺癌II型，PT3N3AM0，IIIB期。術後恢復可，無腹痛、腹脹、噁心、嘔吐等不適。於2015.05.27行SOX方案（奧沙利鉑150MG IVDRIP D1+S-1 60MG PO BID D1-14）化療。現按主診教授建議來我院住院化療。患者起病以來，食慾可，睡眠、精神可，大小便無明顯異常，體重無明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 48, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 80, "end_pos": 106}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 151, "label_type": "藥物", "overlap": 0, "start_pos": 147}, {"end_pos": 170, "label_type": "藥物", "overlap": 0, "start_pos": 167}]}
{"originalText": "患者因“胃竇癌”於2015-7-8在我院全麻上行\\\"遠端胃癌姑息切除癌姑息切除術\\\"，術程順利，術後病理提示胃竇癌（PT4AN3BM1，IV期)。患者術後恢復可，於2015-8-12行SOX（維康達40MG BID PO D1-14+奧沙利鉑 150MG IVDRIP Q3W）方案一程，過程順利，偶感疲乏，餘無噁心、嘔吐、發熱等不適，今為行上程術後輔助化療收入我科。自下次出院以來，患者精神、睡眠可，食慾可，大小便正常，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"end_pos": 40, "label_type": "手術", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 72}, {"end_pos": 99, "label_type": "藥物", "overlap": 0, "start_pos": 96}, {"end_pos": 121, "label_type": "藥物", "overlap": 0, "start_pos": 117}]}
{"originalText": "，患者因“胃竇癌”入我院於2014-12-24在全麻上行\\\"（遠端）胃癌根治術\\\"，術程順利，，術後病理回報:“（胃腫物大體）鏡檢為胃中至低分化腺癌，LAUREN，分型：腸型，浸潤胃壁漿膜層，可見脈管內癌栓及神經束侵犯；網膜組織未見癌。淋巴結4/61枚見腺癌轉移。（近、遠切緣）未見癌。，免疫組化：VEGF（+），HER-2（1+）。PT4AN2M0，IIIB期。”患者術後恢復可，現為行術後輔助化療來我院就診，擬“胃竇癌術後”入我科。自下次出院以來，患者一般情況可，大小便正常，進食量一般，睡眠正常，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 213}]}
{"originalText": "，患者約於4個月前因“胃惡性腫瘤”在我院全麻上行姑息性胃大部切除術+畢II式吻合，手術過程順利，術後患者恢復好，切口癒合好，，術後病理：胃竇部低分化腺癌，區域性呈粘液腺癌影象，浸潤潰瘍型，體積7.5*3.7*2.2CM，侵穿漿膜，累及底部切除面。雙端切線未查見癌。呈三組（3/3個）、五組（2/4個）、六組（5/7個）淋巴結癌轉移。四組（2個）淋巴結未查見癌。，免疫組化染色示：CERBB-2（1+）、SYN（-）、ERCC1瀰漫（+）、β-TUBULIN-III少量（+）、TS較多（+）、RRM1少量（+）、TOPOII少量（+）。根據患者病情具有化療指徵，於2014-08-06開始第一週期化療，，方案為：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時給與升白細胞、護肝、止吐、免疫增強治療，注意觀察患者病情變化,給予升白、止吐等藥物，患者化療耐受可，無明顯化療副反應。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 24, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 76}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 305}, {"end_pos": 322, "label_type": "藥物", "overlap": 0, "start_pos": 318}, {"end_pos": 336, "label_type": "藥物", "overlap": 0, "start_pos": 333}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}]}
{"originalText": "緣於入院前3個月月於我院診為“卵巢癌”，於2013-10-16在我科行“全麻上行盆腔粘連鬆解+闊韌帶腫物切除術+全子宮切除術”，術後病理回報示：卵巢子宮內膜樣腺癌I級，術後恢復良好，傷口癒合II/甲。術後於2013-11-03及2013-11-27予“多西他賽70MG/M2IVGTTD1+洛鉑30MG/M2IVGTTD1”方案化療2次，化療過程順利，第2次化療出現II度骨髓抑制,予升白治療後好轉出院。2013-12-26予“紫杉醇240MGIVGTTD1+洛鉑50MGIVGTTD1”方案第3次化療，化療過程順利，化療後出現II度骨髓抑制,予升白治療後好轉出院。現化療間期已滿，患者無畏冷、發熱，無噁心、嘔吐，無腹痛、腹瀉等不適，今為求進一步診治，門診擬“卵巢子宮內膜樣腺癌(II期，I級)術後”收入院。下次出院以來，精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 83}, {"end_pos": 130, "label_type": "藥物", "overlap": 0, "start_pos": 126}, {"end_pos": 147, "label_type": "藥物", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 190}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 214}, {"end_pos": 232, "label_type": "藥物", "overlap": 0, "start_pos": 230}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 264, "end_pos": 271}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 330, "end_pos": 349}]}
{"originalText": "，患者3月前“結腸癌”於2015-10-14 在全麻上行姑息性乙狀結腸癌切除+橫結腸造瘻術，手術過程順利，術後患者恢復好，切口癒合好，按期拆線。，術後病理：201517712（乙狀結腸）粘液腺癌，浸潤潰瘍型，體積12*6*3CM，侵穿漿膜。 雙端切線未查見癌。 腸壁一站（10個）淋巴結未查見癌。，免疫組化染色示癌組織：SYN（-）、TS（-）、BRAF（-）、MLH1（+）、 MSH2（+）、MSH6（+）、PMS2（+）。根據患者病情具有化療指徵，於2015-10-27、2015-11-24、2015-12-20行化療3次，，方案為：奧沙利鉑150MG D1，亞葉酸鈣0.3G+替加氟0.8G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，為進一步治療，門診以“乙狀結腸癌術後”收入院。患者自發病以來，精神、睡眠可，體重近2月上降5千克。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 143}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 271}, {"end_pos": 288, "label_type": "藥物", "overlap": 0, "start_pos": 284}, {"end_pos": 296, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 347}]}
{"originalText": "患者因家族性結腸息肉病於2010-9-8在我院於全麻上行全結腸切除術+遠端直腸息肉電切術，手術過程順利，術後給予抗感染、營養支援及對症治療，恢復好，好轉出院。病理回示：結腸多發絨毛狀管狀腺瘤，部分腺體呈輕－中度不典型增生；雙端切線未見明顯病變；腸壁一站（19個）、二站（13個）、三站（69個）；“結腸中動脈”（1個）淋巴結，呈反應性增生；慢性闌尾炎。   院外期間患者堅持口服易蒙停等藥物治療，大便成型，約5-6次/日，定期入院複查並行腸鏡檢查及直腸息肉電切治療。現患者為行復查及進一步診療再次來我院就診，門診以\\\"結腸全切除術後、腸息肉\\\"收入院。   患者自下次出院後一般情況可，精神可，飲食、睡眠可，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 162}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 175}, {"end_pos": 192, "label_type": "藥物", "overlap": 0, "start_pos": 189}, {"end_pos": 230, "label_type": "手術", "overlap": 0, "start_pos": 224}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 259, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 270}]}
{"originalText": "，患者2015.11.03在我院於全麻上行“經腹子宮切除+兩附件切除+大網膜切除+腸壁轉移瘤切除術”。2015.11.09，術後常規病理回示：（右附件）高級別漿液性乳頭狀癌，腫瘤體積約4*2.5*2CM。子宮內膜及肌層、宮頸、左附件及大網膜均未查見癌。另送“腸壁轉移瘤”組織內查見癌。，免疫組化：ER（約60%）PR（約10%）P53（+）WT-1（+），NAPSINA(-),KI67陽性率約50%；分泌狀態子宮內膜；慢性宮頸炎；左卵巢黃體囊腫。評估患者病情後，於2015.11.12、2015.12.12、2016.1.6給予紫杉醇（力樸素）270MG+卡鉑（波貝）600MG方案靜脈化療3週期，並給予止吐、補液等對症治療。化療過程順利，副反應輕，好轉出院，現患者為行第4次化療來我院就診，門診以“惡性腫瘤術後化療”收入院。患者自發病以來，飲食及睡眠可，大小便正常，陰道無流血流液，體重無明顯變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 22, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 86}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 134}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 216, "end_pos": 223}, {"end_pos": 268, "label_type": "藥物", "overlap": 0, "start_pos": 265}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 269}, {"end_pos": 281, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"end_pos": 284, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 351, "end_pos": 359}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 385}]}
{"originalText": "，緣於入院前1月於我院診為結腸癌，於2016年10月20日在全麻上行腹腔鏡輔助上乙狀結腸癌根治術。，手術經過如上:探查腹腔內無明顯粘連，無明顯出血，無明顯腹水，未及種植結節，肝臟未見明顯轉移灶，乙狀結腸上段可探及腫瘤，侵出漿膜層，活動度可，周圍未及明顯腫大淋巴結，術後予預防性抗感染、制酸、免疫調節及營養支援等治療。術後恢復可，病理回報（，病理號：20163776），：（乙狀結腸），：大腸潰瘍型管狀腺癌II級，侵出外膜層，手術標本雙切端及另送（下切端）（上切端），均未見癌浸潤。找到腸周淋巴結1/17個，及另送（中間組）淋巴結0/6個、（腸繫膜上動脈根部）淋巴結0/3個，見癌轉移。此次為化療再次就診我院，門診擬結腸癌術後化療收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 48, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 103, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 205}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 312}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}]}
{"originalText": "，緣於入院前16月於我院診斷為直腸癌，於2014年12月01日在全麻上行“腹腔鏡上根治性直腸癌切除術+迴腸造瘻術”，術中見腹腔內無明顯出血，小腸與小腸多節段腸間粘連，盆腔少量黃色腹水，腫瘤位於腹膜返折下3CM，侵出漿膜，周圍可探及多發腫大淋巴結，腫瘤左側盆腔可疑種植結節。手術順利。術後病理回報（201441985），:（直乙交界），：大腸潰瘍型管狀腺癌II級，伴壞死，部分為篩狀粉刺型，侵出漿膜層，癌組織侵犯脈管及神經組織，脈管內見癌栓；手術標本下切端、上切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結1/14個及另送（腸繫膜上動脈根部）淋巴結0/4個見癌轉移。（腹壁結節）送檢纖維、脂肪組織中見腺癌組織浸潤。於2015.01.21，2015.02.13，2015.03.25,2015.04.29行“奧沙利鉑(齊沙)200MG靜滴D1+希羅達1000MG口服BIDD1-14”方案化療，輔以增強免疫、保胃、營養等處理，化療過程中無肝腎功能損害、骨髓抑制等不良反應。入院1月前無明顯誘因出現肛門疼痛，呈陣發性隱痛，無腹痛、腹脹，無發熱、寒戰等，無便血、腹瀉，今為進一步診治再次入院。門診擬“直腸癌術後化療後（PT4AN1M1IV期）”收入我院我科。下次出院後飲食、睡眠可，無腹痛、腹脹、發熱，二便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 180}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 280, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 308}, {"end_pos": 363, "label_type": "藥物", "overlap": 0, "start_pos": 359}, {"end_pos": 366, "label_type": "藥物", "overlap": 0, "start_pos": 364}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"end_pos": 411, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 424, "end_pos": 430}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 435}, {"end_pos": 455, "label_type": "解剖部位", "overlap": 0, "start_pos": 453}, {"end_pos": 467, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 503, "end_pos": 508}, {"end_pos": 546, "label_type": "解剖部位", "overlap": 0, "start_pos": 545}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}]}
{"originalText": "，緣於入院前5月餘（2015.08）因“排便異常”就診我院，查全腹CT（2015.08），：1、乙狀結腸病變，多考慮結腸癌，部分侵及漿膜面可能，伴周圍多發小淋巴結，於2015.08.14行“腹腔鏡上直腸癌根治術（DIXON）”，術後病理示（201529660），：（直腸下段），：腸潰瘍型管狀腺癌II級，大部分為篩狀粉刺型腺癌，伴壞死及鈣化，侵出外膜層，手術標本雙切端、環周切緣及另送(下切端)、(上切端)，均未見癌殘餘，找到腸管周圍淋巴結2/24個，另送(腸繫膜上動脈根部）淋巴結0/4個，見癌轉移，，免疫組化染色結果：KI67（60%陽性），P53（+），P170（+++），GSTπ（-），EGFR（-），5-FU（-），MLH1（+++），MSH-6（+++），基因檢測（20151492），：KRAS和BRAF無突變，術後恢復好，於2015.09.09、2015.09.23、2015.10.7予FOLFOX方案“奧沙利鉑140MGD1+氟尿嘧啶3500MGCIV44HD1+亞葉酸鈣300MGD1-2Q2W”術後輔助化療3個週期，於2015.10.20開始行同步放化療，放療採用IMRT技術，以瘤床為GTVTB，PGTVTBDT50GY/25F，以包括瘤床、骶前、閉孔、髂內、骶3下緣以下髂外淋巴引流區為CTV1，PCTV1DT45GY/25F，予“氟尿嘧啶225MG/M2.D每週5天”方案同步化療，配合腹部熱療。於2015.12.23、2016.01.06行4、5週期FOLFOX方案術後輔助化療，現為繼續治療，門診擬“直腸癌根治術後”收入住院。下次出院後，精神、睡眠、食慾欠佳，大小便正常，體重無明顯變化。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 31, "end_pos": 35}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 61}, {"label_type": "手術", "overlap": 0, "start_pos": 95, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 156, "end_pos": 163}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 241, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"end_pos": 416, "label_type": "藥物", "overlap": 0, "start_pos": 412}, {"end_pos": 428, "label_type": "藥物", "overlap": 0, "start_pos": 424}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 443}, {"end_pos": 537, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}, {"end_pos": 540, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}, {"end_pos": 543, "label_type": "解剖部位", "overlap": 0, "start_pos": 541}, {"end_pos": 548, "label_type": "解剖部位", "overlap": 0, "start_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 550, "end_pos": 554}, {"end_pos": 585, "label_type": "藥物", "overlap": 0, "start_pos": 581}, {"end_pos": 611, "label_type": "解剖部位", "overlap": 0, "start_pos": 609}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 668, "end_pos": 675}]}
{"originalText": "，患者近1個月前（2015-11-6）因“胃癌”於我科行胃癌根治術（畢I式吻合），手術過程順利，，術後常規病理示：（胃）中分化腺癌伴粘液腺癌（後者約佔15%），潰瘍型，切面積4*1.0CM，侵透漿膜達周圍脂肪組織。下上切線及吻合器切線均未查見癌。小彎側淋巴結27枚，其中7枚查見轉移癌（7/27）；大彎側淋巴結10枚（0/10）及網膜組織未查見轉移癌。，免疫組化：CK（+），E-CAD（+），HER-2（2+）。40092.15，術後給予抗炎補液營養支援治療，好轉後出院，現為求化療治療，門診以“胃癌術後化療”收入院。患者自下次出院以來，飲食睡眠可，二便無明顯異常，體重較下次入院無明顯改變。高血壓病史1年餘，最高達150/90MMHG，未治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 23}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 40}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 249, "end_pos": 253}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 297, "end_pos": 300}]}
{"originalText": "，患者3個月餘前因“反覆噯氣半年餘，解黑便3周。”就診我院，完善相關檢查後診斷胃竇癌，排除手術禁忌症後於2015-09-06在全麻上行胃癌根治術（遠端胃大切），術程順利，術後預防感染支援對症等處理，恢復好。，術後病理示：中-低分化腺癌，LAUREN，分型：混合型，浸潤至胃壁漿膜層，脈管內見癌栓，可見神經束侵犯，LN 16/64（+）；PT4N3M0，IIIC期。出院後生活質量可，已於2015.10.8、2015-10-29、2015-11-25行SOX方案（奧沙利鉑 150MG+替吉奧 60MG BID）化療，化療期間無明顯毒副反應，有噁心感，耐受度尚可。現為行上一程化療來我院門診就診，擬“胃癌綜合治療後”收入我科。起病以來，患者精神尚可，食慾尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 42}, {"label_type": "手術", "overlap": 0, "start_pos": 67, "end_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 124}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 235, "label_type": "藥物", "overlap": 0, "start_pos": 231}, {"end_pos": 246, "label_type": "藥物", "overlap": 0, "start_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 306}]}
{"originalText": "，入院前20+天，患者無明顯原因出現大便乾結，次數增多，平均每天3-4次，量少，不成形，伴大便中帶血，伴肛門墜脹、裡急後重，無腹脹、腹痛，無嘔血、黑便，無頭暈、頭痛、發熱等症狀。遂於我院門診就診，，行乙狀結腸鏡並取活檢提示：，電子乙狀結腸鏡：直腸新生物（性質？）；，病理活檢：&LT;直腸&GT;腺癌。以“直腸癌”收入我科。於2016-02-24日在全麻上行腹腔鏡上直腸癌根治術（MILES術式）。術中送病檢（，病理號：1601483），：直腸中等分化腺癌侵及全層，遠近切端均未見癌累及，腸繫膜淋巴結未見癌轉移（0/7）。術後予以抗感染，止血、抑酸護胃等對症支援治療，術後恢復良好，造瘻口通暢，今日前來我院，擬行第一次化療，故以“直腸癌術後第一次化療”收入我科。", "entities": [{"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 156}, {"label_type": "手術", "overlap": 0, "start_pos": 183, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 220, "end_pos": 228}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 315, "end_pos": 320}]}
{"originalText": "，緣於入院前1月，我院診為“胃癌,於2013年11月07日在全麻上行“腹腔鏡上胃癌根治術”，手術順利。，術後病理：（遠端胃大部），：胃體小彎浸潤型印戒細胞癌，侵及漿膜層，侵犯神經。手術標本下端、上端及另送（胃下端切口）均為浸潤。找到小彎淋巴結1個嗎，大彎淋巴結7個，幽門上淋巴結3個，及另送（第1組淋巴結1個），（第7組）淋巴結5個，（第8組）淋巴結1個，（第9組）淋巴結3個，（第12組）淋巴結1個均未見癌轉移。，免疫組化：KI67(30%+),P53(個別細胞陽性)，CK7(+++),CK20（-），VILLIN（++++），CDX-2（++），CEA（++）,CD56(-),SYN（-），CGA（-），HER-2（-），E-CADHERIN（+）。術後給予制酸、抑酶、提高免疫力、營養、補液等支援對症治療，恢復良好,傷口癒合II/甲。今為化療再次入院。門診擬“胃印戒細胞癌”收入院。下次出院以來精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 78}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 391}]}
{"originalText": "，緣於入院前1月餘，於我院診為結腸脾曲癌，於2016-04-11在全麻上行腹腔鏡輔助右半結腸根治性切除術、胃部分切除術，，術中見：探查腫物位於結腸脾曲，大小約10X5X5CM，侵出腸管前壁漿膜層，與前腹膜明顯粘連，侵犯胃大彎後壁，未侵及胰腺、脾臟、腎臟。術後病理示（右半結腸+部分胃壁），：結腸潰瘍型中分化腺癌，大部分為篩狀粉刺型腺癌，侵出漿膜層，未見肯定脈管及神經侵犯，侵及胃漿膜層及漿膜上層，手術標本近切端、遠切端及另送(近切端）、（遠切端)均未見癌浸潤；找到腸周淋巴結31個，均未見癌轉移。送檢胃體粘膜，呈中度慢性淺表性胃炎改變，術後給予對症、營養支援等治療，恢復良好，傷口癒合II/甲。於2015.05.06在我院按“奧沙利鉑250MGD1+卡培他濱1750MGD1-14”方案化療一週期。此次為化療再次就診我院，門診擬結腸癌術後收入院。下次出院以來精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 59}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 167}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 265}, {"end_pos": 317, "label_type": "藥物", "overlap": 0, "start_pos": 313}, {"end_pos": 329, "label_type": "藥物", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 364, "end_pos": 369}]}
{"originalText": "，患者3月前主因“腹痛3月”入院，入院後完善相關檢查，排除手術禁忌症，於2016.04.26在全麻上行胃癌根治術（全胃切除+ ROUX-EN-Y重建），術程順利，術後安返病房，術後經抗感染、抑酸、止血、化痰、靜脈營養支援等治療，，術後病理示：（胃大體）鏡檢為胃中至低分化腺癌，LAUREN，分型：混合型，浸潤至胃壁漿膜層，並累及食管壁至外膜層；可見脈管內癌栓及神經束侵犯；網膜組織未見癌。遠近切緣未見癌。15/31LN(+)。分期PT4AN3MO,IIIC期。 現患者術後恢復良好，為術後行第7程XELOX輔助化療來我院就診。起病以來，患者無頭暈、頭痛，無發熱、咳嗽、咳痰、胸悶、胸痛，精神體力一般，食慾上降，睡眠一般，小便正常，體重較前上降2KG。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 51, "end_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 144}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}]}
{"originalText": "，緣於入院前2+個月於我院診為“宮頸腺癌”，於2013年11月27日於我院在全麻上行廣泛全子宮切除+兩附件切除術+盆腔淋巴結清掃術。，術中見：盆腔無腹水，子宮增大如孕2個月大，表面光滑，右側卵巢一囊腫，大小約3*3CM，與子宮及盆底粘連，分離過程見巧克力樣液體流產，兩側骶韌帶增粗，子宮後壁見紫藍色結節，直腸子宮陷凹變淺，左側附件及右輸卵管未見明顯異常。術後病理回報（201337408），示：（全子宮+兩附件）子宮頸內生浸潤型中分化粘液腺癌（宮頸管亞型），侵犯肌層（浸潤最深處深度約1.0CM），未侵及宮內膜組織，（右、左）宮旁組織及手術標本陰道殘端未見癌浸潤。盆腔淋巴結未見癌轉移，宮體肌間多發性平滑肌瘤，宮內膜呈增生狀態，兩側輸卵管及卵巢未見癌轉移。術後恢復良好，傷口癒合II/甲。術後於2013.12.10及2014.1.8予PT方案“紫杉醇注射液(安素泰)210MGIVGTTD1+注射用洛鉑43MGIVGTTD1”行第1，2次化療。化療後出現I度骨髓抑制,予特爾津升白治療後出院。現患者無畏冷、發熱，無腹痛、腹瀉，無噁心、嘔吐，無頭暈、頭痛等不適，遂就診我院，門診擬“宮頸腺癌(IB1期，II級)術後”收入院。下次出院以來，精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 42, "end_pos": 65}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 197, "end_pos": 228}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"end_pos": 319, "label_type": "解剖部位", "overlap": 0, "start_pos": 314}, {"end_pos": 322, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"end_pos": 375, "label_type": "藥物", "overlap": 0, "start_pos": 372}, {"end_pos": 382, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"end_pos": 401, "label_type": "藥物", "overlap": 0, "start_pos": 399}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 427, "end_pos": 433}, {"end_pos": 458, "label_type": "解剖部位", "overlap": 0, "start_pos": 457}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 472, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}, {"end_pos": 475, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 490, "end_pos": 506}]}
{"originalText": "，緣於入院前2月餘因“下腹部悶痛2月”入院，於2016年12月09日在全麻上行“腹腔鏡上根治性全胃切除術”，術順，術後予制酸、保肝、營養支援、補液等處理，，術後病理示：(全胃)，：胃體小彎潰瘍型低粘附性癌（低分化腺癌），侵犯漿膜層，侵犯脈管及神經組織，手術標本下、上切端及另送（下切端）均未見癌浸潤；找到賁門周淋巴結3/13枚，小彎淋巴結9/9枚，大彎淋巴結0/3枚，幽門下淋巴結0/2枚，幽門上淋巴結0/3枚及另送(11D）淋巴結0/2枚，見癌轉移。另送（第6組淋巴結）、（第10組淋巴結）為纖維脂肪及脈管組織。診斷為“胃低分化腺癌”，於2017.01.07行“樂沙定200MGIVGTTQDD1+希羅達1500MGPOBIDD1-14”方案化療，感耳鳴、噁心、嘔吐，予對症處理後好轉出院。此次為行第2週期化療再次入院，門診擬“胃低分化腺癌術後化療”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 52, "label_type": "手術", "overlap": 0, "start_pos": 40}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 109}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 261, "end_pos": 267}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"end_pos": 303, "label_type": "藥物", "overlap": 0, "start_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 373}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}]}
{"originalText": "，患者因診為直腸癌2013-12-12就診於我院，行放化療，查無手術禁忌症，於2014-3-20全麻上行直腸癌低位前切除術，術後第六天出現吻合口瘻、腹膜炎，於2014-3-26急診行剖腹探查術、腹盆腔沖洗、迴腸造瘻術、腹盆腔置管引流術，術後予抗炎、營養支援治療 ，恢復可。，術後病理：（近端18CM，直徑3CM，距一斷端2CM，距另一斷端 12CM，可見一潰瘍型腫物，大小3.5×XXX3CM， 潰瘍深0.6CM，切面灰白、實性、質硬。直腸放化療後（切除），： 腸潰瘍型中分化腺癌伴粘液形成，大小3.5×XXX3×XXX0.6CM； - 侵至固有肌層； - 腫瘤緩解率約50％； 未見脈管癌栓； 雙端切緣及環周切緣未見癌； 淋巴結未見癌轉移0/21； - ，腫瘤病理分期：YPT2N0。，-免疫組化結果顯示腫瘤細胞:CD44(－),CMET(－),COX2(局灶+),EGFR(+),HEP(－),HER2(1+),KI-67(+60%),MLH1(+＞75%),MSH2(+50～75%),MSH6(+＞75%),P170(+),P27(+),P53(－),TOPOII(+15%),TTF-1(－)。於2014-05-05日行術後第1週期化療，化療方案為“XELOX”，，具體為：奧沙利鉑（樂沙定）240MG D1+卡陪他濱片3片 2/日 D1-14。2014-5-26、2014-6-16，2014-07-10,2014-7-30，2014-08-25，2014-9-19行第2、3、4、5、6、7週期化療。目前恢復良好。為行造口還納再次入院。患者自發病以來精神睡眠食慾尚好，小便如常，大便如下述，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"end_pos": 61, "label_type": "手術", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "手術", "overlap": 0, "start_pos": 91, "end_pos": 117}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 240}, {"end_pos": 546, "label_type": "藥物", "overlap": 0, "start_pos": 542}, {"end_pos": 550, "label_type": "藥物", "overlap": 0, "start_pos": 547}, {"end_pos": 565, "label_type": "藥物", "overlap": 0, "start_pos": 560}]}
{"originalText": "，患者因罹患“胃竇小彎側低分化腺癌”於2013-10-15在我院予行全麻上根治性胃大部切除，畢I式吻合。術後病理（ 201312957），示：胃竇小彎側低分化腺癌，潰瘍型，面積3*3CM，侵達外膜脂肪組織。雙端切線及另送“遠切線”未查見癌。三組（4個）、四組（4個）、五組（1個）、“1、3、7組”（11個）淋巴結未查見癌。，癌組織免疫組化染色示癌組織：β-TUBULIN-III（-）、TS（-）、RRM1（-）、TOPOII陽性細胞數約50%、CERBB-2（-）。，術後病理分期：PT4N0M0，IIIA期。依據患者病情及腫瘤病理與分期繼續術後輔助性化療指徵存在。自下次手術出院（2013-10-25）以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹。現患者為行進一步複查並必要時適當處理而再來我院就診，門診依情以“胃術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 85}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 386, "end_pos": 389}]}
{"originalText": "，緣於入院前2年因食管髓質型鱗狀細胞癌IIIA期（PT3N1M0）在全麻上行食管中段癌切除+食管-胃底弓下吻合術，術後予抗感染、抑酸、營養支援等治療。，術後病理回報：食管髓質型鱗狀細胞癌II級，侵及外膜層，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到（下段食管旁）淋巴結1/1個，（中段食管旁）淋巴結0/1個，（賁門旁）淋巴結0/3個，（胃右動脈旁）淋巴結0/1個，（降主動脈旁）淋巴結1/1個，（隆突上）淋巴結0/3個，（上肺韌帶旁）淋巴結0/3個見癌轉移。，免疫組化：KI67（40%+），P53（+++），P63（+++），CK5/6（++++），CK18（++），CD117（-）。術後予順鉑40MGD1-3+安素泰240MGD1方案化療3週期，輔以保肝、止吐、制酸等治療，患者療程較為順利。近2月來出現右胸肋骨疼痛，無胸悶、氣促，無咳嗽、咳痰，無畏冷、發熱等不適，今為求進一步診治，求診我院門診，擬食管癌術後收入院。此次發病以來，精神、睡眠尚可，食慾如下述，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 33}, {"label_type": "手術", "overlap": 0, "start_pos": 38, "end_pos": 56}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 96}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 304, "label_type": "藥物", "overlap": 0, "start_pos": 302}, {"end_pos": 316, "label_type": "藥物", "overlap": 0, "start_pos": 313}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 408, "end_pos": 413}]}
{"originalText": "，患者緣於入院前1年餘於我院診斷為“胃間質瘤”，於2012.09.13在全麻上行腹腔鏡輔助上胃體間質瘤楔形切除術。，術中見：腫物位於胃體前壁偏小彎側，內生型，漿膜光滑無明顯隆起，與周圍組織無明顯粘連，手術順利。術後病理（291227160），：(胃間質瘤)，：胃間質瘤，危險程度低。術後予抗感染、補液、制酸、營養支援等治療。恢復良好，傷口癒合II/甲。於1年餘前開始口服“格列衛”治療，服用後無訴不適。目前患者為複查，再次就診我院，門診擬“胃間質瘤術後”收入院。自下次出院以來飲食、睡眠正常，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 22}, {"end_pos": 56, "label_type": "手術", "overlap": 0, "start_pos": 40}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"end_pos": 189, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 220, "end_pos": 226}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}]}
{"originalText": "，患者因罹患“結腸癌”於2013-08-06在我院予行全麻上姑息性右半結腸切除術，術後病理（9750.2013），：（橫結腸）腺癌（中度分化），部分呈粘液腺癌影象，浸潤潰瘍型，面積7*6CM，侵穿漿膜，於腸壁脂肪組織內查見轉移灶3處。呈腸壁一站（2/6個）、二站（1/1個）、“腸繫膜根部”（1/1個）、“腸繫膜中動脈根部”（2/2個）淋巴結癌轉移。中間組（1個）淋巴結未查見癌。，術後病理分期：T4N2M0，IIIC期。術後已行6週期化療，，化療方案為：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時給予止吐、升血、增強免疫等治療，因腫瘤指標仍有升高，依情於2014-03-31開始更改化療方案，，具體用藥為：伊利替康200MG D1、D8+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時輔以鎮吐、升血、免疫調節等對症支援治療。化療期間耐受良好。自下次出院以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹。現患者為行復查並輔助化療而再來我院就診，門診依情以“結腸術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠可；肛門排氣排便好。近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 40, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 118, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 185}, {"end_pos": 232, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"end_pos": 245, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 259, "label_type": "藥物", "overlap": 0, "start_pos": 256}, {"end_pos": 335, "label_type": "藥物", "overlap": 0, "start_pos": 331}, {"end_pos": 351, "label_type": "藥物", "overlap": 0, "start_pos": 347}, {"end_pos": 365, "label_type": "藥物", "overlap": 0, "start_pos": 362}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 492, "end_pos": 496}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 528}]}
{"originalText": "，緣於入院前3月餘於我院診為直腸癌，於2015-01-23在全麻上行直腸癌根治術（DIXON手術），術順，術後病理示（201503026），：（直腸），：直腸潰瘍型管狀腺癌II級，侵出外膜層，侵犯神經組織，脈管內見癌栓，腸周纖維脂肪組織中見癌結節。手術標本下、上切端及另送（下切端）、（上切端）均未見癌浸潤。找到腸周淋巴結1/12個，見癌轉移。恢復良好,術後於2015.03.03予“替加氟2.5GCIV（46H）D1+奧沙利鉑（艾恆）150MGIVGTTD1+替加氟2.5GCIV（46H）D3+亞葉酸鈣300MGIVGTTD1-D5”方案化療1次，2015.03.26予“替加氟2.5GCIV（46H）D1+奧沙利鉑（艾恆）150MGIVGTTD2+亞葉酸鈣300MGIVGTTD1-D3”化療1次，過程順利，此次為化療再次就診我院，門診擬直腸癌術後化療後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 89}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 195, "label_type": "藥物", "overlap": 0, "start_pos": 192}, {"end_pos": 214, "label_type": "藥物", "overlap": 0, "start_pos": 210}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 215}, {"end_pos": 234, "label_type": "藥物", "overlap": 0, "start_pos": 231}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 249}, {"end_pos": 291, "label_type": "藥物", "overlap": 0, "start_pos": 288}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 306}, {"end_pos": 313, "label_type": "藥物", "overlap": 0, "start_pos": 311}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 327}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 372, "end_pos": 377}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}]}
{"originalText": "，患者6月前因診斷為食管胸中段癌於我院行腹左胸食管癌切除術，術後患者出現左側胸腔積液，留置胸腔穿刺引流可引出略渾濁液體，，術後病理提示：浸潤性高分化鱗狀細胞癌，大小3×XXX2×XXX1CM；癌侵透固有肌層達外膜層；淋巴結未見癌轉移。，免疫組化結果顯示:CD44(+++),CMET(+++),COX2(+),EGFR(+++),ERCC-1(+50～75%),HER2(－),KI-67(+25～50%),P170(+),P27(+＜25%),P53(－),TOPOII(+＜5%)。術後患者出現吻合口瘻，胸腔感染，給予通暢胸腔引流、胸腔沖洗、抗生素治療、營養支援等治療，複查造影以及胃鏡，提示吻合口瘻癒合，患者胸腔感染治癒，患者可經口進食，主訴進食後返流嘔吐，進食量少。今為進一步治療而入我科。自發病以來，精神睡眠可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 16}, {"end_pos": 29, "label_type": "手術", "overlap": 0, "start_pos": 20}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 42}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 79}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"label_type": "手術", "overlap": 0, "start_pos": 263, "end_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 311}]}
{"originalText": "患者2012年6月因“進行性吞嚥困難”於外院確診“賁門癌”，於2012年7月2日行賁門癌根治性近端胃切除+胃食管膈上吻合術，術中見賁門腫物約7*5大小，第1、2、3組淋巴結腫大，術後病理示賁門腺癌II級，浸潤全層，LN 8/30 (+)，術後恢復可。遵主診教授意見於2012-08-07至11-13行XELOX方案輔助化療5程，現返院行上一程治療。起病以來，患者精神睡眠一般，胃納尚可，二便正常，近3周體重上降3KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 41, "end_pos": 61}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 101}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}]}
{"originalText": "，患者因“升結腸惡性腫瘤”於2014-09-12在我院予行全麻上行根治性左半結腸切除術。（201414180），：回盲部腺癌（中、低度分化），部分呈粘液腺癌影象，隆起型，體積7*6.5*4.5CM，侵達纖維膜，未累及漿膜。雙端切線未查見癌。呈腸壁一站（1/17個）淋巴結癌轉移。二站（4個）、三站（3個）、中間組（15個）、中央組（2個）淋巴結未查見癌。，免疫組化染色示癌組織：TS大部分（+）、SYN（-）。，術後病理分期：T3N1M0 IIIB期。依據患者病情及腫瘤病理與分期繼續術後輔助性化療指徵存在，，查無化療禁忌後術後行輔助化療具體用藥為：奧沙利鉑200MGD1 +亞葉酸鈣0.3G D2-6 +替加氟1G D2-6 靜脈滴注；同時予鎮吐、升血、免疫調節等對症支援治療。患者化療期間總體耐受性好。自下次化療結束以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹。現患者為行進一步複查並必要時適當處理而再來我院就診，門診依情以“升結腸惡性腫瘤術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 12}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 135}, {"end_pos": 279, "label_type": "藥物", "overlap": 0, "start_pos": 275}, {"end_pos": 292, "label_type": "藥物", "overlap": 0, "start_pos": 288}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 408, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 442, "end_pos": 451}]}
{"originalText": "患者於2012年6月因“下腹不適2個月住我院”於2012年6月26日於我院行“根治性左半結腸切除術”。術程順利，術後病理結果回報：升結腸鏡檢為結腸中至低分化腺癌，浸潤至漿膜上層，腸周淋巴結（1/40）見腺癌轉移。術後恢復可，術後診斷升結腸中-低分化腺癌術後 PT3N1M0IIIB期。術後恢復可，後於2012-7-23和2012-8-13行XELOX方案化療2程,耐受可,現患者如期行上程化療，患者一般情況可，飲食、睡眠正常，大小便如常，體重無明顯減輕。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 80}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 116, "end_pos": 141}]}
{"originalText": "，緣於入院3個月前因胃癌就診我院，於2015.4.17全麻上行“腹腔鏡中轉-根治性全胃切除術”，，術中見：腹腔內無腹水，脾臟呈切除術後改變，腹腔、盆地、網膜未見結節，腫瘤位於胃體下段至胃底賁門部，浸潤潰瘍型，大小約7*5CM，侵出漿膜層，侵犯後壁胰體尾並與粘連，中轉開腹再探查，胰體尾後方多發大小約1*1.5CM腫大腹膜後淋巴結，賁門右一1.5CM大小淋巴結，胃右動脈及肝總動脈、肝固有動脈表面見數個1CM大小淋巴結。術後病理（201514107），回報示：食管胃交界處潰瘍型低分化腺癌，侵及將磨層，脈管內見瘤栓，手術下上切端均未見癌轉移。術後於2015.5.13、2015.6.5、2015.6.29予奧沙利鉑（齊沙200MG）IVGTTD1+希羅達1500MGPOBIDD1-14方案行術後3次化療，輔助以制酸保肝補液等對症治療。今為求術後第4次化療，求診我科，門診擬“胃癌術後化療”收住院。患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 12}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 229, "end_pos": 243}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 302}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"end_pos": 326, "label_type": "藥物", "overlap": 0, "start_pos": 323}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 387, "end_pos": 391}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}]}
{"originalText": "緣於入院前5月餘前因食管腹段癌於我科行“右進胸食管腹段癌切除+食管-胃底弓上吻合術”（2014-06-25），術後病理(201420098)示“（腹段食管及近端胃）食管蕈傘型鱗狀細胞癌II-III級，侵及外膜層，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到食管周淋巴結2個，及另送（右上肺門）淋巴結2個，（隆突上）淋巴結6個，（胃右動脈旁）淋巴結4個，（賁門旁）淋巴結2個，均未見癌轉移。胃呈輕度慢性淺表性胃炎”。2個多月前因反覆進食阻塞，考慮為“吻合口狹窄”併入院行“胃鏡上吻合口狹窄擴張術”，按“順鉑40MGD1-3+安素泰240MGD1”方案行術後輔助化療3週期（2014.09.17，2014.10.07，2014.11.06）。療程較為順利，無明顯噁心、嘔吐，無頭痛、頭痛，無嘔血、黑便，無胸悶、胸痛，無氣促、心悸，無腹痛、腹脹等不適。今為求術後第4週期輔助化療再診我院，門診擬“食管上段癌”收住我科。近來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"label_type": "手術", "overlap": 0, "start_pos": 20, "end_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 99}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 200, "end_pos": 209}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 228, "end_pos": 233}, {"end_pos": 250, "label_type": "手術", "overlap": 0, "start_pos": 239}, {"end_pos": 256, "label_type": "藥物", "overlap": 0, "start_pos": 254}, {"end_pos": 268, "label_type": "藥物", "overlap": 0, "start_pos": 265}, {"end_pos": 341, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 399, "end_pos": 404}]}
{"originalText": "，緣於半月餘前因食管下段鱗癌於我院行（2014-2-14）翻身三切口食管下段癌切除+食管-胃底右頸部吻合+第6後肋內固定+空腸造瘻術，術後病理（201403696），：食管潰瘍型鱗狀細胞癌II級，侵出外膜層，手術標本下切端、上切端及另送(食管下切端)均未見癌浸潤；找到食管周淋巴結7個及另送(喉返旁)淋巴結6個、(上段食管旁)淋巴結7個、(隆突上)淋巴結8個、(胃右動脈旁)淋巴結19個、(賁門旁)淋巴結7個、(胃大彎)淋巴結1個，均未見癌轉移。，免疫組化結果：KI67（65%陽性），P53（-），P170（-），GSTπ（++），EGFR（-）。（201403588），：(頸段食管（縫線處為下切端）)，：送檢食管切端組織，未見癌浸潤。術後給予抗感染、營養支援、制酸、霧化祛痰等治療，病情恢復順利，已進食半流質，無明顯噁心、嘔吐，無頭暈、頭痛，無咳嗽、咳痰，無胸悶、胸痛，無腹痛、腹脹，無周身骨骼疼痛等不適。今為求入院術後第1週期化療再診我院，門診擬食管下段癌術後化療收住我科。近來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 29, "end_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 97}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 307}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 385}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 396}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 427, "end_pos": 434}]}
{"originalText": "患者自訴近10年來大便祕結，排便困難，伴進食後腹脹，無血便、黑便、噁心等，無頭暈、乏力、發熱等不適。2015-03外院體檢腸鏡檢查提示距肛16CM腫物，腸鏡能透過，活檢病理提示高分化腺癌。外院腹部CT、胸片未見遠處轉移。門診以“結腸癌”收入我院。2015-04-08全麻上行乙狀結腸切除術（DIXONS’術式），術後病理：中分化腺癌，癌組織浸潤至腸壁外膜層；未見明確脈管及神經束侵犯，切緣未見癌，LN 1/11(+)。術後分期為PT4AN1M0 IIIB期。術後恢復可，2015-04-29、2015-05-20行XELOX方案輔助化療2程，過程順利。現為行上一程化療入院。自下次出院以來，精神可，納眠可，胃納一般，二便正常，體重較前無明顯變化。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 101, "end_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "手術", "overlap": 0, "start_pos": 137, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 174}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}]}
{"originalText": "患者1周餘前在我院診斷為胃癌，於2013-3-20在全麻上行腹腔鏡輔助遠端胃癌根治術，手術過程順利，術後病理結果回報遠端胃區域性殘留粘膜內低分化腺癌（LAUREN分型：混合型；大小1毫米），未見脈管癌栓，淋巴結0/11未見癌轉移，胃殘端及十二指腸殘端未見癌。術後患者出現胃排空障礙，為求進一步治療入院。患者自發病以來精神、睡眠、食慾尚好，大小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 42, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}]}
{"originalText": "，緣於入院前1月餘診斷“直乙交界處結腸癌”，於2013.11.11在我科行“腹腔鏡上直乙交界處結腸癌根治術”，術中見腹腔內無明顯腹水，未見明顯轉移結節，乙狀結腸稍迂曲，腫瘤位於直腸-乙狀結腸交界處，上緣距腹膜返折約7CM，約5×4CM，侵及漿膜層，未侵犯周圍組織，未形成明顯梗阻，周圍未見明顯腫大淋巴結。術順，術畢安返病房，予補液及營養對症支援等治療。術後病理（20335111），示：（直腸）大腸隆起型管狀腺癌II級，侵犯外膜層，手術標本下、上切端及另送（下切端）、（上切端）均未見癌浸潤。找到腫物周圍淋巴結11個，腸周淋巴結21個，及另送（腸繫膜上動脈根部）淋巴結5個，均未見癌轉移。，免疫組化結果：CK20(+)，CK7(-)，VILLIN(+++)，CEA(++)，CDX-2(++)，CD56(-)，CGA（個別+），SY(個別+)，KI67(85%+)。術後恢復出院，後於2013.12.05開始予“奧沙利鉑150MGIVGTTD1+希羅達1000MGPOBIDD2-15”方案行術後第1週期化療，輔以保胃、保肝、止吐等治療，過程順利。現為求術後第2週期化療再次就診我院，門診擬“直乙交界處結腸癌術後”收入院。自下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 20}, {"end_pos": 53, "label_type": "手術", "overlap": 0, "start_pos": 38}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 209}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 410, "label_type": "藥物", "overlap": 0, "start_pos": 406}, {"end_pos": 426, "label_type": "藥物", "overlap": 0, "start_pos": 423}, {"end_pos": 459, "label_type": "解剖部位", "overlap": 0, "start_pos": 458}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 496, "end_pos": 506}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 529}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 532}]}
{"originalText": "患者於2011年6月起前無明顯誘因出現下腹部脹痛不適、納差，無伴發熱、黃疸、嘔吐、黑便等，無處理，2011年9月再次出現右下腹痛，遂到**六院查CT示\\\"胰腺囊腺癌\\\"，9-30在氣管麻上行“胰體尾切除+空腸近端切除+脾切除+結腸脾區切除+ROUX-EN-Y吻合術”，術程順利，術後病理示胰腺粘液性囊腺癌；12月CT複查未見覆發或轉移徵象。半月前患者突覺右下腹痠痛，伴腹脹，遂到外院複查腫瘤標記物CA199 164.1 U/L，CA125 49.6 U/L。2012-4-17**六院PET/CT示：胰腺提殘端高代謝灶，考慮腫瘤復發；腹盆腔、腸旁、腸繫膜、大網膜，肝周圍膜、子宮子宮直腸窩多發高代謝病灶，考慮腹，盆腔廣泛種植性轉移。為進一步診治至我院就診，於2012-4-25/2012-5-24行健擇方案（D1,D8,D15）化療2程，過程順利，化療後II度白細胞上降。入院以來，無頭暈頭痛，無咳嗽咳痰，右下腹有按壓痛，無腹脹，無嘔吐、黑便，精神、胃納、睡眠一般，體重無明顯減輕。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "手術", "overlap": 0, "start_pos": 96, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 144, "end_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 156, "end_pos": 158}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 198, "end_pos": 204}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 214, "end_pos": 219}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 242, "end_pos": 248}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"end_pos": 351, "label_type": "藥物", "overlap": 0, "start_pos": 349}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"end_pos": 413, "label_type": "解剖部位", "overlap": 0, "start_pos": 412}, {"end_pos": 426, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}]}
{"originalText": "，緣於入院前2個月周於我院診斷為乙狀結腸癌，於2014.01.03全麻上行“乙狀結腸癌姑息切除+近端乙狀結腸造瘻+小腸部分切除吻合術”，，術中見：乙狀結腸一菜花樣腫物,大約7.0*4.0*3.0CM，質硬，侵出漿膜，侵犯部分迴腸及小腸繫膜，侵及右髂部盆壁並與其粘連固定，右髂血管及右性腺血管受侵併被包繞，腸繫膜上血管根部可見腫大淋巴結，腫物近端乙狀結腸稍擴張，腸壁明顯水腫增厚。術後予保肝、保胃、營養等治療。術後病理（201400261），：1、（結腸），：大腸隆起型管狀腺癌II級，伴壞死，侵及漿膜層，侵犯神經，手術標本下切端、上切端均未見癌浸潤。找到腫物周淋巴結16個和腸周淋巴結7個均未見癌轉移。2、（小腸），：送檢小腸組織，腸壁全層急慢性炎症細胞浸潤，病變以漿膜層最重，可見組織炎性壞死，伴大量急、慢性炎症細胞浸潤，肉芽組織增生。該病例未檢測到KRAS基因12、13號密碼子熱點突變。該病例未檢測到BRAF基因V600E突變。術後恢復可，於2014.2.7、2014.2.21按“奧沙利鉑150MGIVGTTD1+替加氟3.4GCIV+亞葉酸鈣300MGIVGTTD1-2”方案予術後2期化療，今為術後第3次化療求診我院，門診擬“乙狀結腸癌術後”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 21}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 66}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 119}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 152, "end_pos": 153}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 181}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 241}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 316, "end_pos": 317}, {"end_pos": 448, "label_type": "藥物", "overlap": 0, "start_pos": 444}, {"end_pos": 464, "label_type": "藥物", "overlap": 0, "start_pos": 461}, {"end_pos": 476, "label_type": "藥物", "overlap": 0, "start_pos": 472}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 519, "end_pos": 526}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}, {"end_pos": 552, "label_type": "解剖部位", "overlap": 0, "start_pos": 551}]}
{"originalText": "緣於入院前3個月於我院診為“橫結腸癌”，於2015.12.02在全麻上行“腹腔鏡上橫結腸癌根治性切除術”，術中見“探查腹腔內無明顯出血、粘連、腹水，腫物位於橫結腸中段偏左，可疑侵及漿膜層，未形成梗阻，周圍可見數個腫大淋巴結”，術後病理（201543775）：“大腸隆起型管狀腺癌II級，侵出漿膜層，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到腸周淋巴結14/42個，另送（結腸中動脈根部）淋巴結0/8個，見癌轉移”，術後予對症、營養支援等治療，恢復良好，傷口癒合II/甲出院。於2015.12.29、2016.01.19行“奧沙利鉑（樂沙定）150MGIVGTTQDD1+希羅達1000MGPOBIDD1-14”方案化療，未見明顯化療不良反應。今為行上一週期化療就診我院，門診擬“橫結腸癌術後化療”收入院。自下次出院以來，精神、睡眠、飲食可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 18}, {"end_pos": 51, "label_type": "手術", "overlap": 0, "start_pos": 37}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 142}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 270, "label_type": "藥物", "overlap": 0, "start_pos": 266}, {"end_pos": 274, "label_type": "藥物", "overlap": 0, "start_pos": 271}, {"end_pos": 293, "label_type": "藥物", "overlap": 0, "start_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 350}]}
{"originalText": "患者於2年前因“直腸吻合口漏”在我院於2012年09月04日在全麻上行剖腹探查+腸粘連鬆解術+迴腸單腔造瘻術，手術過程順利，術後給予抗感染及營養支援治療。術後切口癒合較好。現患者一般情況可，造瘻口排氣排便通暢，無腹脹、腹痛，無噁心、嘔吐，無發熱不適，為行小腸造口還納術來我院就診，門診，以“小腸造漏術後”收入院。    發病以來，患者精神好，飲食可，睡眠尚可，小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 54}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 134, "label_type": "手術", "overlap": 0, "start_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 151}]}
{"originalText": "，緣於入院前2月餘因“反覆返酸、噯氣7年”就診我院，，行胃鏡檢查示：“1.胃竇癌2.慢性萎縮性胃炎”，，病理示：“胃管狀腺癌II-III級”，下腹部平掃+，增強示：“胃腫瘤，伴腹腔、腹膜後多發淋巴結腫大”，考慮腫瘤區域性較晚期，遂於2015.04.18、2015.05.11、2015.06.02予“安素泰210MGIVGTTD1+奧沙利鉑（艾恆）150MGIVGTTD2+希羅達1000MGPOBIDD1-14”方案新輔助化療，輔以止吐、制酸、保胃、保肝、營養支援等治療。化療後未見明顯骨髓抑制，一般情況尚可。今為求第4次化療就診我院，門診擬“胃竇癌”收入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 71, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 152, "label_type": "藥物", "overlap": 0, "start_pos": 149}, {"end_pos": 169, "label_type": "藥物", "overlap": 0, "start_pos": 165}, {"end_pos": 172, "label_type": "藥物", "overlap": 0, "start_pos": 170}, {"end_pos": 189, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 243, "end_pos": 247}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 275}]}
{"originalText": "，患者2012年5月出現吞嚥困難，伴下腹部不適，為隱痛，無明顯放射，疼痛間斷髮作，患者無噁心、嘔吐，無明顯黑便，，患者行胃鏡檢查示：食管上段、賁門處佔位，，病理示：低分化腺癌；，免疫組化結果顯示:CK5/6(－),P63(－),CK8/18(+),CK7(+)。後行2次術前新輔助化療，方案為奧沙利鉑+替吉奧。患者於2012年11月29日在全麻上行經腹食管胃交界腺癌根治術，，術後病理回報：（食管胃交界腺癌化療後）食管及胃交界部低分化腺癌，癌灶散在分佈，直徑0.2－0.5CM，侵及深肌層，癌細胞變性顯著（約70％），腫瘤退縮分級（TRG），：1級，未見脈管癌栓；淋巴結未見癌轉移（胃周0/2、胃小彎側0/0、食管胃交界處0/3、大彎側0/1)，食管和胃斷端未見癌，網膜組織未見特殊；，腫瘤病理分期：YPT2NOM0G3 IIA期。患者自發病以來，飲食睡眠好，體重無減輕；患者體重無明顯減輕。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 150, "label_type": "藥物", "overlap": 0, "start_pos": 146}, {"end_pos": 154, "label_type": "藥物", "overlap": 0, "start_pos": 151}, {"end_pos": 186, "label_type": "手術", "overlap": 0, "start_pos": 174}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 219}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}]}
{"originalText": "，緣於入7月餘於我院診斷為胃竇癌，於2016年04月08日在全麻上行腹腔鏡輔助上根治性遠端胃大部切除術，手術順利，術後病理（201611241），：(遠端胃)，：胃竇潰瘍型黏液腺癌，部分為低黏附性癌（印戒細胞癌及未分化癌為主），侵犯脈管及神經組織，脈管內見癌栓，侵出漿膜層。手術標本下切端，上切端及另送(下切端)均未見癌浸潤。找到小彎側淋巴結10/19個，大彎側淋巴結12/13個，幽門下淋巴結5/8個，幽門上淋巴結6/8個，及另送(胃右動脈根部）淋巴結1/6個，見癌轉移。網膜結節為副脾組織。胃壁見異位胰腺組織，胰島細胞增生。，免疫組化染色結果示：CK(PAN)（+++），HER-2（-），KI67（50%陽性），CD56（-），SY（-），CGA（-），E-CADHERIN（++）。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。分別於2016.05.05、2016.05.25、2016.06.17、2016.07.11、2016.08.07、2016.09.05、2016.10.04行“伊利替康200MGIVGTTD1+替吉奧60MGPOBIDD1-14”方案化療，現為行第8次化療再次就診我院，門診擬“胃竇癌（PT4AN3BM0IIIC期）術後化療”收入院。自下次出院後飲食、睡眠可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 51, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 90}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 457, "label_type": "藥物", "overlap": 0, "start_pos": 453}, {"end_pos": 473, "label_type": "藥物", "overlap": 0, "start_pos": 470}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 512, "end_pos": 533}, {"end_pos": 555, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 558, "label_type": "解剖部位", "overlap": 0, "start_pos": 557}]}
{"originalText": "入院前2+月，患者因“乙狀結腸腫瘤”於我科住院治療，完善相關檢查於2014年7月10日在全麻上行腹腔鏡上乙狀結腸癌根治術，術後病理診斷：乙狀結腸粘液性腺癌（中分化）侵及粘膜上淺肌層，雙側切緣未見癌累及，腸繫膜淋巴結見癌累及（1/7），術後給予止血、補液、抗感染、營養支援、護胃等治療，術後恢復可，複查血常規、肝腎功、電解質未見明顯異常。患者病情恢復順利，無特殊不適，切口甲級癒合，好轉出院。目前患者無噁心、嘔吐、腹痛、腹脹、便血等表現，遵醫囑今日入我院，擬行第3次化療，故以\\\"乙狀結腸癌術後第3次化療\\\"收入我科住院治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 17}, {"end_pos": 60, "label_type": "手術", "overlap": 0, "start_pos": 48}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 82}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 154, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 156}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 246}]}
{"originalText": "，2017-10-25在手術室行開腹根治性乙狀結腸切除術。，術後病理：（乙狀結腸血管根部淋巴結乙狀結腸）?XXXXXX結腸隆起型中分化腺癌，大小3×XXX2.5CM?XXXXXX侵及漿膜上纖維脂肪組織?XXXXXX未見脈管癌栓及神經侵犯?XXXXXX雙斷端未見癌?XXXXXX淋巴結可見癌轉移（腸周1/14、乙狀結腸血管根部0/0） ，腫瘤病理分期：PT3N1A； - ，免疫組化結果顯示:BRAF(－),CMET(1+),EGFR(2+),HER2(0),KI-67(+＞75%),MLH1(+),MSH2(+),MSH6(+),PMS2(+)。", "entities": [{"end_pos": 28, "label_type": "手術", "overlap": 0, "start_pos": 16}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}]}
{"originalText": "，患者因“結腸癌並肺轉移”於2014-07-17在我院行姑息性左半結腸切除術，術中輸血2U，切除標本送病理，輸液、預防感染及靜脈營養等對症支援治療。病理診斷（201410878），:左半結腸腺癌（中度分化），浸潤潰瘍型，體積2.7*2.6*0.6CM，侵達外膜脂肪組織。雙端切線未查見癌。腸壁一站（8個）、二站（7個）、中央組（1個）、中間組（11個）淋巴結未查見癌。，免疫組化染色示：ERCC1瀰漫（+）、TS（-）。根據腫瘤病理分期（T3N0M1 IV期)。現患者為行進一步複查並必要時適當處理而再來我院就診，門診依情以“結腸術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 12}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 267}]}
{"originalText": "緣於入院前1月於我院診為“直腸癌”，於2013.12.11在我科行“腹腔鏡上直腸癌根治術DIXON”，術中見腹腔內無明顯腹水，腫物位於腹膜反折處，大小約2.5×2CM，可疑侵及漿膜層，周圍見少許腫大淋巴結。術順，術畢安返病房，予以預防感染、補液、營養支援、調節免疫等治療。術後病理（201336679）示：（直腸）大腸潰瘍型管狀腺癌II級，部分為粘液腺癌，侵出外膜層，外膜面見癌結節形成，手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤。找到腫物周淋巴結1/7個，腸周淋巴結2/7個見癌轉移。另送（腸繫膜上動脈根部淋巴結）為脂肪、脈管及神經組織。術後恢復良好出院。此次為化療再次就診我院，門診擬“直腸癌術後”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 50, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 169}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 235}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 301, "end_pos": 306}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 328}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}]}
{"originalText": "，患者於患者於2月前於我院診斷為：結腸腺癌，在腹腔鏡上結腸腫瘤切除術。，術後病理提示：左半結腸）潰瘍型中分化腺癌，侵及腸壁全層，雙切端未見癌累及，脈管內見癌栓，腸壁淋巴結見癌轉移（2/15）。闌尾未見癌轉移。1月前行第一次化療，化療後無發熱，無噁心嘔吐，無腹痛腹瀉等不適。擬入院行第2次靜脈化療。\\U0004   患者發病以來，神志 清晰，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 21}, {"end_pos": 34, "label_type": "手術", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 43, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}]}
{"originalText": "患者於2004年4月份在本院行右乳癌改良根治術,術後病理診為:右乳腺浸潤性導管癌,淋巴結10/11(+),PT3N3M0,IIIC期,ER(+),PR(-),HER-2(-),KI67(+++).術後以FEC方案化療4程,之後行放療.2004年9月份開始行TAM治療,2004年12月加用雷諾得,2007年9月行卵巢去勢手術,改瑞寧得治療.2010年4月份發現骨轉移(右股骨代謝活躍)行右股骨姑息性放療.2011年初發現肺肝淋巴結等轉移,行多西他賽化療程4程後評價PD,改GX2程,肝病灶PD,行NP方案化療6程,評價SD.後於2012年5月始使用替加氟治療.複查CT示肝轉移灶進展(2012年5月11日肝臟數個低密度灶4×4MM-9×9MM,2012年9月21肝數個低密度灶最大33×24MM).於2012-10-22以“泰素+順鉑”方案化療一程。為進一步治療入院.精神,睡眠,食慾欠佳,大小便正常.體重無明顯變化.。", "entities": [{"end_pos": 23, "label_type": "手術", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 40}, {"end_pos": 147, "label_type": "藥物", "overlap": 0, "start_pos": 144}, {"end_pos": 162, "label_type": "手術", "overlap": 0, "start_pos": 156}, {"end_pos": 167, "label_type": "藥物", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 183}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 224, "label_type": "藥物", "overlap": 0, "start_pos": 220}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 277, "label_type": "藥物", "overlap": 0, "start_pos": 274}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 282, "end_pos": 284}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 364, "label_type": "藥物", "overlap": 0, "start_pos": 362}, {"end_pos": 367, "label_type": "藥物", "overlap": 0, "start_pos": 365}]}
{"originalText": "，緣於入院前2月（2013.08.16）因“子宮內膜混合型腺癌”就診我科行“盆腔粘連鬆解+筋膜外全子宮+兩附件切除+盆腔淋巴結清掃術”。術順，，術後病理回報：宮體混合型腺癌（80％為II型透明細胞腺癌，20％為I型子宮內膜樣腺癌），侵及淺肌層，未侵犯宮頸組織學內口；餘未示明顯異常。，免疫組化表達：KI67（40%+），ER（-），PR（-）。術後恢復可，腹部切口II/甲癒合。術後於2013.8.29,2013.09.22予以“多西他賽140MGIVGTTDL+洛鉑50MGIVGTTDL”方案行術後輔助化療2次，化療過程順利，化療後複查血常規、肝腎功能均未示明顯異常，好轉出院。出院期間未定期複查血常規、肝腎功能。現為進一步化療，就診我院，門診擬“子宮內膜腺癌IA期術後”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 31}, {"label_type": "手術", "overlap": 0, "start_pos": 38, "end_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 115}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 215}, {"end_pos": 234, "label_type": "藥物", "overlap": 0, "start_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 306}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 337}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}]}
{"originalText": "，患者因罹患“直腸腺癌”於2016-09-13在我院予行全麻上直腸腫瘤切除術，，術中見：腹腔內無腹水，腹膜無轉移，肝臟正常。腫物位於腹膜返折下方，直腸與乙狀結腸交界處，約2.5*2.5*1CM大小，腫瘤未侵出漿膜，直腸繫膜根部未觸及明顯腫大淋巴結，腫瘤尚活動。決定行DIXON手術。手術病理(0400.2013），示：直腸腺癌（中度分化），浸潤潰瘍型，體積約5×4×1.2CM，侵達外膜。雙端切線未查見癌。腸壁二站（4個）、中央組（2個）淋巴結未查見癌。免疫組化染色示ERCC（-）、TS(-)。術後行3週期輔助化療，同時輔以鎮吐、升血、免疫調節等對症支援治療。化療過程總體順利,病情穩定出院。現患者為行復查並輔助化療而再來我院就診，門診依情以“直腸癌術後”收入院。自下次出院以來，患者一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 11}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 28}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 52}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 140, "label_type": "手術", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 323, "end_pos": 328}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 385}]}
{"originalText": "，患者於今年8月初開始無明顯誘因出現嘔吐，伴噯氣，於外院行胃鏡檢查示“中段距門齒26-29㎝處後壁見一菜花狀新生物，胃角見一3×2.5㎝潰瘍”。病理“食管中段鱗狀細胞癌；胃角低分化腺癌”。為進一步診治來我院就診。2016年8月25日行“賁門癌根治（全胃切除）+胰腺體尾部切除+脾切除術”，術中探查“腫瘤位於胃體小彎側部，大小約8*7CM，向下侵犯胃底賁門及食管上段2CM，向後侵犯胰腺體部及尾部，脾門淋巴結多發腫大”。術後病理示“（胃大體）鏡檢為低分化腺癌，部分為印戒細胞癌，伴較多粘液分泌，LAUREN，分型：瀰漫型，癌組織侵犯至胃壁漿膜層及食管外膜層，可見多量脈管內癌栓及神經束侵犯；另可見3枚淋巴結，其中2枚見腺癌轉移，另1枚見鱗狀細胞癌轉移。（近切緣），鏡上：食管粘膜組織中見一小團核異型的細胞，核偏位，胞漿有粘液，符合腺癌細胞浸潤，經重新切片觀察已未能找到該團細胞。56/69LN(+)”。分期PT4BN3BM0 IIIC期。然後轉至我科，排除化療禁忌症，於2016-09-30按“奧沙利鉑200MG D1+替吉奧60MGBID D1-14”方案行第1程化療，過程順利。今患者按約回院繼續化療。入院時患者無嘔吐、噯氣，睡眠、精神、食慾可，大小便正常，體重上降約1KG。", "entities": [{"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 92}, {"label_type": "手術", "overlap": 0, "start_pos": 118, "end_pos": 142}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 228}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 232, "end_pos": 237}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 308, "end_pos": 310}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 317, "end_pos": 322}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 450, "label_type": "藥物", "overlap": 0, "start_pos": 446}, {"end_pos": 462, "label_type": "藥物", "overlap": 0, "start_pos": 459}]}
{"originalText": "，患者因左側結腸癌於2013-8-9在全麻上予行左半結腸切除術；相關手術病理（9929.2013），已回：結腸腺癌（中低度分化），部分呈粘液腺癌影象，侵潤潰瘍型，面積8*7CM，侵穿漿膜。少數脈管內查見癌栓，區域性侵犯神經。雙端切線未查見癌。呈腸壁一站（7/8個）、二站（1/3個）、中間組（1/2個）淋巴結癌轉移。腸壁三站（2個）淋巴結未查見癌。，免疫組化染色示癌組織：ERCC1（+）、TS（-）。結合患者病情及腫瘤病理與分期繼續予行術後化療相關輔助治療指徵存在；依情已行4週期化療，，具體用藥為：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6 靜滴，同時輔以鎮吐、升血、免疫調節等對症支援治療（化療期間患者總體耐受性良好）。自第下次化療結束出院以來，患者未訴明顯不適，一般情況保持良好；無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯腹痛、腹脹。為行進一步複查並必要時適當處理而再來我院就診，門診依情以“結腸術後”收入院。目前患者精神及情緒狀態良好，食慾、飲食好，夜間睡眠後；近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 9}, {"end_pos": 31, "label_type": "手術", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 64}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 168}, {"end_pos": 254, "label_type": "藥物", "overlap": 0, "start_pos": 250}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 263}, {"end_pos": 281, "label_type": "藥物", "overlap": 0, "start_pos": 278}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 429, "end_pos": 433}]}
{"originalText": "，緣於入院前2月在我院確診為胃癌，於2014年06月18日在全麻上行“剖腹探查+胃竇腫物活檢術+胃空腸吻合術”，術順，術後病理（201419201），提示：1、（胃壁）間質瘤，腫瘤最大徑約0.8CM，鏡上為梭形細胞為主型，未見顯著異型性，核分裂像4/50HPF，危險程度極低。，免疫組化結果：CD34（+++），DOG1（+++），CD117（+++），P53（++），ACTIN(SM)（-），DESMIN（-），S100（-），KI67（8%+）。（瘤結周邊僅見少量平滑肌組織，無法判斷腫瘤浸潤範圍及切緣情況，請結合術中所見）2、（胃竇體）胃浸潤型低分化腺癌，部分向神經內分泌方向分化，侵及漿膜層。，免疫組合結果：CK(L)（+++），CD68（-），CGA（-），CD56（+），SY（++），KI67（40%+）。術後給予對症、補液治療，恢復良好,傷口癒合II/甲。2014-07-28以“奧沙利鉑150MGD1+紫杉醇150MGD2+替吉奧膠囊(艾奕)40.00MGBID*7D”方案化療1次，並輔以止吐、制酸、保胃保肝等對症處理，化療過程順利。此次為化療再次入院。門診擬“胃癌、胃空腸吻合術後”收入院。自下次出院後精神、飲食、睡眠可，無腹痛、腹脹、發熱，二便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 80, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 281}, {"end_pos": 403, "label_type": "藥物", "overlap": 0, "start_pos": 399}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 411}, {"end_pos": 427, "label_type": "藥物", "overlap": 0, "start_pos": 422}, {"end_pos": 430, "label_type": "藥物", "overlap": 0, "start_pos": 428}, {"end_pos": 463, "label_type": "解剖部位", "overlap": 0, "start_pos": 462}, {"end_pos": 465, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 492, "end_pos": 502}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 524}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 527}]}
{"originalText": "，緣於入院前5個月餘因胃癌，於2015年02月15日在我院行“腹腔鏡輔助上根治性遠端胃大部切除術（D2）”，手術順利。，術後病理：（遠端胃），：胃竇隆起型粘液腺癌，侵及深肌層，脈管內見癌栓，手術標本下切端、上切端及另送（下切端）均未見癌浸潤；找到小彎淋巴結1/22個，大彎淋巴結0/20個，幽門下淋巴結4/7個，幽門上淋巴結1/8個，及另送（胃右動脈根部）淋巴結0/10個見癌轉移。於2015.05.15、2015.06.07行“奧沙利鉑200MG靜滴D1+卡培他濱片(希羅達)1500MG口服BIDD1-14”方案化療第1、2週期，化療過程順利，此次為行第3週期化療再次入院。患者出院後飲食、睡眠可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 81}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 215}, {"end_pos": 234, "label_type": "藥物", "overlap": 0, "start_pos": 229}, {"end_pos": 238, "label_type": "藥物", "overlap": 0, "start_pos": 235}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}]}
{"originalText": "，患者於4月餘前入院，診為結腸癌，於2015-08-11在全麻上行腹腔鏡上左半結腸姑息性切除術，，術中見：腹腔內有淡黃色腹水約200ML，腫瘤位於升結腸中段，明顯侵出漿膜面，形成不完全梗阻，近端腸管明顯增厚擴張，周圍可見數個腫大淋巴結，盆腔內可見多個綠豆大小的種植轉移病灶，遂行下術，術順。術後病理示(左半結腸)，：結腸潰瘍型管狀腺癌II級，侵出外膜層，侵犯神經組織，手術標本雙切端及另送(近切端)、(遠切端)均未見癌浸潤。找到迴腸周淋巴結0/5個、結腸周淋巴結5/22個，及另送(回結腸動脈根部）淋巴結0/3個，見癌轉移。闌尾組織。，免疫組化：CK18（+++），CGA（-），CD56（-），SY（-），KI67（60%）。該病例未檢測到KRAS基因12、13號密碼子熱點突變。該病例未檢測到BRAF基因V600E突變，術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。2015.08.28、2015.09.23、2015.10.21、2015.11.12、2015.12.06行“奧沙利鉑200MGIVGGTD1+希羅達1500MGPOBIDD1-14”方案化療，輔以保胃、保肝、止吐、增強免疫、營養補液等治療。過程順利，未見明顯化療副反應。此次為化療再次入院。門診擬以“升結腸癌伴腹腔種植（PT4BN2AM1IV期)術後化療”收入院，患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 33, "end_pos": 47}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 170}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 451, "label_type": "藥物", "overlap": 0, "start_pos": 447}, {"end_pos": 467, "label_type": "藥物", "overlap": 0, "start_pos": 464}, {"end_pos": 493, "label_type": "解剖部位", "overlap": 0, "start_pos": 492}, {"end_pos": 496, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 543, "end_pos": 568}, {"end_pos": 589, "label_type": "解剖部位", "overlap": 0, "start_pos": 588}, {"end_pos": 592, "label_type": "解剖部位", "overlap": 0, "start_pos": 591}]}
{"originalText": "，患者因\\\"陰道不規則流血持續1月餘，外院診刮病理示宮頸癌10天\\\"入院，入院完善各項檢查，無明顯手術禁忌症，於2012.5.31在在全麻上行“II廣泛性全子宮兩附件切除術+盆腔淋巴結清掃術+腹主動脈旁淋巴結取樣術”，，術中探查：無明顯腹水。肝膈面、肝表面、胰、脾、胃、兩腎、大小腸、大網膜未捫及明顯異常，盆腔及腹主動脈旁可觸及增大淋巴結，子宮增大，約10*8*7CM大小，水腫，宮頸膨大，約5*4*4CM大小，兩附件外觀正常。術後予以抗炎、對症等處理，患者恢復好。，術後病理結果示：中分化鱗狀細胞癌，癌組織浸潤宮頸至深肌層，並累及宮體上段至淺肌層，脈管內見癌栓，左閉孔淋巴結見鱗癌。有放化指徵，經患者及家屬充分知情同意，已入組5010計劃，經隨機抽籤為序貫放化療組（C組）。2012-06-08予以TP方案（紫杉醇240MG+DDP50MGD1-2）化療一療程。後於2012-7-24至2012-8-28行原發灶和轉移灶放療，45GY。今遵主診教授意見前來化療。患者發病以來飲食睡眠不佳,大小便正常，體重無減輕。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"end_pos": 86, "label_type": "手術", "overlap": 0, "start_pos": 72}, {"end_pos": 95, "label_type": "手術", "overlap": 0, "start_pos": 87}, {"end_pos": 107, "label_type": "手術", "overlap": 0, "start_pos": 96}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 355}, {"end_pos": 367, "label_type": "藥物", "overlap": 0, "start_pos": 364}]}
{"originalText": "患者近雙月前因“右下腹疼痛3日”入院，腸鏡檢查示結腸脾曲癌，胸部CT考慮肺部轉移，於2010.09.15在聯合麻醉上行姑息性右半結腸切除術，術後病理示“（結腸）潰瘍型腺癌，分化II級，浸潤全層及周圍脂肪組織，雙切緣未見癌累及。檢出腸旁淋巴結14枚，均未見癌轉移”。患者術後恢復可，10-6、11-3行雙次化療，方案為：樂沙定 200MG，同澳200MG，替加氟1G，D1；5% GW 140ML+替加氟 3.0，化療泵，無特殊不適。現為行第三次化療收治入院。發病以來患者神清精神可，胃納二便睡眠正常，體重無明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 29}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 30, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"end_pos": 69, "label_type": "手術", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 91}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 162, "label_type": "藥物", "overlap": 0, "start_pos": 159}, {"end_pos": 171, "label_type": "藥物", "overlap": 0, "start_pos": 169}, {"end_pos": 180, "label_type": "藥物", "overlap": 0, "start_pos": 177}, {"end_pos": 192, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"end_pos": 201, "label_type": "藥物", "overlap": 0, "start_pos": 198}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}]}
{"originalText": "，緣於入院前2月因確診為胃癌，於2014年04月28日在全麻上行腹腔鏡輔助上姑息性全胃切除術（D2）。手術順利。術後病理（病理號201412821），：(全胃)胃-食管交界潰瘍型腺神經內分泌癌（G3），累及齒狀線，脈管內見癌栓，侵出漿膜外，漿膜外見癌結節，手術標本下切端、上切端及另送(下切端)均未見癌浸潤。找到手術標本小彎淋巴結8個，幽門上淋巴結6個，(第7組）淋巴結9個，(第8組）淋巴結1個，(第11組）淋巴結3個及(第12組）淋巴結1個均未見癌轉移。手術標本賁門右、賁門左、大彎側、幽門下均未查見淋巴結。送檢(第9組淋巴結)鏡上為脈管組織、纖維組織、平滑肌組織、神經組織、脂肪組織及脈管組織。，免疫組化：CD56（+），SY（++），CGA（+），CK18（+++），KI67（35%+），CDX-2（+）。術順，術後恢復良好,排除化療禁忌後，於2014.06.01予“奧沙利鉑（艾恆）150MGD1+裡葆多40MGD2+替吉奧40MGBIDD1-14_”方案化療1次，過程中患者稍有噁心、嘔吐，尚可耐受，予對症處理後症狀明顯好轉出院，此次為化療再次入院。門診擬“胃癌術後化療後”收住入院，出院後飲食、夜休可，大小便如常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 32, "end_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 100}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 393, "label_type": "藥物", "overlap": 0, "start_pos": 389}, {"end_pos": 396, "label_type": "藥物", "overlap": 0, "start_pos": 394}, {"end_pos": 408, "label_type": "藥物", "overlap": 0, "start_pos": 405}, {"end_pos": 418, "label_type": "藥物", "overlap": 0, "start_pos": 415}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 486, "end_pos": 490}]}
{"originalText": "，緣於入院前2年因“右肝內肝內膽管癌”於我院行“右半肝聯合尾狀葉切除+膽總管切除+左前、左後膽腸吻合+腹腔淋巴結清掃+腹腔粘連鬆解+腹壁腫物切除術”，術中輸懸浮紅細胞4U，血漿400ML，術後恢復尚可，定期複查腹部CT，，術後病理示：1.（右半肝），：肝中分化膽管細胞癌。2.（右門Ⅴ）送檢脂肪、纖維組織中見膽管細胞癌浸潤。，免疫組化:CK19(+++)、CK7(+++)、CK20(-)、CDX-2(++)、VILLIN(+++)。出院後無納差、腹脹、腹瀉，無返酸，噯氣，無噁心、嘔吐，無發熱、寒戰及黃疸。20，余天前於我院門診複查MRI示：肝左葉近膈面浸潤性病變伴肝內膽管擴張，考慮為肝內膽管癌。13天前於我院行TACE，共灌注碘化油8ML＋表柔吡星40MG＋洛鉑30MG＋栓塞微球(300-500UM)1支，術後出現發熱，體溫最高達38.9℃，伴畏冷、腹痛，考慮介入術後反應劇烈，治療好轉後出院。今為進一步治療，門診擬“右肝內肝內膽管癌術後復發”收住入院。自下次出院以來，精神、睡眠、食慾欠佳，大、小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 24, "end_pos": 73}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 105, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 135}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 159}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 267, "end_pos": 270}, {"end_pos": 278, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 284, "end_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 299}, {"end_pos": 312, "label_type": "手術", "overlap": 0, "start_pos": 308}, {"end_pos": 319, "label_type": "藥物", "overlap": 0, "start_pos": 316}, {"end_pos": 327, "label_type": "藥物", "overlap": 0, "start_pos": 323}, {"end_pos": 334, "label_type": "藥物", "overlap": 0, "start_pos": 332}, {"end_pos": 343, "label_type": "藥物", "overlap": 0, "start_pos": 339}, {"end_pos": 380, "label_type": "解剖部位", "overlap": 0, "start_pos": 379}, {"label_type": "手術", "overlap": 0, "start_pos": 384, "end_pos": 387}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 413, "end_pos": 423}]}
{"originalText": "，緣於5月餘前因“胃癌”行“腹腔鏡上根治性遠端胃大部切除術”（2015-08-06），，術中見：腹腔內無明顯腹水，盆腔、腹壁、大網膜未見明顯轉移結節，肝臟質地大小正常，未見明顯腫物，膽囊無腫大。胃體小彎側隱約可見病灶，可疑浸潤型癌侵及漿膜層，周圍見腫大淋巴結。術順，術後恢復可。術後病理（201528816），：(遠端胃)，：胃體小彎潰瘍型低粘附性癌，部分為印戒細胞癌，侵及漿膜層。手術標本下、上切端及另送（下切端）均未見癌浸潤。找到小彎淋巴結25/25個，大彎淋巴結3/9個，幽門下淋巴結2/2個，幽門上淋巴結6/6個，及另送(第8組)淋巴結1/1個，(第12組)淋巴結1/1個，見癌轉移。，免疫組化：KI67（10%+），CK7（-），CK20（+++），VILLIN（+++），CDX-2（+++），CEA（+++），CD56（-），CGA（-），SYN（-），E-CADHERIN（++），HER-2（+），PT4AN3M0IIIC期。排除化療前禁忌，於2015.09.23、2015.10.26按“卡培他濱片(希羅達)1500MG口服BID+多柔比星脂質體(裡葆多)注40MG靜滴(基)+奧沙利鉑(樂沙定)200MG靜滴”方案化療，2015.12.23予“艾奕60MG口服D1-14+艾恆200MGD1+裡葆多40MG靜滴D1方案”化療，並輔以止吐、制酸、保肝、增強免疫等治療。化療過程順利，無明顯化療不良反應。今為返院行第4週期化療就診我院，門診擬以“胃癌術後化療”收入院。自發病以來，精神、睡眠、食慾尚可，大小便正常，體徵無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"end_pos": 29, "label_type": "手術", "overlap": 0, "start_pos": 14}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 156, "end_pos": 175}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 459, "label_type": "藥物", "overlap": 0, "start_pos": 454}, {"end_pos": 463, "label_type": "藥物", "overlap": 0, "start_pos": 460}, {"end_pos": 483, "label_type": "藥物", "overlap": 0, "start_pos": 476}, {"end_pos": 487, "label_type": "藥物", "overlap": 0, "start_pos": 484}, {"end_pos": 503, "label_type": "藥物", "overlap": 0, "start_pos": 499}, {"end_pos": 507, "label_type": "藥物", "overlap": 0, "start_pos": 504}, {"end_pos": 535, "label_type": "藥物", "overlap": 0, "start_pos": 533}, {"end_pos": 549, "label_type": "藥物", "overlap": 0, "start_pos": 547}, {"end_pos": 560, "label_type": "藥物", "overlap": 0, "start_pos": 557}, {"end_pos": 585, "label_type": "解剖部位", "overlap": 0, "start_pos": 584}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 632, "end_pos": 636}]}
{"originalText": "患者因“直腸癌”於2014-06-05 在我院於全麻上行直腸癌根治術（DIXON術），手術過程順利，術後給予抗感染及營養支援治療，患者恢復好，切口癒合良好。現患者為術後複查來我院就診。院外期間患者一般情況好，無噁心，無腹痛腹脹脹不適，現患者為行復查及化療再次來院就診，門診以“直腸癌術後”收入院。近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 42}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 143}]}
{"originalText": "患者23天前因“乙狀結腸癌”在我院住院行開腹探查乙狀結腸癌切除術，術中見腹膜及大網膜多發轉移，手術順利，術後恢復可，術後病檢回示乙狀結腸隆起型中分化腺癌，大小3.5×3.0CM，浸潤腸壁全層，達周圍纖維脂肪組織，可見脈管癌栓，腸周淋巴結可見癌轉移（4/15），伴多個腸外癌結節，近腫物斷端及遠腫物斷端未見癌；（腸繫膜結節）纖維脂肪組織中可見中分化腺癌轉移；（腹壁結節）中分化腺癌轉移結節，大小0.5×0.5×0.3CM，病情平穩出院，為求第一次化療，今來我院，門診以“乙狀結腸癌術後”收入院，患者自發病以來食慾可，食量稍少，精神、睡眠可，二便正常，體重近期無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 20, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 156}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 241}]}
{"originalText": "緣於入院前4月餘於我院診斷“胃體癌”，遂於2015.03.05在全麻上行“腹腔鏡上根治性全胃切除術”，術順，術後病理（201507470）：胃體小彎潰瘍型低分化腺癌，侵犯神經組織，侵出漿膜層，手術標本下切端、上切端及另送（下切端）均未見癌侵潤。找到大彎側淋巴結2/6個，小彎側淋巴結6/7個，幽門上淋巴結9/15個，及另送(第7組)淋巴結0/8個，(第8組)淋巴結2/2個，(第9組)淋巴結0/3個，(第10組)淋巴結0/4個，(第11組)淋巴結2/3個，(第12組)淋巴結4/8個見癌轉移。術後予抗感染、補液、營養支援等治療，恢復可，切口II/甲癒合。於2015-03-31、2015-04-20予“伊立替康240MGIVGTTD1替吉奧膠囊(艾奕)60MGPOBIDD1-14”化療2次，輔以止吐、制酸、保胃、營養支援等治療，化療過程順利。今為第3次化療就診我院，門診擬“胃癌術後化療”收住入院，自下次出院以來，精神、食慾、睡眠尚可，大小便正常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 82}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 305, "label_type": "藥物", "overlap": 0, "start_pos": 301}, {"end_pos": 322, "label_type": "藥物", "overlap": 0, "start_pos": 317}, {"end_pos": 325, "label_type": "藥物", "overlap": 0, "start_pos": 323}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 388, "end_pos": 392}]}
{"originalText": "患者2015-04-21因“無明顯誘因出現腹脹，伴便祕、裡急後重，大便成形，偶有便血7月”，外院腸鏡示距肛40CM息肉，0.8×1.2CM，活檢病理腺瘤；2015-04-30行乙狀結腸息肉電切術，病理腺癌，浸潤深度達粘膜上層，無法評估蒂部情況。2015-06-03於我院結直腸科行乙狀結腸切除術，術後病理：腸粘膜慢性炎，局灶粘膜缺損，可見炎性肉芽組織生長及炎性壞死物滲出，結合病史，符合治療後改變，未見癌殘留。切緣未見癌，LN 1/10(+)見癌轉移。出院診斷為乙狀結腸中分化腺癌術後YPT0N1M0 IIIA期。術後9天開始發現腹部傷口滲出暗紅色液體，量較多，遂就診於我院結直腸科，予負壓吸引、抗生素抗感染等對症治療，傷口癒合較前明顯改善，排除化療禁忌症後於2015-07-02、2015-07-28、2015-08-20、2015-09-14、2015-10-12行術後XELOX輔助化療5程，過程順利。2程化療後出現II度轉氨酶升高，予護肝治療後好轉。3程化療後複查未見腫瘤復發、轉移徵象。現為行第6程XELOX方案輔助化療入我科。自下次治療以來，患者無發熱、咳嗽、身目黃染，無骶部痛等，精神可，納眠可，小便無異常，體重無上降。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 97, "label_type": "手術", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 102}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 147, "label_type": "手術", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 231, "end_pos": 256}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 423, "label_type": "解剖部位", "overlap": 0, "start_pos": 422}, {"end_pos": 494, "label_type": "解剖部位", "overlap": 0, "start_pos": 492}]}
{"originalText": "，患者2015-12-29於我院在全麻上行\\\"（遠端）胃癌根治術\\\"，術程順利，，術後病理：“（胃大體）鏡檢為胃中至低分化腺癌（LAUREN分型為混合型），癌組織浸潤至胃壁漿膜上層，可見脈管內癌栓及神經束侵犯；送檢網膜組織未見癌。淋巴結55枚，8枚見腺癌轉移。（近切緣）未見癌。（遠切緣）未見癌。，免疫組化：CK（+），HER2（0），VEGF（+）。”，術後病理提示：胃竇癌（PT3N3M0,IIIB期）。現為行術後第四程SOX方案輔助化療收入我科。起病以來，患者精神尚可，食慾欠佳，大小便正常，無明顯變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 77}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 203}]}
{"originalText": "，緣於入院前4月餘於我院診斷為直腸癌，於2016-06-22在全麻上行腹腔鏡上探查+中轉開腹姑息性直腸癌切除+乙狀結腸造瘻術。術後病理（201621457），：1、（直腸），：直腸潰瘍型黏液腺癌，部分為中分化絨毛狀-管狀腺癌，侵犯腸壁全層及腸周纖維脂肪組織，未及明確侵犯脈管及神經組織，手術標本雙切端均未見癌浸潤；找到腸周淋巴結23個均未見癌轉移。，免疫組化結果：腫瘤細胞CK20（+），CEA（+），P53（+，野生型），CK7（-），EGFR（+），KI67（40%陽性）。2、（盆壁組織），：送檢為增生的纖維及脂肪組織，表面見纖維素樣壞死，間質見多量急、慢性炎症細胞浸潤。，病理：該病例檢測到KRAS基因12號密碼子G12D突變。，病理：該病例未檢測到BRAF基因V600E突變。術後給予對症、營養支援等治療，恢復良好，傷口II/甲癒合。2016.07.20、2016.08.10、2016.09.02、2016.09.22、2016.10.14予“奧沙利鉑200MGIVGTTD1+卡培他濱1500MGPOBIDD1-14”方案化療，輔以制酸、保肝、營養支援、增強免疫力等處理。此次為第6次化療就診我院，門診擬直腸癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，造瘻口排便通暢，小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 116}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 432, "label_type": "藥物", "overlap": 0, "start_pos": 428}, {"end_pos": 449, "label_type": "藥物", "overlap": 0, "start_pos": 445}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 509, "end_pos": 514}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}, {"end_pos": 539, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}]}
{"originalText": "患者於6月前，因“直腸癌”於2015-12-30在我院行“腹腔鏡上直腸癌根治術”，術後病理：（直腸）潰瘍型中分化管狀乳頭狀腺癌，浸及腸壁全層，脈管、神經未見癌侵犯，雙切端未見癌累及，腸壁脂肪中淋巴結未見癌轉移（0/11）。術後患者恢復可，腹瀉，不能控制，進食少，無腹痛腹脹，無發熱等，為進一步治療，擬行第2次化療，門診以“直腸癌術後”收入院。\\U0004   患者自起病以來，精神可，胃納略差，大便次數增多，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"end_pos": 39, "label_type": "手術", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 166}]}
{"originalText": "，患者因患“結腸癌並腸梗阻”於2015-11-25在全麻上行右半結腸切除術+橫結腸兩腔造瘻術，術後給予營養補液、抑酸、抗菌等治療。，術後病理示：（結腸）腺癌（中度分化），浸潤潰瘍型，體積4*3.5*0.6CM，部分侵穿漿膜。 雙端切線未查見癌。 呈腸壁一站（2/7個）、中間組（1/1個）淋巴結癌轉移。 中央組（3個）淋巴結及大網膜組織內未查見癌。，免疫組化染色示：SYN（-）、TS較多（+）。於術後行化療XELOX方案（奧沙利鉑200MG D1+希羅達2G BID D1-14 ）5次。後腫瘤標誌物持續下升，改為洛鉑50MG D1+亞葉酸鈣0.3G D2-6+替加氟1G D2-6。現患者為行復查來我院就診，門診以“結腸癌術後”收入院。自下次出院後，患者一般情況保持良好， 無乏力感，無發熱，無噁心、嘔吐，無反酸、噯氣，無明顯進食不適，未現明顯 腹痛、腹脹；大小便情況良好。目前患者精神及情緒狀態可，食慾、飲食好，夜間睡眠可，大小便正常，近期無明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 90}, {"end_pos": 216, "label_type": "藥物", "overlap": 0, "start_pos": 212}, {"end_pos": 228, "label_type": "藥物", "overlap": 0, "start_pos": 225}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 258}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 268}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 310, "end_pos": 315}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}]}
{"originalText": "，緣於入院前3月餘因“直腸癌”於2016.08.25在我科行“腹腔鏡上直腸根治性切除術+預防性迴腸造瘻術”，術順，恢復良好，術後病理（201630447），：（直腸），：腸隆起型中分化管狀腺癌，侵及深肌層，未見明確侵犯脈管及神經組織，手術標本雙切端及另送（下切端）、（上切端）均未見癌浸潤；找到腸周淋巴結13個，及另送（腸繫膜上動脈根部）淋巴結3個均未見癌轉移。，免疫組化結果：腫瘤細胞示KI67（30%+），P53（30%+），CEA（+），CK7（-），CK20（+），CDX2（+）。因患者要求化療，後於2016.10.24、2016.11.15予“奧沙利鉑（樂沙定）200MGIVGTTD1+卡培他濱1000MGPOBIDD1-D14”方案化療，輔以水化、保肝、止吐、增強免疫力等處理，未出現明顯化療副反應。此後今為第3次化療再次就診我院，門診擬“直腸癌術後化療”收入院。自下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，小便正常，造口排便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 96}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 282, "label_type": "藥物", "overlap": 0, "start_pos": 278}, {"end_pos": 286, "label_type": "藥物", "overlap": 0, "start_pos": 283}, {"end_pos": 304, "label_type": "藥物", "overlap": 0, "start_pos": 300}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 378, "end_pos": 383}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 408}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}]}
{"originalText": "，患者2008年1月因粘液血便在*****診斷為直腸癌，於2008.1.17行直腸癌切除術，，術後病理：直腸中-高分化腺癌侵及腸壁全層，腸繫膜淋巴結3/6見癌轉移，分期PT4N1M0.術後於2008.2.13-2008.4.26行FOLFOX方案化療4程。200.9.10.，19複查CT：直腸壁區域性不規則增厚。2009.10.26放療40GY。2009.12.5、2009.12.25再次行FOLFOX方案化療2程。2010.8.26行直腸癌根治術，9.21二期縫合，，術後病理：直腸高分化腺癌侵及腸壁全層，肛門切緣及切端均為見癌，腸周淋巴結0/2見癌轉移。術後FOLFIRI方案化療3程，末次化療時間2010.10.26.2010.11.23出現會陰部膿腫，行膿腫切開引流術，考慮腸穿孔。2011.2.9行迴腸末端（穿孔部分）切除端側吻合術。2011.3.，7複查CT：盆底少許軟組織影，區域性復發待排，兩側髂血管旁、兩側腹股溝淋巴結，兩側腎盂擴張、積液，考慮輸尿管上端受壓，肝S4、8轉移瘤。2011.3.30，我院會診病理：直腸中分化腺癌，肌層受侵犯，脈管內見癌栓，K－RAS基因野生型。於2011.3.20-2011.7.20行XELOX＋BEV方案化療6程。2、4程化療後評價療效SD。於2011.8.16開始予XELODA單藥維持化療，至今已化療5程。2程化療後評價療效SD,出現輕度手足麻木。現為進一步治療入院。患者近期精神食慾可，大小便正常，體力體重無上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"end_pos": 45, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 142, "end_pos": 144}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 225, "label_type": "手術", "overlap": 0, "start_pos": 219}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 251}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"end_pos": 339, "label_type": "手術", "overlap": 0, "start_pos": 332}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 345}, {"end_pos": 372, "label_type": "手術", "overlap": 0, "start_pos": 355}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 384, "end_pos": 386}, {"end_pos": 389, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"end_pos": 418, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"end_pos": 423, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 439, "end_pos": 447}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 465, "end_pos": 472}, {"end_pos": 527, "label_type": "藥物", "overlap": 0, "start_pos": 524}, {"end_pos": 567, "label_type": "藥物", "overlap": 0, "start_pos": 561}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 598, "end_pos": 599}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 599, "end_pos": 600}]}
{"originalText": "，緣於1個月前入院，診為胃體管狀腺癌，於2014年02月07日在全麻上行“腹腔鏡輔助上根治性全胃切除術+食管空腸ROUX-Y吻合術（D2）”。手術順利。，術後病理示：（全胃），：胃體潰瘍型管狀腺癌（II-III級），浸潤深肌層，侵犯神經，手術標本下、上切端及另送（下切端）均未見癌浸潤。找到賁門旁淋巴結5個，小彎淋巴結3個，幽門下淋巴結1個，幽門上淋巴結2個，及另送（第7組）淋巴結2個，（第8組）淋巴結4個，（第9組）淋巴結3個，（第12組）淋巴結1個均未見癌轉移。，免疫組化：KI67（65%陽性），P53（+），P170（+++），GSTπ（+），EGFR（-），5-FU（+），HER-2（+），CD56（-），CGA（-），SY（-）。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。此次為行術後第1次化療入院，門診擬“胃癌術後”收入院，自出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 107}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 372}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}]}
{"originalText": "，患者2015-03-31因“黑便半年”就診於我院結直腸科，2015-03-31，腹盆MR示：升結腸腫物，考慮為升結腸癌；升結腸系膜多發淋巴結，考慮轉移，遂2015-04-09行全麻上“腹腔鏡左半結腸切除術”，過程順利，，術後病理示：符合中分化腺癌，浸潤至腸壁漿膜上層，可見脈管內癌栓，未見明確神經束侵犯；淋巴結（2/23）可見癌轉移，，分期為：PT3N1BM0 IIIB期，術後恢復可。2015-05-13、2015-06-03、2015-06-28起行XELOX方案化療3程，過程順利。現為行第4程輔助化療入我科。患者3周來，無發熱，胃納可，睡眠一般，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 41, "end_pos": 45}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 60}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 103, "label_type": "手術", "overlap": 0, "start_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 129}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}]}
{"originalText": "，患者因“胃竇癌”於2015-6-24在我院全麻上行\\\"（遠端）胃癌根治術\\\"，術程順利，，術後病理回報:“（胃大體）鏡檢為低分化腺癌，部分為印戒細胞癌（LAUREN，分型：瀰漫型），癌組織浸潤至胃壁漿膜上層；未見明確脈管內癌栓及神經束侵犯；網膜組織未見癌。淋巴結103枚，10枚見癌。（近、遠切緣）未見癌。，免疫組化：CK（+），VEGF（+），HER2（0） ”術後預防感染、抑制分泌、靜脈營養等對症支援處理，恢復好，切口甲級癒合。2015.8.6，2015.9.8行術後輔助化療（替吉奧 60MG BID+奧沙利鉑 150MG）雙程，化療耐受可，擬\\\"胃竇癌綜合治療後\\\"收入我科。從下次出院以來，患者精神尚可，食慾一般，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 99}, {"end_pos": 247, "label_type": "藥物", "overlap": 0, "start_pos": 243}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 256}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 279, "end_pos": 287}]}
{"originalText": "，緣於入院前5月餘於我院診為直腸癌，於2014-11-19在全麻上行腹腔鏡上直腸癌根治術MILES，，術中見：見腹腔內少許粘連，無明顯腹水，子宮及右側附件缺如，呈術後改變。腫瘤於腹膜返折上不可見，周圍可見少許腫大淋巴結。術後病理示（201440196），：（直腸）直腸隆起型管狀腺癌II級，侵出外膜層達周邊纖維脂肪組織，脈管中見癌栓，侵犯神經組織，齒狀線未見癌浸潤。手術標本下、上切端及另送（下切端）及環周切緣均未見癌浸潤。手術標本腫物周找到淋巴結6個，腸周淋巴結10個及另送（腸繫膜上動脈根部）淋巴結1個均未見癌轉移。術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。2014-12-24、2015-01-20、2015-02-13、2015-03-10、2015-04-08予以“奧沙利鉑150MGIVGTTD1+希羅達1000MGPOBIDD1-14”方案化療，並輔以制酸、保肝、水化等治療。化療過程順利，無噁心、嘔吐、乏力、腹瀉等明顯化療副作用。此次為行第6次化療再次就診我院，門診擬直腸癌術後收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 144}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 350, "label_type": "藥物", "overlap": 0, "start_pos": 346}, {"end_pos": 366, "label_type": "藥物", "overlap": 0, "start_pos": 363}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}, {"end_pos": 421, "label_type": "解剖部位", "overlap": 0, "start_pos": 420}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 450, "end_pos": 455}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 479}]}
{"originalText": "，緣於入院前4月餘於我院診斷為胃竇癌，於2015年08月25日在全麻上行“腹腔鏡輔助上根治性遠端胃大部切除+殘胃空腸ROUX-Y吻合術（D2）+闌尾切除術”，手術順利。，術後病理：1、（遠端胃），：胃竇小彎側潰瘍型管狀腺癌II-III級，少數為肝樣腺癌，侵犯神經，脈管內見癌栓，侵及漿膜層。手術標本下切端、上切端及另送（下切端）均未見癌浸潤。找到小彎側淋巴結0/7個，大彎側淋巴結0/3個，幽門下淋巴結1/1個，幽門上淋巴結1/5個，及另送的（第7組）淋巴結0/1個，（第8組）淋巴結0/3個，（第9組）淋巴結0/4個，（第11組）淋巴結0/2個，（第12A組）淋巴結1/2個，（第12P組）淋巴結0/2個，見癌轉移。另送（第10組淋巴結）鏡上為脈管、纖維及脂肪組織。急性單純性闌尾炎。，免疫組化染色結果：CK(PAN)（+++），KI67（60%陽性），CDX-2（+++），CD56（-），CGA（-），SY（-），HER-2（-），HEPACOCYTE（-），GLYPICAN-3（+）。術後予對症、抗感染治療，恢復良好，傷口癒合II/甲，遂出院。2015.10.10、2015.11.27行“伊立替康240MGIVGTTD1+替吉奧膠囊(艾奕)40MGPOBIDD1-14”方案化療，現為行術後第3次化療再入院。門診擬“胃癌術後化療”收住入院。自此次發病以來，精神、睡眠、食慾可，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 334, "end_pos": 342}, {"end_pos": 504, "label_type": "藥物", "overlap": 0, "start_pos": 500}, {"end_pos": 522, "label_type": "藥物", "overlap": 0, "start_pos": 517}, {"end_pos": 525, "label_type": "藥物", "overlap": 0, "start_pos": 523}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 564, "end_pos": 568}]}
{"originalText": "，患者3月餘前（2015-12-24）因“直腸癌”於我院行腹腔鏡直腸癌根治術（DIXON術），，術後常規病理示：（直腸）粘液腺癌伴印戒細胞癌成分（40%），腫瘤切面積8.5*1.7CM，侵透漿膜達周圍脂肪組織。下上切緣、環周切緣、吻合器切緣均未查見癌，腸周淋巴結21枚，均未查見轉移癌（0/21），，病理號：46920.15。術後給予消炎、營養支援治療，病情好轉後出院。後再次入院行XELOX方案化療3週期，現患者為行化療治療來我院，門診以“直腸癌術後化療”收入院。自下次出院來，患者飲食睡眠尚可，大小便無明顯異常，體重較前無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "手術", "overlap": 0, "start_pos": 29, "end_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 77}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 226}]}
{"originalText": "緣於入院前3月於我院診為直腸癌，於2015-07-31在全麻上行腹腔鏡上直腸全系膜切除術(TME)預防性迴腸造口術。術後病理示腸潰瘍型管狀腺癌II級，侵及深肌層。手術標本下、上切端及另送（下切端)、(上切端)均未見癌浸潤。找到腸周淋巴結21個，未見癌轉移。免疫組化結果：KI67（80%+），CK7（-），CK20（+），VILLIN（+++），CDX-2（+++），CEA（++），CD56（-），術後給予對症、營養支援等治療，恢復良好,傷口癒合II/甲。術後未定期複查化療，此次入院為造口還納就診我院。門診擬“直腸癌術後迴腸造口狀態”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 15}, {"label_type": "手術", "overlap": 0, "start_pos": 32, "end_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 74}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 257, "end_pos": 262}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}]}
{"originalText": "，患者1月前因“進食梗阻感伴下腹部隱痛不適2月餘”於2016.3.25在全麻上行全胃切除術+淋巴結清掃術，手術順利，術後患者恢復良好，術後常規病理示（胃）低分化腺癌，瀰漫浸潤型，腫瘤切面積14*1.8CM，侵及漿膜脂肪組織，吻合器切緣及大網膜均未查見癌。小彎側淋巴結7枚，其中5枚（5/7）查見轉移；賁門周圍淋巴結11枚，其中7枚（7/11）查見轉移；大彎側淋巴結2枚（0/2），均未查見轉移。，免疫組化：CK（+）、E-CAD（+）、HER-2（0）。，病理號：10987.16。現患者為行進一步治療來我院就診，門診以“胃癌術後”收入院。患者近期飲食睡眠可，大小便無明顯異常，體重較前略有減輕。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "手術", "overlap": 0, "start_pos": 40, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 88}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 261, "end_pos": 265}]}
{"originalText": "，緣於入院前9天（2016.12.15）因“右卵巢囊腫破裂”急診於我院全麻上行“腹腔鏡上右卵巢囊腫剝除術+盆腔粘連鬆解術”，，術中見：腹腔內見暗紅色血液及凝血塊約400ML，右卵巢見一大小約90×70MM的囊腫，表面有破口，可見活動性出血，囊腫內可見大量暗紅色凝血塊，右卵巢與右側盆壁膜狀粘連，子宮及左側附件外觀未見明顯異常。術順，術後病理（201646465），示：(右卵巢腫物)，：符合卵巢卵黃囊瘤，伴大片出血壞死。期間監測，AFP：（12.14）14235NG/ML、（12.16）9635NG/ML、（12.22）4986NG/ML。術後無特殊不適，切口癒合好。現無腹痛、腹脹、腹瀉，無陰道流血、流液，無尿頻、尿急、尿急，無胸悶、心悸等不適。為行化療再次就診我院，門診遂擬“右卵巢卵黃囊瘤術後”收入院。下次出院以來，患者精神、睡眠、食慾尚可，大小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"label_type": "手術", "overlap": 0, "start_pos": 40, "end_pos": 60}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 142}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 201}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 215, "end_pos": 218}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 316}, {"end_pos": 320, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 341, "end_pos": 350}]}
{"originalText": "，患兒2015年12月16日無明顯誘因出現左下腹脹痛，無嘔吐、腹瀉等症狀，家長自行查體可觸及左下腹巨大包塊，質硬，活動度可，遂於我院就診，，完善B超發現：腹腔內巨大實性佔位（150*90*140MM），肝母細胞瘤可能（侵犯肝右、左葉）。12-25於****行“肝腫瘤切除+膽囊切除術”，術後病理確診肝母細胞瘤，下皮型（胎兒及胚胎型）。2016.1.9入住我科，評估全身檢查後診斷為肝母細胞瘤I期，併入“肝母-SCMC-2011”方案化療。2016.1.10、2.2、2.25、3.21起予CDDP+VCR+5-FU方案*4次化療。此次化療間期已滿，擬收治入院按序化療。   近期患兒無發熱，無咳嗽、喘憋，無吐瀉，胃納精神可，二便正常。，初始資料：，診斷日期：2016.1.11，進入方案：肝母（SCMC-2011），初發影像學檢查及特殊檢查：B，超發現：腹腔內巨大實性佔位（150*90*140MM），肝母細胞瘤可能（侵犯肝右、左葉）。，術後病理：肝母細胞瘤，下皮型（胎兒及胚胎型）。，末次化療時間及方案：2016.3.21予以CDDP+VCR+5-FU，方案化療末次影像檢查：頭顱(MRI平掃+增強）(2016-01-11) 腦部MRI平掃＋增強未見明顯異常。腹部(CT平掃+增強)(2016-01-07) 肝母細胞瘤術後改變，請結合臨床。--胸部(CT平掃)(2016-01-07) 左肺尖條索影，請結合臨床。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 32, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 106}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "手術", "overlap": 0, "start_pos": 130, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 190, "end_pos": 197}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 213}, {"end_pos": 248, "label_type": "藥物", "overlap": 0, "start_pos": 244}, {"end_pos": 252, "label_type": "藥物", "overlap": 0, "start_pos": 249}, {"end_pos": 257, "label_type": "藥物", "overlap": 0, "start_pos": 253}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 357}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 371, "end_pos": 374}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 401, "end_pos": 406}, {"end_pos": 416, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 424, "end_pos": 441}, {"end_pos": 472, "label_type": "藥物", "overlap": 0, "start_pos": 469}, {"end_pos": 477, "label_type": "藥物", "overlap": 0, "start_pos": 473}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 489, "end_pos": 501}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 514, "end_pos": 519}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 531, "end_pos": 542}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 555, "end_pos": 562}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 573, "end_pos": 581}, {"end_pos": 597, "label_type": "解剖部位", "overlap": 0, "start_pos": 594}]}
{"originalText": "，患者2015年5月開始無明顯誘因出現腹瀉、稀爛便為主，1-2次/日，後出現便血，量不多，無黑便、噁心、腹痛、腹脹等，無頭暈、乏力、發熱等不適。外院腸鏡檢查提示距肛22-25CM環周腫物，腸鏡能透過，活檢病理提示粘液腺癌；直腸多發息肉。2015-11-11在我院結直腸科全麻上行“DIXON'S”術，，術後病理回報：1（腸大體）鏡檢為中至低分化腺癌，部分為粘液腺癌，癌組織侵犯腸壁漿膜上層，未見明確脈管內癌栓及神經束侵犯。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央淋巴結）6枚，未見癌。5（中間淋巴結）5枚，未見癌。6（腸旁淋巴結）7枚，1/7見腺癌轉移，並浸潤至結外脂肪結締組織。，免疫組化：ER（-），ERCC1（+），KI67（70%+），MSH2（+），MSH6（+），MLH1（+），PMS2（+）。患者術後恢復良好，於2015-12-08、2015-12-30給予XELOX方案（奧沙利鉑200MG，D1+希羅達 早2000MG晚1500MG，D1-D14）化療2程。2016.1.21因考慮患者化療反應較大，暫停樂沙定化療，先予希羅達單藥化療1程。現為求上一程化療入院，患者近來食慾、睡眠及精神尚可，二便正常，體力、體重無明顯上降。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"label_type": "手術", "overlap": 0, "start_pos": 139, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 174}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 188, "end_pos": 189}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 276, "end_pos": 278}, {"end_pos": 403, "label_type": "藥物", "overlap": 0, "start_pos": 399}, {"end_pos": 416, "label_type": "藥物", "overlap": 0, "start_pos": 412}, {"end_pos": 469, "label_type": "藥物", "overlap": 0, "start_pos": 466}, {"end_pos": 477, "label_type": "藥物", "overlap": 0, "start_pos": 474}]}
{"originalText": "，緣於入院前2月患者因“升結腸癌”，於2015.1.23全麻上行“腹腔鏡上左半結腸根治性切除術”，，術中見：無腹水，肝表面光滑，胃及空腸未見明顯病變。升結腸近肝曲可見一大約5*3*3CM菜花型腫物，質硬，可疑侵出漿膜層,腸繫膜根部未見腫大淋巴結。術後恢復可，術後病理（201503027），：(左半結腸)，：結腸隆起型管狀腺癌II級，部分為粘液腺癌，侵及漿膜層，侵犯神經組織，脈管中見癌栓，手術標本回腸切端、結腸切端及另送（下切端）、（上切端）均未見癌浸潤；找到迴腸周淋巴結2/6個、結腸周圍淋巴結1/10個,及另送(左結腸繫膜根根部)淋巴結0/3個，(回結結腸繫膜腸繫膜根部)淋巴結0/4個，見癌轉移。另見闌尾組織。該病例未檢測到BRAF基因V600E突變。該病例未檢測到KRAS基因12、13號密碼子熱點突變。於2015.02.26予“奧沙利鉑D1150MGIVGTT+卡培他濱1000MGPOD2-15”方案化療，輔以止吐、制酸保胃、保肝等治療，無明顯化療反應。此次為第2次化療再次入院。自下次出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"end_pos": 47, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 174}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 374, "label_type": "藥物", "overlap": 0, "start_pos": 370}, {"end_pos": 391, "label_type": "藥物", "overlap": 0, "start_pos": 387}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 418}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"end_pos": 465, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}]}
{"originalText": "，患者於2016-6-30在全麻上行\\\"（遠端）腹腔鏡輔助胃癌根治術\\\"，，術後病理回報:“（胃大體）（腫物）鏡檢為低分化腺癌，LAUREN，分型：混合型，癌組織累及胃壁淺肌層，可見神經束侵犯，未見明確脈管內癌栓；（潰瘍病灶）鏡檢為低分化腺癌，潰瘍病灶浸潤情況及免疫組化待待補充報告；網膜組織未見癌。淋巴結81枚，3枚見癌。（遠、近切緣）未見癌”。於2016-08-04開始行S-1單藥化療，現為進一步術後輔助化療收入我科。起病以來，患者精神尚可，食慾欠佳，大小便正常，身體無明顯消瘦。", "entities": [{"end_pos": 34, "label_type": "手術", "overlap": 0, "start_pos": 20}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 191, "label_type": "藥物", "overlap": 0, "start_pos": 188}]}
{"originalText": "，患者因“直腸癌”於2015-11-24在腰硬聯合麻醉上行TEM術，手術過程順利，，術後病理示：（直腸）腺癌（中度分化），隆起型，體積2.3*2.1*1CM，侵達粘膜上層。未累及周邊及另送“底部”切除面。術後給予抗感染及營養支援治療，患者恢復好。6個月前患者返院複查行結腸鏡檢查，見手術部位癒合良好，直腸未見明顯異常。2016-3-8，腹盆腔強化CT示：膽囊管結石，直腸壁厚，前列腺增生。於2016-3-9開始行直腸區域性放療，共行25次，DT 5000CGY，同時給予區域性灌腸及激素、維生素、改善微迴圈治療，院外期間患者一般情況好，未再出現便血情況，無噁心，無腹痛腹脹不適，1月前患者查體發現膽囊息肉，直徑約6MM，現患者為行手術治療來院就診，門診以“TEM術後、膽囊息肉”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 21, "end_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 64}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 168, "end_pos": 175}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 182}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 193}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 331}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 332, "end_pos": 336}]}
{"originalText": "患者於2014.6.23因“下腹部脹痛不適並黑便”來我院胃腸外科就診，入院後完善必要的化驗檢查，於2014-6-25行胃鏡檢查，於賁門部小彎處可見菜花樣隆起，大小約5*4CM，周邊粘膜不規則，呈結節狀，質地脆，易出血。侵犯食道上段約3CM。綜合患者病情，轉胸外科後於2014.7.1日行賁門癌根治術，術後給予抗生素預防感染、化痰、止酸等治療。術後病理：胃賁門小彎側腺癌（中度分化），浸潤潰瘍型，體積5*5*1.2CM，累及上段食管。侵穿漿膜達脂肪組織。雙端切線及底部切除面未查見癌。患者術後恢復順利，於2014.7.14出院。   患者於2014.8.6第2次入院，入院後完善檢查，給予奧沙利鉑+多西他賽方案化療，同時給予保肝、升白細胞、止吐等對症治療，化療結束後患者順利出院。   患者現為求進一步治療第3次來我院就診，門診以“胃底賁門癌術後”收入院。患者自下次出院以來無噁心嘔吐，無腹脹腹瀉，無胸悶憋氣，無咳嗽咳痰等症狀，飲食及睡眠可，大小便正常，體重未見明顯變化。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 149, "label_type": "手術", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 176, "end_pos": 196}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 297, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"end_pos": 302, "label_type": "藥物", "overlap": 0, "start_pos": 298}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 372}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}]}
{"originalText": "，患者2014年12月22日於我科全麻上行擴大左半結腸切除術，，術中探查：腫瘤前壁與大網膜粘連，腫瘤後壁與胃後壁侵潤粘連，病變位於橫結腸中段，透漿膜，，術後病理：結腸癌（漿膜上層），潰瘍型，中分化腺癌，II級，斷端無癌，淋巴結可見癌轉移（1/23枚），，浸潤深度：漿膜上層，肌間神經節侵犯（+)，脈管癌栓（+），結外腫瘤種植（1+)，PTNM，分期：T4BN1M0,IIIC期，，免疫組化：KI67（50-70%+）,P53(70-90%+),CA199(+)，CEA(++)，CDX2(>90%+)，GSTP1(+)，EGFR(++)，VEGF(+++)。血管內皮細胞CD34（+）其內可見癌栓，淋巴管內皮細胞D2-40(+)其內未見癌栓。，病理號：1446。患者術後恢復良好，已行XELOX方案4次，現為求進一步輔助化療收入我科，近日無發熱，飲食睡眠可，大小便正常，無腹痛，無便血，近來體重未見明顯變化。ECOG，評分：1分。", "entities": [{"end_pos": 30, "label_type": "手術", "overlap": 0, "start_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 81, "end_pos": 104}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}]}
{"originalText": "緣於入院前3月餘於我院診為“胃癌”，於2014.01.02全麻上行“腹腔鏡上根治性全胃切除+食管空腸ROUX-Y吻合術（D2）”，術中見：腹腔內無明顯腹水，盆腔、腹壁、大網膜無轉移結節，肝臟質地大小正常，未及明顯轉移病灶。術後病理（201400136）示“（全胃）胃體下段小彎側潰瘍型管狀腺癌I級，侵出漿膜層，手術標本下、上切端及另送（下切端）均未見癌浸潤，找到賁門右淋巴結3個，小彎淋巴結8個，大彎淋巴結12個，幽門下淋巴結6個，幽門上淋巴結15個，及另送（胃右動脈旁）淋巴結13個，（肝總動脈旁）淋巴結2個，均未見癌轉移”，術後予對症、營養支援等治療，恢復良好,傷口癒合II/甲。於2014.2.11、2014.3.4、2014.3.27於我院予行“奧沙利鉑200MGIGVTTD1+卡培他濱1000MGPOBIDD1-14”方案化療3次，化療後未見明顯化療副反應，此次為入院再次化療求診我院，門診擬“胃癌術後”收入院。下次出院以來精神、睡眠、飲食可，無腹痛、腹脹、發熱，大小便正常，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 63}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 148}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 327}, {"end_pos": 348, "label_type": "藥物", "overlap": 0, "start_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 403, "end_pos": 407}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 429}, {"end_pos": 433, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}]}
{"originalText": "患者因“宮頸癌”於2015-11-30在我院行經腹廣泛子宮+兩附件切除+盆腔淋巴清掃術，術後病理檢查示：宮頸低分化鱗狀細胞癌，內生浸潤型，腫物切面積9.3*1.8CM,侵達深肌層，（約佔宮壁全層3/4處），陰道壁斷端及右左宮旁組織均未查見癌，送檢右閉孔淋巴結4枚（0/4），左閉孔淋巴結12枚（0/12），右髂血管淋巴結9枚（0/9），左髂血管淋巴結5枚（0/5），均未查見轉移癌。（宮腔）子宮內膜息肉，萎縮狀態子宮內膜。（兩側）輸卵管、卵巢大致正常。術後於2015-12-09應用力樸素+順鉑化療一次，化療過程順利，副反應不重。現患者進食較差，輕度噁心，無嘔吐，無腹脹、腹痛，現為求二次化療入院，門診以“宮頸癌術後化療”收住婦科病房。現一般情況可，睡眠可，進食量少，大小便無異常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 43}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 201}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 244, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 247, "label_type": "藥物", "overlap": 0, "start_pos": 245}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 303, "end_pos": 308}]}
{"originalText": "，緣於入院前2月餘於我院診斷為胃癌，於2015年01月02日在全麻上行遠端胃大部切除術（B-II式）,手術順利。術後病理(201500055)，示:遠端胃)，：胃竇小彎側潰瘍型低分化腺癌（雙灶），侵出漿膜層，累及神經，手術標本下、上切端未見癌浸潤。找到小彎淋巴結12/13個，大彎淋巴結0/1個，幽門上淋巴結1/1個見癌轉移。，基因測結果:計數腫瘤細胞20個HER2/CEN17=1.10HER2/CELL=2.3CEN17/CELL=2.1，結論:HER2基因無擴增,17號染色體呈二倍體。術後恢復可，於2015.02.04、2015.02.27行“鹽酸伊立替康注射液280MG靜滴D1+替吉奧膠囊(艾奕)60.00MG口服BID*D1-14天”方案化療，輔以保肝、制酸、免疫支援等對症處理後，化療過程順利，無特殊化療副反應。目前患者無進食可，無特殊不適，要求進一步行化療，擬“胃癌術後”入院。患者出院後飲食、夜休可，無腹痛、腹脹、發熱，體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 80, "end_pos": 93}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"label_type": "藥物", "overlap": 0, "start_pos": 276, "end_pos": 285}, {"end_pos": 300, "label_type": "藥物", "overlap": 0, "start_pos": 295}, {"end_pos": 303, "label_type": "藥物", "overlap": 0, "start_pos": 301}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 394}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}]}
{"originalText": "，入院前9天（2016.10.25）因“宮頸鱗癌IB1期”於我院氣靜全麻上行“腹式廣泛全子宮切除術+右輸卵管切除術+盆腔淋巴結清掃術+兩側卵巢移位術+腸粘連鬆解術+陰道頂懸吊術”。，術中見：腹腔內無腹水，子宮正常大小，表面光滑，右側輸卵管積水，呈臘腸狀，右闊韌帶前方粘連，左側輸卵管傘部與左卵巢粘連，峽部見一膨出瘤體，大小約1.5CM×1.5CM，表面光滑，質稍硬；兩側卵巢未見明顯異常；肝、脾、膈上、腸管、腸繫膜、腹膜等未見明顯異。術順，術後病理（201638443），示：（全子宮+右側輸卵管），：宮頸內生浸潤性角化性鱗狀細胞癌II級（水平浸潤約5CM，垂直浸潤深度約1.5CM，約＞1/2肌層）。手術標本陰道切端及兩側宮旁組織未見癌浸潤。找到左宮旁淋巴結1個，及另送（右盆腔）淋巴結10個，（左盆腔）淋巴結10個，（右髂總）淋巴結2個，（左髂總）淋巴結7個，均未見癌轉移。現無發熱、咳嗽、咳痰，無腹痛、腹脹、腹瀉，無胸悶、心悸，無噁心、嘔吐等不適。為行化療再次就診於我院，門診遂擬“宮頸鱗癌IB1期術後”收入院。自下次出院以來，患者精神、飲食、睡眠尚可，留置導尿，尿管通暢，尿色清，大便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 39, "end_pos": 88}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 209}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 269}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 336}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 408, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 444, "end_pos": 454}]}
{"originalText": "，緣於入院前2年患者於我院診斷為“胃癌”，於2013年11月22日在全麻上行“腹腔鏡根治性遠端胃大部切除術（畢I式D2R0）”，，術中見：無腹水，盆底、膀胱、未及結節；肝表面光滑，腹膜後、空迴腸未見結節，腫瘤位於胃小彎側胃角處，大小3×3×1.5CM，浸潤潰瘍型，侵出漿膜層，侵及鄰近脂肪組織，腹腔動脈周圍見數個0.8-1CM大小不一腫大淋巴結。術後病理（201336699），：（遠端胃）胃角潰瘍型低分化腺癌，侵出漿膜層，侵犯神經，脈管內見癌栓，手術標本下、上切端及另送（下切端）、（上切端）均未見癌浸潤。找到小彎淋巴結10/15個，大彎淋巴結1/7個，幽門上淋巴結5/5個，及另送（第七組）淋巴結1/2個，（第八組）淋巴結2/7個，（第九組）淋巴結0/4個，（第十二組）淋巴結0/1個，（第十五組）淋巴結0/1個見癌轉移。，免疫組化結果：CK7（++），CK20（-），VILLIN（+++），CEA（-），CDX-2（+++），CGA（-），CD56（-），SY（-），KI67（70%+），HER-2（++）。術後恢復良好,於我院行“多柔比星40MGD1+奧沙利鉑（艾恆）150MGD2+希羅達1000MGBIDD1-14”方案行術後化療8次。化療後出院後，飲食睡眠可，一般情況可。3天前突發腹痛，伴腹脹，肛門停止排氣排便，無噁心嘔吐，無畏冷寒戰，遂就診我院，門診擬“胃癌術後化療後”收住入院，自發病以來，精神欠佳，飲食欠佳，大便未解，小便如常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 19}, {"label_type": "手術", "overlap": 0, "start_pos": 39, "end_pos": 62}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 106, "end_pos": 112}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 190, "end_pos": 205}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 292, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 331, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 345, "end_pos": 354}, {"end_pos": 475, "label_type": "藥物", "overlap": 0, "start_pos": 471}, {"end_pos": 486, "label_type": "藥物", "overlap": 0, "start_pos": 482}, {"end_pos": 489, "label_type": "藥物", "overlap": 0, "start_pos": 487}, {"end_pos": 501, "label_type": "藥物", "overlap": 0, "start_pos": 498}, {"end_pos": 551, "label_type": "解剖部位", "overlap": 0, "start_pos": 550}, {"end_pos": 555, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 559, "label_type": "解剖部位", "overlap": 0, "start_pos": 557}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 588, "end_pos": 592}]}
{"originalText": "緣於入院前2月餘於我院診斷“乙狀結腸癌”，於2016-7-25行“腹腔鏡上乙狀結腸切除術”，術順，術後予營養支援、制酸保胃、增強免疫及維持電解質平衡等治療，術後恢復良好。術後病理：大腸潰瘍型管狀腺癌II級，侵及外膜層。手術標本雙切端及另送(下切端)、(上切端)均未見癌浸潤。找到腸周淋巴結15個，及另送(腸繫膜上A根部）淋巴結1個、(中間組）淋巴結2個，未見癌轉移。於2016.08.21、2016.09.13予“奧沙利鉑200MGIVGTTD1+卡培他濱1500MGPOBIDD1-14”方案化療2週期，療程順利，未出現明顯化療副作用，今為行術後第3次化療再診我院，門診擬“乙狀結腸癌術後化療”收住入院。自下次出院以來，精神、睡眠、食慾尚可，二便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 102}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 174}, {"end_pos": 211, "label_type": "藥物", "overlap": 0, "start_pos": 207}, {"end_pos": 228, "label_type": "藥物", "overlap": 0, "start_pos": 224}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 288, "end_pos": 295}]}
{"originalText": "，患者2016-07-07於我院在全麻上行\\\"腹腔鏡探查+（全胃）胃癌根治術\\\"，，術後病理回報:“（大體）鏡檢為低分化腺癌，部分為印戒細胞癌，LAUREN，分型:瀰漫型，浸潤至胃壁漿膜上層，可見神經束侵犯，未見明確脈管內癌栓；網膜組織未見癌。淋巴結51枚，10枚見癌。（遠、近切緣）未見癌”，診斷“全胃癌（PT3N3M0，IIIB）”。於2016-08-10、2016-09-07、2016-10-08予以SOX方案化療三程，化療過程順利，現患者無返酸、噯氣、噁心、嘔吐、黑便等不適，現為行進一步治療收入我科。起病以來，患者精神尚可，食慾欠佳，大小便正常，近期體重無明顯改變。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 38}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 167}]}
{"originalText": "，患者因2013-1-13外院查CA125 623 U/ML CA199 522 U/ML，01-21，盆腔MR平掃示：1.盆腔右側附件區佔位，考慮來源於右側附件，以囊性成分為主，伴少許實性壁結節 2.盆腔少量積液.後於*****行分段診刮，該院及我院病理檢查均提示腺癌。完善檢查後於2013年01月30日在全身麻醉上行廣泛性子宮切除、兩側輸卵管卵巢切除及盆腔淋巴結清掃術，，術後組織病理檢查報告：1、子宮內膜腺癌診刮術後全子宮標本，內膜未見癌殘留，宮頸、頸管、右左宮旁、陰道壁殘端及兩輸卵管未見癌累及，兩卵巢見癌累及。2、右髂內（0/2）、右腹股溝（0/1）、右髂總（0/1）、左閉孔（0/2）、左髂外（0/2）、左腹股溝（0/2）、左髂總（0/2）淋巴結未見癌轉移。術後予TP方案化療４週期，有噁心嘔吐及骨髓抑制不良反應，對症支援治療後好轉，今患者為求上一週期化療再來我院我科住院治療。\\U0004  患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 16, "end_pos": 21}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 31, "end_pos": 36}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 52, "end_pos": 56}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 71}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 107}, {"end_pos": 120, "label_type": "手術", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 135}, {"label_type": "手術", "overlap": 0, "start_pos": 160, "end_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 211}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 234}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 238}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 358}]}
{"originalText": "，患者2月前因“胃癌”於2014-07-01在在全麻上行胃癌根治術，手術過程順利，術後患者恢復好，切口癒合好，按期拆線。，術後病理：病理診斷 ，:（胃幽門小彎側）腺癌（中度分化），浸潤潰瘍型，體積2*2*0.3CM，侵達深肌層。 雙端切線及另送“遠端”切線未查見癌。 呈五組（1/1個）淋巴結癌轉移。 四組（9個）、六組（4個）及另送“1、3、7組”（11個）淋巴結未查見癌。 ，免疫組化染色示癌組織：CERBB-2（2+）、SYN（-）、ERCC1瀰漫（+）、β-TUBULIN-III（-）、TS多量（+）、RRM1少量（+）、TOPOII較多（+）。根據患者病情具有化療指徵，於2014-07-15開始第一週期化療，，方案為：奧沙利鉑150MG D1，亞葉酸鈣0.3G+替加氟1.0G D2-D6，同時給與升白細胞、護肝、止吐、免疫增強治療，注意觀察患者病情變化,給予升白、止吐等藥物，患者化療耐受可，無明顯化療副反應。   院外期間患者一般情況好，無噁心，無腹痛腹脹不適，現患者為行復查及化療再次來院就診，門診以“胃癌術後”收入院。   近期患者精神可，飲食可，大便次數多，小便正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 10}, {"end_pos": 33, "label_type": "手術", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 183}, {"end_pos": 320, "label_type": "藥物", "overlap": 0, "start_pos": 316}, {"end_pos": 333, "label_type": "藥物", "overlap": 0, "start_pos": 329}, {"end_pos": 341, "label_type": "藥物", "overlap": 0, "start_pos": 338}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}, {"end_pos": 434, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 435}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 465}]}
{"originalText": "緣於入院前3月餘就診我院行胃鏡檢查示：“胃癌”，腹部CT提示“胃體區域性管壁不規則增厚，符合胃癌，侵犯漿膜面，伴鄰近的網膜種植轉移可能及胃周、下腹膜後多發淋巴結轉移；病變與肝右外葉、胰頭間脂肪間隙模糊”。考慮診斷為“胃癌伴腹腔種植轉移”並於2015.04.06、2015.04.29、2015.05.26、2015.06.19予行“奧沙利鉑(艾恆)150MG靜滴D1+紫杉醇注射液(安素泰)180MG靜滴D2+卡培他濱片(希羅達)1000.00MG口服BIDD1-14”方案化療，期間輔以止吐、保肝、營養支援等治療，化療後無特殊不適，今為返院複查行第5週期化療，門診擬“胃癌”收治入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 22}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 24, "end_pos": 28}, {"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 45, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 85, "end_pos": 89}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 116}, {"end_pos": 169, "label_type": "藥物", "overlap": 0, "start_pos": 165}, {"end_pos": 172, "label_type": "藥物", "overlap": 0, "start_pos": 170}, {"end_pos": 186, "label_type": "藥物", "overlap": 0, "start_pos": 183}, {"end_pos": 193, "label_type": "藥物", "overlap": 0, "start_pos": 190}, {"end_pos": 209, "label_type": "藥物", "overlap": 0, "start_pos": 204}, {"end_pos": 213, "label_type": "藥物", "overlap": 0, "start_pos": 210}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 284, "end_pos": 286}]}
{"originalText": "患者於2011-6月無明顯誘因上出現吞嚥困難，進行性加重，伴胸骨後燒灼樣疼痛，程度輕，至我院就診，經檢查確診胸中段食管癌，完善準備後於2011-7-7全麻上行“經左胸下腹頸部食管部分切除+胃食管頸部吻合+二野清掃術”，術後恢復良好，病理示鱗癌，PT3N1M0，左喉返神經旁旁淋巴結轉移。於2011-8至2011-10行“泰素帝+奈達鉑”方案化療4程，過程順利。後於2011-11-8至2011-12-12行輔助性放療（原發灶50GY，25次），過程順利。後定期複查未見明顯腫瘤復發轉移徵象，末次複查時間為2012-6。2012-8-13起患者在我科行CIK細胞治療（QW*4），已回輸2次，回輸後出現發熱，體溫最高達39.5度，對症治療後好轉。現為繼續治療入我科。近來，患者無發熱、畏寒、寒戰，無低熱、盜汗、咳嗽，無心悸，無聲嘶、嗆咳，無骨關節痛，無頭痛、視蒙、嘔吐，精神、睡眠可，大小便基本正常，體重上降3KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 60}, {"label_type": "手術", "overlap": 0, "start_pos": 80, "end_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 129}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 163, "label_type": "藥物", "overlap": 0, "start_pos": 160}, {"end_pos": 167, "label_type": "藥物", "overlap": 0, "start_pos": 164}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}]}
{"originalText": "，患者於2013年6月16日因“停經21週中央型前置胎盤在我院引產”，住院期間（6月18日）行子宮動脈造影術及子宮動脈栓塞術及利凡諾羊膜腔穿刺引產術，，6月22日14：50引產分娩一死嬰，當時胎盤粘連剝離不完整，於6月24日在Ｂ超監測上行清宮術，因胎盤粘連重，清宮不全，術後患者發熱1天，最高38.6℃，胎盤組織送病檢，，病檢結果：胎盤組織局灶玻變，大量炎細胞浸潤；給予“益保世靈”抗感染治療，口服補佳樂增加子宮內膜等治療，本擬擇日複查B超後清宮；但後患者及家屬簽字出院，辦理出院後，患者突然陰道流血增加，約60ML，伴頭暈，乏力，心悸不適，無噁心嘔吐，無呼吸困難，無暈厥，無畏寒發熱等不適；故再次辦理入院，入院時患者一般情況可，生命體徵正常；\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 47, "end_pos": 74}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 113, "end_pos": 115}, {"end_pos": 122, "label_type": "手術", "overlap": 0, "start_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 182}, {"end_pos": 190, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"end_pos": 202, "label_type": "藥物", "overlap": 0, "start_pos": 199}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 218, "end_pos": 220}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 246}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}]}
{"originalText": "，患者因“肝惡性腫瘤術後11月餘，腹脹10余天”於2014-05-31第1次入院。，查體：腹部平坦，下腹部可見一長約25CM“反L”型手術切口，癒合良好。腹軟，上腹輕壓痛，無反跳痛，肝、脾肋上未觸及，MURPHY'S徵陰性，肝、腎區無叩痛，腸鳴音無亢進，移動性濁音陰性。兩上肢無水腫。患者入院後完善相關檢查檢驗，，腹部彩超：肝硬化部分切除術後；肝硬化；膽囊切除術後；腹腔積液（少量）。，心電圖：1.竇性心律2.大致正常心電圖。，明確診斷為：1.肝惡性腫瘤術後2.膽囊切除術後狀態。給予保肝、降酶、抗病毒、利尿及對症支援治療。2014.6.5行DSA上選擇性肝動脈造影及TACE術，並行CIK體細胞治療術。患者病情好轉出院。   出院後患者繼續服用“恩替卡韋分散片、熊去氧膽酸膠囊”，間斷服用“螺內酯片、呋塞米片”，病情穩定，偶有兩上肢凹陷性水腫。為行CIK細胞治療術，分別於2014-07-19、2014-08-23第二、三次入院。入院後完善相關輔助檢查，給予保肝、抗病毒、調節免疫、CIK體細胞回輸及對症支援治療，病情好轉後出院。   患者出院後病情平穩，為複查及進一步診治分別於2014-12-04、2015-04-16、2015-09-28、2015-10-28、2015-12-13、2016-04-07、2016-05-19、2016-8-16、2016-12-14、2017-03-15第四-十三次住院。入院後完善相關檢查，給予抗病毒、調節免疫及對症支援治療，行DSA上選擇性肝動脈造影及TACE術，並行CIK體細胞治療術及TACE術。經治療患者病情好轉出院。   患者出院後繼續服用“恩替卡韋分散片”，病情穩定。因“肝惡性腫瘤術後4年餘”於2017-7-10第14次入院。，查體：心肺查體未見明顯異常，腹部平坦，下腹部可見一長約25CM“反L”型手術疤痕，癒合良好。腹軟，無壓痛，無反跳痛。肝、脾肋上未觸及，MURPHY'S徵陰性，肝、腎區無叩痛，腸鳴音無亢進，移動性濁音陰性。患者入院後完善相關化驗檢查，下腹部MRI平掃+，增強：肝左葉異常訊號，符合肝CA.MR表現，結合病史考慮轉移瘤可能，肝右左葉交界處異常訊號，考慮肝CA治療後改變，較前變化不明顯，符合肝內多發小囊腫表現，脾大。給予保肝、降酶、抗病毒、調節免疫及對症支援治療。於2017年7月12日行DSA上選擇性肝動脈造影+TACE術。經治療患者症狀好轉，因個人原因自動出院，並簽署自動出院協議。   患者出院後病情穩定，繼續服用“恩替卡韋分散片”，無發熱，無腹痛、腹脹、腹瀉，無噁心、嘔吐，無乏力、納差，無反酸、燒心，無嘔血、黑便，無心悸、胸悶、胸痛，無頭暈、頭痛、黑朦、暈厥等。現為複查及進一步治療今來我院，門診以“PHC”收入院。   患者自本次發病以來，神志清，精神可，飲食睡眠佳，大小便未見異常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 12}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 157, "end_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 176, "end_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 191}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 193, "end_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 199, "end_pos": 203}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 222, "end_pos": 229}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 231, "end_pos": 237}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "手術", "overlap": 0, "start_pos": 271, "end_pos": 289}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 324}, {"end_pos": 339, "label_type": "藥物", "overlap": 0, "start_pos": 332}, {"end_pos": 350, "label_type": "藥物", "overlap": 0, "start_pos": 346}, {"end_pos": 355, "label_type": "藥物", "overlap": 0, "start_pos": 351}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"label_type": "手術", "overlap": 0, "start_pos": 637, "end_pos": 655}, {"end_pos": 673, "label_type": "手術", "overlap": 0, "start_pos": 668}, {"end_pos": 706, "label_type": "藥物", "overlap": 0, "start_pos": 699}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 715, "end_pos": 722}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 747, "end_pos": 748}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 748, "end_pos": 749}, {"end_pos": 760, "label_type": "解剖部位", "overlap": 0, "start_pos": 758}, {"end_pos": 766, "label_type": "解剖部位", "overlap": 0, "start_pos": 763}, {"end_pos": 791, "label_type": "解剖部位", "overlap": 0, "start_pos": 790}, {"end_pos": 803, "label_type": "解剖部位", "overlap": 0, "start_pos": 802}, {"end_pos": 805, "label_type": "解剖部位", "overlap": 0, "start_pos": 804}, {"end_pos": 807, "label_type": "解剖部位", "overlap": 0, "start_pos": 805}, {"end_pos": 824, "label_type": "解剖部位", "overlap": 0, "start_pos": 823}, {"end_pos": 826, "label_type": "解剖部位", "overlap": 0, "start_pos": 825}, {"end_pos": 832, "label_type": "解剖部位", "overlap": 0, "start_pos": 831}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 860, "end_pos": 866}, {"end_pos": 876, "label_type": "解剖部位", "overlap": 0, "start_pos": 873}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 883, "end_pos": 886}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 887, "end_pos": 889}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 904, "end_pos": 908}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 918, "end_pos": 924}, {"end_pos": 938, "label_type": "解剖部位", "overlap": 0, "start_pos": 937}, {"end_pos": 948, "label_type": "解剖部位", "overlap": 0, "start_pos": 947}, {"end_pos": 954, "label_type": "解剖部位", "overlap": 0, "start_pos": 953}, {"label_type": "手術", "overlap": 0, "start_pos": 986, "end_pos": 1004}, {"end_pos": 1060, "label_type": "藥物", "overlap": 0, "start_pos": 1053}, {"end_pos": 1068, "label_type": "解剖部位", "overlap": 0, "start_pos": 1067}, {"end_pos": 1071, "label_type": "解剖部位", "overlap": 0, "start_pos": 1070}, {"end_pos": 1074, "label_type": "解剖部位", "overlap": 0, "start_pos": 1073}, {"end_pos": 1106, "label_type": "解剖部位", "overlap": 0, "start_pos": 1105}, {"end_pos": 1109, "label_type": "解剖部位", "overlap": 0, "start_pos": 1108}, {"end_pos": 1112, "label_type": "解剖部位", "overlap": 0, "start_pos": 1111}, {"end_pos": 1116, "label_type": "解剖部位", "overlap": 0, "start_pos": 1115}, {"end_pos": 1119, "label_type": "解剖部位", "overlap": 0, "start_pos": 1118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1147, "end_pos": 1150}]}
{"originalText": "患者於6月前因“解稀爛便”完善檢查發現結腸癌伴肝轉移，2月2日行結腸癌手術切除，手術順利，術後行FOLFOX方案化療2程。2月前複查CT發現肝內病灶較前進展，故於2012-4-17、5-3予以FOLFIRI化療2程，過程順利。複查CT提示肝臟病變較前增大，考慮PD。故予FOLFIRI＋AVASTIN方案化療3程，過程順利。今日為求進一步診治來我院。患者發病以來,無症狀。精神佳,飲食睡眠佳,大小便正常，體重無減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 26}, {"label_type": "手術", "overlap": 0, "start_pos": 32, "end_pos": 37}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 66, "end_pos": 68}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 150, "label_type": "藥物", "overlap": 0, "start_pos": 143}]}
{"originalText": "患兒1年餘前無誘因出現體重逐漸上降，由35KG逐漸上降至25KG，無多飲多尿，無低熱，無咳嗽，無腹瀉，未予治療，半年前出現反覆腹痛，中下腹為主，有夜間痛醒情況，與進食無關，排便後腹痛稍緩解，在我院住院完善檢查後診斷為“炎症性腸病”，5.19在我院用第一次類克，現為進一步治療再次入院。病程中患兒無發熱，無咳嗽，無嘔吐，無便血，無明顯腹痛，患兒目前精神食慾可，睡眠可，大便有少量粘液，日約2次，無便血，小便無殊。患兒近1年餘來口水多，近1年內體重上降10KG。                      第一次入院錄（2016.4.28-2016.5.12）患兒因“體重上降1年餘，腹痛半年”入院，入院後予以低纖維半流質飲食，頭孢他啶聯合奧硝唑抗感染，於5-4行胃鏡、腸鏡檢查術，術順安返。內鏡上見橫結腸瀰漫性息肉樣隆起，潰瘍性改變。考慮炎症性腸病，予以加用常樂康調節腸道菌群。病理報告符合炎症性腸病。患兒無發熱，無明顯腹痛腹脹，嘔血黑便，家屬因經濟問題，要求出院，待部分血報告回，再次入院考慮行生物製劑治療原發病。                       第二次入院錄（2016.5.17-2016.5.21）。", "entities": [{"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"end_pos": 129, "label_type": "藥物", "overlap": 0, "start_pos": 127}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 316, "label_type": "藥物", "overlap": 0, "start_pos": 312}, {"end_pos": 321, "label_type": "藥物", "overlap": 0, "start_pos": 318}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 373}, {"end_pos": 381, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 399}, {"end_pos": 410, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}]}
{"originalText": "，入院前3月，患者曾因“反覆嘔吐”於我院住院治療，並於2016.03.17於我科行腹腔鏡上胃癌根治術，手術順利，，術後病理提示：（胃）潰瘍型中分化管狀腺癌，浸及胃壁全層，雙切端未見癌累及，胃大小彎淋巴結未見癌轉移（分別為0/10、0/10），網膜組織未見癌累及。，診斷為：潰瘍型中分化管狀腺癌（T3N0M0）,術後患者行靜脈化療1次，化療過程中無噁心、嘔吐等不適，今日患者為求第2次化療入院，門診遂以“胃癌術後化療”收住。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"end_pos": 50, "label_type": "手術", "overlap": 0, "start_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 205}]}
{"originalText": "緣於入院前1月餘因“膽石症、急性膽囊炎”就診我院，下腹部CT示：1、膽總管上段多髮結石，伴肝內外膽管擴張。2、急性膽囊炎，膽囊多髮結石。入院後予抗感染，保肝，抑制胰酶分泌，營養支援等治療，於2014.01.16在B超定位上行“膽囊穿刺造瘻術”，術順，術後症狀好轉，家屬要求出院。此次為行進一步治療再次就診我院，門診擬“膽石症PTCD術後”收入院，自發病以來神志清，精神不振，飲食少，睡眠可，二便正常，體重未見明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 25, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 43}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 45, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 67}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 106, "end_pos": 108}, {"end_pos": 120, "label_type": "手術", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 168}]}
{"originalText": "，緣於入院前2月無明顯誘因出現便祕，無裡急後重、排便不盡感，偶伴有血便，為鮮血便，大便附於大便表面。無腹痛、腹脹，無腹瀉，無噁心、嘔吐，無嘔血、黑便，無肛門停止排氣、排便，無畏冷、發熱。就診於我院，，行腸鏡：“乙狀結腸癌”，，病理：“大腸管狀腺瘤下皮呈高級別下皮內瘤變伴癌變”，遂門診擬乙狀結腸癌收入院，發病以來，精神、睡眠、食慾尚可，大便如下述，小便如常，體重無明顯變化。", "entities": [{"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 148}]}
{"originalText": "，患者2年前無明顯誘因出現大便異常，為青色成形軟便，約2-3次/天，無粘液膿血便，無發熱，無腹痛、腹瀉、腹脹，無反酸、燒心，無噁心、嘔吐，無進食阻擋感及哽噎感，無胸骨後疼痛，無乏力、納差，無嘔血、黑便，無停止排便、排氣、腹脹，未診療。患者下述症狀持續存在，未診治。為明確病情，患者20天前於我院查體中心體檢，，查體示：幽門螺旋桿菌抗體陽性。為求進一步治療就診於我院門診，查凝血四項、乙肝五項未見明顯異常，，心電圖：1.竇性心律2.大致正常心電圖，建議行胃腸鏡檢查。患者今日於內鏡室行胃腸鏡檢查，胃鏡提示慢性胃炎，，結腸鏡提示：結腸息肉，並行結腸息肉內鏡上切除治療，操作順利，報告未回，為進一步診治，門診以“腸息肉”收住院。   患者自發病以來，神志清，精神可，飲食、睡眠可，大、小便如前所述，體重近期無明顯變化。", "entities": [{"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 81, "end_pos": 83}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 159, "end_pos": 167}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 203, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 213}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 267}, {"end_pos": 279, "label_type": "手術", "overlap": 0, "start_pos": 270}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 303, "end_pos": 306}]}
{"originalText": "，患者1月前無明顯誘因出現腹瀉，5-6次/日，量少，不成形，混有粘液，無膿血，伴左上腹痛，無明顯放射痛，無發熱，無噁心、嘔吐，無腹脹，於我院急診科就診，，行腹部彩超示：符合急性闌尾炎聲像圖表現。給予“來立信”、“甲硝唑”治療1周，患者左上腹痛消失，仍有腹瀉，5-6次/日，混有粘液，無膿血，未再系統治療。1周前於我門診就診，，行電子結腸鏡示：潰瘍性結腸炎；鏡上取活檢2塊，，病理結果示：（直腸）粘膜充血、水腫，急慢性發炎，區域性粘膜糜爛。建議其住院治療，患者因個人原因，未能入院。患者仍有腹瀉，為求系統治療今來我院，門診以“潰瘍性結腸炎”收入院。   患者自發病以來，神志清，精神可，飲食睡眠可，大便同下，小便正常，近期體重無明顯變化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 78, "end_pos": 82}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 91}, {"end_pos": 103, "label_type": "藥物", "overlap": 0, "start_pos": 100}, {"end_pos": 109, "label_type": "藥物", "overlap": 0, "start_pos": 106}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 177}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 205, "end_pos": 210}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 261, "end_pos": 267}]}
{"originalText": "患者1餘年前無明顯誘因出現大便排出困難，同時伴有排便不盡感，遂至我院診治，行纖維結腸鏡檢查示：結腸息肉，電凝切除，並予“痔瘡栓”等治療（具體不詳），效果尚可，回家後大便困難症狀復現，症狀逐漸加重，未予系統診治。現為系統治療，進一步緩解病情，特來我院，門診以“便祕”收入院患者自發病以來，神志清，精神可，飲食量及夜間睡眠可，小便可，大便每日1次，質軟排出欠通暢，無噁心、嘔吐，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 47, "end_pos": 51}, {"label_type": "手術", "overlap": 0, "start_pos": 52, "end_pos": 56}]}
{"originalText": "患者於50年前漸出現兩上肢淺表蚯蚓狀腫物，以久立、勞累後明顯，休息並抬高患肢後可減輕。無患肢水腫、面板搔癢不適、脫屑、顏色改變。無上肢痠痛、疼痛、發熱、頭痛、噁心。無特殊治療。於3年前漸出現兩小腿面板顏色加深，站立容易疲勞感覺，無上肢疼痛、腫脹，無頭暈、頭痛、胸悶、氣促等不適，於2年前就診我院門診，門診以兩側上肢靜脈曲張收入院。入院後行上肢靜脈造影，術中見：1.左髂總靜脈血栓，中度阻塞，右膕靜脈附壁血栓12.87*53.88MM大小，中度阻塞，右髂總靜脈下段95%狹窄，右髂外靜脈上段後前向75%狹窄，右下下肺動脈栓塞。予行上腔靜脈濾器置入、兩側髂靜脈支架置入等治療。術後予抗凝、改善迴圈等治療。患者恢復順利出院，出院後口服華法林抗凝治療，兩上肢淺表蚯蚓狀腫物無明顯改善，2月前於我科行“左上肢大隱靜脈手術”，手術順利，恢復良好出院，今為進一步治療，再次就診我院，門診擬“右大隱靜脈曲張；左大隱靜脈曲張術後；兩側髂靜脈支架術後；上腔靜脈濾器置入術後”收住入院。患者自發病以來無明顯胸悶、氣短，無發燒，精神狀態一般，食慾一般，睡眠良好，體重無明顯變化，大便正常，小便正常。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 95, "end_pos": 98}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 161}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 169, "end_pos": 175}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 182, "end_pos": 189}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 261}, {"label_type": "手術", "overlap": 0, "start_pos": 264, "end_pos": 282}, {"end_pos": 317, "label_type": "藥物", "overlap": 0, "start_pos": 314}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 322}, {"label_type": "手術", "overlap": 0, "start_pos": 346, "end_pos": 355}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 388, "end_pos": 395}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 396, "end_pos": 405}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 406, "end_pos": 415}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 416, "end_pos": 426}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}]}
{"originalText": "入院前55天因“肝內外膽管結石伴急性膽管炎”於我科行“膽囊切除+膽總管切口取石術+T管引流術”，術順，術後予抗感染、保肝、營養支援等處理。40天前出現左上腹手術切口開裂，並出現黃白色膿性液體流出，量較多，伴切口部位脹痛不適，無畏寒、寒戰、發熱，無噁心、嘔吐，無眼黃、尿黃、面板黃等，診斷“術後切口感染”，予行術後傷口切開清創處理，並予營養支援、補液、加強換藥等治療，後腹痛緩解、切口癒合良好，出院後無腹痛、腹脹、切口紅腫流膿，無噁心、嘔吐、眼黃、尿黃、畏冷、發熱等。今為進一步行“膽道鏡檢查”，門診擬“膽石症術後”收住院。前次出院以來，精神、睡眠、食慾尚可，大小便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 21}, {"label_type": "手術", "overlap": 0, "start_pos": 27, "end_pos": 46}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 144, "end_pos": 150}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 256}]}
{"originalText": "，患者因“腹痛2天”於2017-4-6第1次入院，既往“高血壓病”病史14年，血壓最高達180/110MMHG，在家間斷服用保健品（具體不詳），血壓控制欠佳；14年前有“酒精性脂肪肝、下消化道出血”病史，9年前雙次因“急性胰腺炎”入院治療，7年前及6年前雙次因“慢性胰腺炎急性發作”入院治療，查體發現“2型糖尿病”病史9年，未服用降糖藥物，血糖控制欠佳。否認冠心病等慢性病病史，否認肝炎、結核等傳染病及其接觸史，6年前行“膽囊切除術、膽總管空腸ROUX-EN-Y吻合術”。，查體：T ，: 37.2℃，P ，: 71次/分，R ，: 17次/分，BP ，: 153/88MMHG。心肺查體未見異常。腹部平坦，左側腹部可見一長約20CM縱行手術疤痕，癒合良好。全腹壓痛，無反跳痛，以中下腹為重。肝、脾肋上未觸及，MURPHY'S徵陰性，肝區無叩痛，腸鳴音無亢進，移動性濁音陰性。脊柱無畸形，四肢無畸形，兩上肢無水腫。兩上肢足背動脈搏動正常。，患者入院後完善相關輔助檢查：C反應蛋白 87 MG/L, 葡萄糖 8.52 MMOL/L,同型半胱氨酸 26.30 UMOL/L,血漿凝血酶原時間活動度 61.50 %,活化部分凝血活酶時間 40.8 秒,活化部分凝血活酶比率 1.54 ,血漿D二聚體測定 0.72 MG/L,降鈣素原 0.601NG/ML,中性粒細胞百分比 0.889 ,淋巴細胞計數 0.27× 10^9/L,血小板計數 48 ×10^9/L,HBCAB(ECLIA) 0.008陽性COI,大便潛血陽性 ,，尿常規：粒細胞 +1 ,尿糖 +- ,酮體+2 ,白細胞 80 /UL,鱗狀下皮細胞 15 /UL,消化道腫瘤未見明顯異常。，心電圖診斷：1.竇性心律2.ST-T改變。腹部立位片（20170406），：考慮不完全性腸梗阻，請結合臨床。腹部，CT:胰腺異常改變，考慮慢性胰腺炎急性發作，請結合臨床；膽囊術後CT所見；脂肪肝、脾大。給予抗感染、抑酸、補液、加強營養、提高免疫力等治療。經治療患者病情好轉，2017-04-18，行腸鏡示：1.結腸多發憩室2.降結腸病變性質？，胃鏡示：1.早期食管癌2.慢性萎縮性胃炎3.十二指腸球炎4.十二指腸球部胃黏膜異位。行早期食管癌（癌前病變）內鏡上切除術，，病理診斷：（食管距門齒28CM）鱗狀下皮高級別下皮內瘤變（中度不典型增生）。（十二指腸球部）粘膜水腫，輕度慢性發炎，腺體輕度增生。（降結腸1、2）粘膜水腫及慢性發炎，區域性淺表潰瘍形成，肉芽組織增生，另見片狀滲出物。繼續抑酸、補液、抗感染等治療。於2017-04-24行食管早期病變內鏡上切除術。術後生命體徵平穩，給予禁食、胃腸減壓3天，並給予抑酸、抗感染、補液及對症支援治療。，術後病理示：（食管距門齒28CM）鱗狀下皮高級別下皮內瘤變（面積0.5×0.4CM），未累及切緣及底部切除面。經治療患者症狀好轉，未訴明顯不適，予以出院。   患者出院後病情穩定，無腹痛、腹脹，無噁心、嘔吐，無反酸、燒心，無頭暈、頭痛，無發熱、畏寒，無心慌、胸悶、胸痛，無肩部及腰背部放射痛，無進食阻擋感及哽噎感，無尿頻、尿急、尿痛，尿色、尿量無明顯異常，無腹瀉、便祕，排便1次/天，為黃色成形軟便，肛門未停止排便排氣。今為複查，前來我院就診，門診以“食管惡性腫瘤ESD術後”收入我科。   患者自發病以來，神志清，精神可，飲食、睡眠尚可，大小便如前所述。近期體重未見明顯減輕。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 5}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 193}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "手術", "overlap": 0, "start_pos": 211, "end_pos": 234}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 291, "end_pos": 292}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 331, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 388}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 434, "end_pos": 439}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 449, "end_pos": 452}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 465, "end_pos": 471}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 485, "end_pos": 496}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 505, "end_pos": 515}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 523, "end_pos": 533}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 540, "end_pos": 548}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 559, "end_pos": 563}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 575, "end_pos": 583}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 591, "end_pos": 597}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 611, "end_pos": 616}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 628, "end_pos": 633}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 652, "end_pos": 656}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 665, "end_pos": 668}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 673, "end_pos": 675}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 680, "end_pos": 682}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 686, "end_pos": 689}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 697, "end_pos": 703}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 711, "end_pos": 716}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 724, "end_pos": 727}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 732, "end_pos": 736}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 738, "end_pos": 744}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 745, "end_pos": 750}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 764, "end_pos": 771}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 778, "end_pos": 783}, {"end_pos": 786, "label_type": "解剖部位", "overlap": 0, "start_pos": 784}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 793, "end_pos": 802}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 809, "end_pos": 815}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 818, "end_pos": 821}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 822, "end_pos": 823}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 879, "end_pos": 885}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 887, "end_pos": 892}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 902, "end_pos": 907}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 909, "end_pos": 916}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 918, "end_pos": 924}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 926, "end_pos": 937}, {"end_pos": 956, "label_type": "手術", "overlap": 0, "start_pos": 939}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 964, "end_pos": 966}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 967, "end_pos": 969}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 974, "end_pos": 986}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 997, "end_pos": 1003}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1009, "end_pos": 1015}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1024, "end_pos": 1027}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1036, "end_pos": 1040}, {"end_pos": 1104, "label_type": "手術", "overlap": 0, "start_pos": 1092}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1119, "end_pos": 1120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1120, "end_pos": 1121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1154, "end_pos": 1156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1157, "end_pos": 1159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1164, "end_pos": 1176}, {"end_pos": 1239, "label_type": "解剖部位", "overlap": 0, "start_pos": 1238}, {"end_pos": 1242, "label_type": "解剖部位", "overlap": 0, "start_pos": 1241}, {"end_pos": 1260, "label_type": "解剖部位", "overlap": 0, "start_pos": 1259}, {"end_pos": 1263, "label_type": "解剖部位", "overlap": 0, "start_pos": 1262}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1273, "end_pos": 1274}, {"end_pos": 1277, "label_type": "解剖部位", "overlap": 0, "start_pos": 1276}, {"end_pos": 1280, "label_type": "解剖部位", "overlap": 0, "start_pos": 1279}, {"end_pos": 1285, "label_type": "解剖部位", "overlap": 0, "start_pos": 1283}, {"end_pos": 1289, "label_type": "解剖部位", "overlap": 0, "start_pos": 1286}, {"end_pos": 1327, "label_type": "解剖部位", "overlap": 0, "start_pos": 1326}, {"end_pos": 1349, "label_type": "解剖部位", "overlap": 0, "start_pos": 1347}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1373, "end_pos": 1384}]}
{"originalText": "患者無明顯誘因出現中下腹隱痛下腹隱痛不適，為陣發性（持續時間不詳），進食後加重，無反射痛，與時間及活動無關，伴腹脹、反酸及噯氣，感噁心，無嘔吐，無嘔血及黑便，無明顯咳嗽，有痰，不易咳出，無咯血，時感心悸，無胸悶，院外行冠脈造影、腹部彩超未見異常，給予抑酸、護胃等對症支援治療後症狀無明顯好轉。後腹痛反覆發作（症狀同前），院外行胃鏡檢查示“淺表性胃竇炎”，心電圖無異常，現為求進一步診療，收入我院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，解黃色軟便，小便正常，體重無明顯變化。", "entities": [{"end_pos": 12, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 109, "end_pos": 113}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 114, "end_pos": 118}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 175}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 177, "end_pos": 180}]}
{"originalText": "患者於2012年2月17日因“右上腹陣發性隱痛1月餘”入我院就診，診斷為結腸脾曲MT，並於2012年2月21日行右半結腸根治術。術後患者一般情況好，無腹痛腹脹等不適，生命體徵平穩，切口癒合良好，腹部平軟，無壓痛。患者於2012年2月29日突發腹脹腹痛伴寒戰高熱，原引流管處可見糞渣樣物滲出，認為吻合口瘻明確，予急行橫結腸造瘻術，術中傷口糞塊感染，術後入外科監護室，於2012年3月5日轉入我科。經診治，患者生命體徵平穩，一般情況可，無腹痛腹脹等不適症狀，切口癒合良好，腹部平軟，無壓痛，於2012年4月9日出院。現患者為行造瘻腸段回納術入院。出院至今，病人精神睡眠佳，胃納可，大便成形，顏色無殊，小便正常。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 42}, {"end_pos": 63, "label_type": "手術", "overlap": 0, "start_pos": 56}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 163, "label_type": "手術", "overlap": 0, "start_pos": 157}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 268, "label_type": "手術", "overlap": 0, "start_pos": 261}]}
{"originalText": "，緣於入院前2月餘前無明顯誘因出現中下腹部悶痛不適，為持續性隱，可放射至後背部，與進食無關，無噁心、嘔吐、返酸、噯氣、納差、乏力、消瘦、腹瀉、便祕，無嘔血、黑便，無發熱、咳嗽、咳痰，未予治療，症狀無明顯好轉。1，周前至我院門診行胃鏡檢查示：“胃角潰瘍型CA可能，慢性萎縮性胃炎，黴菌性食管炎”，病理（胃角，201418212），：“送檢6小塊胃黏膜，其中一塊胃黏膜見有少量低分化腺癌浸潤，其餘為淺表胃黏膜呈慢性炎症活動期，增生頸腺呈低級別下皮內瘤變”，遂門診擬“胃癌”收入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重減輕5KG。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 128}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 145}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 180}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 197, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 216, "end_pos": 224}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 231, "end_pos": 233}]}
{"originalText": "，3+年前，患者絕經後出現同房後陰道流血，量少，無血凝塊、腹痛，無頭暈、眼花、乏力等不適，伴輕微外陰瘙癢、少量陰道流液，無異味，患者未予重視，未就診，2月前，患者出現不規則陰道流血，量同月經，無頭暈、眼花、乏力、血凝塊、腹痛及腹脹，遂至我院門診就診，查HPV16型陽性，，陰道鏡提示：宮頸重度糜爛，薄的醋酸白色下皮，婦科彩超提示宮頸偏低迴聲區；建議行宮頸活檢術，，宮頸活檢術後病檢提示：（宮頸）鱗狀細胞癌。1月前，患者來我院住院治療，完善相關檢查後於2016.2.22行腹腔鏡上廣泛性子宮切除術+兩側附件切除+盆腔淋巴結清掃術+盆腔粘連鬆解術，術後病檢（病理號1601341），示：（宮頸）中分化鱗狀細胞癌，侵及宮頸壁全層，脈管內見癌栓，頸管內見癌累及，右、左宮旁，骶韌帶，陰道壁切緣未見癌累及，（右、左盆腔淋巴結）未見癌轉移（0/6、0/10），右、左附件，老年期宮內膜。建議術後化療，待陰道頂端癒合後放療。術後予頭孢美唑鈉抗感染、止血及補液等對症支援治療，於2016.2.27行TP（紫杉醇270MG+柰達鉑140MG）靜脈化療，予護肝、護胃、止吐等對症支援治療，後複查血常規及電解質無異常予以出院，出院後，患者常感噁心、食慾差，上腹墜脹，。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 158, "end_pos": 162}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 180, "label_type": "手術", "overlap": 0, "start_pos": 175}, {"end_pos": 187, "label_type": "手術", "overlap": 0, "start_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 202}, {"label_type": "手術", "overlap": 0, "start_pos": 235, "end_pos": 271}, {"label_type": "手術", "overlap": 0, "start_pos": 291, "end_pos": 303}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 306, "end_pos": 308}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 330, "end_pos": 331}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 339}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 374}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 395, "end_pos": 397}, {"end_pos": 413, "label_type": "藥物", "overlap": 0, "start_pos": 408}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 444}, {"end_pos": 456, "label_type": "藥物", "overlap": 0, "start_pos": 453}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 462}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 519, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}]}
{"originalText": "，患者因“胸悶、憋氣2個月，加重1周”於2014.9.9就診於我院。，入院查體：全身面板無黃染、無瘀點、無出血點。全身淺表淋巴結未觸及腫大。兩肺呼吸音粗糙，有溼性囉音。心界無擴大，心律不規整，心音強弱不等，各瓣膜聽診區未聞及病理性雜音。腹部平坦，腹軟，無壓痛，無反跳痛。肝、脾肋上未觸及，MURPHY'S徵陰性，肝、腎區無叩痛，腸鳴音無亢進，移動性濁音陰性。兩上肢無水腫。，入院後行腹部CT示：賁門及胃小彎壁增厚，小網膜囊區及胰腺後下方多發大小不等結節。，行胃鏡檢查示：胃癌；胃竇隆起（腔外壓迫）。，病理示：腺癌。給予抑酸、護胃、調節免疫、利尿、抗感染等對症支援治療後，患者自覺不適好轉，家屬要求出院，予以出院。   患者出院後仍反覆腹痛，為下腹部悶痛，不伴放射痛，偶有進食阻擋感，伴納差，伴噁心，因“反覆下腹痛半年餘”於2014.12.2再次入院。，查體：貧血貌，眼瞼及口脣蒼白。右側鎖骨下窩可觸及一花生大小的淋巴結，質地韌，與周圍邊界清，餘身淺表淋巴結未觸及腫大。兩肺呼吸音粗糙，兩上肺可聞及溼性囉音，未聞及乾性囉音。心率118次/分，節律規整，各瓣膜聽診區無聞及病理性雜音。腹部平坦，未見胃腸型及蠕動波。腹軟，中下腹部部有壓痛，無反跳痛，中下腹可觸及一包塊，質地韌，與周圍組織分界不清。肝、脾肋上未觸及，MURPHY'S徵陰性，肝、腎區無叩痛，腸鳴音無亢進，移動性濁音陰性。兩上肢輕度凹陷性水腫。兩上肢足背動脈搏動減弱。，輔助檢查：（2014-9-18，本院），胃鏡：1、胃癌；2、胃竇隆起；病理示腺癌；（2014-9-22，本院）腹部，CT：1、膽囊多發小結石，膽囊炎；2、賁門及胃小彎壁增厚，小網膜囊區及胰後下方多發大小不等結節，建議增強掃描。，患者入院後完善相關化驗檢查：，血細胞分析:白細胞計數 10.26×10^9/L，中性粒細胞% 0.829，中性粒細胞 8.51×10^9/L，紅細胞計數 2.70×10^12/L，血紅蛋白 65.0 G/L；，降鈣素原: 0.107 NG/ML；，CRP：115.00 MG/L；，大便分析:隱血 +；癌胚抗原 21.44 NG/ML；，肝功:總蛋白 51.2 G/L；胸部CT+腹部，CT：1、兩肺上葉炎症、胸腔積液；2、賁門及胃小彎病增厚，小網膜囊區及胰腺後下方多發大小不等結節，符合胃癌併發轉移CT表現；3、膽囊多發小結石，膽囊炎；，痰培養：**不動桿菌。患者入院後給予抗感染、抑酸、保護胃粘膜、補充白蛋白、利尿、補鉀、止咳化痰、調節免疫及對症支援治療，並於2014.12.9輸注“B型懸浮去白細胞紅細胞2U”，咳嗽、咳痰、納差較前減輕，住院29天出院。   患者出院後繼續口服“螺內酯 一次3片，一天3次”，病情相對平穩。1周前患者出現黑便，為柏油樣便，量多少不等，次數不詳，伴進食明顯減少，無嘔血、便血，無噁心、嘔吐，無反酸、燒心。4天前患者無明顯誘因地出現咳嗽、咳痰，為白色粘痰，易咳出，2天前出現發熱，體溫最高達38.5℃，昨日最高體溫達38.0℃。現為求進一步系統診治，再次就診，門診以“胃癌，肺炎”收入院。   患者自本次發病以來，神志清，精神欠佳，飲食差，夜間睡眠尚可，小便量約少（具體不詳），近期體重減輕約20KG。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 5}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 191, "end_pos": 195}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 237}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 353, "end_pos": 355}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 386, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 391, "end_pos": 395}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 423}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 461, "end_pos": 462}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 492, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 497, "end_pos": 498}, {"end_pos": 499, "label_type": "解剖部位", "overlap": 0, "start_pos": 498}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"end_pos": 512, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 522}, {"end_pos": 547, "label_type": "解剖部位", "overlap": 0, "start_pos": 546}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}, {"end_pos": 551, "label_type": "解剖部位", "overlap": 0, "start_pos": 549}, {"end_pos": 568, "label_type": "解剖部位", "overlap": 0, "start_pos": 567}, {"end_pos": 570, "label_type": "解剖部位", "overlap": 0, "start_pos": 569}, {"end_pos": 576, "label_type": "解剖部位", "overlap": 0, "start_pos": 575}, {"end_pos": 593, "label_type": "解剖部位", "overlap": 0, "start_pos": 590}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 601, "end_pos": 608}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 639, "end_pos": 641}, {"end_pos": 646, "label_type": "解剖部位", "overlap": 0, "start_pos": 644}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 652, "end_pos": 654}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 669, "end_pos": 674}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 677, "end_pos": 684}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 685, "end_pos": 688}, {"end_pos": 693, "label_type": "解剖部位", "overlap": 0, "start_pos": 691}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 694, "end_pos": 697}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 707, "end_pos": 708}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 749, "end_pos": 754}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 768, "end_pos": 773}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 781, "end_pos": 786}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 799, "end_pos": 804}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 818, "end_pos": 821}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 833, "end_pos": 837}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 852, "end_pos": 855}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 874, "end_pos": 876}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 879, "end_pos": 884}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 900, "end_pos": 903}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 913, "end_pos": 917}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 918, "end_pos": 923}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 926, "end_pos": 932}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 933, "end_pos": 937}, {"end_pos": 942, "label_type": "解剖部位", "overlap": 0, "start_pos": 940}, {"end_pos": 946, "label_type": "解剖部位", "overlap": 0, "start_pos": 943}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 956, "end_pos": 958}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 972, "end_pos": 978}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 978, "end_pos": 980}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 985, "end_pos": 992}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 993, "end_pos": 996}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 998, "end_pos": 1001}, {"end_pos": 1028, "label_type": "解剖部位", "overlap": 0, "start_pos": 1025}, {"end_pos": 1124, "label_type": "藥物", "overlap": 0, "start_pos": 1121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1280, "end_pos": 1282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1283, "end_pos": 1285}]}
{"originalText": "患者既往月經規律，13歲，4-5天/28天，45歲絕經，經量中，無痛經病史，絕經後無異常陰道流血。1+月前，患者因“盆腔巨內巨大囊性包塊”於我院全麻上行經腹全子宮切除術+兩側附件切除術。術後將子宮及附件送病檢。病檢報告回：1、子宮平滑肌瘤。 2、萎縮性宮內膜。 3、慢性宮頸炎。 4、（左）附件。5.右附件附件卵巢交界性粘液性囊腺瘤，局灶癌變。同側輸卵管未見癌累及。術後予以TP方案（紫杉醇210MG+順鉑100MG）化療2日，水化2日，患者化療過程中嘔吐較明顯，毛髮脫落較明顯。餘無畏寒、發熱、反酸、噯氣，無尿頻、尿急、尿痛，無腹痛、腹瀉、腹脹不適，完成化療後予以出院，出院後，患者稍感上腹疼痛不適，毛髮脫落較明顯，無明顯噁心嘔吐，無畏寒發熱，無頭昏乏力等不適，現患者入院要求行第二次化療，門診以“卵巢癌術後”收治入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 68}, {"label_type": "手術", "overlap": 0, "start_pos": 76, "end_pos": 92}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 138}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 171}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 195, "label_type": "藥物", "overlap": 0, "start_pos": 192}, {"end_pos": 203, "label_type": "藥物", "overlap": 0, "start_pos": 201}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 294}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 350, "end_pos": 355}]}
{"originalText": "患者於2014-12-21起床小便時突發頭暈，呈視物旋轉，伴噁心、嘔吐，嘔吐物為非咖啡色胃內容物，隨即意識喪失、摔倒在地，被家屬發現後急呼120來我院，急診行腦、肺CT示“1.左基底節區低密度灶2.左肺下葉病變，較前無明顯變化3.兩肺炎症伴纖維灶4.兩肺上葉鈣化灶、輕度肺氣腫5.心包積液、兩側胸腔積液”，急診以“暈厥原因待查”收住我科，患者醒後發現右側肢體活動不靈，2014-12-22在我科做腦DWI示“左側大腦半球多發急性梗塞灶”，考慮“1.急性腦梗死2.高血壓病（2級 很高危）3.冠狀動脈粥樣硬化性心臟病 心房顫動4.肺炎 兩側胸腔積液5.心包積液6.慢性腎功能不全7.胃CA術後8.直腸CA術後9.膽囊摘除術”，給予“拜阿司匹林、氟伐他汀鈉緩釋片、低分子肝素鈣、神經節苷酯、疏血通、舒普深、沐舒坦”等輸液治療，2014-12-30因呼吸衰竭行氣管插管呼吸機輔助呼吸，病情平穩後於2015-01-23轉入ICU行氣管切開後再轉入我科繼續治療後好轉出院。   患者出院後病情仍有反覆，反覆多次入我科治療，均治療好轉後出院。現患者為氣管切開狀態，右側肢體仍活動不靈，為求進一步治療，我院門診以“腦梗死、冠狀動脈粥樣硬化性心臟病、心房顫動、肺部感染”收入我科。   患者自發病以來，神志清，精神尚可，氣管切開狀態，鼻飼飲食，留置導尿，大便正常。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 20}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 79, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 163}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 198, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 217}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 229}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 231, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 245, "end_pos": 257}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 258, "end_pos": 262}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 264, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 273}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 279}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 288}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 295}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 297, "end_pos": 303}, {"end_pos": 310, "label_type": "手術", "overlap": 0, "start_pos": 305}, {"end_pos": 320, "label_type": "藥物", "overlap": 0, "start_pos": 315}, {"end_pos": 329, "label_type": "藥物", "overlap": 0, "start_pos": 321}, {"end_pos": 336, "label_type": "藥物", "overlap": 0, "start_pos": 330}, {"end_pos": 342, "label_type": "藥物", "overlap": 0, "start_pos": 337}, {"end_pos": 346, "label_type": "藥物", "overlap": 0, "start_pos": 343}, {"end_pos": 350, "label_type": "藥物", "overlap": 0, "start_pos": 347}, {"label_type": "藥物", "overlap": 0, "start_pos": 351, "end_pos": 354}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 372, "end_pos": 376}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"end_pos": 415, "label_type": "手術", "overlap": 0, "start_pos": 411}, {"label_type": "手術", "overlap": 0, "start_pos": 469, "end_pos": 473}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 500, "end_pos": 503}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 504, "end_pos": 516}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 517, "end_pos": 521}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 522, "end_pos": 526}, {"label_type": "手術", "overlap": 0, "start_pos": 552, "end_pos": 556}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}]}
{"originalText": "，1年餘出現接觸性陰道出血，伴輕微腹痛，有少量陰道排液，無異味。，在外院行宮頸活檢提示：中分化鱗癌。後轉我院婦科於2012-07-09行“宮頸癌根治術+兩側附件切除術+盆腔淋巴結清掃術”，，術後病理提示：宮頸中分化鱗癌，浸潤宮頸深肌層，累及宮頸管未見明確脈管癌栓及神經侵犯。遵原主診教授意見於2012-07-26、2012-8-16、2012-9-11行TP方案輔助化療3程。2012-9-19開始行放射治療。現按原主診教授意見返院繼續行TP方案化療。患者一般情況可，飲食入眠可，大小便正常，體重無明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 49}, {"label_type": "手術", "overlap": 0, "start_pos": 69, "end_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 109}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 114}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}]}
{"originalText": "患者1月餘前因“間斷下腹部疼痛1年，加重十餘天”就診，1腹痛呈陣發性絞痛，無發熱，無噁心、嘔吐，當時未作治療，疼痛間斷髮作，在來我院行B超及MRI檢查提示膽囊泥沙樣結石、膽總管末端可疑結石,入院後完善相關化驗檢查，於2013.4.2在全麻上行膽囊切除、膽總管探查取石、T管引流術。術中見膽囊張力高，膽囊壁充血水腫，周圍血管曲張，膽總管粗約2CM，壁厚，術後給予禁食、胃腸減壓、抗感染、保肝、止血、抑酸等治療，病人恢復良好，術後病理回示：急性單純性膽囊炎，現為進一步治療今來我院就診，門診以\\\"膽石症術後\\\"收入院。   患者自出院以來，飲食睡眠良好，大小便正常，體重無減輕。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 29, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 67, "end_pos": 69}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 70, "end_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 94}, {"label_type": "手術", "overlap": 0, "start_pos": 121, "end_pos": 139}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 151}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 185}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 251}]}
{"originalText": "，患者2015-04-26無明顯誘因出現肉眼血尿，無腰痛、發熱等不適，稍有尿頻、尿急、尿痛。，行急診超聲及CT示：\\\"膀胱佔位病變，大小37*29MM\\\"。考慮膀胱癌可能。完善相關檢查並於2015-4-29行經尿道膀胱腫瘤電切術，，術後病理示：“浸潤性高級別尿路下皮癌”，有根治性膀胱切除術指徵，遂於2015-5-5於全麻上行根治性膀胱切除術+迴腸原位新膀胱術，手術順利，術後恢復可。2015-06-11在本科行“順鉑+吉西他濱”化療治療，化療過程順利。現為進一步治療入住本科。起病以來,患者精神尚可,飲食睡眠尚可,無發冷發熱，無咳嗽、咳痰、胸痛及心慌氣短，大便正常，小便如下所述，體重無減輕。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 50, "end_pos": 52}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 59, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 80, "end_pos": 83}, {"end_pos": 114, "label_type": "手術", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 134}, {"end_pos": 145, "label_type": "手術", "overlap": 0, "start_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 163, "end_pos": 180}, {"end_pos": 209, "label_type": "藥物", "overlap": 0, "start_pos": 207}, {"end_pos": 214, "label_type": "藥物", "overlap": 0, "start_pos": 210}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}]}
{"originalText": "，入院前3年餘患者出現左上腹刺痛，伴左側臀部放射痛，難以忍受，伴腹脹、裡急後重不適，月經週期延長，不伴噁心、嘔吐、腹瀉腹脹等不適，行MRI診斷盆腔內囊實性佔位病變，漿液性囊腺癌？累及子宮後壁及直腸左側壁，，CA125：335.4U/ML，，行腹部CT提示：肝左葉後段病灶，考慮轉移可能，遂於2010年6月2日行“全子宮+右附件切除+直腸切除術”，術後病檢回示“盆腔中低分化腺癌，卵巢來源性大，直腸外膜中見癌侵潤”。術後予以6週期紫杉醇210MG+順鉑100MG化療，化療結束時間為2010年11月。2011-12-19患者因複查CA-125 185.4U/ML,盆腔B超未見異常，遂行3週期多西他賽120MG＋奧沙利鉑200MG化療，末次化療時間2012年3月，化療期間行腹部CT提示肝左葉轉移灶，遂於院外行肝轉移灶伽馬刀治療。院外無腹痛等不適。2月餘前患者因無明顯誘因出現左上腹疼痛，呈持續性刀割樣疼痛，坐位或平臥時可稍緩解，無嘔心嘔吐，無腹瀉便祕，無發熱寒顫，無全身骨痛等不適，遂於門診行盆腔彩超示盆腔內混合性包塊，腹部CT提示兩側附件區多發囊狀佔位灶，左輸尿管盆腔段與左附件區佔位灶關係密切伴管壁增厚，考慮卵巢癌復發伴左輸尿管受累可能，肝左葉異常強化影。CA-125、CA-199升高。提示病情進展，遂於我科行一週期吉西他濱+奈達鉑化療，化療後患者出現骨髓抑制，予以升血小板治療後好轉出院。出院後患者左上腹疼痛較前明顯緩解，無噁心嘔吐，無咳嗽咳痰，無腹痛腹脹等不適，今為進一步治療入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 66, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 98}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 103, "end_pos": 108}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 121, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 142}, {"label_type": "手術", "overlap": 0, "start_pos": 156, "end_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 188}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 214}, {"end_pos": 225, "label_type": "藥物", "overlap": 0, "start_pos": 223}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 264, "end_pos": 270}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 281, "end_pos": 285}, {"end_pos": 299, "label_type": "藥物", "overlap": 0, "start_pos": 295}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 305}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 336, "end_pos": 340}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 348}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 435, "end_pos": 436}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 446, "end_pos": 450}, {"end_pos": 453, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 460, "end_pos": 464}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 479, "end_pos": 483}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 483, "end_pos": 485}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 487, "end_pos": 490}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 506, "end_pos": 518}, {"end_pos": 524, "label_type": "解剖部位", "overlap": 0, "start_pos": 521}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 530, "end_pos": 536}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 537, "end_pos": 543}, {"end_pos": 565, "label_type": "藥物", "overlap": 0, "start_pos": 561}, {"end_pos": 569, "label_type": "藥物", "overlap": 0, "start_pos": 566}, {"end_pos": 581, "label_type": "解剖部位", "overlap": 0, "start_pos": 579}, {"end_pos": 606, "label_type": "解剖部位", "overlap": 0, "start_pos": 603}, {"end_pos": 629, "label_type": "解剖部位", "overlap": 0, "start_pos": 628}, {"end_pos": 631, "label_type": "解剖部位", "overlap": 0, "start_pos": 630}]}
{"originalText": "，緣於入院前半月體檢查電子腸鏡示：肝曲見一寬基息肉樣隆起，大小約3×1.5CM，約環1/3周，表面充血，，內鏡診斷：結腸側向發育型腫瘤（LST）；查CEA、AFP、CA199、CA125均正常；無畏冷、寒戰、發熱，無噁心、嘔吐，無腹痛、腹脹、腹瀉，無關節腫痛、消瘦。今為進一步行內鏡治療求診我院，門診擬以“結腸側向發育型腫瘤”收治入院。近半年來，精神、睡眠欠佳，食慾尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 19}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 72}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 78, "end_pos": 81}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 162}]}
{"originalText": "患者2年前無明顯誘因開始出現多食，進食以稀飯為主，每餐約800G，自覺體重上降，具體數值不詳，無明顯口渴、多飲、多尿，無多汗、心悸、盜汗，無腹痛、腹瀉、便祕等不適，未重視，未治療。1+年前患者因血壓升高，在*****住院治療，發現血糖升高，測指血糖最高達18.0MMOL/L，仍有多食的症狀，診斷為“糖尿病”，予以胰島素降糖（具體劑量不詳），好轉出院。出院後規律口服藥物降糖藥（具體藥物不詳），未監測血糖情況。病程中否認活動後心悸、氣促，無四肢麻木、兩上肢水腫等不適。5月前患者出現兩上肢水腫，伴上肢疼痛，按壓時明顯。就診我院，診斷為“2型糖尿病糖尿病周圍神經病變 左上肢深靜脈血栓形成”，給予抗凝、降糖，利尿等對症治療後好轉出院。出院後長期使用“華法林 2.5MG，QD、阿卡波糖 50MG，TID 阿託伐他汀 20MG，QN”對症治療。10+天前患者再次出現兩上肢水腫，呈凹陷性，左側為主，伴有疼痛，按壓時疼痛明顯。病程中無夜間陣發性呼吸困難，無端坐呼吸，無咳嗽、咯痰，無腹痛、腹脹等不適。為進一步診治，就診我院。門診以“水腫待查”收入我科。\\U0004   患者發現血壓升高10年餘，最高170/？MMHG，長期規律口服“珍菊降壓片 1粒 QOD”，未監測血壓，否認胸悶、胸痛等不適。5月前患者在我院行心臟彩超提示“右室及兩房增大”，心電圖提示心房顫動，診斷為“高血壓性心臟病 心臟擴大 心房纖顫”，給予“氨氯地平 5MG，QD，美託洛爾緩釋片 23.75MG，QD”。平時未正規監測血壓。\\U0004   患者本次發病以來， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，食慾及體重同下所述。", "entities": [{"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 122, "end_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 153}, {"end_pos": 160, "label_type": "藥物", "overlap": 0, "start_pos": 157}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 268, "end_pos": 293}, {"end_pos": 328, "label_type": "藥物", "overlap": 0, "start_pos": 324}, {"end_pos": 342, "label_type": "藥物", "overlap": 0, "start_pos": 337}, {"end_pos": 356, "label_type": "藥物", "overlap": 0, "start_pos": 351}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 381}, {"end_pos": 439, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 441}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 463, "end_pos": 467}, {"end_pos": 519, "label_type": "藥物", "overlap": 0, "start_pos": 514}, {"end_pos": 537, "label_type": "解剖部位", "overlap": 0, "start_pos": 536}, {"end_pos": 540, "label_type": "解剖部位", "overlap": 0, "start_pos": 539}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 554, "end_pos": 558}, {"end_pos": 563, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 570, "end_pos": 573}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 575, "end_pos": 579}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 584, "end_pos": 601}, {"end_pos": 610, "label_type": "藥物", "overlap": 0, "start_pos": 606}, {"end_pos": 625, "label_type": "藥物", "overlap": 0, "start_pos": 618}]}
{"originalText": "患者半年前無明顯誘因發現便中帶血，呈鮮紅色，大便成形，不伴裡急後重感，無腹痛、腹瀉，噁心嘔吐等不適，此後下述症狀持續存在，未系統診治。10天前我院門診行腸鏡檢查示“結腸多發息肉”，行病理檢查示：“橫結腸增生性腺瘤性息肉 乙狀結腸低級別管狀腺瘤”，遂入我院要求行結腸鏡電切手術治療。患者病來無發熱寒戰，無咳嗽咳痰，無腹痛、腹瀉，無噁心、嘔吐，無尿頻、尿急及尿痛等不適，飲食睡眠可，精神體力可，近期體重無明顯變化。", "entities": [{"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 98, "end_pos": 121}, {"label_type": "手術", "overlap": 0, "start_pos": 130, "end_pos": 137}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}]}
{"originalText": "入院前2月患者無明顯誘因開始出現吞嚥哽咽感，能正常進食，伴有中下腹隱痛下腹隱痛不適，程度輕微，不影響睡眠，進食後加重，可逐漸自行緩解，無反酸、噯氣，無胸骨後燒灼感，無噁心、嘔吐，無嘔血，無黑便、血便，無裡急後重感，無咳嗽、咳痰，無心悸、胸悶、胸痛，無喘累、氣促、呼吸困難。入院前半月，患者自覺吞嚥哽咽感加重，仍能正常進食，進食時感下腹部及胸骨後脹痛不適，可向左肩背部放射，可自行緩解，無噁心、嘔吐，無嘔血，無黑便、血便，無心悸、胸悶。未治療。今日來我院行胃鏡檢查提示：食管癌？（活檢已取），淺表性胃竇炎伴糜爛。今日為進一步治療收治入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，至患病以來體重減輕約２．５公斤。", "entities": [{"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 30}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 77}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 171}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 237}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 245, "end_pos": 254}]}
{"originalText": "入院前1+年，患者無明顯誘因出現劍突上疼痛，餐後為甚，呈持續性隱痛，尚可忍受，伴下腹脹、納差、反酸、噯氣，無進行性吞嚥困難，無噁心、嘔吐、嘔血、黑便、腹瀉，無肛門停止排便、排氣，無胸痛、胸悶、咯血、呼吸困難，遂於我院就診，行胃鏡檢查提示：胃癌可能性大，病檢回示胃腺癌，患者家屬要求保守治療，經治療後，好轉出院。病程中下述症狀反覆發作，性質同前，自購藥物服用（具體藥物不詳）後下述症狀可緩解。入院前1+小時，患者無明顯誘因出現嘔血，為咖啡色樣胃內容物，量大，具體不詳，有中下腹痛，性質同前，伴頭昏、乏力，無暈厥、意識障礙等，無面板黏膜、牙齦出血。至我科就診，以“下消化道出血”收入我科住院治療。   發病以來，精神欠佳，未進食，睡眠可，大小便正常，體重上降，具體不詳。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 280, "end_pos": 286}]}
{"originalText": "患者因下腹部不適在我院完善相關檢查後確診“胃癌”，於2015-09-23全麻上行\\\"胃癌根治術\\\"（遠端胃大部切除），術程順利，術後預防感染、抑制分泌、靜脈營養等對症支援處理，術後第一天上午開始出現心律加快，最高180多次，查心肌損傷專案心衰專案未見明顯異常，心電圖提示快速房顫，ICU會診後予可達龍控制心律，效果一般，另患者訴全身面板瘙癢，未見皮疹及其他過敏症狀，抗過敏治療效果欠佳。後出現一過性心前區疼痛，程度中等，複查心肌損傷，心電圖等未提示有心梗，患者數天來，心律血壓有波動，心律在54-140多次每分，仍可達龍維持治療。血壓在100-154/70-100MMHG之間，舌上含服心痛定等可維持在正常血壓。9月27日晚出現全身皮疹伴瘙癢，抗過敏治療欠佳，後停止原有補液後皮疹消退瘙癢改善。術後第六天，一般情況尚可，已進食流質拔除引流管患者。出院時患者生命體徵平穩心律64次/分，血壓正常，進食半流胃納可，二便正常。出院至今患者自訴恢復尚可，進食半流質為主，大小便正常，體重上降約4斤。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 139}, {"label_type": "藥物", "overlap": 0, "start_pos": 147, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 152, "end_pos": 153}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 227}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 243}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 290}, {"end_pos": 296, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}]}
{"originalText": "，患者於2011年4月份因\\\"大便次數增多2月餘，CT發現盆腔佔位10天\\\"入住我院綜合科，於5月3日行剖腹探查術，見腫物位於距回盲部150CM迴腸處，行腫物及雙端5CM空腸切除術，術後恢復可，，術後病理：胃腸間質腫瘤，3個核分裂/50HPF,，免疫組化：CD34-、CD117+，S-100(-)、SAM+/-，DES(-),HHF35-；2011-5-11起口服格列衛400MG QD治療至今，耐受可。偶有心前區不適，隨訪心電圖、心功酶等均未見明顯異常。無顏面水腫及面板瘙癢，無噁心、嘔吐、腹痛不適。現入院繼續格列衛化療。患者起病以來，無發熱、乏力、咳嗽、氣促、身目黃染等，精神睡眠可，胃納欠佳，小便正常，大便1-2次/天，體重無明顯上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"end_pos": 57, "label_type": "手術", "overlap": 0, "start_pos": 52}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 90, "label_type": "手術", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"end_pos": 186, "label_type": "藥物", "overlap": 0, "start_pos": 183}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 232}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 257}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 296}]}
{"originalText": "2016-04患者因確診胃癌於我院術前檢查發現左下肺陰影，患者無自覺症狀，無咳嗽、咳痰，無咯血、氣促，無呼吸困難、胸悶，無發熱、消瘦、午後盜汗，無胸痛、骨痛、頭痛、聲嘶，無眼瞼上垂、顏面浮腫、吞嚥困難。患者行胃癌根治術後，今為進一步手術治療肺部病灶，門診擬“左下肺腫物”收入我科。起病以來，患者精神、睡眠、食慾尚可，大小便正常，體重近期無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 93}, {"end_pos": 109, "label_type": "手術", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 134}]}
{"originalText": "，患者絕經10年，於2012-12月無明顯誘因出現陰道不規則出血，量同月經.在外院行子宮內膜分段診刮病理示子宮內膜癌.我院病理會診為惡性苗勒氏混合瘤。為求進一步診治2013-02-21收入我院，入院後完善相關檢查，於2013-02-28在全麻上行全子宮+兩附件切除+盆腔淋巴結清掃+大網膜切除+腹主動脈旁淋巴結活檢術，，術後病理示：子宮內膜樣腺癌（中分化）浸潤至淺肌層，未見癌肉瘤成份。未予特殊治療，於2013-03-15複查既往子宮內物活檢組織診斷為癌肉瘤。2013-04-03~06行IAP方案（IFOD1-D3+裡葆多D1+DDPD1-D4）化療一程，行裡葆多化療初始出現一過性心悸、胸悶、氣促不適，於抗過敏治療後緩解。患者自起病以來，精神、胃納、睡眠可，無頭暈頭痛，胸悶氣促，噁心嘔吐，腹脹腹痛，尿頻尿急，裡急後重等不適，大小便正常，體重無明顯改變。`，外院治療經過：無。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"label_type": "手術", "overlap": 0, "start_pos": 42, "end_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 158}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 178}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 250}, {"end_pos": 262, "label_type": "藥物", "overlap": 0, "start_pos": 259}, {"end_pos": 268, "label_type": "藥物", "overlap": 0, "start_pos": 265}, {"end_pos": 283, "label_type": "藥物", "overlap": 0, "start_pos": 280}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}]}
{"originalText": "2014-4因腎結石查體，胃鏡示胃底佔位，病理低分化腺癌。2014-5胃部介入治療2次（具體不詳），家屬訴複查無變化，2014-7口服藥物治療（具體不詳），2014-10複查胃鏡侵及食道，給予含奧沙利鉑方案化療4週期，家屬訴複查無變化，末次2015-1。家屬訴後口服化療藥至2015-9（具體不詳）。2015-9進食哽噎、嘔吐，鋇餐見食管堵塞大部分，給予放療20余天。2015-10-2當地查CT發現肝轉移。目前進食較前好轉，可進普食，無明顯哽噎感，無嘔吐。近1月自覺右肩部疼痛，口服止痛藥物後效果欠佳，口服阿司匹林後疼痛可緩解4-5小時。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 28}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 101, "label_type": "藥物", "overlap": 0, "start_pos": 97}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 237}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 254}]}
{"originalText": "患者2014-05無明顯誘因出現粘液血便，量少，伴大便次數增加至4-5次/天，稀爛，偶有裡急後重，伴陣發性腹痛。無噁心、發熱等不適。外院腸鏡檢查提示距肛門30CM結腸腫物，腸鏡不能透過。活檢病理提示腺癌。患者遂來我院，門診查CT提示：結腸肝曲、乙狀結腸腸壁增厚，考慮結腸癌。結腸病灶鄰近系膜區域淋巴結腫大，考慮淋巴結轉移。腹主動脈旁、腸繫膜區淋巴結，轉移？右下肺葉斑片影，炎症？患者2014-07-03於我院全麻上行“腹腔鏡上全結腸切除術”，術後診斷“多原發結腸癌 PT3N1AM0,IIIB”期,於2014-08-11予XELOX方案化療1程。現為行上一程化療收住入院，起病以來無發熱，胃納可，睡眠一般，小便正常，體重上降5公斤。", "entities": [{"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 101}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 112, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 136}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 150}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 177}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 188}, {"end_pos": 219, "label_type": "手術", "overlap": 0, "start_pos": 209}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 294, "end_pos": 295}]}
{"originalText": "患者於入院前2月餘在我院胃腸外科因“胃底升結腸印戒細胞癌”行化療期間發現右乳一拳頭大小的無痛包塊，無紅腫壓痛，無面板破潰，無乳房橘皮樣外觀，無乳頭凹陷，無乳頭溢液。轉入我科行了右乳包塊活檢術，病檢結果為：（右乳）分泌粘液癌（印戒細胞癌）， ER（－） PR（－） CERBB-2（－）CEA（+++） ，並行“紫杉醇+希羅達”化療雙個療程，化療期間乳房面板有輕微發紅，無明顯骨髓抑制及胃腸道反應，化療後腫塊有所縮小，出院後發現乳房腫塊又開始緩慢增大，且乳頭回縮，今日患者為求進一步治療入我院，門診以“右乳印戒細胞癌”收入住院。\\U0004   患者於入院前8月我院行左腹股溝腫大淋巴結活檢提示轉移性癌，並行胃鏡、結腸鏡檢查並取活檢，提示為胃底、升結腸印戒細胞癌，並於胃腸外科行數個療程化療，未行胃腸道手術。曾用卡培他濱、奧沙利鉑、倍伐單抗等藥物治療。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 28}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 95, "label_type": "手術", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 118}, {"end_pos": 158, "label_type": "藥物", "overlap": 0, "start_pos": 155}, {"end_pos": 162, "label_type": "藥物", "overlap": 0, "start_pos": 159}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 250, "end_pos": 257}, {"label_type": "手術", "overlap": 0, "start_pos": 283, "end_pos": 294}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 319, "end_pos": 330}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"end_pos": 359, "label_type": "藥物", "overlap": 0, "start_pos": 355}, {"end_pos": 364, "label_type": "藥物", "overlap": 0, "start_pos": 360}, {"end_pos": 369, "label_type": "藥物", "overlap": 0, "start_pos": 365}, {"end_pos": 397, "label_type": "解剖部位", "overlap": 0, "start_pos": 396}]}
{"originalText": "，緣於入院2年前因“嘔血、排黑便”就診於我院，無畏冷、發熱，無口乾、多飲、多尿，無多食、易飢，查“，末梢血糖：HIGH，，尿常規:尿糖3+，酮體3+，蛋白質1+，，血氣分析示：PH7.0，BE-29，LAC3.65MMOL/L，HCO3-1.9MMOL/L，，糞常規：隱血試驗陽性(3+)，，胃鏡：出血性胃炎，慢性萎縮性胃炎，未見活動性出血”，診斷為“糖尿病糖尿病酮症酸中毒、下消化道出血”，予輸血、降糖、補液、制酸保胃、止血等治療，下述症狀好轉，複查尿酮體轉陰，監測空腹末梢血糖7MMOL/L下上，餐後末梢血糖7-14MMOL/L，出院後予“來得時16U、諾和銳三餐前6U”降糖治療，規律注射胰島素，監測空腹末梢血糖7MMOL/L右左，未監測餐後血糖。1年半前無明顯誘因出現噁心、嘔吐，嘔吐物為胃內容物，無頭暈、頭痛，無畏冷、發熱，無咳嗽、咳痰，就診我院，查“末梢血糖HIGH，，血氣分析：PH7.122，PACO219.5MMHG，PAO2110MMHG，BE-23MMOL/L，，尿常規：尿糖3+，酮體3+，，血常規：WBC26.8*10^9/L，NE87.7%，HB138G/L。，糖尿病抗體:穀氨酸脫羧酶抗體陽性(+)。胰島素、C，肽檢查：1.胰島素（空腹）&LT;0.2MU/L，2.胰島素（2H）&LT;0.2MU/L,3.C肽（空腹）&LT;0.02UG/L,C肽（2H）0.02UG/L”，診斷為“1型糖尿病糖尿病酮症酸中毒”，予降糖、補液、感染、制酸保胃等治療，下述症狀好轉，出院後予“諾和銳特充9U早11U午9U晚+來得時7U睡前”降糖治療，後規律注射胰島素，未監測血糖。1年前自測末梢血糖均偏高，餐後2小時末梢血糖16-18MMOL/L，無口乾、多飲，無多食、易飢，無多尿、泡沫尿，就診我院，予“降糖、改善微迴圈、營養心肌、抗凝”等治療後，血糖控制穩定後出院，出院後予“諾和銳特充三餐前5U-9U-4U+來得時9U睡前”，未規律監測血糖，偶測空腹末梢血糖10MMOL/L下上。1月前無明顯誘因出現泡沫尿，無尿頻、尿急、尿痛，無發熱、寒戰，無多飲、多食，未予重視，未處理。今求進一步診治，就診我院，門診“糖尿病糖尿病性腎病？”收入院。自發病以來，精神、食慾、睡眠尚可，小便如下述，大便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 32}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 50, "end_pos": 54}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 65, "end_pos": 67}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 100, "end_pos": 103}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 114, "end_pos": 119}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 134, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 162}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 176, "end_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 194}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 234, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 250, "end_pos": 256}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 272}, {"end_pos": 282, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"label_type": "藥物", "overlap": 0, "start_pos": 297, "end_pos": 300}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 303, "end_pos": 309}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 322, "end_pos": 326}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 381, "end_pos": 385}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 396, "end_pos": 398}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 404, "end_pos": 409}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 418, "end_pos": 422}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 430, "end_pos": 432}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 447, "end_pos": 449}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 452, "end_pos": 454}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 462, "end_pos": 465}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 477, "end_pos": 479}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 501, "end_pos": 511}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 527, "end_pos": 534}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 548, "end_pos": 555}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 569, "end_pos": 575}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 588, "end_pos": 594}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 608, "end_pos": 621}, {"end_pos": 637, "label_type": "解剖部位", "overlap": 0, "start_pos": 636}, {"end_pos": 656, "label_type": "藥物", "overlap": 0, "start_pos": 653}, {"end_pos": 672, "label_type": "藥物", "overlap": 0, "start_pos": 669}, {"label_type": "藥物", "overlap": 0, "start_pos": 687, "end_pos": 690}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 694, "end_pos": 696}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 702, "end_pos": 706}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 715, "end_pos": 719}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 732, "end_pos": 733}, {"end_pos": 773, "label_type": "解剖部位", "overlap": 0, "start_pos": 771}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 782, "end_pos": 784}, {"end_pos": 800, "label_type": "藥物", "overlap": 0, "start_pos": 797}, {"end_pos": 817, "label_type": "藥物", "overlap": 0, "start_pos": 814}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 828, "end_pos": 830}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 833, "end_pos": 839}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 913, "end_pos": 922}]}
{"originalText": "患者2年前無明顯誘因出現左上腹隱痛，間斷性，無放散，自服止痛藥物後可緩解，於外院檢查發現子宮肌瘤，行子宮次全切除術，術後切口癒合不良，時有膿性液體流出，半年後切口癒合，仍有左上腹隱痛，間斷性，較術前頻繁，向腰骶部放散，自服止痛藥物可緩解。近4日左上腹隱痛加重，較劇烈，持續性，自服止痛藥物未緩解，於外院就診發現左側盆腔直徑約10CM囊性包塊。現為求進一步診治入院。患者平素便祕，時有尿頻、尿急、尿痛等尿路感染症狀，白帶可，否認合房出血。病來無發熱乏力，無頭暈頭痛，無胸悶氣短，無腹脹，飲食睡眠可，體重無減輕。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 48}, {"end_pos": 57, "label_type": "手術", "overlap": 0, "start_pos": 50}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}]}
{"originalText": "緣於3天前無明顯誘因感左上肢腫痛，為持續性鈍痛，以左小腿為重，久立或久行後症狀加重，抬高患肢可略緩解。無患肢發涼、淺表血管曲張、紫紺，伴間歇性跛行，無腰痛、咳嗽、咯血等不適。未行特殊治療患肢腫脹無明顯變化。今來我院就診，行上肢深靜脈彩超檢查示左上肢深靜脈血栓形成，為進一步治療，遂收入我科。自發病以來無明顯胸悶、氣短，無發燒，精神狀態一般，食慾一般，睡眠良好，體重無明顯變化，大便正常，小便正常。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 131}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}]}
{"originalText": "，患者9月餘前於我院行全膀胱切除根治術+迴腸導管術，，術後病理提示：膀胱浸潤性癌，結合免疫組化結果，符合高級別浸潤性尿路下皮癌，左閉孔淋巴結、左髂外淋巴結、左髂內淋巴結見癌轉移，並侵出至淋巴結包膜外結締組織。左髂總淋巴結見癌轉移，脈管內見癌栓。左髂總淋巴結見癌轉移，脈管內見癌栓。4月前，患者於我院複查，CT:膀胱術後缺如，區域性未見明顯腫物；左上腹壁見腸管造瘻口。直腸下段前方新增軟組織灶與直腸分界不清，增強掃描強化稍明顯，大小約41MM×17MM。直腸繫膜見多發淋巴結，邊界清，較大者約10MM×7MM，密度均勻。2月前患者出現腹部劇烈疼痛，患者為求進一步診治再次入院，複查CT示膀胱癌根治術後，膀胱術後缺失，直腸下段前方軟組織灶，較前明顯增大，考慮腹膜種植可能性大，直腸繫膜多發小淋巴結，較前增大，腹主動脈旁及小腸繫膜根腸繫膜根部淋巴結，較前未見明顯變化，兩側髂血管旁結節，考慮淋巴結轉移，並兩腎盂、兩輸尿管積水，左上上肺內基底段類結節較前變化不明顯。遂於2014-11-13、2014.12.03、2014-12-23、2015-01-13行GC方案動脈化療（吉西他濱1.2GD1，順鉑20MG，D1-D3）雙週期，化療後患者回家休養。今為求進一步治療再次來我院，門診以\\\"膀胱癌綜合治療後\\\"收入我科。患者發病以來,精神好,飲食睡眠可,無發冷發熱，無咳嗽、咳痰、胸痛及心慌氣短，大便正常，小便如下所述，體重無減輕。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 11, "end_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 84}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 152, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 227}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 288, "end_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 303}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 306, "end_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 330}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 335, "end_pos": 337}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 380}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}, {"end_pos": 487, "label_type": "藥物", "overlap": 0, "start_pos": 483}, {"end_pos": 496, "label_type": "藥物", "overlap": 0, "start_pos": 494}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 540, "end_pos": 548}, {"end_pos": 586, "label_type": "解剖部位", "overlap": 0, "start_pos": 585}]}
{"originalText": "，緣於入院前[主訴單一時間1月主訴單一時間]前無明顯誘因出現中下腹部悶痛部悶痛不適，為持續性隱痛，無其它部位放射，與進食無關，無噁心、嘔吐、返酸、噯氣、納差、乏力、消瘦、腹痛、腹瀉、便祕，無嘔血、黑便，無發熱、咳嗽、咳痰，，此次至我院門診行胃鏡檢查示：“吻合口潰瘍”，，病理：腺癌，遂門診擬“殘胃癌”收入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重無明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 34}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 149}]}
{"originalText": "患者於3月餘前因“肛門墜脹伴疼痛5月餘，加重1月餘。”入院，診斷為直腸腺癌並行腹腔鏡上直腸癌根治術（DIXON）+末端迴腸造口術，手術順利，術後病理診斷：1、（直腸）潰瘍型中分化管狀腺癌，侵及腸壁全層，雙切端未見癌累及，腸壁淋巴結見癌轉移（4/7），脂肪組織中見癌結節。 2、（吻合口殘端）未見癌累及。患者於院外期間未訴腹痛、腹脹，噁心、嘔吐，便血、腹瀉等不適，胃納可，今患者為求還納迴腸末端造口遂來我院，門診以“直腸癌術後”收入我科。\\U0004   患者發病以來，神志 清晰，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 37}, {"label_type": "手術", "overlap": 0, "start_pos": 39, "end_pos": 64}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 245}]}
{"originalText": "，患者入院前6年無明顯誘因出現腹痛，主要為左下腹及左上腹陣發性隱痛不適，疼痛與進食、活動及體位改變無明顯關係，無反酸、噯氣、燒心、噁心、嘔吐等不適，無肩背部放射痛，，曾於我院行胃鏡示：1.食管淺潰瘍；2.淺表性胃竇炎伴糜爛；3.十二指腸球部多發息肉。並行十二指腸球部息肉消融術，，術後活檢示：十二指腸球部息肉伴柱狀下皮化生。後腹痛反覆出現，予對症治療後緩解，患者入院前3月無明顯誘因再發腹痛，部位同前，疼痛程度較前加重，無厭油、納差、乏力、反酸、噯氣等不適，，於我院行胃鏡示：1.慢性非萎縮性胃炎；2.十二指腸球部息肉。今日患者為求進一步診治收入我科治療。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 124}, {"end_pos": 138, "label_type": "手術", "overlap": 0, "start_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 161}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 259}]}
{"originalText": "患者因\\\"直腸癌同期放化療後\\\"於2012年5月25日在我院在全麻上行DIXON手術，術後病理顯示直腸中分化腺癌，癌組織浸潤至腸壁外膜層，淋巴結及切緣未見轉移。因術後10余天發現“陰道中有大便排出”於2012年6月25日行“橫結腸兩腔造瘻術+陰道修補術”。患者術後已於2012年8月3日行XELOX方案化療一程，過程順利，患者訴化療後自覺手麻木3天，現已恢復。患者自發病以來，食慾、睡眠及精神良好，小便正常，體力無上降，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 14}, {"end_pos": 42, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "手術", "overlap": 0, "start_pos": 112, "end_pos": 126}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}]}
{"originalText": "，緣於入院前1個月無明顯誘因出現食物反流，偶於睡覺時從嘴角流出，為胃內容物，伴咳嗽，乏力，進食後、臥位以及夜間明顯，無反酸、燒心，無吞嚥困難、進食障礙，無胸悶、胸痛，無發熱、畏冷，無咳痰，無腹脹、腹痛，就診我院，予“世福素、甘草合劑”等治療後無明顯好轉。入院前7天就診我院消化科，，查腹部CT示：1、右下下腹部殘胃腔管壁明顯增厚伴輕度強化，最厚約24MM，管腔變窄，食管輕度擴張，考慮殘胃癌，建議內鏡檢查，殘胃周圍未見明顯腫大淋巴結。，胃鏡檢查:食管腔見大量液體殘留，影響觀察；距門齒40CM處見一隆起性病灶，表面糜爛、出血，質地組織脆,活檢易出血，管腔狹窄，內鏡不能透過，無法觀察全貌。，考慮:胃癌術後復發？，胃鏡病理示：（距門齒40CM），：乳頭狀-管狀腺癌。予“右卡尼汀、力素營養心肌，氨基酸、脂肪乳營養支援，胸腺五肽增強免疫力，潘妥洛克制酸保胃、頭孢替安抗感染”等處理後症狀稍好轉。今為求進一步診治，就診我院，門診擬“賁門癌”收住入院。自發病以來，精神、飲食、睡眠一般，大小便正常，體重減輕3KG。", "entities": [{"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"end_pos": 111, "label_type": "藥物", "overlap": 0, "start_pos": 108}, {"end_pos": 116, "label_type": "藥物", "overlap": 0, "start_pos": 112}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 157}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 298, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 323, "end_pos": 331}, {"end_pos": 338, "label_type": "藥物", "overlap": 0, "start_pos": 334}, {"end_pos": 341, "label_type": "藥物", "overlap": 0, "start_pos": 339}, {"end_pos": 349, "label_type": "藥物", "overlap": 0, "start_pos": 346}, {"end_pos": 353, "label_type": "藥物", "overlap": 0, "start_pos": 350}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 358}, {"end_pos": 372, "label_type": "藥物", "overlap": 0, "start_pos": 368}, {"end_pos": 381, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 413, "end_pos": 416}]}
{"originalText": "患者4年前因上肢疼痛就診我院，診斷“上肢動脈粥樣硬化閉塞症狀”，於2013年於全麻上行“兩側上肢動脈支架置入術+術中溶栓術”，術順，術後順利出院。患者1月前無明顯誘因於行走100M時出現右側上肢疼痛，休息後好轉，行走後症狀反覆。患者近日症狀加重，行走50M出現右上肢疼痛症狀，休息後症狀好轉。無上肢腫脹，無上肢靜脈曲張，無胸腹部疼痛，無腰部疼痛。現患者為進一步治療就診我院，門診擬以“上肢動脈粥樣硬化閉塞症”收住入院。患者自發病以來，飲食睡眠可，大小便無明顯異常，運動耐量明顯上降。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 61}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 203}]}
{"originalText": "，患者無明顯誘因上自覺中下腹疼痛不適，腹痛性質為陣發性絞痛，劇烈難忍，伴大汗淋漓，伴左肩胛部放射痛，進食油膩食物後無加重。有發熱、噁心、嘔吐史，發熱最高度數不詳。數年前出現面板鞏膜黃染史。2010年5月23日，至我院門診查CT示：肝內外膽管多髮結石伴膽管擴張，慢性肝病，脾腫大，，查B超示：肝內膽管及膽總管多髮結石伴遠端膽管擴張，2010/6/29在肝外科行復雜粘連鬆解、膽總管切開取石、膽道鏡探查、T管引流術，因患者右肝代償性增大明顯，切除右肝患者肝功能無法耐受，故手術未取出嵌頓於右肝管內的結石，術後恢復可。現為求進一步診治，收入本病房。患者發病以來精神可，胃納可，雙便如常，睡眠可，否認明顯體重變化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 136}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 141, "end_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 164}, {"label_type": "手術", "overlap": 0, "start_pos": 179, "end_pos": 205}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}]}
{"originalText": "患者於2009.7.22因殘胃異時性原發癌在全麻上行胃癌根治術（全胃切除+區域淋巴結清掃+ROUX-EN-Y消化道重建術），術後恢復好，病理型別（印戒細胞癌），分期T4、N３、M０。術後18天行全身化療（FOLFIRI），共1次，有特別化療反應，輕微噁心嘔吐，食慾上降。3天前化療結束自動要求出院。出院後感反覆下腹痛，為陣發性絞痛，可自行緩解。伴有食慾不佳，噁心，未嘔吐。今為明確診治入院。\\U0004   患者自起病以來，精神略差，胃納略差，大便次數增多，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 21}, {"end_pos": 61, "label_type": "手術", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 90}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 218}]}
{"originalText": "，患者約於10月前無明顯誘因出現消化不良，餐後飽脹，伴噯氣，偶有反酸，無發熱，無噁心、嘔吐，無腹瀉、黑便，無肛門上墜感及裡急後重感，未規範治療。現患者為求明確診療來我院就診，，門診行胃鏡檢查示:胃體大彎側見一直徑約0.8CM息肉樣隆起，，超聲示：隆起為粘膜上層來源等回聲光團，並有顆粒感，，檢查診斷：1.萎縮性胃炎伴急性活動；2.胃體隆起，SMT?3.十二指腸炎。現為行進一步治療，門診以\\\"胃息肉\\\"收入我科。患者自發病以來，精神可，飲食可，睡眠可，二便正常，體重無明顯改變。", "entities": [{"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 101}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 152, "end_pos": 162}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 164, "end_pos": 169}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 176, "end_pos": 181}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 196, "end_pos": 199}]}
{"originalText": "入院前10+年患者開始出現咳嗽、咳痰，多於冬春季及受涼後發作，抗感染治療有效，每年發作超過3個月。入院前6+年開始出現咳嗽咳痰時伴喘累，逐漸出現活動後心累，於下坡時出現。2014年4月患者曾因下訴症狀發作在我科住院治療，當時查“心臟彩超示右房、左房、左室增大，主動脈瓣、二尖瓣輕度反流，三尖瓣重度反流，肺動脈重度高壓，心包腔積液，右室舒張功能減退。腹部彩超未見明顯異常。胸片示1.右肺中上野團片影，建議CT檢查；2.考慮左下肺感染性病變，肺氣腫；3.心影增大，主動脈少許鈣化；4.考慮左側水平裂少量包裹性積液或水平裂增厚，右上胸壁條片影，考慮少量胸腔積液或胸膜增厚；5.兩膈面粘連，胸椎骨質增生。完善胸部CT示1.考慮左下葉感染，兩上肺支氣管擴張伴感染，以右上肺為甚；2.右心緣不規則低密度影，考慮囊性病變，支氣管囊腫？心包囊腫？心包積液？囊性畸胎瘤？；3.符合慢支炎、肺氣腫伴左上肺大泡形成；4.心影增大，主動脈壁鈣化；5.右側胸腔積液及葉間積液，部分包裹”，考慮診斷“1、慢性阻塞性肺病（急性加重期）肺源性心臟病 2、冠心病 缺血性心肌病型 心臟增大 心房纖顫 心衰 心包腔積液 心功能Ⅲ級 3、支氣管擴張 4. 右肺中上野團片影原因待查”，予以吸氧、抗感染、平喘、改善迴圈、調節代謝、對症治療後好轉出院。出院後患者曾間斷服用利尿劑，未長期服用止咳化痰藥物及家庭氧療。入院前4天，患者受涼後喘累、氣促再發，伴咳嗽、咳痰，自訴痰呈白色絲狀，不易咳出，無咯血，感夜間難以平臥位休息，喜高枕臥位，無畏寒發熱，無潮熱盜汗，無心慌心悸，無胸悶胸痛，無腹脹腹痛，無上肢浮腫等，曾在外診所輸液治療2天，自覺症狀緩解，但昨日夜間再次感咳嗽明顯，伴氣促，故就診我院門診，查“血氣分析全套：二氧化碳總量 39mmol/l、酸鹼度 7.360、二氧化碳分壓 66mmHg、氧分壓 163mmHg、碳酸氫根 37.3mmol/l、標準碳酸氫根 31.90mmol/l、細胞外液鹼剩餘 11.9mmol/l、全血鹼剩餘 8.90mmol/l、血氧飽和度 99%、乳酸 1.00mmol/l，血常規：白細胞數 8.3 10^9/L、血紅蛋白濃度 139g/L、血小板數 181 10^9/L、中性粒細胞百分比 84.21%、淋巴細胞百分比 11.02%，腎功：尿素 9.23mmol/L、肌酐 63.6μmol/l、尿酸 289.2μmol/l，電解質：鉀 3.59mmol/l、鈉 147.1mmol/、氯 104.9mmol/l。胸片示1.左下肺感染性病變，側位肺門增大增濃，建議CT或治療後複查。2.肺氣腫徵。3.左側胸膜增厚。4.胸椎骨質增生，部分椎體楔形變”，為進一步診療收入我科住院。患者此次起病後精神、食慾、睡眠一般，大小便正常，體力體重無明顯變化。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 114, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 125, "end_pos": 127}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 167}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 174, "end_pos": 178}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 185, "end_pos": 187}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 192}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 201, "end_pos": 203}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 230, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 258}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 277}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 278, "end_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 285, "end_pos": 288}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 297}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 300, "end_pos": 304}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 309, "end_pos": 314}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 315, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 339}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 349, "end_pos": 353}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 369}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 370, "end_pos": 375}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 381, "end_pos": 384}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 389, "end_pos": 392}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 400}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 404, "end_pos": 408}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 415, "end_pos": 419}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 438, "end_pos": 452}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 452, "end_pos": 458}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 464}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 465, "end_pos": 472}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 473, "end_pos": 475}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 478, "end_pos": 482}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 483, "end_pos": 485}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 486, "end_pos": 491}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 492, "end_pos": 497}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 500, "end_pos": 505}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 509, "end_pos": 511}, {"label_type": "藥物", "overlap": 0, "start_pos": 565, "end_pos": 568}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 660, "end_pos": 661}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 662, "end_pos": 663}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 666, "end_pos": 667}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 668, "end_pos": 669}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 672, "end_pos": 673}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 674, "end_pos": 675}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 678, "end_pos": 680}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 737, "end_pos": 743}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 753, "end_pos": 756}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 763, "end_pos": 769}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 777, "end_pos": 780}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 789, "end_pos": 793}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 805, "end_pos": 811}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 824, "end_pos": 831}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 843, "end_pos": 848}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 860, "end_pos": 865}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 870, "end_pos": 872}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 888, "end_pos": 892}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 904, "end_pos": 910}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 918, "end_pos": 921}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 934, "end_pos": 942}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 950, "end_pos": 957}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 968, "end_pos": 970}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 982, "end_pos": 984}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 996, "end_pos": 998}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1015, "end_pos": 1016}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1028, "end_pos": 1029}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1041, "end_pos": 1042}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 1055, "end_pos": 1057}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1060, "end_pos": 1063}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1071, "end_pos": 1073}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 1080, "end_pos": 1082}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1091, "end_pos": 1094}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1098, "end_pos": 1102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1107, "end_pos": 1113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1116, "end_pos": 1118}]}
{"originalText": "入院前3+年患者在院外發現腎功能異常，具體不詳，考慮“高血壓腎病”，予以控制血壓、保護腎功能等治療，院外隨訪腎功能不詳。反覆因黑便多次在我院內二科住院，住院後診斷“尿毒症 腎性貧血，高血壓腎病，消化道出血，高血壓心臟病、心功能不全，營養不良”，給予輸血、止血、抑酸、糾正心衰等治療後好轉，後期患者自動出院後於**醫院就診，查血肌酐 638umol/L，尿素氮 22.92mmol/L，血常規：血紅蛋白 89g/L，電解質：血鉀 4.70mmol/L等，診斷“慢性腎臟病5期，腎性貧血，消化道出血，高血壓3級很高危、高血壓心臟病，尿路感染，低蛋白血癥”，急診行深靜脈置管，開始行規律血液透析，並給予止血、抑酸、營養支援、穩定血壓、抗尿路感染、對症等治療後好轉，並於2016-03-14行右前臂動靜脈內瘻吻合術，2016-04-06自動出院轉我科行長期維持性血液透析治療。1-月前受涼後出現咳嗽，家屬在藥店購買“消炎止咳”等藥物給其服用，具體不詳，服藥後症狀無好轉，起床後出現面部浮腫，咳嗽時腹部疼痛，伴有腹瀉，無腹痛腹脹，無噁心嘔吐，無發熱、氣促，無心悸胸悶，無兩上肢水腫，為進一步治療到我院透析室檢查透析後患者症狀無好轉，後收入我科住院，使用依替米星抗感染（7天），查胸部CT：1、考慮兩肺感染性病變，建議治療後複查。2、兩側少-中量胸腔積液。3、右肺尖條片狀及纖維條索狀影，右下肺門稍牽拉下移。4、心影增大，主動脈及冠狀動脈壁鈣化。5、少量心包積液。6、兩側胸膜增厚，左側少許胸膜鈣化。胸椎骨質增生。7、脾臟稍增大。因不除外肺部結核，建議轉往******醫院就診，於2017-10-13轉入******醫院，予以胸腔閉式引流術，莫西沙星抗感染（14天），胎盤多肽增強抵抗力，多索茶鹼舒張支氣管，厄貝沙坦氫氯噻嗪、氨氯地平降壓等治療，查胸水一般細菌塗片、找抗酸桿菌、腺苷脫氨酶測定、CEA、AFP、CA125無明顯異常，T-SPOT弱陽性，複查胸部CT提示：1、氣管左移，肺內血管支氣管束增多增粗，兩側肺較多散在的斑片狀、條索狀高密度影，考慮感染性病變可能；2、胸腔內可見明顯中量積液，密度不均，鄰近胸膜粘連；2、心臟血管及主動脈鈣化。*******醫院評估，目前暫不考慮肺結核診斷；患者目前間斷咳嗽，少許白色粘痰，不易咳出，精神欠佳，食慾差，感活動後心累，氣促較前緩解，無意識障礙大小便失禁，無胸悶胸痛，無心悸、噁心嘔吐，無腹脹腹痛腹瀉，無尿痛尿頻等不適，建議患者繼續抗感染治療，但患者家屬要求轉回我院，今日轉入我院繼續治療。病程中患者精神欠佳，飲食差，昨日解黃色稀便2次，小便約400ml，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 27, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 116, "end_pos": 120}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 162, "end_pos": 165}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 176, "end_pos": 179}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 196, "end_pos": 200}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 229, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 237, "end_pos": 241}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 242, "end_pos": 247}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 248, "end_pos": 256}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 257, "end_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 264, "end_pos": 268}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 269, "end_pos": 274}, {"label_type": "手術", "overlap": 0, "start_pos": 342, "end_pos": 353}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 444, "end_pos": 446}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 455, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 475}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 483}, {"label_type": "藥物", "overlap": 0, "start_pos": 521, "end_pos": 525}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 534, "end_pos": 538}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 543, "end_pos": 550}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 567, "end_pos": 571}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 574, "end_pos": 577}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 592}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 600, "end_pos": 601}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 605, "end_pos": 616}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 621, "end_pos": 625}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 628, "end_pos": 632}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 639, "end_pos": 643}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 644, "end_pos": 650}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 653, "end_pos": 655}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 663, "end_pos": 665}, {"label_type": "手術", "overlap": 0, "start_pos": 707, "end_pos": 714}, {"label_type": "藥物", "overlap": 0, "start_pos": 715, "end_pos": 719}, {"label_type": "藥物", "overlap": 0, "start_pos": 728, "end_pos": 732}, {"label_type": "藥物", "overlap": 0, "start_pos": 738, "end_pos": 742}, {"label_type": "藥物", "overlap": 0, "start_pos": 748, "end_pos": 756}, {"label_type": "藥物", "overlap": 0, "start_pos": 757, "end_pos": 761}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 768, "end_pos": 776}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 778, "end_pos": 782}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 783, "end_pos": 790}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 791, "end_pos": 794}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 795, "end_pos": 798}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 799, "end_pos": 804}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 822, "end_pos": 826}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 831, "end_pos": 833}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 836, "end_pos": 844}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 849, "end_pos": 852}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 881, "end_pos": 883}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 900, "end_pos": 902}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 907, "end_pos": 917}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 936, "end_pos": 939}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 998, "end_pos": 999}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1000, "end_pos": 1001}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1004, "end_pos": 1005}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1013, "end_pos": 1014}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1015, "end_pos": 1016}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1017, "end_pos": 1018}]}
{"originalText": "入院前5+小時，患者被家屬發現呼之不應，無噁心、嘔吐，無四肢抽搐。家屬家中自測血糖3.2mmol/l，家屬給予\\\"糖水\\\"口服後，複查血糖6.5mmol/l，但仍然呼之不應，家屬撥打120接回。入室後立即予以心電監護，吸氧，建立靜脈通道，床旁心電圖示：室下性心動過速。急查血常規、腎功、電解質、心肌酶譜、肌鈣蛋白、D-二聚體，血氣分析，頭顱及胸部CT，於14:23接放射科危急值報告血氣分析:血氧飽和度83.00 %↓、氧分壓45 mmHg↓↓、二氧化碳分壓30 mmHg↓、乳酸11.40 mmol/l↑↑，氧飽和度逐漸上降，告訴患者家屬患者目前情況需要緊急氣管插管，患者家屬表示同意，於14:35分行氣管插管，但患者牙關緊閉，口中假牙無法取出。行血常規:WBC 7.5 10^9/L、RBC 4.51 10^12/L、HGB 128 g/L↓、PLT 213 10^9/L，腎功:UREA 5.44 mmol/L、CREA 57.5 μmol/l、UA 208.8 μmol/l↓，電解質1:K 5.07 mmol/l、Na 141.4 mmol/、Cl 98.1 mmol/l↓，心肌酶譜:AST 34.0 U/L、CK 360.7 U/L↑、CK-MB 15 U/L、LDH 222.9 U/L，高敏肌鈣蛋白:TNT-HSSTT 38.29 pg/ml↑，D_2聚體:D-D 1.90 μg/ml↑，凝血試驗:PT 12.3 秒、INR 1.04 、APTT 17.7 秒↓、FIB 3.41 g/L、TT 16.4 秒，血氣分析全套:TCO2 21 mmol/l↓、pH 7.440 、PCO2 30 mmHg↓、PO2 45 mmHg↓↓、HCO3 20.4 mmol/l↓、SBC 22.40 mmol/l、BE(ecf) -3.8 mmol/l↓、BE(B) -2.80 mmol/l、sO2% 83.00 %↓、Lac 11.40 mmol/l↑↑、GLU 5.80 mmol/l、Na+ 138 mmol/l、K+ 5.0 mmol/l、Ca++ 1.07 mmol/l↓.頭顱CT：考慮右側基底節區腦梗死；左側基底節腔隙性腦梗死。2、腦白質脫髓鞘改變；腦萎縮。3、考慮兩肺感染性病變，建議治療後複查。4、兩側少量胸腔積液。5、主動脈及冠狀動脈壁鈣化。6、胸椎骨質增生。給予補液，營養神經等治療，請我科會診，交代患者病情危重，隨時有生命危險，家屬對病情表示理解，同意轉ICU治療。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 30}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 67, "end_pos": 69}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 104, "end_pos": 108}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 121, "end_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 133}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 168, "end_pos": 175}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 196, "end_pos": 201}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 210, "end_pos": 213}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 223, "end_pos": 229}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 255, "end_pos": 259}, {"label_type": "手術", "overlap": 0, "start_pos": 280, "end_pos": 284}, {"label_type": "手術", "overlap": 0, "start_pos": 302, "end_pos": 306}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 329, "end_pos": 332}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 361, "end_pos": 364}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 374, "end_pos": 377}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 392, "end_pos": 396}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 409, "end_pos": 413}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 426, "end_pos": 428}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 448, "end_pos": 449}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 462, "end_pos": 464}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 477, "end_pos": 479}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 498, "end_pos": 501}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 511, "end_pos": 513}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 525, "end_pos": 530}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 538, "end_pos": 541}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 559, "end_pos": 568}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 588, "end_pos": 591}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 609, "end_pos": 611}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 619, "end_pos": 622}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 629, "end_pos": 633}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 642, "end_pos": 645}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 655, "end_pos": 657}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 672, "end_pos": 676}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 688, "end_pos": 690}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 698, "end_pos": 702}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 712, "end_pos": 715}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 726, "end_pos": 730}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 744, "end_pos": 747}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 761, "end_pos": 768}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 782, "end_pos": 787}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 801, "end_pos": 805}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 815, "end_pos": 818}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 834, "end_pos": 837}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 850, "end_pos": 852}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 865, "end_pos": 866}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 879, "end_pos": 881}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 897, "end_pos": 901}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 904, "end_pos": 913}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 914, "end_pos": 925}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 928, "end_pos": 936}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 937, "end_pos": 940}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 945, "end_pos": 952}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 967, "end_pos": 971}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 974, "end_pos": 985}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 988, "end_pos": 994}]}
{"originalText": "入院前1年，患者因咯血於**醫院診斷“肺癌”（未見報告、具體不詳）。未給予手術、放化療治療，間斷服用中藥治療。病程中反覆咳嗽、咳痰，痰中帶鮮紅色血液。不伴發熱、畏寒、寒戰、反酸、燒心、噯氣、呃逆、頭昏、頭痛、乏力、胸悶、胸痛、心悸、氣促、腹痛、腹瀉、黑便，無暈厥、黑朦、意識喪失。1月前，患者進食火鍋後出現臍周陣發性隱痛，以臍周偏左側為主，無肩背部放射痛，與進食及體位無關，疼痛持續時間不定。伴噁心、納差，飲食較前減少約1/2，以流質為主，伴噯氣，無反酸、燒心、嘔吐、腹瀉、黑便、心悸、氣促、胸悶、胸痛，無畏寒、發熱，肛門未停止排便排氣。於我院消化科住院，複查胸部CT平掃提示“左肺下葉後段團片狀影、右肺上葉腫塊影及兩肺散在多發類圓形影，縱隔及主動脈弓旁多發腫大淋巴結影，考慮肺Ca伴兩肺及縱隔淋巴結轉移”。全腹部增強CT示“膽總管及胰管輕度擴張，胰頭上方及鄰近十二指腸腹壺周圍見增多軟組織影，考慮為淋巴結轉移；鄰近十二指腸壁腫脹，提示腫瘤受侵，右側腎下腺稍增大，轉移可能大；右側腹股溝淋巴結轉移，兩上肺結節考慮肺內轉移；胸9椎體及附件骨質破壞、轉移，右側髂骨多發骨質破壞伴周圍軟組織腫脹，累及鄰近骶髂關節面。右側股骨轉子間骨質破壞，考慮骨轉移”。遂轉入**醫院，完善相關檢查後診斷考慮為“肺癌伴全身多處轉移”（具體不詳），並逐漸出現面板、鞏膜黃染。10+天前，患者無明顯誘因出現解黑便，2-3次/天，量少，無粘液、膿血，伴頭昏、乏力、納差，偶有噯氣，無嘔血、腹痛、腹脹，無反酸、燒心，未予特殊處理。3+小時前，患者無明顯誘因出現噁心、嘔吐3次，嘔吐物為咖啡色胃內容物，無鮮紅色血液及血凝塊，不呈噴射狀，伴腹痛，為持續性隱痛，臍周為主，伴頭昏，如廁時暈厥2次，由家屬攙扶，持續約數十秒後意識恢復，無抽搐，無大小便失禁，無肢體活動障礙。呼叫120送入我院急診科，查指血糖：26.0mmol/L，糞便隱血試驗 陽性，血常規：WBC 13.4*109/L，RBC 1.9*1012/L，PLT 507*109/L，Hb 48g/L，N 92.44%，Hct 15.6%。遂以“肺癌伴全身多處轉移、消化道出血、重度貧血”收入住院。患者此次患病以來，精神、食慾、睡眠欠佳，大便如下述，小便顏色加深，尿量可。體重上降約5kg。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 99}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 153, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 249, "end_pos": 250}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 261}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 280, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 300, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 310}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 338, "end_pos": 352}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 354, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 366}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 367, "end_pos": 369}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 374, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 381, "end_pos": 387}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 408, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 428}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 438, "end_pos": 448}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 449, "end_pos": 460}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 475}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 476, "end_pos": 486}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 487, "end_pos": 492}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 499, "end_pos": 504}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 505, "end_pos": 516}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 519, "end_pos": 522}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 545, "end_pos": 554}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 570, "end_pos": 572}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 612, "end_pos": 613}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 630, "end_pos": 631}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 633, "end_pos": 634}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 680, "end_pos": 681}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 703, "end_pos": 704}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 713, "end_pos": 715}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 719, "end_pos": 720}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 760, "end_pos": 762}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 782, "end_pos": 784}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 796, "end_pos": 802}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 810, "end_pos": 813}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 825, "end_pos": 828}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 840, "end_pos": 843}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 854, "end_pos": 856}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 863, "end_pos": 864}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 872, "end_pos": 875}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 885, "end_pos": 894}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 895, "end_pos": 900}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 901, "end_pos": 905}]}
{"originalText": "患者入院前6年餘無明顯誘因出現心累、氣促，起病初多以活動後明顯，伴胸悶，無明顯胸痛，需胸骨後壓榨感，無上肢浮腫，無夜間陣發性呼吸困難，患者休息後症狀可減輕，曾於*******醫院就診，考慮“冠狀動脈粥樣硬化性心臟病”，並辦理特病，但平素未行相關治療。入院前1年患者因心累加重，並全身多處瘀斑，於******醫院住院治療，行心臟彩超提示“右房增大，室間隔、右室後壁增厚，左室流出道增寬，二尖瓣及主動脈瓣狹窄，二尖瓣及三尖瓣重度反流，反流壓差增高，肺動脈瓣及主動脈瓣輕度反流，心包積液，右室收縮功能正常”，具體治療不詳，出院後患者長期服用“單硝酸異山梨酯緩釋片、阿託伐他汀鈣、厄貝沙坦、曲美他嗪”等藥物，仍有活動後心累不適。半年前患者因活動後胸悶伴胸痛在我科住院，予以改善迴圈、降脂穩定斑塊、利尿減輕心臟負荷等對症治療後好轉出院。近1周患者訴咳嗽、咳痰，痰中偶有鮮紅色血絲，入院前3小時，患者無明顯誘因出現心悸、氣促，伴右側胸痛，右下臂及右後背疼痛，無明顯上肢浮腫，無畏寒發熱，無潮熱盜汗，無意識障礙，無噁心嘔吐等不適，遂來我院就診，急診科查血常規：白細胞數 12.6×10^9/L、血紅蛋白濃度 116 g/L、血小板數 103×10^9/L、中性粒細胞百分比 76.74 %，心肌酶譜：肌酸激酶同工酶 41 U/L。腎功、高敏肌鈣蛋白、電解質未見明顯異常，心電圖示快速型房顫，予以強心、利尿、改善心肌血供等對症處理後患者自覺症狀稍緩解。現為進一步治療收入我科住院。患者1年前因全身多處瘀斑，於******醫院就診，完善檢查發現血小板減少、貧血，查血常規(2016-03-01)PLT 63×109/L、HB 63g/L；住院期間予以骨髓穿刺，考慮缺鐵性貧血、血小板減少性紫癜，予以輸紅細胞懸液2U，並激素治療（目前已停用），自訴複查指標好轉。並於住院期間檢查發現腎功能異常 BUN 19.6mmol/L CREA 223umol/L，原因不明確，因血小板減少未能腎活檢，出院診斷考慮慢性腎臟病（CKD3期），急性腎損害不除外。患者自發病以來精神、食慾較差，大小便未訴異常。近期體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 43, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 134}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 161, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 170}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 231}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 240}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 249}, {"label_type": "藥物", "overlap": 0, "start_pos": 268, "end_pos": 278}, {"label_type": "藥物", "overlap": 0, "start_pos": 279, "end_pos": 285}, {"label_type": "藥物", "overlap": 0, "start_pos": 286, "end_pos": 290}, {"label_type": "藥物", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 306}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 323}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 408, "end_pos": 411}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 416}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 420}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 428}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 473, "end_pos": 476}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 490, "end_pos": 496}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 505, "end_pos": 508}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 521, "end_pos": 529}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 543, "end_pos": 550}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 578, "end_pos": 581}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 582, "end_pos": 587}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 663, "end_pos": 668}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 669, "end_pos": 671}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 688, "end_pos": 691}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 701, "end_pos": 703}, {"label_type": "手術", "overlap": 0, "start_pos": 716, "end_pos": 720}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 723, "end_pos": 728}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 729, "end_pos": 737}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 787, "end_pos": 790}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 802, "end_pos": 806}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 824, "end_pos": 829}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 841, "end_pos": 853}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 854, "end_pos": 859}]}
{"originalText": "患者於入院半年前發現兩上肢浮腫、尿量減少、喘累，到****醫院查血常規： Hb：87g/l，腎功：血肌酐：394umol/L，考慮腎功能不全、腎性貧血，後到**********醫院就診，查腎功：血肌酐：330umol/L，血常規：Hb：89g/l，甲狀旁腺激素 55.5pg/ml，內生肌酐清除率：14.49ml/min，腹部彩超：兩腎結構欠清，實質回聲稍增強，腹腔少量積液；心臟彩超：右室肥厚，少許心包積液；胸部CT平掃：右肺上葉炎症，心臟增大，兩側胸腔積液，給予血液淨化治療、降壓、降糖、糾正貧血、改善迴圈等治療後好轉出院。5月前曾因胸悶心悸於我科住院，考慮診斷“1、慢性腎臟病5期 腎性貧血 2、原發性高血壓3級很高危 高血壓性心臟病 3、2型糖尿病 糖尿病周圍神經病變 糖尿病視網膜病變 4、甲狀腺功能減退 5、心包積液”，予以深靜脈置管、血液透析，糾正貧血，改善心功能，降糖，降壓後症狀好轉出院。入院前半月患者無明顯誘因開始出現咳嗽咳白色粘痰，量少，伴心累氣促，活動後加重，伴顏面及兩上肢水腫，今於我院血透室行透析治療，查血常規：白細胞數 8.8 10^9/L、紅細胞數 3.17 10^12/L、血紅蛋白濃度 91 g/L、血小板數 200 10^9/L、中性粒細胞百分比 86.61 %，腎功：尿素 15.26 mmol/L、肌酐 331.2 μmol/l，電解質2：鉀 4.87 mmol/l、鈉 137.1 mmol/、氯 107.4 mmol/l，透析後感心累氣促減輕，為進一步治療，門診收入我科住院治療。患者自患病以來，精神、睡眠可，食慾差，大便結燥，院外服用瀉藥，具體不詳，後今日解稀便2次，小便偏少，量約500ml/d，體重無明顯變化。22年前因手足麻木在當地醫院查血糖升高，值不詳，診斷為2型糖尿病，先後服用格列齊特、消渴丸降糖，偶測血糖20+mmol/L,曾服用二甲兩胍出現噁心、嘔吐停用，後開始出現視物模糊、兩上肢水腫，2年前開始使用優思林降血糖，血糖控制不詳，現改為諾和銳30 16u/早，12u/晚降血糖，血糖控制可。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 37, "end_pos": 39}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 49, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 75}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 97, "end_pos": 100}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 124, "end_pos": 130}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 161, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 168}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 183}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 188, "end_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 200, "end_pos": 204}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 205, "end_pos": 209}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 218}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 219, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 230}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 269, "end_pos": 270}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 301, "end_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 320}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 323, "end_pos": 328}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 329, "end_pos": 338}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 339, "end_pos": 347}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 350, "end_pos": 357}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 443, "end_pos": 445}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 446, "end_pos": 449}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 470, "end_pos": 473}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 486, "end_pos": 489}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 504, "end_pos": 510}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 518, "end_pos": 521}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 534, "end_pos": 539}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 554, "end_pos": 556}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 570, "end_pos": 572}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 591, "end_pos": 592}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 605, "end_pos": 606}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 619, "end_pos": 620}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 736, "end_pos": 738}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 746, "end_pos": 750}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 758, "end_pos": 763}, {"label_type": "藥物", "overlap": 0, "start_pos": 768, "end_pos": 772}, {"label_type": "藥物", "overlap": 0, "start_pos": 773, "end_pos": 776}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 781, "end_pos": 783}, {"label_type": "藥物", "overlap": 0, "start_pos": 796, "end_pos": 800}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 820, "end_pos": 823}, {"label_type": "藥物", "overlap": 0, "start_pos": 833, "end_pos": 836}, {"label_type": "藥物", "overlap": 0, "start_pos": 850, "end_pos": 855}]}
{"originalText": "患者10+年前始逐漸出現慢性咳嗽、咳痰，每日均咳白色泡沫痰，受涼後症狀加重，偶咳嗽加劇時伴喘累，未特殊治療。5年前患者感體力耐量明顯上降，爬坡及平地快步活動不能耐受，受涼後喘累明顯加重，反覆住院治療，最近一次於2017-10-29於我院泌尿外科住院，給予保留導尿，頭孢唑肟抗感染、血必淨抗炎，抗前列腺增生，止咳祛痰、霧化對症等治療，11月5日轉我科給予哌拉西林他坐巴坦加強抗感染、解痙改善通氣、祛痰、改善微迴圈、改善排尿困難、調脂穩定斑塊、抗血小板聚等治療後好轉出院，出院診斷為：1、慢性阻塞性肺疾病急性加重期；2、泌尿道感染；3、感染性休克 代償期；4、前列腺增生；5、慢性前列腺炎；6、慢性尿瀦留；7、冠心病 冠脈支架及起搏器置入術後；8、高血壓病；9、輕度貧血；10、電解質紊亂；11、兩腎積水；12、慢性膀胱炎 膀胱憩室；13、兩肺結節待查；14、肝囊腫。1天前，患者無明顯誘因出現發熱，自測體溫37.9℃，伴有咳嗽，咳白色泡沫痰，痰不易咳出，喘息明顯，端坐呼吸，無畏寒、寒戰，無噁心、嘔吐，無咳嗽、咳痰，無腰痛不適，尿管導尿中，家人發現尿管中無尿，家屬遂送入我院急診，查血氣分析：PH 7.42，PaO2 93mmHg，PaCO2 31mmHg，標準碳酸氫根22.1mmol/l，實測碳酸氫根20.1mmol/l，BE3.7mmol/l。血常規：白細胞數 14.2×10^9/L、紅細胞數 2.94×10^12/L、血紅蛋白濃度 92 g/L、血小板數 194×10^9/L、中性粒細胞百分比 92.74 %，CRP：22 mg/l 。腎功、心肌酶未見明顯異常，電解質：鉀 3.47 mmol/l、鈉 127.2mmol/l、氯 88.2mmol/l，遂以“發熱待查：肺部感染？尿路感染？感染性休克？”收入我科。有“高血壓”病史7年，口服藥物控制，自訴血壓控制尚可，有“冠心病”病史，2年前行“冠脈支架置入術及起搏器置入術”，術後心率控制在85次/分右左，患者本次患病來，精神、睡眠、食慾欠佳，大便正常，小便如下述，體重無明顯改變。", "entities": [{"label_type": "藥物", "overlap": 0, "start_pos": 132, "end_pos": 136}, {"label_type": "藥物", "overlap": 0, "start_pos": 140, "end_pos": 143}, {"label_type": "藥物", "overlap": 0, "start_pos": 176, "end_pos": 184}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 242, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 258, "end_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 266, "end_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 278, "end_pos": 283}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 292}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 295, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 303, "end_pos": 306}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 319}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 322, "end_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 329, "end_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 337, "end_pos": 342}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 374}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 378, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 458, "end_pos": 459}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 495, "end_pos": 497}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 503, "end_pos": 507}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 515, "end_pos": 520}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 528, "end_pos": 534}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 545, "end_pos": 551}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 562, "end_pos": 564}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 578, "end_pos": 581}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 595, "end_pos": 598}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 613, "end_pos": 619}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 627, "end_pos": 630}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 643, "end_pos": 651}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 660, "end_pos": 663}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 690, "end_pos": 691}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 704, "end_pos": 705}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 718, "end_pos": 719}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 734, "end_pos": 738}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 739, "end_pos": 743}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 744, "end_pos": 748}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 749, "end_pos": 754}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 763, "end_pos": 766}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 790, "end_pos": 793}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 802, "end_pos": 816}]}
{"originalText": "患者30+年前檢查發現血壓高，最高時收縮壓超過200/？mmHg，長期服用降壓藥物（硝苯地平緩釋片、替米沙坦等），自訴血壓控制尚可，起初無頭昏、頭痛，無心悸、無活動後心累、乏力等不適。2016.9.3天患者無明確誘因反覆出現頭暈，急診頭部CT：兩側基底節區腔隙性腦梗死 2、腦白質輕度脫髓鞘改變，腦萎縮。3、基底動脈鈣化，隨訪。收入內1科行胸片：1.兩上肺紋理增多。2.主動脈弓迂曲、鈣化。心臟彩超：室間隔增厚（13.5mm）；三尖瓣輕度反流；肺動脈輕度高壓；右室舒張功能減退。出院診斷：1、原發性高血壓3級極高危，高血壓性心臟病 2、腦動脈供血不足 3、腔隙性腦梗死 4、2型糖尿病 5、冠狀動脈粥樣硬化性心臟病，慢性心衰。院外服藥：苯磺酸右旋氨氯地平2.5mg每日一次，厄貝沙坦氫氯噻嗪1片每日一次，二甲兩胍緩釋片0.5每日雙次，阿卡波糖50mg每日三次，氫氯噻嗪25mg每日一次，螺內酯20mg每日一次；1周前患者感頭昏陣性發作，無視物旋轉、視物模糊，無噁心嘔吐，2天前患者頭昏症狀加重，噁心，納差，心慌，無偏癱，無視野缺損，無四肢抽搐，無黑矇暈厥，為求進一步治療，遂入我院急診科，查血壓190/96mmhg，血糖(靜脈血)：葡萄糖 4.2mmol/l ，血常規：白細胞數 6.0×10^9/L、血紅蛋白濃度 113 g/L ↓、血小板數 181×10^9/L、CRP：C反應蛋白 <1 mg/l，血氣分析：PH 7.36，PCO2 28mmHg，PO2 126mmHg，碳酸氫根：15.8mmol/L，全血鹼剩餘 -8mmol/L，乳酸：10.3mmol/L，胸片：1，兩上肺感染，右上肺可疑環狀或結節狀稍高密度影，不除外支擴，隨訪複查或必要時CT進一步檢查。2，肺氣腫徵。3，主動脈球鈣化。4，胸椎骨質增生。以“高血壓 糖尿病 乳酸酸中毒”收入我科。患者此次患病以來精神食慾差，大便正常，夜尿次數增多，睡眠尚可,體力及體重無明顯改變.近來訴咳嗽，少痰。", "entities": [{"label_type": "藥物", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "藥物", "overlap": 0, "start_pos": 50, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 113}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 160}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 189}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 214, "end_pos": 217}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 238}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 257}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 258, "end_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 268, "end_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 278, "end_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 287, "end_pos": 292}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 295, "end_pos": 307}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "藥物", "overlap": 0, "start_pos": 318, "end_pos": 327}, {"label_type": "藥物", "overlap": 0, "start_pos": 337, "end_pos": 345}, {"label_type": "藥物", "overlap": 0, "start_pos": 352, "end_pos": 359}, {"label_type": "藥物", "overlap": 0, "start_pos": 367, "end_pos": 371}, {"label_type": "藥物", "overlap": 0, "start_pos": 380, "end_pos": 384}, {"label_type": "藥物", "overlap": 0, "start_pos": 393, "end_pos": 396}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 411, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 440, "end_pos": 441}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 467, "end_pos": 469}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 516, "end_pos": 519}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 535, "end_pos": 538}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 551, "end_pos": 557}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 568, "end_pos": 571}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 588, "end_pos": 593}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 607, "end_pos": 609}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 615, "end_pos": 619}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 627, "end_pos": 630}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 639, "end_pos": 643}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 655, "end_pos": 660}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 670, "end_pos": 672}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 684, "end_pos": 686}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 689, "end_pos": 694}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 695, "end_pos": 698}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 715, "end_pos": 717}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 726, "end_pos": 728}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 736, "end_pos": 739}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 743, "end_pos": 749}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 752, "end_pos": 758}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 761, "end_pos": 764}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 765, "end_pos": 768}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 769, "end_pos": 774}]}
{"originalText": "入院前1+年無明顯誘因逐漸出現活動障礙、反應遲鈍、與人交流減少，對周圍事物缺乏興趣、記憶減退，同時有納差、逐漸消瘦，未述明顯腹痛、腹脹、吞嚥梗阻，無胸悶、心悸、發熱，患者長期臥床、有大小便失禁，5月前因納差在我院住院，作胸腹部CT：1、考慮左肺中葉及上葉少許慢性感染。2、左肺下葉尖段外側胸膜上梭形突起，考慮脂肪瘤。3、主動脈及冠狀動脈壁鈣化。4、肺氣腫徵。5、胸椎骨質增生，左側多根肋骨陳舊骨折。6、左側甲狀腺可疑結節影。7、肝右葉內側段小片狀稍低密度影，建議增強掃描。8、兩腎多發小結石；左腎囊腫。9、膽囊結石。10、肝左葉上段見兩邊影，考慮呼吸動度偽影，不除外少許腹腔積液可能。11、腹主動脈壁鈣化。腰椎骨質增生。12、骶管內類圓形稍低密度影，考慮良性病變，骶管囊腫可能。建議結合臨床。因患者呼吸動度較大，掃描範圍內胸腹部部分影象較模糊，建議隨訪複查。診斷為“1.高滲性脫水 2.急性腎功能不全 3.老年痴呆症 4 .重度營養不良”，予糾正電解質、營養支援治療好轉出院。出院後患者反覆有食納差，無噁心、嘔吐，無黃染、厭油，近期患者不願進食，未述明顯腹痛、腹脹，無畏寒、發熱、胸痛、呼吸困難、黑便、嘔血等，今日患者稍有噁心、嘔吐、煩躁不安，無意識障礙，家屬將其送入我院，在門診查血常規：白細胞數 13.0×10^9/L、中性粒細胞百分比 86.04 %，心肌酶譜：穀草轉氨酶 49.0 U/L、肌酸激酶 247.7 U/L、乳酸脫氫酶 343.3 U/L，腎功：尿素 27.62 mmol/L、肌酐 309.1 μmol/l、尿酸 592.5 μmol/l，高敏肌鈣蛋白：高敏肌鈣蛋白T 130.70 pg/ml，電解質1：鈉 168.7 mmol/l、氯 128.0 mmol/l。心電圖提示：快速性房顫。為進一步就診，我院急診科以“老年痴呆、重度營養不良”收入住院。病程中患者精神差，睡眠差，長期大小便失禁，體重減輕不祥。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 110, "end_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 136, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 144, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 157}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 174, "end_pos": 177}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 181, "end_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 214, "end_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 295, "end_pos": 302}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 303, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 313, "end_pos": 315}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 332, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 361, "end_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 390}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 393, "end_pos": 400}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 403, "end_pos": 408}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 412, "end_pos": 418}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 477, "end_pos": 478}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 481}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 490, "end_pos": 491}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 545, "end_pos": 548}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 562, "end_pos": 570}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 584, "end_pos": 589}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 599, "end_pos": 603}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 614, "end_pos": 619}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 633, "end_pos": 635}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 649, "end_pos": 651}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 665, "end_pos": 667}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 688, "end_pos": 695}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 714, "end_pos": 715}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 729, "end_pos": 730}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 744, "end_pos": 747}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 750, "end_pos": 755}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 770, "end_pos": 774}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 775, "end_pos": 781}]}
{"originalText": "入院前6+天患者無明顯誘因出現咳嗽、咳痰，易咳出大量白色粘痰，感陣發性胸悶，左季肋間斷隱痛，休息可緩解，上肢水腫，無頭昏、頭痛、發熱，無胸痛，無腹痛腹瀉，今日為進一步治療，遂來我院，急診查X線：左上肺可疑類圓形淺淡密度影，建議CT進一步檢查。血常規：白細胞數 3.3 10^9/L ↓、紅細胞數 2.70 10^12/L ↓、血紅蛋白濃度 98 g/L ↓、血小板數 32 10^9/L ↓、淋巴細胞絕對值 0.84 10^9/L ↓、紅細胞壓積 27.7 % ↓、平均紅細胞體積 102.6 fL ↑、平均紅細胞血紅蛋白量 36.3 pg ↑、紅細胞體積分佈寬度 56.5 fl ↑、紅細胞體積分佈寬度百分比 15.4 % ↑，CRP：C反應蛋白 5 mg/l，未予處理，以“咳嗽待查”收入我科住院治療。2年前在外院及我院確診“肝癌”，故訴長期悶油、牙齦易出血，易鼻出血，凝血功能異常。2月22日我院腫瘤標誌物：甲胎蛋白 16.90 ng/ml ↑，3月12日我院查乙肝三對：乙肝表面抗原定性 陽性、乙肝核心抗體定性 陽性，肝功3：穀草轉氨酶 87.5 U/L ↑、鹼性磷酸酶 172.5 U/L ↑、總膽紅素 44.7 μmol/l ↑、直接膽紅素 28.2 μmol/l ↑、總膽汁酸 106.84 μmol/l ↑。2015年2月20日我院查全腹增強CT：1，考慮為肝硬化、脾臟輕度增大，建議結合臨床或必要時進一步檢查。2，胰頭體積稍增大，形態欠規則，不除外腫瘤。3，大量腹水，腹膜後及網膜、系膜內多個小結節影，考慮為增大的淋巴結可能，建議CT增強進一步明確。4，右側中上腹部分小腸積氣，伴小液平形成，提示不全性腸梗阻可能大，結合臨床隨訪或CT增強檢查。5，前列腺鈣化。6，腰椎骨質增生。7，掃描野右肺底少許慢性炎症或纖維化；右側胸壁胸膜稍增厚。病程中精神、食慾一般，大小便正常，無明顯體重上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 35, "end_pos": 36}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 113, "end_pos": 115}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 125, "end_pos": 128}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 143, "end_pos": 146}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 163, "end_pos": 169}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 196, "end_pos": 203}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 218, "end_pos": 223}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 233, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 252, "end_pos": 262}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 273, "end_pos": 282}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 293, "end_pos": 305}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 319, "end_pos": 324}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 339, "end_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 367}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 376, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 407, "end_pos": 411}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 439, "end_pos": 447}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 451, "end_pos": 459}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 467, "end_pos": 472}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 484, "end_pos": 489}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 502, "end_pos": 506}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 521, "end_pos": 526}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 541, "end_pos": 545}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 575, "end_pos": 581}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 587, "end_pos": 590}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 591, "end_pos": 593}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 616, "end_pos": 618}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 640, "end_pos": 641}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 643, "end_pos": 645}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 647, "end_pos": 649}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 650, "end_pos": 652}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 674, "end_pos": 676}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 686, "end_pos": 691}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 693, "end_pos": 697}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 707, "end_pos": 713}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 724, "end_pos": 726}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 733, "end_pos": 738}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 741, "end_pos": 747}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 753, "end_pos": 756}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 767, "end_pos": 773}]}
{"originalText": "入院前3年患者在院外發現腎功能異常，具體不詳，考慮“高血壓腎病”，予以控制血壓、保護腎功能等治療，院外隨訪腎功能不詳。反覆因黑便多次在我院內二科住院，住院後診斷“尿毒症 腎性貧血，高血壓腎病，消化道出血，高血壓心臟病、心功能不全，營養不良”，給予輸血、止血、抑酸、糾正心衰等治療後好轉，後期患者自動出院後於**醫院就診，查血肌酐 638umol/L，尿素氮 22.92mmol/L，血常規：血紅蛋白 89g/L，電解質：血鉀 4.70mmol/L等，診斷“慢性腎臟病5期，腎性貧血，消化道出血，高血壓3級很高危、高血壓心臟病，尿路感染，低蛋白血癥”，急診行深靜脈置管，開始行規律血液透析，並給予止血、抑酸、營養支援、穩定血壓、抗尿路感染、對症等治療後好轉，並於2016-03-14行右前臂動靜脈內瘻吻合術，2016-04-06自動出院轉我科行長期維持性血液透析治療，4天前受涼後出現咳嗽，家屬在藥店購買“消炎止咳”等藥物給其服用，具體不詳，服藥後症狀無好轉，今日起床後出現面部浮腫，咳嗽時腹部疼痛，伴有腹瀉，無腹痛腹脹，無噁心嘔吐，無發熱、氣促，無心悸胸悶，無兩上肢水腫，為進一步治療到我院透析室檢查腎功：尿素 9.27 mmol/L、肌酐 540.5 μmol/l、尿酸 313.4 μmol/l，電解質：鉀 4.15 mmol/l、鈉 140.3 mmol/l、氯 104.1 mmol/l、二氧化碳 22.6 mmol/l、鈣 2.11 mmol/l、磷 1.13 mmol/l，血常規：白細胞數 4.1×10^9/L、紅細胞數 3.97×10^12/L、血紅蛋白濃度 121 g/L、血小板數 101×10^9/L、中性粒細胞百分比 82.91 %，透析後患者症狀無好轉，門診以\\\"慢性腎臟病5期，肺炎\\\"收入我科住院治療。病程中患者精神、飲食一般，大便正常，小便約200ml，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 26, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 81, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 101}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 108}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 119}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 161, "end_pos": 164}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 175, "end_pos": 178}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 228, "end_pos": 235}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 240}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 246}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 262}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 267}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 268, "end_pos": 273}, {"label_type": "手術", "overlap": 0, "start_pos": 341, "end_pos": 352}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 444, "end_pos": 446}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 455, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 475}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 476, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 483}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 503, "end_pos": 505}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 518, "end_pos": 520}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 534, "end_pos": 536}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 554, "end_pos": 555}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 568, "end_pos": 569}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 583, "end_pos": 584}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 598, "end_pos": 602}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 615, "end_pos": 616}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 629, "end_pos": 630}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 647, "end_pos": 650}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 663, "end_pos": 666}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 681, "end_pos": 687}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 696, "end_pos": 699}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 712, "end_pos": 720}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 745, "end_pos": 752}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 753, "end_pos": 755}]}
{"originalText": "入院前10余天患者無明顯誘因出現下腹脹，伴納差、大便未解，無反酸、噯氣、燒心，無腹痛、腹瀉、嘔吐，無黑便、嘔吐咖啡色物質及膽汁，未予重視治療。入院前半天患者服用“通便藥物”後出現解暗紅色稀糊樣便，共5次，總量約300g，伴頭昏、乏力、冷汗，伴下腹部不適、心悸、胸悶，伴心悸、氣促，無黑曚、暈厥、嘔吐，為進一步診治遂至我院急診，急診科查心肌酶譜：穀草轉氨酶 27.7 U/L、肌酸激酶 175.9 U/L、肌酸激酶同工酶 22 U/L、乳酸脫氫酶 287.8 U/L，腎功：尿素 27.48 mmol/L、肌酐 92.4 μmol/l、尿酸 340.8 μmol/l，凝血試驗：凝血酶原時間 14.4 秒、國際標準化比值 1.21、活化部分凝血酶原時間 22.1 秒、纖維蛋白原 2.50 g/L、凝血酶時間 15.3 秒，高敏肌鈣蛋白：高敏肌鈣蛋白T 77.89 pg/ml，血常規：白細胞數 9.5×10^9/L、紅細胞數 2.85×10^12/L、血紅蛋白濃度 82 g/L、血小板數 130×10^9/L、中性粒細胞百分比 88.24 %、紅細胞壓積 25.9 %，腹部彩超提示膽囊壁增厚毛糙，考慮“1.急性下消化道出血2.慢性心力衰竭 房顫3.肺部感染4.腸梗阻？”，給予速尿20mg靜推後收入我科。入院前10餘年患者反覆出現勞力性心累氣促，伴間斷夜間陣發性呼吸困難、兩上肢水腫，在外院診斷“冠狀動脈粥樣硬化性心臟病 心衰 房顫”，2+年前患者在我院住院診斷“1.冠狀動脈粥樣硬化性心臟病 缺血性心肌病型 心功能不全 心功能III級 心律失常 心房纖顫伴II°房室傳導阻滯 2.原發性高血壓2級 極高危 3.肺部感染 4.前列腺增生症”。院外長期服用“單硝酸異山梨酯、利尿劑”等治療，穩定期時患者僅能耐受輕度體力活動。病程以來患者精神食慾差，大便同前，小便尚可，體重無改變，體力上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 40, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 43, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 131}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 135}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 172, "end_pos": 177}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 187, "end_pos": 191}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 202, "end_pos": 209}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 217, "end_pos": 222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 236, "end_pos": 238}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 252, "end_pos": 254}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 267, "end_pos": 269}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 288, "end_pos": 294}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 302, "end_pos": 309}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 315, "end_pos": 325}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 333, "end_pos": 338}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 368, "end_pos": 374}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 392, "end_pos": 396}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 408, "end_pos": 412}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 426, "end_pos": 432}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 440, "end_pos": 444}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 456, "end_pos": 464}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 473, "end_pos": 478}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 486, "end_pos": 490}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 492, "end_pos": 495}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 505, "end_pos": 513}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 515, "end_pos": 521}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 522, "end_pos": 524}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 526, "end_pos": 530}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 532, "end_pos": 535}, {"label_type": "藥物", "overlap": 0, "start_pos": 540, "end_pos": 542}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 570, "end_pos": 571}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 591}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 600, "end_pos": 612}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 613, "end_pos": 615}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 616, "end_pos": 618}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 636, "end_pos": 656}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 657, "end_pos": 662}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 663, "end_pos": 670}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 671, "end_pos": 675}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 676, "end_pos": 690}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 693, "end_pos": 705}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 708, "end_pos": 712}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 715, "end_pos": 721}, {"label_type": "藥物", "overlap": 0, "start_pos": 730, "end_pos": 737}]}
{"originalText": "患者7+年前開始出現受涼後咳嗽、伴喘累，需輸液治療緩解，緩解後未長期口服藥物，每年冬春季及天氣變化時易於發病，無胸痛、咯血，多次在外院就診考慮“慢支炎、肺氣腫”。病程中逐漸出現勞力性氣促，初為爬坡及重體力勞動時出現，後平地活動亦感氣促，受涼後喘累氣促明顯加重，反覆在當地醫院輸液治療。近1+年患者先後多次在我院住院治療，診斷“慢性支氣管炎急性發作”，經抗感染、止咳祛痰、平喘等治療病情稍緩解。入院前10天患者無明顯誘因咳嗽咯痰症狀加重，咯痰費力，伴有心慌胸悶，喘累氣促，在*****醫院住院治療1周後病情好轉於昨日出院。入院前4小時患者感咳嗽加重，喉頭有痰不能咯出，劇烈咳嗽後感腹痛，喘累氣促明顯，伴有呼吸困難，大汗淋漓，無畏寒發熱，無噁心嘔吐，無胸痛咯血，無咯粉紅色泡沫痰。家屬呼叫120接入我院，接診途中予以靜推“地塞米松10mg”。到達我院急救部後查血氣分析全套：二氧化碳總量 38 mmol/l、酸鹼度 7.350、二氧化碳分壓 65 mmHg、氧分壓 231 mmHg、碳酸氫根 35.9 mmol/l、標準碳酸氫根 30.70 mmol/l、全血鹼剩餘 7.30 mmol/l、血氧飽和度 100.00 %；血常規：白細胞數 8.7 10^9/L、紅細胞數 5.34 10^12/L、血紅蛋白濃度 148 g/L、血小板數 191 10^9/L、中性粒細胞百分比 82.81 %；腎功：尿素 6.11 mmol/L、肌酐 58.0 μmol/l、尿酸 406.8 μmol/l；電解質1：鉀 4.45 mmol/l、鈉 142.7 mmol/、氯 101.0 mmol/l；C反應蛋白 <1 mg/l。為進一步診療急診以“慢支炎急發、肺氣腫”收我科住院。本次發病以來患者精神食慾較差，大小便如常，睡眠較差，體力上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 56, "end_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 163, "end_pos": 173}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 290}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 324, "end_pos": 325}, {"label_type": "藥物", "overlap": 0, "start_pos": 359, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 385, "end_pos": 391}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 402, "end_pos": 405}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 412, "end_pos": 418}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 427, "end_pos": 430}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 440, "end_pos": 444}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 457, "end_pos": 463}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 477, "end_pos": 482}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 495, "end_pos": 500}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 514, "end_pos": 517}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 530, "end_pos": 533}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 548, "end_pos": 554}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 579, "end_pos": 587}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 599, "end_pos": 601}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 614, "end_pos": 616}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 629, "end_pos": 631}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 650, "end_pos": 651}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 664, "end_pos": 665}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 678, "end_pos": 679}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 693, "end_pos": 698}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 717, "end_pos": 722}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 723, "end_pos": 726}]}
{"originalText": "患者入院前半月患者可能受涼後感咳嗽，咯少許白色粘痰，無痰中帶血，並乏力，輕微認知功能障礙，餘否認畏寒發熱，無潮熱盜汗，無胸痛，無呼吸困難，無上肢浮腫。於*****老年科住院治療，完善輔助檢查，2018-01-15血常規 WBC 8.28x10^9/L、RBC 3.65x10^12/L；BNP 875ng/L；2018-01-15CT提示：右側半卵圓中心及兩側基底節區多發腔隙性腦梗死灶可能。腦萎縮，兩側腦白質脫髓鞘改變。左側下頜竇及篩竇炎症。甲狀腺左葉稍低密度結節；峽部增厚。兩肺散在炎症，以兩肺上葉為甚，建議治療後複查，兩肺散在纖維灶，左肺下葉後段、右肺下葉及右肺上葉背段小結節狀鈣化灶，左肺中葉肺大泡形成，兩腎囊腫。結腸內較多內容物，隨訪。主動脈、弓下動脈、右左冠狀動脈、腹腔幹、肝固有動脈、肝動脈、腸繫膜下動脈、兩腎動脈、脾動脈及兩側髂總動脈髂內外動脈管壁多發鈣化。兩上肢血管彩超：兩上肢動脈硬化伴粥樣斑點形成。兩上肢深靜脈未見異常。心臟彩超提示：右室肥厚伴順應性減退、二尖瓣環、主動脈瓣鈣化；頸動脈彩超提示：兩側頸動脈斑塊形成右側頸內動脈內膜增厚。頭顱MRI提示兩側額頂葉、半卵圓中心、腦室體旁及基底節區、腦橋多發缺血灶及腔梗灶。腦萎縮。考慮診斷“肺部感染”，予以莫西沙星抗感染治療，並繼續改善認知、營養神經、祛痰、冠心病二級預防、控制血糖等處理，治療近9天，患者咳嗽症狀緩解，複查血色素較入院時上降，家屬訴其有黑便表現，複查維生素B12 220.0pg/ml，葉酸＞23.9ng/ml。鐵生化：血清鐵 3.4umol/L 總鐵結合力 47.7umol/L。骨髓穿刺提示骨髓增生活躍，內外鐵陰性。因患者不配合，家屬為方便照顧要求轉入我科繼續住院治療。患者此次患病以來精神、食慾、睡眠一般，大便乾結，小便正常，體力及體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 60, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 110, "end_pos": 113}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 126, "end_pos": 129}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 143, "end_pos": 146}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 167}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 193}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 196, "end_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 200, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 222, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 245}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 251}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 262, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 270, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 282, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 310}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 323, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 327, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 332, "end_pos": 338}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 339, "end_pos": 342}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 349, "end_pos": 352}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 353, "end_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 369, "end_pos": 375}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 375, "end_pos": 382}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 387, "end_pos": 394}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 395, "end_pos": 407}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 410, "end_pos": 413}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 421, "end_pos": 425}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 432}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 439, "end_pos": 450}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 451, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 459, "end_pos": 464}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 474}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 479, "end_pos": 484}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 486, "end_pos": 491}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 492, "end_pos": 497}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 498, "end_pos": 502}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 503, "end_pos": 507}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 508, "end_pos": 510}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 520, "end_pos": 523}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 529, "end_pos": 533}, {"label_type": "藥物", "overlap": 0, "start_pos": 537, "end_pos": 541}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 618, "end_pos": 624}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 636, "end_pos": 638}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 653, "end_pos": 656}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 667, "end_pos": 672}, {"label_type": "手術", "overlap": 0, "start_pos": 684, "end_pos": 688}]}
{"originalText": "入院前30+年，患者常在受涼後出現咳嗽、咳痰，多為白色泡沫痰，並逐漸出現喘累、氣促，好發於冬春季節，每年累計發病時間超過3月，外院診斷為“慢支炎、肺氣腫”，予以抗感染、止咳平喘等治療後可好轉。患者喘累、氣促症狀逐年加重，並逐漸出現間斷兩上肢水腫，外院考慮為“肺源性心臟病”，未利尿、長期低流量吸氧及吸入劑治療。7+年前，患者喘累、呼吸困難明顯，於外院診斷為“支氣管哮喘”（具體檢查報告及診治經過不詳），開始使用沙丁胺醇氣霧劑治療。後患者下述症狀反覆發作，反覆住院治療，完善檢查：心臟彩超：全心增大；主動脈竇部增寬；室間隔、右室後壁動度降低；主動脈瓣鈣化；二尖瓣、三尖瓣重度反流；主動脈瓣中度反流；右室收縮、舒張功能減退；肺動脈收縮輕度高壓。EF31%。肺功能檢查提示重度阻塞性通氣功能障礙，舒張試驗陽性（FEV1 41.7%,FEV1%FVC59.14%）。最近一次於2017-12-30於我科住院治療，給予抗感染、化痰、平喘、改善迴圈等治療後於2018-1-6因患者個人原因自動出院，出院診斷為：1、慢性阻塞性肺疾病急性加重期；2、慢性肺源性心臟病；3、支氣管哮喘；4、冠狀動脈粥樣硬化性心臟病 心律失常 心功能Ⅲ-Ⅳ級；5、慢性胃炎急發。出院後用藥情況不詳。入院前1天，患者再次感下述症狀較前加重，咳嗽、咳白色粘痰，喘累明顯，不能平臥位休息，夜間陣發性呼吸困難，腹脹納差，進食量明顯上降，輕微下腹部疼痛，無畏寒寒戰、發熱，無咯血，無潮熱盜汗，無噁心嘔吐，無胸悶、胸痛，無尿頻、尿急、尿痛等不適，自行服用“平喘藥”（具體不詳），下述症狀無明顯好轉，遂來我院就診，門診以“AECOPD”收入我科進一步治療。患者此次患病以來精神、食慾、睡眠差，大小便正常，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "藥物", "overlap": 0, "start_pos": 205, "end_pos": 209}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 249, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 270, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 280}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 310, "end_pos": 313}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 320, "end_pos": 322}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 333, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 451, "end_pos": 464}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 467, "end_pos": 475}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 478, "end_pos": 483}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 486, "end_pos": 498}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 499, "end_pos": 503}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 504, "end_pos": 511}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 514, "end_pos": 518}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 583, "end_pos": 584}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 598, "end_pos": 601}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 630, "end_pos": 631}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 633, "end_pos": 634}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 686, "end_pos": 692}]}
{"originalText": "入院前5+年，患者因右側肢體乏力，伴口齒不清，在外院明確診斷“腦梗死”，經治療後好轉出院，出院後遺留右側肢體活動輕度障礙及口齒稍含糊，生活可自理。入院前半月，患者反覆出現頭昏，陣發性發作，發作時自覺乏力、站立不穩、心悸，並出現左下肢抽動，伴流涎，在我科住院，診斷：腦梗死後遺症、短暫性腦缺血發作、高血壓病、頸動脈多發硬化性斑塊形成、高脂血症、2型糖尿病？查糖化血紅蛋白：7.1 %。血脂：甘油三酯 3.74 mmol/l、總膽固醇 5.89 mmol/l、低密度脂蛋白膽固醇 3.39 mmol/l，頭頸部CTA示1、兩側基底節區及側腦室體旁腔隙性腦梗死。右側顳、枕葉慢性腦梗死；右側頂葉軟化灶。腦白質脫髓鞘改變；腦萎縮。右側下頜竇炎症或息肉。兩側篩竇炎。食道中段壁增厚，食道旁軟組織增多，建議胃鏡檢查。CTA：主動脈壁較多軟硬斑塊形成，並見多個深大潰瘍；頭臂幹、左側頸內動脈起始部、右側鎖骨上動脈起始段廣泛軟、硬斑塊形成，區域性管腔輕度狹窄；頸內動脈顱內各段、大腦前、中、後動脈各段血管硬化。心臟彩超示右房增大；主動脈竇部增寬；二尖瓣及肺動脈瓣侷限性反流；主動脈瓣中度反流，提示右室舒張功能減退。腹部彩超示脂肪肝；膽囊結石 膽囊腫大；左腎結石。頸動脈彩超示頸動脈粥樣硬化；左側頸動脈中段粥樣斑塊，右側頸動脈多發粥樣斑塊；左側椎動脈流速減慢。予以改善迴圈、改善頭昏等對症治療後好轉出院。入院前1天，患者無明顯誘因再次出現頭昏，伴肢體乏力，發作時伴站立不穩、頭昏加重、眼花，持續1小時右左，無噁心、嘔吐，無大小便失禁、意識喪失，無畏寒、無胸悶、胸痛，無喘累、氣促，無暈厥等，今晨患者活動後再次發作頭昏，故收入我科住院。患者自發病以來精神、食慾一般，大小便未訴異常。近期體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 85, "end_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 152}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 176}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 178, "end_pos": 184}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 194, "end_pos": 198}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 211, "end_pos": 215}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 228, "end_pos": 237}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 250, "end_pos": 256}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 259, "end_pos": 277}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 278, "end_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 297}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 298, "end_pos": 306}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 321}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 322, "end_pos": 327}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 332}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 339}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 352, "end_pos": 355}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 356, "end_pos": 360}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 378, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 382, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 402}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 421, "end_pos": 425}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 430, "end_pos": 439}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 446, "end_pos": 450}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 453}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 456, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 464, "end_pos": 467}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 472}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 478, "end_pos": 482}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 489, "end_pos": 497}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 498, "end_pos": 502}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 503, "end_pos": 506}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 507, "end_pos": 511}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 512, "end_pos": 516}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 517, "end_pos": 521}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 522, "end_pos": 527}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 528, "end_pos": 535}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 536, "end_pos": 543}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 548, "end_pos": 553}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 560, "end_pos": 565}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 579, "end_pos": 580}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 609, "end_pos": 610}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 613, "end_pos": 615}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 627, "end_pos": 628}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 667, "end_pos": 668}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 670, "end_pos": 671}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 696, "end_pos": 697}]}
{"originalText": "入院8年前患者受涼後出現咳嗽、伴喘累，需輸液治療緩解，緩解後未長期口服藥物，每年冬春季及天氣變化時易於發病，無胸痛、咯血，多次在外院就診考慮“慢支炎、肺氣腫”。病程中逐漸出現勞力性氣促，初為爬坡及重體力勞動時出現，後平地活動亦感氣促，受涼後喘累氣促明顯加重，反覆在當地醫院輸液治療。近2年患者先後多次在我院住院治療，診斷“慢性支氣管炎急性發作”，經抗感染、止咳祛痰、平喘等治療病情稍緩解。入院前10天患者受涼後咳嗽咯痰症狀加重，咳黃色痰液，咯痰費力。伴有心慌胸悶，喘累氣促，夜間不能平臥。伴納差，飲食較前明顯減少，每餐進食3-4口飯，伴活動耐力明顯上降，未上床活動。無畏寒、發熱、咳血、胸痛、流涕、打噴嚏。未予診治。入院前5天出現兩上肢水腫。今日患者感氣促明顯，端坐位易氣促，家屬遂呼120送入我院就診，查“血氣分析：PCO2:66mmhg，PO2:38mmhg，PH：7.35，SO2:68%。心電圖示：竇性心動過速，不完全性左束支傳導阻滯，左室肥大，右房肥大。血常規：WBC：9.0*10^9/L，N：74.64%，NEUT：6.75*10^9/L。電解質示：K：5.97mmol/L，Na：135.7mmol/L，Cl：94.3mmol/L。腎功、心肌酶譜無異常。胸片示：兩肺廣發感染，兩側肺門增大增濃，建議結合臨床後複查或CT檢查除外其它。”診斷“慢性阻塞性肺病急性加重，2型呼吸衰竭。”給予“呋塞米利尿、多索茶鹼平喘、地塞米松平喘”對症處理，患者呼吸衰竭明顯，需入住ICU行無創呼吸機治療，但家屬拒絕。請內一科會診後因內一科無床，經溝通後收入我科治療。本次發病以來患者精神食慾較差，大小便如常，睡眠差，體力上降，體重無明顯改變", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 55, "end_pos": 56}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 230}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 293, "end_pos": 294}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 318}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 359, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 371, "end_pos": 374}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 382, "end_pos": 384}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 390, "end_pos": 393}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 398, "end_pos": 401}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 403, "end_pos": 409}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 421}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 422, "end_pos": 426}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 427, "end_pos": 431}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 436, "end_pos": 439}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 460, "end_pos": 464}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 482, "end_pos": 483}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 495, "end_pos": 497}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 510, "end_pos": 512}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 535, "end_pos": 537}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 539, "end_pos": 545}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 546, "end_pos": 550}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 565, "end_pos": 567}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 578, "end_pos": 589}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 590, "end_pos": 596}, {"label_type": "藥物", "overlap": 0, "start_pos": 601, "end_pos": 604}, {"label_type": "藥物", "overlap": 0, "start_pos": 607, "end_pos": 611}, {"label_type": "藥物", "overlap": 0, "start_pos": 614, "end_pos": 618}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 628, "end_pos": 632}]}
{"originalText": "入院前3+月，患者無明顯誘因出現劍突上陣發性隱痛，無肩背部放射痛，疼痛無規律，與進食及體位無關，持續約數十分鐘後可自行緩解，伴噯氣，無反酸燒心、噁心嘔吐、納差、黑便、消瘦、腹脹，無心悸、氣促、胸悶胸痛，於我院門診查胃鏡示：賁門腫瘤可能？活檢示：賁門腺癌（均未見原報告）。故於我院消化內科住院治療，完善胸腹部CT：1.賁門及鄰近胃壁增厚，增強後輕度強化，周圍淋巴結腫大，考慮腫瘤性病變，胃Ca？2.左肺中葉外側段及兩肺上葉少許炎症。3.左肺下葉尖後段少許纖維、鈣化灶；右肺上葉胸膜上可疑淺淡小結節影。4.縱隔及左肺門區淋巴結鈣化。5.脂肪肝，肝左後緣斑點狀鈣化。6.主動脈、冠狀動脈及兩側髂動脈壁鈣化，胸椎、腰椎骨質增生。患方拒絕手術治療，經對症處理後好轉出院，院外患者病情相對穩定。入院前5+天，患者再發下訴腹痛不適，伴噁心欲吐，納差乏力明顯，伴明顯頭昏，嚴重時致體位不能維持，臥床休息後好轉，否認嘔血及便血，無反酸燒心，無心悸、氣促、胸悶胸痛，無咳嗽咯痰，無畏寒發熱等不適，故於*******醫院就診治療，完善胸片：1.雙肺紋理增多；2.左側第7肋間腋側走行皺褶；3.主動脈增寬鈣化。心電圖：竇性心律，正常心電圖。腹部增強CT：胃底及賁門曲佔位性性病變，考慮惡性腫瘤（胃癌可能性大），胃及食管遠端，伴肝臟及淋巴結多發轉移，門靜脈左幹及主幹、脾靜脈、胃引流靜脈（注入門靜脈）多發癌栓。血常規：HB69.2g/L。給予輸注紅細胞懸液2u，白蛋白糾正低蛋白血癥等處理後好轉，建議當地治療，遂來我院，門診以“胃癌伴轉移”收入我科住院治療。患者自患病以來，精神、睡眠一般，飲食如下，大小便未見明顯異常，近期體重未見明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 26, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 86, "end_pos": 87}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 151, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 160}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 163, "end_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 198, "end_pos": 214}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 224}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 266, "end_pos": 269}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 270, "end_pos": 279}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 282, "end_pos": 299}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 300, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 354, "end_pos": 355}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 375, "end_pos": 376}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 412, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 418, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 420, "end_pos": 421}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 456, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 461, "end_pos": 463}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 470, "end_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 485, "end_pos": 492}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 493, "end_pos": 496}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 497, "end_pos": 501}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 504, "end_pos": 507}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 508, "end_pos": 514}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 515, "end_pos": 517}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 518, "end_pos": 521}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 530, "end_pos": 534}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 545, "end_pos": 549}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 551, "end_pos": 553}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 554, "end_pos": 557}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 562, "end_pos": 567}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 568, "end_pos": 570}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 571, "end_pos": 574}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 580}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 589, "end_pos": 591}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 596, "end_pos": 598}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 651, "end_pos": 656}]}
{"originalText": "患者入院前6年無明顯誘因出現心累、氣促，起病初多以活動後明顯，伴胸悶，無明顯胸痛，需胸骨後壓榨感，無上肢浮腫，無夜間陣發性呼吸困難，患者休息後症狀可減輕，曾於*******醫院就診，考慮“冠狀動脈粥樣硬化性心臟病”，並辦理特病，但平素未行相關治療。入院前半年患者因心累加重，並全身多處瘀斑，於******醫院住院治療，行心臟彩超提示“右房增大，室間隔、右室後壁增厚，左室流出道增寬，二尖瓣及主動脈瓣狹窄，二尖瓣及三尖瓣重度反流，反流壓差增高，肺動脈瓣及主動脈瓣輕度反流，心包積液，右室收縮功能正常”，具體治療不詳，出院後患者長期服用“單硝酸異山梨酯緩釋片、阿託伐他汀鈣、厄貝沙坦、曲美他嗪”等藥物，仍有活動後心累不適，近1月患者自覺心累加重，平路緩步行走感心累難以忍受，日常一般活動，如做飯等不能從事，夜間需高枕臥位，感胸悶，時有端坐呼吸，活動後伴有咳嗽，氣喘，痰中偶有鮮紅色血絲，無明顯上肢浮腫，無畏寒發熱，無潮熱盜汗等不適，今日來院就診，為進一步治療收入我科住院。患者半年前因全身多處瘀斑，於******醫院就診，完善檢查發現血小板減少、貧血，查血常規(2016-03-01)PLT 63×109/L、HB 63g/L；住院期間予以骨髓穿刺，考慮缺鐵性貧血、血小板減少性紫癜，予以輸紅細胞懸液2U，並激素治療（目前服用甲潑尼龍 2片/日），自訴複查指標好轉。另外此次住院期間檢查發現腎功能異常 BUN 19.6mmol/L CREA 223umol/L，原因不明確，因血小板減少未能腎活檢，出院診斷考慮慢性腎臟病（CKD3期），急性腎損害不除外。患者自發病以來精神、食慾可，大小便未訴異常。近期體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 106}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 160, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 201}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 234}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 248}, {"label_type": "藥物", "overlap": 0, "start_pos": 267, "end_pos": 277}, {"label_type": "藥物", "overlap": 0, "start_pos": 278, "end_pos": 284}, {"label_type": "藥物", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "藥物", "overlap": 0, "start_pos": 290, "end_pos": 294}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 329}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 360, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 394, "end_pos": 396}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 490, "end_pos": 493}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 503, "end_pos": 505}, {"label_type": "手術", "overlap": 0, "start_pos": 518, "end_pos": 522}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 525, "end_pos": 530}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 531, "end_pos": 539}, {"label_type": "藥物", "overlap": 0, "start_pos": 561, "end_pos": 565}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 599, "end_pos": 602}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 614, "end_pos": 618}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 653, "end_pos": 665}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 666, "end_pos": 671}]}
{"originalText": "患者入院前1+年因發作性胸悶，於2015年10月9日至10月21日在*******醫院住院，冠脈造影檢查示：前降支狹窄20-50%，迴旋支狹窄80%，行支架植入術；術後給予冠心病二級預防口服藥物治療，出院時胸悶明顯緩解。病程中患者未再發作明顯胸悶、胸痛等不適，家屬訴平素監測心率偏慢，未進一步就診。入院前3+小時患者於餐後突發感心前區脹痛感，難以忍受，隨後意識喪失，兩眼凝視，張口呼吸，左手不自主抖動，無大小便失禁，家屬立即按壓“人中”，並予以舌上含服“速效救心丸”等，同時呼叫120急救，下述症狀持續約5min後患者意識恢復，並自主活動，120醫師現場檢視患者清醒，隨機指血糖：7.9mmol/L，接回我院急診科，急診查血常規 WBC 8.5x10^9/L HB 117g/L；凝血試驗 APTT 21.3秒；高敏肌鈣蛋白 23.87pg/ml；電解質 K 3.8mmol/L；腎功能 BUN 11.04mmol/L CREA 152.4umol/L；血氣分析 PH 7.47 PO2 122mmHg PCO2 36mmHg；CT提示：1.兩側基底節區腔隙性腦梗死。2.腦白質脫髓鞘改變；腦萎縮。3.左肺下葉尖段及左肺上葉小結節影，考慮炎性肉芽腫可能，建議短期內複查。4.右肺下葉尖後段少許感染，右肺上葉內前基底段少許慢性感染，建議治療後複查。5.右肺下葉尖後段鈣化灶。6.主動脈壁及冠狀動脈壁鈣化；胸椎骨質增生。7.肝實質內多個類圓形低密度影，考慮為囊腫，部分病灶邊界欠清晰，隨訪或必要時增強檢查。請我科會診後為進一步治療收入我科住院。本次發病以來患者精神食慾較差，大小便如常，睡眠較差，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 12, "end_pos": 13}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 46, "end_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"label_type": "手術", "overlap": 0, "start_pos": 76, "end_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 89}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 125}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 167}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 195}, {"label_type": "藥物", "overlap": 0, "start_pos": 227, "end_pos": 232}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 287, "end_pos": 289}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 315, "end_pos": 318}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 330, "end_pos": 332}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 345, "end_pos": 349}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 356, "end_pos": 362}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 378, "end_pos": 379}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 394, "end_pos": 397}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 410, "end_pos": 414}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 432, "end_pos": 434}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 440, "end_pos": 443}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 452, "end_pos": 456}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 464, "end_pos": 466}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 471, "end_pos": 483}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 486, "end_pos": 494}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 495, "end_pos": 498}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 501, "end_pos": 507}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 508, "end_pos": 512}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 519, "end_pos": 524}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 537, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 549, "end_pos": 558}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 582}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 588, "end_pos": 600}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 601, "end_pos": 607}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 610, "end_pos": 611}]}
{"originalText": "入院前半天患者被家屬發現失語、陣發性大汗淋漓，無大小便失禁，無嘔吐，無抽搐，家屬遂撥打120，由我院120接回，查血氣分析：PH 7.41，PaO2 53mmHg，PaCO2 43mmHg，乳酸1.4mmol/L，腎功：未見明顯異常，肝功：白球比 1.2，電解質：氯 110.6 mmol/l，血常規：白細胞數 9.4×10^9/L、紅細胞數 4.41×10^12/L、血紅蛋白濃度 131 g/L、血小板數 140×10^9/L、中性粒細胞百分比 77.61 %，凝血試驗：纖維蛋白原 4.62 g/L，心肌酶正常。高敏肌鈣蛋白T 33.10 pg/ml，CRP：69 mg/l，D_2聚體：7.07 μg/ml，胸部CT：1，兩側基底節及側腦室體旁少許散在小腔隙灶，結合臨床隨訪複查或必要時MRI進一步檢查。2，腦白質脫髓鞘，腦萎縮，隨訪。3，左肺下葉、中葉及兩上肺感染，隨訪複查。4，肺氣腫徵，右下肺小肺大泡形成。5，主動脈及冠狀動脈壁鈣化。6，兩側胸膜稍增厚，胸椎骨質增生。心電圖：極端的竇性心律不齊，竇性心動過緩，完全性左束支傳導阻滯。予以吸氧、心電監護，指脈氧由85%下升至90%，複查血氣分析：PH 7.41，PaO2 52mmHg，PaCO2 36mmHg，乳酸2.0mmol/L，請我科會診後建議轉ICU進一步治療，家屬拒絕，急診以“I型呼吸衰竭，肺部感染，缺血缺氧性腦病？急性腦梗死？”收入我科。與患者家屬進一步溝通後同意住院，隨後以“肺部感染”收入我科住院治療。患者自發病以來精神、食慾差，睡眠可，大便，小便未訴異常。近半年患者懶言少語，反應遲鈍，但能正確對答。近期體重無明顯減輕。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 62, "end_pos": 64}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 70, "end_pos": 74}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 95, "end_pos": 97}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 120, "end_pos": 123}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 151, "end_pos": 154}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 167, "end_pos": 170}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 185, "end_pos": 191}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 216, "end_pos": 224}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 238, "end_pos": 243}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 259, "end_pos": 266}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 279, "end_pos": 282}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 291, "end_pos": 296}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 325}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 347, "end_pos": 350}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 358, "end_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 374, "end_pos": 387}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 395, "end_pos": 398}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 400, "end_pos": 403}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 412, "end_pos": 423}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 430}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 434, "end_pos": 440}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 441, "end_pos": 444}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 448, "end_pos": 454}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 455, "end_pos": 461}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 462, "end_pos": 472}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 504, "end_pos": 506}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 512, "end_pos": 516}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 524, "end_pos": 529}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 537, "end_pos": 539}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 576, "end_pos": 582}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 583, "end_pos": 587}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 588, "end_pos": 595}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 596, "end_pos": 601}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 628, "end_pos": 632}]}
{"originalText": "患者於入院10月前發現兩上肢浮腫、尿量減少、喘累，到****醫院查血常規： Hb：87g/l，腎功：血肌酐：394umol/L，考慮腎功能不全、腎性貧血，後到**********醫院就診，查腎功：血肌酐：330umol/L，血常規：Hb：89g/l，甲狀旁腺激素 55.5pg/ml，內生肌酐清除率：14.49ml/min，腹部彩超：兩腎結構欠清，實質回聲稍增強，腹腔少量積液；心臟彩超：右室肥厚，少許心包積液；胸部CT平掃：右肺上葉炎症，心臟增大，兩側胸腔積液，給予血液淨化治療、降壓、降糖、糾正貧血、改善迴圈等治療後好轉出院。8月前前患者再次出現心悸、胸悶，伴噁心、納差，無咳嗽、咳痰，無腹痛、腹脹，無肉眼血尿，無頭昏、頭痛，無皮上出血、牙齦出血等不適。在我科住院規律透析治療，3月前因個人原因回當地，但未行透析治療，給予口服藥及胰島素控制血糖等，5天前因活動後氣促在*****就醫，急診入院後給予無創呼吸機、西地蘭強心、呋塞米利尿、改善迴圈、持續血液淨化，補充蛋白等治療後，患者生命體徵平穩，水腫消退，但仍訴心悸不適、血糖波動較大，家屬為進一步診治，到我院就診，門診以\\\"尿毒症、糖尿病、高血壓\\\"收入我科住院治療。患者自患病以來，精神、睡眠可，食慾差，大便正常，小便偏少，量不詳，體重無明顯變化。22年前因手足麻木在當地醫院查血糖升高，值不詳，診斷為2型糖尿病，先後服用格列齊特、消渴丸降糖，偶測血糖20+mmol/L,曾服用二甲兩胍出現噁心、嘔吐停用，後開始出現視物模糊、兩上肢水腫，2年前開始使用優思林降血糖，血糖控制不詳，現改為諾和銳30 16u/早，12u/晚降血糖，血糖控制可。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 38, "end_pos": 40}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 98, "end_pos": 101}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 116, "end_pos": 118}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 142, "end_pos": 149}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 162, "end_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 189, "end_pos": 193}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 205}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 206, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 278, "end_pos": 279}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 296, "end_pos": 297}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 309, "end_pos": 310}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 323}, {"label_type": "藥物", "overlap": 0, "start_pos": 367, "end_pos": 370}, {"label_type": "藥物", "overlap": 0, "start_pos": 407, "end_pos": 410}, {"label_type": "藥物", "overlap": 0, "start_pos": 413, "end_pos": 416}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 489, "end_pos": 492}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 493, "end_pos": 496}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 497, "end_pos": 500}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 557, "end_pos": 559}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 567, "end_pos": 571}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 579, "end_pos": 584}, {"label_type": "藥物", "overlap": 0, "start_pos": 589, "end_pos": 593}, {"label_type": "藥物", "overlap": 0, "start_pos": 594, "end_pos": 597}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 602, "end_pos": 604}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 617, "end_pos": 621}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 641, "end_pos": 644}, {"label_type": "藥物", "overlap": 0, "start_pos": 654, "end_pos": 657}, {"label_type": "藥物", "overlap": 0, "start_pos": 671, "end_pos": 676}]}
{"originalText": "入院前14年患者檢查發現血糖升高，血糖具體值不詳，有口乾、多飲、多尿等症狀，伴四肢麻木，並有感覺異常，自覺肢體冰涼，伴視物模糊，於外院診斷為“2型糖尿病 糖尿病周圍神經病變 糖尿病眼病”，後長期服用“格列美脲、伏格列波糖、羅格列酮”等降血糖，半年前於我科住院，出院後使用“來得時+阿卡波糖”降糖，但院外患者自行加用“格列美脲”降糖，偶有心慌冒汗症狀。1+年前患者因活動後心累心悸，偶有乾咳，感肢體麻木冰涼較明顯，伴有腰部及上肢疼痛，自覺健忘症狀加重，於我院內一科住院，查腎功：尿素 16.00 mmol/L、肌酐 141.7 μmol/l，診斷為“糖尿病腎病、原發性高血壓3級極高危 高血壓性心臟病”，治療後好轉出院；半年前因腹瀉於我科住院，檢查腎功：尿素 19.79 mmol/L、肌酐 225.2 μmol/l及其他檢查，診斷“1.2型糖尿病 糖尿病周圍神經病變 糖尿病眼病 糖尿病腎病 糖尿病植物神經病變 2.原發性高血壓3級 很高危 高血壓性心臟病 3.重度骨質疏鬆 4、甲狀腺功能減退 5、冠狀動脈粥樣硬化心臟病”，治療後好轉出院，出院後未定期隨訪複查，並自行停用相關藥物。3+月前患者感活動及爬坡後心累、氣促明顯，稍休息後能好轉，並出現頭昏痛，無視物旋轉，無耳鳴，無發熱，無嘔吐，無黑便等，在院外自行服藥（具體藥名不詳），效果欠佳,今為求治療，來我科要求住院治療。以“2型糖尿病、糖尿病腎病”收入院。患者此次發病以來精神食慾一般，長期睡眠差，經常服用“安眠藥”，大便正常，訴長期解小便色偏黃，尿量不詳，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 92}, {"label_type": "藥物", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "藥物", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "藥物", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "藥物", "overlap": 0, "start_pos": 136, "end_pos": 139}, {"label_type": "藥物", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"label_type": "藥物", "overlap": 0, "start_pos": 158, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 274, "end_pos": 279}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 280, "end_pos": 291}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 292, "end_pos": 299}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 315}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 342, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 373}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 374, "end_pos": 383}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 384, "end_pos": 389}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 395}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 396, "end_pos": 405}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 408, "end_pos": 420}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 421, "end_pos": 428}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 437}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 440, "end_pos": 447}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 450, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 505, "end_pos": 506}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 524, "end_pos": 525}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 535, "end_pos": 536}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 590, "end_pos": 595}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 596, "end_pos": 601}]}
{"originalText": "入院前16年患者因“肝昏迷”（具體不詳）在“**********醫院”就診，診斷為“乙肝後肝硬化”，給予血漿置換等對症處理後好轉出院。院外未再發作下述疾病，無腹脹、消化道出血等。院外未再口服藥物治療。入院前半年無明顯誘因出現肝區持續性隱痛不適，無陣發性加重，無肩背部放射痛，與進食及體位無關，無明顯緩解方式。無噁心、嘔吐、黑便、反酸、燒心、噯氣、納差、黃疸、畏寒、發熱。在“**********醫院”就診，完善相關檢查後診斷“肝癌”，無手術指徵，給予“介入術”治療後腹痛稍緩解，院外口服“抗病毒、保肝、抗腫瘤”藥物治療。病程中出現黃疸、納差，查肝功異常，總共給予2次介入術，1次海扶刀治療。入院前10天患者再次出現納差，飲食較前減少，食慾減退，伴劍突上陣發性隱痛，無肩背部放射痛，與進食無關。伴全身乏力、心悸，面板逐漸出現黃染，無噁心、嘔吐、黑便。未予診治。家屬發現患者精神變差，乏力明顯，遂送來我院就診，查“血常規：白細胞數 2.9*10^9/L ↓、紅細胞數 3.49 *10^12/L ↓、血紅蛋白濃度 109 g/L ↓、血小板數 97 *10^9/L ↓、中性粒細胞百分比 87.01 % ↑，肝功1：白球比 1.2 ↓、穀草轉氨酶 334.0 U/L ↑、谷氨醯轉肽酶 538.2 U/L ↑、總膽紅素 67.6 μmol/l ↑、直接膽紅素 48.8 μmol/l ↑、間接膽紅素 18.80 μmol/l ↑。電解質正常。”，門診以“肝癌”收入我科。病程中精神、飲食稍差，大便基本正常，小便色黃，體重較前稍減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 80}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 215}, {"label_type": "手術", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 234}, {"label_type": "手術", "overlap": 0, "start_pos": 283, "end_pos": 286}, {"label_type": "手術", "overlap": 0, "start_pos": 289, "end_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 323, "end_pos": 325}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 333, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 352, "end_pos": 353}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 409, "end_pos": 412}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 427, "end_pos": 430}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 448, "end_pos": 454}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 465, "end_pos": 468}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 483, "end_pos": 491}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 506, "end_pos": 509}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 516, "end_pos": 521}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 534, "end_pos": 540}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 553, "end_pos": 557}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 572, "end_pos": 577}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 592, "end_pos": 597}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 625, "end_pos": 627}]}
{"originalText": "患者於入院前40+年，常於受涼後出現咳嗽、咳痰，痰呈白色泡沫痰，下述症狀反覆發作，多在冬春季節反覆發作，常予以抗炎止咳等藥物治療後可緩解。病程中患者逐漸出現喘累氣促，活動耐力上降，曾在我院行胸部CT提示肺氣腫、肺大泡形成。心臟彩超提示射血分數上降，考慮“慢性阻塞性肺疾病、肺源性心臟病”。院外未使用平喘藥物及吸氧。入院前4+月患者因咳嗽、咳痰、喘累復發在我院心內科住院治療，給予“頭孢呋辛抗感染、痰熱清及溴己新祛痰、多索茶鹼平喘、甲潑尼龍平喘”等對症處理後好轉，因心率快未行冠脈CTA檢查，給予出院。院外長期口服“阿司匹林腸溶片（100mg/片）每天1次 每次1片、富馬酸比索洛爾片（5mg/片）每天1次 每次半片、辛伐他汀 每晚1次 每次1片、螺內酯（20mg/片） 每日1次 每次1片、呋塞米（20mg/片） 每日1次 每次1片”治療。入院前10+天患者無明顯誘因出現中下腹陣發性隱痛，以上午飢餓後明顯，無肩背部放射痛，進食後腹痛可稍緩解。伴偶有噯氣、反酸，伴大便改變，每日3次，起始2次解成形黃色大便，後解黃色糊狀大便。無粘液膿血便，無黑便、裡急後重、腹脹。在外未予處理。入院前5天患者受涼後出現明顯喘累、氣促，伴咳嗽，咳白色粘液痰，無胸痛咯血，無心慌胸悶，無噁心嘔吐，無呼吸困難。在家口服下述藥物後無緩解。今日來院就診，為進一步治療門診以“慢性阻塞性肺疾病、腹痛待查”收入我科。患者自發病以來精神稍差，食慾尚可，睡眠一般，大便3次/日，時干時稀，無粘液膿血便，小便正常。近期體力上降，體重無明顯減輕。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 95, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 142}, {"label_type": "藥物", "overlap": 0, "start_pos": 190, "end_pos": 194}, {"label_type": "藥物", "overlap": 0, "start_pos": 198, "end_pos": 201}, {"label_type": "藥物", "overlap": 0, "start_pos": 202, "end_pos": 205}, {"label_type": "藥物", "overlap": 0, "start_pos": 208, "end_pos": 212}, {"label_type": "藥物", "overlap": 0, "start_pos": 215, "end_pos": 219}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "藥物", "overlap": 0, "start_pos": 257, "end_pos": 264}, {"label_type": "藥物", "overlap": 0, "start_pos": 283, "end_pos": 291}, {"label_type": "藥物", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "藥物", "overlap": 0, "start_pos": 323, "end_pos": 326}, {"label_type": "藥物", "overlap": 0, "start_pos": 345, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 387, "end_pos": 389}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 405, "end_pos": 408}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 415, "end_pos": 416}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 521, "end_pos": 522}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 527, "end_pos": 528}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 529, "end_pos": 530}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 574, "end_pos": 582}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 583, "end_pos": 587}]}
{"originalText": "入院前14年患者檢查發現血糖升高，血糖具體值不詳，有口乾、多飲、多尿等症狀，伴四肢麻木，並有感覺異常，自覺肢體冰涼，伴視物模糊，於外院診斷為“2型糖尿病 糖尿病周圍神經病變 糖尿病眼病”，後長期服用“格列美脲、伏格列波糖、羅格列酮”等降血糖，半年前於我科住院，出院後使用“來得時+阿卡波糖”降糖，但院外患者自行加用“格列美脲”降糖，偶有心慌冒汗症狀。1+年前患者因活動後心累心悸，偶有乾咳，感肢體麻木冰涼較明顯，伴有腰部及上肢疼痛，自覺健忘症狀加重，於我院內一科住院，查腎功：尿素 16.00 mmol/L、肌酐 141.7 μmol/l，診斷為“糖尿病腎病、原發性高血壓3級極高危 高血壓性心臟病”，治療後好轉出院；半年前因腹瀉於我科住院，檢查腎功：尿素 19.79 mmol/L、肌酐 225.2 μmol/l及其他檢查，診斷“1.2型糖尿病 糖尿病周圍神經病變 糖尿病眼病 糖尿病腎病 糖尿病植物神經病變 2.原發性高血壓3級 很高危 高血壓性心臟病 3.重度骨質疏鬆 4、甲狀腺功能減退 5、冠狀動脈粥樣硬化心臟病”，治療後好轉出院，出院後未定期隨訪複查，並自行停用相關藥物。半月前患者無明顯誘因開始出現咳嗽，幾乎無痰，伴有咽癢，咳嗽時有溢尿，無畏寒發熱，無胸悶胸痛，無腹脹腹痛，無腹瀉黑便，無上肢水腫，於我院就診，遂門診以\\\"糖尿病，咳嗽待查\\\"收入我科住院治療。患者此次發病以來精神食慾可，長期睡眠差，經常服用“安眠藥”，大便正常，訴長期解小便色偏黃，伴有尿灼熱尿痛，體重無明顯上降", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 92}, {"label_type": "藥物", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "藥物", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "藥物", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "藥物", "overlap": 0, "start_pos": 136, "end_pos": 139}, {"label_type": "藥物", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"label_type": "藥物", "overlap": 0, "start_pos": 158, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 274, "end_pos": 279}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 280, "end_pos": 291}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 292, "end_pos": 299}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 313, "end_pos": 314}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 342, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 373}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 374, "end_pos": 383}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 384, "end_pos": 389}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 395}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 396, "end_pos": 405}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 408, "end_pos": 420}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 421, "end_pos": 428}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 437}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 440, "end_pos": 447}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 450, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 516, "end_pos": 517}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 533, "end_pos": 534}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 535, "end_pos": 536}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 539, "end_pos": 540}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 541, "end_pos": 542}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 545, "end_pos": 546}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 551, "end_pos": 553}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 568, "end_pos": 571}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 572, "end_pos": 576}]}
{"originalText": "入院前4年患者院外測血壓高，最高達230/？mmHg，院外服用坎地沙坦、氨氯地平、卡維地洛藥物控制血壓（具體劑量不詳），院外自測血壓約150-160mmHg，平素未感視物模糊，未感頭昏。2天前患者騎車時不慎跌倒，至兩膝、兩手掌、上巴處擦傷，感頭昏痛，遂於我院門診就診，查血壓170/100mmHg，血脂：甘油三酯 3.72 mmol/l ↑、總膽固醇 6.26 mmol/l ↑、載脂蛋白B 1.48 g/l ↑，血糖(靜脈血)：葡萄糖 9.27 mmol/l ↑，肝功1：谷丙轉氨酶 34.3 U/L、穀草轉氨酶 20.9 U/L、谷氨醯轉肽酶 112.6 U/L ↑，血常規：白細胞數 4.6×10^9/L、紅細胞數 5.24×10^12/L、血紅蛋白濃度 160 g/L、血小板數 256×10^9/L、中性粒細胞百分比 57.80 %、淋巴細胞百分比 35.90 %，腎功能未見異常，予以硝苯地平緩釋片降壓處理後好轉。1天前患者感頭昏減輕，再次於我院就診，查糖化血紅蛋白：糖化血紅蛋白 8.7 %，血糖(靜脈血)：葡萄糖 13.90 mmol/l，尿微量白蛋白定量：尿微量白蛋白 451 mg/L，尿常規：酮體 -、尿膽原 +、蛋白 +、葡萄糖 +++。無意識障礙大小便失禁，無肢體活動受限，否認多飲多食，否認多尿消瘦，無胸悶胸痛，無腹脹腹痛，無上肢水腫，為進一步治療，門診以“高血壓、糖尿病”收入我科住院治療。病程中患者精神、飲食一般，大小便正常，體重無明顯上降。", "entities": [{"label_type": "藥物", "overlap": 0, "start_pos": 31, "end_pos": 35}, {"label_type": "藥物", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"label_type": "藥物", "overlap": 0, "start_pos": 41, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 109}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 114, "end_pos": 116}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 152, "end_pos": 156}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 171, "end_pos": 175}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 190, "end_pos": 195}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 215, "end_pos": 218}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 252, "end_pos": 257}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 267, "end_pos": 273}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 290, "end_pos": 293}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 324, "end_pos": 330}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 339, "end_pos": 342}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 355, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 372, "end_pos": 379}, {"label_type": "藥物", "overlap": 0, "start_pos": 398, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 440, "end_pos": 446}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 461, "end_pos": 464}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 487, "end_pos": 493}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 507, "end_pos": 509}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 512, "end_pos": 515}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 518, "end_pos": 520}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 523, "end_pos": 526}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 545}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 565, "end_pos": 566}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 567, "end_pos": 568}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 571, "end_pos": 572}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 573, "end_pos": 574}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 577, "end_pos": 579}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 593, "end_pos": 596}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 597, "end_pos": 600}]}
{"originalText": "患者7年前始出現反覆咳、喘，平時咳少許白色泡沫痰，平地活動可耐受，爬坡等活動感氣促明顯。近2年活動後氣促明顯加重，檢查發現左側頸部豌豆大小包塊，無疼痛感，因同期被診斷為“肺結核”故考慮腫塊性質為結核，給予HRZ方案抗結核治療2年後停藥。病程中頸部包塊無增大及縮小，持續無疼痛，未進一步檢查。半年多前患者因活動後氣促加重在***二院住院，完善多項影像學檢查後診斷為“左側肺癌”，家屬放棄積極治療，院外對症治療。出院後左側頸部包塊進行性增大，間斷有隱痛不適。近半年多來，反覆因咳喘症狀加重多次在我科住院治療，給予抗腫瘤、抗感染、止咳平喘、對症治療後症狀好轉出院。入院前3月患者感顏面部浮腫，程度不重，於我科治療，考慮為下腔靜脈栓塞。給予治療後可消退，但反覆出現。入院前1+月，患者再次感顏面部浮腫及咳嗽、咳痰、氣促、納差較前加重於我科住院，給予抗腫瘤、抗感染、對症治療，症狀部分緩解。出院後仍感納差、活動後氣促，可耐受10餘米距離行走。入院前12天，患者促、水腫症狀加重，就診我科，診斷“1、左肺周圍型肺癌 2、轉移性淋巴癌 3、慢性阻塞性肺疾病急性加重 4、矽肺 5、陳舊性肺結核 6、壓瘡”，給予抗感染、止咳祛痰、止痛治療後好轉出院。入院前2天，患者再次出現喘累、氣促加重，伴有兩下肢及左上肢明顯水腫，腹脹，腹瀉，稀水樣大便。無明顯咳嗽咳痰，今為求診治，就診我院我科。本次發病以來患者精神食慾睡眠差，小便量少色黃，腹瀉，稀水樣大便，約5-6次/天。體重變化不明顯。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 182, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 444, "end_pos": 451}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 454, "end_pos": 460}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 463, "end_pos": 475}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 478, "end_pos": 480}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 483, "end_pos": 489}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 492, "end_pos": 494}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 539, "end_pos": 542}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 546}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 551, "end_pos": 552}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 554, "end_pos": 555}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 607, "end_pos": 608}]}
{"originalText": "患者入院前3+天患者受涼後感咽痛，並咳嗽，痰液較少，偶咳出少許白色粘痰，無痰中帶血，並畏寒發熱，體溫未測，無胸痛，無胸骨後壓榨感，無明顯心累，無上肢浮腫，入院前1天患者在乘坐公交車時，突發暈倒一次，起病前感頭暈，無黑朦，症狀持續1分鐘右左，無大小便失禁，無抽搐，醒後無遺留言語、肢體功能障礙，今日為求進一步治療收入我科住院。入院前3+年，患者無明確誘因反覆出現胸悶、心累，活動後加重，發作時伴頭暈、肢體麻木、視物模糊，2014年4月在我院查心電圖提示“心房纖顫”，住院治療症狀好轉。後就診於“**醫院”，冠脈造影檢查提示“四支血管病變”，最嚴重者狹窄85%（具體不詳），於**醫院行“冠脈搭橋手術及射頻消融術”，術後常感傷口疼痛，胸悶、心累好轉。院外長期遵矚服用“阿司匹林腸溶片、氯吡格雷、瑞舒伐他汀、美託洛爾緩釋片”，日常平地活動耐受較好，爬樓約4層感胸悶、氣短明顯，需休息緩解，否認肢體水腫、黑朦、暈厥史。近1月來患者無明顯誘因活動後心累氣促較前加重，在我院就診，動態心電圖示：偶發房性早搏，室性早搏（兩源），加速的室性逸搏，ST-T未見明顯改變。胸片：1.兩上肺紋理增多，建議結合臨床。2.右側胸膜增厚或右側胸腔少量積液。3.胸骨區域多個環狀金屬密度影，考慮術後改變。心臟彩超：右房增大；主動脈竇部增寬；室間隔動度降低；二尖瓣、三尖瓣輕度反流；肺動脈瓣侷限性反流；提示右室舒張功能減退。本次發病以來患者精神食慾尚可，大小便如常，睡眠較差，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 54, "end_pos": 55}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 60}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 197}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 220, "end_pos": 223}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 230}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 252, "end_pos": 256}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 261, "end_pos": 267}, {"label_type": "手術", "overlap": 0, "start_pos": 292, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 316}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 319}, {"label_type": "藥物", "overlap": 0, "start_pos": 332, "end_pos": 339}, {"label_type": "藥物", "overlap": 0, "start_pos": 340, "end_pos": 344}, {"label_type": "藥物", "overlap": 0, "start_pos": 345, "end_pos": 350}, {"label_type": "藥物", "overlap": 0, "start_pos": 351, "end_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 377, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 434, "end_pos": 439}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 441, "end_pos": 447}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 448, "end_pos": 456}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 457, "end_pos": 464}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 476, "end_pos": 478}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 481, "end_pos": 484}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 498, "end_pos": 502}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 505, "end_pos": 509}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 516, "end_pos": 518}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 537, "end_pos": 541}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 542, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 547, "end_pos": 552}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 555, "end_pos": 558}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 567, "end_pos": 570}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 579}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 587, "end_pos": 595}]}
{"originalText": "1年前，患者不明原因出現記憶力減退，主要表現為近事記憶減退明顯，遠期記憶正常，當時未引起重視，未予以治療。並進行性加重，半月前出現性格改變，暴躁、易怒，無幻覺、被害妄想；日常基本生活不能自理，且對自己熟悉的家人不認識，不知道何處下廁所；曾到*********神經內科門診就診，行頭顱CT檢查後診斷“老年痴呆”，具體服藥情況不詳。在回家服藥治療觀察過程中出現2次跌倒，無發作先兆，無明顯的頭昏、視物旋轉、噁心、嘔吐，無肢體活動障礙及抽搐，無大小便失禁及意識障礙。家屬自覺患者病情重，再次到*********就診，並住入神經內科，住院過程中出現左側肢體活動障礙，不能行走，進食出現吞嚥困難，飲水嗆咳，行頭顱CT及MRI檢查，診斷“急性腦梗死”，予以“阿司匹林”抗血小板聚集、“阿託伐他汀”調脂，“依達拉奉”抗自由基氧化等對症治療。由於患者不能進食，予以胃管鼻飼，但胃管內抽出暗紅色胃液，考慮“消化道出血”，予以“奧美拉唑、凝血酶粉”等對治療。3天前，患者出現咳嗽、咯痰，咯黃色粘稠痰，且發熱，體溫38.1℃，並出現意識加深，呼之不應，行血氣分析提示呼吸衰竭，轉入重症監護室進一步治療，予以氣管插管，呼吸機輔助呼吸，並予以“莫西沙星”抗感染、營養支援治療。患者病情重，家屬要求轉入我院進一步治療，遂由我院120轉入，門診以“急性腦梗死、急性呼吸衰竭、肺部感染、消化道出血”收住我科。患者患病以來，精神差，一直胃管進食流質，小便正常，大便未解。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 139, "end_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 299, "end_pos": 303}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 304, "end_pos": 307}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 318}, {"label_type": "藥物", "overlap": 0, "start_pos": 323, "end_pos": 327}, {"label_type": "藥物", "overlap": 0, "start_pos": 336, "end_pos": 341}, {"label_type": "藥物", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 399}, {"label_type": "藥物", "overlap": 0, "start_pos": 404, "end_pos": 408}, {"label_type": "藥物", "overlap": 0, "start_pos": 409, "end_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 472, "end_pos": 476}, {"label_type": "手術", "overlap": 0, "start_pos": 492, "end_pos": 496}, {"label_type": "藥物", "overlap": 0, "start_pos": 509, "end_pos": 513}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 559, "end_pos": 564}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 565, "end_pos": 571}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 572, "end_pos": 576}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 577, "end_pos": 582}]}
{"originalText": "入院前9月患者無明顯誘因出現腹脹，無腹痛、腹瀉、黑便，無納差、厭油，無噁心、嘔吐，無反酸、噯氣、燒心。在**醫院就診，完善相關檢查後診斷“乙肝後肝硬化失代償期”，給予“保肝、放腹水、抗病毒”等對症處理後好轉。入院前2月因中下腹隱痛及腹脹在我院內四科住院，行“胃鏡示：慢性非萎縮性胃炎，輕度食管靜脈曲張可能。乙肝三對：乙肝表面抗原定性 陽性，乙肝核心抗體定性 陽性。乙肝DNA＜5E+02，腹部彩超：肝實質回聲異常，符合肝硬化超聲表現，膽囊壁增厚毛糙，脾大；”，診斷“肝硬化失代償期”，給予“泮托拉唑抑酸、還原型谷胱甘肽及甘利欣、門冬氨酸鳥氨酸保肝、保護胃黏膜、改善腹脹等對症處理”後好轉出院。院外口服“恩替卡韋片”抗病毒治療。病程中未出現黑便、嘔血、黃疸等。於2014-12-02在**醫院複診肝硬化，查“腎功、血脂、電解質、AFP無明顯異常。血常規：WBC：3.59*10^9/L，HB：138g/L。肝功：ALT：44IU/L，GGT：134IU/L。ALB：42.9g/L。”。入院前4小時患者勞動時突然出現肝區持續性脹痛，伴陣發性加重，感左側背部放射痛，無肩膀放射痛，與飲食及體位無關。無畏寒、發熱，無噯氣、反酸、燒心，無納差、乏力。遂來我院就診，門診查腹部彩超示“肝硬化，膽囊壁毛糙增厚，脾大，胰腺未見異常。”，為進一步診治，門診以“肝硬化失代償期”收入我科。病程中精神、飲食尚可，大小便正常。體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 142, "end_pos": 150}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 170, "end_pos": 178}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 182, "end_pos": 187}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 194, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 200}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 233, "end_pos": 240}, {"label_type": "藥物", "overlap": 0, "start_pos": 245, "end_pos": 249}, {"label_type": "藥物", "overlap": 0, "start_pos": 252, "end_pos": 259}, {"label_type": "藥物", "overlap": 0, "start_pos": 260, "end_pos": 263}, {"label_type": "藥物", "overlap": 0, "start_pos": 264, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 282, "end_pos": 283}, {"label_type": "藥物", "overlap": 0, "start_pos": 301, "end_pos": 306}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 376, "end_pos": 379}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 392, "end_pos": 394}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 405, "end_pos": 408}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 416, "end_pos": 419}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 428, "end_pos": 431}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 473, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 482, "end_pos": 484}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 531, "end_pos": 535}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 537, "end_pos": 540}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 541, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 549, "end_pos": 550}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 552, "end_pos": 554}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 572, "end_pos": 579}]}
{"originalText": "患者入院前4年活動後感心累、氣促，不伴明顯胸痛，無胸骨後壓榨感，無慢性咳嗽咳痰，經******轉診至*****就診，具體檢查及治療情況不詳，自訴診斷“冠心病、房顫、高血壓”，經治療後症狀緩解出院。出院當時服藥情況不詳，否認服用“華法林”，有服用“阿司匹林腸溶片”病史，近期服用“地高辛、依那普利”，但患者依從性差，常有自行停藥情況。入院前4天患者受涼後感心累加重，平路緩步走即感心累，夜間不能平臥，需高枕臥位，並心前區悶脹感，食慾不振，無飢餓感，伴咳嗽，咯白色粘痰，無痰中帶血，無畏寒發熱，無潮熱盜汗，無胸痛，無胸骨後壓榨感，無明顯上肢浮腫，今日來院就診，門診查心電圖提示快速型房顫。胸片提示1.兩上肺肺紋增多、2.主動脈硬化，心臟重度增大，結合臨床、3.兩側肋膈角欠銳利。血常規：白細胞數 6.8 10^9/L、中性粒細胞百分比 78.34 %，心肌酶譜：穀草轉氨酶 44.8 U/L、肌酸激酶 198.7 U/L、肌酸激酶同工酶 14 U/L、乳酸脫氫酶 241.6 U/L，腎功：尿素 4.48 mmol/L、肌酐 43.0 μmol/l，高敏肌鈣蛋白T 11.93 pg/ml，電解質1：鉀 3.77 mmol/l，D_2聚體 0.54 μg/ml。門診予以靜推“胺碘酮 150mg”，靜滴“丹参川芎嗪5ml”，為進一步治療收入我科住院。病程中患者精神、飲食一般，大小便正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 12}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "藥物", "overlap": 0, "start_pos": 123, "end_pos": 130}, {"label_type": "藥物", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "藥物", "overlap": 0, "start_pos": 143, "end_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 190}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 206, "end_pos": 209}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 252, "end_pos": 253}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 256, "end_pos": 258}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 266, "end_pos": 268}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 291}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 292, "end_pos": 294}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 301}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 308, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 316}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 333}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 357, "end_pos": 365}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 379, "end_pos": 384}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 394, "end_pos": 398}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 409, "end_pos": 416}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 424, "end_pos": 429}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 443, "end_pos": 445}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 458, "end_pos": 460}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 473, "end_pos": 480}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 498, "end_pos": 499}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 512, "end_pos": 517}, {"label_type": "藥物", "overlap": 0, "start_pos": 536, "end_pos": 539}, {"label_type": "藥物", "overlap": 0, "start_pos": 550, "end_pos": 555}]}
{"originalText": "入院前1+月，患者無明顯誘因出現吞嚥梗阻，進食固體食物時明顯，偶有噁心，嘔吐少許白色粘液，不呈噴射狀，不含隔夜宿食，無咖啡色物質及血凝塊，偶有下腹部隱痛，伴腹脹，伴反酸，伴納差，飲食較前減少1/2，以流質為主，無燒心、噯氣，無嘔血、黑便，無黃疸，無腹瀉，無乏力、心悸、頭暈、頭痛，無胸悶、胸痛、呼吸困難，無畏寒、發熱等不適，於1月前就診於我院，完善腹部彩超提示“兩腎結石”，予以口服PPT及曲美布汀治療，患者症狀無明顯好轉。半月前再次就診於我院，完善碳14呼氣試驗陽性，予以“維三聯+PPI”抗HP治療2周，今日於我院完善胃鏡檢查提示“胃底、胃體巨大潰瘍伴出血可能，考慮胃癌可能”（未見報告），為求進一步診治，遂以“吞嚥哽噎原因待查”收入住院。患者此次患病以來精神食慾差，大小便正常，睡眠尚可，體力明顯上降，體重無明顯改變。入院前10年，患者常在受涼後出現咳嗽、咳痰，並逐漸出現喘累氣促，好發於冬春季節，每年累計發病時間超過3月，常就診於******醫院及我院，診斷為“慢支炎、支氣管哮喘”，予以抗感染、止咳平喘等治療後可好轉。院外長期服用氨茶鹼等藥物治療。半月前，患者於我院行肺功能提示“重度混合性通氣功能障礙以阻塞為主（FEV1/FVC 38.28%），舒張試驗陽性”。近期患者受涼後感活動後喘累、氣促較前加重，有咳嗽，咳白色黏痰，痰不易咯出，無畏寒、寒戰、發熱，無咯血、胸痛、呼吸困難等不適。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 125}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 144, "end_pos": 145}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 174, "end_pos": 178}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"label_type": "藥物", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "藥物", "overlap": 0, "start_pos": 238, "end_pos": 245}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 268, "end_pos": 270}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 271, "end_pos": 273}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 285, "end_pos": 287}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 308, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 435, "end_pos": 444}, {"label_type": "藥物", "overlap": 0, "start_pos": 470, "end_pos": 473}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 495, "end_pos": 528}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 589}]}
{"originalText": "入院前2天，患者無明顯誘因出現納差、失語，伴發熱、流涕，但未測體溫，偶有咳痰，無畏寒、寒戰，無頭昏、頭痛，無胸悶、胸痛，無噁心、嘔吐，無腹脹、腹痛，無喘累、氣促，無端坐呼吸、陣發性呼吸困難，無咯血、黑朦、暈厥，無肢體癱瘓、意識障礙、大小便失禁等。今日未進食，精神較差，故家屬送入******，查“血常規示WBC 11.58×10e9/L，RBC 5.30×10e12/L，HGB 144g/L，N 71.1%，L 26.5%。心電圖示室下性心動過速”，故轉入我院急救部治療，送入急診科行床旁心電圖示室下性心動過速，心率213次/分，T 37.9℃，立即予以吸氧、心電監護、NS 16ml+維拉帕米10mg緩慢靜推，靜推約8mg後心律恢復為竇性，心率降至94次/分，同時完善心肌酶譜：穀草轉氨酶 17.2 U/L、肌酸激酶 41.5 U/L、肌酸激酶同工酶 8 U/L、乳酸脫氫酶 245.7 U/L ↑，腎功：尿素 8.28 mmol/L ↑、肌酐 66.2 μmol/l、尿酸 251.6 μmol/l，高敏肌鈣蛋白：40.75 pg/ml ↑，電解質：鉀 3.39 mmol/l ↓、鈉 145.2 mmol/l、氯 107.6 mmol/l，凝血功能大致正常。為進一步治療以“心律失常”收入我科住院。患者自發病以來精神、食慾差，大便乾燥，小便未訴異常。近期體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 51}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 54, "end_pos": 55}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 152, "end_pos": 155}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 169, "end_pos": 172}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 186, "end_pos": 189}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 197, "end_pos": 198}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 205, "end_pos": 206}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 217, "end_pos": 224}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 243, "end_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 249, "end_pos": 256}, {"label_type": "藥物", "overlap": 0, "start_pos": 294, "end_pos": 298}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 341, "end_pos": 346}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 356, "end_pos": 360}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 370, "end_pos": 377}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 384, "end_pos": 389}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 405, "end_pos": 407}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 422, "end_pos": 424}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 437, "end_pos": 439}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 453, "end_pos": 459}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 478, "end_pos": 479}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 494, "end_pos": 495}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 509, "end_pos": 510}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 541, "end_pos": 545}]}
{"originalText": "患者於入院前1年餘即開始反覆出現胸痛症狀，心前區壓榨感，均在活動及進食後出現，不能耐受平地快走，發作後含服“速效救心丸”或休息後可逐漸緩解。病程中曾多次出現突發呼吸困難、大汗、瀕死感，在****醫院等住院治療好轉。9月前，患者進餐後再次突然出現呼吸困難，全身大汗、胸痛，診斷為心力衰竭，於我科住院，給予擴管、抗血小板、降壓、控制心室率治療後好轉出院。入院前1天，患者感氣促加重，有夜間陣發性呼吸困難，如廁即可誘發喘累，伴有咳嗽、咳痰、中下腹疼痛。無心前區壓榨感，無噁心、嘔吐，無發熱、畏寒，肛門有排氣排便。家屬撥打120由*****醫院120送入我院急診科，查血氣分析PH7.43，PO2 104mmHg，PCO2 35mmHg。血常規：白細胞數 6.2×10^9/L、中性粒細胞百分比 78.51 %，心肌酶譜：穀草轉氨酶 38.0 U/L、肌酸激酶同工酶 10 U/L、乳酸脫氫酶 279.5 U/L，腎功：肌酐 115.1 μmol/l，高敏肌鈣蛋白：264.30 pg/ml。電解質、CRP無異常。胸片提示兩肺中上野感染，以左上肺明顯。腹部彩超提示膽總管增寬。給予呋塞米20mg靜推利尿、單硝酸異山梨酯25mg靜滴後患者症狀有所緩解。為進一步治療收治我科。患者此次患病以來精神食慾睡眠差，大便正常，小便量偏少，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "藥物", "overlap": 0, "start_pos": 54, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 227}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 247}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 284, "end_pos": 286}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 291, "end_pos": 294}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 303, "end_pos": 307}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 319, "end_pos": 322}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 335, "end_pos": 343}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 357, "end_pos": 362}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 372, "end_pos": 379}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 387, "end_pos": 392}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 406, "end_pos": 408}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 422, "end_pos": 428}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 453, "end_pos": 455}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 457, "end_pos": 464}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 466, "end_pos": 469}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 472, "end_pos": 476}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 478, "end_pos": 481}, {"label_type": "藥物", "overlap": 0, "start_pos": 486, "end_pos": 489}, {"label_type": "藥物", "overlap": 0, "start_pos": 498, "end_pos": 505}]}
{"originalText": "入院前9月患者無明顯誘因出現腹脹，無腹痛、腹瀉、黑便，無納差、厭油，無噁心、嘔吐，無反酸、噯氣、燒心。在**醫院就診，完善相關檢查後診斷“乙肝後肝硬化失代償期”，給予“保肝、放腹水、抗病毒”等對症處理後好轉。入院前2月因中下腹隱痛及腹脹在我院內四科住院，行胃鏡示：慢性非萎縮性胃炎，輕度食管靜脈曲張可能。乙肝三對：乙肝表面抗原定性 陽性，乙肝核心抗體定性 陽性。乙肝DNA＜5E+02，腹部彩超：肝實質回聲異常，符合肝硬化超聲表現，膽囊壁增厚毛糙，脾大。診斷“肝硬化失代償期”，給予“泮托拉唑抑酸、還原型谷胱甘肽及甘利欣、門冬氨酸鳥氨酸保肝、保護胃黏膜、改善腹脹等對症處理”後好轉出院。院外口服“恩替卡韋片”抗病毒治療。病程中未出現黑便、嘔血、黃疸等。於2014-12-02在**醫院複診，查“腎功、血脂、電解質、AFP無明顯異常。血常規：WBC：3.59*10^9/L，HB：138g/L。肝功：ALT：44 IU/L，GGT：134 IU/L。ALB：42.9g/L。”。2天前勞動時出現肝區持續性脹痛，在我院治療好轉後出院，半天前患者再次出現肝區脹痛，無陣發性加重，無放射痛，與飲食及體位無關。無噯氣、反酸、燒心，無納差、乏力，無面板黃染。為進一步診治，門診以“肝硬化失代償期”收入我科。病程中精神、飲食尚可，大小便正常。體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 151}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 157, "end_pos": 165}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 169, "end_pos": 177}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 181, "end_pos": 186}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 193, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 198, "end_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 237}, {"label_type": "藥物", "overlap": 0, "start_pos": 242, "end_pos": 246}, {"label_type": "藥物", "overlap": 0, "start_pos": 249, "end_pos": 256}, {"label_type": "藥物", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"label_type": "藥物", "overlap": 0, "start_pos": 261, "end_pos": 268}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 274}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 279, "end_pos": 280}, {"label_type": "藥物", "overlap": 0, "start_pos": 298, "end_pos": 303}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 370, "end_pos": 373}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 386, "end_pos": 388}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 399, "end_pos": 402}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 411, "end_pos": 414}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 424, "end_pos": 427}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 446, "end_pos": 448}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 534, "end_pos": 541}]}
{"originalText": "入院前7年無明顯誘因患者感活動後乏力、氣促，不伴頭昏、頭痛、胸悶、心悸、胸痛、暈厥、黑曚、呃逆、反酸、噯氣、燒心、噁心、嘔吐、腹痛、腹脹、腹瀉、黑便。患者於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中如下症狀反覆發生，多次給予輸血治療後病程好轉。2013年4月*****胸片檢查：兩肺紋理增多，心影輕度增大。心臟彩超：右房、右室稍增大，EF正常。血庫：間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）分鐘遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床；新生兒疾病篩查報告單：新生兒G6PD活性試驗1.56（正常）。肝功：總膽紅素 50umol/L，直接膽紅素 10umol/L，ALT 40U/L，AST 18U/L。診斷“G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”明確。經輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促不適，反覆經輸注洗滌紅細胞後緩解。7天前可疑受涼後出現血尿，患者未予處理。今再次出現四肢乏力，活動後氣促伴耳鳴。為求進一步治療今日入我院門診，門診以“G-6-PD酶缺乏症”收入我科。患者此次患病以來，精神狀態差，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 28}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 146, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 175}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 179, "end_pos": 181}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 187, "end_pos": 198}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 321, "end_pos": 332}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 344, "end_pos": 348}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 373, "end_pos": 376}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 383, "end_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 396, "end_pos": 406}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 407, "end_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 414, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 492, "end_pos": 494}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 503, "end_pos": 504}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 525, "end_pos": 535}]}
{"originalText": "患者於入院前40+年，常於受涼後出現咳嗽、咳痰，痰呈白色泡沫痰，下述症狀反覆發作，多在冬春季節反覆發作，常予以抗炎止咳等藥物治療後可緩解。病程中患者逐漸出現喘累氣促，活動耐力上降，曾在我院行胸部CT提示肺氣腫、肺大泡形成，多次在我院住院治療，經抗感染等治療後好轉。病程中曾出現上肢浮腫、氣促，考慮肺源性心臟病。入院前半年，患者因下訴症狀再發於我科住院，行心臟彩超示EF 25%，室間隔、右室後壁增厚；室間隔、右室後壁動度降低；二尖瓣、三尖瓣中度反流；右室舒張、收縮功能減退。考慮“慢性阻塞性肺疾病、肺源性心臟病、冠心病？”，予以抗感染、祛痰、利尿等治療後好轉，建議患者進一步完善冠脈造影，但患者未遵醫囑。患者曾於2017年5月2日在我院行胸部CT提示：1.兩肺上葉感染，治療後複查。2.慢支炎、肺氣腫，肺大泡形成。3.兩下肺纖維斑塊病灶；左肺下葉及右肺上葉支氣管局段性擴張。4.左側肺門及心後軟組織塊影，建議患者定期複查，患者此後未再複查。入院前2天患者受涼感冒，自覺咳嗽，咯黃痰，並覺畏寒發熱，喘累症狀加重，無胸痛咯血，無心慌胸悶，無噁心嘔吐，無腹痛納差，無呼吸困難。今日來院就診，為進一步治療今日到我科住院。患者自發病以來精神、食慾可，進食好，睡眠一般，大便4-5次/日，時干時稀，無粘液膿血便，小便正常。近期體力上降，體重無明顯減輕。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 95, "end_pos": 99}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 154}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 249, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 259}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 289, "end_pos": 293}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 319, "end_pos": 323}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 328, "end_pos": 334}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 343, "end_pos": 346}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 347, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 359, "end_pos": 362}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 369, "end_pos": 373}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 374, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 378, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 389, "end_pos": 393}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 394, "end_pos": 399}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 456, "end_pos": 457}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 462, "end_pos": 463}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 464, "end_pos": 465}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 475}]}
{"originalText": "入院前30+年，患者常在受涼後出現咳嗽、咳痰，多為白色泡沫痰，並逐漸出現喘累、氣促，好發於冬春季節，每年累計發病時間超過3月，外院診斷為“慢支炎、肺氣腫”，予以抗感染、止咳平喘等治療後可好轉。患者喘累、氣促症狀逐年加重，並逐漸出現間斷兩上肢水腫，外院考慮為“肺源性心臟病”，未利尿、長期低流量吸氧及吸入劑治療。7+年前，患者喘累、呼吸困難明顯，於外院診斷為“支氣管哮喘”（具體檢查報告及診治經過不詳），開始使用沙丁胺醇氣霧劑治療。後患者下述症狀反覆發作，反覆住院治療，最近一次於2017-10-29於我科住院治療，給予抗感染、化痰、平喘、改善迴圈等治療後好轉出院，出院診斷為：1.慢性阻塞性肺疾病急性加重期;2、慢性肺源性心臟病;3、支氣管哮喘 ;4、冠心病 頻發多源性房早，頻發室早？院外長期平喘化痰對症治療。入院前2天前，患者受涼後下述症狀較前加重，咳嗽、咳黃白色粘痰，喘累明顯，不能平臥位休息，夜間陣發性呼吸困難，伴有頭昏，偶有頭疼，無畏寒、寒戰、發熱，無咯血，無潮熱、盜汗，無噁心、嘔吐，無腹脹、腹痛，無胸悶、胸痛，無尿頻、尿急、尿痛等不適，自行服用“平喘藥”（具體不詳），下述症狀無明顯好轉，遂來我院就診，門診以“AECOPD”收入我科進一步治療。患者此次患病以來精神、食慾、睡眠差，大小便正常，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "藥物", "overlap": 0, "start_pos": 205, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 303}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 314}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 317, "end_pos": 322}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 330, "end_pos": 337}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 338, "end_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 412, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 418}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 449, "end_pos": 450}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 452, "end_pos": 453}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 456, "end_pos": 457}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 459, "end_pos": 460}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 512, "end_pos": 518}]}
{"originalText": "入院前10餘年，患者無明顯誘因出現活動後心累、氣促，間斷出現兩上肢水腫、夜間喜高枕臥位，偶有胸悶，於當地醫院就診，考慮為“冠心病”。5年前因“心累、氣促”加重，於“**醫院”就診，查“心率30次/分”右左，給予安置“起搏器”，後喘累症狀稍所好轉，平素緩慢走平路即感氣促，無明顯胸悶、胸痛等不適。院外長期口服心臟疾病相關藥物（具體不詳）治療。近1年來，患者反覆因喘累、氣促在我院住院治療，予以改善迴圈、利尿、營養心肌等對症治療後好轉出院。入院前10+天，患者受涼後訴心累、氣促症狀加重，夜間明顯，夜間高枕臥位，難以平臥，伴心悸、胸悶，伴中下腹部不適，伴咳嗽、咳痰，咳出白色粘痰，否認胸痛、心前區壓榨感，無噁心、嘔吐，無咯血、腹瀉等，遂就診於我院急診科，查血常規：WBC 3.9×109/L，HGB 117g/l、N 66.2%。凝血試驗、D2聚體、腎功、電解質、心肌酶譜、肌鈣蛋白均未見明顯異常。腹部彩超示肝膽胰脾腎未見明顯異常。胸片示1.兩肺中上野感染，建議治療後複查。2.心影稍增大，主動脈弓少許鈣化；心臟人工起搏器術後改變，結合臨床。3.胸椎骨質增生。予以平喘、改善迴圈後症狀稍有改善，為進一步治療，門診以“高血壓、肺部感染”收入我科住院治療。患者此次患病以來精神食慾欠佳，大小便未訴異常，睡眠尚可，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 20, "end_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 139}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 232, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 261}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 267, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 293, "end_pos": 296}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 312}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 330, "end_pos": 333}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 355, "end_pos": 356}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 397, "end_pos": 401}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 414, "end_pos": 416}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 419, "end_pos": 426}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 437, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 443, "end_pos": 447}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 471, "end_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 506, "end_pos": 509}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 510, "end_pos": 514}]}
{"originalText": "，患者於2012年03月15日在本院行“經左胸下腹部分食管切除術+胃食管吻合術”，，術後腫瘤標誌物示：AFP 142.3NG/ML;術後定期檢查AFP，發現AFP逐漸升高，未予特殊處理。2015年8月4日，至本院複查MR提示：肝S6/7病灶，考慮小肝癌。肝S6結節，考慮肝硬化結節癌變可能性大。AFP 2777NG/ML。2015年08月19日於局麻上行肝動脈栓塞化療（TACE）術，術中用藥表阿黴素50MG，洛鉑50MG，碘油5ML。術後一般情況良好後出院。2015年9月29日，複查CT示：食管癌術後、肝癌介入術後，肝S6/7結節，碘油沉積良好，門脈期肝S6病灶，建議MR複查。病程中無明顯腹痛、無腹脹、無噁心、無嘔吐、無畏寒、無發熱、無面板搔癢等不適，現為進一步診治收入我科，起病以來，患者精神尚可，食慾如常。大小便正常。體重無明顯上降。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 20, "end_pos": 39}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 51, "end_pos": 54}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 72, "end_pos": 75}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 78, "end_pos": 81}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 108, "end_pos": 110}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 126}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 146}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 147, "end_pos": 150}, {"label_type": "手術", "overlap": 0, "start_pos": 177, "end_pos": 191}, {"end_pos": 200, "label_type": "藥物", "overlap": 0, "start_pos": 196}, {"end_pos": 207, "label_type": "藥物", "overlap": 0, "start_pos": 205}, {"end_pos": 214, "label_type": "藥物", "overlap": 0, "start_pos": 212}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 243, "end_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 259}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 270, "label_type": "藥物", "overlap": 0, "start_pos": 268}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 286, "end_pos": 288}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}]}
{"originalText": "患者自述因乏力體重減輕胃部不適就診於我院，9個月前行胃鏡檢查診斷為胃癌，進一步行超聲檢查示胃竇周圍可見多個低迴聲，大者2.83*1.45CM，進一步行肝膽脾胰超聲提示胰頭周圍腫大淋巴結，8個月前入我科，行紫杉醇脂質體聯合替吉奧方案化療6週期，具體用藥為紫杉醇脂質體270毫克D1，替吉奧60毫克日二次口服D1-D14，化療間期出現II°噁心嘔吐，使用託烷司瓊聯合異丙嗪止吐效果良好，2週期評效為PR，4,6週期評效為維持PR，後改為單藥替吉奧（維康達）口服治療3週期，無明顯不適，現為進一步治療入我科。患者近1月來飲食睡眠一般，精神體力一般，二便基本正常，體重未見明顯減輕，KPS評分80分。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 35}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 75, "end_pos": 81}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 108, "label_type": "藥物", "overlap": 0, "start_pos": 102}, {"end_pos": 113, "label_type": "藥物", "overlap": 0, "start_pos": 110}, {"end_pos": 132, "label_type": "藥物", "overlap": 0, "start_pos": 126}, {"end_pos": 143, "label_type": "藥物", "overlap": 0, "start_pos": 140}, {"end_pos": 179, "label_type": "藥物", "overlap": 0, "start_pos": 175}, {"end_pos": 184, "label_type": "藥物", "overlap": 0, "start_pos": 181}, {"end_pos": 221, "label_type": "藥物", "overlap": 0, "start_pos": 218}, {"end_pos": 225, "label_type": "藥物", "overlap": 0, "start_pos": 222}]}
{"originalText": "，患者6月前因“劍突上隱痛不適伴腹脹1月餘”入院，，入院完善輔助檢查：2016-4-21 ，*****院胃鏡檢查：胃癌 取胃角活檢4塊，，病理診斷：印戒細胞癌。2016-4-26 ，*****病理診斷：（胃角）印戒細胞癌。，全腹部增強CT提示：1.胃體壁區域性稍增厚並明顯強化，考慮胃癌。2.子宮頸體積增大並增強後密度不均，子宮後壁可疑小結節，子宮肌瘤？3.腹膜後多發小淋巴結顯示。完善術前檢查，明確無手術禁忌症後，於2016-05-03全麻上行腹腔鏡上遠端胃大部切除術+放射性粒子植入術，手術順利，，術後病理報告：胃印戒細胞癌，浸及胃壁全層，未見明確脈管及神經侵犯，雙切端未見癌累及。胃大、小彎淋巴結均未見癌轉移（分別為0/8、0/5）。大網膜未見癌轉移。另送（第3、6組）淋巴結均未見癌轉移（均為0/1）。，病理分期：T3N0M0。院外期間患者術後恢復良好，已行5次化療（XELOX方案），未訴發熱、畏寒、噁心、嘔吐、腹瀉等不適。本次擬行第6化療（XELOX方案）入院，門診以“胃癌術後”收入我科。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 58}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 109}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 123, "end_pos": 125}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 139, "end_pos": 141}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 162}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 170, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 186}, {"label_type": "手術", "overlap": 0, "start_pos": 221, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 262}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 265, "end_pos": 266}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 329, "end_pos": 339}, {"end_pos": 410, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 439, "end_pos": 443}, {"end_pos": 471, "label_type": "解剖部位", "overlap": 0, "start_pos": 470}]}
{"originalText": "患者1年前因大便帶血在我院診斷為“結腸息肉”，遂電子結腸鏡上行結腸息肉電切術，病理示管狀腺瘤，今患者為術後複查來診，門診以“結腸息肉術後、內痔”收入院。患者自發病以來神志清，精神可，飲食、睡眠可，小便正常，大便每日1次，質軟排出通暢，不帶膿血及粘液，無肛門腫物脫出、肛門上墜感，無肛周**、肛周瘙癢，無噁心、嘔吐，無腹痛、腹脹，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 21}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}]}
{"originalText": "，入院前6天，患者無明顯誘因出現左下腹部疼痛，呈刺痛，不能耐受，疼痛持續不緩解，向臍部放射，無肩背部放射痛，伴有大汗淋漓，伴有畏寒、發熱（具體溫度不詳，未測），無頭昏、頭痛，無面色蒼白、四肢乏力，無噁心、嘔吐，無嘔血及黑便，面板鞏膜無黃染，當時未予重視，未治療。2天前，患者就診於我院消化內科，，行腹部彩超檢查提示：1.肝實質回聲密集增強、欠均質改變，門靜脈栓子形成，建議進一步檢查；2.右腎結石。，電子胃鏡檢查提示：食管炎，慢性非萎縮性胃竇炎，HP（+）。行下腹部增強CT初步報告懷疑肝門部膽管癌？我科會診後，為明確診斷及進一步治療，建議住院治療，急診科遂以“，肝門佔位性病變：肝門部膽管癌？”收入我科住院治療。   自患病以來，患者精神一般，睡眠及食慾欠佳，大小便正常，近期體重無明顯變化。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 149, "end_pos": 153}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 194, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 222}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 230, "end_pos": 237}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 243, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 282, "end_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 296}]}
{"originalText": "患者半年前無明顯誘因發現便中帶血，呈鮮紅色，大便成形，不伴裡急後重感，無腹痛、腹瀉，噁心嘔吐等不適，此後下述症狀持續存在，未系統診治。10天前我院門診行腸鏡檢查示“結腸多發息肉”，行病理檢查示：“橫結腸增生性腺瘤性息肉 乙狀結腸低級別管狀腺瘤”，遂入我院要求行結腸鏡電切手術治療。患者病來無發熱寒戰，無咳嗽咳痰，無腹痛、腹瀉，無噁心、嘔吐，無尿頻、尿急及尿痛等不適，飲食睡眠可，精神體力可，近期體重無明顯變化。", "entities": [{"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 98, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 121}, {"end_pos": 137, "label_type": "手術", "overlap": 0, "start_pos": 130}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}]}
{"originalText": "患者約1年餘前因“面板黏膜及鞏膜黃染”入院，入院後積極完善相關入院檢查，考慮患者壺腹周圍癌並梗阻性黃疸診斷明確，排除手術禁忌後於2015.12.11在全麻上行胰十二指腸切除術，手術過程順利，病理回示：壺腹部腺癌，中度分化，體積1.5*1.5*1.3CM，侵達肌層。胃切線、十二指腸切線、膽總管切線及胰腺切除面未查見癌。胃周圍（3個）、胰腺周圍（3個）、膽總管旁（2個）、“第十二組”（5個）、“肝十二指腸韌帶”（1個）淋巴結未查見癌。慢性膽囊炎。患者自手術後多次接受吉西他濱化療和細胞回輸治療。患者自下次出院以來，無腹痛、腹脹，無噁心、嘔吐，無發熱、寒戰，無咳嗽、咳痰、呼吸困難，無尿頻、尿急、排尿困難，現患者為求入院複查，來我院就診，門診以“胰十二指腸術後”收入我科。   患者自發病以來，神志清，精神可，飲食欠佳，睡眠可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 51}, {"end_pos": 87, "label_type": "手術", "overlap": 0, "start_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 217, "end_pos": 222}, {"end_pos": 237, "label_type": "藥物", "overlap": 0, "start_pos": 233}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 262, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 322, "end_pos": 329}]}
{"originalText": "2008年8月19日開始出現中下腹痛，主要表現為隱痛，疼痛發作無明顯規律性，近期逐漸加重，不向其他身體部位放射或牽涉。伴有噁心，有嘔吐胃內容物，無嘔血；無黑便；有噯氣，有返酸；無腹脹；無腹瀉。無發熱。2009年1月13日行胃鏡檢查報告提示：胃角MT，胃鏡活檢病理報告（2009-1-14）為（胃角）腺癌。現為行進一步檢查收治入院。發病以來，患者食慾漸差，大便習慣性狀尚正常，小便如常，體重略有減輕。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 151}]}
{"originalText": "入院前5年，患者無明顯誘因出現噯氣，伴飢餓時劍突上不適，無明顯反酸、燒心，無腹脹、腹痛、腹瀉，患者先後就診於我院及外院治療及自服中藥治療（具體不詳），噯氣症狀可緩解，期間患者噯氣及飢餓時劍突上不適反覆發作，入院前半年餘前，患者於我院行胃鏡檢查提示：1.十二指腸球部息肉；2.淺表性胃炎，快速尿素酶檢測（+++），予以對症支援治療（具體不詳），患者噯氣症狀逐漸緩解，現患者為進一步治療十二指腸息肉入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 197}]}
{"originalText": "患者2010年5月無明顯誘因出現大便帶血，呈暗紅至鮮紅色，量不多，症狀一直存在，無明顯減輕或加重。未訴腹痛腹瀉，無便祕。2011年4月於**六院檢查上腹部盆腔MRI及腸鏡檢查提示直腸腫物，於2011-5-5行全麻上直腸癌根治術（DIXON術），術後病理提示直腸高分化腺癌，浸潤至粘膜上層，送檢淋巴結均未出現癌轉移，術後分期為PT1N0M0 I期。術後未行輔助化療，予每3個月定期複查CT及腸鏡，病情一直穩定，未見覆發或轉移徵象。近一個月患者出現咳嗽咳痰，痰量不多，無胸痛氣促等症狀。2012-5複查盆腔MR及腹部CT無復發轉移徵象，行胸部CT檢查，示：右下肺舌段1個、左下肺前段2個轉移瘤。查KRAS基因為野生型。考慮“直腸中分化腺癌（PT1N0M0）術後兩肺轉移，IV期”，於2012-05-17、2012-06-01、2012-6-19、2012-07-10、2012-7-25行FOLFOX方案化療5程。1程化療後患者出現腹瀉3天，每天5-6次，食慾上降約5天，第2-5程化療後無明顯不適。3程化療後CT評價SD。現為進一步治療收入我科。目前患者無頭暈頭痛，無噁心嘔吐、無腹痛腹瀉，精神食慾可，二便正常，體重較前無明顯變化。", "entities": [{"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 74, "end_pos": 82}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 135}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 191, "end_pos": 193}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 249, "end_pos": 253}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 254, "end_pos": 258}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 267, "end_pos": 271}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 310, "end_pos": 336}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 479}, {"end_pos": 490, "label_type": "解剖部位", "overlap": 0, "start_pos": 489}, {"end_pos": 492, "label_type": "解剖部位", "overlap": 0, "start_pos": 491}]}
{"originalText": "患者於2年前因“大便習慣性質改變半年餘”入院，入院後完善相關檢查，考慮診斷直腸癌，於2013-11-21行腹腔鏡輔助上直腸癌根治術+放射粒子植入術，病理分期（T4N1M1)，術後發現直腸吻合口口瘻，於2013-12-30行橫結腸造口術，術後恢復可，於血管外科行右上肢、上腔靜脈造影+上腔靜脈濾器取出術，手術順利，術後恢復可。後規律行6次化療，一般情況可，5月前於我院門診行CT檢查提示：兩上肺新增小結節影；住院後診斷直腸癌肺轉移。已行4次化療，未訴特殊不適，無畏寒、發熱，無反酸、噯氣，無咳嗽、咳痰等不適，現行第5次化療入院。\\U0004   患者自起病以來，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "手術", "overlap": 0, "start_pos": 53, "end_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 98}, {"end_pos": 117, "label_type": "手術", "overlap": 0, "start_pos": 111}, {"label_type": "手術", "overlap": 0, "start_pos": 130, "end_pos": 150}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 186, "end_pos": 188}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 214}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}]}
{"originalText": "，患者2011年8月患者無明顯誘因出現黏液血便，納差、厭油、腹脹，不伴有腹痛、裡急後重、腹瀉、便祕、嘔吐、發熱等症狀。2011－10－12日，下腹部CT檢查示：肝內多發病灶，最大病灶6CM*8CM，考慮轉移瘤可能大。2011－10－12日，腸鏡示：乙狀結腸可見0.6CM*0.8CM腫物，乙狀結腸（距肛門口約20－26CM)可見環腸腔生長腫物；直腸距肛門口8CM處可見大小約0.5×0.6CM粘膜上隆起。乙狀結腸腫物活檢病理為中分化腺癌。2011-10-14日我院病理會診為中分化腺癌，未行特殊治療。2011-10-25在我院行結腸腫塊切除術，2011-11-14、2011-11-29、2011-12-14、2011-12-30在我科行FOLFERI+C225方案4療程，治療後全身出現1度皮疹，現為繼續治療入院。患者近來精神、睡眠尚可，食慾一般，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 30}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 166}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 177}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"end_pos": 271, "label_type": "手術", "overlap": 0, "start_pos": 264}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 327}]}
{"originalText": "患者6年前無明顯誘因出現腹瀉，每天約3-4次，呈糊狀便，無發熱，無反酸、燒心，無噁心、嘔吐，無進食阻擋感及哽噎感，無胸骨後疼痛，無乏力、納差，無嘔血、黑便，無停止排便、排氣、腹痛、腹脹，遂就診於我院，行電子腸鏡提示腸息肉，並於術中行腸息肉切除術（未見具體報告單）。此後患者仍反覆出現腹瀉，每天約3-5次，不成形，多次於我院行結腸鏡，並於術中行腸息肉切除術（具體不詳）。患者近1月餘再次出現腹瀉，性質同前，為進一步診治，門診以“結腸息肉 內鏡上切除術後”收住院。   患者自發病以來，神志清，精神尚可，飲食睡眠可，大便如前所述，小便正常。體重近期無明顯變化。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 110}, {"end_pos": 122, "label_type": "手術", "overlap": 0, "start_pos": 116}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 177, "label_type": "手術", "overlap": 0, "start_pos": 171}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 225}]}
{"originalText": "緣於入院前[主訴單一時間1個月主訴單一時間]前無明顯誘因出現中下腹部悶痛不適，為持續性隱痛，無其它部位放射，與進食無關，無噁心、嘔吐、返酸、噯氣、納差、乏力、消瘦、腹痛、腹瀉、便祕，無嘔血、黑便，無發熱、咳嗽、咳痰，未予治療，症狀無明顯好轉，此次至我院門診行胃鏡檢查示：“胃底間質瘤”，遂門診擬“胃間質瘤”收入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重無明顯變化。", "entities": [{"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 30}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 152}]}
{"originalText": "患者1年餘前無明顯誘因出現左頸部淋巴結腫大，約1－2釐米大小，無發熱、盜汗，無涕中帶血，無嗆咳、聲音嘶啞，當時未予重視，後頸部淋巴結未明顯增大，2015-4-14在我院行左頸部淋巴結活檢，病理形態結合免疫組化提示慢性淋巴細胞白血病/小細胞淋巴瘤（CLL/SLL)。因患者有吞嚥困難，行胃鏡檢查發現慢性淺表性胃炎伴糜爛、膽汁返流，食管粘膜活檢提示粘膜慢性炎症，伴鱗狀下皮輕度不典型增生。2015-4-23行骨髓塗片並免疫流式細胞學檢查符合CLL/SLL診斷。綜合病史診斷明確CLL/SLL（RAI I期）。現患者按期入院複診。患者自發病以來，精神、胃納尚可，二便正常，體重無明顯上降。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 163}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 218, "end_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 251}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 273}]}
{"originalText": "，緣於入院前13天無明顯誘因出現右側腰部疼痛，為持續性絞痛，放射至右上腹部，無發作性血尿、無畏寒、發熱，無明顯尿頻、尿急、尿痛，無少尿及面部、四肢浮腫、無排尿困難及中斷，，於外院查泌尿系彩超示:1.右腎輸尿管中段結石伴右腎積水（中度）2.右腎結石3.左腎積水（輕度）4.子宮切除術後聲像，經解痙止痛治療後腰腹痛緩解（具體不詳），今為求進一步診治，就診我院，，門診查CTU示：右腎多髮結石伴右腎、右輸尿管下段輕度擴張、積水，右輸尿管中上段炎性不全性狹窄可能，先天發育異常待除。門診擬“右輸尿管結石”收住院。發病以來，神可，食慾、睡眠正常，大便無異常，體重未見明顯變化。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 141}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 182, "end_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 247}]}
{"originalText": "患者2016.3因喉癌、舌癌複查時，於****二院2016-03-11行MRI結果示舌癌術後複查，食管下段巨大軟組織腫物，腫瘤侵犯周圍組織，考慮惡性腫瘤，食管癌可能大，並右側鎖骨下上、縱膈淋巴結轉移。右舌、口底術後改變、左側杓會厭壁增厚，考慮炎症可能。行胃鏡檢查病理結果示食管癌（多源性）。2016.3.31就診於我院，2016.4.7給予多西他賽120MG D1，患者一般情況可。現為進一步治療來我科。患者自發病以來，飲食及睡眠差，大小便正常，體重較前有所減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 46}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 107}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 144}, {"end_pos": 174, "label_type": "藥物", "overlap": 0, "start_pos": 170}]}
{"originalText": "，患者2017-2-26傍晚無明顯誘因出現腹痛、腹脹不適，腹痛呈陣發性，上腹為主，有便意未排便，後出現嘔吐數次，自述量較多，嘔吐物先為胃內容物後為膽汁，至27日患者腹痛、腹脹未有緩解遂至當地醫就診，查腹平片提示腸梗阻可能（未見單），患者為求進一步診治至我院就診，，查腹部平片示：考慮直腸梗阻可能，建議複查。腹部立位片未見消化道穿孔徵象。患者今晨排稀水便雙次，量少，未排氣，目前禁食中，仍有腹脹，血壓偏低，心率偏快，四肢發冷，排尿1次約50ML。追問病史，患者2016-2-2因“直腸癌”行HARTMANN+乙狀結腸造瘻術，，術後病理示：腺癌PT4AN2AM0 IIIC期，術後行XELOX方案化療6程，過程順利，於2016-11-24行乙狀結腸造口回納術，術後患者恢復可，排便排氣正常，偶有便祕，近期油膩飲食較多。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 24}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 100, "end_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 108}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 145}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 153, "end_pos": 158}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 165}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 242}, {"label_type": "手術", "overlap": 0, "start_pos": 244, "end_pos": 260}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 268, "end_pos": 285}, {"end_pos": 327, "label_type": "手術", "overlap": 0, "start_pos": 318}]}
{"originalText": "患者於4月餘前因“升結腸腺癌破裂穿孔致急性瀰漫性腹膜炎”在我院行剖腹探查+腹腔粘連鬆解+腸間膿腫引流+升結腸腫瘤切除+末段小腸造口術，手術順利，術後病理檢查結果示：（升結腸）中分化管狀腺癌浸及腸壁全層，雙切端未見癌累及，腸壁淋巴結未見癌轉移（0/8）。術後患者恢復可，今日擬行第四次化療，特來我院就診。\\U0004   患者自起病以來，精神可，胃納可，大便如下述，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 27}, {"label_type": "手術", "overlap": 0, "start_pos": 32, "end_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}]}
{"originalText": "患者於今年5月因發現“身目黃染2周，發現肝門區佔位1周”在我院診斷為原發性肝癌，並於2011.5.27行肝癌切除術+膽囊切除術+膽總管切開取栓術，術後病理為肝細胞性肝癌伴膽管癌栓，術後定期複查，未見明顯復發及殘留。現為進一步治療入院。下次治療至今患者無明顯腹痛、無腹脹、無噁心、無嘔吐、無畏寒、無發熱，，患者精神尚可，食慾如常。大小便正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 20, "end_pos": 21}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 39}, {"label_type": "手術", "overlap": 0, "start_pos": 52, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 89}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}]}
{"originalText": "，患者既往月經規律,14歲,7/30天，，LMP:2012.7.25，因患“子宮腺肌症”於2012-08-09於我院行子宮全切術。手術順利，術後恢復可。15天前，患者無明顯誘因感右側腰部脹痛不適，呈持續性，不能自行緩解，陰道分泌物未見明顯異常。不伴發熱，噁心、嘔吐、腹瀉，無尿頻、尿急、尿痛等症狀。期間患者自行口服抗生素，藥物名不詳，症狀無明顯緩解。2012-09-17來我院門診就診，，婦科彩超示：1、左卵巢囊腫，2、右附件區囊性包塊。今日患者為求進一步診治，收入我科。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 43}, {"end_pos": 64, "label_type": "手術", "overlap": 0, "start_pos": 59}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 194, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 207}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 213}]}
{"originalText": "，患者20年前自述因使用某減肥藥物（具體不詳）後出現體重增加（當時體重52KG），約每年增加約5-10KG，後患者於16年前曾行抽脂手術，術後因腹部疼痛，自述臥床休息近3年，體重依舊進行性增加。至今年，患者體重增加至105KG，病程期間，患者出現數次陣發性室下速，於外院治療後好轉，近半年來未再發作。1月前至我院就診完善相關檢查，ACTH-F節律基本正常，，血脂：，總膽固醇: 4.72MMOL/L；，甘油三酯: 1.80MMOL/L；，高密度脂蛋白膽固醇: 1.25MMOL/L；，低密度脂蛋白膽固醇: 2.65MMOL/L；，非高密度脂蛋白膽固醇: 3.47MMOL/L，肝臟MRS 提示LFC 21%，診斷單純性肥胖，經患者及家屬同意，於2014.6.5日到外科行袖狀胃手術，2014.6.6安返回我科，並給予補液等支援治療。，胃腸道碘水造影示：袖狀胃切除術後，造影劑透過順利。予停靜脈補液，飲水，無明顯不適，逐漸過渡到流質飲食，傷口癒合良好。同時給予指導飲食方案，並予補充善存、維生素D、鈣片、葉酸及鐵劑等。07-24日患者無明顯誘因上出現高熱，最高體溫39.8度，無咳嗽、咳痰，無腹脹、腹痛，無噁心嘔吐等不適。現患者為行進一步診治入住我院。發病以來，患者飲食、睡眠可，二便無殊，術後體重減輕15KG。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 64, "end_pos": 68}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 183, "end_pos": 187}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 201, "end_pos": 205}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 219, "end_pos": 228}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 242, "end_pos": 251}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 265, "end_pos": 275}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 288, "end_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 311}, {"label_type": "手術", "overlap": 0, "start_pos": 335, "end_pos": 340}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 367, "end_pos": 374}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 376, "end_pos": 383}, {"end_pos": 442, "label_type": "藥物", "overlap": 0, "start_pos": 440}, {"end_pos": 447, "label_type": "藥物", "overlap": 0, "start_pos": 443}, {"end_pos": 450, "label_type": "藥物", "overlap": 0, "start_pos": 448}, {"end_pos": 453, "label_type": "藥物", "overlap": 0, "start_pos": 451}, {"end_pos": 456, "label_type": "藥物", "overlap": 0, "start_pos": 454}, {"end_pos": 496, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"end_pos": 499, "label_type": "解剖部位", "overlap": 0, "start_pos": 498}]}
{"originalText": "入院20+年前，患者無明顯誘因出現月經紊亂，無痛經、噁心、嘔吐、腹瀉等症狀。遂於****就診，確診為宮頸癌，並行手術切除，術後予以化療（具體方案不詳），化療過程順利，之後定期複查未見覆發及轉移。10+年前患者因粘連性腸梗阻於我院手術治療，術後因傷口破裂造成腹部切口疝，此後因反覆腹痛及腹瀉，每年數次到我院外科及我科住院治療，診斷不全性腸梗阻，經禁食、胃腸減壓及抗感染等對症處理後腹痛能夠緩解。2015年3月10日患者因外傷在我科行頭顱CT提示右側額部佔位性病變，請結合頭顱MRI增強檢查。頭部MRI(2015-03-10):右側額頂葉佔位性病變，考慮腦膜瘤可能性大，請結合臨床。請相關科室會診評估行顱腦手術風險。建議患者行陀螺刀放療。患者拒絕後出院。2小時前患者無明顯誘因出現間斷腹部隱痛，無噁心嘔吐，無腹瀉，肛門未見排氣。為求進一步診治來我院門診就診，門診以“宮頸癌術後，腸梗阻”收入我科。", "entities": [{"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 133}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 164, "end_pos": 170}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 215, "end_pos": 219}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 227}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 234, "end_pos": 239}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 244, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 262, "end_pos": 267}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 278}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 381, "end_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 387, "end_pos": 390}]}
{"originalText": "患者於2014-2－25在我科行根治性膀胱切除＋迴腸導管術，術中順利，術後恢復好，切口癒合佳。患者出院後出現便祕並會陰部墜脹不適，口服藥物或食物後便祕症狀緩解但會陰部墜脹不適感無明顯改善，到我院行了腸鏡檢查提示：結腸息肉。患者常規復查，除了上腹部切口疝以外無特殊不適；今為拔除PCS盒來我院，門診以\\\"1、膀胱癌根治術後 2、PCS盒植入術後\\\"收入我科。患者發病以來,精神好,飲食睡眠佳,無咳嗽、咳痰、胸痛及心慌氣短，大便正常，小便如下所述，體重無減輕。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 16, "end_pos": 29}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 163, "end_pos": 171}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}]}
{"originalText": "患者2年餘前因“直腸癌”於我院胃腸外科行根治術，術後出現吻合口瘻，後行結腸造口術。出院後患者口服化療藥物4個月，並進行放療1療程。患者於19個月前複查腹部CT時發現肝轉移，後化療4週期，再次複查腹部CT，見肝內轉移病變無明顯吸收。患者於16個月前行結腸還瘻術及肝部分切除術，術後化療6週期。4個月前患者複查肺部CT，發現左肺上葉結節，化療4週期後再次複查肺部CT，見左肺上葉結節無明顯變化，現為求進一步診治來院。患者近來飲食、睡眠及二便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 32}, {"end_pos": 40, "label_type": "手術", "overlap": 0, "start_pos": 35}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 85}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 97, "end_pos": 101}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "手術", "overlap": 0, "start_pos": 124, "end_pos": 136}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 153, "end_pos": 157}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}]}
{"originalText": "4年前開始患者無明顯誘因出現中下腹疼痛，每次持續時間不等，飢餓時較明顯，進食後有加重，偶有打嗝，無反酸、燒心、噯氣，無噁心、嘔吐，無嘔血、黑便，自行服用藥物（具體不詳）後緩解，未予以重視。7天前，患者無明顯誘因再次出現中下腹疼痛，偶有打嗝，無腹脹、燒心，不伴反酸、噯氣、呃逆，不伴嘔吐、腹瀉，不伴嘔血、黑便，無心悸、胸悶、咳嗽、咳痰，今日於我院行胃鏡檢查提示“淺表性胃竇炎伴糜爛、十二指腸降段口粘膜隆起待查、十二指腸球部對吻潰瘍(FORREST IB ） ”，為進一步治療，門診以“消化性潰瘍”收治入院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 189}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 190, "end_pos": 203}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 246}]}
{"originalText": "患者2+月前於我科診斷為“左肝原發性肝癌”，行剖腹探查、左肝腫瘤切除、膽囊切除、左肝結節射頻消融術（術中彩超引導上），術後恢復順利，術後病檢（1410644）結果示：高分化肝細胞性肝癌，肝硬化，慢性膽囊炎，出院後低脂飲食，無腹痛等不適，現患者無咳嗽咳痰，無噁心、嘔吐，無肝區疼痛，無厭油、納差、乏力，無胸悶、胸痛，無腹痛、腹脹，無尿頻、尿急、尿痛，現擬行介入治療，遂來我院門診就診，以“肝癌術後”收住我科。   患病以來，精神食慾可，睡眠較好，大便正常，小便如下訴。體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 20}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 93, "end_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 102}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 197}]}
{"originalText": "，緣於入院前半個月主訴單一時間]前無明顯誘因感中下腹部悶痛不適，為持續性隱痛，無其它部位放射，伴進食時噁心，食慾上降，分量為原來1/4，無嘔吐，無腹痛、腹瀉、便祕，無發熱、咳嗽、咳痰，未予治療，症狀無明顯好轉，3，天前至我院門診行胃鏡檢查示：“胃竇潰瘍浸潤型癌侵及胃角、幽門，慢性萎縮性胃炎”，，病理：(竇小)，:胃低分化癌，遂門診擬“胃癌”收入院。自發病以來，精神、睡眠可，食慾差，大小便如常，體重減輕約4KG。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 162}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 170}]}
{"originalText": "患者於2009-12-18在我院行直腸癌低位前切除術+預防性迴腸造瘻術，術中見腫瘤位於腹膜反折下方3CM，無梗阻穿孔表現，術後病理為隆起型高中分化腺癌，無脈管癌栓，侵犯腸壁至漿膜上，淋巴結無癌轉移0/16，未行進一步治療，定期複查。2010-3-19再次入院行迴腸造口還納術，術後排便習慣較前改變，大便幹，需口服潤腸藥協助排便。一月餘前患者複查CEA升高22NG/ML，無不適主訴，行PET-CT檢查提示肝內高代謝，考慮轉移，無肝外轉移表現。進一步行MRI檢查提示肝S4/8交界轉移瘤，3.8X3.8CM\\U007F肝臟多發囊腫，患者本次為行第二週期MFOLFOX6化療入院，患者自患病以來，精神可，飲食睡眠可，二便如常，體重無明顯減輕。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 17, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"end_pos": 137, "label_type": "手術", "overlap": 0, "start_pos": 130}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 192, "end_pos": 198}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 225, "end_pos": 230}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 232, "end_pos": 242}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 258, "end_pos": 260}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 262, "end_pos": 264}]}
{"originalText": "患者2小時前於我院行胃腸鏡體檢時發現結腸息肉，直徑約0.6CM，於鏡上切除，並於胃鏡上取部分組織活檢。患者無噁心、嘔吐，無反酸、噯氣，無腹痛、腹瀉，無黑便、血便，無發熱、咳嗽，無胸悶、氣促，無頭暈、頭痛，為進一步治療門診以“結腸息肉內鏡上切除術後”收入院。   患者自發病以來精神狀態良好，大小便正常，體重無明顯變化。   自發病以來，患者神志清，精神可，飲食睡眠尚正常。小便量可，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 22}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 123}]}
{"originalText": "，半年前，患者服用元胡止痛片後解鮮紅色約200ML血便1次，伴頭昏、心慌、氣促，無噁心、嘔吐、嘔血，無腹痛、腹瀉等症狀，無裡急後重，無肛門墜脹感，無畏寒發熱，無面板黏膜黃染，入我院胃腸外科，，行胃鏡檢查示：糜爛性全胃炎，予以輸血、補液等治療後好轉出院；出院後患者再次因反覆便血入我科治療，，行腸鏡檢查示：慢性結腸炎；，考慮診斷：1.上消化道出血原因待查；2.慢性結腸炎 3.十二指腸乳頭神經內分泌癌切除術後；予以抑酸、護胃、止血等治療後症狀緩解出院；出院後患者未再出現便血等情況，今日為求複查瞭解病情恢復情況入我科，門診以“便血待查”收入我科。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 14, "label_type": "藥物", "overlap": 0, "start_pos": 9}, {"end_pos": 32, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"end_pos": 35, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 152, "end_pos": 157}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 176}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 203}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 262, "end_pos": 266}]}
{"originalText": "患者半年前因“乙肝病史9年，查體發現肝佔位1周”來我院就診，經檢查診斷“原發性肝癌、乙肝肝硬化”收住院，於2015-09-25在全麻上行左肝腫瘤切除+膽囊切除術。手術順利，病理結果：（左肝）肝細胞肝癌（II級），結節型，體積2*1.5*1.5CM，未累及切除面；結節性肝硬化；膽囊膽固醇性息肉、慢性膽囊炎（201516700）。術後給予抗感染、保肝、補液、營養支援及對症處理，恢復順利出院。4月及2月前來院複查，分別行肝介入治療（TAI），治療後行替加氟+亞葉酸鈣+澤菲靜脈序貫化療，同時給予保肝、升白、止吐、護胃及增強免疫等對症治療，好轉後出院。   患者自下次出院後，一般情況好，無發熱，無腹痛、腹脹、腹瀉及肝區不適，無噁心、嘔吐，無黃疸，飲食睡眠可，大小便正常，體重無減輕。今為複查再次來我院就診，門診以“肝癌術後”收住院。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 47}, {"label_type": "手術", "overlap": 0, "start_pos": 68, "end_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 152}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"label_type": "手術", "overlap": 0, "start_pos": 209, "end_pos": 219}, {"end_pos": 227, "label_type": "藥物", "overlap": 0, "start_pos": 224}, {"end_pos": 232, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"end_pos": 235, "label_type": "藥物", "overlap": 0, "start_pos": 233}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 300}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 356, "end_pos": 360}]}
{"originalText": "，1+年前患者因“子宮內膜癌I期”於2012-08-10日全麻上行全子宮及兩側附件切除術，，術後病檢結果提示：1、高-中分化子宮內膜樣腺癌。患者術後無陰道流血、流液，無明顯腹痛、腹脹，無噁心、嘔吐，無咳嗽、咳痰等不適。患者定期我院門診複查，提示CA125升高及盆腔積液，考慮腫瘤復發，於2013-7-15收入院行第一次化療（紫杉醇180MG+奧沙利鉑180MG），化療期間及化療出院後患者偶有腹瀉。於2013-8-15查子宮內膜癌標記物提示，CA125：148.6U/ L,，組織多肽抗原：110U/L,行第二次化療（紫杉醇180MG+奧沙利鉑180MG），有輕微噁心、嘔吐等不適，無腹痛、黑便、嘔血，無骨痛、皮疹，無陰道流血、流液等不適。現患者要求第3次化療，遂以“子宮內膜癌第3次化療”收入住院。 \\U0004   患者本次發病以來，食慾減退， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 16}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 122, "end_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"end_pos": 165, "label_type": "藥物", "overlap": 0, "start_pos": 162}, {"end_pos": 175, "label_type": "藥物", "overlap": 0, "start_pos": 171}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 215}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 221, "end_pos": 226}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 238, "end_pos": 244}, {"end_pos": 262, "label_type": "藥物", "overlap": 0, "start_pos": 259}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 268}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 334, "end_pos": 339}]}
{"originalText": "緣於入院前6年，就診我院診斷“降結腸癌”，後行“右半結腸切除術”.半天前小時前無明顯誘因發生腹痛，呈持續性悶痛，陣發性加劇，伴腹脹、噁心感，無明顯嘔吐,肛門暫未排氣、排便，無嘔血、黑便，無心悸、氣促，無畏冷、發熱，無肉眼血尿、尿頻、尿急、尿痛。就診於我院急診，行立位腹部平片示：“不全性腸梗阻可能。”為進一步診治，門診擬粘連性腸梗阻收入院，發病以來，精神、睡眠、食慾差，大便如下述，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 19}, {"end_pos": 31, "label_type": "手術", "overlap": 0, "start_pos": 24}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 166}]}
{"originalText": "，患者自述於7.5個月前出現下腹疼痛，伴反酸，無放射痛，期間未就診。4.5個月前腹痛症狀加重，並嘔吐2次胃內容物，就診於我院，，行胃鏡檢查示：胃巨大潰瘍性病變，惡性可能大；十二指腸球部息肉，鉗除。，病理示：十二指腸球部炎性息肉；胃體潰瘍，淋巴組織異型增生，不除外淋巴瘤。，免疫組化支援胃黏膜相關B細胞淋巴瘤：CK下皮（+）CD3散在（+）CD20（++）PAX-5（++）CD68散在（+）KI67（+）＞80% CD5（+/-）CYCLIND1（-）。於2012年12月7日始行COP方案化療2週期，，具體為：環磷醯胺0.6GD1D4，長春新鹼2MGD1，醋酸潑尼松片100MG日一次口服D1-D5，並予卓迪、耐信片、甲硝唑、阿莫西林抗HP治療，化療後無明顯不適。2週期後評效疾病部分緩解（PR），第3-6週期改為CHOP方案化療，，具體為：環磷醯胺1.2GD1，表阿黴素（艾達生）50MGD1、D2，長春新鹼2MGD1，醋酸潑尼松100MGD1-D5，並予高舒達抑酸對症治療。，第4週期評效：維持PR。化療後患者出現II度腹瀉，眼瞼水腫，對症治療後好轉。現為進一步治療入我科。患者近來偶有飯後下腹部不適，飲食可，睡眠一般，精神體力可，周身其他部位無疼痛，二便正常，體重無明顯變化，KPS評分80分，ECOG1分。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 94}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 153}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 256}, {"end_pos": 273, "label_type": "藥物", "overlap": 0, "start_pos": 269}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"end_pos": 305, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 306}, {"end_pos": 313, "label_type": "藥物", "overlap": 0, "start_pos": 310}, {"end_pos": 318, "label_type": "藥物", "overlap": 0, "start_pos": 314}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 372}, {"end_pos": 387, "label_type": "藥物", "overlap": 0, "start_pos": 383}, {"end_pos": 391, "label_type": "藥物", "overlap": 0, "start_pos": 388}, {"end_pos": 406, "label_type": "藥物", "overlap": 0, "start_pos": 402}, {"end_pos": 417, "label_type": "藥物", "overlap": 0, "start_pos": 412}, {"end_pos": 433, "label_type": "藥物", "overlap": 0, "start_pos": 430}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"end_pos": 468, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 498}]}
{"originalText": "患者2015-03因左側股動脈假性動脈瘤於我院就診，行左上肢截肢手術。術後患者定期複查，於2016-02-26查腹部血管CTA提示：腹主動假性動脈瘤，右側髂總動脈起始處管腔狹窄；右腎動脈假性動脈瘤。患者偶有上腹部隱痛，有排尿、排便不盡感，無噁心嘔吐，無嘔血便血黑便，無頭痛頭暈、黑朦暈厥，四肢感覺活動可。患者現為行進一步診療收入病房。病程中，患者神清，精神可，食慾睡眠可，二便無殊，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 20}, {"end_pos": 34, "label_type": "手術", "overlap": 0, "start_pos": 27}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 56, "end_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 98}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}]}
{"originalText": "患者2年前無明顯誘因出現腹痛，為臍周持續性隱痛，伴腹脹不適，無噁心、嘔吐，無反酸、燒心，腹痛於當地診所就診，診斷為“腸炎”給予抗感染、抑酸補、對症處理後病情好轉出院，院外未繼續應用藥物治療；患者2015.11.5無明顯誘因再次出現腹痛，性質同前，於我院消化內科就診，診斷為“腸易激綜合徵”，行胃腸鏡檢查結果示：慢性萎縮性胃炎，入院後給予抑酸、抗氧化、對症治療，患者病情好轉出院。   現患者一月餘前再次出現腹痛，為臍周持續性疼痛，伴下腹飽脹感，食慾不振，無腹瀉、腹水，無發熱、頭痛，無胸悶、胸痛，無噁心、嘔吐，無反酸、燒心，為行進一步診治於我院就診。   患者發病以來，飲食差，睡眠可，大便2次/天，體重減輕2KG。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 60}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 162}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}]}
{"originalText": "患者自今年3月起無明顯誘因出現上腹部隱痛，呈持續性，向腰骶部放散，經量增多為原來的1.5倍。2012年5月24日，於外院行宮腔鏡上子宮內膜息肉切除術，術後病理提示子宮內膜呈增生反應。術後未口服激素類藥物，術後至今腹痛未緩解，2012年11月26日我院門診超聲提示子宮內膜回聲不均，其內高回聲團，注意內膜息肉。現患者為求手術治療入我科。患者平素月經規律，週期30日，經期4-5日，量中等，色鮮紅，偶有經期上腹痛，可忍受。末次月經2012年12月11日。患者近3個月自覺尿頻，每日4-5次，不伴尿急尿痛，病來無頭暈頭迷，無胸悶氣短，無噁心嘔吐，偶有便祕2-3天/次，飲食睡眠可，無明顯體重變化。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 27}, {"end_pos": 74, "label_type": "手術", "overlap": 0, "start_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 81, "end_pos": 83}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 127, "end_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}]}
{"originalText": "，3個月前患者因面板粘膜及鞏膜黃染就診於我院，排除手術禁忌症後，2016年2月17日於我院全麻上行膽囊切除+膽腸吻合+胃腸吻合術，，術後病理示：慢性腺性膽囊炎（，病理號: 201602691）。患者術後病情平穩，順利出院。出院後患者無寒戰、發熱，無腹脹、腹痛，無噁心、嘔吐，無咳嗽、咳痰，無胸悶、憋喘，無尿頻、尿急、尿痛。現患者為術後複查來我科就診，門診以“壺腹周圍惡性腫瘤術後”入院。   患者自出院以後，神志清，精神可，飲食睡眠可，大小便正常，體重較前未見明顯減輕。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 49, "end_pos": 64}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 79}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 189}]}
{"originalText": "患者於30年前漸出現右上肢淺表血管迂曲擴張，以久立、勞累後明顯，休息並抬高患肢後可減輕。無患肢水腫、面板搔癢不適、脫屑、顏色改變。無上肢痠痛、疼痛、發熱、頭痛、噁心。無特殊治療。近2年漸出現小腿面板顏色加深；站立容易易疲勞感覺；3月前就診我院，行上肢靜脈造影及CTV檢查提示右髂靜脈壓迫，行“右側髂靜脈造影+髂靜脈支架置入術+球囊擴張”，術後恢復良好，為進一步治療來我院門診就診，門診以右上肢靜脈曲張收入院。患者自發病以來無明顯胸悶、氣短，無發燒，精神狀態一般，食慾一般，睡眠良好，體重無明顯變化，大便正常，小便正常。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 95, "end_pos": 97}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 123, "end_pos": 129}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 130, "end_pos": 135}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 167}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 200}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}]}
{"originalText": "，緣於入院前5年進食冰冷食物後出現中上腹部悶痛不適，為持續性隱痛，無其它部位放射，無噁心嘔吐，無反酸噯氣，無嘔血黑便等不適。[主訴單一時間14天主訴單一時間]前進食冰西瓜後出現中上腹部悶痛不適，為持續性隱痛，程度較前加重，無其它部位放射，翻身向左側時疼痛有所緩解，無噁心、嘔吐、返酸、噯氣、納差、乏力、消瘦、腹瀉、便祕，無嘔血、黑便，無發熱、咳嗽、咳痰，自行服用胃藥（具體不詳），症狀有所好轉，，此次至我院門診行胃鏡檢查示：“1.胃體潰瘍型癌（早癌可能）。2.賁門炎症。3.慢性萎縮性胃炎”，，病理：（體小），：管狀腺癌II-III級。遂門診擬“胃體癌”收入院。自發病以來，精神、睡眠可，食慾一般，大小便如常，體重無明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 88, "end_pos": 91}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 234}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 237, "end_pos": 244}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 267}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 276}]}
{"originalText": "，患者於半月前無明顯誘因出現進食後中下腹不適，每次持續數分鐘自行緩解，無噁心、嘔吐、反酸、噯氣、燒心，無腹痛、腹脹、腹瀉、便祕，無厭油、納差，未予重視，未特殊處理。，半前至我院門診行胃鏡檢查提示：淺表性胃竇炎伴糜爛，十二指腸球炎，，腹部彩超：肝回聲增多，膽囊息肉樣變。為進一步診治，門診“胃炎”收入我科。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 98, "end_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 114}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 144, "end_pos": 146}]}
{"originalText": "患者2年前行乙狀結腸癌根治術，術後病理為乙狀結腸中分化腺癌，病理分期為PT3N2。術後恢復良好，進行了8週期輔助化療（方案不詳），化療過程順利。之後患者規律複查，未見腫瘤復發轉移徵象。患者2月前複查胸部CT時發現右上肺縱隔旁小結節，約2MM大小，1月後複查胸部CT發現該結節增大為8*5MM，考慮轉移可能大。現為進一步治療而來我院。患者病程中精神好，無咳嗽咳痰、咳血，無胸痛、頭暈、噁心、嘔吐，無胸悶及呼吸困難，無聲音嘶啞、肩臂麻木疼痛、頭面浮腫，睡眠食慾正常，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 14, "label_type": "手術", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 29}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 99, "end_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 106, "end_pos": 109}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 111}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 128, "end_pos": 132}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}]}
{"originalText": "，患者2個月前因“左下腹疼痛12小時”來院就診，以“1.急性膽囊炎2.膽總管結石？”收住我科，入院後完善檢查，給予保肝、護胃、抗感染及對症營養支援等治療，CT，檢查示：肝臟大小形態正常，膽囊飽滿，壁不厚，內未見異常密度影；左肺中葉小結節；肝囊腫；右側腎下腺區異常密度，考慮良性病變可能大。腹部MRI+MRCP檢查示膽總管上端腫瘤待排。2016-06-30在全麻上手術，術中證實為胰頭癌，行胰十二指腸切除術，手術順利，，病理：胰頭中分化腺癌，慢性膽囊炎（201613511）。術後給予抗感染、保肝、抑酸、抑制胰酶分泌、免疫、營養支援及對症處理，恢復順利，好轉出院。出院後病人無明顯不良反應，飲食睡眠可，大小便正常，體重無明顯變化，無噁心、嘔吐，無腹痛、腹脹、腹瀉，無寒戰、發熱，無黃疸，今為複查再次來我院就診，門診以“胰頭癌術後”收入院。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 77, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 123, "end_pos": 128}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 144, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 189, "end_pos": 192}, {"label_type": "手術", "overlap": 0, "start_pos": 194, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 219}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 220, "end_pos": 225}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 323}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 325, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 358, "end_pos": 363}]}
{"originalText": "患者1個月前無明顯誘因出現下腹部不適，進食硬質食物時有哽噎感，哽咽感常在吞嚥水後緩解消失，進食流質無明顯不適。當時無發熱、嘔吐，無乏力，無聲音嘶啞，無嘔血黑便，無頭暈頭痛，無腹瀉腹脹，無黃疸，無咳嗽咳痰，無胸悶胸痛，無憋喘氣促，無全身肌肉關節痠痛，無飲水嗆咳。2013.01.21日患者就診於我院，行胃鏡檢查為食管癌。為進一步治療，門診以\\\"食管癌\\\"收入院。  患者自發病以來，食慾可、睡眠好，大小便正常，體重未見明顯減輕。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 158}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 174}]}
{"originalText": "患者2012年7月無明顯誘因出現下腹部不適，在外院透過胃鏡診斷為胃竇癌，遂於2013-1-31在我院行胃癌根治術（遠端胃大切），術後病理：低分化腺癌，小灶為粘液腺癌，侵及胃壁粘膜上層，1/33(+),PT1BN1M0，IB期。術後恢復良好，於2013-3-1、2013-03-26、2013-04-24、2013-05-28、2013-06-28行單藥希羅達輔助化療5程，化療後患者耐受性良好，今遵原主診醫師意見繼續行原方案化療。近期患者精神、睡眠、食慾可，大小便正常，體重未見明顯減輕。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 35}, {"end_pos": 62, "label_type": "手術", "overlap": 0, "start_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 82}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 85, "end_pos": 86}, {"end_pos": 179, "label_type": "藥物", "overlap": 0, "start_pos": 176}]}
{"originalText": "患者於1年餘前飢餓後出現下腹隱痛，進食後可緩解，無泛酸、噯氣，無噁心、嘔吐、嘔血，無腹瀉、腹脹，無黑便、便血、粘液便，間斷予以藥物治療，症狀略有緩解，10天前外院行胃鏡檢查提示胃竇潰瘍，活檢病理提示低分化腺癌。為進一步診治來我院就診，門診超聲胃鏡提示胃竇後壁潰瘍型腫物，活檢提示低分化腺癌。起病以來，患者無頭暈、頭痛，無發熱、咳嗽、咳痰、胸悶、胸痛，精神體力一般，食慾上降，睡眠一般，小便正常，體重較前無明顯上降。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 104}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 144}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}]}
{"originalText": "入院前10年，患者無明顯誘因出現大便次數、性狀改變，約5~6次/天，大便黃色，糊狀，無粘液、膿血，時有裡急後重，伴腹痛、腹脹，解大便後緩解，無反酸、噯氣，無噁心、嘔吐，無黑便、血便，無尿頻、尿急、尿痛。未引起患者重視，未行診治，症狀可自行好轉，大便次數1-2次/天，之後反覆發作，性質同前，未診治。入院前8天，患者於我院就診，行腸鏡檢查提示：結腸扁平息肉（0.1CM X 0.3CM）。今為行腸鏡上息肉切除術，來我院就診，門診以“結腸息肉”收入我科住院治療。   發病以來，精神、食慾可，睡眠可，大便如下所述，小便正常，近期體重無明顯變化。", "entities": [{"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 177}, {"end_pos": 204, "label_type": "手術", "overlap": 0, "start_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 219}]}
{"originalText": "患者2012年7月因\\\"下腹痛1月\\\"於本院診斷為肝癌，於2012-8-7行肝癌切除+膽囊切除+膽管旁淋巴結切除術，術後病理提示低分化鱗癌，考慮為混合性肝細胞癌（肝細胞性肝癌與膽管細胞癌混合），侵犯肝被摸，未見明確癌栓，未見衛星結節；膽管旁淋巴結1枚見癌轉移。9月11日CT示：腹主動脈旁主動脈腹主動脈旁淋巴結腫大，較前增大，考慮轉移。患者於10月8日開始行腹部放療共15次，期間行MRI檢查發現右側肩胛骨轉移，遂行右肩部放療共10次。放療過程順利，患者未訴特殊不適。2012-11-02複查CT示肝S8強化灶，較前新發。患者1月前開始服用索拉菲尼（多吉美）治療，右肩部、背部、上肢出現皮疹，予以外用藥膏（具體不詳）塗擦後，症狀緩解。現為進一步治療入院。下次治療至今患者無明顯腹痛、無腹脹、無噁心、無嘔吐、無畏寒、無發熱，，患者精神尚可，食慾如常。大小便正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"label_type": "手術", "overlap": 0, "start_pos": 38, "end_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 135, "end_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 143}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 191, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 198, "end_pos": 205}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 246, "end_pos": 248}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"label_type": "藥物", "overlap": 0, "start_pos": 270, "end_pos": 279}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 342}]}
{"originalText": "，患者於2015-6無明顯誘因出現腹瀉，2-3次/天，成形軟便，偶伴黑便，，於2015-08-11於外院行腸鏡示：直腸距肛門9-11CM可見一半圍大腫物，乙狀結腸距肛門20CM處及直腸距肛門13CM處可見5個息肉。病理提示直腸中分化腺癌，大腸多發息肉。，胃鏡示：十二指腸球部潰瘍。2015-8-20外院行下、上、，腹盆CT示：肝右葉巨大腫物，考慮肝癌與轉移瘤鑑別，擬門脈右支癌栓.直腸近段腸壁偏心性增厚。2015-9-22至2015-12-23予FOLFOX化療6程，第2程因4度粒細胞上降予以減量（取消5-FU 0.5G 推注），第2程因4度粒細胞上降予以減量（取消5-FU 0.5G 推注），患者化療耐受可，4、6程化療後複查評價PR。後於2016-01-12全麻上行“腹腔鏡上直腸癌根治術+右半肝切除術+膽囊切除術”，，術後病理示：（直腸）病變符合中分化腺癌，浸潤腸壁全層至漿膜層內，淋巴結0/9（+），癌旁淋巴結1枚，未見癌，切緣陰性。（肝轉移，右半肝）可見腺癌浸潤，符合直腸腺癌肝轉移。術後複查CT未見覆發轉移徵象。術後恢復可，現為行上一步診治來院，自起病以來，患者精神、食慾、睡眠可，二便如常，體重近2周來無明顯上降。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 139}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 157, "end_pos": 161}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 173, "end_pos": 175}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 192}, {"end_pos": 256, "label_type": "藥物", "overlap": 0, "start_pos": 252}, {"end_pos": 288, "label_type": "藥物", "overlap": 0, "start_pos": 284}, {"label_type": "手術", "overlap": 0, "start_pos": 337, "end_pos": 360}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 370}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 377, "end_pos": 382}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 385, "end_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 423, "end_pos": 426}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 427}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 433, "end_pos": 435}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 440, "end_pos": 447}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 452, "end_pos": 454}]}
{"originalText": "患者因“腹痛3周餘”我院完善檢查診斷“直腸癌 CT4N1M0”，2014-03-17我院行橫結腸造瘻術，術後恢復可，2014-03-24行XELOX方案化療1程，患者化療耐受可。1天前患者出現血便。鮮紅色，當時較多，約200ML，於門診止血等對症處理。現為求進一步診治轉來我院。自發病以來，患者無噁心、嘔吐等，無發熱、咳嗽、身目黃染，無骶部痛等，精神、納眠稍差，小便無異常，體重近半年上降不明顯。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 30}, {"end_pos": 51, "label_type": "手術", "overlap": 0, "start_pos": 45}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}]}
{"originalText": "1997-8-6行胃癌根治術，2010.11發現CA724 升高最高1295 ，複查PET-CT檢查未見覆發轉移，之後多次複查CA724 波動在500-800之間，多次查胃鏡提示吻合口炎，給予對症治療，患者感左下腹隱痛下腹隱痛不適，2013.10.15複查血CA724 147 CA199 13.62 ,2013.10.23複查腹部CT檢查提示胰腺佔位，考慮惡性，胰頭周圍，肝門，腹膜後多發多發淋巴結轉移。PET-CT提示：胰頭區高代謝，考慮惡性病變。患者近10天出現午飯後左下腹部脹痛，持續2-3小時候可自行緩解。體重近1月上降2KG.患者胰腺穿刺取病理示低分化腺癌，免疫組化示CEA+,CGA+/-,CD56+/-,SYN+/-,對手術有顧慮，且手術風險較大，2013-11-26行放療30次，2014-1-7放療結束。2013-11-28始行單藥吉西他濱化療4週期。末次2014-1-7.放化療中出現黃疸，對症治療後好轉。化療後患者出現II度白細胞降低、II度血小板降低。2014-1-24複查胰頭區病灶及腹腔淋巴結均較強縮小，胰腺穿刺病理中低分化腺癌，免疫組化CA19+,CK7+,CGA-,SYN-,CD56-,CA199+，符合膽、胰導管來源浸潤性腺癌。CA72.4 明顯上降。2014-1-27病理比對原胃切除標本報告與胰腺腫瘤存在較大形態差異。考慮患者明確胰腺癌，於2014-2-7行第5週期GEM化療，2014-2複查後病灶縮小SD，於2014-2-21開始第六週期化療，因第八天白細胞減少推遲到2014-3-3。2014-4-7第8週期化療。末次給藥2014-4-14.2014-4-21複查評效SD，略有縮小，CA72.4降低至11.12.2014-4-28繼續單藥GEM化療，末次給藥時間2014-9-1.GEM雙週一次，2014-7-24複查胰腺病灶繼續縮小,評效PR。現患者無明顯不適，飲食、睡眠可，體重較前上降約4KG。", "entities": [{"end_pos": 14, "label_type": "手術", "overlap": 0, "start_pos": 9}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 24, "end_pos": 29}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 42, "end_pos": 48}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 63, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 93}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 129, "end_pos": 134}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 138, "end_pos": 144}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 164, "end_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 176}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 203, "end_pos": 209}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 240}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 279, "end_pos": 284}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 376}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 424, "end_pos": 427}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 433, "end_pos": 436}, {"end_pos": 453, "label_type": "解剖部位", "overlap": 0, "start_pos": 450}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 467}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 473, "end_pos": 479}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 520}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 530, "end_pos": 532}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 533, "end_pos": 539}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 567, "end_pos": 571}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 586, "end_pos": 589}, {"end_pos": 607, "label_type": "藥物", "overlap": 0, "start_pos": 604}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 649, "end_pos": 652}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 716, "end_pos": 722}, {"end_pos": 747, "label_type": "藥物", "overlap": 0, "start_pos": 744}, {"end_pos": 768, "label_type": "藥物", "overlap": 0, "start_pos": 765}, {"end_pos": 786, "label_type": "解剖部位", "overlap": 0, "start_pos": 784}]}
{"originalText": "患者於2013年3月因進食時下腹疼痛疼痛不適於我院行胃鏡檢查示距門齒20-22CM右側壁見約環1/3管腔粘膜粗糙糜爛，活檢取病理（病理號：146968）為（食管）鱗狀下皮重度不典型增生，癌變。超聲示胃竇部與胰腺之間淋巴結腫大，大小約1.71*1.61CM。肺CT示食管中下段管壁略增厚，因病變位置較高，不適合手術，於我科行放射治療，同步替吉奧化療，放療後行替吉奧序貫化療2週期，其後定期複查。近1個月自覺頭麻，乏力，擬進一步診治入院。現精神狀態可，自覺乏力，飲食二便睡眠可，病後體重無明顯上降。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 95}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 128, "end_pos": 131}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 171, "label_type": "藥物", "overlap": 0, "start_pos": 168}, {"end_pos": 181, "label_type": "藥物", "overlap": 0, "start_pos": 178}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}]}
{"originalText": "，2015年12月出現間斷便血，，外院腸鏡提示：據肛門8CM腫物，，活檢病理：中分化腺癌，完善分期檢查，CT3N+M0，因身體狀態不考慮手術治療，現為行根治性放療，GTV 50GY CTV 45GY/25F後縮野加量10GY/5F，同時口服卡培他濱。因腎功能不全，放療20次後暫停化療.2016-7-28複查胸腹CT病情平穩，腫標正常。2016-12複查腸鏡及腹盆CT提示病情進展.16-12-26行雷替曲塞單藥減量化療,IV度骨髓抑制/心律失常/肺部感染,此後最佳支援治療.化療後便血消失,2017-2-14複查CT提示腸壁較前變薄.中藥治療.，現症:乏力倦怠明顯，畏寒怕冷,消瘦,上腹墜痛較前加重，納差,頭暈,體質狀況欠佳,ECOG 3分，大便尚可,睡眠良好。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 44}, {"end_pos": 124, "label_type": "藥物", "overlap": 0, "start_pos": 120}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 154, "end_pos": 158}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 180, "end_pos": 184}, {"end_pos": 204, "label_type": "藥物", "overlap": 0, "start_pos": 200}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 214, "end_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 223}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 228}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 257, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 262}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}]}
{"originalText": "，患者於2014-9出現右上腹痛，就診******健院查B超提示右附件區見4.5*3.8*5.1CM混合性包塊，形態不規則，內部回聲強弱不等。2014-11-20複查MRI提示右附件區囊實性腫塊，考慮卵巢癌。2014-11-25行PET-CT提示右附件區團塊狀局灶高代謝病灶，考慮卵巢癌可能大，子宮直腸窩及左中腹部腸繫膜間多個局灶性高代謝病灶，考慮為多發轉移病灶；肝包膜上結節狀低密度影，代謝增高，考慮肝包膜轉移病灶，兩側後胸膜增厚。胃鏡提示胃多發息肉。腸鏡未見明顯異常。於12月8日行彩超引導上盆腔腫物穿刺活檢，，病理示：（盆腔腫物穿刺活檢）鏡檢為低分化腺癌，可見砂粒體及鈣鹽沉積，考慮為卵巢來源，，診斷為：卵巢癌。於2014-12-12及2015-01-05予TC方案（力樸素+卡鉑）化療2程，過程順利。為進一步治療入院，起病以來，精神可，二便正常，體重無明顯變化。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 28, "end_pos": 30}, {"end_pos": 35, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 83, "end_pos": 86}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 103}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 115, "end_pos": 121}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 143}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 212, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 221, "end_pos": 226}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 243, "end_pos": 245}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 280}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 305, "end_pos": 308}, {"end_pos": 340, "label_type": "藥物", "overlap": 0, "start_pos": 337}, {"end_pos": 343, "label_type": "藥物", "overlap": 0, "start_pos": 341}]}
{"originalText": "患者1年前出現嘔血，為鮮血，混有胃內容物。每日多少次，每次約多少ML。不伴頭暈、黑曚、暈厥、心悸、出汗。不伴腹痛。不伴消瘦。不伴發熱。不伴皮疹、面板紫癜、關節痛、鼻衄。於我院就診，查血紅蛋白多少G/L，尿素氮多少MMOL/L，便潛血陰性，行胃鏡檢查提示提示內容，行結腸鏡檢查提示提示內容，行膠囊內鏡檢查提示提示內容，行兩氣囊小腸鏡檢查提示提示內容，行核素檢查提示提示內容，行血管造影檢查提示提示內容，予補液治療，出血停止。此後，患者間斷出現嘔血，每次總量約多少ML，性質同前，於我院行胃鏡檢查提示提示內容，行結腸鏡檢查提示提示內容，行膠囊內鏡檢查提示提示內容，行兩氣囊小腸鏡檢查提示提示內容，行核素檢查提示提示內容，行血管造影檢查提示提示內容。1年前，患者再次出現嘔血，鮮血，混有胃內容物，共數字次，總量約多少ML。不伴頭暈、黑曚、暈厥、心悸、出汗，為求進一步治療收入院。發病以來，精神、飲食、睡眠正常，大便正常，尿色正常，體重無明顯變化。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 81, "end_pos": 83}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 91, "end_pos": 95}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 187, "end_pos": 191}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 309, "end_pos": 313}, {"end_pos": 341, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 361, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}]}
{"originalText": "，2015-4出現進食後下腹飽脹不適，2015-4-22，當地胃鏡：賁門不規則糜爛，胃角約1*1CM潰瘍，活檢病理（賁門）腺癌，（胃角）印戒細胞癌，2015-5-13行根治性全胃切除術，術中見賁門約2*2CM質硬腫物，未侵出漿膜，胃角約3*3CM質硬腫物，侵出漿膜，，術後病理：賁門小彎側腺癌II-III級，LAUREN混合型，2.5*2.5*1CM，達漿膜外，脈管內可見癌栓，未見明確神經受侵，HER2（1+），KI67（+70%）；胃體神經內分泌癌，低分化，3*2*1.5CM，侵全層達漿膜外，未見明確脈管癌栓及神經侵犯，網膜（-），SYN（+），CGA（小灶+），CK（+），CDX2（+），CAM5.2（+），HER2（0），KI67（+40%）；斷端陰性，淋巴結1/29。術前CEA 12.93（0-3），CA242 41.49（0-12）。2015-6-15行XELOX*1，2015-7-8起FOLFOX*7，複查未見明確復發轉移徵象，CEA 6.28，但調整方案TXT+DDP*3，末次2015-12-14。出現左肩部疼痛，2016-01-05外院PET/，CT：多發骨代謝異常，但多考慮為良性病變；升結腸代謝不均勻升高，建議腸鏡。複查腸鏡未見明顯異常，骨MRI未見明確骨破壞2016-9外院複查未見明確腫瘤徵象現食納可，進食後無明顯不適，便祕，體重穩定。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 73}, {"end_pos": 92, "label_type": "手術", "overlap": 0, "start_pos": 84}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 218, "end_pos": 230}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 343, "end_pos": 346}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 425, "end_pos": 428}, {"end_pos": 442, "label_type": "藥物", "overlap": 0, "start_pos": 439}, {"end_pos": 446, "label_type": "藥物", "overlap": 0, "start_pos": 443}, {"end_pos": 467, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 482, "end_pos": 489}, {"end_pos": 493, "label_type": "解剖部位", "overlap": 0, "start_pos": 492}, {"end_pos": 511, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 535, "end_pos": 539}, {"end_pos": 544, "label_type": "解剖部位", "overlap": 0, "start_pos": 543}]}
{"originalText": "，患者於2013年8月起無明顯誘因上出現鮮血便，大便成形，形狀變細，無噁心嘔吐、腹痛、腹瀉、黑便。為求治療遂於我院就診，2014-01-08，我院CT示：右頸IV、V 區淋巴結腫大，轉移？腔靜脈旁及腹主動脈旁多發淋巴結腫大，考慮轉移；肝S8鈣化；兩肺未見明顯異常。2014-01-09，我院MR示：直腸中上段腫物，考慮為直腸癌；直腸周圍、骶前及兩側髂血管旁多發淋巴結，考慮為淋巴結轉移；宮頸納氏囊腫。2014-01-10，我院電子腸鏡示：直腸癌。2014-01-13，我院病理示：（距肛門1-7CM直腸中上段腫物活檢），鏡上：腸粘膜組織中見異型細胞呈片狀或散在分佈，細胞胞漿豐富或透亮，核深染，可見核仁，核分裂象易見，形態符合惡性腫瘤，結合免疫組化結果，符合低分化鱗狀細胞癌。於2014-01-25行PF方案化療1程，過程順利，化療後無訴特殊不適。現擬行上一程化療入院。自患病以來，患者精神、胃納、睡眠可，小便時有裡急後重感，便血，大便成形，呈細條樣，4-5次/日，體重無明顯減輕。", "entities": [{"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 73, "end_pos": 75}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 103, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 163}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 329, "end_pos": 337}]}
{"originalText": "，患者4月前因“宮頸癌IB1期”2015-11-06於我院在全身麻醉上行經腹廣泛子宮切除+兩側輸卵管切除+盆腔淋巴結清掃術。，術中探查見：子宮前位，如孕50天大小，形態不規則，兩側附件未見異常，宮頸增粗，兩側主韌帶、宮骶韌帶無異常，兩側閉孔區及右側髂血管區觸及腫大淋巴結。術後病理39974.，15：結合40009.15（宮頸）中-低分化鱗狀細胞癌，內生浸潤型，腫瘤切面積6.5*1CM，浸潤深度大於宮頸壁厚度1/2，脈管內未見明顯癌栓,陰道斷端、右左宮旁、子宮內膜及肌層、兩側輸卵管均未查見癌。另送右閉孔淋巴結4枚、左閉孔淋巴結5枚、右髂髂血管淋巴結4枚及左髂血管淋巴結3枚，均未見轉移；另送“右髂總及左髂總淋巴結”組織內未查見淋巴結，未查見癌。增殖狀態子宮內膜，子宮腺肌病，兩側輸卵管充血，未見明顯病變，兩側輸卵管系膜囊腫。術後8天未拆線、帶尿管出院。術後行多西他賽+卡鉑方案化療3週期。2016-1-20入院後完善相關檢查，給予宮頸癌術後區域性適型放療。對症處理放療不良反應。現放療結束，今患者為求進一步治療來我院，門診以“宮頸癌術後”收入院。患者自下次出院以來，活動時感頭暈、乏力，一直口服紅源達、複方地茯口服液、長春胺緩釋膠囊補血及對症治療，飲食睡眠可，大便成形，性狀可，持續導尿通暢，尿液清，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 15}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 61}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 231}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 330}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 333, "end_pos": 338}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 363}, {"end_pos": 385, "label_type": "藥物", "overlap": 0, "start_pos": 381}, {"end_pos": 388, "label_type": "藥物", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 417, "end_pos": 422}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 464, "end_pos": 469}, {"end_pos": 489, "label_type": "解剖部位", "overlap": 0, "start_pos": 488}, {"end_pos": 501, "label_type": "藥物", "overlap": 0, "start_pos": 498}, {"end_pos": 509, "label_type": "藥物", "overlap": 0, "start_pos": 502}, {"end_pos": 517, "label_type": "藥物", "overlap": 0, "start_pos": 510}]}
{"originalText": "左半結腸切除+胰十二指腸切除術後4年，PT4BN0M0。術後病理提示：（左半）結腸潰瘍型低分化腺癌，大小7.0×XXX6.0CM，侵透腸壁全層並侵及胰腺外脂肪組織及十二指腸腸壁漿膜層，未見脈管癌栓，淋巴結未見癌轉移（結腸**/13，十二指腸**/1，胰腺周0/4，肝十二指腸韌帶0/1，13組0/1），（近端）、（遠端）、胃斷端、十二指腸斷端及胰腺斷端未見癌；闌尾慢性炎；網膜組織未見特殊。本次定期複查提示肝右外葉偏強回聲結節，直徑1.3CM，較前稍有增大，餘檢查未見腫瘤轉移及復發徵象。腹部CT肝臟未見結節。本次定期複查，未見腫瘤轉移及復發徵象。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 0, "end_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 68}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 86}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 185}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 244, "end_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 248, "end_pos": 250}]}
{"originalText": "2015.8確診胃體胃角印戒細胞癌及管狀腺癌，瀰漫型，HER-2(0)，CT4AN+，2015.9始S1*3-XELOX*2，SD，CEA曾升高，症狀略好轉，C2曾OXA期間可疑過敏。2015-12-15根治性全胃切除術，P0，中低分化腺癌部分印戒，混合型；YPT4AN3B，AFP(－),CMET(0),EBER(－),EGFR(+),HER2(0),MSS，PDL-1(－)。術後基線CT見腹腔幹下方軟組織影約23*20MM？術後選擇XELODA*7，末次2016.6；此處結節漸縮小，末次複查2016.9約為17*8MM，CEA進行性升高，2017.3為57，左側新見少量胸水，左肺中葉炎性改變好轉，體重穩定。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 26}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 66, "end_pos": 69}, {"end_pos": 85, "label_type": "藥物", "overlap": 0, "start_pos": 82}, {"end_pos": 110, "label_type": "手術", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 128}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 225, "label_type": "藥物", "overlap": 0, "start_pos": 219}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 264, "end_pos": 267}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 292, "end_pos": 296}]}
{"originalText": "，於2014年？月予以直腸癌手術，，術後病理：直腸腫物（活檢，2014-01-24），：- 浸潤性中分化腺癌。2. 直腸距肛門5釐米（活檢，2014-01-24），：- 管狀腺瘤。術後予以？週期化療。2016年10月因肺腫物，予以（左肺上葉），切除：術後病理- 肺腺癌，以實性生長方式為主，送檢腫物最大徑2.1CM；- 癌累及髒層胸膜；- 可見脈管癌栓；- 淋巴結未見癌轉移（第10組0/5、第11組0/2、第7組0/1、4R 0/2、2R 0/2、第8組0/3、第12組0/1）；- ，腫瘤病理分期：PT2AN0。，免疫組化結果顯示: ALK-VENTANA(－),CDX2(－),CK20(－),CK7(+),NAPSIN A(－),SATB-2(－),TTF-1(+)，免疫組化表型支援肺原發腺癌。術後予以？週期化療。於2017-1月10日複查發現術後復發，CT，顯示：，胸部增強：左肺上葉術後，支氣管斷端處見結節狀灶，範圍約15X14MM（IMA31），左肺門新見腫大淋巴結，約30X16MM（IMA27），不能除外腫瘤復發伴淋巴結轉移，需進一步檢查明確。左肺下葉後段新見小片狀灶，中央見空洞，大小約18X15MM（IMA24），邊緣模糊不清，其性質待定，建議抗炎後短期複查。右肺未見新發結節。縱隔、右肺門、鎖骨下區及兩腋上未見腫大淋巴結。左側胸膜多處侷限增厚同前相仿。左側見少量胸腔積液。右側未見胸水徵象。於2017-1-25日因淺表淋巴結無腫大（1），左肺上葉原發腺癌術後：PT2AN0M0，左肺門淋巴結轉移；（2）直腸浸潤性中分化腺癌術後，已測EGFR突變陰性，KRAS突變，予以奈達鉑75MG/M*2(分為2天用,70MG/D1,60MG/D2)+培美曲塞500MG/M*2 800MG+恩度15患者近4日出現便祕，口服乳果糖，番瀉葉及甘油灌腸劑治療效果不佳，無明顯腹脹，有排氣。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 54}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 89}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 346, "end_pos": 351}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 382, "end_pos": 384}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 400}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 434, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 441, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 462, "end_pos": 472}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 482}, {"end_pos": 544, "label_type": "解剖部位", "overlap": 0, "start_pos": 542}, {"end_pos": 553, "label_type": "解剖部位", "overlap": 0, "start_pos": 551}, {"end_pos": 557, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 558}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 563}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 594, "end_pos": 598}, {"end_pos": 604, "label_type": "解剖部位", "overlap": 0, "start_pos": 603}, {"end_pos": 625, "label_type": "解剖部位", "overlap": 0, "start_pos": 620}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 632, "end_pos": 642}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 652, "end_pos": 660}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 664, "end_pos": 676}, {"end_pos": 700, "label_type": "藥物", "overlap": 0, "start_pos": 697}, {"end_pos": 736, "label_type": "藥物", "overlap": 0, "start_pos": 732}, {"end_pos": 754, "label_type": "藥物", "overlap": 0, "start_pos": 752}, {"end_pos": 771, "label_type": "藥物", "overlap": 0, "start_pos": 768}, {"end_pos": 775, "label_type": "藥物", "overlap": 0, "start_pos": 772}, {"end_pos": 781, "label_type": "藥物", "overlap": 0, "start_pos": 776}, {"end_pos": 792, "label_type": "解剖部位", "overlap": 0, "start_pos": 791}]}
{"originalText": "，患者1年餘前出現腹瀉，伴間斷血便，2012-07-12，於外院行腸鏡示：距肛門5-10CM見環狀腫物，腸腔狹窄，，行活檢病理示：中分化腺癌。胸片示兩肺多髮結節，盆腔CT示直腸癌可能性大。遂至我院就診，，我院病理會診示：中分化腺癌。於2012-8-15，2012－9行XELOX方案化療2程，同時行放療，過程順利無不適，今遵原主診醫生意見為行檢查入院。患者發病以來,精神一般,飲食睡眠欠佳，大便次數增多，偶有便祕，小便正常，體重無明顯變化。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 71, "end_pos": 73}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 81, "end_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 115}]}
{"originalText": "，2014-4-30行胃癌根治術。中低分化腺癌，PT3N0M0，CMET(-),EGFR(+),HER2(+),未行輔化。2014-12-10考慮腹膜後LNM？2015-3-12入組行SP*6，繼續S-1維持治療，內科建議行肝門淋巴結及腹腔病灶放療，GTV 55GY CTV 50GY/27F，同期替吉奧 40MG BID D1-D5/W，患者未訴明顯不適，，血常規：3.01*109/L PLT 46*109/L。暫停S-1化療,，給予特比澳升血小板治療3天后複查血常規：WBC 2.34*109/L PLT 38*109/L，暫停放療,，給予升血細胞治療後複查：WBC 3.28*109/L PLT 60*109/L,給予單純放療，，複查血常規：PLT 181*109/L WBC 3.73*109/L，目前放療結束，血小板低上III度，白細胞II度，中性粒細胞 I度。2016-6-23，血細胞分析:血小板總數 59.00*10^9/L，白細胞總數 2.97*10^9/L，，腎功三項:丙氨酸氨基轉換酶 42IU/L。2016-6-21，與2016-03-16腹盆腔CT比較：未見覆發及轉移病灶。2016-6-21，與2015-12-11胸部CT比較:未見覆發及轉移病灶。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 79}, {"end_pos": 94, "label_type": "藥物", "overlap": 0, "start_pos": 92}, {"end_pos": 102, "label_type": "藥物", "overlap": 0, "start_pos": 99}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 153, "label_type": "藥物", "overlap": 0, "start_pos": 149}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 195, "end_pos": 198}, {"end_pos": 213, "label_type": "藥物", "overlap": 0, "start_pos": 210}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 223, "end_pos": 226}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 237, "end_pos": 241}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 251, "end_pos": 255}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 283, "end_pos": 286}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 298, "end_pos": 301}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 325, "end_pos": 328}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 339, "end_pos": 342}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 361, "end_pos": 364}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 371, "end_pos": 374}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 378, "end_pos": 383}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 403, "end_pos": 408}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 422, "end_pos": 428}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 446, "end_pos": 454}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 483, "end_pos": 488}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 522, "end_pos": 526}]}
{"originalText": "，2005.6.8行結腸癌根治術，，術後病理：升結腸中分化腺癌，侵及深肌層，斷端陰性，淋巴結轉移0/10，術後身體狀況不佳，未行放化療。\\U0004\\U0004 2010-10月複查，考慮右肺多發轉移，行XELOX化療共7週期；複查胸部CT示病變略縮小,2011-5-16右肺轉移灶手術。術後體重上降約5KG。(2012.1.12)，CEA：4.74NG/ML．2012-3-22 CEA 11.26NG/ML.2012-4-5複查CEA14.37NG/ML.CT發現肺結節較前略增大。因患者體質較弱，口服希羅達單藥治療6週期，耐受性尚可,4CS後複查評效SD。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 116, "end_pos": 120}, {"label_type": "手術", "overlap": 0, "start_pos": 136, "end_pos": 143}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 167, "end_pos": 170}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 191, "end_pos": 194}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 230, "end_pos": 232}, {"end_pos": 235, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 256, "label_type": "藥物", "overlap": 0, "start_pos": 253}]}
{"originalText": "，便祕，便血伴裡急後重2月餘，腸鏡診斷直腸癌，距肛門2-8CM腫物，累及3/4管腔。表面潰瘍形成，周邊不規則隆起，，活檢病理：為中-低分化腺癌。腹部，CT：肝臟S8微小低密度結節影。胸部CT未見異常。盆腔，CT:直腸管壁不規則增厚，周圍筋膜未見明顯增厚，盆腔內未見明顯腫大淋巴結。，盆腔MRI結果：直腸中上段佔位，符合直腸癌（CT4BN2B），累及前列腺，肛門內括約肌及右側肛提肌可疑受累，與精囊腺關係密切。2015.11.，18開始放療GTV:50.6GY/GTV41.8GY/22F.2015.12.01放療9次，患者自訴食慾差，考慮與口服化療藥物有關。，複查肝功：ALT 43。2015.12.14放療18次。2015-3-4行MILES術+肝轉移灶切除。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 71}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 72, "end_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 91, "end_pos": 95}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 106, "end_pos": 108}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 141, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 171}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "手術", "overlap": 0, "start_pos": 317, "end_pos": 330}]}
{"originalText": "，2016-1查體發現直腸佔位，腸鏡提示肛門1-2處直腸可見隆起病變，行區域性活檢，，我院病理會診：直腸粘膜黑色素瘤合併印戒細胞癌;全面檢查未見明確遠處轉移徵象。2016-1-20行擴大切除術，，術後病理：（直腸腹會陰聯合切除），：- 直腸惡性黑色素瘤，並印戒細胞癌，大小2.3×XXX1.5×XXX0.8CM；- 惡性黑色素瘤侵及腸壁固有肌層，腫瘤浸潤厚度約1.1CM；- 印戒細胞癌侷限於粘膜層；- 脈管內未見瘤栓，未見神經侵犯；- 直腸斷端、面板斷端及環周切緣均未見腫瘤；- 腸周淋巴結可見惡性黑色素瘤轉移（1/10）。- ，免疫組化惡性黑色素瘤顯示:HMB-45(+),KI-67(+30%),MELAN-A(+),S100(+)。- ，免疫組化印戒細胞癌顯示:CK(+),CEA(+)，CDX2(+),CK20(+),CK7(－),VIMENTIN(－)，，特殊染色顯示：PAS(+)。，消化腫瘤內科就診意見為：患者直腸腫瘤，複合腫瘤成分，印戒細胞癌僅侵犯粘膜層，目前相對於印戒細胞癌，黑色素瘤分期相對偏晚，同時合併淋巴結轉移，建議治療以黑色素瘤治療為主，印戒細胞癌目前無輔助治療指徵。2016-3開始輔助化療2週期，2017-2複查未見明確轉移徵象。2017-4複查示肝門區、盆腔、腹膜後、兩側髂血管旁新見多發腫大淋巴結，較大約15X10MM（IM69），餘未見明確轉移徵象。基因檢測均為野生型。2017-7複查示腹盆腔、腹膜後及兩側髂血管旁多發腫大淋巴結較前增大，考慮轉移進展。S5新見結節，考慮轉移。2017-7-10行TC方案化療，2017-9複查評效SD。現為進一步治療就診.。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 20}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 64}, {"end_pos": 112, "label_type": "手術", "overlap": 0, "start_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 163}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 192}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 269, "end_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 331}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 412, "end_pos": 416}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 424, "end_pos": 429}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 441, "end_pos": 446}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 447, "end_pos": 451}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 473, "end_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 482, "end_pos": 487}, {"end_pos": 541, "label_type": "解剖部位", "overlap": 0, "start_pos": 539}, {"end_pos": 545, "label_type": "解剖部位", "overlap": 0, "start_pos": 543}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 546}, {"end_pos": 555, "label_type": "解剖部位", "overlap": 0, "start_pos": 550}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 612, "end_pos": 613}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 613, "end_pos": 615}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 616, "end_pos": 617}, {"end_pos": 625, "label_type": "解剖部位", "overlap": 0, "start_pos": 620}, {"end_pos": 647, "label_type": "解剖部位", "overlap": 0, "start_pos": 645}]}
{"originalText": "，2012-5-15我院行乙狀結腸癌根治術。，術後病理：右半結腸潰瘍型中低分化腺癌伴粘液腺癌，3.0*2.5釐米，浸潤腸壁全層，未見脈管癌栓，LN（1/22）.2012-6-12始XELOX*6，末次2012-9-25。化療期間CA724 CEA 進行性增高。2012-10-12再次口服希羅達單藥1週期，後停止治療。，2013-1-28複查腹部CT：右上肺多發小結節，左肺上葉肺大泡，餘腹部情況同前。瘤標正常。2013.6複查胸腹盆未見明確復發轉移，胃小彎側淋巴結略大，CEA 5.36NG/ML,CA72.4 16.93U/ML.2013-12-16腹盆腔、胸，CT：結腸癌術後，吻合口管壁復發徵象，餘同前。CEA 5.10。2015-1，複查:CEA 5.27NG/ML;NSE 15.99NG/ML；胃鏡提示反流性食管炎、慢性胃炎；胸腹盆CT較前未見明顯變化。2016-1-13 胸，CT:兩肺多發小結節，部分稍顯飽滿，仍考慮陳舊灶可能大。2016-1-8 腹盆 ，CT:未見覆發及轉移徵象。近來覺進食咽部不適，胸骨後燒灼感，飲食可，大小便正常，近1年來體重無變化。", "entities": [{"end_pos": 21, "label_type": "手術", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 46}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 114, "end_pos": 119}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 119, "end_pos": 124}, {"end_pos": 147, "label_type": "藥物", "overlap": 0, "start_pos": 144}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 171, "end_pos": 175}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 236, "end_pos": 239}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 250, "end_pos": 256}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 277, "end_pos": 285}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 291}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 325, "end_pos": 328}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 339, "end_pos": 342}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 358, "end_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 369}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 370, "end_pos": 375}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 394, "end_pos": 398}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 432, "end_pos": 439}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 455}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 460, "end_pos": 462}]}
{"originalText": "，2014.12.25 行左半結腸切除。，病理： 結腸潰瘍型中-低分化腺癌，伴有粘液分泌，大小5×XXX7.5CM；癌侵及腸管漿膜層；腸周淋巴結見有癌轉移（3/9），另見多枚癌結節形成；，病理分期：PT4AN2。患者在當地化療，術後XELOX方案6週期後複查。，末次化療時間：2015-5-22.外周神經毒性毒性I度，胃腸道反應I度。2015.6.11 腸鏡檢查提示結腸息肉,活檢良性。2015.6.2 腹部超聲提示肝多發佔位。2015-6-25 ，與2014-12-15腹部CT比較：1.升結腸術後，腸壁未見異常增厚、結節及腫塊。2.肝緣腹膜欠光滑，可疑不均勻增厚伴輕度強化，肝周見少量積液。轉移待除外，追查。3.肝臟形態、大小正常，S5強化灶同前，約29X28MM。S2強化灶同前，約11MM。見肝內多發無強化低密度灶同前，較大約17X10MM。肝內未見新增佔位及異常強化灶，血管及膽管未見異常。2015-8複查腹腔轉移，腹水。2015-07-07甲胎蛋白 3.32NG/ML;癌胚抗原 5.89NG/ML。患者目前自感肝區疼痛半月，體重未見減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 19}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 37}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 187}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 236, "end_pos": 240}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 245, "end_pos": 250}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 268, "end_pos": 269}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 320, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 408, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 414}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 426, "end_pos": 430}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 441, "end_pos": 445}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 462, "end_pos": 463}]}
{"originalText": "，因“嘔吐1天”就診，，2016-8-10CT：腸套疊，2016-08-15行左半結腸切除術，術中見升結腸中段約6*6CM腫物，侵透漿膜，與十二指腸降部緊密粘連，，術後病理: 潰瘍型低分化腺癌（大部分為粘液腺癌，6.5*4.7*2CM）伴灶性壞死，達漿膜外，侵犯間質神經纖維束，間質脈管內查見癌栓，網膜組織查見轉移癌灶，斷端陰性，淋巴結2/33，（十二指腸腸壁）送檢平滑肌及脂肪組織內見低分化腺癌（大部分胃粘液腺癌）。術前CEA正常，餘腫標未查。KRAS/BRAF野生型，未測NRAS術後行伊立替康+氟尿嘧啶+愛必妥化療2週期，伊立替康+卡培他濱+愛必妥2週期，伊立替康+愛必妥2週期，期間間斷愛必妥單藥3週期，末次化療2017-04-06。2017-3出現不全腸梗阻，2017-3-28當地腸梗阻導管置入，，2017-04-14CT：腹膜網膜腸繫膜轉移，2017-04-20、2017-05-15行奧沙利鉑+吉西他濱行腸繫膜下動脈灌注介入化療。進展，2017-05-12開始瑞戈非尼治療。現納差，消瘦，排便困難。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 21, "end_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"end_pos": 46, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 178}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 208}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 211, "end_pos": 214}, {"end_pos": 249, "label_type": "藥物", "overlap": 0, "start_pos": 245}, {"end_pos": 254, "label_type": "藥物", "overlap": 0, "start_pos": 250}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 255}, {"end_pos": 268, "label_type": "藥物", "overlap": 0, "start_pos": 264}, {"end_pos": 273, "label_type": "藥物", "overlap": 0, "start_pos": 269}, {"end_pos": 277, "label_type": "藥物", "overlap": 0, "start_pos": 274}, {"end_pos": 285, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"end_pos": 289, "label_type": "藥物", "overlap": 0, "start_pos": 286}, {"end_pos": 300, "label_type": "藥物", "overlap": 0, "start_pos": 297}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 334}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 346, "end_pos": 349}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 365, "end_pos": 367}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 377}, {"end_pos": 404, "label_type": "藥物", "overlap": 0, "start_pos": 400}, {"end_pos": 409, "label_type": "藥物", "overlap": 0, "start_pos": 405}, {"end_pos": 416, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"end_pos": 442, "label_type": "藥物", "overlap": 0, "start_pos": 438}]}
{"originalText": "，2010-7出現左頸淋巴結腫大，漸吞嚥困難、聲嘶及嗆咳。我院行CT、，胃鏡確診：食管中上段鱗癌 IV期 兩鎖骨下、縱隔淋巴結轉移 左側胸腔積液 心包積液 下腔靜脈壓迫綜合徵。於2010-9-14起行2週期紫衫+DDP化療。末次化療2010-11-9.III°骨髓抑制，低鉀血癥，對症支援後恢復。，2010-10-16CT：食管胸中段管壁增厚較前減輕，縱隔及兩鎖骨下淋巴結較前縮小。，我科計劃放療:GTV55GY/CTV50GY/27F,已放療24次。放療後骨髓抑制II度,予對症處理後好轉.頸部淋巴結較前縮小.放療27次後區域性縮野加量到GTV69GY.右腋上淋巴結腫大，約5X4CM，計劃放GTV60GY/CTV55GY/28F，頭皮頂部轉移，大小約3X3CM，9E放療DT=54GY/18F,已放療9次。2011-7-20開始右鎖骨下及左中頸淋巴結放療，6E放療DT=56GY/28F，已放療3次。考慮腫瘤發展，轉移較快，建議口服化療藥同步治療。2011-7-11開始行同步泰欣生200MG治療,每週1次.近期食慾差。骨掃描提示骨轉移。放療20次,，骨掃描提示:T3骨鹽代謝旺盛灶伴T4可疑溶骨改變.惡性病變不除外.。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 41, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 87}, {"end_pos": 105, "label_type": "藥物", "overlap": 0, "start_pos": 103}, {"end_pos": 109, "label_type": "藥物", "overlap": 0, "start_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 139}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 159, "end_pos": 161}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 167}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 229, "end_pos": 233}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 246}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 277}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 316, "end_pos": 322}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}, {"end_pos": 442, "label_type": "藥物", "overlap": 0, "start_pos": 439}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 466, "end_pos": 469}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}]}
{"originalText": "，患者2003年2月因左乳腺腫塊在外院診斷為左乳腺癌。於2003年3月份行左側乳腺癌改良根治術，，術後病理示：，LN 0/8(+).，術後分期:PT1N0M0,I期。，免疫組化：ER（2+），PR（+），HER-2（3+），KI67（30%+）。於2003-04-22、05-16、06-06、07-07行AC方案（THP90MG+CTX 1.0G）方案輔助化療4程，化療結束後開始口服他莫昔芬至2007年停止。於2010年發現左頸部淋巴結腫大，行局麻上區域淋巴結切除術，，術後病理示：03690.3CM。，鏡上：淋巴結4枚，1/4見低分化腺癌。，免疫組化：ER（3+），PR（2+），HER-2（4+），KI67（5%+）。並行兩側卵巢切除術，口服來曲唑。隨後定期複查。2010-11-25，查CT示：左乳癌術後，區域性未見明顯軟組織腫塊。右側腋窩、兩側鎖骨下窩、胸骨下窩小淋巴結。2013-7月複查胸部CT提示左前縱隔淋巴結腫大，考慮轉移，較前進展，遂於門診行希羅達+赫賽丁方案化療，於2014-05-28複查胸下腹CT，提示左前縱隔、左側鎖骨下窩、左下氣管旁轉移淋巴結較前增大。於2014-06開始門診改服用依西美坦片至今，近期患者出現聲音嘶啞，少許咳嗽。2014-09-04，我院複查CT示：左乳癌術後、，化療後複查：縱隔、兩側鎖骨下、左下氣管旁轉移淋巴結轉移，鄰近胸骨破壞，較前相仿；左側胸骨旁胸壁腫物，考慮轉移，較前相仿；頸部多發小淋巴結，較前稍增多增大。2014-09-11，外院SPECT示：胸骨柄溶骨性病變，考慮骨轉移灶可能性大。遂於2014-09-2在我科行多西他賽單藥化療1程，化療過程順利，無明顯毒副反應。現為進一步治療收入無科。食慾睡眠尚可，無視物旋轉，無黑曚，無噁心、嘔吐，無畏寒、發熱等，大小便無明顯異常，體重較前上降3-4KG。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 26}, {"end_pos": 47, "label_type": "手術", "overlap": 0, "start_pos": 37}, {"end_pos": 161, "label_type": "藥物", "overlap": 0, "start_pos": 158}, {"end_pos": 169, "label_type": "藥物", "overlap": 0, "start_pos": 166}, {"end_pos": 197, "label_type": "藥物", "overlap": 0, "start_pos": 193}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 235, "label_type": "手術", "overlap": 0, "start_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 272}, {"end_pos": 322, "label_type": "手術", "overlap": 0, "start_pos": 315}, {"end_pos": 328, "label_type": "藥物", "overlap": 0, "start_pos": 325}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 348, "end_pos": 350}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 352, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 370, "end_pos": 390}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 400, "end_pos": 404}, {"end_pos": 413, "label_type": "解剖部位", "overlap": 0, "start_pos": 406}, {"end_pos": 434, "label_type": "藥物", "overlap": 0, "start_pos": 431}, {"end_pos": 438, "label_type": "藥物", "overlap": 0, "start_pos": 435}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 456, "end_pos": 461}, {"end_pos": 468, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}, {"end_pos": 475, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 486, "label_type": "解剖部位", "overlap": 0, "start_pos": 483}, {"end_pos": 511, "label_type": "藥物", "overlap": 0, "start_pos": 506}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 545, "end_pos": 547}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 549, "end_pos": 554}, {"end_pos": 564, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}, {"end_pos": 569, "label_type": "解剖部位", "overlap": 0, "start_pos": 565}, {"end_pos": 575, "label_type": "解剖部位", "overlap": 0, "start_pos": 571}, {"end_pos": 588, "label_type": "解剖部位", "overlap": 0, "start_pos": 586}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 598, "end_pos": 600}, {"end_pos": 618, "label_type": "解剖部位", "overlap": 0, "start_pos": 616}, {"end_pos": 624, "label_type": "解剖部位", "overlap": 0, "start_pos": 621}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 646, "end_pos": 651}, {"end_pos": 656, "label_type": "解剖部位", "overlap": 0, "start_pos": 653}, {"end_pos": 665, "label_type": "解剖部位", "overlap": 0, "start_pos": 664}, {"end_pos": 692, "label_type": "藥物", "overlap": 0, "start_pos": 688}]}
{"originalText": "，患者2月餘前無明顯誘因出現左下腹隱痛，間歇性發作，訴起床後1-2小時更嚴重，與進食、體位無關，無牽涉及放射痛。2013-7-11，外院下消化道造影示：胃竇癌（潰瘍型）。2013-7-18，於我院行胃鏡示：小彎側見2×1.6CM潰瘍，表面白苔，周圍粘膜充血水腫。，病理活檢示：（胃竇）低分化腺癌，LAUREN分型混合型。現為進一步診治收入我科。患者自起病以來無明顯噁心、嘔吐，無嘔血、黑便，無發熱、黃疸，無腹脹、腹瀉。食慾睡眠尚可，大便次數減少，2-3天一次，小便無殊，體重略有減輕。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 68, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 147}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}]}
{"originalText": "，緣於入院前4月於我院確診診為直腸癌伴肝轉移，，病理示：（201407122）管狀腺癌。，腹部CT示：1、直腸中、上段部分管壁不規則增厚，考慮直腸CA，周圍及兩側盆壁、腹股溝區及腹膜後多發腫大淋巴結徵。2、肝內多發類圓形低密度影，多考慮轉移瘤。考慮腫瘤晚期，不宜手術切除，於2014.03.20在我院胃腸外科行“奧沙利鉑150MGIVGTTD1+希羅達1000MGPOBIDD2-15”方案化療，我科繼續行氟尿嘧啶1GD1-D4保留灌腸,予以“艾恆200MGD1+希羅達1500MGPOBIDD1-14”方案化療5個週期，過程順利，效果良好，未見明顯化療副反應。，1個月前複查肝臟MRI：1、肝內多發異常訊號，結合病史，符合轉移瘤並囊變，與2014-7-2舊片對比無明顯變化。2、肝多發小囊腫。3、右腎小囊腫。盆腔，MRI:1、中上段直腸癌化療後改變，部分癌組織存活可能，右後側壁病灶與右側肛提肌分界欠清，直腸繫膜內多發小淋巴結。建議治療後複查。2、子宮直腸陷凹少量積液。化療效果良好，並於2014.08.09行腹腔鏡上直腸癌根治術（MILES），術順。術後病理（201426224）1、（直腸+肛門），：送檢帶肛門的直腸切除標本一份，大腸乳頭狀管狀腺瘤，大部分腺體低級別下皮內瘤變，小部分腺體高級別下皮內瘤變。部分割槽域大腸粘膜慢性炎症，表面糜爛。腸周找到淋巴結2/8個見癌轉移，腸周脂肪內找到2個癌結節。2、（提肌組織），：送檢為平滑肌組織和少量脂肪脈管結締組織。術後恢復良好。今為複查再次就診我院，門診以“直腸癌伴肝轉移化療後術後”收入院。下次出院以來精神、睡眠、飲食可，大便如下術，小便正常，體力稍差、體重較前無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 43}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 45, "end_pos": 49}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 75}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 160, "label_type": "藥物", "overlap": 0, "start_pos": 156}, {"end_pos": 176, "label_type": "藥物", "overlap": 0, "start_pos": 173}, {"end_pos": 207, "label_type": "藥物", "overlap": 0, "start_pos": 203}, {"end_pos": 224, "label_type": "藥物", "overlap": 0, "start_pos": 222}, {"end_pos": 235, "label_type": "藥物", "overlap": 0, "start_pos": 232}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 288, "end_pos": 293}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 346}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 349, "end_pos": 354}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 355, "end_pos": 361}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 364, "end_pos": 370}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 405}, {"end_pos": 431, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}, {"label_type": "手術", "overlap": 0, "start_pos": 456, "end_pos": 473}, {"end_pos": 497, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"end_pos": 500, "label_type": "解剖部位", "overlap": 0, "start_pos": 498}, {"end_pos": 508, "label_type": "解剖部位", "overlap": 0, "start_pos": 506}, {"end_pos": 511, "label_type": "解剖部位", "overlap": 0, "start_pos": 509}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 518, "end_pos": 527}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 533, "end_pos": 541}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 547, "end_pos": 555}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 560, "end_pos": 562}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 590, "end_pos": 591}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 655, "end_pos": 667}]}
{"originalText": "，左鎖骨下淋巴結腫大半年，PET-CT示代謝增高，全身其他部位未見明顯佔位及高代謝病灶。，胸CT示：縱膈多發小淋巴結；，胃鏡示：食管距門齒30CM處粘膜粗糙，胃竇部粘膜粗糙分別取活檢。，病理示:食管粘膜慢性炎、胃慢性炎症伴HP感染。鼻咽鏡及氣管鏡檢查未見明顯異常。經特需門診聯合會診，，考慮：原發不明左鎖骨下淋巴結轉移癌，擬區域性放療，GTV60GY/30F/42D。現已完成10F。近腹脹明顯。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 1}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 13, "end_pos": 19}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 45, "end_pos": 48}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 82}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 160}, {"end_pos": 193, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}]}
{"originalText": "，2011.3行直腸癌手術；術後行XELOX方案化療6週期，，末次化療時間：2011.7。2013.11.22門診複查示CEA及CA199升高，癌胚抗原 11.36NG/ML;癌抗原199 80.38U/ML。行PET-CT檢查示肺、右腎下腺、左額葉轉移。多學科會診後考慮首先完善顱腦MR檢查明確診斷後行全腦放療。，2013-12頭顱MRI：考慮轉移瘤。2013.12.5開始行全腦放療。2013-12-26行伊立替康+希羅達化療5週期。因神經毒性III°XXX,第四周期希羅達改為1.5G BID PO,於2014-03-21給予第6週期XELIRI方案化療，，具體用藥為：S 1.95㎡ 伊立替康（開普拓）180MG/㎡ 340MG D1+希羅達1G/㎡ 1.5G BID D1-7，Q14D。3週期評效 縮小SD?6，週期評效：2014.4.1，與2014-2-18比較：右肺上葉結節縮小，原約10*7MM，現約7*6MM，左肺點狀結節（IMA43），縱隔、腋上淋巴結同前，小於10MM。  腹盆，CT:，與2014-2-19比較：肝臟動脈期肝S8強化結節，約13MM（IMA8），門脈期及延遲期呈等密度，血管瘤？異常灌注？建議追查或MRI檢查。右腎下腺不均勻強化腫塊略縮小，現約37X24MM，原約40X30MM，與胰腺尾部及右側膈肌腳分界不清。腹膜後多發小淋巴結同前，較大者約10X6MM（IMA77）。腫標待回報。患者明顯不適，進食可，二便正常，體重6週期上降11KG。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 60, "end_pos": 63}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 64, "end_pos": 69}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 88, "end_pos": 94}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 106, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 127}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 170}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 209, "label_type": "藥物", "overlap": 0, "start_pos": 205}, {"end_pos": 213, "label_type": "藥物", "overlap": 0, "start_pos": 210}, {"end_pos": 239, "label_type": "藥物", "overlap": 0, "start_pos": 236}, {"label_type": "藥物", "overlap": 0, "start_pos": 296, "end_pos": 305}, {"end_pos": 325, "label_type": "藥物", "overlap": 0, "start_pos": 322}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 415}, {"end_pos": 437, "label_type": "解剖部位", "overlap": 0, "start_pos": 429}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 447, "end_pos": 454}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"end_pos": 496, "label_type": "解剖部位", "overlap": 0, "start_pos": 494}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 506, "end_pos": 509}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 520, "end_pos": 523}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 526}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}, {"end_pos": 572, "label_type": "解剖部位", "overlap": 0, "start_pos": 567}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 577, "end_pos": 578}]}
{"originalText": "，5月前患者出現腰部疼痛，對症治療效果差，，2014-8行胸部CT：縱膈及兩肺多發腫大淋巴結，兩側胸腔積液，心包積液，胸椎及其附件、左側肩胛骨、胸骨多發骨質破壞。氣管隆突前淋巴結，EBUS-TBNA：轉移性腺癌，，IHC:CK7(+),TTF-1（-）,CDX2(+),PAX8(-),CGA(-),SYN(-)。完善腹部，CT：肝左葉低密度影，性質待定，胸腰骶椎骨、右側髖骨多發骨質破壞。頭MRI未見異常。骨掃描提示全身廣泛骨轉移。2014-8-19，胃鏡：胃角潰瘍。，病理活檢：胃角低分化腺癌及印戒細胞癌。CEA 1.9NG/ML，CA199 23U/ML。目前患者腰部疼痛5級，食納可，二便如常，體重無明顯增減。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 29, "end_pos": 33}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 47, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 159, "end_pos": 164}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 234}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 254}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 255, "end_pos": 258}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 268, "end_pos": 273}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}]}
{"originalText": "患者20天前因“大便帶血3月。”入院，經腸鏡及病理檢查確診降結腸腺癌。影像學分期為CT3N1M0，IIIB。臨床表現有不全性腸梗阻。2013年1月24日全麻上行右半結腸切除術。病理示：降結腸中分化腺癌，浸潤漿膜上層，0/16LN+。分期PT3N0M0，IIA。術後有排氣排便，能進半流後出院。5天前無明顯誘因出現噁心、嘔吐，伴下腹部脹痛，嘔吐物為膽汁及胃液，最多一天約500ML，未見食物殘渣。肛門有排氣，少量排便，無陣發性絞痛、發熱等。為進一步治療入院。自出院以來，患者無發熱、咳嗽、身目黃染，無骶部痛等，精神可，睡眠差，小便量少，體重上降具體不詳。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 59, "end_pos": 65}, {"end_pos": 87, "label_type": "手術", "overlap": 0, "start_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 100}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 163, "end_pos": 165}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 197, "end_pos": 199}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}]}
{"originalText": "，主因”腹痛”就診，診斷胃癌，於2013.6.11行全胃切除術，未見手術記錄，，術後病理：胃未分化癌，部分低分化癌，侵及胃壁肌層，伴網膜淋巴結可見癌轉移，斷端-，，**三院病理會診：胃低分化腺癌，大部分為印戒細胞癌，浸潤至漿膜上層，未見脈管癌栓及神經侵犯，淋巴結0/4。術後恢復可。飲食少。2013.7.26口服TS-1 50MG BID，完成1週期。自覺頭暈、胃腸不適。因白細胞減少2度、粒細胞減少2度，貧血1度，血象恢復慢，停藥3周，2013-8-31起行第2週期TS-1 40MGBID口服。2013-9-4，複查血常規：WBC3.88，NE2.2，HGB126，PLT205。\\U0004\\U0004 進食較前好轉，體重不足70斤。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 31, "label_type": "手術", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 45, "end_pos": 57}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 60, "end_pos": 61}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 107}, {"end_pos": 160, "label_type": "藥物", "overlap": 0, "start_pos": 156}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 187, "end_pos": 190}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 203, "end_pos": 205}, {"end_pos": 239, "label_type": "藥物", "overlap": 0, "start_pos": 234}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 264, "end_pos": 267}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 272, "end_pos": 274}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 278, "end_pos": 281}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 285, "end_pos": 288}]}
{"originalText": "，緣於入院前2周（2015.07.28）無明顯誘因出現聲音嘶啞，無吞嚥阻塞感，無胸悶、心悸、氣促、咳嗽、咯血，無噁心嘔吐，無畏冷、發熱等不適，未重視，入院前5天，聲音嘶啞加劇，就診我院門診，，查：，電子喉鏡：左聲帶麻痺。頸部，MRI：左側上頸部及所見下縱隔（食管）腫瘤，為惡性可能，建議胸部CT及食管鏡檢查。，胃鏡：食管癌（口頭回報）。頸部+胸部，CT:1、食管全程管壁明顯增厚，考慮食管CA可能，建議食管鏡檢查；病灶右旁、左側鎖骨鎖骨下窩、縱隔內、肝胃間隙多髮結節、腫塊影，考慮淋巴結轉移。2、兩肺下葉肺氣腫；兩肺下葉及左肺中葉慢性炎症。3、右肺上葉結節影，考慮炎性肉芽腫可能，建議HRCT隨訪複查。4、兩側頸動脈鞘間隙、頜上間隙多髮結節影，考慮淋巴結慢性炎性增生可能，建議隨訪複查。今為進一步治療，就診我科，門診擬“食管癌可能”收住入院，發病來，精神尚可，睡眠尚可，食慾尚可，大小便正常，體重無明顯減輕。", "entities": [{"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 104, "end_pos": 107}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 110, "end_pos": 116}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 134}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 143, "end_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 158, "end_pos": 161}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 168, "end_pos": 176}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 196}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 248, "end_pos": 255}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 292, "end_pos": 296}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 363}]}
{"originalText": "，2011.3.4行結腸癌根治術，術後輔助化療6週期，定期複查。2013-3腹部淋巴結增大，開始FOLFIRI+BEV化療6週期。3週期、6週期，評效PR，消化道反應重，，末次化療時間：2013.6.18，，2013-6-28複查腹盆CT：腹部多發淋巴結同前相仿。胸部CT掃描未見佔位徵象。改為希羅達+BEV維持治療20週期，末次化療時間2014-5-4。2013-8-14複查腫瘤較前繼續縮小，無明顯不良反應。2013.10.25複查腹盆CT示腫瘤穩定，2013-12-13行腹盆CT提示病變SD。2014-2-24複查評效為SD。2014-5-5 複查腹盆CT見肝門區腫大淋巴結，腸繫膜血管旁淋巴結。XX主任醫生建議繼續希羅達+BEV聯合治療及擬行腹膜後區域性放療。現患者一般情況可，進食可，大便3-5次/天，體重較前無明顯變化。，計劃：直腸癌腹膜後淋巴結PTV54GY/27F.5-26放療2次。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 59, "label_type": "藥物", "overlap": 0, "start_pos": 56}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 115, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 132, "end_pos": 136}, {"end_pos": 150, "label_type": "藥物", "overlap": 0, "start_pos": 147}, {"end_pos": 154, "label_type": "藥物", "overlap": 0, "start_pos": 151}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 218, "end_pos": 222}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 278, "end_pos": 282}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 315, "label_type": "藥物", "overlap": 0, "start_pos": 312}, {"end_pos": 319, "label_type": "藥物", "overlap": 0, "start_pos": 316}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 326, "end_pos": 327}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 370, "end_pos": 373}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}]}
{"originalText": "，發現右膝腫物10年，逐漸增大。，MRI：右側脛骨平臺明顯骨質破壞，呈稍長T1稍長T2訊號，周圍見較大軟組織腫塊，較大層面約92*82MM（SE8 IM12），增強明顯不均勻強化，累及下上徑約7CM，關節面受侵。右側股骨遠端內側髁見類圓形長T1長T2訊號，增強明顯結節狀強化，右側脛骨骨幹見環狀強化結節，約10MM（SE9 IM44）。我院化療2週期後腫物無明顯縮小。2015.1.4我院右大腿截肢右膝腫物切除及右腹股溝淋巴結清掃術，，術後病理：梭形細胞惡性腫瘤（G2級），大小8×XXX6×XXX2.5CM，伴灶狀壞死（約30%）及鈣化，核分裂像約5個/10HPF；結合免疫組化結果考慮為滑膜肉瘤；可見脈管內瘤栓；淋巴結可見腫瘤轉移（9/，27：右腹股溝7/14，右側髂血管旁1/7，右側閉孔*/6）；，腫瘤病理分期：YPT2BN1。，免疫組化結果顯示:VIMENTIN(+),B-CATENIN(胞膜+),BCL2(區域性+),CD34(－),CD99(+),CK7(+),DESMIN(－),EMA(+),S100(－),SMA(－),KI67(+20%)。術後複查，CT：右腹股溝區及右髂髂外血管旁術後，可見索條影，未見明顯腫大淋巴結。餘腹膜後散在少許長徑不足1CM小淋巴結，未見明顯腫大者。2015.2.16，放療：右腹股溝、右側髂血管旁、右側閉孔淋巴結區域6+10MV-X DT50GY/25F/5W。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"label_type": "手術", "overlap": 0, "start_pos": 194, "end_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 295, "end_pos": 299}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 486, "end_pos": 488}, {"end_pos": 494, "label_type": "解剖部位", "overlap": 0, "start_pos": 489}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 522, "end_pos": 523}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}, {"end_pos": 572, "label_type": "解剖部位", "overlap": 0, "start_pos": 567}, {"end_pos": 581, "label_type": "解剖部位", "overlap": 0, "start_pos": 574}]}
{"originalText": "，患者於2012.11因“腹瀉、腹痛1月餘”到我院就診，2012.11.27，腸鏡示：距肛門10CM可見菜花樣隆起腫物，佔腸腔2/3圈，活檢病理示腺癌。 2012.12.04，胸腹CT示：乙狀結腸壁不均勻增厚，考慮乙狀結腸癌，侵犯漿膜層；腸周及兩側髂血管旁髂血管旁淋巴結淋巴結腫大，考慮轉移；肝S7/8及肝S2病灶，考慮肝轉移瘤。2012.12.11在我院行剖腹探查+術中灌腸+DIXON+闌尾切除術，術後病理為直腸中至低分化腺癌，浸潤至腸壁外膜層，可見神經侵犯及脈管內癌栓，腸繫膜結節見腺癌浸潤，淋巴結6/9（+），分期T3N2M1,IV期。術後恢復可，於2013.1.16至3.19行XELOX方案化療4程（後3程加用AVASTIN），過程順利。2013.4.，8複查CT：直腸癌術後改變，肝臟轉移瘤，較前縮小。2013.4.11至4.25行XELOX方案化療第5程（因擬行手術，停用AVASTIN）。2013.5.，3MR：肝左葉病灶較前縮小，肝S2 病灶，較前未見明顯變化。於2013.5.21行肝轉移瘤切除術，術程順利，，術後病理為：肝左靜脈斷端提示直腸腺癌肝轉移；肝S2腫瘤中分化腺癌，結合病史及免疫組化結果，提示直腸腺癌肝轉移，侵犯肝被膜；肝S8腫瘤符合中分化腺癌，結合病史及免疫組化結果，提示直腸腺癌肝轉移，侵犯肝被膜。術後患者出現發熱、咳嗽，CT示左胸腔積液、左上肺不張合併感染，予對症支援、抗感染、胸腔穿刺抽液後，症狀緩解。術後於2013.6.24-9.5行XELOX方案化療10次。2013.10-2014.1在我科行CIK細胞免疫治療8程，過程順利。2013.12.26複查CT、MR等未見明確復發轉移徵象。2014.3.22複查PET-CT提示直腸癌肝轉移術後化療後，肝臟S2、S7/8病灶代謝活躍，右側腎下腺結節代謝活躍，考慮轉移。骶前及直腸旁數個小結節部分代謝略活躍，右下肺前段小結節代謝未見異常，不排除轉移；考慮疾病進展。患者於2014.4.11-7.22行FOLFIRI+C225方案化療七程，過程順利。2014.6.27，行下腹部MRI檢查：，直腸癌多發轉移化療後複查：肝S8 異常訊號灶，考慮術後改變可能性大，大致同前。肝S2、S8 病灶，較前明顯縮小。右側腎下腺病灶，考慮轉移瘤，較前縮小。現返院化療，訴疲乏，精神一般，食慾可，睡眠可，二便正常，近期體重無明顯減輕。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 75}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 88, "end_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 112}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 164}, {"label_type": "手術", "overlap": 0, "start_pos": 179, "end_pos": 200}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 206, "end_pos": 215}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 219, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 239}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 318, "label_type": "藥物", "overlap": 0, "start_pos": 311}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 336, "end_pos": 338}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 339, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 347, "end_pos": 352}, {"end_pos": 401, "label_type": "藥物", "overlap": 0, "start_pos": 394}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 412, "end_pos": 414}, {"end_pos": 418, "label_type": "解剖部位", "overlap": 0, "start_pos": 415}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}, {"end_pos": 459, "label_type": "手術", "overlap": 0, "start_pos": 452}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 480, "end_pos": 487}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 488, "end_pos": 498}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 513, "end_pos": 520}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 523, "end_pos": 524}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 527, "end_pos": 532}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 534, "end_pos": 539}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 554, "end_pos": 561}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 564, "end_pos": 565}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 580, "end_pos": 582}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 583, "end_pos": 588}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 589, "end_pos": 598}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 699, "end_pos": 701}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 702, "end_pos": 704}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 727, "end_pos": 733}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 735, "end_pos": 746}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 747, "end_pos": 756}, {"end_pos": 768, "label_type": "解剖部位", "overlap": 0, "start_pos": 763}, {"end_pos": 782, "label_type": "解剖部位", "overlap": 0, "start_pos": 780}, {"end_pos": 785, "label_type": "解剖部位", "overlap": 0, "start_pos": 783}, {"end_pos": 804, "label_type": "解剖部位", "overlap": 0, "start_pos": 799}, {"end_pos": 857, "label_type": "藥物", "overlap": 0, "start_pos": 853}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 880, "end_pos": 886}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 890, "end_pos": 900}, {"end_pos": 907, "label_type": "解剖部位", "overlap": 0, "start_pos": 903}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 929, "end_pos": 935}, {"end_pos": 951, "label_type": "解剖部位", "overlap": 0, "start_pos": 946}]}
{"originalText": "，患者2007.4因“右下頸腫物1月”診斷為鼻咽未分化型非角化行癌（T3N2M0），在我院行TP全身化療2週期，根治性IMRT，DT6800CGY/30F/7.5W，區域淋巴結DT6400CGY/30F/7.5W，臨床療效評價為CR，定期複查未見異常。2011.1出現黃疸，於我院PET/CT，檢查示：鼻咽癌並肝、腹腔積腹膜後淋巴結轉移。遂於2011.3.11行ERCP+膽管支架植入術，術後於2011.3.22、2011.4.12、2011.5.4、2011.5.25行TPF化療4程。2011.6.10，複查CT示：肝S4病灶，考慮轉移瘤。肝S4 病灶，考慮肝轉移瘤，對比2011.4.29 日CT,較前稍縮小。肝門區、門腔間隙、腹膜後淋巴結腫大，較前縮小。鼻咽癌治療後，鼻咽腔未見明確佔位性病變。於2011.6.14、2011.7.5行紫杉醇+順鉑+5-FU化療2程。定期複查，2011.10.18複查鼻咽、，頸部及下腹部CT提示：肝S4 病灶，考慮肝轉移瘤，較前無大變化。肝門區、門腔間隙、腹膜後淋巴結腫大，較前無大變化。於2011.10.26在我院CT室行肝轉移瘤微波消融術；2011.12.，19我院下腹部CT:肝S4病灶較前無明顯改變。肝門區、門腔間隙、腹主動脈旁多發淋巴結，部分病灶增大提示腫瘤進展，於2011-12-29予GD(艾素135MG D1+澤菲1.8 D1，8）方案化療1程、2012-01-19、2012-02-14，2012-3-6開始在我科行4程GD方案化療，過程順利。今日入我科繼續化療。自起病以來，患者精神、睡眠可，食慾如常，大小便正常，體重無上降。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 41}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 140, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 168}, {"label_type": "手術", "overlap": 0, "start_pos": 181, "end_pos": 193}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 256, "end_pos": 258}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 285}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 299, "end_pos": 301}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 323, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 338, "end_pos": 340}, {"end_pos": 374, "label_type": "藥物", "overlap": 0, "start_pos": 371}, {"end_pos": 377, "label_type": "藥物", "overlap": 0, "start_pos": 375}, {"end_pos": 382, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 404, "end_pos": 416}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 432}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 448, "label_type": "解剖部位", "overlap": 0, "start_pos": 444}, {"end_pos": 455, "label_type": "解剖部位", "overlap": 0, "start_pos": 449}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 479, "end_pos": 481}, {"end_pos": 492, "label_type": "手術", "overlap": 0, "start_pos": 483}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 506, "end_pos": 511}, {"end_pos": 515, "label_type": "解剖部位", "overlap": 0, "start_pos": 512}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 529}, {"end_pos": 538, "label_type": "解剖部位", "overlap": 0, "start_pos": 534}, {"end_pos": 575, "label_type": "藥物", "overlap": 0, "start_pos": 573}, {"end_pos": 586, "label_type": "藥物", "overlap": 0, "start_pos": 584}]}
{"originalText": "，患者於2011年1月28日因“回盲部腫物”行左半結腸切除術，術後病理證實為瀰漫大B細胞淋巴瘤，予\\\"R-CHOP\\\"方案化療六程，定期複查未見明顯復發徵像。2013年3月複查PET/CT，提示：十二指水平段高代謝灶，考慮淋巴瘤浸潤可能。，我院超聲胃鏡檢查示：十二指腸降段起始部腫物，病理提示中分化腺癌。遂於2013-04-25在我院胃胰科行胰十二指腸切除術（WHIPPLE術），術程順利。，術後病理診斷為：十二指腸中分化腺癌（PT2N0M0）。術後*卡培他濱輔助化療5程。後因手足綜合症停藥。2014年4月患者無明顯誘因出現下腹痛，呈陣發性鈍痛，進食後明顯，後可自行逐漸緩解。，於我院行CT示：，十二指腸腺癌術後：吻合口區未見明顯腫瘤復發。腸繫膜區和腹主動脈旁多發淋巴結，考慮腫瘤復發。肝內多發轉移瘤。肝囊腫。於2014-05-30、2014-06-20、2014-07-11、2014-08-04、2014-08-25、2014-09-22予以替吉奧+奧沙利鉑方案化療6程。化療過程順利。2014-07-15至2014-08-16同期放療，計劃採用VMAT，，放療範圍：GTV包括腹腔幹、腹主動脈旁、腸繫膜區腫大淋巴結；CTV為GTV外擴1.0CM，適當避開周圍腸管等危及器官。GTV和CTV均予以劑量45GY/25F。過程順利，第1程化療後患者自覺腹痛症狀緩解。第4程化療後出現III°血小板上降，予升血小板治療後恢復。6，程化療結束後複查CT示：十二指腸腺癌術後、，放化療後：吻合口區未見明顯腫瘤復發。腸繫膜區和腹主動脈旁多發淋巴結，考慮腫瘤復發，較前縮小。肝內多發轉移瘤，部分較前增大。肝囊腫。左下肺近葉間裂斑片影，範圍較前增大；兩肺類結節，較前為新發，可疑轉移瘤；左肺門淋巴結，考慮轉移瘤可能性大。前列腺鈣化。右股骨頸骨質密度異常，考慮良性可能性大。評價PD。於2014-11-1更改化療方案為貝伐珠單抗+FOLFIRI，過程順利。現患者為行上一程化療入院。患者近期精神，食慾，睡眠可，大小便正常，體重較前無明顯上降。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 30, "label_type": "手術", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 47}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 88, "end_pos": 94}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 114}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 151}, {"label_type": "手術", "overlap": 0, "start_pos": 171, "end_pos": 189}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 222}, {"end_pos": 230, "label_type": "藥物", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 244}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 294, "end_pos": 296}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 311}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 322}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 351}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 352, "end_pos": 355}, {"end_pos": 427, "label_type": "藥物", "overlap": 0, "start_pos": 424}, {"end_pos": 432, "label_type": "藥物", "overlap": 0, "start_pos": 428}, {"end_pos": 495, "label_type": "解剖部位", "overlap": 0, "start_pos": 492}, {"end_pos": 500, "label_type": "解剖部位", "overlap": 0, "start_pos": 496}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 502, "end_pos": 503}, {"end_pos": 511, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 533, "end_pos": 534}, {"end_pos": 578, "label_type": "解剖部位", "overlap": 0, "start_pos": 577}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 596, "end_pos": 599}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 604, "end_pos": 607}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 623, "end_pos": 625}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 627, "end_pos": 635}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 642, "end_pos": 645}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 655, "end_pos": 656}, {"end_pos": 664, "label_type": "解剖部位", "overlap": 0, "start_pos": 660}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 683, "end_pos": 690}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 698, "end_pos": 701}, {"end_pos": 709, "label_type": "解剖部位", "overlap": 0, "start_pos": 702}, {"end_pos": 722, "label_type": "解剖部位", "overlap": 0, "start_pos": 720}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 738, "end_pos": 744}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 755, "end_pos": 760}, {"end_pos": 765, "label_type": "解剖部位", "overlap": 0, "start_pos": 761}, {"end_pos": 808, "label_type": "藥物", "overlap": 0, "start_pos": 803}]}
{"originalText": "，3年前大便帶血，，腸鏡：距肛門約8、9CM各見一腫物，，咬檢病理：惡性腫瘤，傾向未分化癌，術前，CT：盆腔未見明顯腫大淋巴結。於2009-4-30行直腸癌根治術，，術中見：子宮與腹壁粘連，肝臟表面滿布小結節，腫塊位於直腸腹膜反折處，未侵透漿膜，直腸下動脈旁多發淋巴結，，術後病理：直腸中分化腺癌，侵及深肌層，切緣（-），淋巴結（1/3）,PT2N1MO。術後XELOX化療7週期（希羅達 4.0 奧沙利鉑 不詳 ），神經毒性 II度。末次2009-11。術後手術切口破潰，自行好轉。此後定期複查。2012-5複查發現右上腹腫物，，2012-5-25MRI：盆腔右後方上部結節樣訊號異常灶，2012-6-5，結腸鏡：結腸黑變病，未見佔位。，2012-6-11外院PET-CT：沿上腹部切口分佈多髮結節影，右側盆壁增大淋巴結。2012-6-25，我院B超：右盆腔髂血管深方可見低迴聲佔位，，穿刺病理：小圓細胞腫瘤，不除外神經內分泌腫瘤轉移，，免疫組化：CK(+),SYN(+),CGA(-),CD56(+),CDX-2(+),KI67(+5%)。2012-7-11，就診我院腫標：NSE CA199 CEA CA125 均正常，，直腸術後我院病理會診：直腸神經內分泌腫瘤（WHO分級 G2）,，免疫組化：KI-67 約3%。術後即出現便祕，藥物通便，大便未見膿血。進食可，體重無明顯變化。2012.7入組法米替尼治療5週期，評效SD。治療後甲狀腺功能低上II度，2013-12尿蛋白3+終止治療。2013-3CT示盆腔淋巴結較前增大，PD。2013-3-5開始善寧20MG治療，至今一直予善龍治療。2013-11-21住院複查建議繼續善龍治療.2014-2-18腹、盆，CT:右側髂內閉孔區腫大淋巴結同前，約32X27MM（IM118），前腹壁手術切口皮上及腹直肌多發斑片及結節強化灶同前，右側腹直肌增厚、上緣與子宮底及膀胱前壁粘連同前。擬2014-5-15繼續善龍治療。2014-7改為蘭瑞肽治療10次，目前無不適主訴，飲食、大小便正常，體重較前無變化。2014-11-21綜合評效穩定SD，繼續蘭瑞肽治療。2015-6 發現肝轉移，開始希羅達+替莫唑胺治療1週期。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 49, "end_pos": 51}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 81, "label_type": "手術", "overlap": 0, "start_pos": 75}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"end_pos": 194, "label_type": "藥物", "overlap": 0, "start_pos": 191}, {"end_pos": 203, "label_type": "藥物", "overlap": 0, "start_pos": 199}, {"end_pos": 262, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 275, "end_pos": 278}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 279, "end_pos": 281}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 308, "end_pos": 313}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 331, "end_pos": 337}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 409, "end_pos": 418}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 489, "end_pos": 492}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 492, "end_pos": 499}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 499, "end_pos": 502}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 503, "end_pos": 508}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 514, "end_pos": 518}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 525, "end_pos": 534}, {"end_pos": 605, "label_type": "解剖部位", "overlap": 0, "start_pos": 601}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 619, "end_pos": 629}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 637, "end_pos": 640}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 653, "end_pos": 655}, {"end_pos": 661, "label_type": "解剖部位", "overlap": 0, "start_pos": 656}, {"end_pos": 681, "label_type": "藥物", "overlap": 0, "start_pos": 679}, {"end_pos": 695, "label_type": "藥物", "overlap": 0, "start_pos": 693}, {"end_pos": 718, "label_type": "藥物", "overlap": 0, "start_pos": 716}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 730, "end_pos": 736}, {"end_pos": 744, "label_type": "解剖部位", "overlap": 0, "start_pos": 737}, {"end_pos": 749, "label_type": "解剖部位", "overlap": 0, "start_pos": 746}, {"end_pos": 771, "label_type": "解剖部位", "overlap": 0, "start_pos": 768}, {"end_pos": 781, "label_type": "解剖部位", "overlap": 0, "start_pos": 778}, {"end_pos": 799, "label_type": "解剖部位", "overlap": 0, "start_pos": 794}, {"end_pos": 808, "label_type": "解剖部位", "overlap": 0, "start_pos": 805}, {"end_pos": 813, "label_type": "解剖部位", "overlap": 0, "start_pos": 809}, {"end_pos": 832, "label_type": "藥物", "overlap": 0, "start_pos": 830}, {"end_pos": 846, "label_type": "藥物", "overlap": 0, "start_pos": 843}, {"end_pos": 901, "label_type": "藥物", "overlap": 0, "start_pos": 898}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 913, "end_pos": 916}, {"end_pos": 922, "label_type": "藥物", "overlap": 0, "start_pos": 919}, {"end_pos": 927, "label_type": "藥物", "overlap": 0, "start_pos": 923}]}
{"originalText": "因下腹不適半年就診，2012.2胃鏡CT示胃體小彎潰瘍，區域性進展期胃CA。2012.2.28行“腹腔鏡輔助，剖腹胃癌根治術”,術前CEA 1000,2012.3.7 降至328，2012.3.9 105.術後病理：胃竇潰瘍潰瘍型中分化腺癌，侵全層，切緣（-），LN8/11 T4AN3M0 IIIA。HER2免疫組化（-）。2012-4-11於我院開始行3週期化療，方案替吉奧單藥口服2週期。服用藥物無明顯不適。6-20腫標 AFP 15.63（漸進性升高）。 6-21因患者體重上降明顯，暫未行第4週期化療。7-4我院複查血常規、肝腎功（-）。目前患者無明顯不適，進半流質飲食，進食後略感腹脹，二便正常，體重近2周未上降。已行第4週期替吉奧治療。\\U0004\\U0004。", "entities": [{"end_pos": 3, "label_type": "解剖部位", "overlap": 0, "start_pos": 1}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 18, "end_pos": 20}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 36}, {"end_pos": 61, "label_type": "手術", "overlap": 0, "start_pos": 48}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 65, "end_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 119}, {"end_pos": 188, "label_type": "藥物", "overlap": 0, "start_pos": 185}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 212, "end_pos": 216}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 321, "label_type": "藥物", "overlap": 0, "start_pos": 318}]}
{"originalText": "，2012-1因胸痛行下消化道造影示胃體癌，2012-1-16行胃癌根治術，術中見病灶位於胃體後壁約7CM，侵及胰腺體尾部並與橫結結腸繫膜粘連，脾門多發淋巴結腫大，，術後病理：中低分化腺癌，8.8*8*1.8CM,侵及全層，脈管（+），胰腺可見癌侵及，淋巴結27/45，HER-2（-）。2012-3-17開始替吉奧至今年5月，，末次化療時間：2013.5，未放療。\\U0004\\U0004  ，2012-7-27：腹部CT示腸繫膜，大網膜多發淋巴結淋巴結影。，腫標：CEA 8.11 餘正常。胸片未見異常。\\U0004\\U0004  ，2013-1-29頸部CT：右側頸側深可見多發腫大淋巴結，較大約19*10MM腹盆CT未見明確復發轉移徵象，肝實質內多發低密度密度小結節，考慮囊腫。超聲示右腋上淋巴結，1.6*0.6CM。PET-CT定位顯示咽後壁及口咽部SUV值明顯升高，最高10.5，腹部未見明顯異常，不能排除頭頸部腫瘤。行支氣管鏡檢查口咽鼻咽未見明顯異常，未行病理，建議頸部淋巴結穿刺活檢。外科考慮淋巴結位置並較小穿刺困難。 \\U0004\\U0004  2013.7.12B，超：右頸根至鎖骨下多發淋巴結，較前變化不大。腹盆，CT：未見新生病灶。\\U0004\\U0004  目前飲食可，大小便正常，體重增加1KG.為行復查就診。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 11, "end_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 21}, {"end_pos": 37, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 45, "end_pos": 47}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 67}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 94}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 158, "label_type": "藥物", "overlap": 0, "start_pos": 155}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 208, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 214}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 234, "end_pos": 237}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 247, "end_pos": 249}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 278, "end_pos": 282}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 323, "end_pos": 324}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 363, "end_pos": 369}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"end_pos": 380, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 396}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 409, "end_pos": 414}, {"end_pos": 424, "label_type": "解剖部位", "overlap": 0, "start_pos": 422}, {"end_pos": 426, "label_type": "解剖部位", "overlap": 0, "start_pos": 424}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 499, "end_pos": 501}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 515, "end_pos": 520}]}
{"originalText": "，患者2015-7在我院確診為“結腸癌”，於2015-8-12在我院行“腹腔鏡右半結腸切除術+DIXON術”，術中見腫瘤位於降結腸中段，約4*5CM，侵犯漿膜。，探查腹盆腔：肝見2枚巨大轉移灶，位於左肝，大小分別為4*5CM，8*10CM。，術後病理：（降結腸大體）中至低分化腺癌，伴壞死，癌浸潤至腸壁漿膜上層，見神經束侵犯，未見明確脈管內癌栓；另雙枚息肉管狀-絨毛狀腺瘤。手術切緣陰性，淋巴結10/18（+），PMS2（+），MLH1（+），MSH2（+），MSH6（+）。，多基因分型：未見陽性突變位點。，確診為：降結腸癌伴肝轉移（PT3N2BM1,IV期PMMR，RAS野生型）。術後於2015-09-30至2016-02-02行“C225+MFOLFOX6”化療7程。4程後療效評價PR，4程、7程後複查MRI提示肝S2、4、8慮轉移瘤，較前縮小，療效PR。2016-2-14，行MRI示：結腸癌姑息切除術後、，肝轉移化療中：肝S2、4、8慮轉移瘤，較前縮小。2016年03月16日在我院行擴大右半肝切除術，，術後病理：1（S2、3腫物），鏡上：肝見中分化腺癌浸潤，結合病史及免疫組化結果，符合腸腺癌肝轉移；2（S4腫物），鏡上：肝組織中見中分化腺癌浸潤，結合病史及免疫組化，符合腸腺癌肝轉移，另見部分癌細胞退變，考慮為治療後改變；癌旁肝組織呈慢性肝炎G2S3改變。3（肝動脈旁淋巴結）1枚，未見癌。術後於2016-06-01、2016-06-15、2016-08-01行FOLFOX化療第8-10程，過程順利。2017-04-24複查結腸鏡示“升結腸見一長蒂息肉，約2.0X2.0CM，活檢1塊。肝曲見一長蒂息肉，約1.2X2.0CM，活檢1塊”，病理示“1（升結腸長蒂息肉活檢），鏡上：形態符合管狀腺瘤。2（結腸肝曲**息肉活檢），鏡上：形態符合管狀腺瘤”。患者為求內鏡上息肉切除收入我科。近來患者精神、睡眠、食慾可，大小便如常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 53}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 150}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 259, "end_pos": 292}, {"end_pos": 323, "label_type": "藥物", "overlap": 0, "start_pos": 319}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 394, "end_pos": 397}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 399, "end_pos": 408}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 413}, {"end_pos": 424, "label_type": "解剖部位", "overlap": 0, "start_pos": 417}, {"end_pos": 457, "label_type": "手術", "overlap": 0, "start_pos": 449}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 479, "end_pos": 484}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 501, "end_pos": 507}, {"end_pos": 512, "label_type": "解剖部位", "overlap": 0, "start_pos": 510}, {"end_pos": 520, "label_type": "解剖部位", "overlap": 0, "start_pos": 519}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 524, "end_pos": 529}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 544, "end_pos": 551}, {"end_pos": 573, "label_type": "解剖部位", "overlap": 0, "start_pos": 572}, {"end_pos": 596, "label_type": "解剖部位", "overlap": 0, "start_pos": 589}, {"end_pos": 680, "label_type": "解剖部位", "overlap": 0, "start_pos": 677}, {"end_pos": 705, "label_type": "解剖部位", "overlap": 0, "start_pos": 703}, {"end_pos": 738, "label_type": "解剖部位", "overlap": 0, "start_pos": 735}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 753, "end_pos": 757}, {"end_pos": 764, "label_type": "解剖部位", "overlap": 0, "start_pos": 760}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 779, "end_pos": 783}]}
{"originalText": "，2009-6-19當地胃癌手術,術中見大網膜及部分小腸粘連,術後病理低分化腺癌,淋巴結3/4,術後行化療3週期（不詳）。術後即出現進食劍上脹滿,反酸。2010.11.3，複查胃鏡：返流性食管炎。腹部CT（-），B，超：右鎖骨下淋巴結（0.7*0.4CM）。腫標CA72-4 9.95,餘（-）。\\U0004\\U0004  2012.3.21，複查胃鏡：返流性食管炎。，病理：（-）。腫標CA72-4 16.79,餘（-）。\\U0004\\U0004 近來仍進食後劍上脹滿,伴反酸，食納少，服耐信症狀無緩解，術後體重穩定。\\U0004\\U0004 服泮托拉唑後症狀開始有緩解，但近日再發。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 97}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 98, "end_pos": 102}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 131, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 183}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 194, "end_pos": 200}, {"end_pos": 247, "label_type": "藥物", "overlap": 0, "start_pos": 245}, {"end_pos": 278, "label_type": "藥物", "overlap": 0, "start_pos": 274}]}
{"originalText": "2011-11因下腹部不適伴黑便就診，胃竇部腺癌伴腹腔LNM，右鎖骨下LNM。於2011-12-24始DCS， BM IV度，因判效SD症狀無緩解，改為SOX*3+腹腔熱化療3次（順鉑+氟尿嘧啶均減量），症狀緩解。於2012-6-18我院行胃癌姑息切除術，術中見腸繫膜根部及腹主動脈旁LNM，行全胃+D2（腹膜後未清掃？），胃體小彎側潰瘍型低分化腺癌，3.5CM，及胃周圍脂肪組織，未侵透漿膜，脈管癌栓（+），9/25，HER-2 弱陽性。MDT建議口服S1，未進行，於外院行生物免疫治療。2012-8-1複查腹主動脈旁多發LN進展。現腰背部疼痛，2012.8.8 始行FOLFIRI化療7週期，1CS化療後4°骨髓抑制，第二週期減量,仍出現III度骨髓抑制，後續化療均調整劑量，末次化療2012-11-17。3週期評效：縮小SD（右鎖骨下LN明顯縮小），7週期後複查評效結果不詳。我科查房建議放療。進一步諮詢。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 38}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 83}, {"end_pos": 92, "label_type": "藥物", "overlap": 0, "start_pos": 90}, {"end_pos": 97, "label_type": "藥物", "overlap": 0, "start_pos": 93}, {"end_pos": 127, "label_type": "手術", "overlap": 0, "start_pos": 120}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 152, "label_type": "手術", "overlap": 0, "start_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 153, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"end_pos": 229, "label_type": "藥物", "overlap": 0, "start_pos": 227}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 310}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 325, "end_pos": 329}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 366}]}
{"originalText": "，2011-2-16直腸上段癌，CT3N2M0? 新輔助放療30GY/10F，2011-3-23本院行直腸癌低位前切除術，潰瘍中分化腺癌，淋巴結2/16。HER2(2+),因吻合口瘻行橫結腸造瘻術。2011-4 XELOX*8，末次化療2012.3。期間2011.7還納。術前CR（-），化療期間2011.10胸片疑M，CT證實兩肺M，但未更換方案，繼續化療到2012.3.4.\\U0004\\U0004  ，2012-4-9CT：肺內轉移灶進展明顯，腹部CT（-），腫標略高CEA 6.78 CA199 42。目前患者無明顯不適。\\U0004\\U0004  K-RAS ，：12、13密碼子野生型，BRAF 野生型。\\U0004\\U0004  UGT1A1*28 TA(6)/TA(7) UGT1A1*6 211G/G。\\U0004\\U0004  家屬拒絕應用靶向治療 \\U0004\\U0004  FOLFIRI ？化療3週期 \\U0004\\U0004。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 23}, {"end_pos": 60, "label_type": "手術", "overlap": 0, "start_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 91}, {"end_pos": 98, "label_type": "手術", "overlap": 0, "start_pos": 92}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 155, "end_pos": 157}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 160, "end_pos": 162}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 212, "end_pos": 214}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 225, "end_pos": 229}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 237, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 246, "end_pos": 251}]}
{"originalText": "，於2006.6.5行乙狀結腸癌根治術，術後病理分期PT3N0，術後行FOLFOX7*6，之後XEL*3，定期複查。2013.1便血，2013.2.20，複查腸鏡：（距肛門14-17CM）中分化腺癌；（升結腸）管狀腺瘤，I級。2013.3.25行直腸癌低位前切除術，，術後病理：直腸（切除）浸潤性中分化腺癌，大小6.6CM；癌浸及腸周脂肪組織；脈管（-），淋巴結（0/15）；斷端（-）。4月前我院行吻合口擴張，擴張後患者排便困難有緩解，此次為複查來診。我院內鏡上切除肛管病變,術後病理為絨毛狀腺瘤,基底切緣淨。", "entities": [{"end_pos": 19, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"end_pos": 50, "label_type": "藥物", "overlap": 0, "start_pos": 47}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 112}, {"end_pos": 132, "label_type": "手術", "overlap": 0, "start_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 166}, {"end_pos": 205, "label_type": "手術", "overlap": 0, "start_pos": 200}, {"label_type": "手術", "overlap": 0, "start_pos": 229, "end_pos": 238}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 244, "end_pos": 249}]}
{"originalText": "，2010.10.27胃癌根治手術，，術後病理：全胃低分化腺癌，癌組織侵透肌層達周圍脂肪，切緣（-）,，LN:10/18,大網膜未見癌。介入6次，2011.11 腰肌轉移，化療9次（，第1週期：S-1,，第2週期：PTX+S-1;第3,4，週期：奧沙利鉑+S-1; ，第5週期：奧沙利鉑+希羅達；第6.7，週期：PTX+S-1；第8,9，週期：多西他賽).2012-8-1開始放療 5次，目前PET-CT提示腹腔播散轉移，右側豎脊肌不均質腫塊影較前增大。今為進一步診治入院。 食慾可，前段時間便血，現大小便正常，體重變化不大,2012.7.26第一次基因治療，未發熱;7月30熱療，8.2第二次注射發熱40度，8月6日。疼痛未加重 ,8.9第三次基因，10日熱療,2012.8.13熱療中,8.16四次基因治療，HER2+++建議內科會診化療靶向治療，頭暈好轉，疼痛減輕。2012.8.20腰疼腫塊縮小,2012.8.28放療20次，2012.9.3放療27次。", "entities": [{"end_pos": 17, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 81, "end_pos": 85}, {"end_pos": 100, "label_type": "藥物", "overlap": 0, "start_pos": 97}, {"end_pos": 110, "label_type": "藥物", "overlap": 0, "start_pos": 107}, {"end_pos": 114, "label_type": "藥物", "overlap": 0, "start_pos": 111}, {"end_pos": 127, "label_type": "藥物", "overlap": 0, "start_pos": 123}, {"end_pos": 131, "label_type": "藥物", "overlap": 0, "start_pos": 128}, {"end_pos": 143, "label_type": "藥物", "overlap": 0, "start_pos": 139}, {"end_pos": 147, "label_type": "藥物", "overlap": 0, "start_pos": 144}, {"end_pos": 159, "label_type": "藥物", "overlap": 0, "start_pos": 156}, {"end_pos": 163, "label_type": "藥物", "overlap": 0, "start_pos": 160}, {"end_pos": 176, "label_type": "藥物", "overlap": 0, "start_pos": 172}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 196, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 210}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 377, "label_type": "解剖部位", "overlap": 0, "start_pos": 376}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}]}
{"originalText": "，患者定期體檢，2012年4月體檢B超發現肝內佔位，5月8日，在我院查MRI提示：肝右葉佔位性病變，考慮肝癌可能性大,AFP 5303NG/ML,診斷“肝癌”，於2012-5-16於我院肝膽科行“解剖性右半肝切除+膽囊切除術”，，術後病理示：混合性肝細胞和膽管細胞癌（中-低分化）。術後於2012-6-28複查AFP降至29.07NG/ML。2012-07至08月患者在我科行CIK細胞免疫治療6程，過程順利。2012-08-31複查AFP為76.6NG/ML，，肝臟MR示：肝癌術後改變，未見明確復發徵象；肝S6 病灶，考慮海綿狀血管瘤；肝S8 囊腫。2012-09-20複查AFP升至61.9NG/ML，考慮腫瘤復發，遂於2012-09-24在我院肝膽科行局麻上TACE術，術中注入表阿黴素50MG，絲裂黴素6MG，洛鉑50MG，術程順利，術後恢復可。2012-11-28，複查MR示：切緣左旁肝S5新見結節，考慮復發。遂於2012-12-06在我院肝膽一區行肝臟腫瘤微波固化術，手術順利，術後恢復可。術後繼續行CIK細胞免疫治療。2013-11-6複查下腹MRI示切緣旁復發，於2013-11-22日我院肝膽外科行肝癌切除術，術程順利，術後病理示中分化肝細胞性肝癌。2013-12起繼續行CIK細胞免疫治療。2014-05-22我院複查MR提示肝S5、S6、S7、S8 多髮結節，考慮腫瘤復發。現為行進一步治療收入院。患者近期無腹痛、腹脹、噁心、嘔吐，無畏寒、無發熱、面板瘙癢等不適，精神可，食慾如常，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 17, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 35, "end_pos": 38}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 54}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 59, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 78}, {"label_type": "手術", "overlap": 0, "start_pos": 98, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 140}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 155, "end_pos": 158}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 232, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 242}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 269}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 270, "end_pos": 276}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 289, "end_pos": 292}, {"end_pos": 338, "label_type": "手術", "overlap": 0, "start_pos": 333}, {"end_pos": 347, "label_type": "藥物", "overlap": 0, "start_pos": 343}, {"end_pos": 356, "label_type": "藥物", "overlap": 0, "start_pos": 352}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 360}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 391, "end_pos": 393}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 402}, {"end_pos": 441, "label_type": "手術", "overlap": 0, "start_pos": 432}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 479, "end_pos": 484}, {"end_pos": 515, "label_type": "手術", "overlap": 0, "start_pos": 510}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 526, "end_pos": 535}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 571, "end_pos": 573}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 588}, {"end_pos": 618, "label_type": "解剖部位", "overlap": 0, "start_pos": 617}, {"end_pos": 621, "label_type": "解剖部位", "overlap": 0, "start_pos": 620}]}
{"originalText": "，2009.1.1醫腫胃癌根治術，術後即發現腹膜後LNM，DCF入組，PR後放療（末次化療2009.7，末次放療2009.8.31）。自2011.3 始CA199及CA242漸升高，多次複查CT胃鏡等（-），，2012-4-13：，CEA：11.81，，CA199：1723，，CA242:307.5。半年前覺背痛，2012.7.31胸CT左肺下葉6CM腫塊，左肺門及左鎖骨下及縱隔多發LN，氣管鏡（-），頭顱MRI（-)隆突上LN穿刺為低分化癌轉移，結合病史考慮胃癌轉移。2012-7-26，腫標：CEA 30，，CA199:3485，，CA724:19.56 CA242 325.2。，2012-8-9:胃鏡食管探查可見縱隔內龍突上低迴聲結節，，病理：（隆突上淋巴結）可見低分化癌轉移，，考慮胃癌轉移頸部B超：左頸根至鎖骨下淋巴結腫大，考慮轉移；右鎖骨下多發淋巴結。，2012-7-31：胸部CT示左下肺癌，左肺門縱隔及鎖骨下淋巴結轉移可能大，左側胸膜多髮結節，轉移可能大。。2012-8-3，支氣管鏡：未見明顯佔位性病變。2012-8-27開始行紫杉醇+順鉑化療，已完成3週期，自覺咳嗽、背痛症狀部分好轉，腫瘤評估提示左肺轉移及縱隔淋巴結均明顯縮小，判效PR，2012.11.9複查血常規正常。擬行明日化療。目前已完成四周期化療，腹瀉2度，持續4天，已恢復。複查判效。CA199 58.17U/L,CEA正常，腹部超聲提示左腎囊腫，胸部CT提示左肺病灶較前明顯縮小，肺門淋巴結縮小。2012.11.，29複查CA199:58.17U/ML,，CA242:37.29U/ML。 口服TS-1 3週期，無不良反應，無不適主訴，複查血常規、肝腎功能正常。2013.2複查腫瘤標誌物正常，胸部CT提示左肺轉移，今已行放療復位，4月2日開始放療，GTV60GY/30F,同時行替吉奧口服增敏。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 28}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 76, "end_pos": 81}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 95, "end_pos": 97}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 116, "end_pos": 119}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 127, "end_pos": 132}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 139, "end_pos": 144}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 167, "end_pos": 170}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 203, "end_pos": 208}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 232, "end_pos": 236}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 250, "end_pos": 256}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 258, "end_pos": 263}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 270, "end_pos": 275}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 281, "end_pos": 287}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 328, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 348, "end_pos": 352}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 352, "end_pos": 356}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 381}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 396, "end_pos": 400}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 401, "end_pos": 405}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 406, "end_pos": 420}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 427}, {"end_pos": 479, "label_type": "藥物", "overlap": 0, "start_pos": 476}, {"end_pos": 482, "label_type": "藥物", "overlap": 0, "start_pos": 480}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 497}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 512, "end_pos": 516}, {"end_pos": 522, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}, {"end_pos": 569, "label_type": "解剖部位", "overlap": 0, "start_pos": 568}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 587, "end_pos": 592}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 602, "end_pos": 605}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 614, "end_pos": 618}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 619, "end_pos": 623}, {"end_pos": 627, "label_type": "解剖部位", "overlap": 0, "start_pos": 625}, {"end_pos": 641, "label_type": "解剖部位", "overlap": 0, "start_pos": 636}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 657, "end_pos": 662}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 674, "end_pos": 679}, {"end_pos": 697, "label_type": "藥物", "overlap": 0, "start_pos": 693}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 743, "end_pos": 747}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 749, "end_pos": 753}, {"end_pos": 789, "label_type": "藥物", "overlap": 0, "start_pos": 786}]}
{"originalText": "，2007年3患者出現大便乾結，外院腹盆，CT：直腸側後壁管壁增厚，，超聲腸鏡提示：直腸距肛門3CM後壁可見3*4CM隆起，，超聲所見：病灶處可見低迴聲團塊，呈橢圓形，向腔內突出，起源於肌層，直腸腫物穿刺塗片考慮間葉來源腫瘤，可能為間質瘤，2007.3.12給予直腸腫物切除術，，術後病理：直腸梭形細胞腫瘤，最大徑6.5CM,核分裂>5/50HPF,低惡性度，術後未給予格列衛治療。\\U0004\\U0004 2012.9患者出現排便不成形，，在外院腸鏡：肛門3CM可見粘膜上隆起，大小2*2CM,超聲上見腫物起源於固有肌層，考慮間質瘤可能性大。未治療\\U0004\\U0004 2013.10.25患者出現腹脹，排便不成形，，超聲腸鏡：直腸後壁巨大分葉隆起病變，區域性糜爛，侵及肛管1/2，，超聲上：內部回聲不均勻，5*8CM考慮間質瘤，距肛門3CM.。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 18, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 26}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 116, "end_pos": 119}, {"end_pos": 138, "label_type": "手術", "overlap": 0, "start_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 153}, {"end_pos": 188, "label_type": "藥物", "overlap": 0, "start_pos": 185}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 264, "end_pos": 267}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 317, "end_pos": 319}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 344, "end_pos": 346}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 363, "end_pos": 366}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}]}
{"originalText": "，患者2月餘前無明顯誘因出現排便欠通暢，並有肛門堵塞感，無便血及肛門腫物脫出，為行治療於2017-06-19就診於我院肛腸科，，肛診見：截石位，肛門12點至5點位瘢痕組織，範圍約4CM×4CM，皮膚髮白，指診肛管1點位至7點位可觸及高低不平腫物隆起，質韌，固定，移動度差，無明顯觸痛，下界距肛門約4CM，退指指套無染血。，行肛周MR示：肛管右側壁異常改變；尾骨後方軟組織內異常訊號，考慮炎性改變；盆腔內略大淋巴結。患者後於2017.06.21，行電子結腸鏡檢查示：肛管腫物；取部分組織送病理，病理（201714160），示：（肛管）符合派傑氏病（PAGET'S病）；部分為大腸粘膜，呈水腫及慢性發炎，區域性粘膜糜爛。排除相關手術禁忌後，患者於2017.06.26 ，09:45在腰硬聯合麻醉上行直腸病損切除術。術後病理（，病理號：201714675），示：（肛管腫物）低分化腺癌，部分為印戒細胞癌，部分為粘液腺癌。術後應用頭孢替安及替硝唑控制區域性感染，應用核黃素補充能量、促進傷口癒合等綜合治療後，患者恢復可。後為行進一步治療轉入我科，排除相關放療禁忌後，於2017-07-18開始區域性放療，DT5000CGY/25F,放療過程順利，病情平穩出院。今患者為求進一步治療再次就診於我院，門診以“肛管惡性腫瘤”收入我科。  患者自發病以來神志清，精神、飲食好，夜間睡眠可，無發熱，二便未見明顯異常體重無明顯改變。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 104, "end_pos": 106}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 162, "end_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 170}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 178, "end_pos": 180}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 262, "end_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 288}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 353, "label_type": "手術", "overlap": 0, "start_pos": 346}, {"end_pos": 380, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 383, "end_pos": 388}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 392, "end_pos": 397}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 401, "end_pos": 405}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 410}, {"end_pos": 418, "label_type": "藥物", "overlap": 0, "start_pos": 415}, {"end_pos": 430, "label_type": "藥物", "overlap": 0, "start_pos": 427}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 545, "end_pos": 551}]}
{"originalText": "，2014.6體檢發現肝多發轉移，腸鏡提示乙狀結腸癌，2014.7.10行原發灶切除術，2014-8-6開始行7週期XELOX+BEV化療，2014-12-30複查腹部MRI提示肝臟病灶較前略縮小。胸部CR未見異常。治療期間神經炎2度。後換用希羅達+BEV維持治療7週期，末次化療時間2015-6-15，患者耐受性可。2015.5.11複查腫瘤標誌物提示CEA較前升高，2015.5.7複查MRI提示肝轉移變化不大。2015.7複查CEA較前增長，2015-7-6給予XELOX+BEV化療2CS。，2015-7-10盆腔MRI:乙狀結腸術後改變，區域性未見覆發徵象。化驗血常規、肝腎功指標正常。2015-07-15，腹腔MRI與2015-05-07腹部MR對比：肝臟多發轉移瘤較前略縮小。2015.9複查CT提示病灶穩定，2015.9.28換為BEV+XELODA維持治療至今。現患者精神食慾可，大小便正常，體重近期無變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 26}, {"end_pos": 67, "label_type": "藥物", "overlap": 0, "start_pos": 64}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 99, "end_pos": 103}, {"end_pos": 124, "label_type": "藥物", "overlap": 0, "start_pos": 121}, {"end_pos": 128, "label_type": "藥物", "overlap": 0, "start_pos": 125}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 177, "end_pos": 180}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 195, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"end_pos": 243, "label_type": "藥物", "overlap": 0, "start_pos": 240}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 265, "end_pos": 271}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 308, "end_pos": 313}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 324, "end_pos": 328}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 338}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 352, "end_pos": 354}, {"end_pos": 375, "label_type": "藥物", "overlap": 0, "start_pos": 372}, {"end_pos": 382, "label_type": "藥物", "overlap": 0, "start_pos": 376}]}
{"originalText": "，患者於2014年5月無意中出現吞嚥異物感，近幾月來出現吞嚥疼痛，無飲水嗆咳，無呼吸困難，無咳嗽、咳痰等不適。至當地行消炎治療，未見明顯緩解。2014-07-07，外院行病理活檢結果示：（左側口口咽部）非角化型鱗狀細胞癌。2014-07-11，我院病理會診示：中分化鱗狀細胞癌。2014-07-21，我院CT檢查結果示：左側扁桃體佔位，考慮扁桃體癌，侵犯左側舌根、部分舌體、軟顎、牙齦。兩頸IB 區、II 區、III區見多個淋巴結，部分稍大者不除外轉移。右側乳突炎。2014-07-25，我院胃鏡活檢病理：（末段食管、賁門、胃底腫物活檢）鏡檢為中分化鱗狀細胞癌。2014-07-29我院PET/，CT：左扁桃體病灶代謝活躍，符合中分化鱗癌；左頸II區數個淋巴結代謝活躍，考慮轉移；右頸II區淋巴結代謝較活躍，疑轉移。胸上段食管及胃賁門部病灶代謝活躍，符合中分化鱗癌；胃小彎側數個淋巴結代謝略活躍，考慮轉移。胸下段食管區域性代謝略活躍，惡性病變待排；右側氣管食管溝旁數個小淋巴結代謝略活躍，轉移待排。遂於2014-08-06、2014-08-27、2014-09-17行TPF方案化療3程，疾病進展，2014-10-29行吉西他濱+卡鉑化療1程，過程順利。現遵主診教授意見來我科行第3程化療，患者自發病以來，一般情況可，精神可，體重無明顯減輕，大小便正常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 138}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 152, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 167}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 174}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 189}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 227, "end_pos": 232}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 280}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 293, "end_pos": 300}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 314, "end_pos": 319}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 322}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 377, "end_pos": 382}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"end_pos": 408, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 423}, {"end_pos": 513, "label_type": "藥物", "overlap": 0, "start_pos": 509}, {"end_pos": 516, "label_type": "藥物", "overlap": 0, "start_pos": 514}]}
{"originalText": "，患者2011年05月於外院診斷為直腸癌肝轉移，並行直腸癌根治+肝轉移瘤切除術。術後病理具體不詳，術後於2011年06月至2011年11月行FOLFORI方案化療，共6療程。期間2011年7月行肝轉移瘤RFA術，2012年3月因肝內再次復發行RFA術，術後開始口服“希羅達”治療至今。2012年06月05日，在本院複查CT提示：肝S5.8 交界區病灶，較前為新發，考慮轉移瘤可能性大；肝S4 異常密度影，可疑轉移瘤。2012-7，我院CT示：肝S2.4.6.8低密度影，考慮為治療後改變。肝S8病灶，肝S5.8交界區病灶，肝S4異常密度影，較前無大改變。 2012-10，我院肝臟超聲造影：肝S2，S4，S8符合肝轉移瘤。肝S3病灶考慮治療後改變。，介入科會診意見：介入難以根治，，多學科討論後意見：先行全身化療。現為進一步治療入院。2012-10-27、2012-11-13、2012-12-11予FOLFOX化療3程。化療過程順利，無明顯腹痛、無腹脹、無噁心、無嘔吐、無畏寒、無發熱,患者精神尚可，食慾如常。大小便正常。體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 23}, {"label_type": "手術", "overlap": 0, "start_pos": 26, "end_pos": 39}, {"end_pos": 105, "label_type": "手術", "overlap": 0, "start_pos": 97}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 125, "label_type": "手術", "overlap": 0, "start_pos": 121}, {"end_pos": 136, "label_type": "藥物", "overlap": 0, "start_pos": 133}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 159, "end_pos": 161}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 217, "end_pos": 219}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 288, "end_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 304}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 310}, {"end_pos": 314, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"end_pos": 426, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}]}
{"originalText": "，2011-3因腹痛腹脹診為乙狀結腸癌卵巢佔位，2011-8-24行乙狀結腸癌根治、子宮兩附件切除術，結腸潰瘍型粘液腺癌，全層，系膜內癌結節，6/15，兩卵巢卵巢粘液腺癌。術後XELOX*6，至2012-5-11。5-30腹部CT提示大網膜、腸繫膜種植轉移，腹水，肝臟多發M。CEA 350NG/ML，CA 199 206.6U/ML，CA 724 2270U/ML，CA 242 115.73U/ML，HER-2+。2012-6-12給予FOLFIRI+貝伐*6，期間，CEA：318，，CA199：313，，CA125：100，，CA724：1648，6週期評效縮小SD。2012-09-10開始予以貝伐聯合氟尿嘧啶維持治療2週期，因鎖穿管脫出，擬調整為希羅達聯合貝伐珠單抗維持治療。\\U0004\\U0004 現飲食睡眠二便尚可，體重無變化。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"label_type": "手術", "overlap": 0, "start_pos": 34, "end_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 85}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 130}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 138, "end_pos": 141}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 151, "end_pos": 157}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 168, "end_pos": 174}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 184, "end_pos": 190}, {"end_pos": 230, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 236, "end_pos": 239}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 245, "end_pos": 250}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 256, "end_pos": 261}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 267, "end_pos": 272}, {"end_pos": 304, "label_type": "藥物", "overlap": 0, "start_pos": 302}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 306}, {"end_pos": 332, "label_type": "藥物", "overlap": 0, "start_pos": 329}, {"end_pos": 339, "label_type": "藥物", "overlap": 0, "start_pos": 334}]}
{"originalText": "，2011-11-1因頻發嘔吐就診，，行消化道造影：考慮小腸佔位，2011-11-1於我院行部分小腸切除術，，術後病理：小腸隆起型高中分化腺癌，3.5X2.5CM，侵透腸壁全層，未見脈管癌栓，淋巴結（4/15）,兩斷端（-）。2011-12開始奧沙利鉑+希羅達化療8週期，末次化療2012-5-7。後定期複查，影像學未見異常，術前，CEA:7NG/ML,2012-12 CEA開始逐漸升高，2013-4-2 ，CEA:38NG/ML,，CA199:120.2U/ML。，2013-2-22PET-CT:T11椎體低密度伴代謝增高（骨掃描傾向良性病變），兩肺多發小結節，磨玻璃小結節影，模糊類小結節。，小腸鏡：未見明確復發徵象。13.4.12，複查彩超：肝左葉結節無變化，肝S4偏強回聲，觀察。，2014-11-6腹盆CT：小腸及直腸術後改變較前相仿，兩側髂血管旁、腹股溝多發小淋巴結同前。，2014-11-10胸CT：兩肺未見新發結節及斑片影。腫標未見異常。繼續卡培他濱維持治療，複查CEA較前升高。昨日受涼後腹瀉,未予特殊治療,未發熱。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 20, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 30}, {"end_pos": 53, "label_type": "手術", "overlap": 0, "start_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"end_pos": 126, "label_type": "藥物", "overlap": 0, "start_pos": 122}, {"end_pos": 130, "label_type": "藥物", "overlap": 0, "start_pos": 127}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 166, "end_pos": 169}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 185, "end_pos": 188}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 205, "end_pos": 208}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 218, "end_pos": 223}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 244, "end_pos": 250}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"end_pos": 278, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 323, "end_pos": 325}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 356, "end_pos": 360}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 361, "end_pos": 368}, {"end_pos": 380, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 388}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 405, "end_pos": 408}, {"end_pos": 411, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 442, "end_pos": 445}, {"end_pos": 456, "label_type": "解剖部位", "overlap": 0, "start_pos": 455}]}
{"originalText": "左乳腺癌術後5年，骨、肝轉移2年。2009-11-26TXT+TSPA2週期，療效評價不明顯，改用TXT+DDP共用5週期，2週期評效PR，5週期評效維持PR。2010-6-30行兩側卵巢切除術，2010-7-14始服來曲唑至2011-11，複查PD。患者要求門診化療，給予GX方案（GEM 850MG/M2 1.6 D1,8, XELODA 1250MG/M2 2.0 BID D1-14)，因經濟困難，未行GX方案化療。於2011-11-22始給予XELODA 1250MG/M2 BID D1-14(2G BID) Q21D 7週期，末次化療時間：2012.04.17。2、4週期療效評價縮小的SD。6週期療效評效SD。擬繼續第8週期XELODA化療。\\U0004\\U0004  患者訴第7療程出現足底部面板淺皸裂，伴瘙癢，右足底為著。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 0, "end_pos": 6}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 14}, {"end_pos": 30, "label_type": "藥物", "overlap": 0, "start_pos": 27}, {"end_pos": 35, "label_type": "藥物", "overlap": 0, "start_pos": 31}, {"end_pos": 52, "label_type": "藥物", "overlap": 0, "start_pos": 49}, {"end_pos": 56, "label_type": "藥物", "overlap": 0, "start_pos": 53}, {"end_pos": 97, "label_type": "手術", "overlap": 0, "start_pos": 90}, {"end_pos": 112, "label_type": "藥物", "overlap": 0, "start_pos": 109}, {"end_pos": 145, "label_type": "藥物", "overlap": 0, "start_pos": 142}, {"end_pos": 171, "label_type": "藥物", "overlap": 0, "start_pos": 165}, {"end_pos": 232, "label_type": "藥物", "overlap": 0, "start_pos": 226}, {"end_pos": 326, "label_type": "藥物", "overlap": 0, "start_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 352, "end_pos": 354}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}]}
{"originalText": "，體檢提示(2015-11-16)AFP 17.34，CA199 114.1升高,後複查2015-11-23 AFP 19.69,CA199 122.6，2015-12-7 AFP 22.85。2015-12-3，行胃鏡檢查示：反流性食管炎，食管裂孔障礙，賁門炎（重度），賁門潰瘍，淺表性胃炎，，病理示：胃竇幽門型粘膜慢性炎，HP-。腸鏡未見異常。腹部，CT:肝左葉近肝區稍低密度影，局灶性脂肪肝可能，兩側少量胸腔積液。給予抑酸，保胃等治療。   2015-12-21 CA199 142.2，AFP 29.08。2015-12-26，超聲:肝門部可見多發低迴聲淋巴結，最大2.5X1.2CM。肝佔位，考慮MALIGNANT，肝門部多發淋巴結，M不除外。，2015-12-25胸部CT:縱隔多發淋巴結，兩側少量胸腔積液，建議追查。肝臟穿刺活檢示低分化腺癌，免疫組化示膽管癌可能性大。PET-CT示肝內膽管癌可能。2016-1-25行肝動脈泵植入術+1-27和3-1和3-28和4-30肝動脈化療（GP方案）4CS。2CS後評效示肝內病變縮小PR。4CS後PD。動脈化療AFP升高，CA199先降後升。2016-5-30~9-5行動脈化療（OXA+5FU）4CS。治療後AFP和CA199均明顯上降。2CS後評效肝大PR明顯縮小。AFP和CA199均降至正常。4CS後（2016-10-9）評效維持PR（繼續縮小）. 外科再次評估不能切除。停止動脈化療3個月，複查肝內病變進展（肝S8，肝門病變）。2016-12-27復位，計劃IGTV（S8病變及肝門病變）50GY/20F，建議同步口服化療。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 27, "end_pos": 32}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 55, "end_pos": 58}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 87, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 120}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 146}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 174, "end_pos": 179}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 205, "end_pos": 209}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 235, "end_pos": 240}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 247, "end_pos": 250}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 297, "end_pos": 298}, {"end_pos": 315, "label_type": "解剖部位", "overlap": 0, "start_pos": 313}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 338, "end_pos": 342}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 355, "end_pos": 359}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 372, "end_pos": 377}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 383, "end_pos": 386}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 391, "end_pos": 397}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 398, "end_pos": 403}, {"label_type": "手術", "overlap": 0, "start_pos": 416, "end_pos": 423}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"end_pos": 465, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 484, "end_pos": 487}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 490, "end_pos": 495}, {"end_pos": 522, "label_type": "藥物", "overlap": 0, "start_pos": 519}, {"end_pos": 526, "label_type": "藥物", "overlap": 0, "start_pos": 523}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 534, "end_pos": 537}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 538, "end_pos": 543}, {"end_pos": 556, "label_type": "解剖部位", "overlap": 0, "start_pos": 555}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 564, "end_pos": 567}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 568, "end_pos": 573}, {"end_pos": 632, "label_type": "解剖部位", "overlap": 0, "start_pos": 631}, {"end_pos": 641, "label_type": "解剖部位", "overlap": 0, "start_pos": 638}, {"end_pos": 644, "label_type": "解剖部位", "overlap": 0, "start_pos": 642}, {"end_pos": 670, "label_type": "解剖部位", "overlap": 0, "start_pos": 668}, {"end_pos": 675, "label_type": "解剖部位", "overlap": 0, "start_pos": 673}]}
{"originalText": "5+月前無誘因出現同房後陰道出血，量不多，未在意。3+月前單位體檢TCT提示HSIL，遂於外院行陰道鏡檢查及宮頸活檢，病理經我院會診提示CINIII，外院查HPV陽性。於2010-6-7行宮頸冷刀錐切術，術後病理：（宮頸1°5°6°8°9°10°11°12°）CIN3級，累及腺體；(宮頸2°) CIN2級；（宮頸7°）鱗狀下皮粘膜慢性炎；（宮頸3°4°）鱗狀下皮及柱狀下皮粘膜慢性炎；各內口及外口切緣淨。現要求切除子宮治療故收入院。飲食睡眠好，大/小便正常，體重無明顯減輕。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 42}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 74}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 78, "end_pos": 81}, {"end_pos": 101, "label_type": "手術", "overlap": 0, "start_pos": 94}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}]}
{"originalText": "，5年前出現血便，1年前出現進食後下腹不適。2013.8.16，我院腸鏡檢查提示：距肛門15CM乙狀結腸腺瘤，直徑約1.0CM，，活檢病理：乙狀結腸絨毛狀腺瘤（II級），2013.8.30給予腸鏡上腺瘤電切術。2013.26，我院胃鏡檢查提示：胃竇粘膜紅白相間，花斑樣改變，小片狀糜爛，，活檢病理：幽門型粘膜慢性萎縮性炎伴輕度腸化。2014.5.23行結腸鏡檢查後出現腹部不適，腹痛，自訴陰道有淡黃色糞便樣物流出，不伴發熱。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 84}, {"end_pos": 104, "label_type": "手術", "overlap": 0, "start_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 165}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}]}
{"originalText": "，2014.2診斷直腸癌肝轉移，術前予XELOX+BEV*2。2014年6月行直腸癌手術（本院）。2014-10-22、2014-11-14、2014-12-17行肝轉移介入治療。與 2015-02-17，腹部MRI比較：肝臟多發轉移較前增多，大部分增大，小部分略縮小，2015-11-18 TACE，治療後評效PD。2016.1開始行XELIRI+BEV*4，末次2016.02.29。化療期間消化道反應大，乏力，2016-3，本院複查： 肝臟多發多發轉移灶較前縮小。2016-3-21始希羅達+BEV，末次2016.6中。2016-5複查SD。2016.7.12複查肺部CT（-）；腹盆，CT：吻合口左前上方結節較前略增大，原約11X7MM，現約16*10MM。肝多發轉移轉移灶介入治療後，病灶內可見少許碘油沉積；肝臟多發轉移灶較前增大，S5段病灶較大層面原約50*33MM，現約62*38MM。 CEA 1224(2016-5 300)16-7-25至16-8-15 化療XELOX + BEV（500MG）*2.無明顯不良反應。複查CT提示病灶略增大，評估SD。腫瘤標誌物未查。16-9-12至16-10-10 化療XELOX + BEV（500MG）*2.無明顯不良反應。2016-10-29複查胸部CT未見轉移徵象；腹盆增強CT提示吻合口左前上方結節大致同前；肝臟多發多發轉移灶較前略增大，S5病灶原約65X43MM，現約68*43MM。CEA 1247；，CA199：3916。（2016.9.9 CEA 892.2 CA199 2766）2016-11-04 PLT 77 未處理,2016-12-02 PLT 50 給予巨和粒1支/日*3天，2016-12-06 PLT 49,治療後PLT 86。2016-11-7至2016-12-19 化療XELOX + 貝伐珠單抗（500MG）*2.無明顯不良反應。2016-12-26 總膽紅素 23.3μXXXMOL/L，門冬氨酸氨基轉移酶 52IU/L，丙氨酸氨基轉移酶 60IU/L2016-12-26 ，8:33 ，尿常規:尿蛋白 +-2016-12-2 CA72.4 11.94，NSE 34.36NG/ML，CEA 1660NG/ML2017.1.10，複查CT提示:肝臟多發多發轉移灶較前增大，S5病灶原約68X43MM，現約76X45MM（IM59）。左肺上葉背段小結節灶同前，約4X2MM。雙肺未見新發結節及實變影.2017-01-13 PLT 71 ALT 68 AST 58  CEA 23572017.2複查CEA繼續升高2017-1-23 行XELOX +貝伐珠單抗500MG治療，過程順利，無不良反應。2017-2-13 因病情進展行XILIRI+貝伐珠單抗治療500MG1週期。過程順利，無不良反應。2017-3-17 CEA 3039，CA199 6401，CA72-4 19.79，CA125 45.92，NSE 32.19。2017-3-17 TBIL 50.5，DBIL 26.2，IBIL 24.3，NSE 522017-3-20行XILIRI+貝伐珠單抗500MG治療,2017-4-10行XILIRI+貝伐珠單抗500MG治療,2017-3-27 TBIL 27.8，DBIL 17.9，IBIL 9.9，ALT 41，AST 59。WBC 3.33。2017-4-5 TBIL 23.2，DBIL 14.4，ALT 41，AST 59。WBC 3.08，，NEUT：1.87。，CEA：1969，，CA199:3700，，CA125:39.852017-04-17 TBIL 39.2，DBIL 21.2，ALT 36，AST 44。PLT 61。，CEA：2698，，CA199:5077，，CA125:45.322017-04-17 TBIL 21.7，DBIL 13.8，ALT 14，AST 31。PLT 127。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 15}, {"end_pos": 28, "label_type": "藥物", "overlap": 0, "start_pos": 25}, {"label_type": "手術", "overlap": 0, "start_pos": 39, "end_pos": 48}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 85}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 103, "end_pos": 108}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 117}, {"end_pos": 178, "label_type": "藥物", "overlap": 0, "start_pos": 175}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 248, "label_type": "藥物", "overlap": 0, "start_pos": 244}, {"end_pos": 252, "label_type": "藥物", "overlap": 0, "start_pos": 249}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 293, "end_pos": 298}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"end_pos": 361, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 400, "end_pos": 404}, {"end_pos": 450, "label_type": "藥物", "overlap": 0, "start_pos": 447}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 470, "end_pos": 472}, {"end_pos": 523, "label_type": "藥物", "overlap": 0, "start_pos": 520}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 553, "end_pos": 557}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 564, "end_pos": 570}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 572, "end_pos": 575}, {"end_pos": 588, "label_type": "解剖部位", "overlap": 0, "start_pos": 586}, {"end_pos": 603, "label_type": "解剖部位", "overlap": 0, "start_pos": 601}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 625, "end_pos": 628}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 635, "end_pos": 640}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 655, "end_pos": 660}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 665, "end_pos": 671}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 687, "end_pos": 691}, {"end_pos": 722, "label_type": "藥物", "overlap": 0, "start_pos": 719}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 741, "end_pos": 744}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 751, "end_pos": 755}, {"end_pos": 794, "label_type": "解剖部位", "overlap": 0, "start_pos": 789}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 822, "end_pos": 827}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 842, "end_pos": 852}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 859, "end_pos": 867}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 896, "end_pos": 899}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 911, "end_pos": 918}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 925, "end_pos": 928}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 940, "end_pos": 943}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 965, "end_pos": 967}, {"end_pos": 972, "label_type": "解剖部位", "overlap": 0, "start_pos": 970}, {"end_pos": 986, "label_type": "解剖部位", "overlap": 0, "start_pos": 984}, {"end_pos": 1020, "label_type": "解剖部位", "overlap": 0, "start_pos": 1014}, {"end_pos": 1036, "label_type": "解剖部位", "overlap": 0, "start_pos": 1034}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1058, "end_pos": 1061}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1065, "end_pos": 1068}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1072, "end_pos": 1075}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1080, "end_pos": 1083}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1096, "end_pos": 1099}, {"end_pos": 1126, "label_type": "藥物", "overlap": 0, "start_pos": 1121}, {"end_pos": 1173, "label_type": "藥物", "overlap": 0, "start_pos": 1168}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1204, "end_pos": 1208}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1214, "end_pos": 1219}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1225, "end_pos": 1231}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1238, "end_pos": 1243}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1250, "end_pos": 1254}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1270, "end_pos": 1274}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1280, "end_pos": 1284}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1290, "end_pos": 1294}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1300, "end_pos": 1303}, {"end_pos": 1328, "label_type": "藥物", "overlap": 0, "start_pos": 1323}, {"end_pos": 1358, "label_type": "藥物", "overlap": 0, "start_pos": 1353}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1376, "end_pos": 1380}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1386, "end_pos": 1390}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1396, "end_pos": 1401}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1405, "end_pos": 1408}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1412, "end_pos": 1415}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1419, "end_pos": 1422}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1437, "end_pos": 1441}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1447, "end_pos": 1451}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1457, "end_pos": 1461}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1464, "end_pos": 1467}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1471, "end_pos": 1474}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1481, "end_pos": 1485}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1492, "end_pos": 1495}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1502, "end_pos": 1507}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1514, "end_pos": 1519}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1536, "end_pos": 1540}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1546, "end_pos": 1550}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1556, "end_pos": 1559}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1563, "end_pos": 1566}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1570, "end_pos": 1573}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1578, "end_pos": 1581}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1588, "end_pos": 1593}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1600, "end_pos": 1605}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1622, "end_pos": 1626}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1632, "end_pos": 1637}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1642, "end_pos": 1646}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1649, "end_pos": 1653}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1656, "end_pos": 1659}]}
{"originalText": "，CA199升高，，2016-2-18盆腔CT：右附件佔位4.7*4.2CM。，CA199：611.2U/ML。，CA125:91U/ML。月經7天/23天，量中。盆腹，CT：未見異常。，CA199:51.53U/ML。，CA125:44.57U/ML。盆腔，MRI：右側卵巢佔位，考慮內膜異位症合併軟組織成分待除外腫瘤（參閱2016-2-18外院CT報告，此佔位增長不明顯）。無不規則出血。無不適。3-6卵巢癌分期術，術後恢復好，偶有腹痛，便祕。陰道少量流液，約1CM大小衛生巾。，術後病理:(全子宮+兩附件），切除： - 子宮中分化子宮內膜樣腺癌，周圍子宮內膜呈增生改變； - 癌浸潤肌層（<1/2肌層）； - 未見脈管癌栓； - 右左宮旁、大網膜未見癌； - 宮頸粘膜慢性炎； - 右卵巢中分化子宮內膜樣腺癌； - 兩側輸卵管，左側卵巢未見癌； - 闌尾慢性炎； - 淋巴結未見癌轉移（腹主動脈左旁0/2，腹主動脈右旁0/4，左側髂總髂外0/4，左側腹股溝深0/1，左側髂內閉孔0/2，右側髂總髂外0/2，右側腹股溝深0/0，右側髂內閉孔0/6）。於2017-3-31、4-25、5-17、2017-6-7行紫杉醇+卡鉑方案化療。化驗大致正常.2017-6-28再次化療。今日化療前檢查結果大致正常.。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1, "end_pos": 6}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 19, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 40, "end_pos": 45}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 57, "end_pos": 62}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 94, "end_pos": 99}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 111, "end_pos": 116}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 127, "end_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 148}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 174, "end_pos": 176}, {"end_pos": 209, "label_type": "手術", "overlap": 0, "start_pos": 203}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 275}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 278, "end_pos": 280}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 332, "end_pos": 335}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 357}, {"end_pos": 366, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"end_pos": 371, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 378, "end_pos": 383}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 396}, {"end_pos": 410, "label_type": "解剖部位", "overlap": 0, "start_pos": 406}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"end_pos": 431, "label_type": "解剖部位", "overlap": 0, "start_pos": 426}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 436}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"end_pos": 472, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 507}, {"end_pos": 513, "label_type": "解剖部位", "overlap": 0, "start_pos": 511}]}
{"originalText": "，患者4個月前因“腹痛2天，加重半天”就診我科，於2012-10-15全子宮兩附件大網膜闌尾切除、腹壁病灶切除術，，術中見：盆腹腔無液體。肝脾胃未及病灶；腸管表面及腸繫膜可見散在小的粟粒結節。子宮常大，子宮膀胱反折腹膜明顯癌樣增厚，與子宮前壁粘連。子宮後壁與腸管前壁粘連。左卵巢瘤手拳大，與闊韌帶後葉及腸管粘連，右卵巢雞卵大，與周圍組織粘連，大網膜末端增厚，可見癌灶，左側腹壁穿刺點病灶大小4-5CM，侵及腹膜，未達肌層，與大網膜末端病灶緻密粘連。手術順利，病理回報（Z0442250），：C 宮壁內見腺樣癌巢 DE 卵巢漿液性囊腺癌（中分化） F 囊壁組織內見腺樣癌巢 G 網膜組織內見腺樣癌巢 H 闌尾漿膜面見腺樣癌巢。，出院診斷：卵巢漿液性囊腺癌（中分化）IIIｃ期（兩側卵巢、大網膜、盆腔腹膜、腸繫膜、闌尾）2次化療後1個月。患者術前行多西他賽+卡鉑方案化療2次，術後化療2次，末次化療時間2012-11-26，現為求補充治療入我科。出院至今化療副反應輕微，無頭暈頭迷，無噁心嘔吐，無腹脹腹瀉，大小便正常，飲食睡眠可，近期無明顯體重變化。\\U0004高血壓病史5年。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 56}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 103, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 126}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 152}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 186, "end_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 259, "end_pos": 272}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 301, "end_pos": 303}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 318, "end_pos": 336}, {"end_pos": 341, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 346, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 348, "end_pos": 349}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 351, "end_pos": 352}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 372}, {"end_pos": 379, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 437, "label_type": "解剖部位", "overlap": 0, "start_pos": 436}, {"end_pos": 447, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 479, "end_pos": 482}]}
{"originalText": "2013年4月7日患者因發現胰腺佔位3天入我院，4月10日在全麻上行胰十二指腸聯合切除術。術後病理：胰腺中分化腺癌伴粘液腺癌，累及胰腺周圍脂肪組織及神經組織，有脈管癌栓，胰腺周圍淋巴結癌轉移3/6，術後病理分期PT3N1。患者恢復順利，術後行輔助化療4週期，方案為健擇聯合替吉奧，複查提示CEA升高，行CT檢查未見明顯異常，繼續化療2週期，再次複查CEA繼續升高至17NG/ML，複查CT未見明顯異常，與家屬溝通後，現為行第7次化療入院，自發病以來，患者精神可，小便可，大便可，飲食可，睡眠可。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 85, "end_pos": 87}, {"end_pos": 134, "label_type": "藥物", "overlap": 0, "start_pos": 132}, {"end_pos": 139, "label_type": "藥物", "overlap": 0, "start_pos": 136}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 144, "end_pos": 147}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 174, "end_pos": 177}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 192, "end_pos": 194}]}
{"originalText": "，患者7月餘前無明顯誘因出現粘液便血，暗紅色，量少，伴大便次數增加至5-8次/天，稀爛，無腹痛、噁心、發熱等不適。外院腸鏡檢查提示距肛門6-10CM腫物，腸鏡能透過，活檢病理為腺癌。，我院03-16日超聲腸鏡提示：距肛門約3.5-10CM直腸見環周隆起潰瘍型腫物，管腔狹窄，內鏡勉強透過，累及外膜層及周圍脂肪結締組織。腫物與前列腺及精囊腺分界尚清，直腸旁見雙枚腫大淋巴結低迴聲，橢圓形，較大約11.6MMX8.5MM,均質，界清,未見淋巴結結構。03-21日CT，示：左肺中葉外側段、左肺斜裂胸膜上小結節，增殖灶可能性大，不排除轉移。MR，提示：直腸中下段腸壁不規則增厚，符合直腸癌（T3N2），環周切緣小於2MM；直腸周圍系膜內、骶前多發淋巴結，考慮淋巴結轉移可能性大。擬診斷為直腸癌CT3N2MX,為區域性晚期，不除外肺轉移。我科***教授會診後擬行同期放化療。遂於216-03-31、2016-4-21、2016-5-12行XELOX方案化療3程，療程順利，2016-04-22，至2016-5-26採用VMAT技術：GTV 50GY/25F，CTV 46GY/25F。現為上一步化療特來我院。自下次出院以來，患者精神、睡眠、胃納可，二便如常，體重無明顯上降。", "entities": [{"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 229, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 238}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 244}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 267, "end_pos": 269}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 288, "end_pos": 297}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 310}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 350}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 363}, {"end_pos": 516, "label_type": "解剖部位", "overlap": 0, "start_pos": 515}]}
{"originalText": "，1月前無明顯誘因出現腹瀉稀薄便，便末帶少量鮮血，下午為著，日4-5次，裡急後重感明顯，無腹痛，無噁心嘔吐，無“痔瘡”病史，2012-7-9，我院門診腸鏡示：距肛門8-12CM直腸見菜花樣腫物，病變累及1/2圈，，活檢病理示：中分化腺癌；2012-7-11，盆腔MRI提示：直腸中下段佔位，考慮直腸癌，侵透漿膜；直腸繫膜、直腸下動脈旁、兩側髂血管旁多發淋巴結，轉移可能大。，胸部CT示：兩肺多髮結節結節灶，考慮轉移可能大，右上肺原發灶不能除外；肝臟多發低密度灶，考慮囊腫。，CEA:18.82NG/ML,餘正常，患者為進一步治療入院，現患者飲食可，大便稀薄便，便末少量帶鮮血，日4-5次，小便無明顯異常，睡眠可，體重無增減。", "entities": [{"end_pos": 12, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 58}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 118}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 129, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 139}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 173}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 187, "end_pos": 191}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 237, "end_pos": 240}]}
{"originalText": "，患者2015-03-31因“黑便半年”就診於我院結直腸科，2015-03-31，腹盆MR示：升結腸腫物，考慮為升結腸癌；升結腸系膜多發淋巴結，考慮轉移，遂2015-04-09行全麻上“腹腔鏡左半結腸切除術”，過程順利，，術後病理示：符合中分化腺癌，浸潤至腸壁漿膜上層，可見脈管內癌栓，未見明確神經束侵犯；淋巴結（2/23）可見癌轉移，，分期為：PT3N1BM0 IIIB期，術後恢復可。2015-05-13、2015-06-03、2015-06-28、2015-07-20、2015-08-13、2015-09-09起行XELOX方案化療6程，過程順利。5程化療後出現II度白細胞減少，予升白治療後恢復。期間3程化療後於2015-07-15行胸腹盆CT複查未見腫瘤復發轉移徵象。現為行第7程XELOX方案輔助化療入我科。患者3周來，無發熱，胃納可，睡眠一般，大小便正常，體重無明顯上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 41, "end_pos": 45}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 60}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 64}, {"end_pos": 103, "label_type": "手術", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 129}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 288, "end_pos": 291}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 322, "end_pos": 327}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 371, "end_pos": 372}]}
{"originalText": "，2009-1於（右乳癌）行改良根治術，2011-1行左乳癌手術。複查門脈與上腔靜脈之間可見低迴聲淋巴結2.8*1.4CM，全面複查，*左肩X片，胸椎正側位，建議患者拿病，腹部MRI檢查。已行卵巢切除。2013-6-3，查腹部增強MRI示：肝S6、S7多髮結節，考慮轉移可能大，門腔間隙腫大淋巴結，考慮轉移，腰椎及骨盆骨轉移可能，建議骨掃描。患者入組帕妥珠單抗臨床試驗，2013.7.18開始第一週期治療。患者化療後出現感冒樣症狀，昨日出現頭痛，今日查血常規提示II度骨髓抑制，白細胞2.57，中性粒細胞1.29.無腹痛、腹瀉及其他不適。患者已行三週期化療，行評效檢查，今日查血常規結果提示III度骨髓抑制，NE1.0，升白治療中。2013.9.19行第四周期化療，化療後骨髓抑制I度，經升白治療後好轉，2013.10.10行第五週期化療，化療後無特殊不適，2013.11.1給予第6週期化療，後評效檢查維持PR，2013.11.22給予第七週期化療，化療後無特殊不適。2013.12.13給予第8週期化療。患者手足綜合徵II度。2014.1.24給予第10週期化療。2014.3.7第12週期化療,化療後患者臉腫,其他好,評效和繼續靶向治療.2014.4.2就診，化療減量240MG。繼續靶向。，患者化療18週期後評效檢查:，心臟超聲：二、三尖瓣少量返流；，2014-7-30腹部CT:較前相仿；2014.9.17完成第21週期治療，評效檢查。2014.11.21完成24週期治療，預約評效。2015.1.26完成第28週期化療。2015.8.25 C37治療，C39評效維持PR，2015-12-10 C42治療，C42評效維持PR,C48評效維持PR，2016-5-11行C49，6-23行C51,7-14行C52.10-8行C55。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 27, "end_pos": 30}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 68, "end_pos": 72}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 73, "end_pos": 78}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 86, "end_pos": 91}, {"label_type": "手術", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 162}, {"end_pos": 180, "label_type": "藥物", "overlap": 0, "start_pos": 175}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 238}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 239, "end_pos": 242}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 247, "end_pos": 252}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 262, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 303}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 336, "end_pos": 340}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 456, "end_pos": 461}, {"end_pos": 574, "label_type": "解剖部位", "overlap": 0, "start_pos": 569}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 589, "end_pos": 593}]}
{"originalText": "患者於2016-08下旬，無明顯誘因出現下腹痛，以右下腹為主，晚餐進食後明顯，與呼吸、運動無明顯關係，無放射痛，伴食慾減退，無吞嚥梗阻，無噁心嘔吐，無嘔血黑便，感疲乏困倦，有全身面板瘙癢，未見皮疹，無畏寒發熱，無盜汗，於2016-08底至2016-09初在當地診所予“嗎丁啉，1粒，BID；藿安正氣丸，1粒，BID”口服10天，下述症狀有所改善；患者停藥後，下述症狀再次出現，在當地擬診為“胃潰瘍”，自10.9-10.17予“替普瑞酮，1粒，TID；冸托拉唑，2粒，QD；蒲元和胃膠囊，4粒，BID”護胃治療，腹痛可有所改善，但仍反覆發作，患者遂於2016-11初來我院就診，完善電子胃鏡示胃體、胃竇多發潰瘍，考慮淋巴瘤可能性大，HP（2+）；行病理活檢後回報示瀰漫大B細胞性淋巴瘤，GCB型，PET-CT示胃壁部規則增厚代謝活躍，符合淋巴瘤；全身骨髓代謝較活躍，浸潤待排；骨髓結果回報示：1.骨髓增生活躍,塗片未見淋巴瘤細胞侵犯骨髓.2.巨系血小板形成過多,但形態未見明顯異常。2016-12-23予R-CHOP方案化療1程。化療後出現1度骨髓抑制（WBC3.1*10^9/L）,現為為行進一步治療收住我科擬行化療。近期患者精神可，無明顯腹痛，胃納改善，無發熱、盜汗、無頭暈、頭痛，無噁心、嘔吐，無胸悶、心悸。精神、食慾欠佳，睡眠欠佳。大小便正常。體重上降2KG。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 20}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 137, "label_type": "藥物", "overlap": 0, "start_pos": 134}, {"end_pos": 150, "label_type": "藥物", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 198}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 213}, {"end_pos": 229, "label_type": "藥物", "overlap": 0, "start_pos": 225}, {"end_pos": 242, "label_type": "藥物", "overlap": 0, "start_pos": 236}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 295, "end_pos": 304}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 341}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 347, "end_pos": 353}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 354, "end_pos": 355}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 368, "end_pos": 371}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 374, "end_pos": 376}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 408, "end_pos": 411}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 471, "end_pos": 475}, {"end_pos": 521, "label_type": "解剖部位", "overlap": 0, "start_pos": 520}, {"end_pos": 524, "label_type": "解剖部位", "overlap": 0, "start_pos": 523}, {"end_pos": 537, "label_type": "解剖部位", "overlap": 0, "start_pos": 536}, {"end_pos": 540, "label_type": "解剖部位", "overlap": 0, "start_pos": 539}, {"end_pos": 551, "label_type": "解剖部位", "overlap": 0, "start_pos": 550}, {"end_pos": 554, "label_type": "解剖部位", "overlap": 0, "start_pos": 553}]}
{"originalText": "，因下腹部痛行胃鏡提示：胃竇巨大潰瘍，病理示中分化腺癌。，腹部CT提示：肝臟實性佔位。腹腔淋巴結腫大，考慮轉移。CEA 101。2015-4-27 入組HELOISE，行XP+赫賽汀*4,，末次：2015-6-29；PD。入組吡咯替尼治療。2016-02-25 ，15:，27:07  ，CT:468437,對比2015-12-25腹盆CT比較，，較前進展：1.胃竇部胃壁不規則增厚，較前加重，較厚處現約55MM（IM75），表面潰瘍同前，與胃周淋巴結部分融合；病變向下累及胃角、與正常胃壁分界不清同前，漿膜面模糊；胃壁後方區域性與胰腺脂肪間隙消失；肝胃韌帶密度增高，多發索條影同前相仿。腹腔及腹膜後多發淋巴結，較前增大、增多，如原約37X23MM，現約42X40MM（IM75），大網膜略增厚加重。少量盆腔積液徵象。2.肝多發轉移灶，較前增大、增多，如原約102X77MM，現約133X105MM（IM59）。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 2}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 29, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 38}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 56, "end_pos": 60}, {"end_pos": 91, "label_type": "藥物", "overlap": 0, "start_pos": 88}, {"end_pos": 117, "label_type": "藥物", "overlap": 0, "start_pos": 113}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 144, "end_pos": 146}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 166, "end_pos": 170}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 185}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 243, "end_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 258, "end_pos": 259}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 278, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 295, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 296, "end_pos": 297}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 351, "end_pos": 355}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 365}]}
{"originalText": "2015-11自及左腹股溝腫物，當地穿刺病理提示反應性增生，其後發現左髂外佔位，PETCT提示惡性。2016-4-7當地骨科腹膜外左髂窩佔位活檢，病理經我院會診提示轉移性腺癌。CK7-,CK20-。當地TCT及HPV無異常。無陰道異常出血或排液。CEA、CA199及CA72.4升高。我院複查PET/CT仍未發現原發灶。2016-5-16我院婦科手術，大網膜\\\\左側結腸旁溝腹膜活檢\\\\左附件\\\\左側盆腔淋巴結\\\\右側結腸旁溝腹膜\\\\後陷凹腹膜\\\\闌尾\\\\胃壁外生性結節\\\\全子宮+右附件手術切除，結合外院及本院免疫組化結果符合淋巴結轉移性低分化腺癌，腫瘤細胞分化差，考慮原發病灶不明的轉移性低分化腺癌。2016-6-14開始放療：CTV(盆腔引流區+左腹股溝淋巴結) 45GY/25F。放療20次，左腹股溝區壓痛。2016-6-21TP方案化療，紫杉醇過敏（顏面部水腫），停用，2016-6-22改用培美曲賽化療.無噁心嘔吐,腹瀉明顯,5-6次/日。2016-7-14多西他賽+DDP。2016-8-18我科行多西他賽+伯爾定化療1療程，化療後無不適。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 40, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 123, "end_pos": 126}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 127, "end_pos": 132}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 133, "end_pos": 139}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 146, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 187}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 209, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 229}, {"label_type": "手術", "overlap": 0, "start_pos": 237, "end_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 264, "end_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 293, "end_pos": 301}, {"end_pos": 322, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}, {"end_pos": 377, "label_type": "藥物", "overlap": 0, "start_pos": 374}, {"end_pos": 405, "label_type": "藥物", "overlap": 0, "start_pos": 401}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}, {"end_pos": 439, "label_type": "藥物", "overlap": 0, "start_pos": 435}, {"end_pos": 443, "label_type": "藥物", "overlap": 0, "start_pos": 440}, {"end_pos": 460, "label_type": "藥物", "overlap": 0, "start_pos": 456}, {"end_pos": 464, "label_type": "藥物", "overlap": 0, "start_pos": 461}]}
{"originalText": "體檢發現宮頸病變2月，HPV(+),HSIL，宮頸活檢提示局灶可疑早期浸潤。我院病理會診提示宮頸鏡上微小浸潤癌。平時白帶無明顯異常，無同房出血。近來經前及經後陰道少許淋漓出血。2015-9-7宮頸冷刀錐切，術後病理7°XXX8°XXXG2鱗癌。術後陰道出血不多，月經來潮1次，LMP2015-9-20右左，正常。2015-11-2行腹腔鏡宮頸癌根治術,術後病理未及癌殘餘，淋巴結未及轉移。排尿可。陰道分泌物不多。大便乾燥，偶有服藥及區域性開塞露治療，近來未特殊處理，可自行排大便。無兩上肢浮腫。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 18, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 25}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 102, "label_type": "手術", "overlap": 0, "start_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "手術", "overlap": 0, "start_pos": 166, "end_pos": 175}, {"end_pos": 221, "label_type": "藥物", "overlap": 0, "start_pos": 218}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}]}
{"originalText": "，患者於今年9月因“絕經後陰道出血”，在******健院行宮頸活檢示：（宮頸）惡性腫瘤，符合腺癌。，查HPV示：未發現人乳頭瘤病毒感染。遂轉診我院，行病理會診（H147151）（宮頸）病變符合低分化腺癌。，查CT示：宮頸腫塊，符合宮頸癌；少量盆腔積液；雙側宮旁未見明顯腫大淋巴結；肝S2囊腫；右腎小囊腫； 左前心膈角、腹主動脈旁淋巴結稍大；兩上肺慢性炎症、墜積性改變。 擬“宮頸腺癌IB1期”於2014年12月9日行\\\"腹腔鏡上探查+開腹全子宮兩附件切除+大網膜切除術\\\"。術中見子宮形狀規則，大小6*5*4CM，形態無異常，右卵巢肉眼觀無明顯異常，右輸卵管輸卵管壺腹部見大小4*3*3CM菜花狀腫物，左附件肉眼觀無明顯異常，大網膜見一大小6*5*4CM腫物，乙狀結腸前壁、直腸前壁、膀胱後壁、直腸窩及部分腸繫膜表面見直徑0.2-1CM不等種植結節。，術後剖視標本：子宮大小6*5*4CM，內膜未見明顯病變，宮頸糜爛狀，右輸卵管輸卵管壺腹部4*3*3CM大小菜花狀腫物，質脆。術程順利，術後予防感染、補液治療。 ，術後病理示：（直腸表面結節），鏡上：纖維結締組織中見高級別漿液性癌浸潤。（腸表面結節）鏡上為脂肪結締組織，未見癌。（子宮+右附件），鏡上：輸卵管及卵巢組織中見癌組織呈片狀或乳頭狀生長，細胞有異型，核分裂像易見，結合免疫組化結果，符合高級別漿液性癌，另於宮頸外膜及宮頸漿膜層中見高級別漿液性癌浸潤；宮頸粘膜慢性炎；子宮平滑肌瘤；萎縮性宮內膜。（左附件），鏡上：輸卵管及卵巢組織中見高級別漿液性癌浸潤。（大網膜），鏡上：脂肪結締組織中見高級別漿液性癌浸潤。（乙狀結腸腸脂垂），鏡上：脂肪結締組織中見高級別漿液性癌浸潤。，診斷：右輸卵管輸卵管漿液性腺癌IIIC期。於2014-12-15、2015-01-06、2015-02-03及2015-02-26予TC方案（泰素210MG+卡鉑500MG）化療4程，過程順利。出院後定期複查血常規無異常。今為行上一程化療入住我科。今患者精神、胃納、睡眠可，大小便正常，近期體重無明顯減輕。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 43}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 48}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 51, "end_pos": 54}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 101}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 104, "end_pos": 106}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 151}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 195}, {"label_type": "手術", "overlap": 0, "start_pos": 210, "end_pos": 234}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 330, "end_pos": 334}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 339}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 342, "end_pos": 344}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 353, "end_pos": 354}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}, {"end_pos": 466, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}, {"end_pos": 517, "label_type": "解剖部位", "overlap": 0, "start_pos": 515}, {"end_pos": 521, "label_type": "解剖部位", "overlap": 0, "start_pos": 518}, {"end_pos": 529, "label_type": "解剖部位", "overlap": 0, "start_pos": 526}, {"end_pos": 532, "label_type": "解剖部位", "overlap": 0, "start_pos": 530}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 576, "end_pos": 580}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 583, "end_pos": 585}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 590}, {"end_pos": 607, "label_type": "解剖部位", "overlap": 0, "start_pos": 605}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 613, "end_pos": 619}, {"end_pos": 631, "label_type": "解剖部位", "overlap": 0, "start_pos": 628}, {"end_pos": 639, "label_type": "解剖部位", "overlap": 0, "start_pos": 636}, {"end_pos": 642, "label_type": "解剖部位", "overlap": 0, "start_pos": 640}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 684, "end_pos": 691}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 718, "end_pos": 735}, {"end_pos": 788, "label_type": "藥物", "overlap": 0, "start_pos": 786}, {"end_pos": 796, "label_type": "藥物", "overlap": 0, "start_pos": 794}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 845, "end_pos": 846}]}
{"originalText": "，患者於4個月（2014-1）前無明顯誘因出現右上腹疼痛症狀，間歇性痛，大便前及排氣前疼痛，大便後及排氣後疼痛緩解，伴裡急後重感，無腹脹，無肛周疼痛，無噁心嘔吐。並出現黑便，便細，1次/天，無便血。患者自述曾經平臥位時可觸及右上腹腫塊。，後就診於****行腸鏡提示：距肛門30CM見一隆起性病變，環腸壁3/4，表面凹凸不平，有糜爛、破潰及出血。，病理診斷：結腸鋸齒狀腺瘤，結腸腺癌（中分化）。，全腹增強CT提示：腸腔佔位性病變。3個月前（2014-3-12）於全麻上行D3直腸癌前切除術。，術後病理：，浸潤深度：SS。，進展期直腸癌：浸潤潰瘍型，中分化管狀腺癌，斷端無癌，淋巴結未見轉移癌（0/32枚），DUKES“B”期。（，病理號：164000）。1月餘前於（2014-4）行XELOX方案化療2週期，，具體為：奧沙利鉑（艾恆）200毫克D1，卡培他濱（希羅達）1.5，日2次D1-14。病人為求進一步診治入我科，自病來無發熱，精神、睡眠尚可，飲食尚可，小便如常，大便如前所述，體重未見明顯改變。 近1個月患者血壓值偏高，最高值達160/90MMHG，自服絡活喜降壓藥物。", "entities": [{"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 150}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 195}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 197, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 206, "end_pos": 207}, {"end_pos": 243, "label_type": "手術", "overlap": 0, "start_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 260, "end_pos": 280}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 358}, {"end_pos": 365, "label_type": "藥物", "overlap": 0, "start_pos": 363}, {"end_pos": 378, "label_type": "藥物", "overlap": 0, "start_pos": 374}, {"end_pos": 382, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"end_pos": 483, "label_type": "藥物", "overlap": 0, "start_pos": 480}]}
{"originalText": "3月前因便祕，發現直腸腫物,MRI示直腸中上段腫物。行腸鏡上穿刺檢查，病理結果示直腸上段中分化腺癌伴粘液分泌，乙狀結腸腺瘤。盆腔CT示直腸上段佔位，肛提肌受累不除外，直腸腸周及直腸下動脈走行區見多發腫大淋巴結。腹部MR示肝內多發低密度密度結節。胸部CT掃面未見佔位徵象,完善分期檢查，CT4AN2A，現為行術前放化療。放療計劃：GTV50.6GY/CTV41.8GY/22F，3-2放療結束。現患者已放療後3月。患者訴拒絕腸造口。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 20}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 61}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 62, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 69}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 85}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 105, "end_pos": 109}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 212}]}
{"originalText": "，患者2012.01因宮頸癌2程化療後27天入院，2012.01.29在氣管內吸入麻醉行宮頸癌根治術+兩側輸卵管切除術+兩側卵巢懸吊術。，病理結果：宮頸粘膜見潰瘍形成，伴有組織細胞增生，多點區域見CINIII累及腺體，未見明確間質浸潤；子宮平滑肌瘤；增殖期子宮內膜。盆腔淋巴結未見癌，兩側輸卵管粘膜慢性炎。2月6日予艾素110MG、DDP110MG（分D1-D3）化療。之後定期複查，於2013.01.21複查發現陰道殘端贅生物，，行活檢病理示：符合乳頭狀鱗狀細胞癌，因腫瘤以外生性生長為主，未見明確間質浸潤，今為求進一步放療來我科就診。患者發病以來飲食睡眠尚可,大小便正常，體重無減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"label_type": "手術", "overlap": 0, "start_pos": 44, "end_pos": 67}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 98, "end_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 130}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 160, "label_type": "藥物", "overlap": 0, "start_pos": 158}, {"end_pos": 169, "label_type": "藥物", "overlap": 0, "start_pos": 166}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 233}]}
{"originalText": "，於3年前行直腸癌LAR術，PT4AN1M0, 術後行FOLFOX6化療*12\\U0004\\U0004 2011.3氣短，兩肺M，KRAS WT,CEA化療前5.97，2011-3-23開始XELOX化療4週期,複查縮小SD,氣短減輕。膽紅素2度升高，停止OXA（2011-6中旬），化療延遲2周餘，胸悶略有加重，CEA 6.9。 \\U0004\\U0004 2011.6.29繼續XELODA，服藥期間覺胸悶好轉，停藥的1周內覺氣短。，2012-1-10CT:肺病灶增大SD，因XELODA控制症狀尚可,繼服1週期後,胸悶加重,CEA 5.4.\\U0004\\U0004  2012-2-6起行XELOX6週期，耐受好，胸悶明顯好轉, ，3週期後CT：SD（略增大），但CEA穩定，症狀獲益，末次2012.5.13。手足麻木I度，此次消化道反應2度，較前加重，現恢復 \\U0004\\U0004   6，週期評效：，CEA：7.43，淺表淋巴結較前變化不大。胸部，CT：兩肺多髮結節同前，左肺上葉略增大。縱隔淋巴結同前。腹部CT未見新生佔位。\\U0004\\U0004現覺胸悶明顯好轉，睡眠、飲食可，大小便可，體重無變化。", "entities": [{"end_pos": 13, "label_type": "手術", "overlap": 0, "start_pos": 6}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 157, "end_pos": 160}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 227, "end_pos": 229}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 264, "end_pos": 267}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 322, "end_pos": 324}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 334, "end_pos": 337}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 406, "end_pos": 409}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 427, "end_pos": 432}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}, {"end_pos": 446, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"end_pos": 455, "label_type": "解剖部位", "overlap": 0, "start_pos": 450}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 458, "end_pos": 462}, {"end_pos": 484, "label_type": "解剖部位", "overlap": 0, "start_pos": 483}]}
{"originalText": "，2012-10-16外院行全子宮+兩附件切除+盆腔淋巴結清掃術+腸粘連分解術，術後病理示子宮內膜混合性癌，2012-11-6我院病理會診示子宮內膜漿液性癌；漿液性癌侵犯至深肌層（癌距離子宮漿膜表面的距離少於1毫米）；可見大量脈管癌栓。轉移性子宮漿液性癌3/11。2012-11-16行TP方案化療1週期，2012-12-3至2013-1-9放療50GY/25F。2012-12-12、2013-1-9行TP化療2週期.2014-6-24患者右鎖下下淋巴結淋巴結腫大,約2*2CM大小。2014-7-24至2014-8-28放療,GTV60GY/CTV50GY/25F/35D。，複查頸部超聲：右頸根至鎖骨下多發腫大淋巴結，較前稍小。盆腔，MRI：盆腔內多髮結節，轉移？密切追查。2014-10-08 癌抗原125 25.74U/ML恢復正常。，2014-10-29腹部CT：掃及胰頭下方結節。，2014-10-31盆腔MR：盆腔內散在、多發稍長T1稍長T1稍長T2訊號長T2訊號結節較前增大、增多，原較大約9X7MM（SE6 IM5），現約15X11MM（SE4 IM4），現較大約16X13MM（SE4 IM11），原約6MM（SE6 IM12），考慮轉移。2014-11-17複查血常規及肝腎功正常，CEA34.54NG/ML。2014-11-19TP（多帕菲120MGD1+奈達鉑60MGD1-3）化療一週期，化療後噁心、嘔吐、便祕。2014-12-22第2週期TP化療。化療後噁心、嘔吐，乏力。12-30複查血常規示白細胞2.65*10^9/L。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 14, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 45, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 127}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 299}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 301, "end_pos": 303}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 317, "end_pos": 323}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 351, "end_pos": 358}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 383, "end_pos": 387}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 390, "end_pos": 392}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 408, "end_pos": 412}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 553, "end_pos": 556}, {"end_pos": 583, "label_type": "藥物", "overlap": 0, "start_pos": 580}, {"end_pos": 594, "label_type": "藥物", "overlap": 0, "start_pos": 591}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 663, "end_pos": 666}]}
{"originalText": "，2015-03因大便帶血行相關檢查診斷直腸癌，距肛不詳，當地2015-03-31行直腸癌根治術（DIXON），，術後病理：中低分化腺癌，腸壁全層，斷端陰性，淋巴結0/10。MSS。KI67 80%。，術後化療：XELOX 5週期，末次2015-08。無放療。因便血，當地2015-10-23複查腹盆CT未見明顯復發轉移徵象，2015-11-02複查腸鏡提示距肛4CM吻合口處充血、糜爛，，活檢病理：輕中度急慢性炎，肉芽組織增生。近期腫標正常。15-10-23 當地複查CT無明顯復發轉移徵象。近期進食尚可，仍有大便帶血，體重穩定。2016.2.29，複查腸鏡示：吻合口炎16-6 本院複查，。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 23}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 54, "label_type": "手術", "overlap": 0, "start_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 148, "end_pos": 152}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 187}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 235, "end_pos": 237}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 282, "end_pos": 286}]}
{"originalText": "，患者3月前發現小便顏色變紅，不伴尿痛等，當時未予重視。2月前患者自覺排尿時燒灼感，伴排尿中斷，至我院門診就診，，查前列腺特異性抗原：24.540；B，超：前列腺增生；左腎囊腫；殘餘尿50ML。懷疑良性前列腺增生、前列腺炎症，予鹽酸坦洛新緩釋膠囊1#QD，乳酸右氧氟沙星片1#QD口服。後症狀未緩解，1月前複診，，查前列腺特異性抗原：27.200；，血常規：紅細胞計數 3.91X10^12/L；血紅蛋白 128G/L；紅細胞壓積 37.2%；，心電圖：1.竇性心動過緩 2.T波改變(以R波為主導聯T波均低平、兩相)。予頭孢克肟膠囊1#BID，腎下腺色腙片1#TID口服。行經直腸超聲引導上前列腺穿刺活檢，，次日病理結果顯示：前列腺腺癌，GLEASON'S評分4+4=8分。予比卡魯胺片口服，出現皮疹後停藥。2014-4-17行全身骨顯像+，骨斷層顯像：右側第10後肋及腰椎多發放射性略濃聚灶；胸12椎體，骶骨轉移可能；胸腰椎退變。，2014-04-22本院CT：前列腺增生，左後外周帶隆起伴強化，建議MR。2，天前查前列腺特異性抗原：3.560。現為行兩側睪丸切除術收住入院。患者自起病來，精神胃納可，小便同前所述，大便正常，體重無明顯上降。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 58, "end_pos": 66}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 83}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 106}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 123, "label_type": "藥物", "overlap": 0, "start_pos": 114}, {"end_pos": 135, "label_type": "藥物", "overlap": 0, "start_pos": 128}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 198, "end_pos": 202}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 210, "end_pos": 216}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 223, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 229, "end_pos": 235}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 261}, {"end_pos": 279, "label_type": "藥物", "overlap": 0, "start_pos": 273}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 314, "end_pos": 319}, {"end_pos": 344, "label_type": "藥物", "overlap": 0, "start_pos": 339}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 365, "end_pos": 377}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 398, "end_pos": 408}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 430, "end_pos": 432}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 433, "end_pos": 438}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 452, "end_pos": 454}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 460, "end_pos": 468}, {"end_pos": 485, "label_type": "手術", "overlap": 0, "start_pos": 478}]}
{"originalText": "患者因“進食後阻塞感2周”在我院診斷為胸下段食管鱗癌,於2011-6-9行力樸素+奧先達化療一程。並於2011-6-13至2011-7-19行根治性反射治療，原發灶65GY，區域淋巴結50GY，過程順利。放療後吞嚥困難症狀緩解。1月前又出現吞嚥困難，進食流質困難，偶有飲水嗆咳，行胃鏡檢查示食管距門齒約20CM右前壁見結節樣腫物，活檢為鱗狀細胞癌。診斷為食管癌放化療後復發，於2011-12-1行力樸素+奧先達化療一程。效果差，於內科就診，內科認為患者現不適合化療，建議行胃造瘻術。行胃鏡檢查示食管距門齒約16-25CM見食管腫物，覆蓋大量白色壞死物，距門齒約20CM見瘻口，竇道形成。現為行胃造瘻術收入我科。現患者訴吞嚥困難，進食流質困難，咳嗽，咳白色粘液痰，量多，無發熱，氣促，無胸痛，胸悶，無噁心，嘔吐，無腹痛，腹瀉。精神一般，胃納差，二便正常。體重上降約5KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 26}, {"end_pos": 40, "label_type": "藥物", "overlap": 0, "start_pos": 37}, {"end_pos": 44, "label_type": "藥物", "overlap": 0, "start_pos": 41}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 148, "end_pos": 150}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 186}, {"end_pos": 201, "label_type": "藥物", "overlap": 0, "start_pos": 198}, {"end_pos": 205, "label_type": "藥物", "overlap": 0, "start_pos": 202}, {"end_pos": 240, "label_type": "手術", "overlap": 0, "start_pos": 236}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 252}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 279}, {"end_pos": 300, "label_type": "手術", "overlap": 0, "start_pos": 296}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 342}, {"end_pos": 346, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 367, "end_pos": 368}]}
{"originalText": "，2012-6-19行開腹探查，直腸癌切除，結腸造瘻術，術中疑有肝轉移。，術後病理：直腸潰瘍型中分化腺癌，約4.0*3.5CM,侵及腸壁全層並與兩側卵巢炎性粘連，可見脈管癌栓，淋巴結3/15，斷端未見癌。術後於2012-7-9開始XELOX方案化療5週期，未放療，4週期後於2012-11行肝轉移灶射頻消融術。2013-1因肝轉移灶增大，予貝伐珠單抗+伊立體\\U0004\\U0004替康化療一週期，因肝轉氨酶升高，停用貝伐，後又單用伊立替康化療一週期。，2013-6-25複查CT：肝轉移灶增多、增大，骶前多發軟組織結節，轉移？盆腔少量積液，右肺上葉小結節性質待定。KRAS野生型。\\U0004\\U0004目前肛門墜脹感，飲食可，睡眠差，體重上降2KG。2013-6開始愛必妥/***7週期，末次治療時間2013-8-27.評效縮小的SD，。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 11, "end_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 154, "label_type": "手術", "overlap": 0, "start_pos": 145}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 175, "label_type": "藥物", "overlap": 0, "start_pos": 170}, {"end_pos": 193, "label_type": "藥物", "overlap": 0, "start_pos": 176}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 200, "end_pos": 204}, {"end_pos": 211, "label_type": "藥物", "overlap": 0, "start_pos": 209}, {"end_pos": 220, "label_type": "藥物", "overlap": 0, "start_pos": 216}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 338, "label_type": "藥物", "overlap": 0, "start_pos": 335}]}
{"originalText": "，2016-4月間斷便血1月。外院腸鏡見距肛門10CM。病理為高級別下皮內瘤變,部分可見黏膜內癌，完善分期檢查，CT3N2B，外科建議術前放化療，2016-5-12至2016-6-3完成GTV 51GY CTV 40.8GY/34F BID D1-D5/W。2016-8-11行LAR手術，，術後病理：直腸中分化腺癌，部分伴細胞外黏液，，腫瘤消退分級：輕度反應，未見脈管癌栓及神經侵犯；腸周淋巴結7/9，另見多個癌結節（>10）,病理分期YPT3N2B,CM0。術後輔以化療8週期（XELOX*5，卡培他濱單藥*3），末次化療時間2017-1；治療結束後定期複查，CT未見明顯異常；2017-7-11至2017-10-13期間多次複查CEA由7.32升至22.69；CA125由15.10升至55.38；CA199由57.10升至152.70；CA74-2由37.75升至23.55；，2017-9-18：外院，PET-CT：直腸術後，右側腸壁增厚伴代謝活性稍高，上腹部沿大網膜及腸繫膜走形多髮結節影伴代謝活性輕度增高，考慮轉移可能性大，腹膜後淋巴結顯示，不伴代謝升高，骶前軟組織密度影伴環形代謝活性增強，考慮包裹性積液；2017-10月 我院行XELOX+安維汀治療2週期。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 39}, {"end_pos": 144, "label_type": "手術", "overlap": 0, "start_pos": 139}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 158}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 249}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 282, "end_pos": 284}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 317, "end_pos": 320}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 333, "end_pos": 338}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 352, "end_pos": 357}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 372, "end_pos": 378}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 406, "end_pos": 412}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 413, "end_pos": 417}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 420, "end_pos": 421}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 440, "end_pos": 441}, {"end_pos": 475, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 487, "label_type": "解剖部位", "overlap": 0, "start_pos": 485}, {"end_pos": 532, "label_type": "藥物", "overlap": 0, "start_pos": 529}]}
{"originalText": "，患者於2015年3月無明顯誘因出現大便帶鮮血，量少，大便變細、大便習慣改變，2-4天一次，無腹痛、噁心、發熱等不適。外院腸鏡檢查提示距肛門22-24CM腫物，環繞腸腔3/5，腸鏡能透過，活檢病理提示腺癌。於2015-06-09在我院行腹腔鏡上DIXON術，術後恢復可，，術後病理示：乙狀結腸大體鏡檢為中分化腺癌，累及腸壁漿膜上層，淋巴結0/6（+）；另見癌結節3枚。，免疫組化：MSH2（+），MSH6（+），PMS2（+），MLH1（+），KI67（40%+），ER（-），ERCC1（+）。術後診斷PT3N1M0 IIIB期 PMMR，訴術後半年口服5-FU治療（具體不詳）。，2016-12-10我院複查MT：“肝S1病灶，考慮轉移瘤”。2016-12-10行PET/，CT：“吻合口代謝較活躍，請結合臨床；右側髂總血管旁數個淋巴結代謝活躍，考慮轉移，累及右側輸尿管，右腎盂及右輸尿管中下段擴張積液；肝S1低密度結節代謝活躍，考慮轉移”。診斷為RT3N1M1IVB期 PMMR，於2016-12-30、2017-01-14、2017-02-10、2017-02-24、2017-03-10給予FOLFOX方案化療5程，4程化療後療效評價PR,化療後無明顯周圍神經毒性，監測血常規無骨髓抑制。現為上一程治療入院，下次治療至今，患者無明顯腹痛、無腹脹、無噁心、無嘔吐、無畏寒、無發熱,患者精神尚可，食慾如常。大小便正常。體重近半年無明顯上降。", "entities": [{"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 102}, {"label_type": "手術", "overlap": 0, "start_pos": 118, "end_pos": 128}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 160}, {"end_pos": 282, "label_type": "藥物", "overlap": 0, "start_pos": 278}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 310}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 334, "end_pos": 341}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 346}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 396}, {"end_pos": 407, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 544, "end_pos": 548}, {"end_pos": 572, "label_type": "解剖部位", "overlap": 0, "start_pos": 571}, {"end_pos": 576, "label_type": "解剖部位", "overlap": 0, "start_pos": 575}]}
{"originalText": "，患者於2010-11無明顯誘因出現陣發性隱痛不適，2011-1自覺右下腹包塊，不伴發熱，無黃染，無噁心、嘔吐，無腹脹、腹瀉。在我院門診檢查CT示右肝外葉腫物，符合肝癌，肝門區，胃右動脈旁淋巴結轉移。AFP297NG/ML。於2011-2-18在全麻上行右半肝巨大肝癌切除+逆行性膽囊切除+肝門淋巴結清掃術+胃壁修補術，術程順利。，術後病理示：肝細胞肝癌。定期複查，術後1月AFP降至正常。2011-4-8我院PET/CT示肝癌術後，腹膜後淋巴結代謝活躍，考慮轉移瘤。於2011-4-22在我院影像介入科行CT引導上淋巴結射頻消融術，同期行CIK細胞免疫治療2程。後定期自2011-5-24始繼續行CIK細胞免疫治療14程，過程順利。期間定期複查，未見明確腫瘤復發及轉移徵象，末次複查時間為2013-03-14，，胸腹MR示：胰腺體部後方類圓形結節，考慮淋巴結轉移可能性大，建議繼續觀察。現患者為繼續行CIK細胞免疫治療入我科。患者近來精神睡眠可，胃納可，無發熱，腹痛、腹瀉，無噁心、厭食，二便正常，體重無明顯上降。", "entities": [{"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 99}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 100, "end_pos": 103}, {"label_type": "手術", "overlap": 0, "start_pos": 127, "end_pos": 159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 177}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 187, "end_pos": 190}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 205, "end_pos": 211}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 216}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 266, "label_type": "手術", "overlap": 0, "start_pos": 253}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 357, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 367}, {"end_pos": 425, "label_type": "解剖部位", "overlap": 0, "start_pos": 424}, {"end_pos": 433, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 435}]}
{"originalText": "，患者半月餘前無明顯誘因出現右上腹疼痛，為陣發性隱痛，伴輕度排便困難，患者無發熱、噁心嘔吐，無腹脹，大便1-3次/日，無膿血便，隨就診於我院消化內科，，行腸鏡檢查示：進境30CM到乙狀結腸近端，可見巨大不規則粘膜隆起，環周致管腔狹窄，繼續進境困難，取病理結果過未回，，行胃鏡檢查示：胃息肉，非萎縮性胃炎並膽汁反流。2016.3.19，於我院東院區行腸鏡病理結果回示：（乙狀結腸）腺癌。CT，結果回示：肝臟巨大不規則混雜密度灶並肝內膽管擴張，考慮轉移；乙狀結腸區域性壁不規則增厚並壁毛糙、周圍多發略腫大淋巴結，結腸CA並侵透漿膜、並周圍淋巴結轉移可能，建議結合腸鏡；腹膜後多發略腫大淋巴結；門靜脈左支顯示欠清；左腎小囊腫；右側附件囊性密度灶，建議結合超聲；盆腔積液。分析患者結腸癌肝臟轉移，無手術根治條件，轉入我科行化療治療，自2016.3.24起行安維汀+MFOLFOX6方案化療2週期，，具體為：安維汀200MGD1+奧沙利鉑150MGD1+右亞葉酸鈣300MGD1+氟尿嘧啶0.6D1,3.5維持46小時泵入。現患者為求進一步診療來我院，門診以“乙狀結腸癌”收入院，患者近日來，飲食睡眠可，小便正常，體重較前無明顯改變。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 191}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 281, "end_pos": 282}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 303, "end_pos": 308}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 330}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 335, "end_pos": 342}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 373}, {"end_pos": 401, "label_type": "藥物", "overlap": 0, "start_pos": 398}, {"end_pos": 413, "label_type": "藥物", "overlap": 0, "start_pos": 409}, {"end_pos": 426, "label_type": "藥物", "overlap": 0, "start_pos": 421}, {"end_pos": 438, "label_type": "藥物", "overlap": 0, "start_pos": 434}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 474, "end_pos": 479}]}
{"originalText": "，因“體檢左肝佔位”當地確診HCC？，術前未見遠處M，AFP（-），2014.3.23行肝部分切除及膽囊切除術，術中探查無腹水，小結節性肝硬變，S6近髒面，約4*3CM，病理示左葉肝細胞性肝癌，中分化，AFP（-），HEPOTOCYTE（-），術後未治療。術後行肝血管造影（-）。外院2014-12-28腹CT示腹膜後LNM，3.1CM？2015.1.5始行腹膜後LNM放療6300CGY/35F，2015.2.28結束，2015.3.29 CT報告示穩定33*29MM，現AFP正常。2015.4.20口服SORAFINIB，2015.4.20 ，CT：腹膜後佔位相仿，肝腎之間佔位新發？侵及十二指腸，間斷黑便，飲食可，大小便正常，體重無明顯變化。,15-5-5 ，當地胃鏡：十二指腸腫物，病理待報。此次來諮詢進一步治療。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 5, "end_pos": 7}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手術", "overlap": 0, "start_pos": 44, "end_pos": 55}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 131, "end_pos": 136}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 152, "end_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 156, "end_pos": 162}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 185}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 220, "end_pos": 223}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 237, "end_pos": 240}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 275, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 278, "end_pos": 279}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 287}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 288}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}]}
{"originalText": "，2016-6初外院常規體檢腹部超聲發現左肝佔位，HBSAG(-)，ANTI-HCV(-)，AFP 573，CEA、CA199正常。2016-06-14我院PET/，CT：肝右內葉至肝左葉交界處巨大低密度腫塊，考慮惡性（肝癌？）。肝S2低密度結節，囊腫？肝門區、門腔靜脈間少許小淋巴結，性質待定。兩肺散在小結節，未見高代謝，隨訪。2016-6-21行肝中葉切除+膽囊切除術，術中肝S5-8約6CM質軟腫物，侵犯區域性肝被膜，包膜完整，超聲探查其旁另見一約1CM腫物，，術後病理：肝中葉（10X8X7CM）、肝S5部分惡性腫瘤（1CM），可見壞死。，免疫組化結果顯示:CD56(－),CGA(+),CK(+),KI-67(80%+),MGMT(+50～75%),SSTR2(+＞75%),SYN(+),HEP(－),ARGINASE(－),GPC3(－),AFP(灶狀+)，符合肝臟低分化大細胞神經內分泌癌（G3），需排除轉移癌。2016-07-25複查CT肝部分切除術後，區域性見少量積液，追查。現術後恢復好，時有後背隱痛，乏力，無噁心嘔吐，進食後下腹脹，食慾好，食量可，體重術後增加1KG。現體重71KG，身高175CM。大小便可，睡眠質量差，活動量可。，化驗血：2016-07-02 鉀 3.38MMOL/L，丙氨酸氨基轉換酶 103IU/L，前白蛋白 0.09G/L，血紅蛋白 107.00G/，LPET-CT：空腹6小時以下，靜脈注射顯像劑，平靜休息60MIN後行軀幹PET及CT斷層顯像，PET影象經衰減校正及重建後，將PET及CT影象行多平面、，多幅顯示：兩下頜竇粘膜增厚，未見高攝取。口咽部雙側腺體顯影對稱，垂體及甲狀腺伴生理性攝取。兩頸部及鎖骨下區未見明顯異常淋巴結濃聚。雙肺顯影清晰，肺紋理正常，右肺斜裂胸膜上微小結節，未見高攝取。左肺下葉鈣化灶。縱隔及雙側肺門未見異常腫大淋巴結或淋巴結濃聚。胸膜無增厚，胸水徵陰性。肝神經內分泌腫瘤術後，術區見不規則液性密度影，放射性分佈稀疏缺損。餘部肝實質內可見小囊性密度結節，未見高攝取。左下腹腹膜內多發索條影，前腹壁呈術後改變，未見異常高攝取。腹腔內、腹膜後及盆腔內未見腫大淋巴結或淋巴結濃聚。盆腔內未見液性密度影。胃充盈好，胃壁顯影如常。胰腺形態放射性分佈尚好，胰管不擴張。脾放射性分佈均勻。雙側腎臟顯影可，腎實質密度均勻，腎盂、腎盞及輸尿管無擴張。雙側腎下腺顯影大致正常。腹部可見條索狀腸影。膀胱放射性濃聚如常，膀胱壁無增厚。前列腺大小正常，放射性分佈大致正常。視野內軸心骨未見異常放射性濃聚。下、上肢關節帶大致正常。左股骨頭骨島。 1、肝神經內分泌腫瘤術後，術區可見積液，未見生長抑素受體異常高表達灶。左下腹腹膜及前腹壁呈術後改變。 2、右肺斜裂胸膜上微小結節，隨診。 3、兩下頜竇炎症；左肺下葉鈣化灶；肝囊腫；左股骨頭骨島。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 24}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 46, "end_pos": 49}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 54, "end_pos": 57}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 58, "end_pos": 63}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 78, "end_pos": 85}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 112}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"label_type": "手術", "overlap": 0, "start_pos": 175, "end_pos": 186}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 208}, {"end_pos": 241, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 252, "end_pos": 261}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 387, "end_pos": 405}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 425, "end_pos": 427}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 427, "end_pos": 434}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 455}, {"end_pos": 474, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 542, "end_pos": 543}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 555, "end_pos": 563}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 572, "end_pos": 576}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 585, "end_pos": 589}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 600, "end_pos": 606}, {"end_pos": 609, "label_type": "解剖部位", "overlap": 0, "start_pos": 608}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 636, "end_pos": 642}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 647, "end_pos": 650}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 663, "end_pos": 669}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 682, "end_pos": 686}, {"end_pos": 704, "label_type": "解剖部位", "overlap": 0, "start_pos": 697}, {"end_pos": 711, "label_type": "解剖部位", "overlap": 0, "start_pos": 709}, {"end_pos": 715, "label_type": "解剖部位", "overlap": 0, "start_pos": 712}, {"end_pos": 725, "label_type": "解剖部位", "overlap": 0, "start_pos": 722}, {"end_pos": 730, "label_type": "解剖部位", "overlap": 0, "start_pos": 726}, {"end_pos": 744, "label_type": "解剖部位", "overlap": 0, "start_pos": 742}, {"end_pos": 750, "label_type": "解剖部位", "overlap": 0, "start_pos": 749}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 755, "end_pos": 759}, {"end_pos": 777, "label_type": "解剖部位", "overlap": 0, "start_pos": 773}, {"end_pos": 783, "label_type": "解剖部位", "overlap": 0, "start_pos": 781}, {"end_pos": 788, "label_type": "解剖部位", "overlap": 0, "start_pos": 784}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 804, "end_pos": 805}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 816, "end_pos": 826}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 851, "end_pos": 852}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 871, "end_pos": 874}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 884, "end_pos": 885}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 900, "end_pos": 901}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 904, "end_pos": 905}, {"end_pos": 910, "label_type": "解剖部位", "overlap": 0, "start_pos": 908}, {"end_pos": 927, "label_type": "解剖部位", "overlap": 0, "start_pos": 925}, {"end_pos": 937, "label_type": "解剖部位", "overlap": 0, "start_pos": 936}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 941, "end_pos": 942}, {"end_pos": 950, "label_type": "解剖部位", "overlap": 0, "start_pos": 948}, {"end_pos": 962, "label_type": "解剖部位", "overlap": 0, "start_pos": 960}, {"end_pos": 967, "label_type": "解剖部位", "overlap": 0, "start_pos": 966}, {"end_pos": 979, "label_type": "解剖部位", "overlap": 0, "start_pos": 975}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 983, "end_pos": 984}, {"end_pos": 993, "label_type": "解剖部位", "overlap": 0, "start_pos": 991}, {"end_pos": 996, "label_type": "解剖部位", "overlap": 0, "start_pos": 994}, {"end_pos": 1000, "label_type": "解剖部位", "overlap": 0, "start_pos": 997}, {"end_pos": 1009, "label_type": "解剖部位", "overlap": 0, "start_pos": 1004}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1016, "end_pos": 1017}, {"end_pos": 1024, "label_type": "解剖部位", "overlap": 0, "start_pos": 1023}, {"end_pos": 1028, "label_type": "解剖部位", "overlap": 0, "start_pos": 1026}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1036, "end_pos": 1038}, {"end_pos": 1046, "label_type": "解剖部位", "overlap": 0, "start_pos": 1043}, {"end_pos": 1067, "label_type": "解剖部位", "overlap": 0, "start_pos": 1066}, {"end_pos": 1083, "label_type": "解剖部位", "overlap": 0, "start_pos": 1077}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1089, "end_pos": 1095}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1099, "end_pos": 1109}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1132, "end_pos": 1135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1139, "end_pos": 1140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1150, "end_pos": 1154}, {"end_pos": 1172, "label_type": "解剖部位", "overlap": 0, "start_pos": 1168}, {"end_pos": 1179, "label_type": "解剖部位", "overlap": 0, "start_pos": 1175}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1183, "end_pos": 1186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1187, "end_pos": 1193}]}
{"originalText": "，2010-9-21行胃癌根治術，術後病理 低分化腺癌，侵及肌層，達漿膜外，淋巴結1/29.術後腫標CA724 7.74 。術後SOX方案化療2週期。末次化療2010-11-23。因肝功能損害I度，NEUT 2°，腹瀉 1°，色素沉著，低血糖。第3週期改為單藥S-1服藥至2011.2.15,不良反應明顯，停用TS-1，末次化療時間2011.4.11。暫停化療未再服藥.不良反應基本恢復.2011-10-31複查腫瘤標誌物正常，頸部超聲提示右鎖骨下靶環狀淋巴結，腹盆CT未見覆發轉移徵象。2011-11，頸部B超:右頸至鎖骨下多發淋巴結.盆腔B超未見異常,腹部，CT:未見新發病灶,，腫標:正常.2011-12-13頸部B超示，右頸部至鎖骨下淋巴結略增大.CA72.4 9.41\\U0004\\U0004 現乏力氣短，食慾可，夜尿多好轉，大便2次，睡眠欠佳，早醒，夜間口乾。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 50, "end_pos": 56}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 133, "label_type": "藥物", "overlap": 0, "start_pos": 130}, {"end_pos": 159, "label_type": "藥物", "overlap": 0, "start_pos": 155}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 231, "end_pos": 235}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 278, "end_pos": 283}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 314}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 328, "end_pos": 334}]}
{"originalText": "，2017-1-24，外院胃鏡示：距門齒32-35CM鱗癌。影像學檢查提示兩頸部、縱隔、淋巴結轉移，多發骨轉移。2017-2開始行紫杉醇+順鉑方案化療2週期。，末次化療時間：2017-32週期後複查，縱隔淋巴結轉移灶較前縮小，腹腔淋巴結無法對比。2017-5-3，本院胸CT示：食管胸中上段癌，伴縱隔2-8組、兩肺門、鎖骨下區、右腋區及胃周瀰漫腫大淋巴結轉移。2017-5-8，腹部CT示：肝臟多髮結節，考慮轉移。腹腔及腹膜後腫大淋巴結，考慮轉移。胸12、多個腰椎多發異常密度灶，考慮轉移。現病人進食困難，睡眠可。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 27, "end_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 55}, {"end_pos": 68, "label_type": "藥物", "overlap": 0, "start_pos": 65}, {"end_pos": 71, "label_type": "藥物", "overlap": 0, "start_pos": 69}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 134, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 146}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 169}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 189, "end_pos": 193}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 211}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}]}
{"originalText": "2016.1曾經出現小腸穿孔，保守治療後好轉。2016-9-27 因顱內佔位，病理活檢診斷DLBCL。2016.10.PETCT顯示顱內無明確佔位，但是迴腸末端代謝活躍，考慮淋巴瘤侵及，SUV 20.99. 2016.11出現腸梗阻，2016.11.15行因腸梗阻加重行部分小腸切除術，術後病理DLBCL。我院病理會診DLBCL. 無發熱、盜汗及消瘦。2016.12.16行第1週期R-THO化療，療後無不適，12.26血常規提示WBC 2.15*10E9/L,NEU 0.87*10E9/L,PLT及HB正常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 34, "end_pos": 35}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 59, "end_pos": 64}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 132}, {"end_pos": 142, "label_type": "手術", "overlap": 0, "start_pos": 135}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 215, "end_pos": 219}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 231, "end_pos": 234}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 247, "end_pos": 250}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 251, "end_pos": 253}]}
{"originalText": "因“下腹堵脹感、腰痠”就診，2016-4檢查見胰頭十二指腸間佔位（未見報告），2016-4-22腹腔鏡轉開腹，姑息性腹膜後腫瘤切除+膽囊切除，術中見腹膜後腫瘤下極位於肝門處，呈多結節融合狀，術後病理：結節狀腫瘤組織，6.5X3X2CM和11.5X7X3.5CM，瘤組織由密集排列的小圓形餘短梭形細胞組成，伴大片壞死，結合組化考慮PNET；膽囊體部菜花樣腫物，3X2.5X1CM，腺癌，浸潤膽囊壁全層，頸部切緣未見腫瘤術後恢復可。", "entities": [{"end_pos": 4, "label_type": "解剖部位", "overlap": 0, "start_pos": 2}, {"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 25, "end_pos": 29}, {"label_type": "手術", "overlap": 0, "start_pos": 48, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 189, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}]}
{"originalText": "，剖宮產術後4月（孕期體重增加20KG），常規產後檢查發現宮頸病變，2014.1.29因宮頸癌行手術治療（廣泛子宮全切+腹主動脈旁淋巴結取樣+盆腔淋巴結切除+兩側卵巢懸吊）。，我院會診病理：中分化鱗狀細胞癌，可見脈管癌栓，浸潤深度1.4CM，累及宮頸，淋巴結無轉移。患者現術後恢復良好，現大小便正常。，14-3-5盆腹MRI：陰道殘端左下方不規則訊號，大網膜及腹膜瀰漫增厚，較大42*28MM。腹膜瀰漫增厚轉移可能。14-3-10PET-CT複查陰道殘端及殘端左側不規則軟組織影伴代謝活躍，腹膜考慮非轉移，行盆腔放療，，計劃：CTV45GY/25F，2014-3-27開始放療，放療7次，大便次數多，2-3次/天。", "entities": [{"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 44, "end_pos": 47}, {"label_type": "手術", "overlap": 0, "start_pos": 53, "end_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 103}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 157, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 163, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 197, "end_pos": 198}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 215, "end_pos": 221}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 223, "end_pos": 225}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 246}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}]}
{"originalText": "，患者於2010.9因\\\"乏力尿黃半年\\\"在我院肝膽科就診，入院後完善檢查診斷為壺腹周圍癌，於2010.9.14行胰十二指腸切除術，術中探查見腫瘤位於十二指腸乳頭部，大小約3.5CM×2.5CM×2.5CM，向右侵及胰頭部組織，未侵犯上腔靜脈、門靜脈及腸繫膜下動靜脈，腹腔有約100ML淡黃色清亮腹水，肝臟、膽囊、胃、空腸、腹膜、盆底均未見異常，術後病理提示壺腹部中分化腺癌，部分為粘液腺癌，，分期為：T3N1M0。術後恢復可，並定期複查，未行放化療。術後3次（2010.12.6、2011.2.24、2011.5.5）複查CEA、CA19-9，CEA分別為3.38、13.1、43.43NG/ML，CA19-9分別為16.55、46.05、169.7U/ML。2011.5.6複查CT提示肝轉移瘤， 於2011-5-27、6-19、7-9、7-30、8-20、9-22行GP方案化療6程，過程順利。2程及4程後CT療效評價為SD。2011.10.11，複查CT示：壺腹癌WHIPPLE 術後改變。肝臟轉移瘤，較前稍縮小。現為進一步治療入院。患者近來無噁心、嘔吐，無腹痛、腹瀉，無畏寒發熱。精神、食慾、睡眠尚可，大小便正常，體重較前無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 45}, {"end_pos": 65, "label_type": "手術", "overlap": 0, "start_pos": 57}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 148, "end_pos": 149}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 163}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 207}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 262, "end_pos": 265}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 266, "end_pos": 272}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 273, "end_pos": 276}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 300, "end_pos": 306}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 341, "end_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 345, "end_pos": 349}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 406, "end_pos": 408}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 429, "end_pos": 431}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 433, "end_pos": 446}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 449, "end_pos": 454}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 483, "end_pos": 484}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 486, "end_pos": 487}]}
{"originalText": "乙狀結腸癌，不完全性腸梗阻，2012.4.18行乙狀結腸根治術，肝轉移，肺轉移。術後行FOLFOX化療9週期。目前腫瘤進展。\\U0004\\U0004 入組FOLFIRI + AFLIBERCEPT後PD，2013-4入組帕尼單抗，化療11次。皮疹\\U0004\\U0004 2013-9-4CT：肝左葉轉移灶較前增大，現約7.5X6.7CM（IM52），原為5.3X5.2CM（IM52），內部碘油沉積減少，仍呈不均勻異常強化。腰1椎體左前下緣骨皮質模糊、部分消失，骨質密度不均勻減低，周邊增高，轉移可能大。肺部病灶大致同前。 帕尼單抗治療後評估肝轉移進展，評效PD，肺轉移較小，發展較慢，建議介入科治療，優先控制肝轉移\\U0004\\U0004 目前無明顯不適。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 0, "end_pos": 5}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 6, "end_pos": 13}, {"end_pos": 31, "label_type": "手術", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"label_type": "藥物", "overlap": 0, "start_pos": 87, "end_pos": 98}, {"end_pos": 114, "label_type": "藥物", "overlap": 0, "start_pos": 110}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 144, "end_pos": 146}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "藥物", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 221}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 232, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 253, "end_pos": 254}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 275}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 283, "end_pos": 286}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 309}]}
{"originalText": "，患者2年餘前（2009.11）因“腹瀉”就診********查腸鏡提示升結腸癌，行升結腸癌根治術，手術及術後病理不詳，術後行9個週期FOLFOX化療，末次化療2010.4結束。化療後患者出現II度的神經毒性，主要表現為手足麻木明顯。患者2011.1.6複查CT發現肝臟轉移瘤，2011.1.12行肝轉移瘤微波固化術，2011.2.22CT提示肝轉移，兩上肺轉移瘤，2011.2.23再次行肝轉移瘤微波固化術。2011.3.1起行FOLFIRI方案化療8次，末次2011.7.28，總體療效SD。此後患者停止化療。2011-11-24，我院CT示：“，與2011-10-21片對比：兩肺多發轉移瘤較前增大；肝內多發病灶，較前明顯增多、增大。腹腔幹旁及腸繫膜根部軟組織影及結節灶，考慮淋巴結轉移可能性大,較前明顯。子宮直腸窩內多髮結節，考慮種植轉移可能性大。膀胱後壁結節狀增厚，考慮轉移瘤可能性大。右側髂內外血管旁淋巴結，可疑轉移。”於2011-11-25、12-9、12-27、2012-1-12行CPT-11+C225化療4程。近來，患者自覺左中上腹疼痛，胃納食慾不佳，大便幹，血尿，伴尿頻、尿痛，偶有尿失禁，近2天乏力明顯，體重近期上降2KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 42}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 129, "end_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 138}, {"end_pos": 158, "label_type": "手術", "overlap": 0, "start_pos": 149}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 168, "end_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 182}, {"end_pos": 204, "label_type": "手術", "overlap": 0, "start_pos": 195}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 270, "end_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 298}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 325, "end_pos": 326}, {"end_pos": 361, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 378, "end_pos": 380}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"label_type": "藥物", "overlap": 0, "start_pos": 449, "end_pos": 455}, {"label_type": "藥物", "overlap": 0, "start_pos": 456, "end_pos": 460}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 479}]}
{"originalText": "2014年2月在當地行左側卵巢癌手術，兩側附件及子宮切除，術後病理見卵巢癌及淋巴結轉移，區域性無放療，已行化療，手術後予以6週期脂質體紫杉醇+卡鉑，化療中因腹膜後淋巴結腫大爾後予以THP2週期。近期於2015年3月3日查B超見腹膜後淋巴結轉移，盆腔無復發。2015-3-12始行第1週期吉西他濱+順鉑，具體：吉西他濱1000MG/M2 1.6G D1，D8 +順鉑40MG/M2 66MG D1，D8 Q21D。用藥後面板瘙癢，給予抗過敏治療。3月19行第1週期第8天治療。因藥物過敏，於2015年4月2日予以第2週期GP化療，具體同第1週期.擬於4月23日予以2週期化療複查。2週期療效短徑縮小總療效SD(短徑縮小)，故於2015年4月27日予以GP+恩度治療，擬於2015-5-18日行復查腹部CT療效為SD（較一個月前略變平，餘病灶無變化），改為TAMOXIFEN治療+腹膜後淋巴結放療。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 11, "end_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 43}, {"end_pos": 69, "label_type": "藥物", "overlap": 0, "start_pos": 63}, {"end_pos": 72, "label_type": "藥物", "overlap": 0, "start_pos": 70}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 92, "label_type": "藥物", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 120}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 146, "label_type": "藥物", "overlap": 0, "start_pos": 142}, {"end_pos": 149, "label_type": "藥物", "overlap": 0, "start_pos": 147}, {"end_pos": 157, "label_type": "藥物", "overlap": 0, "start_pos": 153}, {"end_pos": 181, "label_type": "藥物", "overlap": 0, "start_pos": 179}, {"end_pos": 328, "label_type": "藥物", "overlap": 0, "start_pos": 326}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"end_pos": 384, "label_type": "藥物", "overlap": 0, "start_pos": 375}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}]}
{"originalText": "，患者2月前無明顯誘因出現腹部陣發性隱痛不適，漸加重，無噁心、嘔吐等，大便1次/日，成形便為主，無血便，無頭暈、乏力、發熱等不適。就診外院，CT提示左上肺結節，右中上腹病變考慮小腸來源惡性腫瘤可能性大。為求進一步診治轉來我院，CT提示左肺上葉外基底段腫物，考慮周圍型肺肺癌癌可能性大。左肺中葉、右肺下葉舌段、兩肺上葉條索灶，考慮慢性炎症。左下氣管旁、兩上氣管旁、隆突上、左肺門淋巴結，可疑淋巴結轉移。甲狀腺兩葉病變，考慮結節性甲狀腺腫可能性大。結腸鏡檢查未見異常。2016-05-26行肺部腫瘤穿刺結果提示非霍奇金淋巴瘤，T細胞性。2016-06-13PET/CT提示右中上腹小腸病變代謝活躍，符合淋巴瘤，左肺上葉病灶代謝活躍，考慮浸潤，腸繫膜多發淋巴結代謝活躍，左肺門淋巴結代謝活躍，疑浸潤。2016-06-30全麻上行剖腹探查術，術中腫瘤固定，浸潤小腸繫膜，腫瘤不可切除，腫瘤近遠端空腸迴腸側側吻合術。於 2016-07-20至2016-07-23 給予 CHOP（，環磷醯胺：1G，，長春地辛：6MG，，吡柔比星：70MG） 方案化療1程。化療後出現IV°骨髓抑制，發熱，最高達39°大便潛血陽性，後給予患者升白，抗感染（萬古黴素，舒普深，右氧氟沙星）、抑酸護胃,生長抑素等治療後，體溫降至正常，大便潛血轉為陰性。第一程化療後，腹痛消失，腹部腫物較前明顯縮小。2016-08-19開始予第二程IMVP-16方案化療（，IFP：7G，，VP-16：300MG，，MTX：45MG*2次，，DXM：20MG*3D），化療後出現IV度白細胞降低，伴發熱，大便潛血陽性，，2016-08-22複查CT：對比2016-5-24 ，片：右中上腹小腸病灶，考慮符合淋巴瘤，浸潤腸繫膜，包繞、部分包繞腹主動脈、兩側髂總血管。病灶周圍、腸繫膜、大網膜、腹主動脈周圍、兩側髂總動脈周圍多發淋巴結，考慮腫瘤浸潤可能性大。左肺上葉外基底段腫物，考慮淋巴瘤浸潤可能性大，較前增大。左肺多發小結節、小斑片狀影及右肺上葉片狀影，淋巴瘤浸潤與炎症鑑別，建議複查。左肺中葉、右肺下葉舌段、兩肺上葉條索灶，考慮慢性炎症，大致同前。右鎖骨下區、縱隔、左肺門淋巴結，較前未見明顯變化。肝腫大。肝S7 囊腫。盆腔積液。予泰能、伏立康唑抗感染，G-CSF升白，丙球提升免疫力治療後好轉。近幾日患者仍有反覆發熱，體溫最高38.8度，未予抗生素治療可自行退熱。現患者再次就診，患者現流質飲食中，飲食睡眠可，大小二便如常。體重上降4KG。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 113, "end_pos": 115}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 137}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 173}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 179}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 191}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 217}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 265}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 276, "end_pos": 282}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 302}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 332, "end_pos": 338}, {"end_pos": 366, "label_type": "手術", "overlap": 0, "start_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 376, "end_pos": 378}, {"end_pos": 402, "label_type": "手術", "overlap": 0, "start_pos": 393}, {"end_pos": 440, "label_type": "藥物", "overlap": 0, "start_pos": 436}, {"end_pos": 449, "label_type": "藥物", "overlap": 0, "start_pos": 445}, {"end_pos": 459, "label_type": "藥物", "overlap": 0, "start_pos": 455}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 495, "end_pos": 499}, {"end_pos": 518, "label_type": "藥物", "overlap": 0, "start_pos": 514}, {"end_pos": 522, "label_type": "藥物", "overlap": 0, "start_pos": 519}, {"end_pos": 528, "label_type": "藥物", "overlap": 0, "start_pos": 523}, {"end_pos": 539, "label_type": "藥物", "overlap": 0, "start_pos": 535}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 551, "end_pos": 555}, {"end_pos": 574, "label_type": "解剖部位", "overlap": 0, "start_pos": 572}, {"end_pos": 615, "label_type": "藥物", "overlap": 0, "start_pos": 612}, {"end_pos": 625, "label_type": "藥物", "overlap": 0, "start_pos": 620}, {"end_pos": 636, "label_type": "藥物", "overlap": 0, "start_pos": 633}, {"end_pos": 649, "label_type": "藥物", "overlap": 0, "start_pos": 646}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 677, "end_pos": 681}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 697, "end_pos": 699}, {"end_pos": 721, "label_type": "解剖部位", "overlap": 0, "start_pos": 715}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 728, "end_pos": 731}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 734, "end_pos": 735}, {"end_pos": 749, "label_type": "解剖部位", "overlap": 0, "start_pos": 745}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 752, "end_pos": 756}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 762, "end_pos": 763}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 770, "end_pos": 774}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 777, "end_pos": 783}, {"end_pos": 810, "label_type": "解剖部位", "overlap": 0, "start_pos": 802}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 815, "end_pos": 818}, {"end_pos": 832, "label_type": "解剖部位", "overlap": 0, "start_pos": 830}, {"end_pos": 848, "label_type": "解剖部位", "overlap": 0, "start_pos": 844}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 852, "end_pos": 855}, {"end_pos": 872, "label_type": "解剖部位", "overlap": 0, "start_pos": 868}, {"end_pos": 879, "label_type": "解剖部位", "overlap": 0, "start_pos": 873}, {"end_pos": 884, "label_type": "解剖部位", "overlap": 0, "start_pos": 880}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 900, "end_pos": 915}, {"end_pos": 926, "label_type": "解剖部位", "overlap": 0, "start_pos": 925}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 929, "end_pos": 935}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 936, "end_pos": 940}, {"end_pos": 944, "label_type": "藥物", "overlap": 0, "start_pos": 942}, {"end_pos": 949, "label_type": "藥物", "overlap": 0, "start_pos": 945}, {"end_pos": 958, "label_type": "藥物", "overlap": 0, "start_pos": 953}, {"end_pos": 963, "label_type": "藥物", "overlap": 0, "start_pos": 961}]}
{"originalText": "，緣於入院4個月因漸進性消瘦就診我院，查全身，PET-CT：1、肝左葉前段高代謝結節；肝胃間隙、胰頭周邊、腹膜後、左側鎖骨鎖骨下窩多發高代謝腫大淋巴結；盆腔內膀胱直腸陷窩高代謝結節；以下徵象考慮惡性腫瘤多發轉移可能性大，建議必要時左側鎖骨下窩淋巴結活檢。2、縱隔內、兩側肺門區多髮結節影，部分伴鈣化，代謝增高，不除外淋巴結轉移。3、“脾臟切除術後”改變，右下下腹部多髮結節影，代謝未見增高，考慮副脾代償性增生可能。4、右腎下極形態欠規則，代謝未見增高。5、四肢近端骨髓代謝增高，兩側髂骨代謝輕度增高，考慮反應性改變可能，腫瘤浸潤待排除，建議隨訪複查或骨穿檢查。於（2016.6.1）行B超引導上左頸部腫物粗針活檢術，左頸部腫物活檢病理結果回報（201618813）（左頸），：送檢淋巴結穿刺標本，其內見特異性肉芽腫性炎，並見乾酪樣壞死及多核鉅細胞，考慮淋巴結肉芽肉芽腫性炎症，不排除淋巴結結核病可能。，特殊染色結果：該病例結核分枝桿菌（TB），核酸檢測結果：陰性。查麻醉胃鏡示內鏡診斷食管中段早癌、賁門癌，行賁門及食管中段佔位活檢，胃鏡病理（201619435），：1、（賁門）淺表賁門粘膜，間質中量急、慢性炎症細胞細胞浸潤，表面粘膜糜爛，區域性腺下皮呈高級別下皮內瘤變。2、（食管中段）送檢少量食管粘膜，間質少量急、慢性炎症細胞浸潤，鱗狀細胞輕度增生並局灶高級別下皮內瘤變。結合相關檢查回報，考慮“賁門癌伴肝臟、盆底種植、多發淋巴結轉移可能；食管癌”，將情況詳告知患者及家屬，其表示理解，同意按賁門癌IV期開始全身化療，分別於（2016.6.14、07.09、08.11、09.05）予“裡葆多35MG靜滴D1+奧沙利鉑200MG靜滴D1+替吉奧60MG口服D1-D14Q3W”一線姑息化療4個週期，過程順利，期間化療2個週期後複查療效評價SD。目前無明顯腹痛、腹脹、噁心、嘔吐，無黑便、腹瀉，無畏冷、發熱、寒戰，現為進一步治療，求診我院，門診擬“賁門癌”收入住院。自下次出院以來，精神尚可，睡眠尚可，食慾尚可，大小便正常，體重無明顯上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 20, "end_pos": 29}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 173}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 230}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 307, "label_type": "手術", "overlap": 0, "start_pos": 292}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 391, "end_pos": 397}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 422, "end_pos": 426}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 442, "end_pos": 452}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 454, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 486, "end_pos": 488}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 526, "end_pos": 534}, {"end_pos": 542, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 547, "end_pos": 549}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 567, "end_pos": 586}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 599, "end_pos": 618}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 621, "end_pos": 624}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 647, "end_pos": 653}, {"end_pos": 697, "label_type": "藥物", "overlap": 0, "start_pos": 694}, {"end_pos": 710, "label_type": "藥物", "overlap": 0, "start_pos": 706}, {"end_pos": 723, "label_type": "藥物", "overlap": 0, "start_pos": 720}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 778, "end_pos": 779}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 781, "end_pos": 782}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 794, "end_pos": 795}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 824, "end_pos": 827}]}
{"originalText": "，2014-5-19因乏力，便祕，便血半年，伴兩上肢水腫，外院2014-5-19HGB 40+，予輸血，盆MRI發現腸道病變。我院2014-5腸鏡確診乙狀結腸中分化腺癌。術前鎖穿置管後暈厥，出現不全腸梗阻，對症好轉治療後。2014-6-16行乙狀結腸癌手術。2014-6-23，術後病理：侵及周圍纖維脂肪組織；未見脈管癌栓；（近端）及（遠端）切緣未見腫瘤；腸周淋巴結可見癌轉移（6/13）；腫瘤病理分期PT3N2A。，免疫組化結果顯示:CD44(+),CMET(+),COX2(++),EGFR(++),HEP(－),HER2(0+),KI-67(+25～50%),MLH1(+＞75%),MSH2(+＞75%),MSH6(+＞75%),P170(++),P27(+＞75%),P53(+＞75%),TOPOII(+25～50%),TTF-1(－)。2014-6-4 CEA 36.29。術後恢復好，飲食好，體力可，二便正常，術後體重略有增加。2014-7-22 腹盆部，CT：乙狀結腸術後，吻合口未見異常增厚及強化。肝內多發微小結節，追查。2014-7-24，腹部超聲：肝內多髮結節，觀察；左腎結節，錯構瘤？腫瘤標誌物正常。考慮患者高齡，體質弱，考慮單藥術後輔助治療。2014-7-25開始希羅達 1G/早，1.5G/晚 D1-14 Q3W 。2014-8-1血常規正常，總膽紅素 23.5μXXXMOL/L;間接膽紅素 19.10μXXXMOL/L，K 5.53。患者多次血鉀高，無不適，囑減少進食香蕉，多飲水排尿，暫無特殊處理。患者複查後血常規、肝腎功能基本正常。2014-8-14第2週期，8-14總膽紅素 27.9μXXXMOL/L;間接膽紅素 22.70μXXXMOL/L。8-21總膽紅素 38.3μXXXMOL/L;直接膽紅素 7.0μXXXMOL/L;間接膽紅素 31.30μXXXMOL/L。血常規正常。停希羅達保肝治療1周，2014-8-28血常規正常，總膽紅素 29.8μXXXMOL/L;直接膽紅素 8.1μXXXMOL/L;間接膽紅素21.7μXXXMOL/L，較前上降。最後1日希羅達2014-9-3，2週期化療後，輕度食慾上降，進食可，二便正常，體重無明顯變化。9-4中性粒細胞絕對值1.81*10^9/L，總膽紅素 46.8μXXXMOL/L;直接膽紅素 6.1μXXXMOL/L;間接膽紅素 40.70μXXXMOL/L。2014-9-5，腹部腫瘤標誌:癌抗原72.4 7.40U/ML。2014-9-5超聲示肝內多髮結節，繼續觀察。建議必要時結合增強影像學檢查左腎結節，錯構瘤？較前變化不大。9-11膽紅素較前略有上降。2014-9-18血常規正常，總膽紅素 45.7μXXXMOL/L;直接膽紅素 8.3μXXXMOL/L;間接膽紅素 37.40μXXXMOL/L。2014-9-19血常規正常 總膽紅素 33.4     直接膽紅素 5.6     間接膽紅素 27.8，腹部B超：肝內多髮結節，繼續觀察。建議必要時結合增強影像學檢查左腎結節，錯構瘤？較前變化不大。", "entities": [{"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 40, "end_pos": 43}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 52, "end_pos": 56}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 84}, {"label_type": "手術", "overlap": 0, "start_pos": 87, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 102}, {"end_pos": 128, "label_type": "手術", "overlap": 0, "start_pos": 121}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 383, "end_pos": 388}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 432, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 439, "end_pos": 445}, {"end_pos": 460, "label_type": "解剖部位", "overlap": 0, "start_pos": 459}, {"end_pos": 487, "label_type": "解剖部位", "overlap": 0, "start_pos": 486}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 501, "end_pos": 504}, {"end_pos": 550, "label_type": "藥物", "overlap": 0, "start_pos": 546}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 587, "end_pos": 591}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 606, "end_pos": 611}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 638, "end_pos": 640}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 703, "end_pos": 707}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 722, "end_pos": 727}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 747, "end_pos": 751}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 766, "end_pos": 771}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 785, "end_pos": 790}, {"end_pos": 816, "label_type": "藥物", "overlap": 0, "start_pos": 813}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 838, "end_pos": 842}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 857, "end_pos": 862}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 876, "end_pos": 881}, {"end_pos": 907, "label_type": "藥物", "overlap": 0, "start_pos": 904}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 950, "end_pos": 958}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 970, "end_pos": 975}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 989, "end_pos": 994}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1008, "end_pos": 1013}, {"end_pos": 1074, "label_type": "解剖部位", "overlap": 0, "start_pos": 1073}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1104, "end_pos": 1107}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1119, "end_pos": 1122}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1138, "end_pos": 1141}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1144, "end_pos": 1148}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1163, "end_pos": 1169}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1182, "end_pos": 1187}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1218, "end_pos": 1222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1232, "end_pos": 1237}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 1246, "end_pos": 1251}, {"end_pos": 1263, "label_type": "解剖部位", "overlap": 0, "start_pos": 1262}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1293, "end_pos": 1296}]}
{"originalText": "，2015-6-25胃癌術，術後化療8週期，末次2015-12。2016-7，複查胃鏡：吻合口炎，胃瀦留2016-11納差，消瘦，後來出現腹痛，，排便不暢2017-02頭部皮上結節：增生的纖維組織內可見異型細胞單層“列兵”樣或圍繞面板附屬器“靶環”樣浸潤，結合免疫組化符合低分化腺癌，結合病史考慮胃癌轉移。HER2(0),CEMT(1+),EGFR(1+)，CAM5.2(+),CK(+),CK20(散在+),CK7(+),CEA(散在+)。2017-3-20PET-CT 1、胃癌術後，胃腸吻合口略增厚，代謝近周圍本底水平，炎症？請結合胃鏡檢查；腹盆腔多發小結節/小淋巴結，腹膜後小淋巴結，伴或不伴輕度代謝，請對比既往老片以除外轉移；腹盆腔少量積液，伴代謝，不除外轉移；枕後面板小結節，未見明顯高代謝，請結合病理。2、左肺下葉及右肺上葉結節、類結節，未見高代謝，隨訪。3、腦部未見明顯異常代謝徵象。兩基底節區鈣化灶。肝多發小囊腫。肝S6鈣化。左腎囊腫。右股骨肌腱附著處炎性或非特異性攝取。2017-3-23，2017.4.24,2017.5.16給予單藥紫杉醇化療3週期，現覺食納差，乏力，現發熱。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 230, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 295, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 338}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}, {"end_pos": 389, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 409, "end_pos": 415}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 422, "end_pos": 426}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 427}, {"end_pos": 481, "label_type": "藥物", "overlap": 0, "start_pos": 478}]}
{"originalText": "，下腹脹痛，2014-8-28因腹痛行胃鏡確診“胃體竇不規則腫物（印戒細胞癌，瀰漫型）”，CA199：199，，CA724：3409，，CEA：13，CT4BNXM0?2014-9-18始SOX*2,末次2014-10-31，症狀未好轉，CA199略升高，CA724略上降，胃壁增厚略加重。2014-11-20我院行遠端胃癌根治術，15*15CM，侵透漿膜，，部分侵及胰腺：印戒細胞癌伴粘液腺癌，瀰漫型，部分腫瘤細胞變性壞死，侵犯漿膜層，脈管癌栓及神經侵犯，11/30，轉移灶HER-2(0),YPT4AN3A。2014-1-9始PX*4--2015.4.8因神經毒性III度改為XELODA單藥，耐受改善，，NEU：1.19。", "entities": [{"end_pos": 3, "label_type": "解剖部位", "overlap": 0, "start_pos": 1}, {"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 42}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 45, "end_pos": 50}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 56, "end_pos": 61}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 68, "end_pos": 71}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 119, "end_pos": 124}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 128, "end_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 138}, {"end_pos": 165, "label_type": "手術", "overlap": 0, "start_pos": 158}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 201}, {"end_pos": 296, "label_type": "藥物", "overlap": 0, "start_pos": 290}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 305, "end_pos": 308}]}
{"originalText": "，2016-3出現進食吞嚥困難，，2016-4-23外院胸CT：食管中下段佔位，氣管旁、腔靜脈旁、隆突前未見腫大淋巴結。2016-4-19，胃鏡：腫物距門齒25CM，表面潰爛出血，上緣未描述，活檢病理未回報。3週期PTX+卡鉑治療後，2週期評效獲益。先第3週期化療已完成。2016.8.1開始區域性放療，予食管病灶及縱膈腫大淋巴結，GTV60GY/CTV50GY/28F，已完成8F，未訴明顯不適。擬同步PTX45MG/M^2 單藥每週方案化療。現吞嚥困難較前緩解，尚可進普食，可小口進食，偶有反流、呃逆，近期體重未上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 28, "end_pos": 31}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 110, "label_type": "藥物", "overlap": 0, "start_pos": 107}, {"end_pos": 113, "label_type": "藥物", "overlap": 0, "start_pos": 111}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 204, "label_type": "藥物", "overlap": 0, "start_pos": 201}]}
{"originalText": "，患者2015年1月無明顯誘因出現腹瀉，大便稀爛，帶血，偶有裡急後重，伴間歇腹部絞痛。外院腸鏡檢查提示距肛門10CM腫物，腸鏡不能透過，遂轉診我院，行盆、腹腔CT平掃+增強（2015-05），：符合直腸癌，侵犯漿膜層及腸周系膜；腸周多發淋巴結，考慮轉移瘤；肝S8結節，考慮轉移瘤。，診斷考慮：直腸癌並肝轉移（CT4N+M1A），於2015-05至2015-6給予XEXLOX（樂沙定200MG+希羅達1500MG BID D1-14）方案2程，評價PR,2015-08-10全麻上行腹腔鏡DIXON+開腹肝轉移瘤切除術。術中探查腫瘤位於腹膜反折下2CM處直腸，腫瘤突破漿膜，固定，大小4CM×5CM，肝S8實質內2枚腫物，分別1CM及2CM，予切除。，術後病理：1（直腸大體），鏡上：腸壁粘膜層至深肌層見少量粘液腺癌浸潤，未見明確脈管及神經束侵犯；另於腸壁粘膜至外膜層見多量粘液湖形成，伴纖維組織增生及炎症細胞浸潤，結合病史，符合治療後改變，MANDARD，分級：TRG3級。（中間淋巴結）鏡上見2個癌結節。淋巴結0/5陽性。MLH1（+），PMS2（+），MSH2（+），MSH6（+）；（肝腫物），鏡上：肝組織中見粘液腺癌浸潤，結合病史及免疫組化，符合腸癌肝轉移，癌旁肝組織部分肝細胞脂肪變性。，術後分期：PT2N1CM1A，IV期。2015-09-02、2015-09-24、2015-10-30、2015-12-04給予XELOX方案4程。2016-03-16，複查肝MRI提示：肝S6結節，考慮轉移瘤，較前為新發病灶。遂於2016-4-5行介入消融治療，治療後未繼續化療。2016-6-6MR，示：直腸癌肝轉移瘤消融術後，肝S6異常訊號灶，呈消融術後改變，未見明顯活性。肝內多髮結節，考慮轉移瘤，部分較前新發，肝S4病灶較前增大。右肺下葉、上葉類結節灶，建議必要時行胸部CT檢查。2016-6-21，複查CT示：兩肺結節，考慮轉移瘤。肝多發轉移瘤。2016-7-5、07-26、8-12、2016-09-01給予FOLFIRI方案4程，化療過程順利無特殊不適。末次化療至今，患者精神、睡眠、食慾可，二便如常，體重無明顯上降。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 75, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 114, "end_pos": 115}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 163}, {"end_pos": 191, "label_type": "藥物", "overlap": 0, "start_pos": 188}, {"end_pos": 200, "label_type": "藥物", "overlap": 0, "start_pos": 197}, {"label_type": "手術", "overlap": 0, "start_pos": 241, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 268, "end_pos": 279}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 333, "end_pos": 335}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 342, "end_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 376, "end_pos": 377}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 439}, {"end_pos": 497, "label_type": "解剖部位", "overlap": 0, "start_pos": 496}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 509, "end_pos": 513}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 528, "end_pos": 533}, {"end_pos": 537, "label_type": "解剖部位", "overlap": 0, "start_pos": 536}, {"end_pos": 542, "label_type": "解剖部位", "overlap": 0, "start_pos": 541}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 637, "end_pos": 641}, {"end_pos": 647, "label_type": "解剖部位", "overlap": 0, "start_pos": 644}, {"label_type": "手術", "overlap": 0, "start_pos": 675, "end_pos": 679}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 699, "end_pos": 701}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 704, "end_pos": 715}, {"end_pos": 719, "label_type": "解剖部位", "overlap": 0, "start_pos": 716}, {"end_pos": 741, "label_type": "解剖部位", "overlap": 0, "start_pos": 740}, {"end_pos": 763, "label_type": "解剖部位", "overlap": 0, "start_pos": 760}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 770, "end_pos": 777}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 788, "end_pos": 792}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 807, "end_pos": 809}, {"end_pos": 813, "label_type": "解剖部位", "overlap": 0, "start_pos": 811}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 822, "end_pos": 828}]}
{"originalText": "，緣於入院前4個月（2015.9）因排便次數增多伴血便，就診我院胃腸外科，，查腹部CT示：直腸上段右前壁偏心性管壁增厚，符合直腸癌改變，病變下上範圍約40MM，累及周徑約50%，病變直腸上緣距肛門口約61MM，病變直腸前緣與前列腺及精囊腺界限較清楚，兩側提肛肌無明顯受累及，直腸周圍間隙少許淋巴結輕度增大。，盆腔MRI示：直腸浸潤性病變，符合直腸癌（T3期），病灶上緣距離肛門約5.4CM，請結合臨床。診斷為“直腸癌”，（2015年9月29日）在全麻上行“腹腔鏡上直腸癌根治術MILES”，術順，術後病理回報（201535378），：（直腸），：大腸潰瘍型乳頭狀腺癌II級，侵及外膜層，手術標本下、上切端及另送(下切端)均未見癌浸潤。找到腸周淋巴結1/12個見癌轉移，另於腸粘膜面見雙個息肉樣隆起，鏡上分別為腸管狀腺瘤，伴低級別下皮內瘤變及腸增生性息肉。2、(腸繫膜上動脈根部淋巴結），：送檢為脂肪、脈管、纖維結締組織。術後（11.10）查盆腔，MRI：術區、肛周及臀部浸潤性病變，為感染性病變合併多發膿腫、瘻管形成，累及前列腺、精囊腺、部分腸管及尾骨。予中醫中藥治療後，複查盆腔MR（11.30），：術區、肛周及臀部浸潤性病變，為感染性病變合併多發膿腫、瘻管形成，累及前列腺、精囊腺、部分腸管及尾骨。與2015-11-10舊片比較，病變範圍較前縮小，部分膿腔縮小、吸收，前列腺後下方膿腔較前增大。考慮患者無腹痛、發熱等臨床症狀，血炎症指標正常，與患者及家屬溝通後開始輔助化療。（2015-12-02）開始予“奧沙利鉑150MG靜滴D1+氟尿嘧啶3500MG微量泵泵入D1+亞葉酸鈣250MG靜滴D1-2Q2W”輔助化療4個週期，過程順利。目前無明顯腹痛、腹脹，無畏冷、發熱，無肛門墜脹感，現為繼續治療求診我科，門診以“直腸癌術後”收住入院。自下次出院以來，精神、食慾、睡眠尚可，大小便如常，體重無明顯增減。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 39, "end_pos": 43}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 45, "end_pos": 49}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 65}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 95}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 111}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 139}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 154, "end_pos": 159}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 179}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 205, "end_pos": 208}, {"end_pos": 243, "label_type": "手術", "overlap": 0, "start_pos": 228}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 286}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 337}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 376}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 380}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 420, "end_pos": 426}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 430}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"end_pos": 468, "label_type": "解剖部位", "overlap": 0, "start_pos": 465}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 488, "end_pos": 492}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 507}, {"end_pos": 538, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}, {"end_pos": 542, "label_type": "解剖部位", "overlap": 0, "start_pos": 539}, {"end_pos": 547, "label_type": "解剖部位", "overlap": 0, "start_pos": 545}, {"end_pos": 550, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}, {"end_pos": 589, "label_type": "解剖部位", "overlap": 0, "start_pos": 586}, {"end_pos": 605, "label_type": "解剖部位", "overlap": 0, "start_pos": 604}, {"end_pos": 659, "label_type": "藥物", "overlap": 0, "start_pos": 655}, {"end_pos": 673, "label_type": "藥物", "overlap": 0, "start_pos": 669}, {"end_pos": 691, "label_type": "藥物", "overlap": 0, "start_pos": 687}, {"end_pos": 726, "label_type": "解剖部位", "overlap": 0, "start_pos": 725}, {"end_pos": 729, "label_type": "解剖部位", "overlap": 0, "start_pos": 728}, {"end_pos": 741, "label_type": "解剖部位", "overlap": 0, "start_pos": 739}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 760, "end_pos": 765}]}
{"originalText": "，2014-9進食哽噎，胃鏡示距門齒41CM低分化腺癌，2014-11-15行食管胃結合部癌根治術，術後病理；中-低分化腺癌，混合型，侵及肌層外脂肪纖維組織，癌栓+，14/40，切緣-；PT3N3A，CMET(+),EGFR(+),HER2（2+），本院FISH未擴增。，2014-12-15術後基線CT：食道癌術後，吻合口壁增厚，周圍片狀軟組織密度，右上包裹性液氣胸，術後改變？術前後腫標正常。2014-12-19始XELOX*6，食慾減退I度，自訴XELODA減量一片仍耐受差,末次2015.3.8,體重上降16KG。2015.4.28複查（-），2015-8-5，我院胃鏡：吻合口狹窄，擇期擴張。CA72.，4：8.13。現半流食，停化療後近5月內體重5KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"end_pos": 49, "label_type": "手術", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 66}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 148, "end_pos": 152}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"label_type": "藥物", "overlap": 0, "start_pos": 226, "end_pos": 232}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 301, "end_pos": 308}]}
{"originalText": "，2010-04-01行胃癌根治術（胃全切），，術後病理：低分化腺癌，術後化療，腹腔灌注2次，靜脈化療8次。後定期複查。現發現盆腔腫物，心包區腫物，肝臟前方軟組織影。2017-10-07出現腹痛，以右下腹及左上腹為主，2017-10-17 ，CT：左腎盂積液伴輸尿管擴張，左腎周炎症。梗阻於輸尿管盆段水平。左側附件區實性佔位性病變（4.5CM），心包前方不規則腫塊，考慮腫瘤性病變。盲腸後方、盆底多發強化結節，種植轉移？腹膜後淋巴結略腫大，盆腔少量積液。予抗感染治療後疼痛明顯好轉。，2017-10-19PET-CT：肝臟前方軟組織影，惡性病變轉移待除外，左側附件區軟組織，腹膜後及盆腔內多發淋巴結及小結節影，無代謝增高。2017-10-25，超聲引導腫物穿刺病理：符合胃癌轉移，CA125(-),CDX2(+),PAX2(-),CK7(+)現食納可，覺左側腹部脹痛不適，不能右側臥位，右側胸部疼痛，無咳嗽、胸悶，大小便正常，無陰道不規則出血，體重無上降。", "entities": [{"end_pos": 22, "label_type": "手術", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 34}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 252, "end_pos": 258}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 291, "end_pos": 293}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 322, "end_pos": 324}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 335, "end_pos": 337}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"end_pos": 397, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 416, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}]}
{"originalText": "，因體檢發現便潛血陽性就診，2013-8-20於我院行結腸肝區癌切除術，，術後病理：橫結腸結腸潰瘍型中分化腺癌，伴粘液分泌、壞死及鈣化灶，大小3.8×XXX3.1CM，侵及腸周纖維脂肪組織，可見脈管癌栓及神經侵犯，腸管雙斷端未見腫瘤，淋巴結見癌轉移3/14（腫物周圍1/5、腸周2/9），，腫瘤病理分期：PT3N1B，恢復良好，自覺傷口處稍硬。2013-10-19行XELOX化療4週期，無明顯不適，繼續口服希羅達，末次化療2014-2-13。現咽部有痰，不易咳，易困，食慾可，大便可，時有腹痛，睡眠欠佳。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"end_pos": 35, "label_type": "手術", "overlap": 0, "start_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 55}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 207, "label_type": "藥物", "overlap": 0, "start_pos": 204}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}]}
{"originalText": "，患者1+年前經常上腹痛伴上墜感，未引起重視，未做任何檢查。於7月20號右左給予健康查體發現卵巢囊腫大小約120MM×90MM右左（具體大小不詳），建議進一步診療，遂於2017年8月5日來我院就診，，門診B超示：子宮切除術後，膀胱後方探及大小約128MM×96MM×110MM的囊性回聲，內見分離，透聲可。，CDFI：囊壁及分離未見明顯血流訊號。兩側卵巢顯示不清。，超聲提示：子宮切除術後；膀胱後方囊性包塊。現患者仍有上腹部隱痛，無陰道流血，無發熱等不適，門診以“卵巢囊腫”收入院。   患者自發病以來，精神、飲食好，睡眠欠佳，大小便無異常，體重無明顯改變。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 50}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 112}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 195, "end_pos": 197}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 232, "end_pos": 236}]}
{"originalText": "患者因“子宮平滑肌肉瘤”於2015.11.11在全身麻醉上行經腹子宮+兩附件+盆腔淋巴結清掃+大網膜部分切除術。手術順利，病理結果（40522.15）（子宮）平滑肌肉瘤，體積約9*7.6*6.5CM，細胞密集區，核分裂象＞10個/10HPF。右左宮旁、（右左骨盆漏斗）結締組織，均未查見腫瘤細胞。右閉孔淋巴結3枚、左閉孔淋巴結5枚、右髂血管淋巴結4枚、左髂血管淋巴結3枚、右髂總淋巴結1枚及左髂總淋巴結2枚，其內均未查見腫瘤。慢性宮頸炎伴腺體鱗化。子宮平滑肌瘤。（兩側）輸卵管急慢性炎，卵巢黃體，左側卵巢並單純性囊腫。第一次化療前查CA-125:40.65U/ML,2015.12.8，2015.12.29行多西他賽120MG+吉西他濱1.2G D1 D8方案化療，2016-01-21行多西他賽120MG+吉西他濱1.2G及2016-01-30行吉西他濱1.0G方案化療；2016-2-15行多帕菲120MG+吉西他濱1.2G及2016-02-22行吉西他濱1.0G方案化療；2016-3-9行多帕菲120MG+吉西他濱1.2G及2016-03-17行吉西他濱1.0G方案化療。 現患者為求化療，來我院就診，門診以“子宮平滑肌肉瘤”收入院。患病以來，精神尚可，飲食睡眠可，大小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 11}, {"label_type": "手術", "overlap": 0, "start_pos": 30, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 125}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 133}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 223}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 230}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 231, "end_pos": 258}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 266, "end_pos": 272}, {"end_pos": 308, "label_type": "藥物", "overlap": 0, "start_pos": 304}, {"end_pos": 318, "label_type": "藥物", "overlap": 0, "start_pos": 314}, {"end_pos": 348, "label_type": "藥物", "overlap": 0, "start_pos": 344}, {"end_pos": 358, "label_type": "藥物", "overlap": 0, "start_pos": 354}, {"end_pos": 378, "label_type": "藥物", "overlap": 0, "start_pos": 374}, {"end_pos": 400, "label_type": "藥物", "overlap": 0, "start_pos": 397}, {"end_pos": 410, "label_type": "藥物", "overlap": 0, "start_pos": 406}, {"end_pos": 430, "label_type": "藥物", "overlap": 0, "start_pos": 426}, {"end_pos": 451, "label_type": "藥物", "overlap": 0, "start_pos": 448}, {"end_pos": 461, "label_type": "藥物", "overlap": 0, "start_pos": 457}, {"end_pos": 481, "label_type": "藥物", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 509, "end_pos": 516}]}
{"originalText": "，患者2月前因“進食梗阻感半月餘”於2015.12.29在全麻上行近端胃癌根治術，手術順利，術後患者恢復良好，術後常規病理示（胃）低-中分化腺癌伴神經內分泌分化，潰瘍型，腫瘤切面積3*0.8CM，侵達漿膜。下、上切緣及吻合器切緣未查見癌。小彎側淋巴結12枚，大彎側淋巴結1枚及另送食管旁淋巴結1枚，均未查見轉移癌。網膜組織未查見癌。，免疫組化：CK19（+），E-CAD（+），HER-2（0），SYN（+），CGA（-）。，病理號：47508.15。現患者為行進一步治療來我院就診，門診以“胃癌術後”收入院。患者近期飲食睡眠可，大小便無明顯異常，體重較前略有減輕。", "entities": [{"end_pos": 40, "label_type": "手術", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 84}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 250}]}
{"originalText": "，患者5月餘前因“粘液血便2月餘。”入我院，完善檢查考慮橫結腸腺癌，遂於203-10-29我院行腹腔鏡上橫結腸切除手術，，術後病理：中分化腺癌，浸潤至腸壁漿膜上層，未見明確脈管及神經束侵犯。（中央組淋巴結）7枚，6/7見腺癌轉移；（中間組淋巴結）2枚，1/2見腺癌轉移；（腸旁淋巴結）8枚，8/8見腺癌轉移，脈管內見癌栓；，術後分期：PT3N2BM0 IIIC期。術後外院行XELOX方案化療5程；化療過程中發現右上腹包塊，遂行PET-CT檢查吻合口放射性攝取升高，右側腹壁內放射性攝取升高；外院行腸鏡檢查提示吻合口復發，中分化腺癌浸潤。為求進一步治療，隨來我院。自發病以來，患者無噁心、嘔吐等，無發熱、咳嗽、身目黃染，無骶部痛等，精神可，納眠可，小便無異常，體重上降不明顯。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 33}, {"end_pos": 59, "label_type": "手術", "overlap": 0, "start_pos": 48}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 122}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 214, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 261, "end_pos": 266}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}]}
{"originalText": "，病史見前，2008.1行結腸癌手術，術後，定期複查。2010.3.17發現肝轉移，行手術，口服希羅達*8。2010.9末次。2012.2.28複查腫標正常。，CT:左髂血管旁及左腹股溝腹股溝淋巴結增大 （42*23MM，2011.11 34*17MM）3月查瘤標一項略升高（具體不詳）。2012.3.12，多學科查房意見：根據影像檢查考慮淋巴結轉移可能性較大，但腫標正常，建議隨訪複查暫不予特殊治療。2012-5-29我院複查腹盆CT示左側髂血管旁及左側腹股溝淋巴結較前增大（44*26MM，2012.2 42*23MM），2012-5-31腫標均正常。\\U0004\\U0004  2012-09-07來院複查，，今結果已歸：腫標正常。胸片未見異常。腹盆CT與2012-05-29比較未見腫瘤進展表現。\\U0004\\U0004  現時有左下腹不適，乏力，食慾差，近期體重有上降。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 13, "end_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"end_pos": 51, "label_type": "藥物", "overlap": 0, "start_pos": 48}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 80, "end_pos": 82}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 214, "end_pos": 218}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 319, "end_pos": 321}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 326, "end_pos": 330}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}]}
{"originalText": "，患者1+月前因子宮縱隔行宮腔鏡子宮縱隔電切術。，術前查TCT示：低度鱗狀下皮內病變。，術後複查行陰道鏡宮頸活檢病理示：慢性宮頸炎，部分鱗狀下皮增生活躍，符合低級別鱗狀下皮內病變，局灶不除外高級別鱗狀下皮內瘤變（CINII）；，免疫組化：P16（區域性鱗狀下皮及腺體鱗狀下皮全層+），KI67+,結合HE形態，結果支援區域性高級別鱗狀下皮內病變（CINII），累及腺體。患者術後陰道流血淋漓不淨，無腹痛，無接觸性出血。為求進一步治療來我院就診，門診遂以“宮頸病變”收入院。患者自發病以來，無頭暈、乏力，無噁心、嘔吐，無腹痛、腹瀉，飲食睡眠可，大小便無異常，體重無增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 12}, {"end_pos": 23, "label_type": "手術", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 42}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 177}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 229}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}]}
{"originalText": "，患者2011年12月因“腹部脹痛半年餘”於外院行超聲、MR檢查發現兩側卵巢腫物伴腹水。隨後於我院就診，，行腸鏡檢查示：結腸肝區處粘膜充血腫脹，周圍見白斑，腸腔明顯變性狹窄，內鏡無法透過。，活檢病理：中至低分化腺癌。胃鏡未見明顯異常。經全院專家大會診後於2011.12.15行剖腹探查術，術中見肝區結腸腫物及兩卵巢腫物，盆、腹腔腹膜廣泛種植，腹水約1500ML。遂行左半結腸切除+兩卵巢切除。術中及術後腹腔熱灌注化療3次(43℃1小時,，術中：5－FU 2G ,，術後：5－FU 1G 2次)。，末次腹腔熱灌注化療時間：2011.12.19。，術後病理示：1、右卵巢15×12×7CM， 左卵巢13×9×6CM，鏡檢為低分化腺癌，大部分為粘液腺癌，符合腸腺癌轉移。2、肝曲結腸腫物大小為4×4×2CM，鏡檢為粘液腺癌，浸潤至腸壁外膜層，未見明確血管及神經束侵犯。淋巴結7/25（+），，K-RAS：野生型。經院內專家大會診後建議行C225+FOLFIRI方案化療。現為求進一步治療入院。患者精神、納眠可，大小便正常，近期體重無明顯上降。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 28, "end_pos": 30}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 107}, {"end_pos": 143, "label_type": "手術", "overlap": 0, "start_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 151}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 170}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "手術", "overlap": 0, "start_pos": 183, "end_pos": 195}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 226, "label_type": "藥物", "overlap": 0, "start_pos": 222}, {"end_pos": 239, "label_type": "藥物", "overlap": 0, "start_pos": 235}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 294}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 309, "end_pos": 331}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 358}, {"end_pos": 419, "label_type": "藥物", "overlap": 0, "start_pos": 415}]}
{"originalText": "2011年4月起患者出現無誘因大便帶血，診斷為乙狀結腸腺癌，2011.7.13我院全麻上行腹腔鏡DIXON術，左側附件切除術，術中診斷為直腸下段癌晚期，肝轉移。術後病理示：(直腸)潰瘍型腺癌，分化III級，伴大片壞死，侵及全層及周圍脂肪組織，脈管內見癌栓，神經見癌累及；雙切緣未見癌累及。術後門診全身化療五次。2011-10-28ＭＲＩ乙狀結腸MT病例，肝內多發轉移瘤；肝、兩腎多發小囊腫，肝內膽管輕度擴張。為進一步診治收入我院，患病以來精神胃納可，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 29}, {"label_type": "手術", "overlap": 0, "start_pos": 45, "end_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 102}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 174}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 184}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 221, "end_pos": 222}]}
{"originalText": "，2012.12.21行手術探查，術中見回盲部腫物，腫物與大網膜粘連，行左半結腸切除術，，病理：中分化腺癌，網膜組織見癌結節。侵及漿膜上斷端淨，淋巴結0/21。2013-1-15行FOLFOX*10週期。，末次：2013-6-4.已行DC-CIK回輸3次。治療期間複查未見腫瘤復發轉移徵象。\\U0004\\U0004 10週期後患者出現神經毒性II度，持續不緩解，停止化療。此次入院複查，2013-6-27，外院查盆腔B超：左卵巢囊腫。胸部CR未見異常。腹部B超未查。\\U0004\\U0004。", "entities": [{"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 20}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 53}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 206, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 216}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 217, "end_pos": 221}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 226, "end_pos": 230}]}
{"originalText": "患者1個月前因腹部疼痛伴發熱、寒戰於我科住院治療，膽囊結石、膽囊穿孔、膽總管結石於我科住院治療，給予抗生素治療並行膽囊穿刺置管引流術，術後患者病情平穩，帶管出院。13天前患者再次出現腹痛伴發熱，膽囊引流管不通暢，於我院給予生理鹽水衝管後仍不通暢，2016-2-4行CT檢查提示“左肺大泡，冠狀動脈鈣化；兩肺間質性病變；心包積液並心包增厚；膽總管結石；膽囊結石並膽囊炎；膽囊穿孔不除外，清結合臨床；腹水，腹膜增厚；腸管擴張，胃竇壁厚，請結合臨床”，給予抗生素治療4天，腹痛好轉，未再發熱，膽囊穿刺引流管仍不通。現患者為求進一步診療，來我科門診，以“膽囊結石、膽總管結石”收入院。患者自發病以來，患者飲食、睡眠差，大小便未見明顯異常，體重較前有所減輕，具體不詳。既往糖尿病史10餘年，平時服用二甲兩胍、格列齊脲，血糖控制可。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 40}, {"end_pos": 66, "label_type": "手術", "overlap": 0, "start_pos": 57}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 132, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 144, "end_pos": 148}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 188}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 283}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 334}, {"end_pos": 348, "label_type": "藥物", "overlap": 0, "start_pos": 344}, {"end_pos": 353, "label_type": "藥物", "overlap": 0, "start_pos": 349}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 354, "end_pos": 356}]}
{"originalText": "患者因“便血10年餘，加重2月”於2013年5月到我院就診，經完善檢查診斷為直腸腺癌（CT3NXM0），予2013-05-17日起行術前XELOX方案化療3程＋同期放療共50GY/25次，末次放療時間2013-08-01，末次化療時間2013-08-06，療程順利，自訴便血減少，現大便3-4次/天，複查MR示腫物有所縮小，於2013-11-21給予希羅達方案化療1程，2013-12-11全麻上行腹腔鏡探查+橫結腸兩腔造口術+經陰直腸陰道瘻修補術。術後希羅達單藥化療至今5程，現為求進一步診治入住我院。近雙月，患者精神、食慾、睡眠尚可，小便正常，體重上降2KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 51}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 152, "end_pos": 154}, {"end_pos": 178, "label_type": "藥物", "overlap": 0, "start_pos": 175}, {"label_type": "手術", "overlap": 0, "start_pos": 199, "end_pos": 224}, {"end_pos": 230, "label_type": "藥物", "overlap": 0, "start_pos": 227}]}
{"originalText": "，患者2014-12月因升結腸癌於2014-12-05我院行“腹腔鏡左半結腸切除術”，，術後病理：結腸中分化腺癌，癌組織浸潤腸壁漿膜上層，未見淋巴結轉移。術後未行輔助治療，規律隨診。2015-03-16查CEA 170.9NG/ML，CA199 193.4U/ML，遂行PET/CT檢查，示右附件區體積增大，區域性代謝活躍，疑惡性病變，腸癌轉移與原發瘤相鑑別；甲狀腺右葉低密度影代謝活躍，考慮甲狀腺癌可能性大；右股骨頸及股骨下段骨質破壞，代謝較活躍，疑骨良性病變，不除外甲狀腺癌轉移可能，建議隨診。2015-04-09全麻上行“甲狀腺右葉+峽部切除+右VI區淋巴結清掃術+右側喉返神經探查術+全子宮兩附件切除術”，，術後病理：結腸癌卵巢轉移；結節性甲狀腺腫。術後於2015-5-7、05-28行XELOX方案化療2程，化療後出現II度噁心、I度腹瀉，未規律監測血象，複查2次血常規未見骨髓抑制。現遵主診教授意見未行上一程化療入院。近期以來，患者精神、睡眠可，食慾一般，大便2-3次/天，成形便，小便基本正常，近期體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 102, "end_pos": 105}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 117, "end_pos": 122}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 135, "end_pos": 141}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 171}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 240}, {"label_type": "手術", "overlap": 0, "start_pos": 263, "end_pos": 304}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 312, "end_pos": 327}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}]}
{"originalText": "，患者因\\\"體檢發現宮頸癌3周。\\\"於2014-2-11在我院全麻上行\\\"腹腔鏡上宮頸癌根治術(II型子宮切除+兩側附件切除+盆腔淋巴結清掃術）\\\"。，術後病理示：宮頸低分化鱗狀細胞癌，癌組織侵犯至宮頸淺肌層並累及宮頸管淺肌層，未累及陰道穹窿，未見明確脈管及神經束侵犯；盆腔淋巴結未見癌；兩附件，兩側主韌帶、骶韌帶，陰道殘端未見癌。2014-2-26、2014-3-19、2014-4-8予以TP方案化療一程，化療過程順利，現為進一步化療入院。患者無發熱畏寒，無腹痛腹瀉，無胸悶氣促，精神可，睡眠可，胃納可，大小便無異常，體重無明顯減輕。，既往化療及腫瘤標誌物情況：，化療藥物毒副反應：。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 37, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 101}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 109}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 251}]}
{"originalText": "，患者4年前外院直腸癌根治術，，手術病理：具體不詳，術後未行放化療，中藥治療，2月前出現腰骶部疼痛，，外院核磁提示：骶前佔位，PET/CT，檢查提示：骶前高代謝增高灶，考慮區域性復發，給予骶前復發病灶精確放療，GTV 55GY CTV 50GY/27F，同期卡培他濱 825MG/M2 BID D1-D5/W，目前放療結束後1年後複查，吻合口復發，，活檢病理：腺癌，KRAS 突變型，2016-4-28給予XELOX方案化療1週期，患者大便較前好轉，未訴便血,2016-5-17繼續XELOX方案化療2週期，2016-6-7行第三週期XELOX方案化療，目前患者噁心、嘔吐I度，腹瀉2次/日，水樣便，小便正常，飲食稍少，睡眠可。", "entities": [{"end_pos": 14, "label_type": "手術", "overlap": 0, "start_pos": 8}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 63, "end_pos": 69}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 132, "label_type": "藥物", "overlap": 0, "start_pos": 128}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 190}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}]}
{"originalText": "，患者3月前無明顯誘因出現噁心，進食後腹脹明顯，無嘔吐，無進食困難，無腹痛、腹瀉。當時未予重視。1月前前患者就診於我院，門診行胃鏡檢查，，鏡上診斷：食管病變待病理，慢性非萎縮性胃炎。，病理診斷：（食管）鱗狀下皮呈重度不典型增生。2016-3-8行共聚焦胃鏡檢查，，鏡上診斷：食管糜爛，非萎縮性胃炎。，病理診斷：（食管）粘膜鱗狀下皮呈中度至重度不典型增生伴慢性炎症。後為行內鏡上治療，於我院消化內科住院治療。給予抑酸對症治療，查胸部CT示發現縱隔及左肺門淋巴結腫大，轉移瘤不除外，2016-3-29行左側頸部淋巴結穿刺活檢，，病理示：淋巴結內查見轉移的低分化癌，建議檢查肺。隨後患者門診行支氣管鏡檢查，刷檢物未見病理細胞，建議行EBUS-TBNA檢查，近患者為求進一步診治再次來我院，門診以“縱隔淋巴結腫大”收入我科。患者自發病來飲食上降，睡眠可，大小便無改變，體重無減輕。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 82, "end_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 148}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 181}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 213, "end_pos": 217}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 279}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 345, "end_pos": 352}]}
{"originalText": "，患者3年餘前（2010年）無明顯誘因出現左下腹疼痛，呈針刺樣疼痛，持續時間短暫，可自行緩解，無腹脹、嘔吐，未特殊檢查治療。2013-7出現左下腹疼痛疼痛加重，呈陣發性絞痛，無放射痛，伴腹脹，飲食量減少或適當活動腹脹可緩解，無嘔吐及發熱。並有便血，遂就診於我院，，結腸鏡示：結腸肝曲佔位，腸腔環周狹窄，腸鏡不能透過。腹盆腔，CT：1、升結腸腸壁增厚，考慮結腸癌，侵犯漿膜。2、升結腸腸周、腸繫膜根部及腹膜後多發腫大淋巴結，考慮轉移。胸部CT未見轉移徵象。術前，CEA：19.87NG/ML；，術前分期：CT4AN+M0。2013-7-25於我院行“全麻上剖腹探查、左半結腸切除術”，術中見腹膜、大網膜多發轉移，腹腔多發淋巴結腫大。術中予氟尿嘧啶植入劑、防粘連貼膜、可吸收止血紗/海綿、銅綠假單胞菌注射液。患者術後間斷低熱，傷口區域性疼痛，2013-8-7行傷口拆線，後每日午後低熱，體溫最高38.5℃，物理降溫可降至正常，現傷口局部發紅，自服右氧氟沙星後略好轉。現為進一步診治收入院。患者病來飲食睡眠好，大小便如常，體重無減輕。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 158, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 188, "end_pos": 193}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 199}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 201}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 216, "end_pos": 220}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 230, "end_pos": 233}, {"label_type": "手術", "overlap": 0, "start_pos": 274, "end_pos": 289}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 294, "end_pos": 295}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 322, "label_type": "藥物", "overlap": 0, "start_pos": 318}, {"end_pos": 351, "label_type": "藥物", "overlap": 0, "start_pos": 342}, {"end_pos": 425, "label_type": "藥物", "overlap": 0, "start_pos": 420}]}
{"originalText": "患者於2010-6-13在我院診斷為\\\"右乳浸潤性導管癌\\\"，完善檢查後於2010-6-25、2010-7-16、2010-8-6行TEC方案新輔助化療3程，2010-8-26全麻上行右乳癌改良根治術+右鎖骨下淋巴結活檢術，術後病理示浸潤性導管癌，ER++/PR++，HER-2(-),YPT1N3M0，IIIC期，於2010-9-9、2010-9-30行TEC化療2程，因3度骨髓抑制改GX方案化療2程，2010-12-14～2011-1-20原發灶及區域淋巴結50GY放射治療。後定期隨診，2012年5月發現CA153升高，2012-6-4我院PET/CT檢查示肝VIII段考慮轉移。2012-6-6乳腺科聯合會診建議排除婦科疾病後行兩側卵巢切除去勢手術。2012-6-18行\\\"腹腔鏡上兩側卵巢切除術\\\"。於2012-7-2、7-25、8-16、9-5、9-26、10-18、11-06、11-29給予NVB+XELODA方案姑息性化療8程。現8程後已行CT複查，結果未回。下程化療後出現噁心、食慾上降、右肩關節不適等，現為繼續治療入院。入院時患者一般情況良好，偶有胸悶，無氣促等不適，訴周身遊走性疼痛，因今晨滑到，訴有右側肘部及踝關節疼痛。患者精神、胃納、睡眠可，大小便正常，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 28}, {"label_type": "手術", "overlap": 0, "start_pos": 92, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 123}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 256, "end_pos": 261}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 274, "end_pos": 280}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 329, "label_type": "手術", "overlap": 0, "start_pos": 319}, {"end_pos": 353, "label_type": "手術", "overlap": 0, "start_pos": 342}, {"end_pos": 407, "label_type": "藥物", "overlap": 0, "start_pos": 404}, {"end_pos": 414, "label_type": "藥物", "overlap": 0, "start_pos": 408}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 430, "end_pos": 432}, {"end_pos": 459, "label_type": "解剖部位", "overlap": 0, "start_pos": 455}, {"end_pos": 487, "label_type": "解剖部位", "overlap": 0, "start_pos": 486}, {"end_pos": 517, "label_type": "解剖部位", "overlap": 0, "start_pos": 513}, {"end_pos": 521, "label_type": "解剖部位", "overlap": 0, "start_pos": 518}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 529, "end_pos": 530}]}
{"originalText": "患者自述於2年7個月前因體檢時查腹部超聲發現胃區回聲不均勻,後查胃鏡檢查示胃竇部巨大潰瘍性病變取病理為低分化腺癌,`後於我院腫瘤外科行胃癌根治術（2011-7-4），術中見腫物位於胃竇部大彎側,已侵透漿膜,腹腔粘連較輕,術後病理為進展期胃癌，中、低分化腺癌及粘液腺癌，腫物浸透漿膜，淋巴結3/27枚轉移，病理號為126582。後入我科行樂沙定聯合替吉奧方案化療8週期，具體為奧沙利鉑（樂沙定） 250毫克 D1靜點，替吉奧（愛斯萬） 60毫克 D1-D14日雙次口服，末次化療時間2012-1，化療結束後於我科行生物治療1週期，定期複查未見覆發轉移徵象，1年8個月前入院複查CA724下升達98.3NG/ML，予替吉奧60毫克日二次口服D1-D14，並行生物治療9週期。近來患者偶有乏力，現為進一步治療入我科。患者近1月飲食睡眠一般，精神體力可，周身無疼痛，二便基本正常，體重無明顯變化，ECOG評分1分。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 23}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 56}, {"end_pos": 72, "label_type": "手術", "overlap": 0, "start_pos": 67}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 133}, {"label_type": "藥物", "overlap": 0, "start_pos": 168, "end_pos": 171}, {"end_pos": 176, "label_type": "藥物", "overlap": 0, "start_pos": 173}, {"end_pos": 191, "label_type": "藥物", "overlap": 0, "start_pos": 187}, {"end_pos": 195, "label_type": "藥物", "overlap": 0, "start_pos": 192}, {"end_pos": 211, "label_type": "藥物", "overlap": 0, "start_pos": 208}, {"end_pos": 215, "label_type": "藥物", "overlap": 0, "start_pos": 212}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 287, "end_pos": 292}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 306}]}
{"originalText": "因“體檢左肝佔位”當地確診HCC？，術前未見遠處M，AFP（-），2014.3.23行肝部分切除及膽囊切除術，術中探查無腹水，小結節性肝硬變，S6近髒面，約4*3CM，病理示左葉肝細胞性肝癌，中分化，AFP（-），HEPOTOCYTE（-），術後未治療。術後行肝血管造影（-）；外院2014-12-28腹CT示腹膜後LNM，3.1CM？2015.1.5始行腹膜後LNM放療6300CGY/35F，2015.2.28結束，2015.3.29 CT報告示穩定33*29MM，現AFP正常。2015.4.20口服SORAFINIB，同時2015.4.20 CT：腹膜後佔位相仿，肝腎之間佔位新發？侵及十二指腸，間斷黑便，飲食可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 26, "end_pos": 29}, {"label_type": "手術", "overlap": 0, "start_pos": 43, "end_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 99}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 100, "end_pos": 103}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 107, "end_pos": 117}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 130, "end_pos": 135}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 151, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 184}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 236, "end_pos": 239}, {"end_pos": 262, "label_type": "藥物", "overlap": 0, "start_pos": 253}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 274, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 278, "end_pos": 279}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 290}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}]}
{"originalText": "患者宮頸癌IIB期。2012-7-13於外院行TP方案化療1週期。2012-8-31行廣泛性全子宮切除+盆腔淋巴結清掃術，術後病理會診示子宮、兩附件及淋巴結：1.宮頸，浸潤性低分化鱗癌，癌浸潤宮頸壁全層，區域性延伸到宮旁組織，可見脈管癌栓，手術切緣未見腫瘤，轉移性宮頸鱗癌見於2個淋巴結/57，右髂內1/1，右閉孔1/14。2012-9-29複查腹部增強CT示腹主動脈旁多發淋巴結，較大者轉移待排；左側腎盂、輸尿管輕度積水。盆腔增強MR示兩側腹股溝多發小淋巴結。2012-10-18行TP方案化療1週期。後於當地行放療，具體不詳。2015-4我院複查示右肺上葉轉移，縱膈淋巴結轉移。2015-4-12,5-8，6-8，7-15、2015-9-14多西他賽120MGD1+奈達鉑50MGD1-2化療5程。2015-6-2胸CT示右肺上葉不規則結節明顯縮小。2015-8-31複查胸部增強CT右肺上葉結節繼續減小。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 2, "end_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 60}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 81, "end_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 98}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 135}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 211, "end_pos": 217}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 223}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 289}, {"end_pos": 326, "label_type": "藥物", "overlap": 0, "start_pos": 322}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 334}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 358, "end_pos": 361}, {"end_pos": 366, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 387, "end_pos": 393}, {"end_pos": 397, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}]}
{"originalText": "，患者1月餘前無明顯誘因出現大便帶血，與大便混合，呈膿血狀，遂於2013-6-4就診我院行結腸鏡檢查發現距肛門55CM橫結腸中段、30CM乙狀結腸見雙枚息肉，均為廣基，前者約3CM大小，後者約1CM大小，頭部充血，輕度分葉狀改變，質地柔軟。，術後病理示:(橫結腸)絨毛狀管狀腺瘤，III級，（乙狀結腸）粘膜急慢性炎症。於2013-6-26在我院行橫結腸腺瘤切除術,，術後病理示:橫結腸高級別下皮內瘤變,部分惡變(粘膜內癌)。為求進一步手術治療入院。患者自發病以來精神睡眠食慾尚好，小便如常，大便如下述，體重無明顯改變。", "entities": [{"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 158}, {"end_pos": 181, "label_type": "手術", "overlap": 0, "start_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 189, "end_pos": 211}]}
{"originalText": "，緣於4月前(2016.07.14)因食管胃交界部腺癌於我院行根治性全胃切除+食管-空腸ROUX-EN-Y吻合術，，術中探查：無腹水，肝臟表面光滑，未觸及結節。大網膜與右側腹腔粘連，腹膜後、空迴腸未見明顯病變，賁門未觸及明顯腫塊，術前賁門癌診斷明確，遂決定行賁門癌根治術。術順，術後予禁食、胃腸減壓、抗感染、制酸、腸內外營養支援等治療。術後病理（201624597），：（全胃），：食管胃交界早期淺表隆起型（0-IIA型，腫瘤主體位於胃）管狀腺癌II級，區域性為黏液腺癌，侵及黏膜上層。手術標本下切端、上切端及另送(下切端)均未見癌浸潤。找到賁門周淋巴結0/5個，小彎側淋巴結1/1個，大彎側淋巴結0/2個，見癌轉移。於2016.07.26腹腔引流袋有淡黃色液體流出，數字胃腸示根治性全胃切除術+食管-空腸吻合術後，吻合口瘻。予腹腔引流、舒普深聯合甲硝唑加強抗感染治療，多次複查消化道提示吻合口癒合良好，病情好轉、穩定。於2016.10.11行“泰素240MGIVGTTD1+順鉑60MGIVGTTD1、2Q3W”方案化療1週期，輔以保肝、護胃、止吐、對症支援等治療。過程順利，2016.10.13出院。出院後患者出現骨髓抑制，白細胞低至1.1×10^9/L，血紅蛋白低至77G/L，血小板低至46×10^9/L，予住院治療恢復白細胞至8×10^9/L，血紅蛋白至85G/L，血小板低108×10^9/L後出院。今為行第二週期化療就診我院，門診擬食管胃交界部腺癌術後化療後收住我科。近來，精神、睡眠、飲食一般，大小便如常，體重無明顯增減。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 27}, {"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 56}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"end_pos": 135, "label_type": "手術", "overlap": 0, "start_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 146, "end_pos": 147}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 234}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 338, "end_pos": 361}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 363}, {"end_pos": 371, "label_type": "藥物", "overlap": 0, "start_pos": 368}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 373}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 388}, {"end_pos": 424, "label_type": "藥物", "overlap": 0, "start_pos": 422}, {"end_pos": 439, "label_type": "藥物", "overlap": 0, "start_pos": 437}, {"end_pos": 468, "label_type": "解剖部位", "overlap": 0, "start_pos": 467}, {"end_pos": 471, "label_type": "解剖部位", "overlap": 0, "start_pos": 470}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 513, "end_pos": 516}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 529, "end_pos": 533}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 541, "end_pos": 544}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 576, "end_pos": 580}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 587, "end_pos": 590}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 622, "end_pos": 632}]}
{"originalText": "，患者於8月前無明顯誘因出現腹痛，遂就診**六院，，行胃鏡檢查示：距門齒36CM處可見一腫物，，活檢病理示：低分化鱗狀細胞癌。，行CT示：肝、腹膜及腹膜後淋巴結轉移。2013-06-21至2013-12-05行DCX方案化療6程。5程化療後出現聲嘶。6程化療後出現味覺消失。對症處理後緩解。2、5，程化療後CT示：轉移瘤較前縮小。2013-12-05行DX方案化療1程。後予希羅達維持4個月。後再改為DCX方案化療2程，2程後評價為PD。於2014-09-22行FOLFIPI方案化療1程。今為求進一步診治來我院。患者發病以來。精神佳,飲食睡眠不佳,大小便正常，體重無減輕。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 62}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 65, "end_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 82}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 153, "end_pos": 155}, {"end_pos": 190, "label_type": "藥物", "overlap": 0, "start_pos": 187}]}
{"originalText": "，2010年2月患者因“進行性身目黃染2+月”於我院就診，行MR(2010-2-8)，示：“肝內外膽管、膽總管擴張，十二指腸大乳頭佔位性病變，腺瘤與腺癌鑑別。門腔間隙淋巴結腫大”。遂於2010-3-1我院行“胰十二指腸切除術”，手術過程順利，術後病理示“十二指腸乳頭中分化腺癌，浸潤腸壁淺肌層；未累及胰腺及胃壁組織；網膜組織未見癌。淋巴結（0/9）陽性。”術後分期T2N0M0。於2010-4-28至2010-11-5口服希羅達8程，化療耐受可。2012年1月底，患者無明顯誘因出現右下腹陣發性針刺狀疼痛並腰背部疼痛，偶影響睡眠，2012-3-20我院PET/CT，提示：“右鎖下、腹腔肝門區及腹主動脈旁多個淋巴結代謝活躍，考慮轉移瘤。胰腺略腫大，代謝略活躍，請結合臨床。”，右鎖下下淋巴結活檢示：“破碎的淋巴細胞及結締組織中見分化腺癌浸潤”。2012-4-18行FOLFOX方案化療1程，下程化療後骨髓抑制0度，現患者進一步治療入我院。目前患者一般情況可，胃納、睡眠一般，大小便正常，體重上降約2.5KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 17}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 76}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 112, "label_type": "手術", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 153, "end_pos": 154}, {"end_pos": 214, "label_type": "藥物", "overlap": 0, "start_pos": 211}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 276, "end_pos": 282}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 320, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 429}]}
{"originalText": "患者2011年4月因肝癌於我院行復雜肝癌切除（肝中葉切除）+膽總管探查+T管引流術，術中見腫瘤位於肝中葉，IV、V、VIII段，左側緊靠膽囊床底部，向上緊貼騎跨肝總管右左肝管分叉並壓迫第一肝門右外葉，大小約10*9*8CM，界清，無包膜。術後病理檢查示(肝左葉)腺癌伴大片壞死，脈管內見癌栓，結合病史及酶標結果，考慮膽囊癌肝轉移。術後患者恢復可，常規隨訪，2012-8-27患者於我院行腹部MRI檢查示肝右外葉見直徑約1.1CM結節狀長T1長T2訊號，邊界不清，增強掃描動脈期邊緣強化，放射學診斷原發性肝癌術後，肝右外葉結節，考慮復發灶可能，為求進一步治療收入院。患者自發病以來，胃納雙便可，精神睡眠可，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 16, "end_pos": 41}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 158, "end_pos": 164}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 193, "end_pos": 198}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 248, "end_pos": 255}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}]}
{"originalText": "，患者半年前出現下腹部不適，，行胃鏡：胃小彎、胃角不規則潰瘍，，病理：中低分化腺癌。2012-3-14行胃癌根治術+肝轉移切除，，術中見：胃小彎、胃角胃壁增厚，侵出漿膜。，術後病理：低分化腺癌，侵出漿膜，切緣（-），淋巴結1/4，肝轉移低分化腺癌。\\U0004\\U0004 術後予以4週期SOX化療，末次化療時間2012-07-5.未予以繼續化療。 2012-10-09 CEA 117.8，較前升高。，PET-CT：肝門區及胃小彎淋巴結轉移，肝多發轉移瘤。2012.11.2開始我科住院行“紫杉醇+希羅達”方案二線化療5週期。消化道反應I度，輕微指端麻木I度，HFS II度。2週期評效SD，4週期評效縮小SD。，末次化療時間：2013-1-29.此後建議區域性放療，未行。2013-3-11當地複查CT。CEA較前升高80+至200+。2013-3-14PET/CT，電話回報：肝門區、肝左後葉高代謝，考慮轉移，腹腔淋巴結腫大，性質待定，第10棘突輕度代謝，性質待定。，給予肝轉移病灶及腹腔淋巴結精確放療 GTV 55GY CTV 50GY/28F，希羅達 825MG/M2 BID D1-D5/W，目前放療7次\\U0004\\U0004。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 41}, {"label_type": "手術", "overlap": 0, "start_pos": 52, "end_pos": 63}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 91, "end_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 123}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 186, "end_pos": 189}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 202, "end_pos": 208}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 228}, {"end_pos": 249, "label_type": "藥物", "overlap": 0, "start_pos": 246}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 250}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 350, "end_pos": 352}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 353, "end_pos": 356}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 378, "end_pos": 384}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 390}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"end_pos": 425, "label_type": "解剖部位", "overlap": 0, "start_pos": 420}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 438, "end_pos": 441}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 444}, {"end_pos": 480, "label_type": "藥物", "overlap": 0, "start_pos": 476}]}
{"originalText": "，患者2013年3月因“納差，面板黃染”，外院行PET/CT，示：膽總管上段近胰頭惡性腫瘤；胃小彎、胰頭周圍多發淋巴結轉移灶。後至**一院，於2013-04-02全麻上行“胰十二指腸切除、門靜脈節段切除、人工血管原位移植術、上腔靜脈部分切除、修補術”，術程順利，術中見病灶位於胰頭部，大小約4CM×5CM，瘤體 侵犯門靜脈壁和上降靜脈壁前壁。，術後病理：胰腺導管低分化腺癌，可見癌組織侵犯神經束並累及十二指腸粘膜上層，腸繫膜淋巴結內可見轉移癌（2/3）。術後恢復可。2013-04-08，複查CT示：殘餘胰腺未見異常。後轉診我院，於2013-04-27～8-6行健擇1.6G D1，8+白蛋白紫杉醇200MG D1，8方案化療5程。後定期複查未見明顯異常，現為行復查入院。患者精神、睡眠可，胃納一般，大小便正常，近期體重無明顯上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 24, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 61}, {"label_type": "手術", "overlap": 0, "start_pos": 86, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 163, "end_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 186}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 246, "end_pos": 248}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 283, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"end_pos": 299, "label_type": "藥物", "overlap": 0, "start_pos": 293}, {"end_pos": 346, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}]}
{"originalText": "，患者因“宮頸癌IIA1期”於2011年05月26日在我院行“全麻上宮頸癌根治術（保留神經III型廣泛子宮切除術+兩側附件切除術+盆腔淋巴結清掃術）”，，術後病理回報示：宮頸低至中分化鱗狀細胞癌，浸潤至宮頸及頸管外膜層，脈管內見癌栓，右左髂總、右左髂外、左閉孔淋巴結見鱗狀細胞癌轉移，陰道殘端前見鱗狀細胞癌轉移。患者有術後放化療指徵，於家屬商量後計划行序貫放化療。遂於2011年6月8日予TP方案（詳見上表）化療1程，過程順利。患者於2011年6月23日及7月11日出現2次“不全腸梗阻”在我院給予保守治療後好轉。2011年7月18日繼續按原方案化療1程。SCC於第1程化療後由8.7NG/ML降至正常。於2011年8月11日至10月14日給予外照射+後裝放療（原發灶60GY，區域淋巴結60GY，後裝12GY），放療過程順利，患者無不適。2011年12月14日入院行第3程化療，方案同前，入院時查SCC升高至2.0NG/ML，胸片示右肺少許增殖灶，為排除復發已行PET-CT檢查（尚未見單）。現為求進一步治療再次收入院。現患者睡眠可，精神可，食慾可，大小便正常，體重無明顯變化。，既往化療及腫瘤標誌物情況：。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 13}, {"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 106}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 134, "end_pos": 141}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 243}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 278, "end_pos": 281}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 399, "end_pos": 402}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 414, "end_pos": 416}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 417}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 432, "end_pos": 438}]}
{"originalText": "，2007-6-14，腸鏡：距肛門60CM見腫物，2007年6月21日行右半結腸切除術，，術後病理：結腸潰瘍型中高分化腺癌，部分粘液腺癌，侵及漿膜外，切緣陰性，淋巴結1/18。PT4N1M0。術後FOLFOX4化療8週期，第8週期出現皮疹、呼吸困難，停止化療，末次化療2008-1-25。2008-4-29複查MRI發現肝多髮結節，血管瘤可能。CA199 305 CEA(-)。2008-6-19腫標正常，肝結節無變化。之後定期複查。\\U0004\\U0004 2011-9-14，血生化示：膽紅素、GGT、ALT、AST略增高。腫標CEA 7.09,，血常規：，WBC:2.66,PLT 57。胸片、腹盆B超（-）。\\U0004\\U0004 2012-8-2外院查CEA 正常，血常規WBC 1.82 N1.0 PLT 55 。未服藥治療。\\U0004\\U0004 患者飲食睡眠好，二便正常。常規復查。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 68}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 155, "end_pos": 158}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 169}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 245, "end_pos": 248}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 249, "end_pos": 252}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 253, "end_pos": 256}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 266, "end_pos": 269}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 297, "end_pos": 299}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 300, "end_pos": 304}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 332, "end_pos": 335}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 342, "end_pos": 345}]}
{"originalText": "2005-8-25行賁門癌根治術，術後病理：中分化腺癌，侵及肌層，脈管未見癌栓，淋巴結未見轉移。術後未行放化療，定期複查，未發現異常。偶有反酸、噯氣。目前複查胃鏡近端胃術後,吻合口潰瘍,反流行食管炎.病理未見癌細胞.頸部超聲示右頸根部多發淋巴結.盆腔超聲示前列腺鈣化.胸部CT兩肺結節,較前無變化.餘未見異常.腹部CT示賁門癌術後,未見覆發,轉移.腫標示CEA5.16.C13呼氣試驗陰性.。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 81, "end_pos": 99}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 108, "end_pos": 112}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 123, "end_pos": 127}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 134, "end_pos": 138}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 155, "end_pos": 159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 165}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 177, "end_pos": 180}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 185, "end_pos": 192}]}
{"originalText": "2014-4 胃癌出血 胃全切術。術後化療3週期，末次複查是2014-12?2017-02-20 CA199 61.34，CA724 189.2,2017-03-03腹盆CT：全胃術後，吻合口未見異常增厚強化。吻合口上方腹主動脈右前方見軟組織團塊影，邊界模糊，包繞脾血管，與腹腔幹分界不清，範圍約67*37MM。病灶與胰腺、脾臟、右腎下腺及腹主動脈分界不清。肝、腎囊腫。2017-03 進展，紫杉醇 +S1 * 5 末次2017.06.72017-7-7開始腹腔轉移病灶放療GTV 50GY/CTV 45GY/25F，同步 替吉奧60MG BID D1-5/W。2017-7-17放療7次，患者未訴明顯不適。白細胞 1度，2017-7-25放療13次，患者訴進食輕度不暢。2017-8-1完成18次，血小板減低1度。2017-8-8完成23次。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 49, "end_pos": 54}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 61, "end_pos": 66}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 83, "end_pos": 87}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"end_pos": 199, "label_type": "藥物", "overlap": 0, "start_pos": 196}, {"end_pos": 203, "label_type": "藥物", "overlap": 0, "start_pos": 201}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 265, "label_type": "藥物", "overlap": 0, "start_pos": 262}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 304, "end_pos": 307}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 350, "end_pos": 353}]}
{"originalText": "，2016.9因進食梗咽就診，外院胃鏡檢查提示食管鱗癌，於2016.9.29開始2週期TP+泰欣生方案化療，末次化療10.21。化療反應不重，化療後進食梗咽症狀減輕。患者2週期複查評效，經全科查房討論，患者原發病灶及胃周淋巴結較前縮小，但縱隔淋巴結較前增大，結合患者近期聲音嘶啞，較前加重。建議行縱隔淋巴結放療，放療同時根據個人經濟情況加用泰欣生。2016-11-22今日復位；2016-11-23 開始放療 GTV食管病灶及陽性淋巴結；CTV亞臨床病灶及淋巴引流區；95%PTV50.4GY CTV50.4GY GTV56GY/28F；同步放化療TXT/NDP 20MG/M2,QW。患者輸注氨磷汀噁心，停輸。2016-12-01完成放療2次，已行第2週期同步化療。昨晚患者出現打嗝，持續3小時自行緩解，無其他不適主訴。2016-11-16，血常規:白細胞總數 8.73*10^9/L，血紅蛋白 95.00G/L，血小板總數 419.00*10^9/L。，肝腎功:總膽汁酸 11.9μXXXMOL/L。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 27}, {"end_pos": 49, "label_type": "藥物", "overlap": 0, "start_pos": 46}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 173, "label_type": "藥物", "overlap": 0, "start_pos": 170}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"end_pos": 277, "label_type": "藥物", "overlap": 0, "start_pos": 274}, {"label_type": "藥物", "overlap": 0, "start_pos": 278, "end_pos": 281}, {"end_pos": 300, "label_type": "藥物", "overlap": 0, "start_pos": 297}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 376, "end_pos": 381}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 394, "end_pos": 398}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 408, "end_pos": 414}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 433, "end_pos": 437}]}
{"originalText": "，2009.2前因便血查腸鏡示距肛門5CM 直腸腺癌，行術前放療50.6GY，同時口服希羅達增敏，於2009-5行直腸癌切除術，分期T1N0M0，術後行FOLFOX 化療8週期，末次化療2009-11，神經毒性III度。此後定期複查，2010-12發現左肺佔位，3CM，腫標正常，於2011-1-26行胸腔鏡上左肺轉移切除術。術後恢復可，2011-2-24開始口服希羅達單藥治療4週期，2011-6停藥。2012.2複查CEA 6.34NG/ML,腹部超聲示肝小囊腫(2011.1PET-CT見肝內多發低密度,囊腫?),胸/盆CT未見明顯異常。2012.2.29，腫標：CA72-4 9.46 ,CEA正常。\\U0004\\U0004 2012-09-25腹部CT、胸部正位片未見腫瘤復發轉移。，腫標：CA724 12.65. 10-16胸部CT未見明顯佔位病變。\\U0004\\U0004 ，2013-3腹盆CT：骶前間隙軟組織增厚同前相仿，較厚仍約19MM。肝內多發低密度灶同前，傾向囊腫。 原肝S4及S5動脈期斑片狀強化灶顯示欠清。 左上腹腸繫膜多發小淋巴結同前。胸，CT：左肺上葉不規則索條影同前。 腫標正常。血常規、生化基本正常。患者近期無不適，足底麻木緩解，進食可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 26}, {"end_pos": 46, "label_type": "藥物", "overlap": 0, "start_pos": 43}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 72}, {"end_pos": 162, "label_type": "手術", "overlap": 0, "start_pos": 151}, {"end_pos": 185, "label_type": "藥物", "overlap": 0, "start_pos": 182}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 210, "end_pos": 213}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 224, "end_pos": 228}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 229, "end_pos": 233}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 240, "end_pos": 246}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 255, "end_pos": 257}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 260, "end_pos": 265}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 285, "end_pos": 292}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 298, "end_pos": 301}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 327, "end_pos": 331}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 332, "end_pos": 337}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 350, "end_pos": 355}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 368, "end_pos": 372}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 401, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 410}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 429}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 442, "end_pos": 444}, {"end_pos": 450, "label_type": "解剖部位", "overlap": 0, "start_pos": 447}, {"end_pos": 453, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"end_pos": 471, "label_type": "解剖部位", "overlap": 0, "start_pos": 468}, {"end_pos": 474, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 483, "end_pos": 487}, {"end_pos": 492, "label_type": "解剖部位", "overlap": 0, "start_pos": 488}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 526}]}
{"originalText": "，患者於2009.5.25在我院行腹腔鏡上結腸癌切除。術中發現肝轉移，，術後病理：乙狀結腸潰瘍型高中分化腺癌伴粘液分泌，6*5CM，侵及腸壁全層，未見脈管癌栓，切緣（-），LN 5/17；肝轉移灶內見中分化腺癌浸潤，直徑1CM，符合結腸癌轉移，切緣（-）。患者術後行3週期FOLFOX化療，複查示肝內病灶較前進展。並於2010-05-06在我科行TACE+肝動脈留管化療，，化療方案為：，化療方案：OXA 100MG IA H0-6，CF 0.3G IV H4-6，5-FU 1.5G IA H6-48，7-10天一次，共2次，化療結束後出院。此次患者現為進一步行介入治療收住我科，自出院以來食慾可，睡眠佳，大小便尚可，體重未見明顯減輕。", "entities": [{"end_pos": 26, "label_type": "手術", "overlap": 0, "start_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 41, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 116, "end_pos": 121}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"label_type": "手術", "overlap": 0, "start_pos": 173, "end_pos": 183}, {"end_pos": 202, "label_type": "藥物", "overlap": 0, "start_pos": 199}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 217}, {"end_pos": 237, "label_type": "藥物", "overlap": 0, "start_pos": 233}]}
{"originalText": "，10+天前，患者因“咳嗽、呼吸困難”就診於我院呼吸內科，，行胸部CT增強:左肺中央型肺CA，伴左肺下葉阻塞性肺不張，縱隔內及降主動脈動脈旁多發淋巴結轉移，左肺上葉動脈內癌栓可能，兩側胸腔積液，心包積液；顱腦增強，CT:左額、頂葉及右顳、頂葉病變，多系轉移瘤；頸部，CT:頸部多發淋巴結腫大。行左側頸部頸部淋巴結活檢，病理示（1504186），：左側淋巴結轉移性腺癌，考慮肺來源，診斷左肺中央型肺腺癌 IV期 縱膈、頸部淋巴結及腦轉移，予以胸腔穿刺、心包穿刺等姑息治療，請我科會診後建議轉科治療，但患者及家屬拒絕；後患者出院。出院後患者無明顯咳嗽、咳痰，活動後呼吸困難明顯，口服紅豆杉中成藥抗腫瘤。4天前，患者無明顯誘因出現左上肢腫脹，無面板紅腫、皮溫高，患者未予重視及診治，腫脹繼續加重，患者今日為進一步治療就診於呼吸科，行彩超示兩側胸腔大量積液，上肢彩超示左上肢深靜脈血栓形成，門診以肺癌收入我科。   自患病以來，患者精神、食慾欠佳，睡眠差，大、小便正常，體重上降12KG。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 31, "end_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 96}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 101}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 102, "end_pos": 109}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 130, "end_pos": 135}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 173, "end_pos": 183}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 217}, {"label_type": "手術", "overlap": 0, "start_pos": 220, "end_pos": 224}, {"label_type": "手術", "overlap": 0, "start_pos": 225, "end_pos": 229}, {"end_pos": 292, "label_type": "藥物", "overlap": 0, "start_pos": 289}, {"end_pos": 315, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 366, "end_pos": 374}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 375, "end_pos": 379}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 380, "end_pos": 388}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 396}]}
{"originalText": "患者2015.12無意中發現右側腋窩有一約2*2CM的腫塊，質硬，活動可，無疼痛及壓痛，伴有咳痰，痰中可見黑色顆粒，偶有腹痛、反酸，無發熱，無噁心、嘔吐等明顯不適，行胃鏡檢查示慢性非萎縮性胃炎，後自覺腫塊逐漸增大，於2016.4.27行右側腋窩腫塊切除術，術後病理示：（右腋窩）淋巴結內轉移性鱗狀細胞癌，CT示符合右肺上葉纖維灶影像表現，雙側胸腔積液，為求進一步治療收入我科。患者自發病以來，飲食睡眠可，大小便正常。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 96}, {"end_pos": 127, "label_type": "手術", "overlap": 0, "start_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 134, "end_pos": 151}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 152, "end_pos": 154}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 175}]}
{"originalText": "，2013-4-20行左半結腸癌切除術，術後OLF化療2週期，SOX4週期，末次2013-10.2014-10左附件轉移。2014-11-4左卵巢+全子宮切除術。術後環磷醯胺+順鉑化療2週期，TP4週期。2015-8上腹痛，，CT：卵巢癌術後復發，行區域性放療。複查CT提示肝左葉轉移瘤。DP化療2週期。，2015-12-31MRI：肝轉移，陰道殘端復發，盆腔多髮結節，髂血管旁旁淋巴結腫大，考慮轉移，直腸壁增厚，考慮轉移。MFOLFOX6化療5週期，末次2016-4-15。期間複查SD。目前患者陰道出血較前增多，肛門墜脹感。", "entities": [{"end_pos": 19, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 55, "end_pos": 60}, {"end_pos": 80, "label_type": "手術", "overlap": 0, "start_pos": 70}, {"end_pos": 87, "label_type": "藥物", "overlap": 0, "start_pos": 83}, {"end_pos": 90, "label_type": "藥物", "overlap": 0, "start_pos": 88}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 113, "end_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 116, "end_pos": 121}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 132, "end_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 142}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 162, "end_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 169}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 176}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}]}
{"originalText": "，患者1年前無明顯誘因開始出現上腹疼痛，陣發性，無向其他部位放射，患者未引起重視，自行服藥（具體不詳），效果不明顯，病情反覆。，後於外院行腸鏡檢查示：結腸肝曲腫物，病理符合高分化腺癌。2011.1.10PET/CT，示：結腸癌並肝內多發轉移，遂來我院就診。於2011.1.26在我院行左半結腸切除術，術程順利，，術後病理示：中分化腺癌。，分期為：PT3N1M1。術後於2011.2.17至2011.9.7行FOLFIRI方案化療9程。末次化療後2011.9.16，複查CT示：升結腸癌術後改變。肝臟多發轉移瘤，較前未見明顯變化，後於2011-9-30行肝轉移瘤微波消融術。現為進一步治療入院，自起病以來，患者一般情況好，胃納睡眠可，二便正常，體重無明顯改變。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 91}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 101, "end_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 120}, {"end_pos": 149, "label_type": "手術", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 180}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 234, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 244}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 254}, {"end_pos": 285, "label_type": "手術", "overlap": 0, "start_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 310, "end_pos": 311}]}
{"originalText": "患者約1月前開始無明顯誘因出現面板黏膜及鞏膜黃染明，遂來我院就診，診斷為膽管癌，排除手術禁忌後，於2014-12-22在全麻上行胰十二指腸切除術，手術過程順利，術後給予抗感染、營養支援、補液、保肝等治療，術後病理示：膽總管中分化腺癌。患者術後出現消化道出血，於2014-12-30行腹腔動脈造影+栓塞術。患者現恢復良好，因醫保政策變更，辦理出入院手續。   患者現神志清，精神尚可，禁飲食，睡眠可，小便色黃，大便正常，體重較前減輕約5KG。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 20}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"end_pos": 72, "label_type": "手術", "overlap": 0, "start_pos": 64}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 128}, {"end_pos": 151, "label_type": "手術", "overlap": 0, "start_pos": 141}]}
{"originalText": "患者2011年行直腸癌手術治療，具體不詳。2014年6月無明顯誘因出現肛周疼痛，為陣發性疼痛，性質表述不清。不伴有腹痛、腹瀉等其他不適。疼痛發作與天氣變化無關。未行診治。2014年11月疼痛加重，疼痛性質同前。疼痛程度較重，影響日常生活及睡眠。2015-1-23患者入院後完善各項輔助檢查，CT檢查結果示：肝囊腫， 兩腎囊腫，肝內膽管輕度擴張，膽囊炎 胰腺脂肪浸潤，直腸癌術後改變，盆腔及側腹股溝淋巴結腫大，膀胱壁增厚，前列腺增生並鈣化，右側腹股溝疝，明確診斷後給予鎮痛、營養神經等治療。2015.04.01患者因“神經痛”再次入院，給予盆腔病灶適形放療，DT60GY/30F方案放療。疼痛較前明顯減輕，病情好轉，生活質量改善，准予出院。患者近1個月以來，肛周疼痛，食慾差，大便可，小便失禁1月，眠可，近3個月體重未見明顯減輕。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 163, "end_pos": 167}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 188}, {"end_pos": 193, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 206}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 258, "end_pos": 261}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 328}]}
{"originalText": "，宮內孕不全流產清宮（2015-3-12）時，，宮頸活檢：低分化鱗癌，宮腔少許低分化鱗癌，已經月經來潮。2015-4-14腹腔鏡宮頸癌根治術。，病理：低分化癌。脈管癌栓。術後恢復好。術後化療3程，7-13末次化療。停化療後複查盆腹CT未見明顯異常。，盆腔B超：膀胱充盈可，子宮切除術後。兩側附件區未見明顯佔位。兩側髂血管周圍未見明顯腫大淋巴結。盆腔可見少量積液，範圍約5.7X1.6CM。盆腔少量積液。腹部B超提示右鎖骨下、兩側腹股溝淋巴結，繼續觀察。SCC結果未出。2016-8複查未見異常。現聽力上降，大小便可。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 1, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 8, "end_pos": 10}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 34}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 44}, {"end_pos": 70, "label_type": "手術", "overlap": 0, "start_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 113, "end_pos": 117}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 125, "end_pos": 129}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 142}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 201, "end_pos": 205}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 220}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 226, "end_pos": 229}]}
{"originalText": "2013.5 直腸癌同時性右肺兩發M，新輔助放化療（FOLFOX+直腸放療），肺M進展，原發灶好轉，2013.8.13直腸癌根治術，FOLFOX*2，肺M增大，2013.10.10 行胸腔鏡上切除右下肺M切除，術後行FOLFIRI+C225*4，肺M為SD，我院MDT考慮肺M行伽馬刀，2013.11.26~12.7同時完成末次化療。放療後SD，2014.1.17 完成回納術。2014-3-13 我院CT見右上肺M約15*13MM(同外院)，腹盆腔CT（-）。因右肺M鄰近血管，放療後病灶，口服XELODA觀察，因經濟原因未聯合貝伐，2014.3.17始XELODA*4，複查示右上肺M仍13MM，但周圍新見片狀實變，放療後改變？現一般可，大便4-6次/天。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 18}, {"end_pos": 35, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"end_pos": 65, "label_type": "手術", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 77}, {"end_pos": 104, "label_type": "手術", "overlap": 0, "start_pos": 92}, {"end_pos": 120, "label_type": "藥物", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 138}, {"label_type": "手術", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "手術", "overlap": 0, "start_pos": 185, "end_pos": 188}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 201, "end_pos": 203}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 222, "end_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 232, "end_pos": 235}, {"end_pos": 254, "label_type": "藥物", "overlap": 0, "start_pos": 248}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 265}, {"end_pos": 284, "label_type": "藥物", "overlap": 0, "start_pos": 278}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}]}
{"originalText": "患者2010年11月22日因發現直腸癌於外院行DIXON術，術後病理經我院會診為中分化腺癌，浸潤至外膜程，LN（＋）0/4。術後分期PT4N0M0。術後予替加氟＋CF+CPT-11化療6程（3周方案）。末次2011年7月。近2月患者大便變細，帶血，轉診我院，行腸鏡示乙狀結腸粘膜隆起，病理示高級別下皮內瘤變，取材淺表。胸部CT示兩肺多發轉移可能。盆腔MR示吻合口左旁腫塊，考慮區域性復發可能性大。2012-7-24、2012-08-07、2012-8-21、2012-9-4、2012-9-25、2012-10-09、2012-10-23、2012-11-6及2012-11-26行FOLFOX方案化療9程，2012-8-30CT示兩肺病灶較前縮小,療效評價為SD.第5程化療後出現血小板降低，經治療後好轉，予輔助放療後，給予希羅達口服3片BID PO，治療2療程，現為進一步治療來我科就診。患者發病以來,精神、飲食睡眠可,小便時有困難，大便帶血，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"end_pos": 29, "label_type": "手術", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 45}, {"end_pos": 80, "label_type": "藥物", "overlap": 0, "start_pos": 77}, {"end_pos": 83, "label_type": "藥物", "overlap": 0, "start_pos": 81}, {"label_type": "藥物", "overlap": 0, "start_pos": 84, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 153}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 159, "end_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 164, "end_pos": 170}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 173, "end_pos": 177}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 312, "end_pos": 314}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 340, "end_pos": 343}, {"end_pos": 365, "label_type": "藥物", "overlap": 0, "start_pos": 362}]}
{"originalText": "，患者1個月餘前無明顯誘因出現大便帶鮮血，量少，伴大便次數增加至4次/天，不成形，偶有裡急後重。無腹痛、噁心、發熱等不適。2014-11-07外院腸鏡檢查提示距肛門18CM腫物，腸鏡不能透過。活檢病理提示腺癌。我院進一步完善胸部CT及腹盆MRI，未見遠處轉移。未見手術禁忌，2014-12-15全麻上行乙狀結腸切除術，，術後病理回報：（乙狀結腸大體）鏡檢為中分化腺癌，浸潤至漿膜上層，未見明確脈管內癌栓及神經束侵犯；近遠切緣未見癌，區域淋巴結（2/16）。，免疫組化：PMS2（+）， MSH2（+），MSH6（+），MLH1（+）。，術後分期：乙狀結腸癌（PT3N1M0）。患者術後恢復可，現為求進一步診治來本院就診併入住本科。起病以來無發熱，胃納可，睡眠一般，小便正常，體重上降3公斤。", "entities": [{"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 112, "end_pos": 116}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 117, "end_pos": 122}, {"end_pos": 158, "label_type": "手術", "overlap": 0, "start_pos": 151}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 287}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}]}
{"originalText": "，患者1月餘（2016-3-17）前因胃癌於我院行腹腔鏡胃癌根治術（畢I），，術後常規病理示：，病理號：09731.16。（胃）低分化粘液腺癌，潰瘍型，腫物切面積5.2*1.5CM，侵及胃壁深肌層。雙端切緣、吻合器切緣及網膜組織均未查見癌。小彎側淋巴結12枚及網膜內淋巴結1枚，均未查見轉移。，免疫組化：CK（+），HER-2（0），E-CAD(+)。術後第1天患者出現心梗，給予對症處理，患者無不適後出院。出院後患者無發熱，無噁心嘔吐，無腹痛腹脹等不適，現患者為行化療治療來我院，門診以“胃癌術後化療”收入院。自發病來，患者飲食睡眠尚可，二便無明顯異常，體重較前稍減輕。高血壓30餘年，冠心病5年餘，口服絡活喜、倍他樂克、硝酸異山梨酯、阿司匹林等藥物治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"end_pos": 37, "label_type": "手術", "overlap": 0, "start_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 61, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 94}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 187}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 245, "end_pos": 249}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 297}, {"end_pos": 306, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 311, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"end_pos": 318, "label_type": "藥物", "overlap": 0, "start_pos": 312}, {"end_pos": 323, "label_type": "藥物", "overlap": 0, "start_pos": 319}]}
{"originalText": "，外院確診胃癌1周,2016年3月1日胃大部切除\\\\胃空腸吻合,空腸空腸吻合術,，術後病理:胃竇大彎側，4.5CM，印戒細胞癌，瀰漫型，漿膜上浸潤，可見脈管癌栓並神經侵犯，胃周小彎側2/4,大彎側5/25，殘端陰性，大網膜未見癌。PT3N3M0。目前恢復可。HER2-。血液腫瘤標誌物不高。術後化療3週期，便祕，自覺有腰背部疼痛不適。血小板降低52*109/L。，末次化療時間：2016-5-27.2016-7-13開始給予術後放療，CTV 45GY/25F/35D，同期替吉奧 40MG BID D1-D5/W，2016 08 01WBC 2.1*109/L 暫停化療 生白治療後複查 2016-8-8 ，9:54 (紫)血細胞分析（五分類），:中性粒細胞百分數 73.90%，白細胞總數 2.44*10^9/L，血紅蛋白 123.00G/L目前放療18次。患者訴噁心，乏力，失眠。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 7}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 39}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 67}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 162}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 167, "end_pos": 170}, {"end_pos": 240, "label_type": "藥物", "overlap": 0, "start_pos": 236}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 267, "end_pos": 270}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 324, "end_pos": 329}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 340, "end_pos": 345}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 358, "end_pos": 362}]}
{"originalText": "絕經後陰道出血半年。患者外院就診超聲示子宮內膜增厚，兩附件囊實性團塊6+CM。外院行分段診刮，病理回報宮腔為高分化內膜樣腺癌。2017-8-23行開腹子宮內膜癌分期手術+大網膜切除術，術後病理回報： 高分化子宮內膜樣癌，大小5×XXX2×XXX1.5CM；未見脈管癌栓及神經侵犯；癌組織大部分侷限於內膜層，部分浸潤淺肌層＜內1/2肌壁厚，癌組織未累及宮頸內口，骶韌帶斷端未見癌；宮旁未見癌；兩側漏斗韌帶未見癌；大網膜未見癌；子宮平滑肌瘤多枚，直徑0.2-0.4CM；淋巴結未見癌轉移0/40；兩側卵巢子宮內膜樣腺癌，術後診斷，子宮內膜高分化內膜樣腺癌IIIA期，建議術後補充放化療，因MSH陽性，建議基因檢查除外LYNCH綜合徵。2017-9-7婦科行紫杉醇+伯爾定化療1次。我科2017-9-25開始放療，95%PTV(全盆腔) 45GY/25F，現已放療17次，患者訴肛周疼痛，大便次數增多，排尿不適感，白細胞減少3度，中性減少2度。2017-10-31放療結束，現無不適主訴，今日查血常規大致正常。2017-11-15於婦科化療1週期，11-21血常規示WBC 0.90，NE 0.79，HB 98。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"end_pos": 29, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 62}, {"label_type": "手術", "overlap": 0, "start_pos": 73, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 109}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 257}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 280}, {"end_pos": 329, "label_type": "藥物", "overlap": 0, "start_pos": 326}, {"end_pos": 333, "label_type": "藥物", "overlap": 0, "start_pos": 330}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 404, "end_pos": 407}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 480, "end_pos": 483}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 489, "end_pos": 491}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 497, "end_pos": 499}]}
{"originalText": "，患者於2013年8月起無明顯誘因上出現鮮血便，大便成形，形狀變細，無噁心嘔吐、腹痛、腹瀉、黑便。為求治療遂於我院就診，2014-01-08，我院CT示：右頸IV、V 區淋巴結腫大，轉移？腔靜脈旁及腹主動脈旁多發淋巴結腫大，考慮轉移；肝S8鈣化；兩肺未見明顯異常。2014-01-09，我院MR示：直腸中上段腫物，考慮為直腸癌；直腸周圍、骶前及兩側髂血管旁多發淋巴結，考慮為淋巴結轉移；宮頸納氏囊腫。2014-01-10，我院電子腸鏡示：直腸癌。2014-01-13，我院病理示：（距肛門1-7CM直腸中上段腫物活檢），鏡上：腸粘膜組織中見異型細胞呈片狀或散在分佈，細胞胞漿豐富或透亮，核深染，可見核仁，核分裂象易見，形態符合惡性腫瘤，結合免疫組化結果，符合低分化鱗狀細胞癌。於2014-01-25，2014-02-18、03-12、04-02行PF方案化療4程，過程順利，化療後無訴特殊不適。2，程後CT療效評價：PR。4，程化療後CT評價：PR。現擬行上一程化療入院。自患病以來，患者精神、胃納、睡眠可，小便時有裡急後重感，便血，大便成形，呈細條樣，4-5次/日，體重無明顯減輕。", "entities": [{"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 73, "end_pos": 75}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 103, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 163}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 329, "end_pos": 337}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 401, "end_pos": 403}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 417, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 447, "end_pos": 448}]}
{"originalText": "，患者自述於2016年2月因發熱、腹痛就診於我院急診外科，完善相關檢查示乙狀結腸佔位、乙狀結腸穿孔，遂於2016-2-26於我院胃腸外科行乙狀結腸癌切除術、遠端閉鎖、近端造瘻術，，術後病理：低分化管狀腺癌，腫物浸透侵及外膜，腸壁組織伴炎性改變，淋巴結轉移不詳，病理號Z0520138，，術後分期：PT4BNXM0。，免疫組化：，A2:CK(+)CDX2(+)S-100(-)CD34(血管+V0)KI-67(約30%+）P53(+++)SYNAPTOPL(+)，術後腹痛等不適消失。於2016-4-8予患者XELOX方案化療1週期，，具體為：奧沙利鉑200MGD1靜滴，希羅達1500MGD1-14日雙次口服，化療過程順利。於2016年4月17日因膽囊炎入我院急診對症治療，停希羅達口服治療。現為進一步治療入我科。患者1個月來飲食較差，睡眠可，精神體力可，造瘻口偶有腹瀉症狀，排尿正常，體重減輕4KG，周身無疼痛，ECOG評分1分。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 43, "end_pos": 49}, {"label_type": "手術", "overlap": 0, "start_pos": 69, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 113}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 271}, {"end_pos": 288, "label_type": "藥物", "overlap": 0, "start_pos": 285}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 324, "end_pos": 327}, {"end_pos": 341, "label_type": "藥物", "overlap": 0, "start_pos": 338}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}]}
{"originalText": "，患者2016年7月4日腹部外傷後出現左側下腹痛伴肉眼血尿，2016-07-05就診***三院，，急診CT檢查示：左腎腫瘤（約8.4*7.9CM）並腎出血、左側腎靜脈受累可能性大。，胸片示：兩肺紋理增粗，兩肺未見實性病變。於2016-07-08在全麻上行左腎根治性切除+腎周粘連鬆解+腸粘連鬆解+闌尾切除術+腹膜後淋巴結活檢術。，術後病理示：（左側）腎臟伴左兩相分化的惡性腫瘤，考慮腎母細胞瘤，癌組織侵犯腎門脂肪組織，腎門部血管內可見瘤栓，輸尿管斷端未見腫瘤侵犯。腹主動脈旁淋巴結可見腫瘤轉移（1/1），闌尾未見腫瘤轉移。術後恢復可。術後未行化療及放療。，送我院病理會診：符合腎母細胞瘤[以胚芽細胞為主，可見局灶原始下皮分化（約佔5%）]；腫瘤累及纖維脂肪組織，可見脈管內瘤栓及神經組織侵犯；送檢淋巴結（約2枚）2/2見腫瘤轉移。術後複查，CT：未見腫瘤。，臨床診斷為：左腎母細胞瘤 IIIB期。於2016-08-03行ACT-D+VCR方案化療1程。現為行上程化療收入我科。患者現一般可，無發熱、咳嗽，無腹痛、腹瀉，無頭痛、頭暈，無血尿，無 尿痛，飲食可，大小便正常。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 51, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 61}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "手術", "overlap": 0, "start_pos": 127, "end_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 202, "end_pos": 204}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 288, "end_pos": 293}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 370, "end_pos": 372}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 397}, {"label_type": "藥物", "overlap": 0, "start_pos": 410, "end_pos": 415}, {"end_pos": 419, "label_type": "藥物", "overlap": 0, "start_pos": 416}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 453}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}]}
{"originalText": "，患者因2017年2月初感覺上腹部不適，遂到**********就診行腸鏡檢查，結果提示區域性炎症。後仍有上腹部不適腹部不適感，並漸加重。遂再次行腸鏡檢查，提示回盲部腫物，病理仍未能明確診斷。遂來我院腹部外科就診，***教授建議手術切除腸腫物已明確病變性質。於2017-03-01在**********行升結腸腫物切除術。，術後病理經我院會診後示：（回盲部腫物），鏡上見淋巴細胞瀰漫浸潤；細胞大，異型明顯；核大核仁明顯；核分裂可見。淋巴細胞浸潤腸壁黏膜層、肌層深層。考慮瀰漫大B細胞淋巴瘤，非GCB亞型，KI67（90%+）。FISH，分子檢測：BCL-2、BCL-6及C-MYC均（-）。BM，穿刺及活檢：未見腫瘤細胞。2017-03-24 我院PET/CT，示：，瀰漫大B細胞淋巴瘤回盲部切除術後：回盲部術後缺如，吻合口、殘餘升結腸及迴腸呈條狀放射性較濃密，SUV約5.1，腸壁略增厚。左上腹術區數個淋巴結放射性略濃密，SUV約1.9，大者約0.5×0.6CM，疑炎性病變；兩側扁桃體放射性濃密，SUV約11.1，考慮炎性病變。，臨床診斷：（回盲部）瀰漫大B細胞淋巴瘤，非GCB亞型IA期 。2017-04-11行R-CDOP方案化療1程，現為行上一程化療入院。起病以來，一般情況可，有腹部不適感，無明顯腹痛，梗阻，無肉眼血便，黑便等症狀。患者起病以來無發熱、盜汗、體重減輕等B症狀。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 101}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 159, "label_type": "手術", "overlap": 0, "start_pos": 151}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 221, "end_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 250}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 323, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 333, "end_pos": 349}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 350, "end_pos": 355}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 388, "end_pos": 389}, {"end_pos": 397, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 471, "end_pos": 495}, {"end_pos": 546, "label_type": "解剖部位", "overlap": 0, "start_pos": 544}, {"end_pos": 554, "label_type": "解剖部位", "overlap": 0, "start_pos": 553}]}
{"originalText": "，患者6個月前無意間捫及右上腹包塊，約8*8釐米，觸之不痛，就診於****行全腹CT及胃鏡檢查取病理示胃癌，就診於我院腫瘤外科，行全胃切除術，，術中見：腫物位於胃小彎後壁，約4*4*2.5釐米，侵及漿膜層。，術後病理為：進展期胃癌，隆起型，高-中分化管狀腺癌，淋巴結4/33枚轉移。術後恢復良好，於我科行XELOX方案化療5週期，，具體用藥為：奧沙利鉑200毫克D1,希羅達1.5日二次D1-D14,2週期患者出現II度腹瀉，將希羅達改為早1.0，晚1.5口服D1-D14；術後3月評效無復發。現為進一步治療入我科，患者近一個月無周身疼痛，飲食正常，睡眠不佳，排尿正常，稀便2-4次/日，精神體力一般，體重未見明顯上降，KPS評分80分。 患者診斷慢性粒細胞白血病4個月，口服羥基尿1.0日一次，白細胞控制於3.6*10~9/L,粒細胞控制於2.4*10~9/L。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 38, "end_pos": 42}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 53}, {"end_pos": 70, "label_type": "手術", "overlap": 0, "start_pos": 65}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 80, "end_pos": 83}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 129}, {"end_pos": 176, "label_type": "藥物", "overlap": 0, "start_pos": 172}, {"end_pos": 187, "label_type": "藥物", "overlap": 0, "start_pos": 184}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 324, "end_pos": 332}, {"end_pos": 341, "label_type": "藥物", "overlap": 0, "start_pos": 338}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 348, "end_pos": 351}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 365, "end_pos": 368}]}
{"originalText": "，患者2年前開始出現進食後胸骨後不適，梗塞感，稍覺胸背部麻漲感，無噁心、嘔吐，無咳嗽氣促，無聲嘶、嗆咳。於**六院就診行胃鏡檢查，胃鏡提示距門齒30-35CM處食管腫物，病理為“鱗癌”,CT示食管中段侷限性增厚伴腫塊形成，管腔狹窄，考慮食管癌。隨後入我院胸科治療，2013-03-01行全麻上“經右胸食管癌切除術＋食管胃弓下吻合術”，，術後病理：賁門旁淋巴結1枚，見鱗狀細胞癌轉移,餘淋巴結未見轉移。，食管腫物大體:鏡檢為中至低分化鱗狀細胞癌，浸潤至食管壁外膜層，未見明確脈管及神經束侵犯。術後常規復查。3周前無明顯誘因上出現聲嘶，無吞嚥梗阻，無飲水嗆咳，無胸背疼痛，無咳嗽氣促，無噁心嘔吐等不適，2015-01-13於我院查胸+下腹，CT：食管癌術後，吻合口未見明顯異常；左側氣管食管溝腫大淋巴結，考慮轉移瘤。右肺纖維灶；左肺下葉小斑片影，考慮增殖灶可能性大；肝S2、4、6、8囊腫；右腎囊腫；甲狀腺兩葉多髮結節，考慮結節性甲狀腺腫可能性大。考慮患者食管癌術後復發，我科擬放療收治入院。起病以來，患者精神、食慾、睡眠尚可，目前可進食普食，大小便正常，近1月體重減輕（具體不詳）。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 93, "end_pos": 95}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 121}, {"label_type": "手術", "overlap": 0, "start_pos": 147, "end_pos": 165}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 188}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 221}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 227}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 313, "end_pos": 320}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 321, "end_pos": 326}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 366, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 381, "end_pos": 392}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 393, "end_pos": 397}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 417}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 426, "end_pos": 433}]}
{"originalText": "，患者於2014年12月因“絕經4年，陰道少量出血15天”為主訴，至****大學附屬*****健院就診，，行宮腔診刮術後病理示：子宮內膜腺癌I級。於2014-12-12在全麻上行全宮+兩附件+盆腔淋巴結清掃術，術中情況不詳。，術後病理示：子宮符合漿液性腺癌並子宮內膜樣腺癌，侵犯肌層全層，脈管內見癌栓，子宮上段見癌累及，子宮頸間質及脈管見癌，兩側卵巢見癌，腹主+髂總淋巴結見癌（右1/8，左2/8），餘盆腔淋巴結陰性。確診為IIIC2期。術後於我院2015-1-14、2015-2-10各一程TC方案化療（力撲素 210 MG+鉑樂定 450MG），現患者二程化療後三週，患者及家屬要求進一步治療入院。患者自發病以來，精神欠佳，飲食及睡眠尚佳，大小便正常。無明顯體重減輕。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 59, "label_type": "手術", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 64, "end_pos": 72}, {"end_pos": 104, "label_type": "手術", "overlap": 0, "start_pos": 89}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 136}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 256, "label_type": "藥物", "overlap": 0, "start_pos": 253}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 264}]}
{"originalText": "，自述平素體健，月經規則，3月前無誘因始出現陰道流血，2011年6月3日******健院就診，，宮頸活檢示：宮頸鱗癌。2011年6月9日在我院擬診為1、宮頸鱗癌1B2期，2、中度貧血。分別於6月10日及6月30日予TP方案（力樸素270MG+DDP120MG）新輔助化療2程，化療順利。於07月28日在我院行宮頸癌根治術+兩附件切除術（II型全子宮切除術），08月05日TP方案補充化療1療程。化療後血象持續在正常範圍，現收住院進一步治療。患者近期精神、睡眠可，食慾如常，大小便正常。，既往化療及腫瘤標誌物情況：，化療藥物毒副反應：。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 84}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 91}, {"end_pos": 115, "label_type": "藥物", "overlap": 0, "start_pos": 112}, {"end_pos": 124, "label_type": "藥物", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 178}]}
{"originalText": "因“便血1年”在**行直腸活檢提示黑色素瘤，於2016.4.6在全麻上行腹腔鏡探查，經腹會陰直腸癌聯合根治術，術後病理：直腸黑色素瘤，侵透腸壁全層達周圍脂肪組織，緊鄰環周切緣，淋巴結轉移，腸周8/14，結腸下動脈根部0/3。目前傷口恢復尚好，會陰部傷口仍有少量滲液。2016-5入院開始T1方案輔助治療6週期。近期出現左腰背部及放射性疼痛，當地腰椎發現多發椎體轉移，諮詢診治。2017-5-4行L5椎體介入治療（骨水泥），擬行區域性放療，5.9在我科行TP+恩度治療*2週期，2017-5-18開始骨轉移灶放療PTV30GY/10F。2017.6複查腰5椎體固化，自述疼痛消失，感覺好。擬行第3週期化療,預約檢查及入院.。", "entities": [{"end_pos": 15, "label_type": "手術", "overlap": 0, "start_pos": 11}, {"label_type": "手術", "overlap": 0, "start_pos": 36, "end_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 230, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 278, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}]}
{"originalText": "，患者於2012-9-24以“停經後不規則陰道流血14個月,咳嗽咯血3個月”為主訴入院，完善相關化驗檢查，甲胎蛋白測定>1210.00NG/ML，血清人絨毛膜促性腺激素測定20127.00MIU/ML。，確定診斷為：盆腔包塊（卵巢生殖細胞惡性腫瘤可能大）；肺轉移及腦轉移不除外，腦血栓不除外。於2012-9-26至2012-12-4行BEP（博萊黴素+依託伯苷+順鉑）聯合靜脈化療3次。化療過程順利，副反應輕微。化療後咳嗽咳痰較前減輕。於2012-12-19全麻上行左側附件切除術。，術後病理號:Z0445679ABE(左側卵巢)大片壞死組織中見少量變性的異型細胞,可符合化療後惡性腫瘤組織。術後行BEP（博萊黴素+依託伯苷+順鉑）聯合靜脈化療3次，現為求補充治療入院。患者出院至今咳嗽咳痰較前減輕，近日著涼後感冒，飲食欠佳，睡眠可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 53, "end_pos": 59}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 73, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 128, "end_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"end_pos": 175, "label_type": "藥物", "overlap": 0, "start_pos": 171}, {"end_pos": 180, "label_type": "藥物", "overlap": 0, "start_pos": 176}, {"end_pos": 183, "label_type": "藥物", "overlap": 0, "start_pos": 181}, {"end_pos": 240, "label_type": "手術", "overlap": 0, "start_pos": 233}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 307, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 312, "label_type": "藥物", "overlap": 0, "start_pos": 308}, {"end_pos": 315, "label_type": "藥物", "overlap": 0, "start_pos": 313}]}
{"originalText": "，患者9月前無明顯誘因出現腹瀉伴便祕，到外院就診，，病理示：中分化腺癌。2010-8-10行左半結腸切除術+有附件切除術，，術後病檢示：（升結腸）中分化腺癌，左附件考慮結腸癌轉移。2010-9-26至2010-11-15行盆腔及原發灶放射治療。2010-9-27，2010-10-18，2010-11-10行XELOX方同期化療3程。2010-12-10複查CT，療效評價為PR，2011-3-18開始予單藥希羅達化療。現遵主診教授醫囑入院希羅達化療。患者發病以來,精神佳,飲食睡眠可,大小便如常，體重無明顯減輕。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 30, "end_pos": 35}, {"label_type": "手術", "overlap": 0, "start_pos": 46, "end_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 78}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 89}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 179, "end_pos": 181}, {"end_pos": 207, "label_type": "藥物", "overlap": 0, "start_pos": 204}, {"end_pos": 223, "label_type": "藥物", "overlap": 0, "start_pos": 220}]}
{"originalText": "2011年10月31日行左半結腸切除、直腸癌切除（HARTTMANN）術，術後直腸殘端漏，行腹盆腔沖洗引流術，術後行希羅達化療。此次複查腹盆腔CT提示：1、直腸、左半結腸切除術後，骶前低密度區範圍同前，現約36X23MM（IM112），其周圍多發索條影同前。左半結腸吻合口未見增厚及異常強化。右上腹造瘻口未見異常強化。2、肝多發轉移灶較前增多、增大，如原較大約20X18MM（IM55），現約42X31MM（IM49）現較大病變約為54X43MM（IM55）。肝囊腫較前無變化，現約24X20MM（IM57）。3、腹膜、網膜及系膜增厚，並見小結節灶，約為9MM（IM67），腹腔內見腹水。腹主動脈內斑塊影較前略大（IM57）。\\U007F4、左腎盂、下段輸尿管輕度擴張緩解，兩腎小囊腫、膀胱前壁增厚同前。脾、胰腺、膽囊、腎下腺、前列腺、精囊腺未見異常。\\U007F5、腹腔、腹膜後、盆腔未見腫大淋巴結。掃及諸骨未見明確骨質破壞徵象。此次腫瘤標誌物較2012-8均明顯升高。\\U0004\\U0004。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 12, "end_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 44}, {"end_pos": 54, "label_type": "手術", "overlap": 0, "start_pos": 46}, {"end_pos": 61, "label_type": "藥物", "overlap": 0, "start_pos": 58}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 68, "end_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 89}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 257, "end_pos": 258}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 294}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 337, "end_pos": 342}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 345}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 371, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 387, "end_pos": 388}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 391}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 410, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}]}
{"originalText": "，患者自述於2.5月前因發熱就診於我院，體溫波動於37-38攝氏度之間，無咳嗽咳痰，無腹痛腹瀉，檢查提示血沉升高，盜汗，肺腹CT提示胃壁增厚伴胃周淋巴結腫大，進一步行胃鏡檢查提示胃體後壁不規則潰瘍並隆起，胃竇中段大彎見2處潰瘍，病理診斷為胃粘膜相關淋巴瘤，，免疫組化：CD20（-）。入我科完善相關檢查分期為胃黏膜相關淋巴瘤(II1B期)，行COP方案化療3週期，，具體為：環磷醯胺1100毫克D1靜點，長春新鹼2毫克D1靜點，醋酸潑尼松100毫克D1-5口服。無明顯不良反應。2週期評效穩定。末次化療(2011-3-26)距今3周，患者現一般狀態可，飲食二便正常，現體溫正常，無盜汗，體重上降1公斤，KPS評分90分。", "entities": [{"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 52, "end_pos": 54}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 60, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 169}, {"end_pos": 191, "label_type": "藥物", "overlap": 0, "start_pos": 187}, {"end_pos": 206, "label_type": "藥物", "overlap": 0, "start_pos": 202}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 214}]}
{"originalText": "2010-9-21我院行直腸癌根治術，術前分期？術前放療10次，YPT4AN0M0,術後FOLFOX*3-XELODA*3,末次2011.2.\\U0004\\U0004 2012-4兩肺多發小M，行BEV+XELOX*4，治療後血壓最高160/100MMHG，2週期縮小SD，4週期又略縮小，未達PR？末次用藥2012.8。 2012-9-3在空總行左肺3處M-R刀治療。2012-11-16胸CT，左肺治療後病灶縮小，但右肺門新發轉移灶約2.5CM，腹CT未見新發M。\\U0004\\U0004  目前乏力，無咳嗽，體重無明顯上降。擬2013-1-10行右肺門轉移灶放療GTV 60GY/15F，同步口服希羅達1.5G BID 增敏化療。\\U0004\\U0004。", "entities": [{"end_pos": 18, "label_type": "手術", "overlap": 0, "start_pos": 12}, {"end_pos": 59, "label_type": "藥物", "overlap": 0, "start_pos": 53}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 101, "label_type": "藥物", "overlap": 0, "start_pos": 98}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"label_type": "手術", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 195, "end_pos": 198}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 225, "end_pos": 228}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 276, "end_pos": 281}, {"end_pos": 304, "label_type": "藥物", "overlap": 0, "start_pos": 301}]}
{"originalText": "，患者自訴於2013-08-30在**一院因“直乙交界癌”行腸癌根治術，，術後病理：直腸中分化腺癌（T4N0M0IIB期），並且檢查口服希羅達化療，已經化療8個療程。術後一個月，患者開始自覺大便不暢，偶不成形，稀便，偶有便血，餘無特殊不適。遂來我院門診就診，行胸部CT平掃+，增強檢察：兩肺下葉肺氣腫，肝多發低密度病變，考慮肝囊腫，左腎囊腫。盆腔MR平掃+，增強檢察：直腸癌術後，直腸下段吻合口處軟組織影，考慮復發可能性大。，心臟彩超及心功能測定：右左心房稍增大，主動脈增寬並主動脈關閉不全，二尖瓣前葉脫垂並關閉不全（輕微，右心室收縮功能正常，舒張功能減低（I級）。，行結腸腫物病理活檢：結腸粘膜可見腺癌浸潤。2014-7-4、7-31、8-26行“XELOX”方案化療3程，過程順利，化療後未見明顯不適。患者目前放療中，已放療23次，訴有裡急後重感。今為求進一步診治來我院，擬“直腸癌術後吻合口復發”收住我科，患者發病以來,精神佳,飲食睡眠佳,小便正常，體重無減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 28}, {"end_pos": 35, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 61}, {"end_pos": 71, "label_type": "藥物", "overlap": 0, "start_pos": 68}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 130, "end_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 150}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 170}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 171, "end_pos": 181}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 189}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 213, "end_pos": 217}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 258}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 294, "end_pos": 296}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 400}]}
{"originalText": "患者於2011年8月因“間隙便血4月”在我院行腸鏡檢查示：直腸腫物，活檢為高分化腺癌；升結腸見一粗蒂0.8×0.8CM息肉，橫結腸見一1.2×1.5CM長蒂息肉，病理活檢為管狀腺瘤；乙狀結腸見1.0×1.0CM粗蒂息肉，活檢為管狀-絨毛狀腺瘤。在我院行經腹直腸癌根治術（DIXON術），術後病理為中分化腺癌，浸潤腸壁淺肌層，淋巴結未見轉移，診斷為直腸中分化腺癌DUCKA期，術後定期複查。現為行內鏡上治療結腸息肉收入院，患者無發熱，盜汗，無便血、黑便，無腹痛，腹脹，無噁心，嘔吐，無頭痛，頭暈等。睡眠、精神、胃納尚可，小便正常，體重無明顯改變。", "entities": [{"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 42}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 90}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 121}, {"label_type": "手術", "overlap": 0, "start_pos": 126, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 157}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 173, "end_pos": 186}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}]}
{"originalText": "，因便血，2014-7-1，外院腸鏡：乙狀結腸距肛門27CM菜花樣病變，3*4CM，，活檢病理：高分化腺癌。未見術前腫標。2015-7-4行乙狀結腸癌根治術。，術中：腫瘤位於乙狀結腸，3CM ，侵透漿膜，系膜根部質硬，不除外轉移。，術後病理：潰瘍型中分化腺癌。大小3*2.5*1CM，浸潤腸壁全層達外膜，有漿膜被覆處未突破間皮層，可見神經侵犯及脈管癌栓，淋巴結3/12，CEA+++ CA199+++ EGFR- HER2）（SP3）- P53- TOP11A 20-30%,KI6780% MSH1+ MSH2+ MSH 6+ PMS2+。術後傷口癒合差,至2015-3傷口完全癒合.2015-4口服希羅達*6，末次2015-7-15.術後未複查。2015-10-23 腹部，CT:乙狀結腸術後，右側髂血管旁及腹膜後淋巴結腫大，轉移？。右腎下腺結節，性質待定。2015-10-15 癌抗原199 45.38U/ML，癌抗原125 41.32U/ML目前患者食慾可，無不適，乏力明顯 體重無變化。", "entities": [{"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 53}, {"end_pos": 78, "label_type": "手術", "overlap": 0, "start_pos": 70}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 144, "end_pos": 145}, {"end_pos": 304, "label_type": "藥物", "overlap": 0, "start_pos": 301}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 336, "end_pos": 341}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 348}, {"end_pos": 354, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 373, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 392, "end_pos": 398}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 409, "end_pos": 415}]}
{"originalText": "，患者3-4年前發現大便不成型，無便中帶血，不伴有粘液，無黑便，無腹痛，易腹瀉，無裡急後重。無噁心、嘔吐，無發熱，下述症狀與飲食無明顯關係。患者未在意，未系統診治。2012年3月於本院行結腸鏡發現直腸息肉0.3×0.6CM，未予特殊處置。，一週前患者於**複查結腸鏡示:，升結腸：近盲腸見多處瘢痕改變，近回盲盲瓣見1指狀息肉，大小約1.5*0.5CM，光滑，取材1塊。，病理示：升結腸炎性息肉。今為進一步診治及行腸息肉電切術入我科。患者病來精神可，飲食睡眠可，尿量正常，近期體重無明顯變化。", "entities": [{"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 98, "end_pos": 102}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 189, "end_pos": 196}, {"end_pos": 212, "label_type": "手術", "overlap": 0, "start_pos": 206}]}
{"originalText": "，患者自述於3年3個月因無意捫及左乳一腫物，於我院行乳腺超聲及鉬靶懷疑惡性可能性大，後於我院乳腺外科行乳腺根治性切除術(2008.2.23)。術中見腫物5.5×4.0×3.5釐米，，術後病理為：浸潤性導管癌，淋巴結6/12枚轉移（病理號381609），免疫組化：ER(+++)，PR(+++),，HER-2:陰性。術後在乳腺外科行CE方案化療4週期，，具體方案為：環磷醯胺1.0毫克，表阿黴素130毫克。期間行放療1週期。後序貫紫杉醇4週期(具體計量不詳）.化療時出現脫髮，輕度噁心。化療結束後口服他莫西芬。1年餘前常規體檢中發現肝有一病灶，約1.0CM，未行系統治療。11個月前行卵巢去勢術，9個月前開始口服瑞寧德。8個月前複查，病情進展，遂入我科行GX方案化療8週期，，具體方案為：吉西他濱（健澤）1.6D1，1.2D8,卡培他濱（希羅達）1.5日二次口服D1-14，因骨髓抑制較重，第2週期*吉西他濱改量為1.4D1,D8，並用唑來膦酸鈉（蓋寧）抗骨轉移治療，期間評效，病情穩定，末次化療距今3周，未出現II度以下不良反應，為繼續治療入我科。近1個月來飲食睡眠正常，二便基本正常，體重正常。KPS評分90分。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 26, "end_pos": 30}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 31, "end_pos": 33}, {"end_pos": 59, "label_type": "手術", "overlap": 0, "start_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 97, "end_pos": 103}, {"end_pos": 186, "label_type": "藥物", "overlap": 0, "start_pos": 182}, {"end_pos": 196, "label_type": "藥物", "overlap": 0, "start_pos": 192}, {"end_pos": 217, "label_type": "藥物", "overlap": 0, "start_pos": 214}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 249}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 296, "label_type": "手術", "overlap": 0, "start_pos": 291}, {"end_pos": 308, "label_type": "藥物", "overlap": 0, "start_pos": 305}, {"end_pos": 347, "label_type": "藥物", "overlap": 0, "start_pos": 343}, {"end_pos": 350, "label_type": "藥物", "overlap": 0, "start_pos": 348}, {"end_pos": 367, "label_type": "藥物", "overlap": 0, "start_pos": 363}, {"end_pos": 371, "label_type": "藥物", "overlap": 0, "start_pos": 368}, {"end_pos": 403, "label_type": "藥物", "overlap": 0, "start_pos": 399}, {"end_pos": 422, "label_type": "藥物", "overlap": 0, "start_pos": 417}, {"end_pos": 425, "label_type": "藥物", "overlap": 0, "start_pos": 423}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 427}]}
{"originalText": "，患者2014年1月因\\\"左下腹痛10天\\\"於本院診斷為肝癌，2014年1月22日行TACE術，術中用藥表阿黴素50MG，絲裂黴素6MG，伯爾定300MG，碘油20ML。並於2014年02月12日於全麻上行肝癌切除+膽囊切除術，術程順利，，術後病理提示：中分化肝細胞性肝癌。術後恢復良好出院。2015-1-6於局麻上行肝動脈栓塞化療（TACE）術，術中用藥法瑪新50MG，伯爾定300MG，碘化油7ML。術後定期複查，，我院2015年01月22日CT示：對比2015.01.04 日MR，肝癌綜合治療後，肝S2、6 段碘油沉積較緻密結節，考慮介入治療後改變，未見明顯腫瘤活性。肝S6 段結節，考慮腫瘤活性結節可能。為求進一步診治收入我科病房。患者下次出院以來食慾睡眠可，精神可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 30}, {"end_pos": 47, "label_type": "手術", "overlap": 0, "start_pos": 42}, {"end_pos": 56, "label_type": "藥物", "overlap": 0, "start_pos": 52}, {"end_pos": 65, "label_type": "藥物", "overlap": 0, "start_pos": 61}, {"end_pos": 72, "label_type": "藥物", "overlap": 0, "start_pos": 69}, {"label_type": "藥物", "overlap": 0, "start_pos": 78, "end_pos": 80}, {"label_type": "手術", "overlap": 0, "start_pos": 103, "end_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 136}, {"label_type": "手術", "overlap": 0, "start_pos": 159, "end_pos": 173}, {"end_pos": 181, "label_type": "藥物", "overlap": 0, "start_pos": 178}, {"end_pos": 189, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"end_pos": 198, "label_type": "藥物", "overlap": 0, "start_pos": 195}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 223, "end_pos": 225}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 241, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 244, "end_pos": 246}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"label_type": "藥物", "overlap": 0, "start_pos": 259, "end_pos": 261}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}]}
{"originalText": "，患者於２０天前無明顯誘因出現進食固體食物時吞嚥梗咽感，進食半流質食物順利，無胸痛，無氣促，無聲音嘶啞，無發熱。到本院就診，，行胃鏡檢查示：距門齒29－35CM前壁右側見粘膜隆起，表面高低不平，潰瘍形成，質硬，易出血，食管腔輕度狹窄；病理為鱗癌。，胸部ＣＴ示：食管中上段MT。今為進一步診治入院。起病以來，精神睡眠可，胃納一般，大小便正常，體重無明顯減輕。", "entities": [{"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 39}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 122}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 124, "end_pos": 128}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 130, "end_pos": 137}]}
{"originalText": "患者一個月前因“腹痛、腹瀉一月”就診外院，腸鏡提示距肛門15CM腫物，內鏡無法透過；活檢病理腺癌。腹CT示肝S7佔位，考慮轉移瘤。診斷“直腸癌肝轉移”為求進一步診治來本院就診，MDT會診建議先行手術解除梗阻因素，再行化療。遂於2014-06-05行腹腔鏡上DIXON術，術後第五日出現吻合口微小漏，經對症處理後好轉。術後病理示：直腸中至低分化腺癌，侵犯漿膜上層，可見脈管內癌栓及神經束侵犯，5/10LN（+）PT3N2AM1A IVA期。2014-07-04行MFOLFOX6（樂沙定+5-FU）方案一程。自下次出院以來，食慾、睡眠及精神一般，排便大致正常，無明顯腹脹、嘔吐，小便正常，體重上降改變不明顯。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 12, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 48}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 49, "end_pos": 52}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 53, "end_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 74}, {"end_pos": 134, "label_type": "手術", "overlap": 0, "start_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 164, "end_pos": 173}, {"end_pos": 242, "label_type": "藥物", "overlap": 0, "start_pos": 239}, {"end_pos": 247, "label_type": "藥物", "overlap": 0, "start_pos": 243}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}]}
{"originalText": "，患者因“不規則陰道流血伴陰道排液1+年”,，診斷性刮宮病理提示：（宮腔）子宮內膜樣腺癌，G2；，我院病理會診提示：子宮內膜樣腺癌G2-3，宮頸管搔刮組織見少量粘膜組織及少量異型的內膜腺體。於2011-12-21在我院行\\\"II型全子宮切除+兩側附件切除+盆腔淋巴結清掃+腹主動脈旁淋巴結活檢術\\\"，，術後病理示：（子宮）中至低分化子宮內膜樣腺癌，浸潤子宮深肌層；宮頸及宮頸管粘膜慢性炎；兩附件未見明顯病變；右閉孔淋巴結見癌轉移（1/3）。，診斷：子宮內膜腺癌IIIC期（G3），有放化療指徵，已預約2012-03-13開始放療。並於2011-12-29、2012-01-20予TP方案（泰素270MGD1，DDP60MGD1-2）化療2程，過程順利，反應較輕。並予高孕激素治療。現為行第3程化療收入院。出院以來，患者無發熱、頭痛、咳嗽、腹痛、腹脹、腰痠、上肢疼痛等不適，無明顯噁心、嘔吐，精神、胃納好，大便較祕結，小便正常，體重無明顯減輕。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 47}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 69}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "手術", "overlap": 0, "start_pos": 112, "end_pos": 147}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 173}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 188}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 239}, {"end_pos": 296, "label_type": "藥物", "overlap": 0, "start_pos": 294}, {"end_pos": 307, "label_type": "藥物", "overlap": 0, "start_pos": 304}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 334}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 363}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}, {"end_pos": 373, "label_type": "解剖部位", "overlap": 0, "start_pos": 372}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 380, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 398, "end_pos": 399}]}
{"originalText": "，患者於2012-01出現胃脹、便血等症狀，2012-02-20就診於**三院，行胃鏡病理活檢提示胃底賁門癌。2012-02-23，**一院CT檢查示：胃底賁門-小彎側惡性腫瘤，可疑周圍淋巴結轉移。2012-03-06，行PET-CT示：胃底賁門部-胃小彎惡性腫瘤（胃癌？）；胃周圍淋巴結轉移。後於2012-03-08在**一院氣管內麻醉上行“胃癌根治術”，術程順利。，術後病理示：胃印戒細胞癌，侵及胃壁全層，並穿透漿膜層；伴淋巴結轉移（10/42）。，術後分期：T4AN3AM0,III期。2012-03至2012-08行化療8程（奧沙利鉑+替吉奧4程，因胃腸道反應大，後改口服替吉奧4程）。患者2012-11起在我院行CIK細胞免疫治療，2014－3－，3複查CT：右腋窩淋巴結稍腫大，考慮轉移瘤。腹腔幹右旁、腹主動脈右旁、兩側髂血管旁淋巴結，較前增多、增大，考慮轉移，可疑右側腎下腺受侵犯。現為繼續治療收入我科。自起病以來，患者精神、睡眠可，食慾如常，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 76, "end_pos": 88}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 111, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 137}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 177, "label_type": "手術", "overlap": 0, "start_pos": 172}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 201}, {"end_pos": 271, "label_type": "藥物", "overlap": 0, "start_pos": 267}, {"end_pos": 275, "label_type": "藥物", "overlap": 0, "start_pos": 272}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 293, "label_type": "藥物", "overlap": 0, "start_pos": 290}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 332, "end_pos": 334}, {"end_pos": 341, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 354, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 361, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 373, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}]}
{"originalText": "2011-8突發嘔血，就診外院完善檢查後診為胃間質瘤；2011-8-18行胃大部切除術，術後病理：胃腸道間質瘤，呈多結節狀分佈，累及胃及大網膜，大小直徑1-7CM，腫瘤細胞中度異型，未見明確壞死，偶見核分裂像（2-3個/50HP）,周圍淋巴結可見腫瘤侵犯1/9,免疫組化;CK-,CD117+,CD34+,S-100-,KI67 5%,脂肪、血管及淋巴組織未見腫瘤，2011.9.6開始服格列衛術後予格列衛10天（9-17停藥），但噁心、嘔吐明顯。2011-9-30出現發熱，外院考慮呼吸道感染，查血常規示骨髓抑制II，外院予升白、抗感染治療後好轉。2011-12-13複查腹CT示小腸多發軟組織密度影，考慮多髮間質瘤，肝門區多髮結節，轉移？為進一步治療就診。昨天起開始服格列衛。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 26}, {"end_pos": 43, "label_type": "手術", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 49, "end_pos": 55}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 197, "label_type": "藥物", "overlap": 0, "start_pos": 194}, {"end_pos": 203, "label_type": "藥物", "overlap": 0, "start_pos": 200}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 287, "end_pos": 290}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 310}, {"end_pos": 339, "label_type": "藥物", "overlap": 0, "start_pos": 336}]}
{"originalText": "，患者2012年03月無明顯誘因出現進食後嘔吐，無腹痛腹脹，無腹瀉黑便，無大便性狀改變。2012－05下述症狀加重，出現左上腹陣發性隱痛。現為進一步診治隨來我院，我院門診現為進一步治療入院。2012年05月16日胸部、下腹、上腹部、盆腔，CT：左上腹部腸壁明顯增厚，考慮腸癌可能性大，腸周脂肪間隙結節，考慮淋巴結轉移;肝右外葉病灶，可疑轉移瘤;胸部、盆腔未見明確佔位性病變;左側陰囊稍增大並異常密度影。2012.5.24行“左半結腸切除+乙狀結腸部分切除+盆腔結節切除+腹腔熱灌注化療術”，過程順利。，術後病理：盲腸中至低分化腺癌，術後分期為 PT4BN0M1B,IVB期。2012年7月2日至2013年12月4日予MFOLFOX6化療12週期，第二週期開始，加用貝伐珠單抗11次，過程順利，2012年12月27日至2014年03月12日予貝伐珠單抗加卡培他濱化療19週期。下次化療後，患者恢復良好，手足稍脫皮，未見滲液，評價手足綜合症較前稍好轉。現為進一步治療入院。自下次出院以來，患者精神、睡眠可，胃納如常，小便正常，體重未見明顯改變。", "entities": [{"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 27}, {"end_pos": 32, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 106, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 126, "end_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 144}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "手術", "overlap": 0, "start_pos": 212, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 286}, {"end_pos": 337, "label_type": "藥物", "overlap": 0, "start_pos": 332}, {"end_pos": 375, "label_type": "藥物", "overlap": 0, "start_pos": 370}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 376}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 400, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 413, "end_pos": 418}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}]}
{"originalText": "患者於一月前無明顯誘因出現胸背痛，外院CT示左肺上葉團塊影，大小約3.7*4.2*3.3CM，邊緣毛糙並可見毛刺，增強後見輕度強化。無咳嗽咳痰咯血，無胸悶氣促，無胸痛聲嘶，無發熱盜汗，無頭暈乏力等症狀。我院PET/CT示左上肺腫塊代謝活躍，考慮左上肺癌；隆突上淋巴結代謝活躍，考慮轉移；T2轉移灶代謝活躍，侵犯相鄰椎管；胸下段食管區域性代謝活躍。ECT示T2代謝活躍，可疑骨轉移。聲胃鏡示食管下段未見明顯佔位，縱隔多發淋巴結腫大；肺腫物穿刺活檢示左上肺中至低分化腺癌。EGFR基因為野生型。診斷為左上肺低分化腺癌，CT2N2M1,IV期。2012-6-14予AP方案化療一程，2012-6-19起行胸椎放療，未結束。現為行第二程化療來我院。末次化療後，精神食慾睡眠可，大小便正常，體力體重無明顯改變。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 145}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 188}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 222, "end_pos": 232}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 267}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}]}
{"originalText": "，患者2016-6無明顯誘因出現腹部陣發性疼痛不適，無噁心、嘔吐，治療後好轉。近1月來疼痛加重，陣發性絞痛，無噁心、嘔吐等，無伴大便習慣改變，無血便，無頭暈、乏力、發熱等不適。外院腸鏡檢查提示距離肛門30CM腫物，腸腔狹窄，腸鏡無法透過，活檢病理提示考慮腺癌。外院CT胸腹盆腔未見明顯異常。患者於2016-08-11全麻上行右半結腸切除+惡性腫瘤腔內灌注治療，，術後病理回報：1（腸大體）鏡檢為腸中至低分化腺癌，部分為粘液腺癌，癌組織浸潤至腸壁漿膜上層，可見神經束侵犯，未見明確脈管內癌栓。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央淋巴結）6枚，2/6見腺癌轉移。5（中間淋巴結）10枚，未見癌。6（腸旁淋巴結）鏡上為脂肪結締組織，未見淋巴結，未見癌。，免疫組化：ER（-），ERCC1（+），MLH1（+），MSH2（+），MSH6（+），PMS2（+），KI67（約65%）。現遵原主診教授行術後輔助化療.患者於2016-09-02、2016-09-23、2016-10-20、2016-11-11、2016-12-05行XELOX方案化療5程.起病以來胃納尚可，睡眠一般，小便正常，體重有所上降。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 129}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 132, "end_pos": 134}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"label_type": "手術", "overlap": 0, "start_pos": 162, "end_pos": 179}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 197, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 482, "end_pos": 483}]}
{"originalText": "，患者2014-10-7行胃癌根治術，，術後病理：食管賁門小彎側潰瘍型中分化腺癌，侵及漿膜外纖維脂肪組織，癌向下累及賁門齒狀線下部分食管壁。切緣陰性，大網膜未見癌種植，淋巴結8/28轉移。術前術後血腫標不詳。術後未行基線影像檢查。術後行多西他賽100MG+奧沙利鉑100MG方案化療4週期，末次化療2015-1，化療反應不重。2015-5CT家屬訴無特殊，未見報告和片子。2015-6-29胃鏡示返流性食管炎，殘胃炎。2015-8上旬出現右側肋部出現腫物，無壓痛，不活動，質硬。，2015-9-2腦胸腹CT：後縱隔和腹膜後淋巴結較前明顯。左肺上葉結節較前增大。現進食可，二便正常，體重較前上降。", "entities": [{"end_pos": 18, "label_type": "手術", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 68}, {"end_pos": 122, "label_type": "藥物", "overlap": 0, "start_pos": 118}, {"end_pos": 132, "label_type": "藥物", "overlap": 0, "start_pos": 128}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 198, "end_pos": 208}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 248, "end_pos": 253}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}]}
{"originalText": "患者自述於２年半前因腹瀉、血便就診於我院，行腸鏡檢查示乙狀結腸腫物，病理為(乙狀結腸)腺癌，直腸低級別絨毛管狀腺瘤，病理號為107993。後於我院腫瘤外科行乙狀結腸癌根治術，左卵巢囊腫切除術，術中見病灶3*4.5*1.5釐米，浸潤漿膜，術後病理為乙狀結腸癌，浸潤潰瘍型，中分化管狀腺癌，淋巴結0/20枚轉移，斷端無癌，直腸低級別管狀腺瘤，左卵巢包涵囊腫，病理號108417。術後腹瀉、血便等不適改善，恢復良好。術後4周入我科行MFOLFOX7方案化療共6週期，用藥為奧沙利鉑150毫克，同奧300毫克，方克5.0，末次化療距時間為2010-6，化療過程中出現2度骨髓抑制，對症處理後好轉。半月前出現上腹疼痛不適，呈間斷性疼痛，疼痛可忍受，評分為2分。現為進一步診治入我科。患者1個月來飲食睡眠正常，精神體力可，二便基本正常，體重無明顯變化，KPS評分90分。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 57}, {"end_pos": 86, "label_type": "手術", "overlap": 0, "start_pos": 78}, {"end_pos": 95, "label_type": "手術", "overlap": 0, "start_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 168}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 237, "label_type": "藥物", "overlap": 0, "start_pos": 233}, {"end_pos": 245, "label_type": "藥物", "overlap": 0, "start_pos": 243}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 251}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}]}
{"originalText": "，患者約於2011年7月上旬發現右頸部腫物，漸增大，大小約6*10CM。遂來我院就診，我院行胃鏡病理示胃角腺癌，，行頸胸部部CT示：右鎖骨下窩團塊狀，大小約6*10CM。2011-08-02，行頸部胸部下腹部上腹部盆腔CT示：符合胃癌，右鎖下，隆突上，胃小彎側，膈腳後，食管旁，腹主動脈旁廣泛淋巴結轉移。遂入住本科，，診斷：胃癌並右鎖骨下、縱膈、腹腔淋巴結轉移。於2011.8.10、2011.9.2予\\\"愛斯萬+多帕菲\\\"化療二程。第一程化療後曾出現血白細胞II度降低、肝功能輕度受損；治療後恢復；第二程化療後出現III度腹瀉，在當地予抗感染等治療後好轉。化療後患者右側頸部腫物較前縮小。現應約復入院繼續化療。患者近來精神、睡眠可，食慾一般，無噁心、嘔吐，無吞嚥梗阻，無腹脹腹痛，大小便無明顯異常，體重較下程治療前上降約4斤。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 55}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 58, "end_pos": 64}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 97, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 151}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 180}, {"end_pos": 206, "label_type": "藥物", "overlap": 0, "start_pos": 203}, {"end_pos": 210, "label_type": "藥物", "overlap": 0, "start_pos": 207}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 227, "end_pos": 230}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 336}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}]}
{"originalText": "因腹盆腔腫物，於2015-5-20行卵巢癌減瘤術，術後恢復可。術後於力樸素+伯爾定化療7程，末次化療2015-11-6。無不適。2015.10.27MRI提示較前好轉。2015.12.9行腫瘤細胞減滅術，術中粘連重，行右側輸尿管支架置入，術後盆腔引流600ML，12.22出院，23日盆腔引流1580，24日盆腔引流2970，2015.12.29膀胱鏡檢查+右輸尿管支架調整+左輸尿管支架置入。術後無陰道流液，近期自覺尿痛。憋氣。後於2016-3取出DJ管。術後化療後半年。患者甲狀腺功能異常。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 1, "end_pos": 4}, {"end_pos": 24, "label_type": "手術", "overlap": 0, "start_pos": 18}, {"end_pos": 37, "label_type": "藥物", "overlap": 0, "start_pos": 34}, {"end_pos": 41, "label_type": "藥物", "overlap": 0, "start_pos": 38}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"end_pos": 101, "label_type": "手術", "overlap": 0, "start_pos": 94}, {"end_pos": 118, "label_type": "手術", "overlap": 0, "start_pos": 109}, {"label_type": "手術", "overlap": 0, "start_pos": 173, "end_pos": 196}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 239, "end_pos": 242}]}
{"originalText": "，患者於2007年4月因肝內膽管細胞癌在外院行肝左葉部分切除術+膽囊切除術,術後恢復良好,於2007年6月行TACE.2007年7月患者隨訪出現梗阻性黃疸（考慮可能與化療或腫瘤復發有關）,經激素使用後好轉.2007年9月患者黃疸又出現升高,行PTCD引流,並在右左肝管內留置金屬支架.2007年12月患者黃疸再次升高,給予更換PTCD引流管,但效果不佳。於2008年1月25日行原位肝移植術。2008年3月10肝功能異常，TB/，CB：48.3/41.6，A/，G:37/31,ALT/，AST:380/219，，R-GT：304。，肝穿刺病理示：肝組織內可見12個肝小葉,其間門管區可見較多單核細胞浸潤(PI=2),小膽管炎可見(BI=1),小靜脈內膜炎較顯著(VI=2),細胞性排斥(RAI=5/9)存在. 肝小葉內肝細胞廣泛淤膽，伴羽毛樣變，灶性壞死及細胞凋亡顯著.建議排除病毒性損傷.予保肝　服用聯苯兩脂，抗病毒，調整排異藥物後肝功能正常。2008年5月23日肝功能示TB/，CB:81.3/62.5，A/，G:42/28, ALT/AST ，:33/88，，R-GT:276.　，FK506:11.9,現為保肝,調整抗排異治療收住入院。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 19}, {"label_type": "手術", "overlap": 0, "start_pos": 23, "end_pos": 37}, {"end_pos": 58, "label_type": "手術", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 77}, {"end_pos": 127, "label_type": "手術", "overlap": 0, "start_pos": 121}, {"end_pos": 141, "label_type": "手術", "overlap": 0, "start_pos": 130}, {"label_type": "手術", "overlap": 0, "start_pos": 161, "end_pos": 170}, {"end_pos": 195, "label_type": "手術", "overlap": 0, "start_pos": 189}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 215, "end_pos": 217}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 228, "end_pos": 232}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 239, "end_pos": 242}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 244, "end_pos": 247}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 257, "end_pos": 261}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 310, "end_pos": 313}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 361, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 399, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"end_pos": 406, "label_type": "藥物", "overlap": 0, "start_pos": 402}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 438, "end_pos": 440}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 442, "end_pos": 444}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 455, "end_pos": 459}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 467, "end_pos": 474}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 484, "end_pos": 488}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 495, "end_pos": 500}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 509}]}
{"originalText": "，患者半月前無明顯誘因上發現腹部包塊，無疼痛不適、無反酸燒心，腫塊呈進行性生長，患者未行正規檢查治療，現自感腫塊增大明顯，求治我院門診，，查腫瘤標誌物提示：CA125 2306 U/ML，CA15-3 259.5 U/ML，CA19-9 2736 U/ML，CA72-4 66.06 U/ML，CEA 23.77 NG/ML ，NSE 32.38 NG/ML，HE4 &GT;1500PMOL/L。，門診擬診斷為：“，腹腔腫物：左側卵巢癌?”收入我院胃胰科。2014-09-29全麻上行卵巢癌腫瘤細胞減滅術（盆腔巨大腫物切除術+子宮兩附件切除+盆腔淋巴結清掃+大網膜切除+腹主動脈旁淋巴結活檢術）。，術後病理提示：（左卵巢）高級別漿液性腺癌，（大網膜）未見癌，（兩側盆腔淋巴結、腹主動脈旁淋巴結）均見腺癌轉移。術後診斷為卵巢高級別漿液性腺癌IIIA1（II）期。2014年10月18日、2014年11月8日行TC方案（伯爾定700MG+力樸素270MGD3）靜脈化療一程，過程順利,患者化療後未尊囑定期複查血常規。現為行上一步治療入院。起病以來，患者精神尚可，食慾可，大小便正常，身體無明顯消瘦。，既往化療及腫瘤標誌物情況：，化療藥物毒副反應：。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 78, "end_pos": 83}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 94, "end_pos": 100}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 112, "end_pos": 118}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 147, "end_pos": 150}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 164, "end_pos": 167}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 180, "end_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 219}, {"label_type": "手術", "overlap": 0, "start_pos": 243, "end_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 320}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 380}, {"end_pos": 412, "label_type": "藥物", "overlap": 0, "start_pos": 409}, {"end_pos": 421, "label_type": "藥物", "overlap": 0, "start_pos": 418}]}
{"originalText": "，緣於入院前2年半因“右腎下腺區佔位”住我院泌尿外科，查腹部，CT：1、胃底大彎側腫瘤性病變，多考慮間質瘤，2、兩腎下腺未見明顯佔位性病變，後轉我院腫瘤外科，於2013年09月27日在全麻上行“腹腔鏡上胃體間質瘤切除術”，，術中見：無腹水，盆底、膀胱、未及結節，肝表面光滑，空迴腸未見結節，腹腔動脈周圍未見明顯腫大淋巴結，腫瘤位於胃體大彎側，外生型，大約3CM×4CM，包膜完整，表面可見腫瘤壞死，遂行下術，手術順利，術後予預防感染、補液、營養支援等治療，術後恢復好，術後病理（201330085），：，腫瘤來源:原發；，部位:胃；，腫瘤大小:5CM(最大直徑)；，核分裂數:5/50HPF；，組織學診斷:梭形細胞型；，手術切緣:陰性；，腫瘤性壞死:無；，腫瘤細胞顯著異型:無；，腫瘤浸潤部位:肌層至漿膜層；，免疫組化:CD117(+++)，CD34(+++)，DESMIN(-)，S-100(-)，KI-67(5%+)，H-CALDESMON(++)，DOG1（+++）；，病理診斷:胃間質瘤，危險程度中等。術後予“格列衛400MGQD”靶向輔助治療，期間偶有嘔吐、腹瀉，對症處理後好轉。現無腹痛、噁心、嘔吐，無腹瀉，無納差、乏力，無發熱，今為進一步診治，門診擬“胃間質瘤術後”收住入院。自下次出院以來，精神、睡眠、食慾尚可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 15}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 28, "end_pos": 33}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 109, "label_type": "手術", "overlap": 0, "start_pos": 97}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 443, "end_pos": 447}, {"end_pos": 462, "label_type": "藥物", "overlap": 0, "start_pos": 459}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 497}, {"end_pos": 508, "label_type": "解剖部位", "overlap": 0, "start_pos": 507}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 533, "end_pos": 539}]}
{"originalText": "患者因患“直腸癌”於2012.11.29於我院在全麻上行腹腔鏡上直腸癌根治術（MILES）＋放射粒子植入術，術後病理檢查報告：直腸蕈樣型中分化管狀腺癌浸及深肌層，未見明確血管神經侵犯，肛門及下切緣未見癌累及，腸壁淋巴結未見癌轉移（0/17）。患者病理提示為T2N0M0，根據AJCC分期第七版為I期。術後恢復可，患者術前曾行一次新輔助化療，故本次入院擬行第二次化療。\\U0004   患者發病以來，神志 清晰，精神可，胃納可，大便如常，小便如常，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手術", "overlap": 0, "start_pos": 28, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 75}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 209, "end_pos": 210}]}
{"originalText": "病人診斷為食管上段癌，於2012-8-30全麻上行經右胸上段食管癌切除、食管胃主動脈弓上吻合、淋巴結廓清術。術中順利，術後抗炎支援治療，術後狀態恢復良好。經口進食病人無不適，後可以出院。1天前突然嘔吐出1口暗紅色血，就診於我院門診，行肺CT檢查，後病人間斷出現嘔吐出數口鮮血，並於今日下午9時大嘔血一次，約嘔出鮮血500毫升，予病人止血補液輸血抗休克等對症治療，積極請消化內鏡、介入科會診，於內鏡科行胃鏡檢查，吻合口周圍未見出血點。於介入科行血管造影，未見出血。遂收入我科住院繼續治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 10}, {"label_type": "手術", "overlap": 0, "start_pos": 25, "end_pos": 53}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 221, "end_pos": 225}]}
{"originalText": "患者2月前因酒後腹痛、大便發黑，嘔血1次伴眩暈，行胃鏡檢查確診為胃低分化腺癌，遂於2009-7-2在我院行遠端胃癌根治+B-I式吻合術，術後恢復良好，病理回報：胃竇部潰瘍型低分化腺癌，大小約2.7*1.7CM，侵透漿膜，淋巴結2/28可見轉移，並於2009-8-14開始行FOLFOX7方案化療，化療後副反應評價食慾不振1°，噁心1°，嘔吐2°，手足綜合症1°。現為行第2週期輔助化療入院。患者自前次出院以來精神，睡眠，飲食可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 38}, {"label_type": "手術", "overlap": 0, "start_pos": 53, "end_pos": 67}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 80, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 173, "end_pos": 178}]}
{"originalText": "，患者門診，2011-1-4因胃癌於外院行胃癌根治術，術後恢復可。術後行化療3次，2012-9因闌尾炎行手術，，術後病理：可見癌細胞（未見癌）。2013年1月餘出現大便困難，就診於外院查腹盆部，CT：1,肝內膽管擴張，膽管中段狹窄，考慮佔位性病變，2.腹水。MRCP提示肝內外膽管擴張，考慮膽總管中段狹窄。直腸壁增厚。近期腹部疼痛加重明顯，向腰、臀、上肢放射，影響休息，目前口服泰勒寧2片後只能5小時略好，飲食少，大便差，腹脹、氣鼓，脫肛；小便困難,尿痛，尿急，輕度黃染。忍痛習慣，同理溝通。辦麻卡，指導用藥。（5200）。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"end_pos": 26, "label_type": "手術", "overlap": 0, "start_pos": 21}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 48, "end_pos": 51}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 93, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 108}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 115}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 126, "end_pos": 127}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 129, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 135, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 153, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 192, "label_type": "藥物", "overlap": 0, "start_pos": 189}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}]}
{"originalText": "，患者2個月前因\\\"陰道接觸性出血3＋月\\\"就診**一院，，活檢提示：宮頸鱗狀細胞原位癌累及腺體，區域性見小灶浸潤癌。遂於2011－12－12行\\\"廣泛全宮切＋兩側附件切除術＋盆腔淋巴結清掃術\\\"。，手術後病理：宮頸低分化鱗狀細胞癌，癌組織浸潤宮頸1CM,盆腔各淋巴結未見異常。2011－12－27給予TP方案化療一程，現入我科行輔助放療。。患者自起病以來，精神胃納食慾可，大小便正常，體重無明顯上降。", "entities": [{"end_pos": 12, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 48}, {"label_type": "手術", "overlap": 0, "start_pos": 73, "end_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 115}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}]}
{"originalText": "，患者5個月前因降結腸癌，不全腸梗阻，肝轉移，肺轉移，在我科行右半結腸切除術，術中見腫瘤位於降結腸近脾曲，透漿膜，環周，近端腸管略增粗，腸壁水腫，呈不全梗阻狀，腸繫膜上血管根部及腹主動脈前方淋巴結腫大融合成團，浸潤固定。，術後病理進展期結腸癌：浸潤潰瘍型，中分化腺癌，淋巴結見轉移癌（5/12枚）DUKES“C”期。（，病理號：163101）。術後行XELOX方案化療2個週期後，改為FOLFIRI方案繼續化療術後恢復良好，現為行化療入院。病來進食可，睡眠佳，二便正常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 8, "end_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 13, "end_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 26}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 133}]}
{"originalText": "患者因進食哽噎感20日來診，既往有間斷聲音嘶啞2-3年，近日加重1月外院胃鏡檢查提示食管胃癌（病理回報示鱗狀下皮上可見低分化腺癌浸潤），胸部CT示食管佔位性病變，腹水。腹部B超提示肝硬化，腹水。進食目前能進食固體食物，體重有上降。\\U0004\\U0004我院胃鏡示胃食管結合部隆起潰瘍型腫物（病理未回)，瘤標示CEA5.44，CA724 7288U/ML，CA125 100.2U/ML，NSE 38.22NG/ML，CYFRA21-1 10.87NG/ML。HER2(3+).\\U0004\\U0004腹部CT示胃食管交界癌，腫瘤侵透漿膜可能大，腹膜瀰漫轉移。胃周多發淋巴結，考慮轉移可能大。肝臟低密度小結節，囊腫？追查。\\U007F\\U0004\\U0004腹腔大量積液。胸部增強示：胃腔充盈擴張欠佳，食道上段、胃底賁門壁增厚。右側少量胸水。\\U007F\\U0004\\U0004\\U007F\\U0004\\U0004。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 59, "end_pos": 64}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 68, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 73, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 81, "end_pos": 82}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 84, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 95}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 155, "end_pos": 158}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 163, "end_pos": 168}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 178, "end_pos": 183}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 194, "end_pos": 197}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 209, "end_pos": 218}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 251, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 262}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 279}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 280, "end_pos": 281}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 329, "end_pos": 335}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 336}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 342}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 368, "end_pos": 369}]}
{"originalText": "2011-7出現大便帶血，伴腹痛，2011-12-20腸鏡診斷直腸癌，2012-1-6行直腸癌前切術，術中見腫瘤位於腹膜反折下3CM，術後病理：直腸隆起型神經內分泌瘤，G2，大小2.5*2.59*1.2，侵犯漿膜層，切緣陰性，腸繫膜淋巴結5/5，癌結節1枚，免疫組化CGA+,SYN++,CD56+,CK18+++,KI-67<10%。術後XELOX方案化療6週期，末次2012-6-27,2013-5-23PET-CT檢查時肝內多發轉移，2013-6-9給予XEIRI方案化療2週期，評效PD。2013-7-10 奧曲肽掃描見陽性病灶，2013-8-1給予善龍20MG治療1次。2013-09-01及9-29給予善龍30MG治療.2013-11-14和2014-1-2行TAE治療，2013-12評效腹部CT示肝左葉病變基本無活性。2014-2-8複查腹部CT示肝右左葉病變均明顯縮小，均無明顯活性。2014-5-8隨訪複查腹部CT示肝內病變均繼續縮小，未見明顯活性。2014-8複查CT肝內病灶較前明顯增大有活性；2014-8月和9月行雙次EP方案動脈化療.2014-10-13腹部CT示肝內病變明顯增大.2014-10-16和2014-11-18行肝動脈TACE術2次.。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"end_pos": 50, "label_type": "手術", "overlap": 0, "start_pos": 44}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 204, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 219}, {"end_pos": 261, "label_type": "藥物", "overlap": 0, "start_pos": 258}, {"end_pos": 281, "label_type": "藥物", "overlap": 0, "start_pos": 279}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"end_pos": 339, "label_type": "手術", "overlap": 0, "start_pos": 336}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 351, "end_pos": 355}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 377, "end_pos": 381}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 413, "end_pos": 417}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 418}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 443, "end_pos": 445}, {"end_pos": 446, "label_type": "解剖部位", "overlap": 0, "start_pos": 445}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 491, "end_pos": 495}, {"end_pos": 497, "label_type": "解剖部位", "overlap": 0, "start_pos": 496}, {"end_pos": 535, "label_type": "手術", "overlap": 0, "start_pos": 527}]}
{"originalText": "2012.2行XELOX+AVASTIN結腸癌新輔助化療,共計2週期，2012.4.12行乙狀結腸癌+部分膀胱切除手術，術後病理：中分化腺癌，侵及全層及膀胱，脈管（-），切緣（-）LNM0/21.術後行XELOX共計4週期，末次化療2012.8.18。\\U0004\\U0004術前及現在標誌物正常。腹水內細胞學陰性，但CA125>300\\U0004\\U0004\\U0004\\U0004\\U0004\\U0004噁心，嘔吐，腹脹，淋巴結轉移\\U0004\\U0004外院超聲提示腹水，腹穿放腹水後未在漲，繼續化療 \\U0004\\U0004複查血常規提示白細胞減少1度，血小板減少1度，轉氨酶升高1度。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 23}, {"end_pos": 59, "label_type": "手術", "overlap": 0, "start_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 159, "end_pos": 164}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 237}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 273, "end_pos": 276}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 289, "end_pos": 292}]}
{"originalText": "，患者2007.4因“右下頸腫物1月”診斷為鼻咽未分化型非角化行癌（T3N2M0），在我院行TP全身化療2週期，根治性IMRT，DT6800CGY/30F/7.5W，區域淋巴結DT6400CGY/30F/7.5W，臨床療效評價為CR，定期複查未見異常。2011.1出現黃疸，於我院PET/CT，檢查示：鼻咽癌並肝、腹腔積腹膜後淋巴結轉移。遂於2011.3.11行ERCP+膽管支架植入術，術後於2011.3.22、2011.4.12、2011.5.4、2011.5.25行TPF化療4程。2011.6.10，複查CT示：肝S4病灶，考慮轉移瘤。肝S4 病灶，考慮肝轉移瘤，對比2011.4.29 日CT,較前稍縮小。肝門區、門腔間隙、腹膜後淋巴結腫大，較前縮小。鼻咽癌治療後，鼻咽腔未見明確佔位性病變。於2011.6.14、2011.7.5行紫杉醇+順鉑+5-FU化療2程。定期複查，2011.10.18複查鼻咽、，頸部及下腹部CT提示：肝S4 病灶，考慮肝轉移瘤，較前無大變化。肝門區、門腔間隙、腹膜後淋巴結腫大，較前無大變化。於2011.10.26在我院CT室行肝轉移瘤微波消融術；2011.12.，19我院下腹部CT:肝S4病灶較前無明顯改變。肝門區、門腔間隙、腹主動脈旁多發淋巴結，部分病灶增大。現為進一步治療入院。自起病以來，患者精神、睡眠可，食慾如常，大小便正常，體重無上降。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 22, "end_pos": 41}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 140, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 168}, {"label_type": "手術", "overlap": 0, "start_pos": 180, "end_pos": 193}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 256, "end_pos": 258}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 285}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 299, "end_pos": 301}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 323, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 334}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 338, "end_pos": 340}, {"end_pos": 374, "label_type": "藥物", "overlap": 0, "start_pos": 371}, {"end_pos": 377, "label_type": "藥物", "overlap": 0, "start_pos": 375}, {"end_pos": 382, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 408, "end_pos": 416}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 432}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 448, "label_type": "解剖部位", "overlap": 0, "start_pos": 444}, {"end_pos": 455, "label_type": "解剖部位", "overlap": 0, "start_pos": 449}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 479, "end_pos": 481}, {"end_pos": 492, "label_type": "手術", "overlap": 0, "start_pos": 483}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 506, "end_pos": 511}, {"end_pos": 515, "label_type": "解剖部位", "overlap": 0, "start_pos": 512}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 529}, {"end_pos": 539, "label_type": "解剖部位", "overlap": 0, "start_pos": 534}, {"end_pos": 544, "label_type": "解剖部位", "overlap": 0, "start_pos": 541}]}
{"originalText": "，患者因“進食後腹脹20余天”於2015.11.4來我院就診，，胃鏡檢查：慢性非萎縮性胃炎，胃角潰瘍（性質待定），幽門管隆起（性質待定），，取病理示：（胃竇）腺癌，（胃角）高級別下皮內瘤變（重度異型增生）。2015.11.4患者入院後完善輔助檢查，經積極術前準備，於2015-11-07在全麻上行胃癌根治術（畢I式）。手術順利，術後經抗感染及營養支援治療，患者恢復良好，無腹痛、腹脹、發熱等不適，已進流質飲食，引流管已拔除並拆除全部縫線，出院。院外未行其他治療，定期複查。2016.4.21來我院複查，，CT：胃癌術後，胃壁厚，肝臟多發低密度影，考慮轉移瘤，請結合臨床，肝臟小囊腫，膽囊炎。現為進一步治療，門診以“胃癌”收入我科，發病以來患者精神可，飲食睡眠可，二便較前無明顯異常。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 45}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 46, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 75, "end_pos": 81}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 102}, {"label_type": "手術", "overlap": 0, "start_pos": 148, "end_pos": 158}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 252, "end_pos": 254}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 255, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 261}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 285, "end_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 294}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 309}]}
{"originalText": "，患者4月前無明顯誘因出現全腹隱痛，自行緩解，症狀反覆，大便1-2次/天，成形，無血便、黑便、噁心等，無頭暈、乏力、發熱等不適。外院腸鏡檢查提示升結腸腫物。活檢病理提示腺癌。，我院鋇灌腸提示：升結腸癌。，我院行腹盆MR檢查示：升結腸病變，考慮升結腸癌。左半結腸繫膜區淋巴結，考慮轉移可能性大。肝S6異常訊號灶，考慮囊腫可能性大，建議複查。患者入院完善相關檢查，診斷“升結腸腺癌 CT3N1M0”，未見手術禁忌，2014-10-30全麻上行腹腔鏡左半結腸切除術，，術後病理分期：升結腸中至低分化腺癌伴粘液腺癌，PT3N1M0,III期。於2014-12-04給予XELOX方案化療1程順利，現遵原主診教授意見入院行上次化療。患者自起病以來無發熱，胃納可，睡眠一般，大小便正常，體重上降3KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 105, "end_pos": 109}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 125}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 183, "end_pos": 196}, {"end_pos": 229, "label_type": "手術", "overlap": 0, "start_pos": 219}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 266}, {"end_pos": 323, "label_type": "解剖部位", "overlap": 0, "start_pos": 322}]}
{"originalText": "，入院前2月餘，患者因“中下腹疼痛伴噁心半天”入我院消化內科。予以禁食禁飲，抑酸護胃及抑制胰液分泌、抑制胰酶活性、維持水電解質、酸鹼平衡及補液等對症治療。，MRCP：1.胰腺體尾部稍增大，胰周少許滲出影，提示胰腺炎，結合臨床隨訪。2.膽總管上端多發小結石並膽總管輕度擴張。3.膽囊多髮結石。4.左腎下極小囊腫。5.肝周少許積液。請我科會診後於轉入我科，完善術前相關檢查，排除手術禁忌後於6月20日在全麻上行膽道探查+術中膽道鏡取石檢查+膽囊切除術+T管引流術。，術後組織病理學檢查報告：慢性膽囊炎。院外患者間斷夾閉T管，T管引流金黃色膽汁，量可。現患者因膽道術後近2月，為拔T管入院。\\U0004   患者自起病以來，精神略差，胃納略差，大便如常，小便如常，體重未見明顯上降。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 78, "end_pos": 82}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 104, "end_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 144}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 147, "end_pos": 154}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 163}, {"label_type": "手術", "overlap": 0, "start_pos": 203, "end_pos": 229}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 243, "end_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 277, "end_pos": 281}]}
{"originalText": "入院前3年，患者因肝癌於我院行肝癌射頻消融術，術中見肝臟萎縮，大小約２３×１２×７ｃｍ，以肝右葉萎縮明顯，肝臟色暗紅，表面佈滿大小不等結節，邊緣銳利，肝左葉第VIII段位置可捫及一質硬包塊，大小約２×３ｃｍ，邊界較清晰。遂行開腹射頻消融術＋膽囊切除術＋化療泵置入術。術後恢復可，規律行化療及口服抗腫瘤藥物，定期複查，入院前2年餘因肝癌復發於我院行介入手術，現因肝癌復發，擬行第三次介入手術入院，患者患病以來精神差，飲食差，二便正常。\\U0004   患者自起病以來，精神可，食慾欠佳，睡眠可，大小便可，體重未見明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"end_pos": 22, "label_type": "手術", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 26, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 45, "end_pos": 50}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 165, "end_pos": 169}, {"label_type": "手術", "overlap": 0, "start_pos": 173, "end_pos": 177}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 184}, {"label_type": "手術", "overlap": 0, "start_pos": 190, "end_pos": 194}]}
{"originalText": "，患者於3月餘前，因查體發現CEA升高，且有大便習慣改變，就診於我院胃腸外科，完善相關檢查，於2016年5月20日行胃鏡檢查，，病理示：胃竇腺癌，排除手術禁忌，於2016年5月24日在全麻上行手術治療（具體術式不詳）。手術過程順利，，術後病理示：胃竇大彎側腺癌（中-低度分化），大部分呈乳頭狀腺癌，浸潤潰瘍型，體積3*3*0.5CM，侵達深肌層。雙端切線未查見癌。呈六組（1/4個）淋巴結癌轉移。三組（1個）、四組（5個）、五組（3個）、“1、3、7組”（4個）淋巴結未查見癌。術後於2016年6月25日行1週期化療，，方案：奧沙利鉑200MG D1+亞葉酸鈣0.3G D2-6 +替加氟1000MG D2-6，同時輔以保肝、保胃及止吐等對症支援治療，化療過程順利。化療結束後出院。患者為求放療於2016年7月20日入住我科，完善相關輔助檢查，排除禁忌，於2016年7月21日行全身化療，，方案：奧沙利鉑200MGD1+替吉奧60MG BID D1-D14，同時輔以保肝、保胃及止吐等對症處理，患者胃腸道反應輕，化療過程順利，化療結束後於2016年8月9日開始行區域性放療，共放療14次，DT2520CGY，同步口服替吉奧40MG BID化療，未見明顯放化療反應，耐受可，患者於2016年8月29日拒絕繼續放療，經反覆勸說無效，簽字為證。排除禁忌，於2016年9月1日行原方案全身化療，化療過程順利，好轉出院。   患者自下次出院後，病情尚穩定，未述特殊不適，飲食睡眠尚可，大小便正常。體重未見明顯減輕。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 148}, {"end_pos": 267, "label_type": "藥物", "overlap": 0, "start_pos": 263}, {"end_pos": 280, "label_type": "藥物", "overlap": 0, "start_pos": 276}, {"end_pos": 294, "label_type": "藥物", "overlap": 0, "start_pos": 291}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"end_pos": 315, "label_type": "解剖部位", "overlap": 0, "start_pos": 314}, {"end_pos": 402, "label_type": "藥物", "overlap": 0, "start_pos": 398}, {"end_pos": 413, "label_type": "藥物", "overlap": 0, "start_pos": 410}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 434, "end_pos": 435}, {"end_pos": 438, "label_type": "解剖部位", "overlap": 0, "start_pos": 437}, {"end_pos": 510, "label_type": "藥物", "overlap": 0, "start_pos": 507}]}
{"originalText": "，患者5月餘前（2013年6月）於我院肛腸外科確診直腸癌伴肝轉移，，肝臟增強MR示：肝臟內可見多發大小不一的類圓形長T1長T2訊號影，最大者位於肝右外葉，呈不規則團塊狀，大小4.47×3.13CM,增強掃描病灶邊緣明顯不均勻強化，中心強化不明顯。於我院肛腸外科行FOLFOX新輔助化療2週期。複查全腹CT提示肝臟多發佔位縮小，最大者位於肝右外葉，大小2.8×2.1CM，3月餘前（2013年8月8日）於我院肛腸外科行直腸癌低位前切除術，術後恢復良好，，術後病理回報：進展期直腸癌，潰瘍浸潤型，中分化腺癌，II級，斷端無癌，，浸潤深度:透漿膜，脈管癌栓（+），肌間神經節侵犯（+），結外腫瘤種植（+），淋巴結可見癌轉移（3/12枚），DUKES，分期：C2期,（，病理號：508）。患者術後拒絕行基因檢測及應用靶向藥物，繼續FOLFOX輔助化療2週期。2013年10月28日複查全腹CT提示肝臟多發佔位，較大者位於右外葉，大小約4.0*2.8CM,提示疾病進展，後轉入我科，行FOLFOX輔助化療1週期。下週期化療後出現肝功異常，口服兩環醇進行保肝降酶治療。末次化療距今3周，現為求進一步治療收入我科，飲食睡眠可，精神體力可，小便正常，大便日一次略乾燥，近來體重未見明顯減輕。ECOG，評分：1分。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 34, "end_pos": 36}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 148, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 154, "end_pos": 156}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 217, "label_type": "手術", "overlap": 0, "start_pos": 208}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 233, "end_pos": 255}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 388, "end_pos": 392}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 394, "end_pos": 396}, {"end_pos": 469, "label_type": "藥物", "overlap": 0, "start_pos": 466}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}]}
{"originalText": "，患者2015年3月18日於外院行卵巢癌減滅術，具體手術情況不詳，，術後病理示：冰凍及常規石蠟結果報告（冰凍盆腔腫物、大網膜及後送的兩側卵巢腫瘤）病變符合中分化腺癌。術後未進行上一步處理。1月餘前出現上腹脹，無呼吸困難，無頭暈眼花，來我院門診就診，2015-07-29，我院CT提示：盆底巨大不規則團塊狀囊實性腫物，考慮腫瘤復發灶；盆腔內見少量積液；大網膜及腸繫膜密度增高，可疑種植轉移；左側腹股溝區腫大淋巴結，考慮轉移瘤。現為進一步治療，依主診教授意見收入我科行化療，2015-10-20更換方案為“順鉑+伊立替康”,療效欠佳，按主診教授意見更換為“裡葆多+洛鉑”，入院化療。起病以來，患者精神、飲食可，睡眠稍差，大小便正常，體重較術前增加4KG。", "entities": [{"end_pos": 23, "label_type": "手術", "overlap": 0, "start_pos": 17}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 137, "end_pos": 139}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 168}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 180}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 253, "label_type": "藥物", "overlap": 0, "start_pos": 251}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 254}, {"end_pos": 279, "label_type": "藥物", "overlap": 0, "start_pos": 276}, {"end_pos": 282, "label_type": "藥物", "overlap": 0, "start_pos": 280}]}
{"originalText": "患兒1天前無明顯誘因出現陣發性哭鬧，伴嘔吐，嘔吐物為胃內容物，無咖啡樣物，共5次。發熱體溫最高38.5℃，無腹瀉，無咳嗽、咳痰。患兒家屬急帶患兒到我院兒急診就診，B超檢查示：下腹略偏左探及一約類圓形包塊，縱切面呈橢圓形，周圍商清晰，範圍約39*18*16MM，考慮腸套疊可能。為求進一步治療，急診以“腸套疊”收入我科行空氣灌腸整復術。患兒自發病以來，神志清，精神可，飲食不佳，小便可，大便1次，伴血絲。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 153}, {"end_pos": 166, "label_type": "手術", "overlap": 0, "start_pos": 159}]}
{"originalText": "，術前“貧血，腸梗阻”，術前未行腸鏡，2013-12-15行降結腸根治術，術中見降乙交界處約4X3X2CM腫物，近段結腸及部分小腸擴張積氣，術後“（降結腸）中分化絨毛狀管狀腺癌，伴部分粘液腺癌及部分印戒細胞癌，腫瘤侵及漿膜，斷端-，1/29，另送腹主A旁0/3，靜脈內癌栓，HER2(1+)”，術前CEA 12.49（0-3.4），術後正常，XELOX*5，末次2014-5-14，醫腫CT考慮肝單發M，但PET-CT未見肝異常高代謝，切口處軟組織影SUV 4.4，延遲5.6。現CEA 2.4。，我院會診：中分化腺癌伴黏液腺癌侵透漿膜層；HER-2(2+)，FISH 無擴增，免疫組化MSI，KRAS、NRAS、BRAF均野生型。肝造影示肝左葉膈面病灶傾向M。腹壁取病理為炎症。，NSE：34.9.我院2014-7-7MDT考慮目前肝臟病灶性質不明，且原病理提示部分粘液腺癌，建議密切隨訪。現複查CT可疑肝新發模糊結節，但MRI未考慮。2016-1-26複查核磁未見異常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 6}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 36, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 104}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 149, "end_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 193, "end_pos": 195}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 203, "end_pos": 209}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 240, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 254, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 320, "end_pos": 323}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 331, "end_pos": 332}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 384, "end_pos": 388}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 399, "end_pos": 401}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 412, "end_pos": 415}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 430, "end_pos": 432}]}
{"originalText": "患者1月前無明顯誘因出左上腹隱痛，排便後有緩解，外院CT示升結腸佔位，腹水。12-3就診予我院，胸腹盆CT:升結腸近肝曲腸壁腫物，考慮結腸癌，侵犯腸繫膜。肝包膜、腸繫膜、大網膜、壁層腹膜見呈結節狀不均勻增厚，考慮腫瘤種植。腹腔、盆腔積液。診斷為升結腸腺癌腹腔多發種植，伴不完全腸梗阻，為解除梗阻、改善症狀、減輕腫瘤負荷，2014-12-12探查腹盆腔，原發病灶位於升結腸，質硬，腸周系膜多發種植灶，固定，與十二指腸及胰腺關係不清，腹壁、大網膜、肝包膜多發種植灶，考慮腫瘤晚期，原發灶無法完整切除，行“大網膜切除+胃空腸吻合術+迴腸-橫結腸吻合術”，術後恢復可。2014-12-30、2015-01-15、2015-01-30給予FOLFOX方案化療3程順利，無不適。3程後複查療效評價為SD。現為行第4程化療入院。患者起病以來，精神睡眠一般，胃納一般，小便可。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 26, "end_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 37}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 48, "end_pos": 53}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 67, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 73, "end_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 81, "end_pos": 82}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 173}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 175}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 190}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 215, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 223}, {"label_type": "手術", "overlap": 0, "start_pos": 250, "end_pos": 272}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}]}
{"originalText": "患者於2011-6月無明顯誘因上出現吞嚥困難，進行性加重，伴胸骨後燒灼樣疼痛，程度輕，至我院就診，經檢查確診胸中段食管癌，完善準備後於2011-7-7全麻上行“經左胸下腹頸部食管部分切除+胃食管頸部吻合+二野清掃術”，術後恢復良好。病理示：(胸下段食管）送檢食管一段長10CM，距一端3CM處可見一大小4.5*3*1.5CM腫物；鏡檢為食管中分化鱗狀細胞癌，左喉返神經旁淋巴結（2/5)轉移。分期為PT3N1M0，III期。於2011-8至2011-10行“泰素帝+奈達鉑”方案化療4程，過程順利。後於2011-11-8至2011-12-12行輔助性放療（原發灶50GY，25次），過程順利。後定期複查未見明顯腫瘤復發轉移徵象。2012-8-13起患者於我科行CIK細胞免疫治療至今，既往回輸後曾出現發熱，體溫最高達39.5度，對症治療後好轉。後回輸過程順利。現為繼續行CIK細胞免疫治療入我科。自下次治療以來，患者無吞嚥不適，無發熱、畏寒，精神、睡眠可，大小便基本正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 60}, {"label_type": "手術", "overlap": 0, "start_pos": 80, "end_pos": 107}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 178}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 232, "label_type": "藥物", "overlap": 0, "start_pos": 229}, {"end_pos": 236, "label_type": "藥物", "overlap": 0, "start_pos": 233}]}
{"originalText": "患者於2005年9月在**一院行胃癌D2根治術，術後分期T3N2M0,術後病理示低分化腺癌，浸潤全層，6、7、8、11組淋巴結見轉移，術後2005-11-14始XELOX方案化療3程，2005-12改行FOLFOX方案化療3程（末次化療時間2006-3-16），後定期複查。患者2011年12月6日複查CT示：吻合口周圍胃壁增厚，肝S3轉移瘤，肝門區及腹膜後淋巴結轉移。PET/CT示吻合口代謝增高，吻合口炎。肝S3轉移，肝門區及腹膜後淋巴結轉移，胃鏡示吻合口病變，遂來我院診治，行S-1口服11程，訴噁心，手足麻木。現患者食慾較差，睡眠尚可，精神可，體重上降3KG。", "entities": [{"end_pos": 23, "label_type": "手術", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 45}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 165, "end_pos": 171}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 184}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 185, "end_pos": 191}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 200, "end_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 205, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 223}, {"end_pos": 244, "label_type": "藥物", "overlap": 0, "start_pos": 241}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}]}
{"originalText": "，患者2014-05無明顯誘因出現大便帶鮮紅血，量較少，伴少量粘液，有大便習慣改變，表現為大便次數增多，約2-3次/天，大便形狀變細，間有解稀爛便，輕微腹脹，無腹痛、無噁心、嘔吐，無氣促、胸悶等。未予重視。近5月餘來下述症狀逐漸加重，大便頻繁，伴裡急後重感。外院腸鏡檢查提示距肛門7CM直腸腫物，大小3CM×2CM，腸鏡能透過。活檢病理提示腺癌。後於外科完善相關檢查，經解釋病情患者同意入組希羅達聯合奧沙利鉑新輔助化療對比術前放療+希羅達低危區域性晚期直腸癌的隨機對照臨床試驗。於2014-10-15至2014-11-17行術前放療，同期予希羅達口服化療，期間出現納差、噁心、嘔吐1次。2015-01-04全麻上行腹腔鏡DIXON+迴腸造瘻術，，術後病理回報：鏡檢為中分化腺癌，浸潤至腸壁外膜層，未見脈管內癌栓及神經束侵犯，TRG級，：II級。YPT3N0MO,IIA期，2015-02-15、2015-03-10行2程XELOX化療方案。為行第3程XELOX化療方案，現轉入我科。患者自末次化療後，食慾、睡眠及精神尚好，小便正常，體力、體重無明顯上降。", "entities": [{"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"end_pos": 198, "label_type": "藥物", "overlap": 0, "start_pos": 195}, {"end_pos": 204, "label_type": "藥物", "overlap": 0, "start_pos": 200}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 228}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 269}, {"label_type": "手術", "overlap": 0, "start_pos": 306, "end_pos": 320}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 332, "end_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 342}]}
{"originalText": "2014-8因便血查胃鏡示賁門佔位，病理示中分化腺癌。當地行賁門癌根治術。術後給予吉西他濱+奈達鉑*1，FOLFOX*6，末次化療2015-2.間斷中藥治療。2015-3發現腫標增高。2015-9-17CT示縱膈、殘胃周圍及腹膜後多發腫大淋巴結，肝內多發低密度密度灶，均考慮轉移。兩肺多髮結節，考慮轉移，盆腔積液。胃鏡吻合口粘膜充血水腫，周圍見結節樣增生。距門齒25CM食管中段見1.5CM隆起型病變。病理示吻合口慢性炎，食管中段腺癌。目前患者進食欠佳，大小便正常，無黑便。體重穩定。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 13, "end_pos": 15}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 21, "end_pos": 26}, {"end_pos": 36, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"end_pos": 45, "label_type": "藥物", "overlap": 0, "start_pos": 41}, {"end_pos": 49, "label_type": "藥物", "overlap": 0, "start_pos": 46}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 101, "end_pos": 103}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 113}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 152, "end_pos": 156}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 217}]}
{"originalText": "，患者半年前無明顯誘因出現大便次數增多，4-5/日，偶排血便，無噁心嘔吐，無腹脹腹痛等不適。，在外院行腸鏡檢查示：距肛10-15CM菜花樣腫物，堵塞腸腔，，病理結果為：腺癌。於2016年3-1月就診我院，，行結腸鏡檢查示：距肛10-15CM菜花樣腫物，堵塞腸腔，，病理結果為：腺癌.。2016-3-8，盆腔MRI示：直腸下段-乙狀結腸病變，符合腸癌。於2016-3-10行全麻上行腹腔鏡上DIXON術，，術後病理示：（腸大體）鏡檢為中至低分化腺癌。患者術後病理分期為PT4AN0M0 IIB期。術後於2016-03-31給予1次FOLFOX方案化療現患者返院行進一步治療。精神食納可，無裡急後重，體重增加約1KG。", "entities": [{"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 86}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 151, "end_pos": 156}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 174}, {"end_pos": 200, "label_type": "手術", "overlap": 0, "start_pos": 190}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 216, "end_pos": 223}]}
{"originalText": "，2017-1-24，外院胃鏡示：距門齒32-35CM鱗癌。影像學檢查提示兩頸部、縱隔、淋巴結轉移，多發骨轉移。2017-2開始行紫杉醇+順鉑方案化療2週期。，末次化療時間：2017-3。2週期後複查，縱隔淋巴結轉移灶較前縮小，腹腔淋巴結無法對比。2017-5-3，本院胸CT示：食管胸中上段癌，伴縱隔2-8組、兩肺門、鎖骨下區、右腋區及胃周瀰漫腫大淋巴結轉移。2017-5-8，腹部CT示：肝臟多髮結節，考慮轉移。腹腔及腹膜後腫大淋巴結，考慮轉移。胸12、多個腰椎多發異常密度灶，考慮轉移。2017-5-23行第1週期TP方案化療。2017-6-15行第2週期化療。4週期後複查，原發灶及縱隔、腹腔、腹膜後淋巴結轉移灶較前變化不大，肝轉移灶較前增多增大，肺新見多發小結節，考慮轉移；綜合判效PD。患者目前進食哽噎明顯，經全科查房討論建議行放療或支架置入解決進食問題。2017-7-10 流食。放療科擬行放療。2017-7-17 已完成定位。2017-7-20 放療計劃復位驗證無誤，準備放療。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 27, "end_pos": 29}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 55}, {"end_pos": 68, "label_type": "藥物", "overlap": 0, "start_pos": 65}, {"end_pos": 71, "label_type": "藥物", "overlap": 0, "start_pos": 69}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 135, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 147}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 170}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 190, "end_pos": 194}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 212}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 328}]}
{"originalText": "，2012-6腸鏡示直乙交界佔位（距肛門10-15CM），印戒細胞癌。盆腔MRI提示子宮附件佔位，，腫標：CA724 10.77，，CA125:112,2012-7-4行乙狀結腸癌切除+兩側附件佔位切除，術中腫物固定於前方膀胱後壁、盆腔側壁，具體不詳。7-19始行XELOX+泰欣生600MG*8週期，末次化療2012-12-20。 自2013-1-11單藥希羅達1.5G BID D1-14 Q3W+泰欣生600MG/周維持治療中。 2013-5-20，多學科會診：建議盆腔放療，同時聯合泰欣生治療。放療前可以繼續希羅達1.5G BID D1-14 Q3W+泰欣生600MG/周治療。 現進食、體力可，無明顯不適，一般情況可。放療計劃50GY/25次，2013-6-14開始放療，2013.7.18放療結束。現乏力，腰痠，食慾差，大便可，無便血。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 29, "end_pos": 34}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 35, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 44, "end_pos": 46}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 53, "end_pos": 58}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "手術", "overlap": 0, "start_pos": 85, "end_pos": 101}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 118}, {"end_pos": 141, "label_type": "藥物", "overlap": 0, "start_pos": 138}, {"end_pos": 182, "label_type": "藥物", "overlap": 0, "start_pos": 179}, {"end_pos": 204, "label_type": "藥物", "overlap": 0, "start_pos": 201}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 248, "label_type": "藥物", "overlap": 0, "start_pos": 245}, {"end_pos": 261, "label_type": "藥物", "overlap": 0, "start_pos": 258}, {"end_pos": 283, "label_type": "藥物", "overlap": 0, "start_pos": 280}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}]}
{"originalText": "，患者2016.11體檢發現肝內佔位，病程中無明顯腹痛、無腹脹、無噁心、無嘔吐、無畏寒、無發熱、無面板搔癢等不適，歲就診於我院，2016年11月18日於全麻上行肝癌切除+膽囊切除術，術程順利，術後予護肝、護胃，抗感染，調節免疫對症治療後好轉，，術後病理提示：中至低分化肝細胞癌（梁索型），癌組織侵犯肝被膜上方，未見明確壞死及衛星結節，可見脈管內癌栓，未見明確神經束侵犯。2017.4.28，複查增強CT提示：肝癌術後改變，肝S5術區少量積液，較前減少；肝S5近切緣處新增低密度結節，考慮復發灶可能性大。肝S2低密度結節，考慮囊腫可能性大。肝硬化；脾腫大。肝周、脾周少量積液；肝周腹膜稍增厚、模糊，請結合臨床。上腔靜脈旁、門腔間隙淋巴結稍大，較前相仿。T10右側椎弓根緻密灶，考慮骨島，較前相仿。左上肺條片灶，考慮侷限性肺不張。現為進一步診治收入我科，起病以來，患者精神尚可，食慾如常。大小便正常。體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"label_type": "手術", "overlap": 0, "start_pos": 80, "end_pos": 90}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 150}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 199, "end_pos": 201}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 208}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 269, "end_pos": 272}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 278}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 280, "end_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 288}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 310}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}]}
{"originalText": "，術前，CA199:38，，CEA：6.5，2010.6.28行升結腸癌根治術，隆起型中分化腺癌，0/31，PT3N0M0，未輔化。2013.7末次腸鏡（-），定期複查。2013-10-15腹CT曾疑有S8結節M？經MRI考慮良性，及肝多發囊腫。2012.10始CA199升高約50，至2014.5為91，TPSA 6.25，且ALT，AST約300，對症後上降；2014.11複查CA199同前，但MRI示肝S8富血供結節由11MM增至22MM，M？超聲造影肝S8結節為轉移。2014-12-16於我院行肝RFA治療。複查。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 4, "end_pos": 9}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 39, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 48}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 95, "end_pos": 98}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 122}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 131, "end_pos": 136}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 153, "end_pos": 157}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 164, "end_pos": 167}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 168, "end_pos": 171}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 191, "end_pos": 196}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 226, "end_pos": 228}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"label_type": "手術", "overlap": 0, "start_pos": 253, "end_pos": 257}]}
{"originalText": "，間斷下腹不適5年，2015-8-25，我院胃鏡：十二指腸球部多發淺潰瘍，降段乳頭遠端對側潰瘍病變，，病理:降部形態結合IHC，符合神經內分泌腫瘤,KI-67(+15%)；CT示肝左葉多發轉移，奧曲肽掃描（-）？2015-9-9在我院行胰十二指腸切除+左肝部分切除，，術後病理：NET G3，3.2*3.0CM，伴表面潰瘍，核分裂像12個/10HPF，十二直腸壁外脂肪組織；瘤栓及神經+，：未侵及胰腺，2/18，KI-67(25%)。術後MRI（-），，NSE：18.8。2015.10始善龍至今，末次2015.2.17.現複查CT肝S8新見5MM結節，餘無不適.。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 36}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 73}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 86, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 96}, {"end_pos": 100, "label_type": "藥物", "overlap": 0, "start_pos": 97}, {"label_type": "手術", "overlap": 0, "start_pos": 118, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 145}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 227, "end_pos": 230}, {"end_pos": 246, "label_type": "藥物", "overlap": 0, "start_pos": 244}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 264, "end_pos": 266}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}]}
{"originalText": "患者於2008-10-7在外院行兩側卵巢+兩側附件+大網膜切除術，術後分期IIIC期，術後TP方案化療7程，末次化療時間2009年7月。後定期複查，2010年8月複查CA125升高，彩超提示盆腔腫塊。2010年9月26日全麻上行再次卵巢癌細胞減滅術，術後病理提示兩側附件漿液性乳頭狀腺癌II-III級，直腸旁溝腫物，鏡上見纖維組織中見低分化腺癌浸潤，考慮卵巢漿液性乳頭狀腺癌浸潤，術後行TP方案輔助化療。現患者於2012-12-25複查PET-CT提示覆發，為進一步化療就診。", "entities": [{"end_pos": 32, "label_type": "手術", "overlap": 0, "start_pos": 16}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 83, "end_pos": 88}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 124, "label_type": "手術", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 131, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 172}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 187}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 218, "end_pos": 224}]}
{"originalText": "，患者於2016-11-15主因“確診乙肝肝硬化4年餘，末次內鏡治療後一年餘”就診於我院消化科，，全面複查：2016-11-16，行胃鏡檢查：食管胃底靜脈曲張治療後改變，胃瀦留，未行內鏡上治療。，核磁回報：肝IV、VIII段交界處及右葉II段佔位，建議普美顯，2016-11-28，於我院行普美顯核磁檢查：肝MT綜合治療後，肝內多發斑片狀、結節狀異常訊號影，呈T1WI稍低訊號，T2WI稍高訊號，DWI高訊號，大者約20X14MM，增強後動脈期明顯強化，門脈期及延遲期強化減退，後期呈相對低訊號；肝左後葉切緣見片狀異常訊號，T1WI呈稍低訊號，T2WI呈混雜訊號，約3.0×3.8CM，動態增強早期見病灶輕度異常強化，門脈期及延遲期呈相對高訊號（考慮術後改變）；肝右外葉術區見類圓形異常訊號，直徑約3.4CM，T1WI呈低訊號為主伴周圍稍高訊號，T2WI呈高訊號，增強後邊緣強化；肝左前葉另見一直徑1.6CM結節灶，T1WI呈低訊號，T2WI呈高訊號，增強後見邊緣結節狀輕度強化，靜脈及延時期強化範圍向病灶中心充填；脾臟增大，訊號尚均勻；胰腺及所見右腎無異常；左腎見囊性無強化灶，大小約2.3×3.0CM；腹腔內無積液。肝胃間隙及胰頭前緣可見腫大淋巴結，較大直徑約35MM，環形強化。現患者為進一步治療入住我科。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 79}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 98, "end_pos": 100}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 121}, {"end_pos": 129, "label_type": "藥物", "overlap": 0, "start_pos": 126}, {"end_pos": 148, "label_type": "藥物", "overlap": 0, "start_pos": 145}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 148, "end_pos": 150}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 161}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 390}, {"end_pos": 460, "label_type": "解剖部位", "overlap": 0, "start_pos": 458}, {"end_pos": 471, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"end_pos": 482, "label_type": "解剖部位", "overlap": 0, "start_pos": 480}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 503, "end_pos": 504}, {"end_pos": 514, "label_type": "解剖部位", "overlap": 0, "start_pos": 510}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 515, "end_pos": 517}]}
{"originalText": "，患者1月前體檢發現直腸腫物，，外院腸鏡提示：直腸距肛門5-9CM腫物，，活檢病理：腺癌，完善分期檢查，CT3N+M0，2016-3-23給予XELOX方案化療1週期，現為行術前放化療,2016-4-14至2016-5-14給予術前放療 GTV 51GY/CTV 40.8GY/34F BID，目前放療結束，2016-4-25，20165-5-16同期XELOX方案化療2週期，患者訴大便次數同前，便意較前增加。腹瀉 1度，面板反應1度，噁心0度，乏力1度，泌尿系0度，骨髓抑制0度,2016-6-2繼續給予鞏固化療1週期。2016-7-22直腸癌根治術，，手術病理：（直腸，放化療後），切除：- 腸壁粘膜層至固有肌肌層內散在中分化腺癌組織（癌殘留約15%），伴纖維組織增生及慢性炎細胞浸潤，符合治療後改變，NCCN TRG，分級：2級；- 未見脈管內癌栓及神經侵犯；- 近端、（遠端切緣）未見癌；- 腸周淋巴結未見癌轉移（0/4）；- ，腫瘤病理分期：YPT2N0。卡培他濱化療2週期。", "entities": [{"end_pos": 12, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 42, "end_pos": 44}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"end_pos": 277, "label_type": "手術", "overlap": 0, "start_pos": 271}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 318}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"end_pos": 438, "label_type": "藥物", "overlap": 0, "start_pos": 434}]}
{"originalText": "，患者2012-05-25前因“便血3月餘”入院，經腸鏡及病理檢查確診乙狀結腸腺癌。外院影像學檢查提示肝肺多發轉移,分期CT4N1M1IV期。患者經綜合科病例討論建議先行手術治療。2012年6月1日全麻上行腹腔鏡DIXON術，術後恢復良好。，病理示：中分化腺癌，浸潤至漿膜上層，6/15LN+，可疑脈管癌栓。分期PT3N2M1B，IVB，後於2012年6月21日行XELOX方案化療1週期，後分別於2012年7月16日至2013年02月17日行XELOX+貝伐珠單抗化療11週期，過程順利，複查腫瘤評價SD。2013年3月13日、2013年4月02日、2013年4月23日、2013年5月16日、2013年6月5日、2013年06月25日為維持治療，予卡培他濱+貝伐珠單抗化療六週期。2013-07-14CT示兩肺多發佔位，考慮轉移，較前進展，右肺門淋巴結較前增大，肝多發佔位，考慮轉移，較前相仿。臨床未達PD標準，療效總體評價為SD，繼續原方案化療，於2013-7-16至2013-11-27繼續行卡培他濱+貝伐珠單抗化療7程。2013-12-31，我院MDT會診：結合患者外院CT，評估患者腫瘤進展PD，建議患者行XELOX或FOLFIRI基礎化療，遂於2014-02-10至2015-1-14我院行FOLFIRI+貝伐珠單抗化療19程，化療後耐受尚可。於2015-1-26複查CT，，提示：乙狀結腸癌術後改變，區域性未見明確復發徵。肝、肺轉移灶較前無明顯改變。2015-01-28、2015-02-11、2015-02-26、2015-03-11、2015.03.25、2015.04.15再行FOLFIRI+貝伐珠單抗化療6程，療效SD。現為行上程化療入院。患者發病以來,精神佳,飲食睡眠佳,大小便正常，體重無減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 57}, {"end_pos": 112, "label_type": "手術", "overlap": 0, "start_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 130}, {"end_pos": 233, "label_type": "藥物", "overlap": 0, "start_pos": 228}, {"end_pos": 330, "label_type": "藥物", "overlap": 0, "start_pos": 326}, {"end_pos": 336, "label_type": "藥物", "overlap": 0, "start_pos": 331}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 352, "end_pos": 354}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 355, "end_pos": 361}, {"end_pos": 378, "label_type": "解剖部位", "overlap": 0, "start_pos": 372}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}, {"end_pos": 454, "label_type": "藥物", "overlap": 0, "start_pos": 450}, {"end_pos": 460, "label_type": "藥物", "overlap": 0, "start_pos": 455}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 490, "end_pos": 492}, {"end_pos": 565, "label_type": "藥物", "overlap": 0, "start_pos": 560}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 591, "end_pos": 593}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 598, "end_pos": 605}, {"end_pos": 619, "label_type": "解剖部位", "overlap": 0, "start_pos": 618}, {"end_pos": 621, "label_type": "解剖部位", "overlap": 0, "start_pos": 620}, {"end_pos": 712, "label_type": "藥物", "overlap": 0, "start_pos": 707}]}
{"originalText": "，患者2個月餘前無明顯誘因出現左上腹隱痛，後自行緩解，患者未予進一步診治，後症狀反覆，按壓左上腹有疼痛，偶有大便帶血，伴頭暈，乏力，無腹脹、噁心，無發熱等不適。外院腸鏡檢查提示距肛70CM腫物，腸鏡不能透過，活檢病理提示腺癌。於2015-04-29在我院全麻上行左半結腸切除術+左側卵巢切除術+盆底結節切除術+腹腔熱灌注化療，於2015-05-04再次行腹腔熱灌注化療術，，術後病理：中分化腺癌，癌組織累及腸壁漿膜上層，可見脈管內癌栓，左卵巢囊腫。，鏡上：卵巢組織中見中分化腺癌浸潤，結合病史及免疫組化結果，符合腸腺癌轉移。（盆底結節2），鏡上：纖維結締組織中見腺癌浸潤。2015-05-27、2015-06-17給予XELOX方案化療2程順利.現患者為進一步診治來我院就診，起病以來，無發熱、咳嗽、身目黃染，無骶部痛等，精神可，納眠可，小便無異常，體力體重無明顯上降。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 110, "end_pos": 112}, {"label_type": "手術", "overlap": 0, "start_pos": 131, "end_pos": 162}, {"end_pos": 185, "label_type": "手術", "overlap": 0, "start_pos": 177}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 218, "end_pos": 223}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 234, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 261}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 283}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}]}
{"originalText": "，患者1年2月前因乏力，進食後上腹部脹痛就診於我院門診，，行腸鏡檢查示：結腸癌，結腸多發息肉，後就診於我院腫瘤外科行左半結腸切除術、胃腸吻合術（手術日期為2010年10月15日），術後病理為進展期左半結腸癌，浸潤潰瘍性，低-中分化腺癌，淋巴結7/26枚轉移，病理號為118494。術後恢復良好，術後2.5個月於我院慢性病院行單藥卡培他濱（希羅達）口服化療一週期，後入我科行FOLFOX方案化療3週期，具體用藥為奧沙利鉑（艾恆）150毫克，亞葉酸鈣（同奧）0.3，替加氟4.0，化療後曾出現1度腹瀉，後改為XELOX方案化療4週期，，具體為：奧沙利鉑（艾恆）150毫克，卡培他濱（希羅達）3.0日二次口服，因血小板減少不能耐受改希羅達口服化療3週期，今為再次化療入院。患者近一月來飲食睡眠可，精神體力可，大小便正常，體重無明顯上降。KPS評分80分。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 46}, {"label_type": "手術", "overlap": 0, "start_pos": 58, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 117}, {"label_type": "藥物", "overlap": 0, "start_pos": 164, "end_pos": 173}, {"label_type": "藥物", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "藥物", "overlap": 0, "start_pos": 219, "end_pos": 227}, {"end_pos": 234, "label_type": "藥物", "overlap": 0, "start_pos": 231}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 246}, {"label_type": "藥物", "overlap": 0, "start_pos": 270, "end_pos": 278}, {"label_type": "藥物", "overlap": 0, "start_pos": 284, "end_pos": 293}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 303, "end_pos": 306}, {"end_pos": 316, "label_type": "藥物", "overlap": 0, "start_pos": 313}]}
{"originalText": "，患者於1月餘前無明顯誘因出現間斷下腹部隱痛，可耐受，無規律，不影響睡眠，無伴腹脹、噯氣，無噁心、嘔吐等；1周前開始出現身目黃染，進行性加重，伴小便顏色加深，無伴畏寒、寒戰、發熱，無陶土樣大便，無頭昏、頭痛。2017-04-13，於我院門診行胃鏡檢查示：十二指腸乳頭處見隆起型腫物，表面見潰瘍，周邊粘膜粗糙充血，活檢病理未出；，行CT檢查示：十二指腸乳頭部增厚並見結節狀軟組織影，範圍約14MM×13MM×22MM，部分邊界欠清，增強掃描各期較明顯強化，胰管、膽總管、膽囊管、膽囊及肝內膽管不同程度擴張；，診斷：十二指腸乳頭部佔位性病變，伴肝內外膽管、胰管擴張，壺腹癌？肝小囊腫。左肺中葉侷限性肺不張；左肺中葉鈣化灶。左肺上葉後基底段斑片灶，考慮炎症。右肺尖增殖灶。盆腔未見明確病變。，生化檢查示：ALT/AST明顯升高，TBIL/DBIL升高，腫瘤標誌物，CA199:292.4U/ML，後於2017-04-18在我院內鏡科行“ERCP術+膽道支架置入術”，術程順利，術後予暫禁食、預防感染及營養支援等治療。現患者恢復可，黃疸較前消退，複查ALT/AST明顯上降，TBIL/IBIL較前明顯上降，無述不適，今為進一步治療入我科。自起病以來，患者精神、睡眠稍差，食慾上降，大便正常，小便黃呈茶色，體重有上降約10KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 19}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 39}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 167}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 256, "end_pos": 263}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 270, "end_pos": 280}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 300}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 349, "end_pos": 356}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 361, "end_pos": 370}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 379, "end_pos": 384}, {"label_type": "手術", "overlap": 0, "start_pos": 415, "end_pos": 428}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 471, "end_pos": 478}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 483, "end_pos": 492}]}
{"originalText": "，患者於2015年4月行檢查胃鏡示：胃竇、胃體交界大彎偏後壁見一處不規則隆起性病變，大小約2.0*2.5CM。，後於2015年5月入我院腫瘤外科行胃鏡病理回報：腺癌。院外PET-CT示腹盆腔內多髮結節，不除外富粘液成分腫瘤轉移。外科考慮患者胃癌伴腹腔多發轉移可能性大，不適於手術治療，後多次行化療。16-2-17日行下消化道全程造影(DR)(鋇劑)，提示：胃全切除術後。食管上段管腔變細，狹窄，考慮良性改變。今為求進一步治療入我科，患者近來進食後吞嚥困難，疼痛，嘔吐，為白色泡沫狀，睡眠一般，精神體力尚可，二便正常。體重較前減輕約5KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 80, "end_pos": 82}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 85, "end_pos": 91}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 129}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 158, "end_pos": 174}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 178, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 187}]}
{"originalText": "，緣於入院2個月前因胃癌就診我院於2015.4.29全麻上行“腹腔鏡上根治性全胃切除術ROUX-EN-YD2R0”，，術中見：腹腔內無腹水，盆地、膀胱、系膜均未見明顯種植結節，肝臟表面所見部分光滑，空迴腸未見結節，腫瘤位於胃體大彎側，浸潤潰瘍型，大小約7*5*4CM，侵出漿膜層，肝總動脈、胃右動脈旁見數個0.8-1.0CM大小淋巴結。術後病理（201515896），回報示：胃體潰瘍型管狀腺癌2-3級，侵及漿膜層，脈管內癌栓，累及神經，手術標本下上切端均未見癌浸潤。找到賁門左淋巴結3/8，賁門右淋巴結2/6，大彎側淋巴結9/9，第7組淋巴結2/4，第9組淋巴結1/4，見癌轉移。術後於2015.5.23、2015.6.16予奧沙利鉑200MGIVGTTD1+希羅達3000MGPOD1-14方案術後化療2週期，輔助以制酸保肝增強免疫等對症治療。今為求術後第3次化療，求診我科，門診擬“胃癌術後化療”收住入院。自發病來，患者精神好，飲食好，睡眠好，大小便無異常，體重無變化。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 31, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 188, "end_pos": 201}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 246}, {"end_pos": 318, "label_type": "藥物", "overlap": 0, "start_pos": 314}, {"end_pos": 334, "label_type": "藥物", "overlap": 0, "start_pos": 331}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 363}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 398}]}
{"originalText": "，2010-7-8行乙狀結腸癌根治術，，病理：中分化腺癌，侵及層外結締組織，未見癌栓，淋巴結0/11。2010-9-7術後基因檢測MSS（******），：穩定。2010-8起口服希羅達輔助化療7週期。用藥期間出現一度手足綜合症，I度噁心，體重無變化。2011.1停藥。\\U0004\\U00042011-11複查結腸鏡示結腸多發息肉,病理示回盲部升結腸腺瘤，考慮腺瘤較小，未行切除。2012-2複查腫標、生化正常，胸片示主動脈弓前下方結節、左下下肺可疑結節大致同前。\\U0004\\U0004   2012-4-19於三院行結腸鏡上結腸息肉鉗切。，病理：管狀腺瘤1-2級。腫標正常。腹B超、胸片（-）。\\U0004\\U0004   2012-8-9，我院複查腹部B超：肝右葉低迴聲區，非均勻性脂肪肝？盆腔B超、腫標（-）。胸，CT：兩肺多發小結節無變化。\\U0004\\U0004   目前患者無不適，2012/11/14，複查：腫瘤標誌物正常，血常規正常，肝腎功正常。\\U0004\\U0004。", "entities": [{"end_pos": 18, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 23, "end_pos": 28}, {"end_pos": 93, "label_type": "藥物", "overlap": 0, "start_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 160, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 170, "end_pos": 178}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 181, "end_pos": 183}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 207, "end_pos": 209}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "手術", "overlap": 0, "start_pos": 261, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 276, "end_pos": 284}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 290, "end_pos": 293}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 294, "end_pos": 296}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 328, "end_pos": 332}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 345, "end_pos": 348}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 349, "end_pos": 353}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}]}
{"originalText": "，2013-12體檢發現結腸腫物.術前化療XELOX次，2CS 縮小SD，4CSPD.2014-07-28我院外科行乙狀結腸癌切除、肝部分切除。，術中見：無腹水，無腹腔粘連，有肝轉移，無腹膜、大網膜轉移、無腹盆臟器轉移、無腹腔多發淋巴結腫大、有小腸、結腸梗阻、擴張、無腫瘤區域性穿孔。，病灶：腫瘤位於直腸-乙狀結腸交界處、侵犯盆壁、腸繫膜環周、未見腫物穿孔、可見近端結腸梗阻、伴擴張水腫、距肛緣約15CM，與側腹壁關係、相對活動、腫瘤侵犯至肌層、手術性質為根治性。，術後病理：，乙狀結腸：隆起型中分化腺癌，大小5X8CM，侵及周圍脂肪組織，近端、遠端切緣未見腫瘤、未見脈管癌栓、淋巴結轉移（-）。肝S6肝組織，中分化腺癌轉移，，腫瘤病理分期：PT3N0M1. ，免組化結果：CD44+,CMET+,EGFR+,HEP-,HER2 (1+),KI-67( +75%),MLH1(+50~75%）TOPOII +25~50% TTF-1 -。近期飲食可，二便如常。術後體重減低15KG。求進一步治療就診。14-9本院複查，，PET：吻合口高代謝，肝內多髮結節，盆腔多髮結節，肺內多髮結節。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "手術", "overlap": 0, "start_pos": 58, "end_pos": 71}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 83}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 129}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 251}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 304, "end_pos": 309}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 459, "end_pos": 462}, {"end_pos": 471, "label_type": "解剖部位", "overlap": 0, "start_pos": 470}, {"end_pos": 479, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}]}
{"originalText": "，患者2010年8月出現咽痛伴吞嚥困難，2010.8.30行全麻電視喉鏡喉咽新生物活檢術，2010.9.1全麻全喉切除+左頸淋巴結清掃術，手術順利，術後安返，標本送病理，傷口癒合II/甲。術後病理（S2010-21480），提示：（全喉）低分化鱗形細胞癌，浸潤喉室壁至軟骨（約2/3層），神經束見癌累及，切緣未見腫瘤累及。左頸大塊組織內查見淋巴結11枚，其中2枚見癌轉移。術後在我院行放療1月，具體不詳。2016-08出現進食梗阻感，進食困難，2016-09-09，行胃鏡提示：食管MT，術後病理（G2016-47953），提示：低分化鱗形細胞癌；2016-09-14，胸部CT提示：食道中段MT。於2016-10-08、2016-10-29、2016-11-19、2016-12-12、2017-1-2、2017-1-232017-2-122017-03-052017-03-28化療，，具體用藥：多西他賽 110MG D1，奈達鉑 110MG D1 Q3W.期間2016-11-182017-01-22我院胸部CT增強評估病情穩定。2017-3-27我院複查胸部CT增強提示病情進展，更換化療方案，排除化療禁忌、簽訂化療知情同意書，於2017-04-21行化療，，具體用藥：伊立替康0.1G D1、D8，卡培他濱2# BID PO D1-14，Q3W。2017-4開始針對食管病灶進行放療，計劃放療22次，目前已行17次，餘不詳。現患者為求進一步診治來我院就診。", "entities": [{"end_pos": 44, "label_type": "手術", "overlap": 0, "start_pos": 32}, {"label_type": "手術", "overlap": 0, "start_pos": 55, "end_pos": 68}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 127}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 132}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 265, "end_pos": 273}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 292, "end_pos": 298}, {"end_pos": 404, "label_type": "藥物", "overlap": 0, "start_pos": 400}, {"end_pos": 417, "label_type": "藥物", "overlap": 0, "start_pos": 414}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 455, "end_pos": 461}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 481, "end_pos": 487}, {"end_pos": 543, "label_type": "藥物", "overlap": 0, "start_pos": 539}, {"end_pos": 558, "label_type": "藥物", "overlap": 0, "start_pos": 554}, {"end_pos": 590, "label_type": "解剖部位", "overlap": 0, "start_pos": 588}]}
{"originalText": "，患者2012-10-12因孕足月行剖宮產術，術中發現右側卵巢有一約3.0*3.3CM大小贅生物,另有一約3.0*3.3CM大小囊腫,術中行贅生物+囊腫切除,因急診手術,術中未行冰凍.，術後病理提示:符合混合性下皮腫瘤(低惡性)，於2012-11-06前來本院就診，病理經我院會診示；右側卵巢腫物高級別粘液性乳頭狀囊腺癌，，本院行胃鏡示：慢性淺表性胃炎，腸鏡示無明顯異常，剖宮產術後恢復好，無腹痛，腹脹不適，於2012-12-13我院行保留生育功能分期手術（患者附件切除+患側盆腔淋巴結清掃+腹主動脈旁淋巴結清掃或活檢+大網膜切除+闌尾切除）。今為求進一步診治來我院。患者發病以來,精神可,飲食睡眠可,大小便正常，體重無明顯減輕。", "entities": [{"end_pos": 22, "label_type": "手術", "overlap": 0, "start_pos": 18}, {"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 27}, {"end_pos": 78, "label_type": "手術", "overlap": 0, "start_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 151, "end_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 176}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "手術", "overlap": 0, "start_pos": 218, "end_pos": 271}]}
{"originalText": "，患者因便血2014-10-23在**一院行“直腸癌根治術”，，術後病理：粘液腺癌，浸潤腸壁全層並突破漿膜層，達漿膜外脂肪組織。淋巴結轉移（1/1）。診斷“PT4NXM0”,術後恢復可，便血消失。後S1/希羅達輔助化療6月，末次化療時間2015-3。後定期複查未見覆發、轉移。2016-4出現噯氣，無腹痛、腹瀉，飲食正常，未進一步診治。2016-11-25，我院PET-CT示：吻合口左旁子宮後方、右梨狀肌內緣骶前及左腹腔升結腸旁多個病灶代謝較活躍，脾臟結節代謝較活躍，考慮轉移；左附件區小片狀軟組織影代謝較活躍。MRI，示：肝內多發病變，可疑囊性轉移瘤可能性大。脾臟多發異常訊號灶，考慮轉移瘤可能性大。左結腸旁溝結節，可疑轉移瘤。，基因分子診斷示：KRAS基因為突變型，突變亞型為G13D。其餘基因均為野生型。診斷“直腸癌綜合治療後肝、脾、腹膜等多發轉移 KRASG13D突變型”，2017-01-07開始予FOLFOX+AVASTIN化療，今日為進一步治療入院，術後患者神清，精神可，睡眠、飲食可，二便正常，體重無明顯變化。", "entities": [{"end_pos": 29, "label_type": "手術", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 44, "end_pos": 45}, {"end_pos": 101, "label_type": "藥物", "overlap": 0, "start_pos": 99}, {"end_pos": 105, "label_type": "藥物", "overlap": 0, "start_pos": 102}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 181, "end_pos": 187}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 203}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 209, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 214}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 243}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 302, "end_pos": 306}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 359, "end_pos": 362}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 371, "end_pos": 372}]}
{"originalText": "，2014-11-6外院全麻上行結腸癌根治術，術後病理分期PT4AN0M0，IIB期，術後XELOX輔助化療6週期。定期複查，未見明顯異常。2017-1-16，複查胸部CT提示：右肺上葉背段腫物，性質待定。腹部CT未查2017.1.16，腸鏡：直腸、乙狀結腸息肉。，行息肉切除後病理：生化性息肉行XELIRI+BEV方案化療6週期，，不良反應：鼻粘膜出血、食慾不振。2017-6-13行右肺上葉背段病變穿刺活檢+微波消融術,術後發燒39.5度，術後1周胸部CT示消融壞死區完全覆蓋腫瘤組織。周圍炎性滲出。抗炎治療後好轉，。", "entities": [{"end_pos": 22, "label_type": "手術", "overlap": 0, "start_pos": 16}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 103, "end_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 122, "end_pos": 131}, {"end_pos": 158, "label_type": "藥物", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 173}, {"label_type": "手術", "overlap": 0, "start_pos": 193, "end_pos": 211}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 226, "end_pos": 230}]}
{"originalText": "，2，周前於我院行胃鏡檢查發現：胃底、胃體見數十個息肉，半球形，大小約0.4-1.0CM,粘液湖色清，少量。，胃鏡診斷：1.慢性萎縮性胃炎2.胃多發息肉3.十二指腸球部炎症。，病理診斷：（竇大）胃竇粘膜，呈輕度慢性萎縮性胃炎。無腹痛、腹脹，無噁心、嘔吐，無反酸、噯氣，無嘔血、排黑便，今為進一步診治，門診擬“胃多發息肉”收住入院。近2周來，精神、睡眠正常，大便正常，小便正常，體重無明顯變化。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 62, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 78, "end_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 112}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 154, "end_pos": 159}]}
{"originalText": "，患者3個月前（2014年2月）因腹脹進行性加重就診於我院，，行胃鏡檢查示：賁門低分化腺癌。遂於我院胃腸外科行根治性全胃切除術。術中見腫物位於賁門小彎側，侵及漿膜。，術後病理：(胃)低分化腺癌，(淋巴結)淋巴結轉移癌(3/14)，另見淋巴結旁癌結節一枚，，病理號：Z0470555。，術後分期：T3N2M0 IIIA期。術後腹痛消失，胃區偶有牽拉樣疼痛。體能恢復良好，為進一步治療入我科。完善相關檢查，患者腎功能略有異常，為減少腎功能損傷，予SOX方案化療2週期，，用藥為：奧沙利鉑200毫克D1靜點，替吉奧120毫克日二次口服D1-7。末次化療前7日患者出現I°噁心、嘔吐，7日後逐漸好轉。化療後未出現骨髓抑制，現患者化療結束3周，為求再次化療入院。患者近2周來飲食睡眠一般，精神體力可，二便正常，病來體重上降15公斤，ECOG評分1分。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 45}, {"end_pos": 63, "label_type": "手術", "overlap": 0, "start_pos": 55}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 108}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 168}, {"end_pos": 241, "label_type": "藥物", "overlap": 0, "start_pos": 237}, {"end_pos": 254, "label_type": "藥物", "overlap": 0, "start_pos": 251}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 302, "end_pos": 306}]}
{"originalText": "，患者2012年2月16日於******體檢CT、，彩超發現：肝左葉佔位性病變，考慮為結節型原發性肝癌可能性大；肝內多發囊腫。腫瘤標誌物，AFP:5.01。後於2012.3.6在我院行“肝左葉肝癌切除+膽囊切除術”，術程順利，術後恢復可，，術後病理：中分化肝細胞性肝癌，梁索型；未見脈管內癌栓及神經束侵犯；癌旁肝組織呈結節性肝硬化改變。術後一直行日達仙免疫治療至今。為鞏固治療,於2012-4-10起在我科行CIK細胞回輸治療至今,過程順利。術後定期複查無腫瘤復發轉移徵象，AFP正常，末次複查時間為2015-03-18。現為繼續行CIK細胞治療入院。3月來，患者精神、納眠可，大小便正常，近期體重無明顯上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 22, "end_pos": 24}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 43, "end_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 62}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 69, "end_pos": 72}, {"label_type": "手術", "overlap": 0, "start_pos": 93, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 134}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 165}, {"end_pos": 176, "label_type": "藥物", "overlap": 0, "start_pos": 173}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 237, "end_pos": 240}]}
{"originalText": "患者於2008年行原發性肝癌切除術，2012-11月於我科行肝動脈化療栓塞術，術後恢復良好，20天前患者面板鞏膜黃染，肝區輕度疼痛，發熱，體溫最高為39.5度，於外院行抗炎降黃及保肝等保守治療無效，於2013-08-08在局麻上行經皮經肝膽道支架置入術及外引流術。現03-10化驗示總膽紅素114UMOL/L，直接膽紅素91UMOL/L，並面板及鞏膜黃染，小便色深，大便可。現為求再次介入治療入我科住院。患者精神狀態尚可，肝區輕度壓痛，無反跳痛及肌緊張，睡眠尚可，近一月體重減輕月4KG。", "entities": [{"end_pos": 17, "label_type": "手術", "overlap": 0, "start_pos": 9}, {"end_pos": 38, "label_type": "手術", "overlap": 0, "start_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "手術", "overlap": 0, "start_pos": 115, "end_pos": 131}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 141, "end_pos": 145}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 155, "end_pos": 160}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 212}]}
{"originalText": "，因“胸悶”就診，2013-5-21CT發現胰頭鉤突部佔位，考慮為PNET，2013-5-31奧曲肽掃描提示胰頭部SSR陽性灶，2013-06-05行胰十二指腸切除術，術中見胰頭區約2-3CM腫物，，術後病理：神經內分泌腫瘤，2.6X2CM，侷限於胰腺組織內，核分裂像2/10HPF，未見脈管癌栓及壞死，斷端均陰性，淋巴結0/3，SYN(+),CGA(-),CD56(+),CK(+),MAP2(+),NSE(+),KI67(+5%)。術前腫標基本正常（未查NSE）。術後未進一步治療，定期複查。2015-10起腰背部疼痛，進行性加重，對症治療效果欠佳。，2015-11-23複查CT：肝門部異常軟組織影，轉移可能大。肝內外膽管擴張，考慮膽腸腸吻合口處梗阻可能。肝臟多發動脈期強化灶，異常灌注？腹腔多發淋巴結腫大，轉移？2015-12-2進一步查F18-PET/CT及GA68-PET/CT均見肝門部軟組織影及腸繫膜多發淋巴結腫大，但無高攝取；C7-T2骨轉移，給予唑來磷酸治療。患者已放療科會診，目前行放療前準備，活動後背痛明顯，服用泰勒寧、貼用多瑞吉，目前飲食可，大小便正常，近2月體重上降約3KG。", "entities": [{"end_pos": 4, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 18, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 33, "end_pos": 37}, {"end_pos": 50, "label_type": "藥物", "overlap": 0, "start_pos": 47}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 83, "label_type": "手術", "overlap": 0, "start_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 112}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 229, "end_pos": 232}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 290, "end_pos": 292}, {"end_pos": 295, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 309, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 319, "end_pos": 328}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 377, "end_pos": 383}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 389, "end_pos": 395}, {"end_pos": 399, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 405, "end_pos": 406}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 422, "end_pos": 430}, {"end_pos": 437, "label_type": "藥物", "overlap": 0, "start_pos": 433}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 471, "label_type": "藥物", "overlap": 0, "start_pos": 468}, {"end_pos": 477, "label_type": "藥物", "overlap": 0, "start_pos": 474}]}
{"originalText": "，進食哽咽感，我院確診EGJ中低分化腺癌伴印戒細胞癌，混合型，UT4AN2，SIWERTII型，並見十二指腸降部SMT，2016.8.8行ESD切除1CM佔位，病理為絨毛狀管狀腺瘤；術前腫標正常，2016.8.11行全胃切除術，未見腹腔M，CY0，RESOLVE B，，術後病理：中低分化腺癌伴印戒細胞癌，混合型，2.5×XXX2CM；外膜纖維脂肪組織；脈管癌栓及神經侵犯+；18/49；AFP(－),CMET(1+),EGFR(－),HER2(0),PDL-1(5%+),MSS，EBER(－)。術後恢復可，腹脹，，CA125:49；易呃逆。體重穩定。術後1月行化療替吉奧+奧沙利鉑化療3週期，末次化療時間2016.11.噯氣，進食可，睡眠可，大小便無明顯異常。術後體重增加5KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 11, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 59}, {"end_pos": 72, "label_type": "手術", "overlap": 0, "start_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 83, "end_pos": 90}, {"end_pos": 113, "label_type": "手術", "overlap": 0, "start_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 156}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"end_pos": 287, "label_type": "藥物", "overlap": 0, "start_pos": 284}, {"end_pos": 292, "label_type": "藥物", "overlap": 0, "start_pos": 288}]}
{"originalText": "，患者體檢發現盆腔腫塊，於4-7行剖腹探查，，術中見：盆腹腔腹膜充血、增厚，腹腔內見淡黃色腹水約200ML；左卵巢腫瘤8×7×9CM，部分囊性（多房性），部分呈外生型菜花狀，表面有粘液附著；右卵巢多房性囊腫6×5×5CM，與闊韌帶後葉粘連；子宮前位，正常大小，但子宮、直腸、膀胱漿膜面均可見直徑2-１CM大小不等之病灶，實質性，後陷凹病灶直徑6釐米，封閉；大網膜未見明顯病灶，橫膈及肝、脾、胃等臟器未及明顯腫塊；腹主動脈及盆腔淋巴結未捫及腫大。遂行腫瘤減滅術（全子宮+兩附件+闌尾+大網膜+盆腔病灶）。，術後病理：(左附件)卵巢腺癌,部分割槽可見沙粒體,考慮漿液性乳頭狀腺癌,分化II級；(全子宮+左附件)左卵巢漿液乳頭狀腺癌,分化II級,左輸卵管未見癌累及,子宮內膜呈萎縮性改變,慢性宮頸炎；闌尾慢性炎,部分割槽漿膜面見癌組織累及。患者術前CA125為407.1IU/ML，術後複查降至295.4IU/ML。術後於04-13、5-7、5-27，化療：辰易210MG IVGTT+DDP100MGIP，化療反應輕。，5-26CA19-9：12.6U/ML；，CA125：17.1IU/ML，現為行第四次化療入院。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"end_pos": 21, "label_type": "手術", "overlap": 0, "start_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 45, "end_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 54, "end_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 95, "end_pos": 103}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 250, "label_type": "手術", "overlap": 0, "start_pos": 224}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 257, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 278, "end_pos": 286}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 293, "end_pos": 318}, {"end_pos": 323, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 329, "end_pos": 331}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 345}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 346, "end_pos": 351}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 369, "end_pos": 374}, {"end_pos": 426, "label_type": "藥物", "overlap": 0, "start_pos": 424}, {"end_pos": 441, "label_type": "藥物", "overlap": 0, "start_pos": 438}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 460, "end_pos": 466}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 477, "end_pos": 482}]}
{"originalText": "，患者3月餘前無明顯誘因出現排便習慣改變，表現為裡急後重，間歇伴有便血，量少，色暗紅，伴粘液，外院腸鏡檢查提示距離肛門10-15CM直腸腫物，腸腔狹窄，腸鏡勉強可透過。活檢病理提示中分化腺癌。2016-9-6我院病理會診示中分化腺癌。2016-9-6我院胸部+全腹部+盆腔CT示直腸中下段~乙狀結腸管壁明顯增厚，考慮直腸~結腸癌，可疑浸潤腸周間隙。骶前、直腸周圍系膜區數個淋巴結，考慮轉移瘤。右下肺尖後段、左中肺葉內側段結節，可疑轉移。於2016-09-18行“腹腔鏡上DIXON術”，，術後病理示：1（腸大體）鏡檢為中分化腺癌，癌組織浸潤至腸壁漿膜上層，可見脈管內癌栓及神經束侵犯；切緣未見癌。區域淋巴結3/11（+），並浸潤結外脂肪結締組織。，免疫組化：ER（-），ERCC1（+），PMS2（+），MLH1（+），MSH2（+），MSH6（+），KI67（40%+）。2016-10-25、2016-11-16、2016-12-07、2017-1給予XELOX方案化療4程順利，現為進一步治療而來我院。出院以來，胃納、睡眠可，小便正常，偶有大便困難，4-5次/天成形大便，體重上降5KG。", "entities": [{"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 95}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 116}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 127, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 149}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 158, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 170}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 179}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 207}, {"end_pos": 241, "label_type": "手術", "overlap": 0, "start_pos": 231}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 271, "end_pos": 272}, {"end_pos": 460, "label_type": "解剖部位", "overlap": 0, "start_pos": 459}]}
{"originalText": "，患者於3個月前因“肝佔位”於我院行“膽囊切除+右半肝切除+門靜脈切開取栓術”，手術過程順利，標本送病理。，術後病理示：1.（右半肝），：肝臟原發性巨塊型中分化肝細胞癌，伴壞死，侵及肝被膜，周邊肝組織呈結節性肝硬化表現。另送的（門靜脈旁）淋巴結1個，未見癌轉移。2.（門靜脈），：送檢組織中見癌細胞浸潤。3.（膽囊），：送檢膽囊組織。，免疫組化：CK18（+++），GLYPICAN-3(+++),CD10(血管+)，CEA（-），KI67(60%+)。術後患者恢復良好。11月6日就診我院，行“TACE”，示：動脈期肝內見新生血管，主要集中於右、左肝交界處，部分融合成塊，範圍約5.0*2.5CM，門靜脈主幹及肝內分支顯影清楚，未見明顯癌栓形成徵象。碘油灌注後大部分沉積於結節染色區，手術順利。無噁心、嘔吐，無腹痛、腹脹，無眼黃、尿黃、面板黃。今為行介入治療來我院，門診擬“肝癌術後復發”收住入院。患者自發病以來，神志清，精神好，飲食睡眠好，大小便正常。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 10, "end_pos": 11}, {"label_type": "手術", "overlap": 0, "start_pos": 19, "end_pos": 38}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 107}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 252, "label_type": "手術", "overlap": 0, "start_pos": 248}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 300}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"end_pos": 328, "label_type": "藥物", "overlap": 0, "start_pos": 326}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 363}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 388, "end_pos": 394}]}
{"originalText": "，患者11月前因\\\"下腹部疼痛1月餘\\\"於本院診斷為胰腺癌，2015年06月15日於全麻上行姑息性胰十二指腸切除術，術中發現腫瘤侵犯SMV，及門靜脈與脾靜脈交匯處，長度約4CM，腫瘤侵犯結腸中動、靜脈，術中病理提示為腺癌，向家屬說明病情及手術範圍，需切除血管、橫結腸等器官，患者家屬表示考慮手術風險較大，放棄行根治性手術，改行姑息性胰十二指腸切除術，術程順利，術後予護肝、護胃，抗感染，調節免疫對症治療後好轉，，術後病理提示：中至低分化腺癌，結合免疫組化結果，考慮為胰腺導管來源，浸潤胰腺組織及十二指腸至腸壁粘膜上層，可見神經束侵犯及脈管內癌栓。術後未行化療及放療。3天餘前無明顯誘因出現嘔血，鮮紅色，量約500ML，於我院急診處理後病情穩定。，2016年05月25日我院CT：胰頭佔位WIPPLE術後，，對比2015-8-3片：腹膜後軟組織影，較前增大，轉移瘤可能性大。胃－空腸吻合處腸劈頭增厚，術後改變可能性大。現為進一步治療入院。下次治療至今患者無明顯腹痛、無腹脹、無噁心、無畏寒、無發熱，，患者精神尚可，食慾如常。大小便正常，體重有上降約2KG。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 26, "end_pos": 29}, {"end_pos": 57, "label_type": "手術", "overlap": 0, "start_pos": 46}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 110}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 174, "label_type": "手術", "overlap": 0, "start_pos": 163}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 237}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 252, "end_pos": 253}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 336, "end_pos": 338}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 339, "end_pos": 351}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 365, "end_pos": 366}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 429}, {"end_pos": 434, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}]}
{"originalText": "，患者於6月前行因便血到我院就診，行直腸癌根治切除術，，術後病理結果：直腸中分化腺癌，浸及深肌層，見脈管內癌栓形成。直腸切緣未見癌累及，腸周淋巴結見癌轉移4/8（IIIB期））。分期T2、N2、M0。術後2周行全身化療（FOLFOX，方案：奧沙利鉑130MGD1+亞葉酸鈣600MGD1+氟尿嘧啶2000MGD1D2泵入），共9次，有噁心不適，有脫髮，肝功不全；無腹瀉、細胞降低、肝功能損害等不良反應。患者有肛門墜脹不適。本次擬行10次化療收住入院。\\U0004   患者自起病以來，精神略差，胃納略差，大便成形，便條較細，小便如常，體重未見明顯上降。", "entities": [{"end_pos": 26, "label_type": "手術", "overlap": 0, "start_pos": 18}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 42}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 124, "label_type": "藥物", "overlap": 0, "start_pos": 120}, {"end_pos": 136, "label_type": "藥物", "overlap": 0, "start_pos": 132}, {"end_pos": 148, "label_type": "藥物", "overlap": 0, "start_pos": 144}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 248}]}
{"originalText": "，患者因診斷為直腸癌2014-9-27行剖腹探查，術中見癌灶以下腸管增粗、脹氣，於腹膜反折下上觸及巨大質硬腫瘤，無活動度，腸周可觸及多發腫大淋巴結，腸繫膜根部淋巴結稍增大，腫瘤與周圍組織粘連、固定，手術無根治切除，遂行乙狀結腸單腔造口，遠端封閉。術後行FOLFOX方案化療4週期，外科建議術前放化療，2014-12-23於外科行奧沙利鉑+替吉奧方案化療，2014-12-25起在我科開始放療，，方案：GTV 50.6GY CTV 41.8GY/22F，期間同步口服替吉奧口服60MG BID，D1-5/W。患者便血癥狀基本緩解。完善常規檢查,於2015-03-31日全麻滿意，行開腹探查、直腸癌HARTMANN切除術，術程順利,術後患者恢復可,已進半流食,排氣排便通暢,醫囑出院.，術後病理：直腸癌放療,結腸造口術後，直腸（切除），： - 經多點取材，未見癌組織殘留； - 腸壁全層見慢性炎細胞及組織細胞浸潤，伴黏液池形成，符合治療後改變； - AJCC/NCCN ，TRG: 0級； - 未見脈管癌栓； - 腸周淋巴結未見癌轉移（0/6）； - 近腫物斷端及遠腫物斷端未見癌； - ，腫瘤病理分期：YPT0N0。術後未行化療，複查腸鏡，現為行造瘻還納入院。患者自發病以來，飲食睡眠好，體重無減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 24, "label_type": "手術", "overlap": 0, "start_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "手術", "overlap": 0, "start_pos": 109, "end_pos": 122}, {"end_pos": 168, "label_type": "藥物", "overlap": 0, "start_pos": 164}, {"end_pos": 172, "label_type": "藥物", "overlap": 0, "start_pos": 169}, {"end_pos": 235, "label_type": "藥物", "overlap": 0, "start_pos": 232}, {"label_type": "手術", "overlap": 0, "start_pos": 289, "end_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 346, "end_pos": 349}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 352, "end_pos": 358}, {"end_pos": 361, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 386, "end_pos": 388}, {"end_pos": 460, "label_type": "解剖部位", "overlap": 0, "start_pos": 455}]}
{"originalText": "，2016年7月患者無誘因出現進食梗咽感，未診治，後患者哽咽感加重，，外院行胃鏡檢查：進鏡30CM可見食管中段見一3/4周不規則潰瘍性病變，底凹凸不平，鏡身不能透過，活檢4塊，，病理：（食管中段）低分化鱗癌，，鋇餐：食管中段可見長度約6CM病變，管壁僵硬，胸、腹部，CT:胸中段食管管壁環周性增厚。2016-12-15 昨日放療結束.1月後複查胸部、腹部CT及鎖骨下B超未見腫瘤復發徵象，食管區域性腫瘤較前縮小。", "entities": [{"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 103}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 128, "end_pos": 135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 136, "end_pos": 141}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 172, "end_pos": 179}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 180, "end_pos": 185}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}]}
{"originalText": "，患者2010-5月體檢發現肝臟佔位，2010-05-17，我院B超：肝左葉實質佔位-考慮MT可能大，肝硬化，脾腫大；AFP(-)。2010-5-18我院肝外科行“肝動脈結紮插管＋腫瘤活撿術＋肝腫瘤無水酒精注射術＋膽囊切除術”，：術中探查腫瘤位於VI段，大小3.5×3×3CM，單結節型，邊界清，無子灶，肝硬化結節0.8-1.0CM。無癌栓,未見腫大淋巴結，肝門無阻斷。，穿刺病理：肝細胞肝癌,分化II級。術後（2010.5.27-2010.10.18）導管化療6次,化療過程中出現血小板、白細胞II二級降低。規律隨訪無復發徵象，，2014-10-28腹部CT:肝左葉MT治療後，肝右葉復發灶可能大(1.4*1.4CM低密度灶，動態增強後動脈期輕度強化，延遲期相對低密度)；肝硬化，脾腫大，門脈高壓;AFP(-)。2014-10-29 B，超：右葉實質佔位-考慮MT可能；肝左葉實質佔位-考慮MT綜合治療後改變，肝硬化，脾腫大。2014-11-4，行RFA術:在B超引導上肝腫瘤射頻消融毀損術，針對肝右葉20×12MM病灶現為行RFA入院。12-10 我院下腹部，MRI：肝MT綜合治療後，肝左葉多枚復發灶，肝右葉病灶基本壞死，肝硬化伴多發硬化結節形成，脾大，門脈高壓。現為行介入治療收住我院。病程中患者精神、食慾、睡眠可，大小便如常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 54}, {"label_type": "手術", "overlap": 0, "start_pos": 82, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 152, "end_pos": 155}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 202}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 245, "end_pos": 248}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 276, "end_pos": 280}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 281, "end_pos": 289}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 337, "end_pos": 340}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 368, "end_pos": 371}, {"end_pos": 389, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 406, "end_pos": 409}, {"end_pos": 429, "label_type": "手術", "overlap": 0, "start_pos": 425}, {"end_pos": 446, "label_type": "手術", "overlap": 0, "start_pos": 431}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 449}, {"end_pos": 467, "label_type": "手術", "overlap": 0, "start_pos": 464}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 478, "end_pos": 480}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 482, "end_pos": 485}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 486, "end_pos": 494}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 514, "end_pos": 517}]}
{"originalText": "9月年前患者於外院因CEA升高查體發現乙狀結腸MT肝轉移，肝內為單發病灶，於外院行乙狀結腸MT切除術，術後病理為乳頭狀腺癌。術後患者恢復好，未行任何治療。3月前者複查肝臟MRI示肝內病灶明顯增多、增大，CEA持續升高，於5月9日、6月17日及8月4日在我科行3次介入治療，術後予保肝、止吐、抑酸等治療後，恢復可。2008-08-12，PSA升高，檢查診斷前列腺癌，無行兩側睪丸切除手術，給藥物去勢+康士德治療出院，今再來我科檢查行介入治療，現患者一般情況好，納可，眠可，二便無殊。<?XML:NAMESPACE PREFIX = O />。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 28}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"end_pos": 50, "label_type": "手術", "overlap": 0, "start_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 61}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 83, "end_pos": 88}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"end_pos": 192, "label_type": "手術", "overlap": 0, "start_pos": 184}, {"end_pos": 202, "label_type": "藥物", "overlap": 0, "start_pos": 199}]}
{"originalText": "，患者6個月前診斷“網膜漿液性腺癌”，於2011年5月27日、6月20日行TP化療（多西他賽+卡鉑）2次，化療過程順利，於2011-7-18於我科行全子宮切除、兩側骨盆漏斗韌帶高位結紮、大網膜、闌尾切除術。，手術評價：無肉眼殘留。，術後病理：卵巢漿液性腺癌。術後恢復良好。術後於2011-8-15至2011-9-29行TP方案化療3次，過程順利，現為補充化療入我科。出院至今，輕微噁心乏力，無腹痛腹脹，飲食差，睡眠可，大小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 17}, {"end_pos": 46, "label_type": "藥物", "overlap": 0, "start_pos": 42}, {"end_pos": 49, "label_type": "藥物", "overlap": 0, "start_pos": 47}, {"label_type": "手術", "overlap": 0, "start_pos": 74, "end_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 128}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}]}
{"originalText": "，患者因月經淋漓不盡1年於2014-10-19就診******健院，行TCT檢查結果為HSIL，行陰道鏡檢查+宮頸活檢，病理為（宮頸12點）中分化鱗狀細胞癌，（宮頸3、6、9點）HSIL。2014-10-24就診我院，行腹盆CT，提示宮頸增大，區域性可見軟組織腫塊，大小約19MM×20MM×29MM，邊界不清，病灶侵犯後穹窿，考慮為宮頸癌。，會診外院宮頸活檢病理：（宮頸）鱗狀下皮呈CIN III改變，伴少許間質浸潤，因組織破碎，難以評估浸潤範圍。2014年11月3日在我院行宮頸LEEP治療，，術後病理：中分化鱗狀細胞癌，癌組織侵潤宮頸肌層，可見脈管內癌栓。11月13日於全麻上行II型改良根治性子宮切除+兩附件切除，，術後病理：（子宮+兩附件）鏡檢為宮頸中至低分化鱗狀細胞癌，浸潤宮頸及頸管深肌層（&GT;1/2肌層），並累及宮體上段淺肌層（&LT;1/2肌層），未累及陰道穹窿，可見脈管內癌栓，未見明確神經束侵犯；右閉孔淋巴結見鱗狀細胞癌轉移。向患者及家屬交代病情，充分知情後，患者及家屬同意入5010，隨機後入序貫放化療組。於2014-11-21、2014-12-23予TP（艾素+順鉑）方案化療，並於2015-1至2015-3行輔助放療45GY/25F。現為行上一程化療入院。近來患者一般情況可，睡眠、食慾可，二便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 43, "end_pos": 47}, {"label_type": "手術", "overlap": 0, "start_pos": 49, "end_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 78}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 110, "end_pos": 114}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 169}, {"end_pos": 177, "label_type": "手術", "overlap": 0, "start_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"end_pos": 244, "label_type": "手術", "overlap": 0, "start_pos": 238}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 261}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 267, "end_pos": 269}, {"label_type": "手術", "overlap": 0, "start_pos": 291, "end_pos": 309}, {"end_pos": 319, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"end_pos": 323, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 327, "end_pos": 339}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 342}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 365, "end_pos": 367}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"end_pos": 416, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 417, "end_pos": 422}, {"end_pos": 494, "label_type": "藥物", "overlap": 0, "start_pos": 492}, {"end_pos": 497, "label_type": "藥物", "overlap": 0, "start_pos": 495}]}
{"originalText": "，患者2013年7月無明顯誘因，逐漸出現便次增多，未予系統診治，其後病情反覆發作。2014年6月始，下述症狀加重，一日10餘次，大便不成形，夾有黏液，偶有便中帶血，偶有腹痛腹脹，以上腹為主，便後減輕，無噁心嘔吐，無反酸燒心，就診於本院，在門診行腸鏡（2014-7-20），檢查示：乙狀結腸，，直腸：距肛緣17-10CM可見不規則隆起樣病變，環周，表面潰瘍形成，覆汙穢苔，取材6塊，質脆，易出血。於2014-08-04全麻上直腸癌低位前切除術，術後病理回報進展期直腸癌，粘液腺瘤及中分化管狀腺癌，斷端無癌，淋巴結未見轉移癌，送檢盆壁組織見轉移癌。2014-9-14開始行放療，同步化療2週期（奧沙利鉑150MGD1+替吉奧60MG日雙次口服D1-14），現放療中，為行第3週期化療入院。病來精神狀態可，無乏力，無發熱，飲食睡眠尚可，體重術後至今無明顯改變。", "entities": [{"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 220, "label_type": "手術", "overlap": 0, "start_pos": 211}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 227, "end_pos": 246}, {"end_pos": 299, "label_type": "藥物", "overlap": 0, "start_pos": 295}, {"end_pos": 310, "label_type": "藥物", "overlap": 0, "start_pos": 307}]}
{"originalText": "，患者2011年5月1日因尿頻尿急在外院檢查，行B超及CT檢查提示盆腔包塊，建議進一步檢查。遂就診於我院，於2011-5-27全麻上行全子宮+兩側附件切除+大網膜切除+盆腔淋巴結清掃+腹主動脈旁淋巴結切除術。，術中探查：腹水500ML,淡黃。左卵巢腫瘤融合大小約12×7×6CM,實性，表面光滑，分葉狀，質脆，左側輸卵管與盆腔腫塊融合，右卵巢4*4*3CM。子宮大小約7×6×5CM，後壁與左側附件腫物粘連緊密，餘未見明顯異常。，術中冰凍病理報告:左卵巢中分化漿液性腺癌。術後病理回報兩側卵巢中分化漿液性乳頭狀腺癌。盆地結節見癌轉移。送檢各組淋巴結未見癌轉移。腹水細胞學可疑癌細胞。，術後診斷：兩卵巢腺癌IIB期。患者術後恢復可，於2011-6-7、2011-6-30、2011-8-9行TP（北華素240MG IV+伯爾定600MG IP）化療方案三程，過程順利。出院後定期複查血常規白細胞最低3.4X10~9/L,血小板正常,現為進一步化療再次住院。近期食慾、精神、睡眠可，小便無明顯異常，大便規律，成形，軟，體重無明顯上降。，既往化療及腫瘤標誌物情況：，化療藥物毒副反應：。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 24, "end_pos": 26}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 27, "end_pos": 29}, {"end_pos": 35, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "手術", "overlap": 0, "start_pos": 67, "end_pos": 103}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 126}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 235}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 242, "end_pos": 257}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 297, "end_pos": 306}, {"end_pos": 350, "label_type": "藥物", "overlap": 0, "start_pos": 347}, {"end_pos": 362, "label_type": "藥物", "overlap": 0, "start_pos": 359}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 393, "end_pos": 396}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 409, "end_pos": 412}]}
{"originalText": "，患者2015.11.18因胃癌並肝轉移於我院行全胃切除術，，術後常規病理示：（胃）中低分化腺癌，潰瘍型，腫瘤切面積9*2CM，侵透漿膜達周圍脂肪組織，脈管內查見癌栓並查見神經侵犯。下上切緣吻合器切緣及術中送檢食管切緣未查見癌。小彎側淋巴結17枚，其中3枚查見轉移（3/17）；大彎側淋巴結4枚，均未查見轉移（0/4），網膜組織未查見癌。免疫組化;CK19(+)、E-CAD（+）、HER-2（3+）。，病理號：41745.15。術後給予消炎營養支援治療，病情好轉後出院。後行SOX方案化療1週期，，具體藥物為：奧沙利鉑150MG D1+替吉奧3粒 BID*14天，後患者腫瘤指標較前明顯增高，考慮進展，行多西他賽+卡培他濱方案化療2週期，，具體藥物為：多西他賽120MG D1+卡培他濱3粒 BID*14天，耐受良好。2016.4複查CT示胃CA治療後,考慮左肺門淋巴結、肝臟多發轉移，較前片病變進展，兩肺小結節，較前片無明顯變化，建議隨訪，縱隔淋巴結略腫大，左肺侷限性炎症，兩肺纖維灶，右腎多發囊腫，腹腔及盆腔積液，改用伊立替康+順鉑化療1週期，，具體藥物為：伊立替康360MG D1+順鉑40MG D2-4，化療後無明顯不適，現患者為行上一週期化療收入院。自下次出院來，患者飲食睡眠可，二便無明顯異常，體重較前無明顯改變。神經性頭痛20餘年，發作時自行口服止痛藥物治療。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 20}, {"end_pos": 29, "label_type": "手術", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 52}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 260, "label_type": "藥物", "overlap": 0, "start_pos": 256}, {"end_pos": 272, "label_type": "藥物", "overlap": 0, "start_pos": 269}, {"end_pos": 307, "label_type": "藥物", "overlap": 0, "start_pos": 303}, {"end_pos": 312, "label_type": "藥物", "overlap": 0, "start_pos": 308}, {"end_pos": 331, "label_type": "藥物", "overlap": 0, "start_pos": 327}, {"end_pos": 344, "label_type": "藥物", "overlap": 0, "start_pos": 340}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 368, "end_pos": 370}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 371, "end_pos": 377}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 380}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 387, "end_pos": 393}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}, {"end_pos": 427, "label_type": "解剖部位", "overlap": 0, "start_pos": 422}, {"end_pos": 433, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 441, "label_type": "解剖部位", "overlap": 0, "start_pos": 439}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 445, "end_pos": 451}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 452, "end_pos": 459}, {"end_pos": 466, "label_type": "藥物", "overlap": 0, "start_pos": 462}, {"end_pos": 469, "label_type": "藥物", "overlap": 0, "start_pos": 467}, {"end_pos": 486, "label_type": "藥物", "overlap": 0, "start_pos": 482}, {"end_pos": 497, "label_type": "藥物", "overlap": 0, "start_pos": 495}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 564, "end_pos": 569}]}
{"originalText": "，患者於2010年10月因\\\"上腹痛伴大便習慣改變\\\"外院行腸鏡，病理示中分化腺癌；，外院B超示：盆腔內雙個巨大團塊，左側145*101MM，右側94*85MM，考慮卵巢來源可能性大；盆腔大量積液。為進一步治療來我院就診，考慮乙狀結腸癌伴不完全梗阻、盆腔腫物，2010-10-25我院行\\\"子宮切除+兩附件切除+DIXON術+大網膜切除術開腹惡性腫瘤特殊治療術\\\"，術中5-FU1000MG腸腔化療，門靜脈5-FU250MG化療，中人氟安800MG腹腔化療，病理回報乙狀結腸中分化腺癌，兩側卵巢轉移瘤，中央組淋巴結轉移4/15，PT4BN2M1。術後恢復良好，，2010-11-10我院CT：乙狀結腸癌術後，肝S5、6段肝轉移。遂2010-11-16至2011-5-19行FORFIRI方案化療8程，過程順利。2011-1-13，我院CT複查：乙狀結腸癌術後、化療後，肝轉移瘤較前縮小、好轉（較大病灶），較小病灶較前無明顯變化，不排除為肝囊腫。療效評價為SD。2011-4-6轉外科行\\\"肝轉移瘤切除術\\\"，術後病理（463585），：符合腸癌肝轉移。後於2011-05-20至2011-08-05繼續FORFIRI方案化療4程，2011-09-05複查CT未見腫瘤復發情況。2012-02-21複查CT提示右下肺及右上肺結節、左前丅壁結節，考慮轉移瘤，兩肺肺多髮結節狀小空洞影未排除轉移。考慮腫瘤復發，今收住院進一步治療，入院患者自覺無不適，胃納、睡眠可，二便如常。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 36, "end_pos": 41}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 45, "end_pos": 47}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 124}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "手術", "overlap": 0, "start_pos": 145, "end_pos": 180}, {"end_pos": 189, "label_type": "藥物", "overlap": 0, "start_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 195, "end_pos": 196}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"end_pos": 207, "label_type": "藥物", "overlap": 0, "start_pos": 203}, {"end_pos": 219, "label_type": "藥物", "overlap": 0, "start_pos": 215}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 225}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 233, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 243, "end_pos": 250}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 293, "end_pos": 295}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 296, "end_pos": 303}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 304, "end_pos": 313}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 367, "end_pos": 369}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 372, "end_pos": 379}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 384, "end_pos": 388}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 418, "end_pos": 421}, {"end_pos": 451, "label_type": "手術", "overlap": 0, "start_pos": 444}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 470, "end_pos": 475}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 527, "end_pos": 529}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 550, "end_pos": 552}, {"end_pos": 557, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 561, "label_type": "解剖部位", "overlap": 0, "start_pos": 558}, {"end_pos": 579, "label_type": "解剖部位", "overlap": 0, "start_pos": 577}, {"end_pos": 580, "label_type": "解剖部位", "overlap": 0, "start_pos": 579}, {"end_pos": 623, "label_type": "解剖部位", "overlap": 0, "start_pos": 622}]}
{"originalText": "，下次入院，患者於今年５月，患者因腹痛於我院住院治療，診斷為胰腺癌和２型糖尿病，因患者胰腺腫瘤侵犯血管，難以行根治手術，於2012-05-21日在全麻上行剖腹探查+膽腸吻合+胃腸吻合+膽囊切除術。術後患者恢復良好，無特殊不適。\\U0004　　本次入院，入院前半月前，患者無明顯誘因出現兩上肢水腫，呈凹陷性，中度，伴面色蒼白，兩眼瞼浮腫，全身乏力，食慾減退，無咳嗽、咳痰，無身黃、眼黃、尿黃，無噁心、嘔吐，無腹脹、腹痛等不適，夜間能平臥入睡，無端坐呼吸，下述症狀持續存在，未給予特殊治療，兩上肢浮腫及面色蒼白症狀緩慢加重，為求進一步治療，2012年12月24日，我院查血常規：，WBC：8.62×109/L，，N：29.9%，，RBC：2.37×1012/L，，HB:73G/L，，PLT：252×109/L。門診因“浮腫原因待查，中度貧血”收入院。\\U0004   患者自起病以來，精神較萎，睡眠差，胃納極差，大便次數減少，色基本正常，尿量減少，體重上降。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 30, "end_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 34, "end_pos": 39}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "手術", "overlap": 0, "start_pos": 77, "end_pos": 97}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 288, "end_pos": 291}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 304, "end_pos": 305}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 313, "end_pos": 316}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 330, "end_pos": 332}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 340, "end_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 365, "end_pos": 369}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 400, "end_pos": 401}]}
{"originalText": "，緣於入院前6小時於進食後出現中下腹部痛，疼痛劇烈，呈刀割樣、持續性，無陣發性加劇，伴肩部放射痛，無噁心、嘔吐、嘔血，無腹瀉、黑便、便血，無發熱、畏冷、寒戰，無咳嗽、咳痰，無尿頻、尿急、尿痛，遂急診我院，，急查腹部立位平片示：兩膈上游離氣體，考慮消化道穿孔。，腹部彩超：1.急診腹腔內大量氣體干擾；2.肝實質回聲增粗、增亮；3.膽囊體積增大，壁毛糙；4.肝內外膽管擴張；5.胰腺稍大、回聲異常；6.少量腹水；7.脾多發鈣化斑；8.前列腺輕度增生並結石；9.腹主動脈粥樣硬化聲像改變。，心電圖：竇性心律。，肝腎功能：ALT124U/L，AST96U/L，LDH639U/L，BUN11.5MMOL/L，CRE127UMOL/L，UA697UMOL/L；血常規、DIC+血凝未見明顯異常。考慮“消化道穿孔可能”，予禁食、胃腸減壓、“生長抑素”抑制消化液分泌，“舒普深、奧硝唑”抗感染及制酸、補液等處理後，腹痛稍緩解。現為行手術治療，急診擬“，腹痛待查：消化道穿孔？”收住我科。自發病以來，精神、睡眠差，進食狀態，大便未解，小便正常，體重無變化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 105, "end_pos": 111}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 140}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 184}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 224}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 228, "end_pos": 236}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 267, "end_pos": 270}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 276, "end_pos": 279}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 286, "end_pos": 289}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 300, "end_pos": 303}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 313, "end_pos": 315}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 345, "end_pos": 350}, {"end_pos": 368, "label_type": "藥物", "overlap": 0, "start_pos": 364}, {"end_pos": 381, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 385, "label_type": "藥物", "overlap": 0, "start_pos": 382}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 424, "end_pos": 429}]}
{"originalText": "患者一個月前因“白帶混血，性交後陰道流血”於外院行宮頸錐切術，術後病理我院會診：浸潤癌深度約3—4MM，有脈管浸潤，鱗癌（中分化）。因盆腔炎性重，不宜手術，於4月14日行BEP方案化療，過程順利，複查血常規回報正常，准予出院。出院後口服拜覆樂及西黃丸3***治療。末次月經為2010年1月，具體日期不詳。出院至今，無發熱，無明顯消瘦乏力及腹痛腹脹，飲食睡眠良好，大小便正常。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 30, "label_type": "手術", "overlap": 0, "start_pos": 25}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 65}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 121, "label_type": "藥物", "overlap": 0, "start_pos": 118}, {"end_pos": 125, "label_type": "藥物", "overlap": 0, "start_pos": 122}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}]}
{"originalText": "，2010-2-4行直腸癌根治術（距肛緣2CM），中分化腺癌，侵及腸壁全層，未透外膜層，脈管癌栓（+），淋巴結5/22，絨毛狀管狀腺瘤I級，切緣（-）。OXA+FU*12，末次2010-11。未行放療。定期複查。術前，CEA：2.7，但2012-9 CEA 10NG/ML，2012-11CT及PET-CT示左盆底肌肉增厚伴瀰漫性輕度代謝增高，炎性？刀口處疼痛？2013-5查CEA升至60，CT示左盆底異常組織影略增大，同左側臀肌分界不清，2次B超上穿刺（-），2013.5始希羅達*1，，2013-7-3：CEA升至87NG/ML，刀口疼痛略加重，影響睡眠，體重無變化。後CEA升至80NG/ML，肛周流液，盆腔CT及PETCT提示左盆底肌肉增厚，輕度代謝增高，臨床考慮復發，曾雙次活檢均為陰性，但PETCT提示左盆底肌肉增厚代謝增高，臨床考慮復發。建議再行活檢明確診，超聲科拒行穿刺，患者本人及家屬認同直腸癌術後復發，並同意放療。經MDT討論後，認為直腸癌術後盆腔復發診斷基本明確，建議放療，同時完善全身檢查。2013.8.7 CEA 94.1NG/ML，腹胸部CT未見明顯異常。已行放療，劑量方案為GTV 60GY/30F。無其他特殊不適。末次放療2013-9-18。放療期間同時口服希羅達（6片/日）。已於12月初停服希羅達。2013-12-18 ，腫標：癌胚抗原 38.28NG/ML，癌抗原72.4 12.06U/ML，癌抗原242 23.3U/ML2014-02-21開始行3週期FOLFIRI化療。過程順利。複查PD，近期腹脹，間斷腹瀉，左上肢水腫，體重減輕。腹平片小腸不全梗阻可能大，建議治療後複查。", "entities": [{"end_pos": 16, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 67}, {"end_pos": 79, "label_type": "藥物", "overlap": 0, "start_pos": 76}, {"end_pos": 82, "label_type": "藥物", "overlap": 0, "start_pos": 80}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 109, "end_pos": 112}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 125, "end_pos": 128}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 144, "end_pos": 146}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 147, "end_pos": 153}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 188, "end_pos": 191}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 223, "end_pos": 225}, {"end_pos": 242, "label_type": "藥物", "overlap": 0, "start_pos": 238}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 255, "end_pos": 258}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 288, "end_pos": 291}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 306, "end_pos": 316}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 351, "end_pos": 356}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 404, "end_pos": 411}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 437}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 466, "end_pos": 471}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 481, "end_pos": 486}, {"end_pos": 549, "label_type": "藥物", "overlap": 0, "start_pos": 546}, {"end_pos": 567, "label_type": "藥物", "overlap": 0, "start_pos": 564}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 583, "end_pos": 587}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 599, "end_pos": 606}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 617, "end_pos": 623}, {"end_pos": 671, "label_type": "解剖部位", "overlap": 0, "start_pos": 670}, {"end_pos": 676, "label_type": "解剖部位", "overlap": 0, "start_pos": 675}, {"end_pos": 681, "label_type": "解剖部位", "overlap": 0, "start_pos": 678}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 689, "end_pos": 692}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 692, "end_pos": 698}]}
{"originalText": "，患者主因3周前因“貧血”，行胃鏡檢查提示：十二指腸球部粘膜光滑，降段後壁見一半球樣隆起，約3*2CM大小，表面粘膜充血伴糜爛，，病理提示：管狀絨毛狀腺瘤型息肉，，腸鏡檢查提示：橫結腸見一潰瘍型隆起型病變，充滿管腔全周，鏡身無法透過，，提示：橫結腸癌，，病理提示：腺癌，，我院病理會診提示：（結腸）高級別絨毛管狀腺瘤，伴癌變和粘膜肌浸潤；，我院CT提示：結腸肝曲腸壁不規則增厚及強化，較厚約25MM(圖81)，漿膜面模糊，部分層面與肝上緣及膽囊關係密切；鄰近可見散在小淋巴結，較大約13*7MM，，提示： 結腸肝曲腸壁不規則增厚及強化，符合癌，肝上緣及膽囊受侵？為求進一步手術治療入院。患者自發病以來精神睡眠尚好，納差，小便如常，大便褐色，近1個月體重上降5KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 12}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 80}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 158}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 172, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 217}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 252, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 272, "end_pos": 273}, {"end_pos": 278, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}]}
{"originalText": "，患者因子宮肌瘤於2014-01-08在我院手術探查，術中快速冰凍提示子宮平滑肌肉瘤，遂行全子宮＋兩側附件切除術+盆腔淋巴結清掃術。，術後病理回示：（全子宮），鏡上：腫瘤細胞呈束狀或編織狀排列，瘤細胞梭形或卵圓形，核深染，異型性明顯，可見瘤鉅細胞，核分裂像易見，可見壞死，結合免疫組化結果，病變診斷為平滑肌肉瘤；未見明確脈管及神經束侵犯；增殖期子宮內膜；子宮多發性平滑肌瘤。兩附件及淋巴結未見腫瘤。術後診斷“子宮平滑肌肉瘤IB期”。於2014-01-27、2014-02-25行脂質體多柔比星+異環磷醯胺方案化療2程。化療過程順利，無明顯化療反應，定期複查血常規提示白細胞正常。今遵囑返院行上一療程化療。患者病來，精神好，飲食睡眠及大小便正常，體重無明顯減輕。，外院治療經過：無。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 4, "end_pos": 8}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 35, "end_pos": 42}, {"label_type": "手術", "overlap": 0, "start_pos": 45, "end_pos": 65}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 174}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 186}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 214}, {"end_pos": 246, "label_type": "藥物", "overlap": 0, "start_pos": 239}, {"end_pos": 252, "label_type": "藥物", "overlap": 0, "start_pos": 248}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 283, "end_pos": 286}]}
{"originalText": "，患者2011年09月在本院診斷為肝內膽管細胞癌，並於2011年11月01日、2012年02月28日行肝動脈灌注化療術雙次，術中用藥5-，FU:0.5MG，，健擇：1.2G，2012年04月11日，複查CT提示：膽管癌介入治療後；右肝管內病變較前稍縮小；肝右葉肝內膽管擴張。於2012-04-19於全麻上行膽管癌切除術。後定期複查。2016.12.16患者無明顯誘因出現眼黃、面板黃，2017-1-11在我科行PTCD術，術程順利。複查，CT:，右肝內膽管細胞癌術後綜合治療後複查：左肝管近端管腔內軟組織灶，較前增大，復發腫瘤可能性大。肝左葉肝內膽管擴張程度較前減低。脾稍大。於2017-2-6行肝腫瘤微波消融術。 患者目前無腹痛腹脹、無噁心嘔吐、無畏寒發熱,精神尚可，食慾如常。大小便正常。體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 17, "end_pos": 24}, {"end_pos": 59, "label_type": "手術", "overlap": 0, "start_pos": 51}, {"end_pos": 71, "label_type": "藥物", "overlap": 0, "start_pos": 66}, {"end_pos": 81, "label_type": "藥物", "overlap": 0, "start_pos": 79}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 101, "end_pos": 103}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 114}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 127, "end_pos": 136}, {"end_pos": 159, "label_type": "手術", "overlap": 0, "start_pos": 153}, {"end_pos": 210, "label_type": "手術", "overlap": 0, "start_pos": 205}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 219, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 238}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 306, "label_type": "手術", "overlap": 0, "start_pos": 298}, {"end_pos": 314, "label_type": "解剖部位", "overlap": 0, "start_pos": 313}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}]}
{"originalText": "2011-4-2因盲腸癌行左半結腸癌根治術手，術後病理示回盲部中低分化腺癌，部分伴粘液腺癌分化，漿膜層，脈管癌栓，未侵及闌尾，斷端-，0/18，術前腫標均正常，PT3N0M0,化療*6，具體不詳，末次2011.8。2012-2出現肛門上墜感，右側腹痛，體重同前。2012-2-28腹部CT示右側結腸旁溝及橫結腸內轉移可能，查PET/CT示橫結腸上方/右結腸/直腸前方軟組織腫塊並代謝活躍，考慮轉移,腫標正常.2012.3.15始行XELIRI化療7週期;腹盆CT：腹盆腔系膜內多髮結節及腫塊，M。評效SD\\U0004\\U0004 現飲食可，兩手脹痛1級，兩腳水泡，口腔潰瘍1級。近3天大便稀，1-2次/天。\\U0004\\U0004 預期複查判效。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"end_pos": 21, "label_type": "手術", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 47}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 123, "end_pos": 124}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 162, "end_pos": 168}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 227, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 232, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 235}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 277}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 282, "end_pos": 286}]}
{"originalText": "，患者3個月前因“腹痛2天，加重半天”就診我科，於2012-10-15全子宮兩附件大網膜闌尾切除、腹壁病灶切除術，，術中見：盆腹腔無液體。肝脾胃未及病灶；腸管表面及腸繫膜可見散在小的粟粒結節。子宮常大，子宮膀胱反折腹膜明顯癌樣增厚，與子宮前壁粘連。子宮後壁與腸管前壁粘連。左卵巢瘤手拳大，與闊韌帶後葉及腸管粘連，右卵巢雞卵大，與周圍組織粘連，大網膜末端增厚，可見癌灶，左側腹壁穿刺點病灶大小4-5CM，侵及腹膜，未達肌層，與大網膜末端病灶緻密粘連。手術順利，病理回報（Z0442250），：C 宮壁內見腺樣癌巢 DE 卵巢漿液性囊腺癌（中分化） F 囊壁組織內見腺樣癌巢 G 網膜組織內見腺樣癌巢 H 闌尾漿膜面見腺樣癌巢。，出院診斷：卵巢漿液性囊腺癌（中分化）IIIｃ期（兩側卵巢、大網膜、盆腔腹膜、腸繫膜、闌尾）2次化療後1個月。患者術前行多西他賽+卡鉑方案化療2次，術後化療1次，末次化療時間2012-10-24，現為求補充治療入我科。出院至今化療副反應輕微，無頭暈頭迷，無噁心嘔吐，無腹脹腹瀉，大小便正常，飲食睡眠可，近期無明顯體重變化。 高血壓病史5年。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "手術", "overlap": 0, "start_pos": 35, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 83}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 103, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 126}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 140}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 152}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 186, "end_pos": 187}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 259, "end_pos": 272}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 318, "end_pos": 336}, {"end_pos": 341, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 346, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 351, "end_pos": 352}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 372}, {"end_pos": 379, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 437, "label_type": "解剖部位", "overlap": 0, "start_pos": 436}, {"end_pos": 447, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 474, "end_pos": 477}]}
{"originalText": "，患者於2011年4月份因\\\"大便次數增多2月餘，CT發現盆腔佔位10天\\\"入住我院綜合科，於5月3日行剖腹探查術，見腫物位於距回盲部150CM迴腸處，行腫物及雙端5CM空腸切除術，術後恢復可，，術後病理：胃腸間質腫瘤，3個核分裂/50HPF,，免疫組化：CD34-、CD117+，S-100(-)、SAM+/-，DES(-),HHF35-；2011-5-11起口服格列衛400MG QD治療，耐受可。偶有心前區不適，隨訪心電圖、心功酶等均未見明顯異常。無顏面水腫及面板瘙癢，無噁心、嘔吐、腹痛不適。現入院繼續格列衛化療。患者起病以來，無發熱、乏力、咳嗽、氣促、身目黃染等，精神睡眠可，胃納欠佳，小便正常，大便1次/天，體重無明顯上降。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 31}, {"end_pos": 57, "label_type": "手術", "overlap": 0, "start_pos": 52}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 90, "label_type": "手術", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"end_pos": 186, "label_type": "藥物", "overlap": 0, "start_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 204}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 258, "label_type": "藥物", "overlap": 0, "start_pos": 255}]}
{"originalText": "2006年6月發現胃MT，行胃大部切除術後，２月前胃鏡顯示未見腫瘤復發徵象。雙年前外院發現肝內佔位，考慮胃MT肝轉移，曾在外院及我院行多次化療。複查CT肝內病灶及腹膜後病灶SD。於201１－5－5患者仰臥位，以4F RH導管插管至腹腔幹影示膈動脈與腹腔動脈共幹,肝左葉單發巨大腫瘤血管染色，超選擇插管至腫瘤血管支，灌注注入拓喜14ｍｇ，另以奧鉑150MG+ＴＨＰ30MG+超液化碘油4ML製成混懸液行栓塞，碘油沉積良好。為進一步鞏固治療，收住入院。目前，患者神清，食慾可，睡眠正常，二便正常，體重無明顯減輕。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 14, "end_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 45, "end_pos": 46}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 58}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 74, "end_pos": 76}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 81, "end_pos": 82}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 163, "label_type": "藥物", "overlap": 0, "start_pos": 161}, {"end_pos": 172, "label_type": "藥物", "overlap": 0, "start_pos": 170}, {"label_type": "藥物", "overlap": 0, "start_pos": 178, "end_pos": 181}, {"end_pos": 191, "label_type": "藥物", "overlap": 0, "start_pos": 186}, {"end_pos": 205, "label_type": "藥物", "overlap": 0, "start_pos": 203}]}
{"originalText": "，患者平素月經規則，LMP 2015-11-07，量中，無明顯異常。患者2015-11-13就診*********中心，行婦科檢查，，宮頸TCT檢查提示：有非典型腺細胞，懷疑腺癌。，盆腔彩超：子宮小肌瘤，宮頸前脣異常回聲（17×19×16MM），性質待查。兩側附件暫未見明顯異常。進一步行陰道鏡檢查+宮頸活檢，，術後病理提示：宮頸3、6、9、11點均為高-中分化腺癌。後於我院就診，考慮為宮頸腺癌IIA1期，遂於2015-11-22在我院全麻上行“經腹III型全子宮切除+兩側附件切除+兩側盆腔淋巴結清掃+腹主動脈旁淋巴結切除術”，術程順利，，術後病理示：（全子宮）鏡檢為高至中分化腺癌，形態與（右附件）結節相似，結合免疫組化結果，符合漿液性癌；癌組織浸潤宮頸全層至外膜層及脂肪結締組織，並累及陰道穹窿及子宮體上段；可見脈管內癌栓及神經束侵犯。術後於2015-12-03行“紫杉醇+順鉑”方案化療1程，同時配合行CIK細胞免疫治療。化療後因兩上肢疼痛，考慮深靜脈血栓，予2015-12-10至2015-12-16在**一院行抗血栓治療，2015-12-16複查彩超示兩上肢血管通暢。2015-12-16開始繼續在我科行CIK細胞免疫治療。定期複查未見腫瘤復發、轉移，末次複查時間2016-02-15。現患者為行CIK細胞回輸入我科。起病以來，患者精神、胃納可，大小便無明顯異常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 89}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 101}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"label_type": "手術", "overlap": 0, "start_pos": 144, "end_pos": 154}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 176, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 194, "end_pos": 203}, {"label_type": "手術", "overlap": 0, "start_pos": 224, "end_pos": 264}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 286, "end_pos": 293}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 330}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 352, "end_pos": 355}, {"end_pos": 390, "label_type": "藥物", "overlap": 0, "start_pos": 387}, {"end_pos": 393, "label_type": "藥物", "overlap": 0, "start_pos": 391}, {"end_pos": 423, "label_type": "解剖部位", "overlap": 0, "start_pos": 420}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 433}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 480, "end_pos": 482}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 483, "end_pos": 488}, {"end_pos": 577, "label_type": "解剖部位", "overlap": 0, "start_pos": 576}]}
{"originalText": "，患者2006-11無明顯誘因便血2周，，外院腸鏡示：至肛門2-3CM腫物，直腸中分化腺癌。2006-11在我院行MILES術，病理示中分化腺癌，浸潤深肌層，淋巴結0/3，脈管內見癌栓，PT2N0M0，I期.術後於2007-05至2008-01-28行XELODA單藥化療4程。後定期複查。，2013-03-26複查CT：兩肺轉移；縱隔及兩肺門多發淋巴結轉移；腹主動脈及兩髂血管旁多發淋巴結轉移。，肺部病灶穿刺活檢示：中分化腺癌，提示腸癌轉移可能性大。遂於2013-04-27至2013-10-09在我科行一線FOLFOX方案化療9程，3程後評價SD，6程後評價PR，9程後評價PD。患者擬參加阿柏西普臨床試驗，因血小板偏低，不符合入組篩選條件。2013-11-04行二線CPT-11單藥化療1程，11-27、2013-12-17、1-3行CPT-11+安維汀化療3程，4程化療後CT評價示SD。下程化療後出現I度嘔吐，經對症處理後恢復。現為繼續上程化療收入院。現患者一般情況可，大小便正常，體重無明顯變化。", "entities": [{"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 45}, {"end_pos": 63, "label_type": "手術", "overlap": 0, "start_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 67, "end_pos": 72}, {"end_pos": 132, "label_type": "藥物", "overlap": 0, "start_pos": 126}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 158, "end_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 165}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 217, "end_pos": 219}, {"end_pos": 301, "label_type": "藥物", "overlap": 0, "start_pos": 297}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"end_pos": 342, "label_type": "藥物", "overlap": 0, "start_pos": 336}, {"end_pos": 376, "label_type": "藥物", "overlap": 0, "start_pos": 370}, {"end_pos": 380, "label_type": "藥物", "overlap": 0, "start_pos": 377}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 390, "end_pos": 392}]}
{"originalText": "緣於3年前診為胃癌，在我院全麻上行根治性全胃切除術，手術順利。術後給予對症、抗感染治療，恢復良好,傷口癒合II/甲。此後患者定期複查。2月餘前因感中下腹悶痛不適，自服藥物治療症狀仍反覆就診我院，查全腹CT+增強：1、胃大部切除術後改變，吻合口區管壁無明顯增厚，吻合口周圍未見明顯腫大淋巴結，下腹部腹膜後少許淋巴結增大，建議隔期複查。2、胰腺尾部及脾門部脂肪間隙模糊伴斑片狀密度增高影，增強掃描輕度強化，多考慮術後改變，建議隔期複查。3、肝內少許小囊腫，脾臟明顯增大。考慮“胃癌術後腹腔轉移”，遂於2014.09.15予“伊立替康280MG靜滴D1，替吉奧膠囊(艾奕)80MG口服D1-14”方案，化療順利，化療後無噁心、嘔吐，無腹痛、腹瀉等不適，今為行上一療程化療再次就診我院，門診查體後擬“胃癌術後腹腔轉移”收住我科。自發病以來，精神睡眠食慾如常，大小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 7, "end_pos": 9}, {"end_pos": 25, "label_type": "手術", "overlap": 0, "start_pos": 17}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 98, "end_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 115}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 244}, {"end_pos": 264, "label_type": "藥物", "overlap": 0, "start_pos": 260}, {"label_type": "藥物", "overlap": 0, "start_pos": 274, "end_pos": 283}, {"end_pos": 315, "label_type": "解剖部位", "overlap": 0, "start_pos": 314}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 346, "end_pos": 354}]}
{"originalText": "，間斷腹痛，2016-10我院PET-CT及外院胃鏡等確診胃體下段後壁大彎潰瘍，印戒細胞癌，瀰漫型；腹腔腹膜後LNM及腹膜卵巢M；，CA199:128；2016-10-19腹腔鏡上兩卵巢切除術+腹腔熱灌注，CY0，右腹腔數枚結節，胃體病灶未侵透漿膜，，術後病理：右左卵巢約4CM，印戒細胞癌及低分化腺癌；傘端+；右輸卵管系膜內脈管癌栓，左側未累及；術後SOX*2（腹痛納差腹瀉嘔吐，S1未完成）--XELOX*2（奧沙利鉑較前減量，N上降III度，XELODA僅7日），末次2017-2-9。休息至今，2017.3胸腹盆CT示穩定，基本無不適，體重增加3KG。", "entities": [{"end_pos": 4, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 15, "end_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "手術", "overlap": 0, "start_pos": 86, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 108, "end_pos": 109}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 151}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 160}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 193, "label_type": "藥物", "overlap": 0, "start_pos": 191}, {"end_pos": 211, "label_type": "藥物", "overlap": 0, "start_pos": 207}, {"end_pos": 230, "label_type": "藥物", "overlap": 0, "start_pos": 224}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 257, "end_pos": 262}]}
{"originalText": "，胃癌根治術術後複查。2014-4-28胃癌手術，，術後腫瘤病理分期：PT3N3B。術後行SOX方案2週期。末次化療2014-6月。2015-6-5B，超：腹膜後多發淋巴結，傾向M肝內鈣化灶，肝囊腫，膽囊淤膽.2015-6-9，與2014-05-12腹部CT比較：1 胃癌術後較前相仿，吻合口壁未見增厚及異常強化。2 腹腔內積氣消失，盆腔內見少量積液。肝門靜脈及腹膜後新見多發腫大融合淋巴結，較大約46X26MM，考慮轉移。兩側髂血管旁未見腫大淋巴結。3 肝右葉低密度灶較前增大，仍未見強化，原約8X4MM，現約11X9MM。", "entities": [{"end_pos": 6, "label_type": "手術", "overlap": 0, "start_pos": 1}, {"label_type": "手術", "overlap": 0, "start_pos": 20, "end_pos": 24}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 79}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 96, "end_pos": 99}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 125, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 160}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 182}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}]}
{"originalText": "，患者16年4月因“大便次數增多2月”於我院診斷為直腸癌，2016-04-21我院超聲腸鏡考慮直腸癌（UT3N1）結腸多發息肉。病理提示中分化腺癌。2016-04-22，我院MRI示：考慮直腸上段病變，符合直腸癌，侵及腸壁全層。直腸周小淋巴結，轉移可能性大。於2016-05-05至07-13行4程XELOX方案化療，，同期2016-05-27至2016-06-30行放療：PTV1 50GY/25F;PTV2 46GY/25F，複查病灶較前縮小。2016-08-24全麻上行腹腔鏡DIXON，，術後病理：1（腸大體），鏡上：腸壁粘膜上層中見少許異型腺體浸潤，結合病史及免疫組化結果，符合中分化腺癌，未見明確脈管內癌栓及神經束侵犯；另見纖維組織增生，伴鈣化及淋巴細胞、多核鉅細胞等炎症細胞浸潤，符合治療後改變；，腫瘤消退分級：MANDARD TRG 2級。2（近切緣）未見癌。3（遠切緣）未見癌。4（中央組淋巴結）鏡上為脂肪結締組織，未見淋巴結，未見癌。5（中間組淋巴結）1枚，未見癌。6（腸旁淋巴結）1枚，未見癌；另見少許腸壁組織，未見癌。，免疫組化：CK（+），CK20（+），CDX-2（+）。患者術後恢復可。2016-9-29在我院行奧沙利鉑+卡培他濱方案化療1程，過程順利。現為進一步治療入院。自起病以來，患者訴有上腹痛，無腹脹，無噁心、嘔吐，無發熱、畏寒。精神、睡眠良好，胃納可，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 25, "end_pos": 28}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 47, "end_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 63}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 68, "end_pos": 73}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 87, "end_pos": 90}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 103, "end_pos": 106}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 110}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 246, "label_type": "手術", "overlap": 0, "start_pos": 238}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 299}, {"end_pos": 450, "label_type": "解剖部位", "overlap": 0, "start_pos": 445}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 462, "end_pos": 463}, {"end_pos": 525, "label_type": "藥物", "overlap": 0, "start_pos": 521}, {"end_pos": 530, "label_type": "藥物", "overlap": 0, "start_pos": 526}, {"end_pos": 564, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}, {"end_pos": 568, "label_type": "解剖部位", "overlap": 0, "start_pos": 567}, {"end_pos": 593, "label_type": "解剖部位", "overlap": 0, "start_pos": 592}]}
{"originalText": "，患者因“直腸癌放療後”於2017-2-22在全麻上行腹腔鏡輔助直腸癌低位前切除，末段迴腸預防性造口聯合右側卵巢切除術，手術過程順利，，術後病理提示：2017-02-27 1、（直腸，放化療後），切除： - 瘤床充分取材，各層均見粘液湖，散在少量退變的癌細胞簇，間質纖維組織增生，伴炎細胞浸潤，符合治療後反應，AJCC/NCCN TRG ，分級：1級； - 未見脈管癌栓及神經侵犯； - 癌浸潤至肌層外的維脂肪組織。 -（近端）、（遠端）及環周切緣未見癌； - 淋巴結未見癌轉移（腸周0/6、腸繫膜上動脈根部0/1)； - ，腫瘤病理分期：YPT3N0；2、（右卵巢），切除： - 輸卵管副中腎管囊腫雙枚，直徑1.5-2.5CM； - 輸卵管未見特殊； - 未見卵巢組織。術後恢復順利。術後行1週期XELOX化療，，化療後出現嚴重反應：消化道反應IV級，頭暈臥床一週餘，希羅達未口服。改用予更改單藥口服希羅達2.5G，QD,D1-14。已服用希羅達2月，目前已停藥。術後3月行復查行胸部CT檢查見右肺上葉佔位，考慮轉移。1周前複查，血常規、生化、凝血、感篩未見明顯異常，腹部CT未見腫瘤復發或轉移，，腸鏡：未見吻合口狹窄、新生物，直腸及乙狀結腸結腸粘膜充血糜爛，已取病理。，胸部CT見：右肺上葉佔位21MM*16MM，較前增大。現患者為求造口還納收入我院。患者術後一般情況可，飲食、睡眠可，精神食慾可，未見明顯體重變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 5, "end_pos": 11}, {"label_type": "手術", "overlap": 0, "start_pos": 27, "end_pos": 59}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 252}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 291, "end_pos": 300}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 388, "label_type": "藥物", "overlap": 0, "start_pos": 385}, {"end_pos": 404, "label_type": "藥物", "overlap": 0, "start_pos": 401}, {"end_pos": 424, "label_type": "藥物", "overlap": 0, "start_pos": 421}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 441, "end_pos": 445}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 448, "end_pos": 452}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 485, "end_pos": 489}, {"end_pos": 517, "label_type": "解剖部位", "overlap": 0, "start_pos": 515}, {"end_pos": 522, "label_type": "解剖部位", "overlap": 0, "start_pos": 518}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 522, "end_pos": 524}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 537, "end_pos": 541}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 547}]}
{"originalText": "，患者因絕經後陰道出血2015-03-31外院行“診斷性刮宮”，，病理提示：宮腔腺癌，結合鏡檢和免疫組化，考慮來源於宮頸。在我科於2015-04-21在全麻上行“經腹全子宮兩兩側附件切除附件切除術+盆腔淋巴結清掃術”，手術順利，，術後病理提示：宮頸病變診斷為中至低分化腺癌，部分為粘液腺癌，累及宮頸外膜層，未累及陰道穹窿，可見脈管內癌栓及神經束侵犯；萎縮性宮內膜；（左閉孔深淋巴結）9枚，1/9見腺癌轉移。術後診斷“宮頸腺癌IB1期”，有術後放化療指徵。之後患者在我院完成同期放化療，末次治療時間為2015年6月。之後患者定期複查，2015年12月發現CA199 581UMOL/L,PET/CT，檢查提示：，宮頸癌術後放化療後：陰道殘端區域性代謝較活躍，疑復發；腹主動脈右旁淋巴結代謝略活躍，疑轉移。，診斷：宮頸腺癌綜合治療後復發。2016年1月6-7日、2月2-3日及2月26-27日行“TP”方案化療3療程，第3程化療出現II度腹瀉，II度貧血，兩上肢水腫。3程化療後我院CT示腹主動脈右旁淋巴結，可疑轉移瘤。，2016-05-21我院PET-CT：，複發性宮頸癌放療中：陰道病灶代謝較活躍，腹主動脈右旁淋巴結代謝較活躍，疑殘留，請結合臨床；骶前淋巴結代謝較活躍，疑轉移。左上肺斑片影代謝略活躍，疑炎性病變。L4椎體壓縮性骨折。L4/5、L5/S1椎間盤突出。 今為行放療收入我科。發病以來，患者精神、胃納差，大小便無明顯異常，體重無明顯變化。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"label_type": "手術", "overlap": 0, "start_pos": 25, "end_pos": 30}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 42}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "手術", "overlap": 0, "start_pos": 81, "end_pos": 107}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 136}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 149}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 216}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 276, "end_pos": 282}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 292, "end_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 305, "end_pos": 310}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 365}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 422, "end_pos": 424}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 438, "end_pos": 440}, {"end_pos": 450, "label_type": "解剖部位", "overlap": 0, "start_pos": 441}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 470, "end_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 478, "end_pos": 484}, {"end_pos": 490, "label_type": "解剖部位", "overlap": 0, "start_pos": 488}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 498}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 523}, {"end_pos": 541, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 556, "end_pos": 565}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 566, "end_pos": 581}, {"end_pos": 604, "label_type": "解剖部位", "overlap": 0, "start_pos": 603}]}
{"originalText": "，患者2014-12因行體檢發現腫瘤標記物增高，，遂於外院行腸鏡檢查示：乙狀結腸距肛門約16CM處息肉，距肛門60CM結腸肝曲處菜花樣腫物。2015-01-06在我院全麻上行腹腔鏡左半結腸切除術+TEM，，術後病理：（結腸大體）鏡檢為結腸中分化腺癌，浸潤至腸壁漿膜上層，未見明確脈管及神經束侵犯；淋巴結24枚，未見癌。另直腸腫物鏡檢為管狀-絨毛狀腺瘤，部分割槽域呈高級別下皮內腫瘤改變。，免疫組化：ER（-），ERCC1（+），MLH1（+），MSH2（+），MSH6（+），PMS2（+），KI67（70%+）。2015-02-04、03-03、2015-03-30行XELOX方案化療3程，化療後出現周圍神經毒性HFS1度。現為求進一步診治來本院就診併入住本科。患者自發病以來，食慾、睡眠及精神良好，小便正常，體力、體重無明顯上降。", "entities": [{"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 41}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 101}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 117, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 129}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 175}]}
{"originalText": "，患者2009年罹患\\\"左梨狀窩鱗癌\\\"（CT3NOMO）,2009.06.10，2009.07.02予以\\\"DDP 30MG D1-5+5-FU 800MG D1-5+博安黴素10MG D1,3,5\\\"2程新輔助化療後，2009.07.31行\\\"全喉切除術+左頸根治性頸清掃術\\\"。術後病理（426431），：左梨狀窩鱗癌（YPT3N2M0，IVA期）。2009.08.31-2009.10.15行術後輔助放療（原發灶60GY/30次/46DAYS+區域淋巴結50GY/25次/40DAYS）。治療結束後，多次隨訪，頸部MRI提示無轉移及復發表現。2012年01月因\\\"氣管造瘻口見血絲痰1月餘\\\"入我院住院治療，2012年01月18日行\\\"胸腔鏡輔助上右下肺葉切除及縱隔淋巴結清掃術\\\"，，術後病理示：中分化鱗狀細胞癌，PT2AN0M0，IB期。術後恢復順利，治療後多次隨訪無復發。2015-4發現左側頸部腫塊，逐漸增大，入我院複查，，行頸部胸部CT檢查報提示：甲狀腺左葉及後方腫物，淋巴結轉移侵犯甲狀腺？甲狀腺原發惡性腫瘤並淋巴結轉移？右側氣管食管溝及隆突上淋巴結腫大，考慮淋巴結轉移可能性大；胸上段上段食管壁腫物。行胃鏡檢查發現食管多發腫物。，頸部IV區腫物穿刺活檢病理提示：甲狀腺組織見癌浸潤，符合鱗狀細胞癌。，食管右側壁腫物活檢病理提示：中分化鱗狀細胞癌。於2015-05-12、6-3給予力撲素+順鉑+氟尿嘧啶方案化療2程順利，複查CT示SD，2015-06-25繼續完成第3程化療。現按期入院化療。發病以來，患者精神尚可，飲食尚可，二便正常，睡眠尚可，體重上降約2KG。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"end_pos": 58, "label_type": "藥物", "overlap": 0, "start_pos": 55}, {"end_pos": 73, "label_type": "藥物", "overlap": 0, "start_pos": 69}, {"end_pos": 89, "label_type": "藥物", "overlap": 0, "start_pos": 85}, {"label_type": "手術", "overlap": 0, "start_pos": 124, "end_pos": 139}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 156, "end_pos": 177}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"label_type": "手術", "overlap": 0, "start_pos": 322, "end_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 353, "end_pos": 374}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 421, "end_pos": 427}, {"end_pos": 438, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 455, "end_pos": 470}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 471, "end_pos": 485}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 520, "label_type": "解剖部位", "overlap": 0, "start_pos": 518}, {"end_pos": 531, "label_type": "解剖部位", "overlap": 0, "start_pos": 526}, {"end_pos": 545, "label_type": "解剖部位", "overlap": 0, "start_pos": 542}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 554, "end_pos": 559}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 561, "end_pos": 563}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 575, "end_pos": 583}, {"end_pos": 604, "label_type": "藥物", "overlap": 0, "start_pos": 601}, {"end_pos": 607, "label_type": "藥物", "overlap": 0, "start_pos": 605}, {"end_pos": 612, "label_type": "藥物", "overlap": 0, "start_pos": 608}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 623, "end_pos": 625}]}
{"originalText": "，患者2008-8-29因“血便2月”入我院，術前診斷為盲腸癌，完善術前檢查，排除手術禁忌症後於2008-9-3行左半結腸切除術，，術後病理：回盲部中分化腺癌，浸潤至腸壁全層，淋巴結未見癌轉移（0/20），P-T3N0M0 IIA期。術後拒絕進一步行輔助化療，定期隨訪。2013-11-5因“腹痛1周，加重1天”，就診我院門診查腹部CT示：橫結腸腸壁明顯不均勻增厚，考慮腸癌可能性大，侵犯腸周間隙；腸繫膜根部、腹主動脈周圍多發團片影，考慮轉移瘤；，腸鏡：橫結腸近吻合口見一15*15MM腫物，穿刺病理中分化腺癌。，結直腸癌單病種全科會診意見：患者橫結腸癌腹腔多發轉移瘤，考慮手術完整切除腫瘤的可能性小，建議行全身化療。於2013-11-28、2013-12-13、2014-1-7給予FOLFOX方案化療3程，過程順利。第2程化療後出現4度中性粒細胞上降，予G-CSF升白後恢復正常；並出現口腔粘膜潰爛，對症處理後好轉。3程時予行減量化療。今為行上程化療入院，目前患者一般情況尚可，飲食、精神、睡眠可，小便正常，大便每日1次，不成形，無血便，無明顯腹痛、腹脹，無咳嗽發熱等不適，近期體力體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 28, "end_pos": 31}, {"end_pos": 64, "label_type": "手術", "overlap": 0, "start_pos": 57}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 164, "end_pos": 168}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 187}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 200}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 250, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 284}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 370, "end_pos": 375}, {"end_pos": 384, "label_type": "藥物", "overlap": 0, "start_pos": 379}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 395, "end_pos": 397}, {"end_pos": 475, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}]}
{"originalText": "患者於今晨起床時無明顯誘因突然出現頭迷，視物下上晃動，不伴視物旋轉、不伴耳鳴、伴噁心未吐。患者頭迷與頭位、體位無關。於我院急診行頭CT檢查，未見確切異常。給予患者改善腦迴圈、營養腦神經治療。下述症狀好轉。為進一步診治入院，病來無發熱，無頭痛，無意識障礙，無複視，無肢體活動不靈，無肢體麻木。精神狀態可，飲食差，睡眠可，二便正常，近期體重無明顯變化。 血脂高，平素服用血脂康；冠心病6-7年，否認高血壓、糖尿病病史；特發性震顫； 服用他汀類藥物後走路踩棉花感； 2002年因子宮內膜鱗狀下皮異常增生行子宮全切術；。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 64, "end_pos": 67}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 186, "label_type": "藥物", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 187, "end_pos": 190}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 197, "end_pos": 200}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 204}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 238}, {"end_pos": 254, "label_type": "手術", "overlap": 0, "start_pos": 249}]}
{"originalText": "，患者於2012-9-14給予宮頸癌根治術+兩側卵巢切除術，，術後病理回報：（全子宮）宮頸中至低分化鱗狀細胞癌，浸潤宮頸深肌層，累及陰道穹窿部及宮頸管深肌層；脈管內見癌栓；子宮平滑肌瘤；右閉孔淋巴結2/6（+）、左閉孔淋巴結3/8（+），陰道殘端前壁見鱗狀細胞癌浸潤，陰道殘端後壁見鱗狀下皮原位癌，陰道殘端右見可疑癌細胞。患者有外照射、後裝及化療指徵，於2012-09-21予TP（力撲素+順鉑）方案術後輔助化療一程，過程順利。出院後每天均有陰道流血水，少量，每天換3-4張護墊，精神、食慾可，睡眠欠佳。無腹痛、腹瀉、嘔吐、發熱、咳嗽，覺手腳麻木，大小便正常，體重減輕4斤。，既往化療及腫瘤標誌物情況：，化療藥物毒副反應：。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 15, "end_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 58, "end_pos": 60}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 75}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 86, "end_pos": 92}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 131}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 194, "label_type": "藥物", "overlap": 0, "start_pos": 191}, {"end_pos": 197, "label_type": "藥物", "overlap": 0, "start_pos": 195}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}]}
{"originalText": "，2016-11-09順產一活男嬰。2016-11-18複查彩超提示宮腔內異常團塊，35*23MM、51*12MM，2016-12-23複查彩超提示宮腔內異常團塊19*15MM。產後一直惡露不淨。2017-01-31出現陰道出血多，2017-02-04複查彩超提示宮頸部混合回聲團33*25*28MM。2017-02-20複查宮頸實質性低迴聲團30*27*30MM（疑子宮粘膜上肌瘤）,2017-2-21行宮腔鏡上子宮粘膜上腫物切除術，術中見宮頸口一4*4*5CM組織物堵塞，蒂粗，位於子宮上段。術後病理提示骨外尤文肉瘤/原始神經外胚葉腫瘤（ES/PNET）。後病理送**一院會診（宮頸）小圓細胞惡性腫瘤，考慮為軟組織尤文肉瘤可能性大。FISH，檢測結果：EWS基因易位FISH檢測陽性。我科全科討論建議行PET-CT檢查，如無遠處轉移則行手術切除子宮及區域淋巴結，卵巢可保留。PET-CT，提示疑子宮肉瘤術後：子宮上段代謝略活躍，術後改變與殘留鑑別，請結合臨床；盆腔少量積液。子宮內膜區代謝略活躍，左附件區低密度影代謝較活躍，疑生理性改變。兩側乳腺體積增大代謝活躍，結合臨床，符合哺乳期生理性改變。兩腋窩數個小淋巴結代謝略活躍，疑炎性病變。於2017-04-05入我科住院治療，住院期間請骨與軟組織腫瘤科會診後建議先行新輔助化療6程，於2017.4.12-4.16，行AI化療：表柔比星90MG D1+異環磷醯胺3.2G D1-D5。過程順利出院。現患者為進一步診治，收入院。起病以來，患者一般情況良好，睡眠可，食慾好，二便正常，體重無明顯變化。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 135}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 191}, {"end_pos": 217, "label_type": "手術", "overlap": 0, "start_pos": 203}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 243, "end_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 254, "end_pos": 279}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 302}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 309, "end_pos": 313}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 353, "end_pos": 359}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 374}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 389, "end_pos": 395}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 399, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 408}, {"end_pos": 434, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 439, "end_pos": 441}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 450}, {"end_pos": 475, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}, {"end_pos": 503, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 594, "label_type": "藥物", "overlap": 0, "start_pos": 590}, {"end_pos": 607, "label_type": "藥物", "overlap": 0, "start_pos": 602}]}
{"originalText": "，入院前1+月，患者因便血在我院住院治療，行腸鏡、活檢等檢查提示直腸癌，遂在準備充分情況上，於2014.10.29在全麻上行經腹會陰聯合直腸癌根治術，，術中見：腫瘤位於腹膜返折上方，直腸下段，距離肛緣小於6釐米，下段直腸腸壁不規則增厚，長度約為8CM，管腔狹窄，管壁僵硬，漿膜面被腫瘤侵犯，見米粒樣小結節。術後病檢結果（病理號201440454），：<直腸>腺癌，中分化，浸潤全層，腸繫膜下見癌結節，淋巴結見癌轉移，為6/6，近切緣及遠切緣未見癌累及。TNM分期為III期（T3N2M0），有化療指徵，術後患者一般情況恢復可，遂於2014.11.17開始FOLFOX 6 方案化療（奧沙利鉑 150MG D1，亞葉酸鈣 700MG D1，氟尿嘧啶 2G D1-D2）。化療過程中訴精神欠佳、納差、噁心，化療完成後逐漸恢復，化療間期精神、食慾恢復可，無頭昏、頭痛、胸痛、腹痛、四肢痛，大便成形，無血便及黑便。現化療間期已到，為行第2次化療來院。\\U0004   患者本次發病以來，食慾正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，體重無明顯變化。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 32, "end_pos": 35}, {"end_pos": 74, "label_type": "手術", "overlap": 0, "start_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 108, "end_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 175, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 191, "end_pos": 192}, {"end_pos": 295, "label_type": "藥物", "overlap": 0, "start_pos": 291}, {"end_pos": 309, "label_type": "藥物", "overlap": 0, "start_pos": 305}, {"end_pos": 323, "label_type": "藥物", "overlap": 0, "start_pos": 319}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}, {"end_pos": 382, "label_type": "解剖部位", "overlap": 0, "start_pos": 381}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"end_pos": 389, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}]}
{"originalText": "，患者3月前無明顯誘因出現下腹隱痛，用餐後疼痛加重，伴惡性、嘔吐，反酸、噯氣及少量黑便，2月，餘前於外院行胃鏡檢查：考慮胃癌，肺部發現可疑結節；，行PET-CT檢查示：胃癌，左肺多髮結節，FDG代謝無增高，考慮轉移可能性大。，轉來我院行CT檢查示：胃癌，兩肺類結節，考慮炎性病變可能性大。2月25日胃胰科收住入院後按“胃竇癌伴不全梗阻”之診斷於2014年2月28日行“胃癌姑息性切除術”，術中見腫瘤呈浸潤潰瘍型，3×5CM大小，漿膜浸潤S2，並見腫瘤侵犯十二指腸球部及十二指腸韌帶瀰漫性增厚，胃大部切除後行畢II式吻合，手術操作順利，術後恢復順利。，術後病理結果回報：（胃大體）鏡檢為胃中至低分化腺癌（LAUREN，分型：混合型），癌組織侵犯胃壁漿膜上層，可見脈管內癌栓及神經束侵犯；網膜組織未見癌；LN（+）10/31。之後於4月1日入住我科行奧沙利鉑+替吉奧方案化療一程，化療順利，化療後未出現明顯化療副反應。今再來我科求治要求繼續治療。患者近來精神及食慾尚可，無發熱及嘔血黑便，無噁心嘔吐及腹痛，大小便無異常，體重較下次住院減少2.5KG。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 60, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 74, "end_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 84, "end_pos": 86}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 97, "label_type": "藥物", "overlap": 0, "start_pos": 94}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 118, "end_pos": 120}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 124, "end_pos": 126}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 159, "end_pos": 167}, {"end_pos": 192, "label_type": "手術", "overlap": 0, "start_pos": 184}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"label_type": "手術", "overlap": 0, "start_pos": 246, "end_pos": 259}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 292, "end_pos": 315}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 322}, {"end_pos": 377, "label_type": "藥物", "overlap": 0, "start_pos": 373}, {"end_pos": 381, "label_type": "藥物", "overlap": 0, "start_pos": 378}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}]}
{"originalText": "，2011.7.6因胃竇癌手術，，病理：胃竇潰瘍型低分化腺癌，可見脈管癌栓，淋巴結6/16。斷端淨，術後SOX化療4週期，因胃腸反應嚴重，調整為S-1單藥化療4週期。末次化療時間2012.6.。化療期間體重減輕5KG。化療後體重穩定。2012-7-23 複查腹盆CT未見覆發轉移徵象。胸片無異常。7-4胃鏡提示吻合口炎，未見覆發。，超聲：右鎖骨下淋巴結同前。進食可，大小便正常，體重無上降。複查彩超膽囊多髮結石，餘未見腫瘤復發及轉移表現。\\U0004\\U0004   2012.10.複查胸片及腹盆腔B超、頸部B超未見覆發及轉移。2012.11.28複查腫標正常。\\U0004\\U0004   2012.12.12，胃鏡：胃癌遠端胃切除術後，殘胃炎。\\U0004\\U0004  目前患者近1月來，進食後反酸，食慾欠佳。大小便正常。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 20, "end_pos": 30}, {"end_pos": 75, "label_type": "藥物", "overlap": 0, "start_pos": 72}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 129, "end_pos": 133}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 142, "end_pos": 144}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 155, "end_pos": 159}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 199, "end_pos": 205}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 244, "end_pos": 246}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 247, "end_pos": 252}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 253, "end_pos": 257}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 320}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 321, "end_pos": 324}]}
{"originalText": "，患者3年前行胰十二指腸切除術，病理示低分化腺癌。一年前行4次靜脈化療，具體用藥不詳，化療後複查CT發現肝門區轉移，在外院行伽瑪刀治療。隨後在08-02及08-03行介入治療，術中使用奧鉑150MG、氟尿苷1G、砝碼新50MG，2008年12月在我科行第四次介入治療，術中用藥FUDR0.75G、艾恆150MG、THP50MG灌注化療，<?，XML:NAMESPACE PREFIX = O NS = \\\"，URN:，SCHEMAS-MICROSOFT-COM:，OFFICE:OFFICE\\\" />術後患者恢復良好，2009年1月初在我科行第五次介入治療，注入奧鉑150MG，FUDR(氟脲苷）1.0MG，THP50MG灌注化療,術後患者恢復好。為進一步治療入住我科。目前患者無畏寒發熱，無噁心嘔吐，無腹脹腹痛，食納尚可，二便正常，夜眠尚可。", "entities": [{"end_pos": 15, "label_type": "手術", "overlap": 0, "start_pos": 7}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 24}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 48, "end_pos": 50}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 52, "end_pos": 57}, {"label_type": "手術", "overlap": 0, "start_pos": 62, "end_pos": 67}, {"end_pos": 94, "label_type": "藥物", "overlap": 0, "start_pos": 92}, {"end_pos": 103, "label_type": "藥物", "overlap": 0, "start_pos": 100}, {"end_pos": 109, "label_type": "藥物", "overlap": 0, "start_pos": 106}, {"end_pos": 142, "label_type": "藥物", "overlap": 0, "start_pos": 138}, {"end_pos": 150, "label_type": "藥物", "overlap": 0, "start_pos": 148}, {"end_pos": 159, "label_type": "藥物", "overlap": 0, "start_pos": 156}, {"end_pos": 283, "label_type": "藥物", "overlap": 0, "start_pos": 281}, {"label_type": "藥物", "overlap": 0, "start_pos": 289, "end_pos": 298}, {"end_pos": 307, "label_type": "藥物", "overlap": 0, "start_pos": 304}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}]}
{"originalText": "，2016-8-5行經肛直腸腫物切除術。，術後病理：（直腸腫物），切除：- 中分化腺癌，伴粘液腺癌，大小6×XXX5×XXX4CM；- 癌累及固有肌層；- 未見脈管癌栓；- 各切緣未見癌；- ，腫瘤病理分期：PT2NX。，免疫組化結果顯示腫瘤細胞:BRAF(－),CD147(+),CMET(2+),EGFR(2+),HER2(0),KI-67(90%+),MLH1(+＞75%),MSH2(+＞75%),MSH6(+＞75%),PMS2(+＞75%)。術前，MRI：直腸上段前壁可見菜花狀腫物，較大層面約47X37MM（SE5 IM34），長度範圍約42MM（SE3 IM12），病變表面可見較多長T2訊號成分。病變區外膜面光滑，病變上緣向上達肛提肌與直腸交界水平，與肛門內外括約肌及肛提肌分界清；直腸周圍系膜內、直腸下動脈走行區見散在小淋巴結，小於5MM，訊號均勻。2016-9-8開始放療，，計劃瘤床及淋巴引流區：CTV 50GY/25F,2016-9-20放療7次。已經放療21次。目前尿頻。2016-10-14結束放療.2016-11-10化驗CEA8.78NG/ML。", "entities": [{"end_pos": 19, "label_type": "手術", "overlap": 0, "start_pos": 10}, {"end_pos": 29, "label_type": "解剖部位", "overlap": 0, "start_pos": 27}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 236}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 327}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 346, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 350, "end_pos": 352}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 477, "end_pos": 480}]}
{"originalText": "患者1個多月前無明顯誘因出現大便困難，變細，成形，有裡急後重，大便2-3次/天。無伴粘液血便、腹痛、噁心嘔吐等不適。在外院予腸鏡檢查，示距肛26CM乙狀結腸見菜花樣腫物，腸鏡不能透過，病理腺癌；距腫物5CM處見已息肉，大小1X1X0.5CM。CT提示肝臟多發佔位，考慮轉移瘤。於2012-2-20在我院行全麻上行“DIXON+結腸灌洗術”，手術順利,病理示：乙狀結腸中分化腺癌，浸潤至漿膜層，息肉為管狀絨毛狀腺瘤，3/12LN（+），分期PT4N1M1，IV期。術後擬以FOLFOX+AVASTIN方案化療。因術後6周內，於2012.3.12及3.27行FOLFOX方案化療二程，2012.4.16行FOLFOX+AVASTIN化療一程，過程順利。 2012-04-27複查CT評價療效為SD。今為進一步治療入院。下次出院以來，患者每日排便4-5次，成形。無噁心、嘔吐等，無發熱、咳嗽、身目黃染，無骶部痛等，精神可，納眠可，小便無異常，體重上降不明顯。", "entities": [{"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 125, "end_pos": 127}, {"label_type": "手術", "overlap": 0, "start_pos": 157, "end_pos": 168}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 188}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 199, "end_pos": 206}, {"end_pos": 249, "label_type": "藥物", "overlap": 0, "start_pos": 242}, {"end_pos": 314, "label_type": "藥物", "overlap": 0, "start_pos": 307}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 337, "end_pos": 339}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}]}
{"originalText": "，2014-05-27全麻上行左肝部分切除、膽囊切除術。術後予以保肝、靜脈營養、抗感染等治療，患者術後恢復可，已恢復飲食，傷口縫線未拆除，癒合可。，病理回報：中-低分化肝細胞肝癌（II～III級；2灶，直徑2-4CM）；未見脈管癌栓；肝切緣及肝被膜未見腫瘤；膽囊多發性膽固醇息肉，直徑0.1-0.2CM，膽囊粘膜慢性炎。考慮癌活性灶。2014-6-26、2014-7-28於我科行介入治療。，於2014-11-26門診MRI檢查示：肝左葉區域性切除術後，殘餘肝實質內見散在多發稍長T1稍長T1稍長T2訊號T2訊號結節，較大者約9，X7MM：，AFP:54.65(NG/ML),升高明顯，於2014-12-9於我科行介入治療，DSA造影未顯示病灶，行肝臟動脈灌注化療後症狀好轉出院。，於2015-1-28於我院複查：AFP170.8(NG/ML)。於2015-03-18 ，腹部MRI比較：肝左葉區域性切除術後，肝臟介入治療後，殘餘肝實質內散在多發稍長T1稍長T1稍長T2訊號長T2訊號結節較前增多增大，較大者現約21X15MM（SE5 IM10），原約12X8MM（SE11 IM9），增強掃描動脈期強化較前明顯，門脈及延遲期仍呈邊緣強化。(黃)，血清CA19-9測定:甲胎蛋白 369.5(NG/ML)↑,癌胚抗原 3.45(NG/ML),癌抗原199 33.05(U/ML);肝內多發轉移較前進展。現患者為行上一次介入治療入院。患者自發病以來精神、睡眠、食慾尚好，大小便如下述，體重無明顯改變。", "entities": [{"label_type": "手術", "overlap": 0, "start_pos": 15, "end_pos": 27}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 89}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 139}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 216, "end_pos": 225}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 270, "end_pos": 273}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 356, "end_pos": 359}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 385, "end_pos": 390}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 393, "end_pos": 402}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 524, "end_pos": 530}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 533, "end_pos": 537}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 552, "end_pos": 556}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 569, "end_pos": 575}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 588, "end_pos": 594}]}
{"originalText": "，2天前，患者無明顯誘因出現左下腹痛，為隱痛，陣斷性發作，坐立位疼痛好轉，夜間腹脹，伴有噁心，嘔吐，為飯後嘔吐，嘔吐物為胃內容物，伴有反酸，噯氣，伴有燒心，無悶油，無腹瀉，無頭昏頭痛，無發熱盜汗，無咳嗽咳痰，無胸悶心悸。一天前發現小便顏色改變，變為濃茶色，尿量無改變，仍感腹痛，與前一天無改變。來我院門診就診，，行相關檢查示：，肝功：，谷丙轉氨酶：1189Ｕ/L，，穀草轉氨酶：661U/L,，鹼性磷酸酶：201U/L,，γ-谷氨醯胺轉移酶：457U/L,，總膽紅素：85.6μMOL/L,，直接膽紅素：65.9μMOL/L,，σ膽紅素：25.5μMOL/L；，彩超示：1.肝回聲增多，隨訪；2.膽囊摘除術後；3.脾偏大；4.膽管、胰、腎未見異常。，胃鏡示：1.反流性食管炎（2級）；2.淺表性胃炎伴糜爛；3.十二指腸球炎伴糜爛。\\U0004   患者1月前自行服用陰陽五行散（肉桂，苦杏仁，薏仁，蓮米，桑葚），出現下述症狀後停藥，停藥後症狀無好轉。門診以“肝功能減退，胃炎”收入我科。\\U0004 患者本次發病以來，食慾差，神志清，精神佳，睡眠欠佳，小便呈濃茶色，大便顏色正常、不成形，體重無明顯改變。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 39}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 168, "end_pos": 173}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 183, "end_pos": 188}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 197, "end_pos": 202}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 211, "end_pos": 220}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 229, "end_pos": 233}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 246, "end_pos": 251}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 264, "end_pos": 268}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 281, "end_pos": 283}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 298, "end_pos": 304}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 307}, {"end_pos": 315, "label_type": "解剖部位", "overlap": 0, "start_pos": 313}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 316}, {"end_pos": 319, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 337}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 352}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 355, "end_pos": 364}, {"end_pos": 388, "label_type": "藥物", "overlap": 0, "start_pos": 383}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 429, "end_pos": 434}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 435, "end_pos": 437}]}
{"originalText": "1.5月前患者因“下腹脹痛2月，查體發現胰腺佔位5天”入院。入院後完善各項必須化驗檢查，明確胰腺佔位診斷。7月30日手術，探查見胰腺前方組織呈炎性粘連，胰腺質硬，呈慢性炎症改變，腫塊位於胰頭，約5*3CM，包繞腸繫膜下動、靜脈血管，侵及周圍組織，無法根治切除。行胰腺腫瘤射頻消融、無水酒精注射+膽總管十二指腸吻合，胃空腸吻合+膽囊切除術。過程順利,術後給予營養抗炎保肝對症支援治療，病情逐漸恢復，按時拆線切口甲級癒合，後因腹腔積液於8-10行腹腔穿刺術+閉式引流。引出淡黃色腹水，量減少後予以拔除腹腔引流。患者進食後有下腹飽脹感，8-21 行下消化道泛影葡胺造影檢查，提示胃蠕動無力，禁食靜脈營養治療，促進胃功能恢復。後行下消化道造影見胃腸蠕動有改善，進食軟食後無明顯腹部不適，好轉出院。現為術後1.5月，近一週飲食欠佳，下腹飽脹感明顯，為進一步診治今來我院就診，門診以“胰腺腫瘤”收入院。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 20, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 48}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 115}, {"label_type": "手術", "overlap": 0, "start_pos": 131, "end_pos": 168}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 215}, {"label_type": "手術", "overlap": 0, "start_pos": 221, "end_pos": 231}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 271, "end_pos": 281}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 311, "end_pos": 317}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 334, "end_pos": 335}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 386, "end_pos": 390}]}
{"originalText": "，患者2011-5月因“下腹部不適”就診於**三院，胃鏡診斷“胃竇癌”，於2011-5-20**三院行胃癌根治術，，術後病理：中分化腺癌，LN（5/17），PT4AN2AM0,IIIB期，術後予MFOLFOX化療6程（末次化療2011-10-20）。術後恢復可，後定期複查。於2012年6月開始感下腹部,後背部疼痛，疼痛評分6-7分。2012-6-13，外院CT示：胰頭部佔位，遂轉至我院，2012-6-18，我院CT示：胰頭左旁吻合處軟組織影，考慮復發，侵犯胰頭，查CEA 13.34 U/L，AST,ALT,膽紅素，總膽汁酸明顯升高。為進一步治療收入我院外科，腹部超聲示肝內膽管普遍擴張，遂於2012年7月5日行ERCP膽道支架植入術，術後ALT,AST,膽紅素，膽汁酸明顯降低。於2012年7月16日至2012-11-19行S1+LV化療9程。3程及6程後評價為SD。化療中患者感1度乏力，並輕度噁心，無明顯白細胞，血紅素，血小板上降。2012-12-1複查CT示“胰頭區軟組織影，較2012-10-08增大”。評價為PD。患者為晚期胃癌，一線治療進展，遂於2012-12-04、12-21行二線化療FOLFOX方案2程，化療中出現II°噁心嘔吐，對症處理後好轉，近來患者腹部疼痛明顯，現仍予多瑞吉8.4MG 可維持無疼痛約48小時。患者精神可、食納差，雙便正常，病來體重上降十餘斤。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"end_pos": 56, "label_type": "手術", "overlap": 0, "start_pos": 51}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 63, "end_pos": 68}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 179, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 207, "end_pos": 209}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 234, "end_pos": 237}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 248, "end_pos": 251}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 252, "end_pos": 255}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 259}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 260, "end_pos": 264}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 282, "end_pos": 286}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 319, "label_type": "手術", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 322, "end_pos": 325}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 330, "end_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 334, "end_pos": 337}, {"end_pos": 367, "label_type": "藥物", "overlap": 0, "start_pos": 365}, {"end_pos": 370, "label_type": "藥物", "overlap": 0, "start_pos": 368}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 407, "end_pos": 410}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 411, "end_pos": 414}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 415, "end_pos": 418}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 432, "end_pos": 434}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 438}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 468, "end_pos": 472}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 539, "end_pos": 540}, {"end_pos": 552, "label_type": "藥物", "overlap": 0, "start_pos": 549}]}
{"originalText": "，患者於2011年1月28日因“回盲部腫物”行左半結腸切除術，術後病理證實為瀰漫大B細胞淋巴瘤，予\\\"R-CHOP\\\"方案化療六程，定期複查未見明顯復發徵像。2013年3月複查PET/CT，提示：十二指水平段高代謝灶，考慮淋巴瘤浸潤可能。，我院超聲胃鏡檢查示：十二指腸降段起始部腫物，病理提示中分化腺癌。遂於2013-04-25在我院胃胰科行胰十二指腸切除術（WHIPPLE術），術程順利。，術後病理診斷為：十二指腸中分化腺癌（PT2N0M0）。術後*卡培他濱輔助化療5程。後因手足綜合症停藥。2014年4月患者無明顯誘因出現下腹痛，呈陣發性鈍痛，進食後明顯，後可自行逐漸緩解。，於我院行CT示：，十二指腸腺癌術後：吻合口區未見明顯腫瘤復發。腸繫膜區和腹主動脈旁多發淋巴結，考慮腫瘤復發。肝內多發轉移瘤。肝囊腫。於2014-05-30、2014-06-20、2014-07-11予以替吉奧+奧沙利鉑方案化療第1、2、3程。化療過程順利。7月15日開始同期放療計劃採用VMAT，，放療範圍：GTV包括腹腔幹、腹主動脈旁、腸繫膜區腫大淋巴結；CTV為GTV外擴1.0CM，適當避開周圍腸管等危及器官。GTV和CTV均予以劑量45GY/25F。現已放療14次。今患者為進一步診治收入我科。放化療以來，患者無頭暈、頭痛，無咳嗽、咳痰、胸悶、胸痛，精神體力可，食慾可，睡眠一般，大小便正常，體重較前無明顯上降。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 30, "label_type": "手術", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 38, "end_pos": 47}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 88, "end_pos": 94}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 136}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 146, "end_pos": 151}, {"label_type": "手術", "overlap": 0, "start_pos": 171, "end_pos": 189}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 222}, {"end_pos": 230, "label_type": "藥物", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 239, "end_pos": 244}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 294, "end_pos": 296}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 322}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 351}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 352, "end_pos": 355}, {"end_pos": 394, "label_type": "藥物", "overlap": 0, "start_pos": 391}, {"end_pos": 399, "label_type": "藥物", "overlap": 0, "start_pos": 395}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 449}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 453}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 459, "end_pos": 460}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 490, "end_pos": 491}, {"end_pos": 551, "label_type": "解剖部位", "overlap": 0, "start_pos": 550}, {"end_pos": 554, "label_type": "解剖部位", "overlap": 0, "start_pos": 553}, {"end_pos": 564, "label_type": "解剖部位", "overlap": 0, "start_pos": 563}, {"end_pos": 567, "label_type": "解剖部位", "overlap": 0, "start_pos": 566}]}
{"originalText": "患者2個月前因下腹不適及黑便發現胃癌，於2009-11-24在我科行遠端胃癌根治術，術後病理結果為：胃竇小彎側潰瘍型低分化腺癌伴印戒細胞癌，大小4.0×2.6CM，侵及胃壁全層，未侵透漿膜層，可見脈管癌栓，淋巴結可見癌轉移（1/38,第1組0/2，第3組1/11，4SB 0/2，4SD 0/5，第5組0/2，第6組0/5，第7組0/7，第8組0/0，8P 0/3，12組0/0，12A 0/0，14組0/1，系膜前葉0/0），胃斷端及（十二指腸殘端）未見癌；網膜未見特殊。術後恢復順利。術後行2週期輔助化療，方案MFOLFOX7(OXA100MG/M,CF400MG/M,5FU2400MG/M)，過程順利。今天為行術後第三週期化療入院。自發以來精神食慾可，小便正常，體重無明顯上降。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"end_pos": 41, "label_type": "手術", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 269, "label_type": "藥物", "overlap": 0, "start_pos": 266}, {"end_pos": 280, "label_type": "藥物", "overlap": 0, "start_pos": 278}, {"end_pos": 292, "label_type": "藥物", "overlap": 0, "start_pos": 289}]}
{"originalText": "入院前10餘年患者開始出現勞力性心累氣促、伴有胸痛，多為心前區疼痛，無顏面四肢浮腫，無咯粉紅色泡沫痰，患者曾在*******醫院就診，考慮“冠心病、心絞痛”（具體診療情況不詳）。患者近雙年下述症狀發作較頻繁，安靜休息及夜間均有發作，含服“速效救心丸”症狀能緩解。入院前6+小時患者無明顯誘因再次出現心悸心累，自訴胸腹部疼痛，但具體部位及疼痛性質描述不清，無噁心、嘔吐、腹瀉，無畏寒、發熱，無潮熱、盜汗，無尿頻、尿急、尿痛，無喘累、氣促，無端坐呼吸、陣發性呼吸困難等，家屬喂服“消炎利膽片、速效救心丸”後症狀逐漸緩解。入院前3小時患者下述症狀再次加重，呻吟不止，伴有喘累氣促，大汗，仍有胸腹部疼痛，無噁心嘔吐，無腹瀉，無咯粉紅色泡沫痰，無暈厥黑朦，家屬再次喂服“消炎利膽片、速效救心丸”無效，隨後呼叫120。我院120急救人員到達後予以舌上含服“硝酸甘油0.5mg”後接回急救部，查血常規示WBC 6.8×109/l，N 69.9%，PLT179*109/l；腎功、電解質、心肌酶譜、凝血試驗均正常；肌鈣蛋白32.97pg/ml，D-二聚體1.6ug/ml。腹部彩超示肝回聲欠均質；膽囊結石。心電圖提示快速型心房纖顫，完全性右束支傳導阻滯。為進一步診療收入我科住院。患者自發病以來精神、食慾差，大小便未訴異常。近期體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 24}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 35, "end_pos": 37}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 37, "end_pos": 39}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 73}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "藥物", "overlap": 0, "start_pos": 119, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 185}, {"label_type": "藥物", "overlap": 0, "start_pos": 238, "end_pos": 243}, {"label_type": "藥物", "overlap": 0, "start_pos": 244, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 292, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 306}, {"label_type": "藥物", "overlap": 0, "start_pos": 330, "end_pos": 335}, {"label_type": "藥物", "overlap": 0, "start_pos": 336, "end_pos": 341}, {"label_type": "藥物", "overlap": 0, "start_pos": 372, "end_pos": 376}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 394, "end_pos": 397}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 408, "end_pos": 409}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 416, "end_pos": 419}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 449, "end_pos": 453}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 464, "end_pos": 469}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 478, "end_pos": 482}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 490, "end_pos": 494}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 495, "end_pos": 498}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 500, "end_pos": 507}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 508, "end_pos": 518}]}
{"originalText": "入院2+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。1年前在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理，反覆出現黑便，口服“埃索美拉唑腸溶膠囊、雲南白藥膠囊、斑蝥膠囊”等對症處理可緩解。因“黑便、貧血”多次在我科住院給予抑酸止血輸血處理好轉出院。7天前患者再次出現解黑便，每2日1次黑色不成型大便，感頭昏、四肢乏力。在我院門診就診，給予“卡絡黃鈉及蘭索拉唑”治療後無好轉，查血常規：WBC：1.9*10^/9L，HB：47g/L，為進一步治療，門診以“胃癌伴出血，失血性貧血”收入我科。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 227}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 235, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 337, "end_pos": 340}, {"label_type": "手術", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "藥物", "overlap": 0, "start_pos": 380, "end_pos": 389}, {"label_type": "藥物", "overlap": 0, "start_pos": 390, "end_pos": 396}, {"label_type": "藥物", "overlap": 0, "start_pos": 397, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 469}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 471, "end_pos": 473}, {"label_type": "藥物", "overlap": 0, "start_pos": 487, "end_pos": 491}, {"label_type": "藥物", "overlap": 0, "start_pos": 492, "end_pos": 496}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 509, "end_pos": 512}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 524, "end_pos": 526}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 544, "end_pos": 549}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 550, "end_pos": 555}]}
{"originalText": "入院前8年無明顯誘因患者感活動後乏力、氣促，不伴頭昏、頭痛、胸悶、心悸、胸痛、暈厥、黑曚、呃逆、反酸、噯氣、燒心、噁心、嘔吐、腹痛、腹脹、腹瀉、黑便。患者於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中如下症狀反覆發生，多次給予輸血治療後病程好轉。2013年4月*****胸片檢查：兩肺紋理增多，心影輕度增大。心臟彩超：右房、右室稍增大，EF正常。血庫：間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）分鐘遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床；新生兒疾病篩查報告單：新生兒G6PD活性試驗1.56（正常）。肝功：總膽紅素 50umol/L，直接膽紅素 10umol/L，ALT 40U/L，AST 18U/L。診斷“G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”明確。經輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促不適，反覆經輸注洗滌紅細胞後緩解。3天前患者再次出現乏力、氣促，伴腹脹、小便色紅。為求進一步治療今日入我院門診，門診以“G-6-PD酶缺乏症”收入我科。患者此次患病以來，精神狀態差，小便色紅，大便正常，體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 28}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 146, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 175}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 179, "end_pos": 181}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 187, "end_pos": 198}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 321, "end_pos": 332}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 344, "end_pos": 348}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 373, "end_pos": 376}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 383, "end_pos": 386}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 396, "end_pos": 406}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 407, "end_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 414, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 483, "end_pos": 484}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 510, "end_pos": 520}]}
{"originalText": "入院前1+天，患者於受涼後出現咳嗽，未見咳痰，納差，拒絕進食，伴噁心嘔吐胃內容物，吐詞欠清晰，否認嘔血及黑便，否認咯血，否認畏寒發熱，否認寒戰，否認疼痛呻吟，餘症狀不能表述，遂就診我院，急診科查頭胸部CT：1.兩側半卵圓中心及兩側基底節區腔隙性腦梗死，部分為陳舊性腔隙性腦梗死；腦幹陳舊性腔隙性腦梗死。2.腦白質脫髓鞘改變；腦萎縮。3.兩側額頂顳部蛛網膜上腔增寬或硬膜上積液。4.兩側篩竇及額竇炎。5.右肺下葉及兩肺上葉感染性病變，建議結合臨床。6.兩肺下葉陳舊病灶。8.心影稍增大，主動脈壁及冠狀動脈壁鈣化；9.兩側胸膜稍增厚，胸椎骨質增生。10.甲狀腺右葉小結節影。故以“肺部感染”收入我科住院治療。患者自患病以來，精神、飲食、睡眠差，大小便失禁，近期體重無明顯變化。入院前8+年，患者因跌倒於**醫院就診，診斷為腦梗死，之後患者反覆出現頭暈不適，陣性加重，受涼後易誘發加重，自行服用“眩暈片”後症狀可緩解，曾檢查發現頸腦血管狹窄，失去支架植入治療指徵，長期服用“血塞通、阿司匹林腸溶片”控制病情。多次於我院內一科住院治療，診斷“1.腦動脈供血不足 2.腔隙性腦梗死 3.原發性高血壓3級 極高危”，近3+年逐漸出現四肢活動受限，長期臥床，飲水稍嗆咳，偶有主動言語，近1+天病情加重後吐詞欠清晰，大小便失禁。", "entities": [{"label_type": "影像檢查", "overlap": 0, "start_pos": 97, "end_pos": 102}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 105, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 150}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 153, "end_pos": 161}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 162, "end_pos": 165}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 168, "end_pos": 187}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 190, "end_pos": 198}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 215}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 257, "end_pos": 261}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 280}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 288, "end_pos": 292}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 359, "end_pos": 362}, {"label_type": "藥物", "overlap": 0, "start_pos": 395, "end_pos": 398}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 411, "end_pos": 417}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 434, "end_pos": 437}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 438, "end_pos": 445}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 469, "end_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 479, "end_pos": 485}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 488, "end_pos": 500}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 510, "end_pos": 512}]}
{"originalText": "患者入院前2年，無明顯誘因開始出現反覆咳嗽、咳膿痰、活動後氣促，伴兩上肢水腫、腹脹、納差，平臥位時咳嗽明顯，不能耐受日常活動，無畏寒、發熱及潮熱、盜汗，無胸痛、咯血等不適。於我院內二科就診，行胸部CT提示左側胸腔積液，給予抽液及抗炎等治療後症狀好轉出院。但患者依從性差，未規律服藥，此後氣促、咳嗽反覆發作，多次住院治療。患者於2015.10月下述症狀再次加重，於**醫院就診，行心臟彩超提示：全心增大，室壁動度減低，三尖瓣重度返流，卵圓孔未閉。BNP、轉氨酶及腫瘤標誌物異常增高。給予強心、利尿等治療後症狀好轉出院。後患者反覆因下訴症狀多次在我院住院治療。1月前（2017.04.20）患者因再發咳嗽、氣促入院，診斷“1、擴張型心肌病 全心擴大 慢性心功能不全 心功能III級 2、肺部感染 3、胃潰瘍 4.右側膕靜脈血栓形成（急性期）”，建議患者至下級醫院進一步治療靜脈血栓，患者至**醫院行上肢靜脈彩超示上肢靜脈未見血栓,遂回我科繼續治療並症狀好轉出院。入院前10天，患者受涼後感咳嗽、咳痰，氣促症狀加重，活動耐量較前明顯減少，兩上肢水腫明顯，伴腹部不適、頭昏痛，無咯血、胸痛，無發熱、畏寒，無噁心嘔吐、腹瀉等，現患者為進一步治療收治我科。患者此次患病以來精神食慾差，大小便正常，睡眠欠佳，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 36}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 108}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 189, "end_pos": 193}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 197, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 318, "end_pos": 322}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 323, "end_pos": 330}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 338}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 341, "end_pos": 345}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 348, "end_pos": 351}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 368}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 397, "end_pos": 403}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 466, "end_pos": 469}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 475, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 481}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 488, "end_pos": 489}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 504, "end_pos": 505}]}
{"originalText": "入院前10+年患者體檢時發現血壓升高，最高血壓收縮壓達180mmHg，診斷為“原發性高血壓病”，無心悸、氣促、胸悶、胸痛、頭昏、頭痛。在外口服“羅布麻”降壓治療血壓控制差，病程中間斷出現兩上肢水腫，在外口服“利尿藥”後可緩解。偶有心悸，因血壓控制差在“*********”就診，給予“厄貝沙坦氫氯噻嗪片150mg 每次1片每天1次口服，美託洛爾緩釋片47.5mg 每天次1片每天1次口服，右旋氨氯地平片（施慧達）2.5mg 每次1片每天1次口服，麝香保心丸22.5mg 每次2片每天3次口服”等對症治療。監測血壓可。入院前4天飲入冷水後出現腹瀉，每天解10餘次黃色稀水樣便，無粘液膿血便，無腹痛、噁心、嘔吐，無畏寒、發熱。在外口服“止瀉藥”（具體不詳）後腹瀉好轉。入院前2天出現心悸，偶有胸前區壓榨感，伴納差、四肢乏力，感眼花，無黑朦、眩暈，無胸痛、夜間陣發性呼吸困難，無畏寒、發熱，無腹痛、腹脹、噁心、嘔吐。在外口服“麝香保心丸 45mg 每天3次口服、美託洛爾緩釋片47.5mg 每天1次口服”等處理後無緩解。在“*****醫院”就診，查“心電圖提示快速型心房纖顫”，遂來我院就診，為進一步診治，門診以“納差待查，高血壓、心房纖顫”收入我科。病程中精神、飲食較差，大便目前正常，小便正常，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 39, "end_pos": 46}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 55, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 65}, {"label_type": "藥物", "overlap": 0, "start_pos": 72, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 116}, {"label_type": "藥物", "overlap": 0, "start_pos": 142, "end_pos": 151}, {"label_type": "藥物", "overlap": 0, "start_pos": 168, "end_pos": 175}, {"label_type": "藥物", "overlap": 0, "start_pos": 194, "end_pos": 206}, {"label_type": "藥物", "overlap": 0, "start_pos": 223, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 270, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 296}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 339, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 355, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 372, "end_pos": 373}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 393, "end_pos": 394}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 396, "end_pos": 397}, {"label_type": "藥物", "overlap": 0, "start_pos": 410, "end_pos": 415}, {"label_type": "藥物", "overlap": 0, "start_pos": 428, "end_pos": 435}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 472, "end_pos": 475}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 477, "end_pos": 484}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 504, "end_pos": 508}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 509, "end_pos": 512}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 513, "end_pos": 517}]}
{"originalText": "入院前2+年患者反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。後反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。入院前1+年在**醫院就診，行胃鏡及病理活檢提示“胃早癌”，未行手術治療出院。又在**********就診，仍提示“胃早癌”，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理，反覆出現黑便，口服“埃索美拉唑腸溶膠囊、雲南白藥膠囊、斑蝥膠囊”等對症處理可緩解。因“黑便、貧血”多次在我科住院給予抑酸、止血、輸血處理好轉出院。入院前6天患者再次出現解黑便1次，具體量不詳，感頭昏、四肢乏力加重。今日在我院門診就診，查血常規：WBC：1.4*10^/9L，HB：38g/L，為進一步治療，門診以“下消化道出血、胃癌伴出血，肝硬化”收入我科。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 44, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 51}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 97}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 169, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 191}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 199, "end_pos": 203}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 204, "end_pos": 210}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 212, "end_pos": 218}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 232, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 343}, {"label_type": "手術", "overlap": 0, "start_pos": 350, "end_pos": 354}, {"label_type": "藥物", "overlap": 0, "start_pos": 384, "end_pos": 393}, {"label_type": "藥物", "overlap": 0, "start_pos": 394, "end_pos": 400}, {"label_type": "藥物", "overlap": 0, "start_pos": 401, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 471, "end_pos": 472}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 476}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 496, "end_pos": 499}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 511, "end_pos": 513}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 531, "end_pos": 537}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 538, "end_pos": 543}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 544, "end_pos": 547}]}
{"originalText": "入院前16年患者發現血糖高，最高時20mmol/l右左，後給予降糖藥物，未監測血糖，未重視及正規治療。於1+年前因頭昏在我院內一科住院治療，完善檢查後診斷1、腦動脈供血不足2、高血壓病3級極高危組 室間隔增厚3、2型糖尿病 糖尿病腎病 糖尿病周圍神經病變4、腔隙性腦梗死5、高脂血症。給予門冬胰島素早14IU中14IU晚12IU，重組甘精胰島素注射液（長秀霖筆芯） 每次14IU,皮上注射/晚，病程過程中伴有兩眼視物模糊、飛蚊症、視力上降，伴遠段肢體麻木，伴夜尿增多（每晚3次），10月前因“血糖高，兩上肢水腫”於我院住院，診斷為“2型糖尿病  糖尿病眼病  糖尿周圍病神經病變 糖尿病腎病 腎性貧血、原發性高血壓3級極高危 高血壓心臟病 心功能Ⅱ級”。2周前患者無明顯誘因突感頭暈、伴視物旋轉，行走站立不穩，伴舌頭麻木，無耳鳴，無噁心、嘔吐，無肢體偏癱，無口齒不清，無吞嚥困難、飲水嗆咳，自行服用“腦絡通膠囊”後逐漸緩解，當仍感陣發性頭昏不適及舌麻，且反覆出現兩上肢水腫，無乏力、發熱、無頭昏頭痛、無視物旋轉、無心悸氣促、無咳嗽、咳痰、無腹痛、腹瀉，無尿頻、尿急、尿痛，無胸悶、胸痛，無活動後氣促，為進一步治療，今日來我院就診，門診收入我科住院治療。患病來精神、飲食可，大小便如常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 58}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 79, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 99, "end_pos": 104}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 127}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 141}, {"label_type": "藥物", "overlap": 0, "start_pos": 144, "end_pos": 149}, {"label_type": "藥物", "overlap": 0, "start_pos": 165, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 253}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 266, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 278}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 280, "end_pos": 289}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 290, "end_pos": 295}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 301, "end_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 319}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 320, "end_pos": 325}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 339, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 356, "end_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 362, "end_pos": 363}, {"label_type": "藥物", "overlap": 0, "start_pos": 400, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 418, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 424}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 431, "end_pos": 434}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 445, "end_pos": 446}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 447, "end_pos": 448}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 470, "end_pos": 471}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 473, "end_pos": 474}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 487, "end_pos": 488}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 490, "end_pos": 491}]}
{"originalText": "入院前2年患者在院外發現腎功能異常，具體不詳，考慮“高血壓腎病”，予以控制血壓、保護腎功能等治療，院外隨訪腎功能不詳。半年來患者因黑便多次在我院內二科住院，住院檢查診斷“尿毒症 腎性貧血，高血壓腎病，消化道出血，高血壓心臟病、心功能不全，營養不良”，給予輸血、止血、抑酸、糾正心衰等治療後好轉，後期患者自動出院後於**醫院就診，查血肌酐 638umol/L，尿素氮 22.92mmol/L，血常規：血紅蛋白 89g/L，電解質：血鉀 4.70mmol/L等，診斷“慢性腎臟病5期，腎性貧血，消化道出血，高血壓3級很高危、高血壓心臟病，尿路感染，低蛋白血癥”，急診行深靜脈置管，開始行規律血液透析，並給予止血、抑酸、營養支援、穩定血壓、抗尿路感染、對症等治療後好轉，並於03-14行右前臂動靜脈內瘻吻合術，04-06自動出院轉我科行長期維持性血液透析治療，1月來患者間斷解黑便，偶有咳嗽咳痰，並仍感活動後心累，無畏寒發熱，無胸悶胸痛，今日患者無明顯誘因再次發現解3次黑便，量約50-200ml不等，無腹痛腹脹，無噁心嘔吐，無發熱氣促，無心悸胸悶，無兩上肢水腫，為進一步治療，門診以\\\"慢性腎臟病5期 消化道出血\\\"收入我科住院治療。病程中患者精神、飲食一般，大便正常，小便約200ml，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 26, "end_pos": 31}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 106, "end_pos": 112}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 123}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 165, "end_pos": 168}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 179, "end_pos": 183}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 199, "end_pos": 203}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 214, "end_pos": 216}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 232, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 244}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 245, "end_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 259}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 260, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 277}, {"label_type": "手術", "overlap": 0, "start_pos": 340, "end_pos": 351}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 411, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 414}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 449, "end_pos": 450}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 467, "end_pos": 468}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 469, "end_pos": 470}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 473, "end_pos": 476}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 491, "end_pos": 498}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 499, "end_pos": 504}]}
{"originalText": "入院1+年前患者服用“頭痛粉”後解黑色成形大便，共3次，量約250g/次，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院查“Hb32g/L”，診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院住院8次餘，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。2+月前患者因再次解黑便在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。入院1+月前在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。1周前出現全身乏力、活動後心悸不適，無黑便、腹痛、納差、畏寒、發熱。在*******醫院就診查血常規提示HB：49g/L（未見報告）。今日為行輸血治療遂來我科住院，門診以“胃癌”收入我科。病程中精神稍查，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "藥物", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 105, "end_pos": 107}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 129}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 136}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 149}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 211, "end_pos": 217}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 233}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 245}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 246, "end_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 254, "end_pos": 266}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 274, "end_pos": 281}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 354, "end_pos": 357}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 393}, {"label_type": "手術", "overlap": 0, "start_pos": 399, "end_pos": 403}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 437}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 445, "end_pos": 446}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 475, "end_pos": 477}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 509, "end_pos": 511}]}
{"originalText": "患者於入院前2年即開始反覆出現胸痛症狀，有心前區壓榨感，均在活動及進食後出現，不能耐受平地快走，發作後含服“速效救心丸”或休息後可逐漸緩解。病程中曾多次出現突發呼吸困難、大汗、瀕死感，在****醫院等住院治療好轉。1+年前患者進餐後再次突然出現呼吸困難，全身大汗、胸痛，診斷為“冠心病、心力衰竭”，於我科住院，給予擴管、抗血小板聚集、降壓、控制心室率等治療後好轉出院。入院前3月及入院前1月患者因氣促伴呼吸困難在我科住院，心臟彩超提示：右房、右室、左房增大；肺動脈增寬；主動脈瓣鈣化；肺動脈瓣輕度反流；二尖瓣、三尖瓣中度反流；右室收縮功能減退，心包腔積液。經擴冠利尿等治療病情好轉出院。入院前10天患者受涼後出現咳嗽、咳痰，為白色泡沫痰，無發熱、畏寒，無喘累，無心悸、胸悶等不適。自行口服“強力枇杷露”等藥物後自覺咳嗽有所好轉。今日患者感心累氣促加重，伴納差，感心前區緊縮感，持續數分鐘，含服速效救心丸後症狀可緩解，無畏寒發熱，無反酸噯氣，無明顯胸痛，無夜間陣發性呼吸困難，無顏面四肢浮腫。養老院醫生送其入我院，急診科查心電圖：房撲，心率69次/分。指血糖7.9mmol/l。為進一步診治，收治我科。患者此次患病以來精神一般，食慾差，大小便正常，睡眠尚可，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 16}, {"label_type": "藥物", "overlap": 0, "start_pos": 54, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 147}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 211, "end_pos": 215}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 221, "end_pos": 223}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 251, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 258}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 331, "end_pos": 332}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 334, "end_pos": 335}, {"label_type": "藥物", "overlap": 0, "start_pos": 345, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 369, "end_pos": 370}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 381, "end_pos": 384}, {"label_type": "藥物", "overlap": 0, "start_pos": 396, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 424}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 438, "end_pos": 440}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 440, "end_pos": 442}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 460, "end_pos": 463}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 464, "end_pos": 466}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 476, "end_pos": 478}]}
{"originalText": "入院1+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。隨後在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。2天前患者出現解黑色稀便，每天一次，總量約500g,伴頭昏、四肢乏力。在我院門診輸液（卡洛磺、奧美拉唑）後仍解黑便，查：血常規：白細胞數 2.2×10^9/L、紅細胞數 2.57×10^12/L、血紅蛋白濃度 57 g/L。現為進一步治療，門診以“胃癌，失血性貧血”收入我科。病程中精神差，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 235}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 243, "end_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "手術", "overlap": 0, "start_pos": 353, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 404, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 407, "end_pos": 409}, {"label_type": "藥物", "overlap": 0, "start_pos": 420, "end_pos": 423}, {"label_type": "藥物", "overlap": 0, "start_pos": 424, "end_pos": 428}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 441, "end_pos": 444}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 457, "end_pos": 460}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 475, "end_pos": 481}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 501, "end_pos": 503}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 504, "end_pos": 509}]}
{"originalText": "患者入院前1+年（2015.5），無明顯誘因開始出現反覆咳嗽、咳膿痰、活動後氣促，伴兩上肢水腫、腹脹、納差，平臥位時咳嗽明顯，不能耐受日常活動，無畏寒、發熱及潮熱、盜汗，無胸痛、咯血等不適。於我院內二科就診，行胸部CT提示左側胸腔積液，給予抽液及抗炎等治療後症狀好轉出院。但患者依從性差，未規律服藥，此後氣促、咳嗽反覆發作，多次住院治療。患者於2015.10月下述症狀再次加重，於**醫院就診，行心臟彩超提示：全心增大，室壁動度減低，三尖瓣重度返流，卵圓孔未閉。BNP、轉氨酶及腫瘤標誌物異常增高。給予強心、利尿等治療後症狀好轉出院。後患者反覆因下訴症狀在我院住院治療。入院前9天，患者受涼後感咳嗽、咳痰，為白色粘痰，氣促症狀加重，活動耐量較明顯減少，有夜間陣發性呼吸困難，兩上肢水腫明顯，無咯血、胸痛，無發熱、畏寒，無頭暈、頭痛等，並於2天前在我科住院，診斷“1、擴張型心肌病 全心擴大 慢性心功能不全 心功能III級 2、肺部感染 3、胃潰瘍 4.右側膕靜脈血栓形成（急性期）”，建議患者至下級醫院進一步治療靜脈血栓。今日患者出院後至**醫院行上肢靜脈彩超示上肢靜脈未見血栓。現患者為繼續治療肺部感染及心衰收治我科。患者此次患病以來精神食慾差，大小便正常，睡眠欠佳，體重變化不詳。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 86, "end_pos": 87}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 105, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 117}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 198, "end_pos": 202}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 206, "end_pos": 207}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 349, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 360, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 364}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 383, "end_pos": 389}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 390, "end_pos": 394}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 395, "end_pos": 402}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 403, "end_pos": 410}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 413, "end_pos": 417}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 420, "end_pos": 423}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 426, "end_pos": 440}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 474, "end_pos": 480}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 481, "end_pos": 483}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 498, "end_pos": 500}]}
{"originalText": "患者於入院1-月前發現兩上肢浮腫、尿量減少、喘累，到****醫院查血常規： Hb：87g/l，腎功：血肌酐：394umol/L，考慮腎功能不全、腎性貧血，後到**********醫院就診，查腎功：血肌酐：330umol/L，血常規：Hb：89g/l，甲狀旁腺激素 55.5pg/ml，內生肌酐清除率：14.49ml/min，腹部彩超：兩腎結構欠清，實質回聲稍增強，腹腔少量積液；心臟彩超：右室肥厚，少許心包積液；胸部CT平掃：右肺上葉炎症，心臟增大，兩側胸腔積液，給予血液淨化治療、降壓、降糖、糾正貧血、改善迴圈等治療後好轉出院。1天前患者再次出現心悸、胸悶，伴噁心、納差，無咳嗽、咳痰，無腹痛、腹脹，無肉眼血尿，無頭昏、頭痛，無皮上出血、牙齦出血等不適。今為進一步治療，到我院就診，門診收入我科住院治療。患者自患病以來，精神、睡眠可，食慾差，大便正常，小便偏少，量不詳，體重無明顯變化。22年前因手足麻木在當地醫院查血糖升高，值不詳，診斷為2型糖尿病，先後服用格列齊特、消渴丸降糖，偶測血糖20+mmol/L,曾服用二甲兩胍出現噁心、嘔吐停用，後開始出現視物模糊、兩上肢水腫，2年前開始使用優思林降血糖，血糖控制不詳，現改為諾和銳30 16u/早，12u/晚降血糖，血糖控制可。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 38, "end_pos": 40}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 98, "end_pos": 101}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 116, "end_pos": 118}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 142, "end_pos": 149}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 162, "end_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 189, "end_pos": 193}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 201, "end_pos": 205}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 206, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 222}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 278}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 296}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 299}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 312}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 320, "end_pos": 322}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 401}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 409, "end_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 421, "end_pos": 426}, {"label_type": "藥物", "overlap": 0, "start_pos": 431, "end_pos": 435}, {"label_type": "藥物", "overlap": 0, "start_pos": 436, "end_pos": 441}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 444, "end_pos": 446}, {"label_type": "藥物", "overlap": 0, "start_pos": 459, "end_pos": 463}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 483, "end_pos": 486}, {"label_type": "藥物", "overlap": 0, "start_pos": 496, "end_pos": 499}, {"label_type": "藥物", "overlap": 0, "start_pos": 513, "end_pos": 518}]}
{"originalText": "患者於入院前2年即開始反覆出現胸痛症狀，有心前區壓榨感，均在活動及進食後出現，不能耐受平地快走，發作後含服“速效救心丸”或休息後可逐漸緩解。病程中曾多次出現突發呼吸困難、大汗、瀕死感，在****醫院等住院治療好轉。1+年前患者進餐後再次突然出現呼吸困難，全身大汗、胸痛，診斷為“冠心病、心力衰竭”，於我科住院，給予擴管、抗血小板聚集、降壓、控制心室率等治療後好轉出院。入院前3月及入院前1月患者因氣促伴呼吸困難在我科住院，心臟彩超提示：右房、右室、左房增大；肺動脈增寬；主動脈瓣鈣化；肺動脈瓣輕度反流；二尖瓣、三尖瓣中度反流；右室收縮功能減退，心包腔積液。經擴冠利尿等治療病情好轉出院。入院前半月患者受涼後出現咳嗽、咳痰，為白色泡沫痰，無發熱、畏寒，無喘累，無心悸、胸悶等不適。自行口服“強力枇杷露”等藥物後自覺咳嗽有所好轉。入院前1周，患者因下訴症狀在我院住院治療，經治療後好轉出院。今日患者感心累氣促加重，感心前區緊縮感，持續數分鐘，含服速效救心丸後症狀可緩解，無畏寒發熱，無反酸噯氣，無明顯胸痛，無夜間陣發性呼吸困難，無顏面四肢浮腫。養老院醫生送其入我院，為進一步診治，收治我科。患者此次患病以來精神一般，食慾差，大小便正常，睡眠尚可，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "藥物", "overlap": 0, "start_pos": 54, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 147}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 211, "end_pos": 215}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 221, "end_pos": 223}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 251, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 258}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 330, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 333, "end_pos": 334}, {"label_type": "藥物", "overlap": 0, "start_pos": 344, "end_pos": 349}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 398, "end_pos": 399}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 409}, {"label_type": "藥物", "overlap": 0, "start_pos": 421, "end_pos": 426}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 448, "end_pos": 449}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 463, "end_pos": 465}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 465, "end_pos": 467}]}
{"originalText": "入院前5小時，患者躺在廁所背家屬發現呼之不應，無四肢抽搐，無大小便失禁，周圍環境未見嘔吐物，家屬立即送入我院急診科。查心率230次/分，心電圖提示房顫伴快速心室率，血壓測不出，給予維拉帕米5mg靜推後患者心率逐漸上降至120-130次/分，意識逐漸恢復，查血氣分析全套：酸鹼度 7.320、二氧化碳分壓 23 mmHg、氧分壓 145 mmHg、標準碳酸氫根 15.60 mmol/l、乳酸 6.40 mmol/l，血常規：白細胞數 11.2 10^9/L、中性粒細胞百分比 86.24 %，心肌酶譜：穀草轉氨酶 71.0 U/L、肌酸激酶 1569.1 U/L、肌酸激酶同工酶 60 U/L、乳酸脫氫酶 329.4 U/L，腎功：尿素 32.95 mmol/L、肌酐 319.4 μmol/l，高敏肌鈣蛋白：高敏肌鈣蛋白T 353.40 pg/ml，電解質1：鈉 160.4 mmol/、氯 119.6 mmol/l，D_2聚體 2.20 μg/ml。頭部CT提示：左側中葉前回小片密度減低病灶，考慮腦梗死。腦萎縮、腦白質脫髓鞘改變。給予腦苷肌肽靜滴，5%葡萄糖靜滴補液，為進一步診治收治我科。患者此次起病以來精神、食慾、睡眠一般，大小便正常，體力及體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 26}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 68, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 81}, {"label_type": "藥物", "overlap": 0, "start_pos": 90, "end_pos": 94}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 135, "end_pos": 138}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 145, "end_pos": 151}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 160, "end_pos": 163}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 173, "end_pos": 179}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 193, "end_pos": 195}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 212, "end_pos": 216}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 229, "end_pos": 237}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 251, "end_pos": 256}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 266, "end_pos": 270}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 282, "end_pos": 289}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 297, "end_pos": 302}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 316, "end_pos": 318}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 332, "end_pos": 334}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 355, "end_pos": 362}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 381, "end_pos": 382}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 395, "end_pos": 396}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 410, "end_pos": 415}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 427, "end_pos": 431}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 434, "end_pos": 438}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 451, "end_pos": 454}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 455, "end_pos": 458}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 459, "end_pos": 467}, {"label_type": "藥物", "overlap": 0, "start_pos": 470, "end_pos": 474}, {"label_type": "藥物", "overlap": 0, "start_pos": 477, "end_pos": 482}]}
{"originalText": "患者7年前始出現反覆咳、喘，平時咳少許白色泡沫痰，平地活動可耐受，爬坡等活動感氣促明顯。近2年活動後氣促明顯加重，檢查發現左側頸部豌豆大小包塊，無疼痛感，因同期被診斷為“肺結核”故考慮腫塊性質為結核，給予HRZ方案抗結核治療2年後停藥。病程中頸部包塊無增大及縮小，持續無疼痛，未進一步檢查。半年多前患者因活動後氣促加重在***二院住院，完善多項影像學檢查後診斷為“左側肺癌”，家屬放棄積極治療，院外對症治療。出院後左側頸部包塊進行性增大，間斷有隱痛不適。近半年多來，反覆因咳喘症狀加重多次在我科住院治療，給予抗腫瘤、抗感染、止咳平喘、對症治療後症狀好轉出院。入院前3+月患者感顏面部浮腫，程度不重，於我科治療，考慮為下腔靜脈栓塞。給予治療後可消退，現浮腫較重加重。近2月患者反覆因顏面部浮腫及咳嗽、咳痰、氣促、納差較前加重於我科住院，給予抗腫瘤、抗感染、對症治療，症狀部分緩解。最近1次住院患者病情相對穩定於昨日出院，院外患者仍感氣促，伴腹脹、納差，無發熱、畏寒，無明顯咳嗽、咳痰，無心悸、胸悶、胸痛，無腹痛、腹瀉等。家屬撥打我院120接入我院，為進一步診治再次收入我科。本次發病以來患者精神食慾睡眠差，小便量少色黃，腹瀉，稀水樣大便，約5-6次/天。體重變化不明顯。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 182, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 288, "end_pos": 291}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 308, "end_pos": 314}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 340, "end_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 442, "end_pos": 443}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 445, "end_pos": 446}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 448, "end_pos": 449}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 452, "end_pos": 453}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 455, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 509, "end_pos": 510}]}
{"originalText": "1天前患者因“便祕、乏力”到**醫院就診，查：血常規：血紅蛋白濃度 84 g/L ↓、紅細胞壓積 26.9% ↓，腎功：尿素 6.33 mmol/L、肌酐 146.8 μmol/l ↑、尿酸 317.3 μmol/l，凝肝功4：白蛋白 28.6 g/l ↓、球蛋白 29.2 g/l。大便常規：顏色：黑色。性狀：稀。紅細胞：1+，隱血：陽性。心電圖：正常。胸部CT：1.慢性支氣管炎、肺氣腫伴兩肺上葉感染。2.主動脈鈣化。3.兩側胸膜增厚。診斷為\\\"慢性支氣管炎急性發作，高血壓病、腎功能不全、消化道出血\\\"予對症治療（具體治療不詳），住院期間出現解黑色稀便，約10次，每次量約20-50g，後解雙次暗紅色血便，含血凝塊，總量約100g,感頭昏、乏力加重。出現嘔吐可疑褐色胃內容1次，無血凝塊,總量約100g，病程中未訴腹痛、胸痛、呼吸困難、畏寒、發熱、陰道流血等。下述情況無改善，遂建議轉我院就診，要求住院治療。門診測P71次/分，BP：132/73mmhg，門診給予靜脈注射蛇毒血凝酶注射液 2U，蘭索拉唑 40mg 靜脈滴注，為進一步診治，以“消化道出血”收入我科。患者此次患病以來，精神狀態欠佳，小便同前。近期體重無明顯減輕.長期服用頭痛粉，每2-3包/天。", "entities": [{"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 27, "end_pos": 33}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 43, "end_pos": 48}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 60, "end_pos": 62}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 75, "end_pos": 77}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 93, "end_pos": 95}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 129, "end_pos": 132}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 158, "end_pos": 161}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 165, "end_pos": 167}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 171, "end_pos": 174}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 185, "end_pos": 191}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 205, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 217}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 225, "end_pos": 235}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 240}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 241, "end_pos": 246}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 247, "end_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 320, "end_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 360, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 364}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 377, "end_pos": 379}, {"label_type": "藥物", "overlap": 0, "start_pos": 439, "end_pos": 447}, {"label_type": "藥物", "overlap": 0, "start_pos": 451, "end_pos": 455}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 475, "end_pos": 480}, {"label_type": "藥物", "overlap": 0, "start_pos": 521, "end_pos": 524}]}
{"originalText": "患者入院前3天被家屬發現多於活動時心累、氣促，未示意胸悶、胸痛，無明天咳嗽咳痰，無畏寒發熱，無咽痛流涕，無腹脹、無腹痛等其他不適，患者家屬自行給予服用“感冒藥、頭孢”無明顯好轉。入院前半天患者家屬察覺其喘累加重，送至******就診，給予“氨茶鹼、地塞米松、甲潑尼龍”等藥物治療後緩解不明顯，遂來院急診科，急診查心電圖提示快速性房顫。心室率132次/分，ST段改變。查心肌酶譜：穀草轉氨酶 39.6 U/L、肌酸激酶 157.6 U/L、肌酸激酶同工酶 12 U/L、乳酸脫氫酶 283.4 U/L，腎功：尿素 11.67 mmol/L、肌酐 67.3 μmol/l、尿酸 408.3 μmol/l，凝血試驗：國際標準化比值 1.18，電解質1：鉀 3.69 mmol/l，D_2聚體：D_2聚體 30.05 μg/ml，血常規：白細胞數 8.4×10^9/L、血紅蛋白濃度 101 g/L、中性粒細胞百分比 86.84 %，高敏肌鈣蛋白T 46.61 pg/ml；急診血壓 203/141mmHg，給予硝酸甘油靜滴降壓，並靜推呋塞米 20mg後，患者喘累逐漸減輕，為進一步治療收入我科住院。病程中患者精神、飲食一般，大小便正常，體力明顯上降，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 26, "end_pos": 27}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 58}, {"label_type": "藥物", "overlap": 0, "start_pos": 120, "end_pos": 123}, {"label_type": "藥物", "overlap": 0, "start_pos": 124, "end_pos": 128}, {"label_type": "藥物", "overlap": 0, "start_pos": 129, "end_pos": 133}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 156, "end_pos": 159}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 161, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 177, "end_pos": 182}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 189, "end_pos": 194}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 204, "end_pos": 208}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 219, "end_pos": 226}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 234, "end_pos": 239}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 253, "end_pos": 255}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 269, "end_pos": 271}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 284, "end_pos": 286}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 305, "end_pos": 312}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 323, "end_pos": 324}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 343, "end_pos": 348}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 381, "end_pos": 387}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 396, "end_pos": 404}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 414, "end_pos": 420}, {"label_type": "藥物", "overlap": 0, "start_pos": 452, "end_pos": 456}, {"label_type": "藥物", "overlap": 0, "start_pos": 464, "end_pos": 467}]}
{"originalText": "入院前30+年，患者常在受涼後出現咳嗽、咳痰，多為白色泡沫痰，並逐漸出現喘累、氣促，好發於冬春季節，每年累計發病時間超過3月，外院診斷為“慢支炎、肺氣腫”，予以抗感染、止咳平喘等治療後可好轉。患者喘累、氣促症狀逐年加重，並逐漸出現間斷兩上肢水腫，外院考慮為“肺源性心臟病”，未利尿、長期低流量吸氧及吸入劑治療。7+年前，患者喘累、呼吸困難明顯，於外院診斷為“支氣管哮喘”（具體檢查報告及診治經過不詳），開始使用沙丁胺醇氣霧劑治療。入院前3小時，患者受涼後下述症狀較前加重，咳嗽、咳黃白色粘痰，咳痰費力，喘累、氣促、呼吸困難明顯，不能平臥位休息，無畏寒、寒戰、發熱，無頭昏、頭痛，無咯血，無潮熱、盜汗，無噁心、嘔吐，無腹脹、腹痛，無胸悶、胸痛，無尿頻、尿急、尿痛等不適，自行服用“感冒藥”（具體不詳），下述症狀無明顯好轉，遂就診於我院急診科，查血氣分析：PH 7.44，PCO2 40mmHg，PO2 112mmHg，SPO2 99%，予以甲強龍 80mg抗炎平喘、多索茶鹼 0.2g解痙舒張支氣管、布地奈德+異丙託溴銨霧化吸入治療，患者喘累較前稍有緩解，現收入我科進一步治療。患者此次患病以來精神、食慾、睡眠差，大小便正常，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 69, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 73, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "藥物", "overlap": 0, "start_pos": 205, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 283, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 287}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 312}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 316}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 319}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 376, "end_pos": 378}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 384, "end_pos": 388}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 396, "end_pos": 399}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 408, "end_pos": 412}, {"label_type": "藥物", "overlap": 0, "start_pos": 419, "end_pos": 422}, {"label_type": "藥物", "overlap": 0, "start_pos": 432, "end_pos": 436}, {"label_type": "藥物", "overlap": 0, "start_pos": 449, "end_pos": 453}, {"label_type": "藥物", "overlap": 0, "start_pos": 454, "end_pos": 459}]}
{"originalText": "入院前4+年，患者因足底外傷後經久不愈於**醫院就診發現血糖高，明確診斷“2型糖尿病”，患者無典型多飲、多食、多尿、消瘦等不適，口服“二甲兩高、格列齊特、阿卡波糖片”降血糖，偶測空腹血糖13mmol/L右左，餐後血糖未監測。平素飲食控制欠佳，病程中逐漸出現四肢指端面板閃電樣針刺感，無口渴、多飲、多食、多尿，體重無明顯變化，無明顯視力上降、便祕腹瀉交替等。入院前半年因自發性胰腺炎住院治療期間，改諾和銳30 三餐前皮上注射降血糖，院外監測血糖空腹波動於6-9mmol/L右左。入院前1周患者於受涼後出現全身痠痛、多汗、發熱，未測體溫，伴口渴、多飲、多食、多尿，無頭昏、頭痛、流涕、鼻塞，無噁心、嘔吐、反酸、噯氣、燒心，無胸悶、心悸、胸痛，無腹脹、腹痛、黑便等。未特殊診治。入院前3+天下述症狀逐漸加重，今日感口渴、乏力、全身痠痛明顯，自測血糖26.6mmol/L。為進一步診治入院，門診以“2型糖尿病”收入我科。自患病患者精神、食慾差，大便正常，偶有腹瀉，小便正常，體重無明顯變化。有高脂血症，平素未口服降脂藥。1+年前發現“輕度貧血”未特殊診治，入院前3+月因貧血輸血治療。入院前3+月患者於我院行胃鏡示：慢性非萎縮性胃炎，行腸鏡檢查示：結腸息肉。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 37, "end_pos": 42}, {"label_type": "藥物", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "藥物", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 89, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 130}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 173}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 190}, {"label_type": "藥物", "overlap": 0, "start_pos": 198, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 281, "end_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 284, "end_pos": 285}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 310, "end_pos": 311}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 313, "end_pos": 314}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 316, "end_pos": 317}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 320, "end_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 323, "end_pos": 324}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 369, "end_pos": 371}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 395, "end_pos": 400}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 425, "end_pos": 426}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 442, "end_pos": 446}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 463, "end_pos": 467}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 481, "end_pos": 483}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 504, "end_pos": 512}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 520, "end_pos": 524}]}
{"originalText": "入院前9小時患者安靜休息時突然出現噁心、嘔吐，共嘔吐4次，起始2次嘔吐咖啡色胃內容物，內含血凝塊，後嘔吐鮮紅色血液，具體量不詳。伴解黑色糊狀大便3次，具體量不詳。伴心悸，無腹痛、腹脹、反酸、噯氣、燒心，無氣促、胸悶、胸痛，無畏寒、發熱。患者未引起重視，在家口服“阿莫西林、感冒藥”等處理後無緩解。於4小時前進食後再次出現嘔吐1次胃內容物，內含血液及血凝塊，伴心悸、頭昏、出汗，家屬急送入我院急診科，查“心肌酶譜：肌酸激酶同工酶 96 U/L ↑↑、乳酸脫氫酶 466.1 U/L ↑，腎功：尿素 22.82 mmol/L ↑，肝功1：白球比 1.2 ↓、穀草轉氨酶 59.9 U/L ↑、谷氨醯轉肽酶 1684.1 U/L ↑、直接膽紅素 12.3 μmol/l ↑，電解質1：鉀 5.93 mmol/l ↑，血常規：白細胞數 7.8×10^9/L、血紅蛋白濃度 128 g/L ↓、紅細胞壓積 38.2 % ↓，凝血試驗正常。腹部彩超：脂肪肝，脾稍大。”查BP：96/58mmHg，心率104次/分，考慮“下消化道出血，失血性休克”給予“止血、補液擴容抗休克”處理後收入我科治療。病程中患者精神差，進入少許稀飯，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 86, "end_pos": 87}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 106}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 108, "end_pos": 109}, {"label_type": "藥物", "overlap": 0, "start_pos": 131, "end_pos": 135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 183}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 206, "end_pos": 213}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 224, "end_pos": 229}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 245, "end_pos": 247}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 267, "end_pos": 270}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 277, "end_pos": 282}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 294, "end_pos": 300}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 314, "end_pos": 319}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 339, "end_pos": 340}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 359, "end_pos": 362}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 375, "end_pos": 381}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 392, "end_pos": 397}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 414, "end_pos": 418}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 419, "end_pos": 422}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 424}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 454, "end_pos": 460}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 466}]}
{"originalText": "入院前2年於院外發現腎功能異常，具體不詳，考慮“高血壓腎病”，予以控制血壓、保護腎功能等治療，院外隨訪腎功能不詳。半年前患者因黑便於我院內二科住院，經治療後好轉。入院前2月前因噁心嘔吐伴黑便再次於我院內二科住院，檢查診斷“尿毒症 腎性貧血，高血壓腎病，消化道出血，高血壓心臟病、心功能不全，營養不良”，給予輸血、止血、抑酸、糾正心衰等治療後好轉，後期患者自動出院後於**醫院就診，查血肌酐 638umol/L，尿素氮 22.92mmol/L，血常規：血紅蛋白 89g/L，電解質：血鉀 4.70mmol/L等，診斷“慢性腎臟病5期， 腎性貧血，消化道出血，高血壓3級很高危、高血壓心臟病，尿路感染，低蛋白血癥”，急診行深靜脈置管，開始行規律血液透析，並給予止血、抑酸、營養支援、穩定血壓、抗尿路感染、對症等治療後好轉，並於03-14行右前臂動靜脈內瘻吻合術，04-06自動出院，出院後患者間斷解黑便，偶有咳嗽咳痰，並仍感活動後心累，無畏寒發熱，無胸悶胸痛，今日複診透析時，查隱血試驗 弱陽性，為進一步治療，門診以\\\"慢性腎臟病5期 消化道出血\\\"收入我科住院治療。病程中患者精神、飲食一般，大便正常，小便約250ml，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 24, "end_pos": 29}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 114}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 115, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 120, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 126, "end_pos": 131}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 132, "end_pos": 138}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 144}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 145, "end_pos": 149}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 191, "end_pos": 194}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 205, "end_pos": 208}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 225, "end_pos": 229}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 240, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 258, "end_pos": 265}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 267, "end_pos": 271}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 277}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 278, "end_pos": 286}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 287, "end_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 294, "end_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 304}, {"label_type": "手術", "overlap": 0, "start_pos": 367, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 424}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 425, "end_pos": 426}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 437, "end_pos": 441}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 458, "end_pos": 465}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 466, "end_pos": 471}]}
{"originalText": "入院前1+年餘患者出現兩上肢凹陷性水腫，在外院查血肌酐大於300umol/L，彩超示兩腎縮小，診斷為“腎功能不全、高血壓腎病”，予降壓、保腎等治療後好轉出院（具體不詳）。病程中患者未予特殊重視及治療。4月前患者發作心累、氣促、乏力，入*******醫院就診，查血肌酐大於800umol/L，診斷為“慢性腎臟病5期”，行右前臂動靜脈內瘻成形術及左頸內靜脈置管術，後行3次/周維持性血液透析治療，並長期服用“替米沙坦”等藥物控制血壓，收縮壓維持在140-160mmHg；血紅蛋白逐漸上降（具體不詳），長期使用促紅素糾正腎性貧血。2月餘前患者出現咳嗽、咳痰不適，咳黃色膿痰，易咳出，於外院抗感染等治療後好轉（具體不詳）。1月前患者突發心累、氣促不適，在我科診斷“慢性腎臟病5期 腎性貧血、高血壓3級、急性右心衰、高鉀血癥”，予以對症治療後好轉，患者好轉出院後遂轉入我科行維持性血液淨化治療。2天前患者透析治療後自覺心累、氣促加重，伴夜間睡眠障礙，端坐呼吸，無兩上肢水腫，無咯粉紅色泡沫痰，無胸痛、咯血，無發熱、咳嗽，遂今日來我院住院進一步檢查及治療。患者自患病以來，精神、食慾較差，大便正常，小便約500ml/天，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 44}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 51, "end_pos": 56}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 108}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 156}, {"label_type": "手術", "overlap": 0, "start_pos": 159, "end_pos": 179}, {"label_type": "藥物", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 257, "end_pos": 261}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 315}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 328, "end_pos": 335}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 336, "end_pos": 340}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 341, "end_pos": 346}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 347, "end_pos": 352}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 353, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 429}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 442, "end_pos": 443}]}
{"originalText": "入院1+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。隨後在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。1周前患者感頭昏、乏力，面色蒼白，未解黑便，無腹痛、腹脹，無暈厥，門診查 血常規：白細胞數 1.7×10^9/L、血紅蛋白濃度 37 g/L、紅細胞壓積 15.1 %，現為進一步治療，以“胃癌，貧血”收入我科。病程中精神差，飲食可，大便正常，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 235}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 243, "end_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "手術", "overlap": 0, "start_pos": 353, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 400, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 404}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 418, "end_pos": 421}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 434, "end_pos": 440}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 448, "end_pos": 453}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 471, "end_pos": 473}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 474, "end_pos": 476}]}
{"originalText": "患者於入院前2年即開始反覆出現胸痛症狀，有心前區壓榨感，均在活動及進食後出現，不能耐受平地快走，發作後含服“速效救心丸”或休息後可逐漸緩解。病程中曾多次出現突發呼吸困難、大汗、瀕死感，在****醫院等住院治療好轉。1年前患者進餐後再次突然出現呼吸困難，全身大汗、胸痛，診斷為“冠心病、心力衰竭”，於我科住院，給予擴管、抗血小板聚集、降壓、控制心室率等治療後好轉出院。入院前2月患者因氣促伴呼吸困難在我科住院，心臟彩超提示：右房、右室、左房增大；肺動脈增寬；主動脈瓣鈣化；肺動脈瓣輕度反流；二尖瓣、三尖瓣中度反流；右室收縮功能減退，心包腔積液。經擴冠利尿等治療病情好轉出院。入院前1天患者無明顯誘因感心累氣促加重，中下腹疼痛，活動時腹部牽扯痛，感噁心，乾嘔一次，無畏寒發熱，無反酸噯氣，無咳嗽咯痰，無心前區壓榨感，無顏面四肢浮腫，無呼吸困難。家屬護送患者到我院就診，測隨機指血糖7.2mmol/l，心電圖提示竇性心動過速，輕度ST段壓低，T波倒置（V5-6）。為進一步治療以“冠心病 心力衰竭”收入我科。患者此次患病以來精神食慾較差，睡眠一般，大便正常，小便量偏少，伴有輕微尿痛，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "藥物", "overlap": 0, "start_pos": 54, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 138, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 204, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 214, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 225}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 248, "end_pos": 251}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 265, "end_pos": 270}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 317}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 349, "end_pos": 352}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 357, "end_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 359, "end_pos": 361}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 386, "end_pos": 388}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 398, "end_pos": 401}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 403, "end_pos": 409}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 417}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 418, "end_pos": 428}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 437, "end_pos": 440}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 441, "end_pos": 445}]}
{"originalText": "入院1+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。7月前在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。1周前患者開始出現解黑色軟便，總計5次，總量約1000g,感頭昏、四肢乏力。活動後加重,到我院門診輸液治療2天，仍反覆黑便,今日到我科就診,現為進一步治療，門診以“丙肝後肝硬化，胃癌，失血性貧血”收入我科。病程中精神差，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 227}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 235, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 337, "end_pos": 340}, {"label_type": "手術", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 400, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 405}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 452, "end_pos": 458}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 459, "end_pos": 461}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 462, "end_pos": 467}]}
{"originalText": "入院前1+年患者無明顯誘因出現腹脹，無腹痛、腹瀉、黑便，無納差、厭油，無噁心、嘔吐，無反酸、噯氣、燒心。在**醫院就診，完善相關檢查後診斷“乙肝後肝硬化失代償期”，給予“保肝、放腹水、抗病毒”等對症處理後好轉。既往在我院行“胃鏡示：慢性非萎縮性胃炎，輕度食管靜脈曲張可能。乙肝三對：乙肝表面抗原定性 陽性，乙肝核心抗體定性 陽性。乙肝DNA＜5E+02，腹部彩超：肝實質回聲異常，符合肝硬化超聲表現，膽囊壁增厚毛糙，脾大；診斷“肝硬化失代償期”，給予“泮托拉唑抑酸、還原型谷胱甘肽及甘利欣、門冬氨酸鳥氨酸保肝、保護胃黏膜、改善腹脹等對症處理”後好轉出院。院外口服“恩替卡韋片”抗病毒治療。病程中未出現黑便、嘔血、黃疸等。入院前6小時患者突然出現肝區持續性脹痛，無陣發性加重，感左側背部放射痛，與飲食及體位無關。無畏寒、發熱，有噯氣、反酸、燒心，無納差、乏力，無面板黃染。遂來我院就診，門診查腹部彩超示“符合肝硬化改變，膽囊壁增厚粗糙，脾臟輕度增大，腹腔未見積液。”，血常規：血小板數 45 10^9/L。為進一步診治，門診以“肝硬化失代償期”收入我科。病程中精神、飲食欠佳，大小便正常。體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 23}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 70, "end_pos": 80}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 116, "end_pos": 124}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 125, "end_pos": 135}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 141, "end_pos": 149}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 153, "end_pos": 161}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 165, "end_pos": 170}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 209}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 214, "end_pos": 221}, {"label_type": "藥物", "overlap": 0, "start_pos": 226, "end_pos": 230}, {"label_type": "藥物", "overlap": 0, "start_pos": 233, "end_pos": 240}, {"label_type": "藥物", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"label_type": "藥物", "overlap": 0, "start_pos": 245, "end_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 264}, {"label_type": "藥物", "overlap": 0, "start_pos": 282, "end_pos": 287}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 324}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 338, "end_pos": 342}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 395, "end_pos": 399}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 403, "end_pos": 406}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 409, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 424, "end_pos": 426}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 437, "end_pos": 440}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 463, "end_pos": 470}]}
{"originalText": "入院1+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。7月前在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。1周前患者開始出現解黑色軟便，總計3次，總量約800g,感頭昏、四肢乏力。活動後加重,到我院門診輸液治療6天，仍反覆黑便,今日到我科就診,現為進一步治療，門診以“丙肝後肝硬化，胃癌，失血性貧血”收入我科。病程中精神差，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 227}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 235, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 337, "end_pos": 340}, {"label_type": "手術", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 400}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 402, "end_pos": 404}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 451, "end_pos": 457}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 458, "end_pos": 460}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 466}]}
{"originalText": "入院前5月，患者無明顯誘因出現咳嗽，咯白色黏液痰，伴痰中少量帶血，無發熱、咳嗽，無夜間盜汗，在**醫院檢查診斷為“肺癌？”，予以對症治療後好轉，遂到**醫院檢查，完善胸部CT檢查後仍診斷“肺癌及肺部感染”，但細胞分型不詳，未行手術治療，後予以“頭孢、雲南白藥膠囊”等藥物對症治療，好轉出院。曾於2017.1在我院住院查胸部CT：1.左肺下葉近肺門處佔位性病變伴下葉支氣管狹窄、閉塞，考慮肺Ca伴阻塞性肺不張，建議結合臨床。2.肺氣腫徵；兩肺上葉少許感染，建議治療後複查。3.縱隔內及左肺門多個淋巴結影，部分腫大，考慮轉移可能大；兩肺散在細小結節，考慮肺內轉移可能？左側第3後肋骨質轉移，隨訪。4.心包少量積液；左側胸膜增厚或少許積液；主動脈壁及冠狀動脈壁鈣化。5.肝囊腫。6.肝左後葉斑片狀稍低密度影，不除外轉移，建議進一步下腹部CT平掃+增強檢查。因咯血治療效果差到***二院就診診斷：中央型佔位病變。阻塞性肺炎。其後患者仍反覆咳嗽、伴少量咯血，2月前患者感右上肢乏力，活動喘累明顯，今日來我院門診檢查，門診以“肺癌”收入我科進一步檢查及治療。病程中患者精神、飲食差，大、小便正常，體重明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 57, "end_pos": 59}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 83, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 94, "end_pos": 101}, {"label_type": "藥物", "overlap": 0, "start_pos": 122, "end_pos": 124}, {"label_type": "藥物", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 159, "end_pos": 163}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 166, "end_pos": 190}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 193, "end_pos": 203}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 213, "end_pos": 217}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 240}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 264, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 275, "end_pos": 282}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 282, "end_pos": 292}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 298, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 309}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 317, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 332, "end_pos": 335}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 338, "end_pos": 342}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 362, "end_pos": 372}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 401}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 402, "end_pos": 407}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 430, "end_pos": 433}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 457, "end_pos": 459}]}
{"originalText": "入院1+年前患者因反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。2天前出現全身乏力、活動後心悸不適，有頭昏，無意識障礙，解黑色軟便，無腹痛、無噁心、嘔吐，無畏寒、發熱。在我院門診輸液（具體不詳）無好轉，現為進一步治療，門診以“胃癌，消化道出血”收入我科。病程中精神稍查，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 45, "end_pos": 46}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 98}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 105}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 107, "end_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 118}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 179, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 201}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 214, "end_pos": 220}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 222, "end_pos": 234}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 242, "end_pos": 249}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 310, "end_pos": 313}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"label_type": "手術", "overlap": 0, "start_pos": 350, "end_pos": 354}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 387, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 393, "end_pos": 394}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 455, "end_pos": 457}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 458, "end_pos": 463}]}
{"originalText": "入院9+年前無明顯誘因患者感活動後乏力、氣促，無頭昏、頭痛、胸悶，無心悸、胸痛，無暈厥、黑曚，無呃逆、反酸、噯氣，無燒心、噁心、嘔吐，無腹痛、腹脹，無腹瀉、黑便。於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中下述症狀反覆發生，多次給予輸血治療後病情好轉。2013年4月*****檢查：間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）分鐘遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床；新生兒疾病篩查報告單：新生兒G6PD活性試驗1.56（正常），肝功能提示異常（具體不詳），診斷“溶血性貧血，G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”明確，經輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促，多次在我院住院，反覆經輸注洗滌紅細胞後緩解。入院前7天患者再次出現乏力、氣促、精神差，伴心悸，無腹痛、腹瀉、血便。為求進一步治療今日入我院門診，門診以“溶血性貧血”收入我科。病程中精神較差，飲食尚可，大便小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 28}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 34, "end_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 37, "end_pos": 38}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 92, "end_pos": 97}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 153, "end_pos": 164}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 287, "end_pos": 298}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 324, "end_pos": 329}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 330, "end_pos": 340}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 341, "end_pos": 347}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 429, "end_pos": 430}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 433, "end_pos": 434}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 437}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 461, "end_pos": 466}]}
{"originalText": "患者7年前始出現反覆咳、喘，平時咳少許白色泡沫痰，平地活動可耐受，爬坡等活動感氣促明顯。近2年活動後氣促明顯加重，檢查發現左側頸部豌豆大小包塊，無疼痛感，因同期被診斷為“肺結核”故考慮腫塊性質為結核，給予HRZ方案抗結核治療2年後停藥。病程中頸部包塊無增大及縮小，持續無疼痛，未進一步檢查。半年多前患者因活動後氣促加重在***二院住院，完善多項影像學檢查後診斷為“左側肺癌”，家屬放棄積極治療，院外對症治療。出院後左側頸部包塊進行性增大，間斷有隱痛不適。近半年多來，反覆因咳喘症狀加重多次在我科住院治療，給予抗腫瘤、抗感染、止咳平喘、對症治療後症狀好轉出院。入院前3月患者感顏面部浮腫，程度不重，於我科治療，考慮為下腔靜脈栓塞。給予治療後可消退，但反覆出現。1+月前患者再次感顏面部浮腫及咳嗽、咳痰、氣促、納差較前加重於我科住院，給予抗腫瘤、抗感染、對症治療，症狀部分緩解。出院後仍感納差、活動後氣促，可耐受10餘米距離行走。1天前患者氣促、水腫症狀加重，現為求進一步治療來我院住院。本次發病以來患者精神食慾睡眠一般，小便量少色黃，大便次數增多，呈黃色稀便，約2次/天。體重變化不明顯。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 182, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 290}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 338, "end_pos": 341}]}
{"originalText": "無明顯誘因反覆全身疼痛5+年，以頸、腰、兩膝、兩上肢為主，感兩上肢冷痛、麻木，時輕時重，受涼後加重，兩上肢乏力，陣發性頭昏痛，有下肢麻木症狀，視物模糊，長期睡眠差，記憶力減退，無心慌、胸悶、咳嗽、發熱、盜汗等，無間歇性跛行及大小便障礙，先後在*******醫院及我科住院治療診斷為“重度骨質疏鬆症，腰椎間盤突出症、兩膝退行性骨關節炎、老年性痴呆、腔隙性腦梗死”，經治療後症狀緩解（具體不詳）；無誘因以下復發加重7天，為進一步治療，遂來我科就診，門診以“骨質疏鬆症”收治入院。2型糖尿病13年，目前口服阿卡波糖片、格列美脲及甘精胰島素降血糖，明確有糖尿病眼病、糖尿病腎病 糖尿病周圍神經病，目前血糖控制可，病程中患者出現四肢麻木，視物模糊多年，並有感覺異常，上肢發冷。高血壓病史13年，血壓最高180/？mmHg，未規律服藥降壓藥，目前口服坎地沙坦酯片降血壓，自訴血壓控制可，於*******醫院診斷為“原發性高血壓3級 極高危 高血壓性心臟病 ”，1月前活動後心累心悸，自覺心跳明顯，於我院內科住院治療，治療後症狀緩解。患者患病以來精神一般，食慾可，大小便正常，近期無明顯體重減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 20, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 26}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 93}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 149, "end_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 166}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 167, "end_pos": 172}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 173, "end_pos": 179}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 226, "end_pos": 231}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "藥物", "overlap": 0, "start_pos": 250, "end_pos": 255}, {"label_type": "藥物", "overlap": 0, "start_pos": 256, "end_pos": 260}, {"label_type": "藥物", "overlap": 0, "start_pos": 261, "end_pos": 266}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 273, "end_pos": 278}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 279, "end_pos": 284}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 285, "end_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 309, "end_pos": 311}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 330}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 333, "end_pos": 336}, {"label_type": "藥物", "overlap": 0, "start_pos": 369, "end_pos": 375}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 401, "end_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 414, "end_pos": 421}]}
{"originalText": "患者入院前1+年（2015.5），無明顯誘因開始出現反覆咳嗽、咳濃痰、活動後氣促，伴兩上肢水腫、腹脹、納差，平臥位時咳嗽明顯，不能耐受日常活動，無畏寒、發熱及潮熱、盜汗，無胸痛、咯血等不適。於我院內二科就診，行胸部CT提示左側胸腔積液，給予抽液及抗炎等治療後症狀好轉出院。但患者依從性差，未規律服藥，此後氣促、咳嗽反覆發作，多次住院治療。患者於2015.10月下述症狀再次加重，於**醫院就診，行心臟彩超提示：全心增大，室壁動度減低，三尖瓣重度返流，卵圓孔未閉。BNP、轉氨酶及腫瘤標誌物異常增高。給予強心、利尿等治療後症狀好轉出院。入院前2小時，患者咳嗽、氣促症狀再次發作，伴劍突上疼痛，無咯血、胸痛及端坐呼吸，無兩上肢水腫等不適，遂為進一步治療就診於我院，急診查胸片示：1.左上肺感染，結合臨床或必要時複查。2.左側胸腔少量積液；左膈面似稍抬高，結合臨床或必要時進一步CT檢查。3.心影增大，主動脈弓鈣化。4.胸椎骨質增生。併為進一步治療，以“擴張型心肌病 心功能衰竭 肺部感染”收入我科住院。患者此次患病以來精神食慾差，大小便正常，睡眠尚可，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 86, "end_pos": 87}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 105, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 111, "end_pos": 117}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 198, "end_pos": 202}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 206, "end_pos": 207}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 311}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 333, "end_pos": 335}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 339, "end_pos": 344}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 358, "end_pos": 366}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 367, "end_pos": 370}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 386, "end_pos": 390}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 393, "end_pos": 394}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 398, "end_pos": 402}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 407, "end_pos": 413}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 424, "end_pos": 430}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 436}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 437, "end_pos": 441}]}
{"originalText": "10+小時前，患者進食油膩食物後出現腹痛，以中下腹為著，呈持續性脹痛，伴陣發性加劇，伴大汗淋漓，伴噁心、嘔吐4-5次，嘔吐物為胃內容物，非噴射狀，無咖啡色及膽汁樣液體，無畏寒、發熱、心悸、胸悶、胸痛，無咳嗽、咯痰、呼吸困難，無腹瀉、解黑大便。在“***醫院”輸液治療（具體藥物及劑量不詳）後無明顯緩解，遂由我院120急救入院，急診行腹部彩超：脂肪肝；胰頭增大，胰周積液，建議結合澱粉酶檢查密切隨訪；膽囊壁毛糙；脾大。腹腔積液。電解質2：鉀 3.74 mmol/l、鈉 135.7 mmol/、氯 101.8 mmol/l、葡萄糖：21.63 mmol/l，血澱粉酶：326.7U/L 乳糜血，血常規：白細胞數 9.6 10^9/L、紅細胞數 4.88 10^12/L、中性粒細胞百分比 83.31 %、中性粒細胞絕對值 8.02 10^9/L，尿常規：酮體++，蛋白+-，葡萄糖：++++ 比重：1.020 尿胰蛋白酶原-II 陽性，尿澱粉酶L:1260.5U/L。急診以“急性重症胰腺炎”收住我科。自發病以來，患者神志清晰，精神差，未進食，小便正常，未解大便，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 98}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 114}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 166, "end_pos": 170}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 171, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 177}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 202}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 212}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 218, "end_pos": 219}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 232, "end_pos": 233}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 246, "end_pos": 247}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 261, "end_pos": 264}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 278, "end_pos": 282}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 300, "end_pos": 303}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 316, "end_pos": 319}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 334, "end_pos": 342}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 351, "end_pos": 359}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 376, "end_pos": 378}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 381, "end_pos": 383}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 386, "end_pos": 389}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 395, "end_pos": 397}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 404, "end_pos": 413}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 417, "end_pos": 422}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 437, "end_pos": 444}]}
{"originalText": "入院前10+年患者反覆出現咳嗽、咳痰，多於冬春季及受涼後發作，抗感染治療有效，每年發作超過3個月。入院前6+年開始出現咳嗽咳痰時伴喘累，逐漸出現活動後心累，病情穩定期可耐受短距離平地慢步活動。反覆多次於我院住院治療，2017-12-08再次加重於我科住院，診斷“1.慢性阻塞性肺疾病  急性加重期  肺源性心臟病 II型呼吸衰竭，呼吸性酸中毒合併代謝性鹼中毒 代償期，肺性腦病；2.支氣管擴張伴感染；3.胸腔積液；4、肺大泡；5、冠狀動脈粥樣硬化性心臟病  缺血性心肌病型  心房纖顫 心包積液 心力衰竭 心功能III級；6.前列腺增生症；7、尿路感染。”，給予抗感染、平喘、化痰等治療後好轉出院。入院前1天，患者氣喘加重，進食及穿衣感明顯喘累，不能耐受平地一般活動，夜間需高枕臥位休息，無畏寒、發熱，無明顯咳嗽咳痰，無潮熱、盜汗，無胸痛、咯血，無心慌、胸悶，無噁心、嘔吐，無腹脹、腹痛，無顏面四肢浮腫等不適，今為求進一步治療來我院就診，門診以“慢性阻塞性肺疾病 肺源性心臟病”收入我科。本次發病以來患者精神食慾較差，大便如常，小便色黃，睡眠一般，體力明顯上降，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 141}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 143, "end_pos": 148}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 150, "end_pos": 156}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 157, "end_pos": 164}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 165, "end_pos": 183}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 184, "end_pos": 188}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 191, "end_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 229, "end_pos": 236}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 238, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 243, "end_pos": 247}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 248, "end_pos": 252}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 253, "end_pos": 260}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 269}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 367, "end_pos": 368}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 377, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 388, "end_pos": 389}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 391, "end_pos": 392}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 395, "end_pos": 397}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 397, "end_pos": 399}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 423, "end_pos": 431}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 432, "end_pos": 438}]}
{"originalText": "1年前患者無明顯誘因解黑色成形大便，量約250g/次，伴頭昏、乏力、面板黏膜蒼白，無嘔血、腹痛、腹脹、腹瀉，無反酸、噯氣、燒心，無口乾、顏面肢體水腫、腹圍增大。於我院查“Hb32g/L”，診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。3月前，患者無明顯誘因再次出現解黑便，為黑色糊狀大便，每天1次，每次量約100-150g，伴頭昏、乏力、心悸。於我院查“Hb 53 g/L，無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。1天前，患者無明顯誘因再次出現解黑大便1次，黑色成形大便，量約100g，無黏液膿血，無暈厥、黑朦、意思喪失。今晨再次解黑色軟便約50g。於我院門診查大便常規：黑色 軟便，隱血試驗 陽性。為進一步就診，遂於我院就診，擬“下消化道出血”收入住院。病程中精神、睡眠欠佳，飲食尚可，大便如下述，小便正常。體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 45, "end_pos": 46}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 70}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 85, "end_pos": 87}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 100, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 112, "end_pos": 116}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 118, "end_pos": 121}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 123, "end_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 214}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 219, "end_pos": 220}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 227, "end_pos": 229}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 242, "end_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 262, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 272, "end_pos": 276}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 277, "end_pos": 283}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 285, "end_pos": 297}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 407, "end_pos": 411}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 418, "end_pos": 422}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 442, "end_pos": 448}]}
{"originalText": "入院前1+年患者無明顯誘因反覆出現兩上肢水腫，間斷出現鼻衄，無心悸、氣促，無胸悶、胸痛，無厭油、納差、黃疸、消瘦，無面板瘀斑瘀點，無腹痛、腹脹、腹瀉，無噁心、嘔吐，無血尿、膿尿，在外院就診具體不詳。入院前2月無明顯誘因出現腹脹，無腹痛、反酸、噯氣、燒心，於2015-08-28在“*******醫院”就診，查“腹部彩超：肝實質回聲不均質增強，脾大，門脈系增寬。下腹部CT：肝硬化，門脈高壓並胃底-食道上段靜脈曲張、脾大。腹膜水腫增厚，腹腔中量積液，慢性肝病性膽囊。乙肝提示小三陽。肝功：白蛋白：25.5g/L。凝血：凝血酶原時間：23.4秒，APTT：43.7秒。血常規：血小板：21*10^9/L，HB：91g/L，WBC：2.96*10^9/L。”，診斷為“乙肝後肝硬化失代償期，低白蛋白血癥。”，給予“保肝、輸人血白蛋白、糾正貧血、抑酸”等對症處理後緩解出院。院外口服“中藥”治療，口服中藥後解暗褐色稀糊狀大便，無噁心、嘔血。入院前1天患者再次覺腹脹明顯，無腹痛、噁心、嘔吐，遂來我院住院治療，門診以“肝硬化”收入我科。病程中精神、飲食尚可，大小便正常，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 28}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 41, "end_pos": 42}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 116}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 155, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 161}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 176}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 180, "end_pos": 185}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 189}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 190, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 217, "end_pos": 223}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 224, "end_pos": 231}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 243, "end_pos": 246}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 258, "end_pos": 264}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 271, "end_pos": 275}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 286, "end_pos": 289}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 300, "end_pos": 302}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 309, "end_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 341}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 348}, {"label_type": "藥物", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 427}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 432, "end_pos": 433}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 454, "end_pos": 457}]}
{"originalText": "入院前8年無明顯誘因患者感活動後乏力、氣促，不伴頭昏、頭痛、胸悶、心悸、胸痛、暈厥、黑曚、呃逆、反酸、噯氣、燒心、噁心、嘔吐、腹痛、腹脹、腹瀉、黑便。患者於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中如下症狀反覆發生，多次給予輸血治療後病情好轉。2013年4月*****檢查：間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）分鐘遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床；新生兒疾病篩查報告單：新生兒G6PD活性試驗1.56（正常）。肝功能提示輕度異常。診斷“G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”明確。經輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促不適，反覆經輸注洗滌紅細胞後緩解。7天前患者再次出現乏力、氣促，伴胸悶、腹脹，無腹痛、腹瀉、血便、血尿。為求進一步治療今日入我院門診，門診以“G-6-PD酶缺乏症”收入我科。患者此次患病以來，精神狀態差，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 28}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 149, "end_pos": 160}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 283, "end_pos": 294}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 316, "end_pos": 326}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 327, "end_pos": 333}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 334, "end_pos": 339}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 404}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 407}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 410, "end_pos": 411}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 414}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 441, "end_pos": 451}]}
{"originalText": "入院前1年餘患者出現兩上肢凹陷性水腫，在外院查血肌酐大於300umol/L，彩超示兩腎縮小，診斷為“腎功能不全、高血壓腎病”，予降壓、保腎等治療後好轉出院（具體不詳）。病程中患者未予特殊重視及治療。5月前患者發作心累、氣促、乏力，入*******醫院就診，查血肌酐大於800umol/L，診斷為“慢性腎臟病5期”，行右前臂動靜脈內瘻成形術及左頸內靜脈置管術，後行3次/周維持性血液透析治療，並長期服用“替米沙坦”等藥物控制血壓，收縮壓維持在140-160mmHg；血紅蛋白逐漸上降（具體不詳），長期使用促紅素糾正腎性貧血。後患者多次因突發心累、氣促，入我院予對症治療後好轉出院，出院後遂轉入我科行維持性血液淨化治療。2天前患者透析治療後自覺心累、氣促明顯，如走平路十餘步即感心累、氣促，伴胸悶，常在活動時發作，持續約十幾分鍾或含服速效救心丸可好轉，伴夜間睡眠障礙，無兩上肢水腫，無咯粉紅色泡沫痰，無胸痛、咯血，無發熱、咳嗽。2小時前患者感心累、氣促明顯加重。遂來我院住院進一步治療。患者自患病以來，精神、食慾較差，大便正常，小便約300-400ml/天，體重無明顯改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 23, "end_pos": 26}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 38, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 41, "end_pos": 43}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 50, "end_pos": 55}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 56, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 106, "end_pos": 107}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 129, "end_pos": 132}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 148, "end_pos": 155}, {"label_type": "手術", "overlap": 0, "start_pos": 158, "end_pos": 178}, {"label_type": "藥物", "overlap": 0, "start_pos": 201, "end_pos": 205}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 256, "end_pos": 260}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 269, "end_pos": 270}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 320, "end_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 338}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 345}, {"label_type": "藥物", "overlap": 0, "start_pos": 365, "end_pos": 370}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 386}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 400}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}]}
{"originalText": "5小時前無明顯誘因患者解暗紅色血便2次，約250ml,伴心悸，無頭暈、黑曚，無腹痛，無裡急後重、肛門墜脹，無反酸、噯氣、燒心，無嘔血，無意識喪失，自訴近1月兩上肢輕度凹陷性水腫，未引起重視。急診120接入院，入院後解暗紅色血便150ml,急查肝功2：TP 60.9 g/l、ALB 30.0 g/l ↓、ALT 28.1 U/L、AST 54.0 U/L ↑、GGT 289.2 U/L ↑，電解質1：K 2.56 mmol/l ↓、Na 136.5 mmol/ ↓、Cl 95.2 mmol/l ↓，血型：ABO \\\"B\\\"型、RhD 陽性，血常規：WBC 2.6 10^9/L ↓、HGB 63 g/L ↓、PLT 56 10^9/L ↓、NEUT% 64.30 %、HCT 20.3 % ↓、MCV 79.0 fL ↓、MCH 24.5 pg ↓、MCHC 310 g/L ↓，腎功、凝血象無明顯異常。下腹部彩超：脂肪肝；脾大；腹腔少量積液。為進一步診治，門診以“中度貧血，消化道出血”收入我科。患者此次患病以來，精神狀態欠佳，小便正常，大便如下。體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 81}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 125, "end_pos": 127}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 137, "end_pos": 140}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 152, "end_pos": 155}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 165, "end_pos": 168}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 180, "end_pos": 183}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 217, "end_pos": 219}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 234, "end_pos": 236}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 254, "end_pos": 257}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 265, "end_pos": 268}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 276, "end_pos": 279}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 293, "end_pos": 296}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 322, "end_pos": 327}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 336, "end_pos": 339}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 349, "end_pos": 352}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 363, "end_pos": 366}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 377, "end_pos": 381}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 404, "end_pos": 409}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 410, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 414, "end_pos": 415}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 417, "end_pos": 423}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 435, "end_pos": 439}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 440, "end_pos": 445}]}
{"originalText": "患者7年前始出現反覆咳、喘，平時咳少許白色泡沫痰，平地活動可耐受，爬坡等活動感氣促明顯。近2年活動後氣促明顯加重，檢查發現左側頸部豌豆大小包塊，無疼痛感，因同期被診斷為“肺結核”故考慮腫塊性質為結核，給予HRZ方案抗結核治療2年後停藥。病程中頸部包塊無增大及縮小，持續無疼痛，未進一步檢查。半年前患者因活動後氣促加重在***二院住院，完善多項影像學檢查後診斷為“左側肺癌”，家屬放棄積極治療，院外對症治療。出院後左側頸部包塊進行性增大，間斷有隱痛不適，偶給予口服止痛藥物可有效緩解疼痛。近半年來，患者反覆因咳喘症狀加重多次在我科住院治療，給予抗腫瘤、抗感染、止咳平喘、對症治療後症狀好轉出院。入院前2月患者感顏面部浮腫，程度不重。1月前患者感顏面部浮腫及咳嗽、咳痰、氣促較前加重於我科住院，給予抗腫瘤、抗感染、對症治療，症狀部分緩解。入院前3小時，患者無明顯誘因咳嗽、咳痰加重，為白色粘稠痰，伴喘累不適，無發熱、畏寒，無心悸、胸悶、胸痛，無腹痛、腹瀉，現為求進一步治療來我院。本次發病以來患者精神食慾睡眠一般，小便量少色黃，大便次數增多，約4-5次/天。體重變化不詳。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 65}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 206, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 324}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 410, "end_pos": 411}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 414}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 416, "end_pos": 417}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 420, "end_pos": 421}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 424}]}
{"originalText": "患者於入院前1天，患者受涼後出現發熱、精神萎靡，無咳嗽、咽痛、畏寒、寒戰等不適，遂就診於當地診所，測體溫提示：39.5℃，給予“頭孢呋辛”等治療後症狀無好轉。患者出現嗜睡，呼之有反應，不能應答，無四肢抽搐、大小便失禁、口吐白沫等，遂就診於我院急診科，測體溫：41℃，出現寒戰、抽搐，無口吐白沫、大小便失禁及意識喪失等不適、肢體偏癱等不適。查頭顱CT及胸部CT提示：右側頂部蛛網膜上腔增寬，腦萎縮，兩上肺感染，縱膈可見小淋巴結，兩側胸膜稍增厚。血氣分析+乳酸：酸鹼度 7.530 ↑、二氧化碳分壓 33.6 mmHg ↓、鹼剩餘，5mmol/l ↑，高敏肌鈣蛋白T 33.02 pg/ml ↑，血常規：白細胞數 12.2 10^9/L ↑、中性粒細胞絕對值 8.76 10^9/L ↑，超敏C反應蛋白 <1 mg/l。給予“腦苷激肽、神經節苷脂、甘露醇、奧美拉唑、清開靈、安定”等治療後，未再發熱，仍意識欠清，呈嗜睡狀，呼之有反應，可簡單對答，遂為進一步治療，以“肺部感染”收入我科住院治療。患者自發病以來精神、食慾欠佳，睡眠可，大小便未訴異常。近期體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "藥物", "overlap": 0, "start_pos": 64, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 100}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 170, "end_pos": 174}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 175, "end_pos": 179}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 191}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 194, "end_pos": 197}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 198, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 217}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 229, "end_pos": 232}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 241, "end_pos": 247}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 260, "end_pos": 263}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 274, "end_pos": 281}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 300, "end_pos": 303}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 319, "end_pos": 327}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 342, "end_pos": 349}, {"label_type": "藥物", "overlap": 0, "start_pos": 361, "end_pos": 365}, {"label_type": "藥物", "overlap": 0, "start_pos": 366, "end_pos": 371}, {"label_type": "藥物", "overlap": 0, "start_pos": 372, "end_pos": 375}, {"label_type": "藥物", "overlap": 0, "start_pos": 376, "end_pos": 380}, {"label_type": "藥物", "overlap": 0, "start_pos": 381, "end_pos": 384}, {"label_type": "藥物", "overlap": 0, "start_pos": 385, "end_pos": 387}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 435}]}
{"originalText": "入院前1+年患者無明顯誘因反覆下腹陣發性疼痛，無放射痛，伴腹脹、反酸、噯氣，進食後明顯，同時出現乏力、勞累感、全身浮腫，無噁心、嘔吐，無胸悶、心悸，無咯血、發熱。入院前1+月前患者因腹痛、乏力、全身浮腫在我科住院，作下腹部CT提示胃小彎及胃竇壁不規則增厚，部分向腔內突入的軟組織影，伴胃竇腔變窄，考慮惡性腫瘤可能大，不完全除外淋巴瘤；腹腔較多積液，下腹部腸壁增厚、水腫；左側腎下腺結節影，右側腎下腺稍增粗，考慮轉移？腺瘤均不除外；左腎下極較大囊腫；右腎小囊腫；兩上肺感染，兩側胸腔少量積液；胸椎及腰椎骨質增生，胸、腹主動脈壁鈣化，因患者一般情況差未做胃鏡及病理檢查，診斷為“1、胃惡性腫瘤 2、中度貧血 3、肺部感染 4、重度營養不良”，予奧美拉唑抑酸，溴己新祛痰，強力枇杷露止咳，螺內酯、呋塞米利尿消腫治療後好轉出院。入院前10天患者下腹疼痛加重，伴腹脹、納差、乏力，伴頭昏、乏力、心累氣促，仍有四肢水腫，無咯血、發熱、夜間端坐呼吸，無腹瀉、黑便，現為進一步治療，門診以“胃惡性腫瘤”收入我科住院治療。病程中患者精神、飲食、睡眠差，大小便正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 108, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 145}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 177}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 179}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 190}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 199}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 208, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 215, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 226}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 230, "end_pos": 235}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 236, "end_pos": 244}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 245, "end_pos": 254}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 255, "end_pos": 264}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 289, "end_pos": 294}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 297, "end_pos": 301}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 304, "end_pos": 308}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 311, "end_pos": 317}, {"label_type": "藥物", "overlap": 0, "start_pos": 320, "end_pos": 324}, {"label_type": "藥物", "overlap": 0, "start_pos": 327, "end_pos": 330}, {"label_type": "藥物", "overlap": 0, "start_pos": 333, "end_pos": 338}, {"label_type": "藥物", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"label_type": "藥物", "overlap": 0, "start_pos": 345, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 368, "end_pos": 370}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 376, "end_pos": 377}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 386, "end_pos": 387}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 393}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 437, "end_pos": 442}]}
{"originalText": "8+年前無明顯誘因患者感活動後乏力、氣促，不伴頭昏、頭痛、胸悶、心悸、胸痛、暈厥、黑曚、呃逆、反酸、噯氣、燒心、噁心、嘔吐、腹痛、腹脹、腹瀉、黑便。患者於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中如下症狀反覆發生，多次給予輸血治療後病情好轉。2013年4月*****檢查：間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）分鐘遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床；新生兒疾病篩查報告單：新生兒G6PD活性試驗1.56（正常）。肝功能提示異常。診斷“G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”明確。經輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促，反覆經輸注洗滌紅細胞後緩解。7天前患者再次出現乏力、氣促、精神差，伴血尿，無腹痛、腹瀉、血便。為求進一步治療今日入我院門診，門診以“G-6-PD酶缺乏症”收入我科。患者此次患病以來，精神狀態差，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 26, "end_pos": 27}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 35, "end_pos": 36}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 92}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 148, "end_pos": 159}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 282, "end_pos": 293}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 323}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 324, "end_pos": 330}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 331, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 407}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 434, "end_pos": 444}]}
{"originalText": "入院1+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。6月齊納在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。1天前患者出現解黑色軟便1次，總量約500g,感頭昏、四肢乏力。活動後加重,自服雲南白藥,今日到我院就診,現為進一步治療，門診以“胃癌，失血性貧血”收入我科。病程中精神差，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 202, "end_pos": 206}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 207, "end_pos": 213}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 227}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 235, "end_pos": 242}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 338, "end_pos": 341}, {"label_type": "手術", "overlap": 0, "start_pos": 347, "end_pos": 351}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 395, "end_pos": 396}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 398, "end_pos": 400}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 436, "end_pos": 438}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 439, "end_pos": 444}]}
{"originalText": "入院前10月，患者服用“頭痛粉”後解黑色成形大便，共3次，量約250g/次，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院查“Hb32g/L”，診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。2月前，患者無明顯誘因再次出現解黑便，為黑色糊狀大便，每天1次，每次量約100-150g，伴頭昏、乏力、心悸。於我院查“Hb 53 g/L，無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。2天前，患者無明顯誘因再次出現解黑大便1次，呈糊狀，量約100g，無黏液膿血，伴乏力、頭昏，於**醫院輸液治療後無明顯好轉（具體不詳），遂於我院就診，擬“下消化道出血”收入住院。病程中精神、睡眠欠佳，飲食尚可，大便如下述，小便正常。體重無明顯減輕。", "entities": [{"label_type": "藥物", "overlap": 0, "start_pos": 12, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 106, "end_pos": 108}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 121, "end_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 144, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 241}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 248, "end_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 263, "end_pos": 269}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 283, "end_pos": 285}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 293, "end_pos": 297}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 298, "end_pos": 304}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 306, "end_pos": 318}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 397, "end_pos": 398}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 437}]}
{"originalText": "入院前1年患者無明顯誘因出現腹部不適，中下腹脹痛、臍周脹氣明顯，偶有陣發性加重，多自行緩解，伴早飽，但無明顯進食量上降，伴每日解黃色軟便1次/日，無反酸、噯氣、燒心，無噁心、嘔吐、腹瀉，無嘔血、黑便、消瘦，在我科住院行胃鏡提示“慢性非萎縮性胃炎，HP（+）”，結腸鏡提示“結腸直腸多發性息肉”，並行“腸鏡上結腸直腸多發性息肉氬氣刀治療術”，腹部增強CT提示“1.胰腺尾部豐滿，強化略微減低，腸區及腹膜數個小淋巴結顯影，密切隨訪；2.肝左葉多發小囊腫；3.兩腎多發囊腫；4.兩肺底少許炎症，結合臨床；5.腰椎骨質增生”。住院期間給予抑酸、改善胃腸道動力等治療後症狀緩解出院。入院前2周患者再次出現腹部不適，主要為劍突上緊縮感，每次持續數小時可自行緩解，進餐後可減輕，改變體位及按壓症狀無加重及減輕，伴頭昏、乏力。入院前半天患者出現上腹脹痛，無腹瀉、黑便、肛門停止排氣排便，無反酸、噯氣、燒心，無厭油、嘔吐，無潮熱、盜汗，無納差、粘液膿血便、進行性消瘦，門診以“腹脹原因待查”收入我科。患者此次患病以來，精神狀態欠佳，食慾正常，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 114, "end_pos": 122}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 123, "end_pos": 125}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 136, "end_pos": 145}, {"label_type": "手術", "overlap": 0, "start_pos": 150, "end_pos": 168}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 170, "end_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 195, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 251, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 297, "end_pos": 299}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 349, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 364, "end_pos": 366}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 370, "end_pos": 371}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 376, "end_pos": 378}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 429, "end_pos": 435}]}
{"originalText": "入院8+年前無明顯誘因患者感活動後乏力、氣促，不伴頭昏、頭痛、胸悶、心悸、胸痛、暈厥、黑曚、呃逆、反酸、噯氣、燒心、噁心、嘔吐、腹痛、腹脹、腹瀉、黑便。患者於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中如下症狀反覆發生，多次給予輸血治療後病情好轉。2013年4月*****檢查：間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）分鐘遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床；新生兒疾病篩查報告單：新生兒G6PD活性試驗1.56（正常）。肝功能提示異常。診斷“G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”明確。經輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促，反覆經輸注洗滌紅細胞後緩解。7天前患者再次出現乏力、氣促、精神差，無腹痛、腹瀉、血便。為求進一步治療今日入我院門診，門診以“G-6-PD酶缺乏症”收入我科。病程中精神較差，飲食尚可，大便小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 25, "end_pos": 26}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 34, "end_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 37, "end_pos": 38}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 65}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 70, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 89, "end_pos": 94}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 150, "end_pos": 161}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 284, "end_pos": 295}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 315, "end_pos": 325}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 326, "end_pos": 332}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 333, "end_pos": 338}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 404, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 407, "end_pos": 408}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 432, "end_pos": 442}]}
{"originalText": "入院1+年前患者出現反覆解黑色大便，伴頭昏、乏力、面板黏膜蒼白，無反酸、噯氣、燒心，無嘔血、腹痛、腹脹、腹瀉，無噁心、嘔吐、暈厥，無口乾、顏面肢體水腫、腹圍增大。於我院診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。期間反覆因解黑便於我院多次住院，我院無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，下消化道出血原因不能明確，建議行小腸鏡、腹部血管DSA檢查，患者拒絕，給予止血、糾正貧血、抑酸等對症處理後症狀好轉出院，未再正規檢查及治療。隨後在**醫院就診，行胃鏡及病理活檢提示胃早癌，未行手術治療出院。又在**********就診，仍提示胃早癌，建議患者行胃切除術，但患者拒絕。院外口服“中藥”對症處理。2天前患者出現解黑色稀便，伴頭昏、四肢乏力。在我院門診輸液（具體不詳）無好轉，現為進一步治療，門診以“胃癌，失血性貧血”收入我科。病程中精神差，飲食可，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 19, "end_pos": 20}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 180, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 210, "end_pos": 214}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 215, "end_pos": 221}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 223, "end_pos": 235}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 243, "end_pos": 250}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 313, "end_pos": 316}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "手術", "overlap": 0, "start_pos": 353, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 391, "end_pos": 392}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 394, "end_pos": 396}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 430}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 431, "end_pos": 436}]}
{"originalText": "入院前4月患者無明顯誘因出現活動後氣促，偶有心悸，無明顯胸悶、心前區壓榨感，無噁心、嘔吐，無發熱、畏寒，無咳嗽、咳痰，無黑朦、暈厥等不適。未引起重視。2天前下述症狀加重，伴納差、尿量減少，有夜間陣發性呼吸困難等，均未就醫。入院前半天患者氣促、喘累明顯，伴心悸，不能平臥，尿量較少，無發熱、畏寒，無咳嗽、咳痰，無噁心、嘔吐等不適。家屬送其入我院急診科，查體溫37.8℃，氧飽和度78%，血壓169/69mmHg。血氣分析:PH 7.39，PaO2 46mmHg，PaCO2 28mmHg，HCO3- 19.2mmol/l。血常規：WBC 30.1*10^9/L，HGB 97g/l，NEUT% 9.54%，LYMPH 87.31%。電解質、腎功、心肌酶譜、肌鈣蛋白未見異常。心電圖：房顫伴快速心室率。給予呋塞米20mg靜推利尿，生理鹽水20ml+西地蘭0.2mg靜推，生理鹽水250ml+硝酸甘油10mg靜滴後患者自覺氣促症狀好轉，解小便200餘ml。為進一步診治收治我科。此次起病以來患者精神、飲食、睡眠差，大小便如下述，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 128}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 218, "end_pos": 222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 230, "end_pos": 235}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 243, "end_pos": 248}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 264, "end_pos": 267}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 280, "end_pos": 283}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 290, "end_pos": 295}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 302, "end_pos": 307}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 336, "end_pos": 339}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 348}, {"label_type": "藥物", "overlap": 0, "start_pos": 351, "end_pos": 354}, {"label_type": "藥物", "overlap": 0, "start_pos": 363, "end_pos": 367}, {"label_type": "藥物", "overlap": 0, "start_pos": 372, "end_pos": 375}, {"label_type": "藥物", "overlap": 0, "start_pos": 383, "end_pos": 387}, {"label_type": "藥物", "overlap": 0, "start_pos": 393, "end_pos": 397}]}
{"originalText": "入院前4小時患者在刷牙時突然出現暈厥1次，伴意識障礙，自述數分鐘後自行清醒，因無家屬在旁，具體情況不詳。但患者否認四肢抽搐、口吐白沫、大小便失禁、偏癱等。無大汗淋漓、心悸、氣促、頭昏、發熱。自行口服1粒“升血藥”（具體不全）後未再處理。病程中逐漸出現下腹部陣發性隱痛不適，無肩背部放射痛，疼痛持續時間不定。入院前2小時出現解黑色稍成型大便1次，量約500g，伴全身大汗、心悸，無噁心、嘔血、反酸、燒心。遂來我院急診急診，急診查“血型：ABO血型 \\\"A\\\"型、RhD血型 陽性，血常規：白細胞數 10.5×10^9/L ↑、紅細胞數 4.18×10^12/L ↓、血紅蛋白濃度 126 g/L ↓、血小板數 88×10^9/L ↓、中性粒細胞百分比 84.61 % ↑、紅細胞壓積 39.3 % ↓，腎功：尿素 15.14 mmol/L ↑，電解質1：鉀 4.47 mmol/l。凝血試驗正常。自描心電圖正常。”考慮“下消化道出血”，給予抑酸止血後急診以“下消化道出血”收入我科。病程中精神差，未進食，大便如下述，小便正常，體重無改變。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 125, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 186}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 217, "end_pos": 222}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 230, "end_pos": 235}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 243, "end_pos": 246}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 262, "end_pos": 265}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 282, "end_pos": 288}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 299, "end_pos": 302}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 316, "end_pos": 324}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 335, "end_pos": 340}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 353, "end_pos": 355}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 376, "end_pos": 377}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 399, "end_pos": 402}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 409, "end_pos": 415}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 428, "end_pos": 434}]}
{"originalText": "7+月前患者無明顯誘因出現下腹部隱痛，伴反酸，納差，與*******醫院行胃鏡：胃竇低分化腺癌；院外自服中藥,為進一步治療。病程中進食量少，腹脹不適，自訴解稀糊大便，伴粘液，未予重視。20天前患者無明顯誘因出現下腹部伴臍周疼痛，陣發性加重，進食後明顯，伴後背放射痛，稍進食後乾嘔，飲食量急劇上降，幾乎未進食，感肛門墜脹，有便意，未解便，與我院就診，2017-12-29日複查胃鏡，胃竇: 查見環周隆起、僵硬，觸之易出血，表面散在潰瘍病灶，取活檢4塊。活檢胃竇腺癌。腹部CT增強：1、胃竇壁侷限性增厚，增強掃描明顯強化；中上腹部部分小腸管壁明顯增厚、水腫；腹腔及盆腔少量積液；腹膜後多個腫大淋巴。入院後給予禁食，抑酸，抗感染，止痛治療，患者腹痛明顯好轉，住院5天后自動出院。院外間斷嘔吐胃內容物，無嘔血。4天前患者持續臍周疼痛，陣發性加重，進食後明顯，飲食量上降原來2/3，少量流質，伴腰背脹痛，有肛門排便，精神差，夜間疼痛明顯，故以“胃癌”收入我科。病程以來患者精神、食慾欠佳，1日前解黃色成形大便，小便正常，近半月體重體力上降2斤。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 40, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 70, "end_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 157}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 192}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 227, "end_pos": 231}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 232, "end_pos": 238}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 263}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 265, "end_pos": 269}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 279}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 280, "end_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 290}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 342, "end_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 358, "end_pos": 360}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 394}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 398, "end_pos": 400}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 417, "end_pos": 419}]}
{"originalText": "入院前7年無明顯誘因患者感活動後乏力、氣促，偶有頭昏，偶有胸悶、心悸，偶有反酸、噯氣，無頭痛、胸痛、暈厥、黑曚、燒心、噁心、嘔吐、腹痛、腹脹、腹瀉、黑便。於*****醫院診斷“溶血性貧血”，給予輸血等處理後病情緩解。病程中下述症狀反覆發生，多次給予輸血治療後病程好轉。2013年4月*****胸片檢查：兩肺紋理增多，心影輕度增大。心臟彩超：右房、右室稍增大，EF正常。間接Coomb’s試驗（+）P，陽性對照（+++），P。骨髓象：增生性骨髓象，紅系增生旺盛。2014-4-24（******醫院）遺傳學檢驗報告單：未檢測到送檢樣本中G6PD基因G1388A，G1376T，A95G三個常見突變位點，結合臨床確診“G-6-PD酶缺乏症，貧血性心臟病，肝功能不全”。輸洗滌紅細胞後病情好轉。出院後患者反覆出現乏力、氣促不適，心悸、胸悶不適，在我院多次輸洗滌紅細胞懸液後好轉。近1周患者再次出現下述症狀，為求進一步治療，門診以“G-6-PD酶缺乏症，溶血性貧血”收入我科。患者患病以來，精神狀態欠佳，大小便正常，體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 44, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 146, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 165, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 175}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 179, "end_pos": 181}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 184, "end_pos": 195}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 307, "end_pos": 317}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 318, "end_pos": 324}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 325, "end_pos": 330}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 361, "end_pos": 362}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 364, "end_pos": 365}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 412, "end_pos": 422}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 423, "end_pos": 428}]}
{"originalText": "患者入院前2+年多於活動後感心累，心悸，自覺“心跳”明顯，休息後可減輕，並胸悶，偶有心前區隱痛，自覺胸骨後壓榨感，含服“速效救心丸”後症狀可減輕，不伴反酸、噯氣、噁心嘔吐等不適，患者未正規治療。近半年來患者逐漸出現上肢浮腫，於*****醫院就診，具體治療不詳，考慮“冠心病”，平時服用藥物情況不詳。入院前1周患者自覺心累、心悸症狀加重，再次就診於該院，查血常規 RBC 3.42×1012/L 凝血試驗 PT 15.8s INR 1.31 肝功 AST 11.5U/L，心肌酶譜、血糖、血脂、甲功5相正常；心臟彩超提示右心房、左心房增大，右室舒張順應性降低，二尖瓣、三尖瓣及主動脈瓣、肺動脈返流，EF 53%；給予利尿、營養心肌、控制心室率等治療（據患者提供出院記錄），該院診斷“冠心病、心臟擴大、房顫、慢性心功能不全、心功能 2-3級，高血壓2級很高危、腔隙性腦梗死、腦動脈供血不足、慢性胃炎”。患者自覺症狀有所緩解，但仍有心悸不適，今日家屬要求轉入我院繼續治療。病程中患者精神、飲食一般，大小便正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 37, "end_pos": 38}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"label_type": "藥物", "overlap": 0, "start_pos": 60, "end_pos": 65}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 109}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 133, "end_pos": 136}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 181, "end_pos": 184}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 202, "end_pos": 204}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 211, "end_pos": 214}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 223, "end_pos": 226}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 253, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 262}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 266}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 269, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 279, "end_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 283, "end_pos": 286}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 292, "end_pos": 295}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 298, "end_pos": 300}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 340, "end_pos": 343}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 344, "end_pos": 348}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 349, "end_pos": 351}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 352, "end_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 360, "end_pos": 368}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 369, "end_pos": 377}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 378, "end_pos": 384}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 392}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 393, "end_pos": 397}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 414}]}
{"originalText": "2天前無明顯誘因患者感中下腹隱痛，呈持續性，伴腹脹，陣發性加重。有肛門排氣排便。不伴發熱、畏寒、寒戰、反酸、燒心、噯氣、呃逆、頭昏、頭痛、乏力、胸悶、胸痛、心悸、氣促、腹瀉、黑便。腹痛與進食、活動、體位無明顯關係，無肩背部放射痛。5小時前腹痛加重，呈劇痛，立即入我院急診，查血常規：白細胞數 11.6×10^9/L、中性粒細胞百分比 77.64 %、淋巴細胞百分比 18.32 %、嗜酸性粒細胞百分比 0.24 %、中性粒細胞絕對值 9.02×10^9/L，腎功：尿素 2.32 mmol/L、尿酸 522.7 μmol/l，血澱粉酶 58.6 U/L，電解質1：鉀 2.26 mmol/l、鈉 127.6 mmol/、氯 84.1 mmol/l。腹部平片：上腹部腸曲積氣、擴張，提示腸梗阻？結合臨床或必要時進一步CT檢查；腰椎骨質增生；考慮兩上肺炎症，結合臨床。彩超：中度脂肪肝；膽囊輕度增大 請結合臨床；左腎囊腫；右腎切除術後。急診以“腹痛待查”收入我科。患者此次患病以來，精神狀態欠佳，大小便正常。體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 24}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 141, "end_pos": 144}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 175, "end_pos": 182}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 191, "end_pos": 200}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 208, "end_pos": 216}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 232, "end_pos": 234}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 247, "end_pos": 249}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 263, "end_pos": 267}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 282, "end_pos": 283}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 296, "end_pos": 297}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 310, "end_pos": 311}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 324, "end_pos": 328}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 329, "end_pos": 332}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 342, "end_pos": 346}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 357, "end_pos": 359}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 362, "end_pos": 368}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 371, "end_pos": 376}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 382, "end_pos": 384}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 385, "end_pos": 390}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 391, "end_pos": 393}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 404, "end_pos": 408}, {"label_type": "手術", "overlap": 0, "start_pos": 409, "end_pos": 414}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 420, "end_pos": 424}]}
{"originalText": "入院前13年患者檢查發現血糖升高，血糖具體值不詳，有口乾、多飲、多尿等症狀，伴四肢麻木，並有感覺異常，自覺肢體冰涼，伴視物模糊，於外院診斷為“2型糖尿病 糖尿病周圍神經病變 糖尿病眼病”，後長期服用“格列美脲、伏格列波糖、羅格列酮”等降血糖，血糖控制情況不詳。病程中患者無顏面四肢浮腫，無面板瘙癢，無肢體乏力，無噁心嘔吐，無腹脹腹痛，無便祕腹瀉交替，無心累氣促等不適，既往長期在***第三人民醫院住院。8月前患者因活動後心累心悸，偶有乾咳，感肢體麻木冰涼較明顯，伴有腰部及上肢疼痛，自覺健忘症狀加重，於我院內一科住院，查腎功：尿素 16.00 mmol/L、肌酐 141.7 μmol/l，診斷為“糖尿病腎病”，治療後好轉出院。1月前患者出現活動後心累，以下坡明顯，無兩上肢水腫，無胸悶、胸痛，無黑曚、暈厥，無夜間不能平臥，小便量正常。今為進一步診治，以“1、2型糖尿病 糖尿病腎病 2、高血壓 高血壓性心臟病”收入我科住院治療。患者此次發病以來精神食慾可，長期睡眠差，經常服用“安眠藥”，大小便正常，體重無明顯上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 77, "end_pos": 86}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 87, "end_pos": 92}, {"label_type": "藥物", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "藥物", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "藥物", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 136, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 163}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 177}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 212, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 238}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 263, "end_pos": 265}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 279, "end_pos": 281}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 299, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 324, "end_pos": 325}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 334, "end_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 342}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 345}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 380, "end_pos": 385}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 386, "end_pos": 391}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 394, "end_pos": 397}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 398, "end_pos": 405}]}
{"originalText": "1+年前患者無明顯誘因解黑色成形大便，量約250g/次，伴頭昏、乏力、面板黏膜蒼白，無嘔血、腹痛、腹脹、腹瀉，無反酸、噯氣、燒心，無口乾、顏面肢體水腫、腹圍增大。於我院查“Hb32g/L”，診斷為“1、消化道出血原因待查 2、重度貧血3、肝硬化4、慢性丙型肝炎”，拒絕行胃鏡檢查，給予止血、糾正貧血、抑酸等對症治療，未解黑便後自動出院。病程中多次出現黑便即來我科住院治療，曾於2015-06-17行“無痛胃鏡示胃底靜脈曲張（1條），F1，紅色徵陰性；胃體黏膜隆起，不除外靜脈曲張；十二指腸球炎”，考慮下消化道出血原因不能明確，給予“止血、糾正貧血、抑酸”等對症處理後症狀好轉出院，未再正規檢查及治療。入院半天前，患者再次解黑大便1次，黑色成形大便，量約50g，無黏液膿血，無噁心、嘔吐、嘔血，無暈厥、黑朦，無出冷汗、心悸表現。於我院門診查“大便常規：黑色 軟便，隱血試驗 陽性（+）。”為進一步就診，遂於我院就診，擬“消化道出血”收入住院。病程中精神、睡眠欠佳，飲食尚可，大便如下述，小便正常。體重無明顯減輕。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 86, "end_pos": 88}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 101, "end_pos": 110}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 113, "end_pos": 117}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 119, "end_pos": 122}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 124, "end_pos": 130}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 205, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 227}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 240, "end_pos": 246}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 250, "end_pos": 262}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 271, "end_pos": 273}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 358, "end_pos": 359}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 370, "end_pos": 374}, {"label_type": "實驗室檢驗", "overlap": 0, "start_pos": 381, "end_pos": 385}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 409, "end_pos": 414}]}
{"originalText": "患者入院前2年無明顯誘因檢查時發現\\\"肺部結節\\\"，當時患者無明顯咳嗽、胸痛等不適，建議患者定期隨訪或進一步檢查，患者未遵醫囑。入院前1月患者感咳嗽，多以乾咳為主，偶可咳出少許白色泡沫痰，並痰中帶血，活動後感氣喘，無畏寒發熱，無胸痛，無潮熱盜汗等不適，於我院複查胸部CT發現肺部結節與2015年對比明顯增大，考慮“惡性腫瘤”，於8天前患者於*****行PET/CT，診斷“左肺上葉近肺門處及左肺上葉後基底段佔位性病變，代謝活性增高，考慮惡性腫瘤可能”，檢查當晚患者突發胸痛，以劍突上劇烈疼痛，並胸悶、大汗淋漓，於*****急診就診，考慮“急性上壁、後壁、左室心肌梗死”，急診行發現左冠近中段完全閉塞，植入支架1枚，術後患者胸痛好轉，繼續冠心病二級預防強化治療，此次住院請該院呼吸內科會診，考慮“有創檢查”風險較高，未建議進一步檢查及特殊治療，入院前1天患者自該院心內科出院，但患者仍覺咳嗽，咯痰，痰中無出血，今日到我院就診，為進一步治療收入我科住院。。病程中患者精神、飲食一般，大小便正常，體重無明顯上降。", "entities": [{"label_type": "疾病和診斷", "overlap": 0, "start_pos": 19, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 114, "end_pos": 115}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 131, "end_pos": 135}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 137, "end_pos": 141}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 176, "end_pos": 179}, {"label_type": "影像檢查", "overlap": 0, "start_pos": 180, "end_pos": 182}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 186, "end_pos": 224}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 248}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 269, "end_pos": 283}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 295}, {"label_type": "手術", "overlap": 0, "start_pos": 300, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 312}, {"label_type": "疾病和診斷", "overlap": 0, "start_pos": 318, "end_pos": 321}]}
